0001585364-16-000426.txt : 20161110 0001585364-16-000426.hdr.sgml : 20161110 20161110172448 ACCESSION NUMBER: 0001585364-16-000426 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 90 CONFORMED PERIOD OF REPORT: 20161001 FILED AS OF DATE: 20161110 DATE AS OF CHANGE: 20161110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PERRIGO Co plc CENTRAL INDEX KEY: 0001585364 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 0627 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36353 FILM NUMBER: 161989231 BUSINESS ADDRESS: STREET 1: TREASURY BUILDING STREET 2: LOWER GRAND CANAL STREET CITY: DUBLIN STATE: L2 ZIP: L2 2 BUSINESS PHONE: 269-673-8451 MAIL ADDRESS: STREET 1: 515 EASTERN AVENUE CITY: ALLEGAN STATE: MI ZIP: 49010 FORMER COMPANY: FORMER CONFORMED NAME: PERRIGO Co Ltd DATE OF NAME CHANGE: 20130828 10-Q 1 cy16q310q.htm 10-Q Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_______________________________________________
 FORM 10-Q
_______________________________________________
[X]
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended: October 1, 2016
OR
[  ]
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to             
Commission file number 001-36353
_______________________________________________
Perrigo Company plc
(Exact name of registrant as specified in its charter)
_______________________________________________
Ireland
 
Not Applicable
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
 
Treasury Building, Lower Grand Canal Street, Dublin 2, Ireland
 
-
(Address of principal executive offices)
 
(Zip Code)
+353 1 7094000
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
________________________________________ 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such report), and (2) has been subject to such filing requirements for the past 90 days.    YES [X]    NO  [ ]
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    YES  [X]   NO [ ]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer”, “accelerated filer”, and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer  [X]
  
Accelerated filer  [  ]
Non-accelerated filer  [  ]
  
Smaller reporting company  [  ]
(Do not check if a smaller reporting company)
  
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   [ ]  YES  [X] NO
As of November 4, 2016, there were 143,374,427 ordinary shares outstanding.


PERRIGO COMPANY PLC
FORM 10-Q
INDEX
 
PAGE
NUMBER
 
 
PART I. FINANCIAL INFORMATION
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
 
 
 
2
 
 
 
3
 
 
 
4
 
 
 
5
 
 
 
6
 
 
 
7
 
 
 
8
 
 
 
9
 
 
 
10
 
 
 
11
 
 
 
12
 
 
 
13
 
 
 
14
 
 
 
15
 
 
 
16
 
 
 
17
 
 
 
 
 
 
 
 
 
 
 
 
PART II. OTHER INFORMATION
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


Cautionary Note Regarding Forward-Looking Statements
    
Certain statements in this report are “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our, or our industry's, actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by any forward-looking statements. In particular, statements about our expectations, beliefs, plans, objectives, assumptions, future events or future performance contained in this report, including certain statements contained in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” are forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “potential” or the negative of those terms or other comparable terminology.

Please see Item 1A of our Form 10-KT for the transition period from June 28, 2015 to December 31, 2015 and Part II, Item 1A of this Form 10-Q for a discussion of certain important risk factors that relate to forward-looking statements contained in this report. We have based these forward-looking statements on our current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control, including the timing, amount and cost of share repurchases, future impairment charges, our ability to achieve our guidance, and the ability to execute and achieve the desired benefits of announced initiatives. These and other important factors, including those discussed in our Form 10-KT for the transition period from June 28, 2015 to December 31, 2015, in this Form 10-Q under "Risk Factors" and in any subsequent filings with the Securities and Exchange Commission, may cause actual results, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements in this report are made only as of the date hereof, and unless otherwise required by applicable securities laws, we disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
    
TRADEMARKS, TRADENAMES AND SERVICE MARKS

This report contains trademarks, trade names and service marks that are the property of Perrigo Company plc, as well as, for informational purposes, trademarks, trade names, and service marks that are the property of other organizations. Solely for convenience, certain trademarks, trade names, and service marks referred to in this report appear without the ®, ™ and SM symbols, but those references are not intended to indicate that we or the applicable owner, as the case may be, will not assert, to the fullest extent under applicable law, our or their rights to such trademarks, trade names, and service marks.


1
Perrigo Company plc - Item 1

PART I.     FINANCIAL INFORMATION

ITEM 1.        FINANCIAL STATEMENTS (UNAUDITED)

PERRIGO COMPANY PLC
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in millions, except per share amounts)
(unaudited)
 
 
Three Months Ended
 
Nine Months Ended
 
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Net sales
$
1,354.9

 
$
1,344.7

 
$
4,219.1

 
$
3,925.4

Cost of sales
848.6

 
795.9

 
2,622.7

 
2,369.7

Gross profit
506.3

 
548.8

 
1,596.4

 
1,555.7

 
 
 
 
 
 
 
 
Operating expenses
 
 
 
 
 
 
 
Distribution
21.6

 
24.9

 
65.9

 
63.3

Research and development
50.2

 
41.6

 
142.5

 
139.7

Selling
154.6

 
167.9

 
506.9

 
391.6

Administration
108.6

 
123.6

 
316.8

 
343.3

Impairment charges
1,679.9

 
—

 
2,127.1

 
—

Restructuring
6.6

 
2.2

 
17.9

 
3.1

Total operating expenses
2,021.5

 
360.2

 
3,177.1

 
941.0

 
 
 
 
 
 
 
 
Operating income (loss)
(1,515.2
)
 
188.6

 
(1,580.7
)
 
614.7

 
 
 
 
 
 
 
 
Interest expense, net
54.6

 
43.4

 
163.2

 
132.7

Other expense, net
1.0

 
13.0

 
34.1

 
294.2

Loss on extinguishment of debt
0.7

 
—

 
1.1

 
0.9

Income (loss) before income taxes
(1,571.5
)
 
132.2

 
(1,779.1
)
 
186.9

Income tax expense (benefit)
(316.3
)
 
19.6

 
(383.7
)
 
112.7

Net income (loss)
$
(1,255.2
)
 
$
112.6

 
$
(1,395.4
)
 
$
74.2

 
 
 
 
 
 
 
 
Income (loss) per share
 
 
 
 
 
 
 
Basic
$
(8.76
)
 
$
0.77

 
$
(9.74
)
 
$
0.51

Diluted
$
(8.76
)
 
$
0.77

 
$
(9.74
)
 
$
0.51

 
 
 
 
 
 
 
 
Weighted-average shares outstanding
 
 
 
 
 
 
 
Basic
143.3

 
146.3

 
143.2

 
144.4

Diluted
143.3

 
146.9

 
143.2

 
145.0

 
 
 
 
 
 
 
 
Dividends declared per share
$
0.145

 
$
0.125

 
$
0.435

 
$
0.375

  
See accompanying Notes to the Condensed Consolidated Financial Statements

2
Perrigo Company plc - Item 1

PERRIGO COMPANY PLC
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(in millions)
(unaudited)
 
Three Months Ended
 
Nine Months Ended
 
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Net income (loss)
$
(1,255.2
)
 
$
112.6

 
$
(1,395.4
)
 
$
74.2

Other comprehensive income (loss):
 
 
 
 
 
 
 
Foreign currency translation adjustments
27.0

 
(39.8
)
 
71.8

 
50.9

Change in fair value of derivative financial instruments, net of tax
3.6

 
0.1

 
(3.5
)
 
5.6

Change in fair value of investment securities, net of tax
9.8

 
2.5

 
18.4

 
(2.4
)
Change in post-retirement and pension liability adjustments, net of tax
(0.2
)
 
—

 
0.3

 
3.7

Other comprehensive income (loss), net of tax
40.2

 
(37.2
)
 
87.0

 
57.8

Comprehensive income (loss)
$
(1,215.0
)
 
$
75.4

 
$
(1,308.4
)
 
$
132.0

See accompanying Notes to the Condensed Consolidated Financial Statements


3
Perrigo Company plc - Item 1

PERRIGO COMPANY PLC
CONDENSED CONSOLIDATED BALANCE SHEETS
(in millions)
 
(Unaudited)
 
 
 
October 1,
2016
 
December 31,
2015
Assets
 
 
 
Cash and cash equivalents
$
362.7

 
$
417.8

Accounts receivable, net of allowance for doubtful accounts of $4.4 million and $3.0 million, respectively
1,129.2

 
1,193.1

Inventories
884.6

 
844.4

Prepaid expenses and other current assets
250.6

 
289.1

Total current assets
2,627.1

 
2,744.4

Property and equipment, net
881.3

 
886.2

Goodwill and other indefinite-lived intangible assets
5,282.7

 
7,281.2

Other intangible assets, net
8,340.9

 
8,190.5

Non-current deferred income taxes
129.3

 
54.6

Other non-current assets
206.3

 
237.0

Total non-current assets
14,840.5

 
16,649.5

Total assets
$
17,467.6

 
$
19,393.9

Liabilities and Shareholders’ Equity
 
 
 
Liabilities
 
 
 
Accounts payable
$
507.9

 
$
554.9

Payroll and related taxes
106.8

 
125.3

Accrued customer programs
325.5

 
398.0

Accrued liabilities
258.7

 
308.4

Accrued income taxes
76.2

 
85.2

Current indebtedness
265.0

 
1,018.3

Total current liabilities
1,540.1

 
2,490.1

Long-term debt, less current portion
5,638.0

 
4,971.6

Non-current deferred income taxes
1,169.3

 
1,563.7

Other non-current liabilities
448.9

 
332.4

Total non-current liabilities
7,256.2

 
6,867.7

Total liabilities
8,796.3

 
9,357.8

Commitments and contingencies - Note 14
 
 
 
Shareholders’ equity
 
 
 
Preferred shares, $0.0001 par value, 10 million shares authorized
—

 
—

Ordinary shares, €0.001 par value, 10 billion shares authorized
8,151.4

 
8,144.6

Accumulated other comprehensive income
71.5

 
(15.5
)
Retained earnings
449.0

 
1,907.6

Total controlling interest
8,671.9

 
10,036.7

Noncontrolling interest
(0.6
)
 
(0.6
)
Total shareholders’ equity
8,671.3

 
10,036.1

Total liabilities and shareholders' equity
$
17,467.6

 
$
19,393.9

 
 
 
 
Supplemental Disclosures of Balance Sheet Information
 
 
 
Preferred shares, issued and outstanding
—

 
—

Ordinary shares, issued and outstanding
143.4

 
143.1


See accompanying Notes to the Condensed Consolidated Financial Statements

4
Perrigo Company plc - Item 1

PERRIGO COMPANY PLC
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
(unaudited)
 
Nine Months Ended
 
October 1,
2016
 
September 26,
2015
Cash Flows From (For) Operating Activities
 
 
 
Net income (loss)
$
(1,395.4
)
 
$
74.2

Adjustments to derive cash flows
 
 
 
Depreciation and amortization
556.3

 
470.4

Loss on acquisition-related foreign currency derivatives
—

 
300.0

Share-based compensation
16.1

 
29.7

Impairment charges
2,127.1

 
—

Loss on extinguishment of debt
1.1

 
0.9

Non-cash restructuring charges
17.9

 
3.1

Deferred income taxes
(507.2
)
 
7.7

Other non-cash adjustments
34.5

 
15.3

Subtotal
850.4

 
901.3

Increase (decrease) in cash due to:
 
 
 
Accounts receivable
113.6

 
(30.9
)
Inventories
(29.9
)
 
(28.6
)
Accounts payable
(51.8
)
 
(6.5
)
Payroll and related taxes
(40.0
)
 
(26.6
)
Accrued customer programs
(74.7
)
 
17.7

Accrued liabilities
(42.8
)
 
46.7

Accrued income taxes
9.7

 
0.3

Other
(31.0
)
 
(6.7
)
Subtotal
(146.9
)
 
(34.6
)
Net cash from (for) operating activities
703.5

 
866.7

Cash Flows From (For) Investing Activities
 
 
 
Acquisitions of businesses, net of cash acquired
(432.1
)
 
(2,499.9
)
Asset acquisitions
(65.1
)
 
(4.0
)
Additions to property and equipment
(84.6
)
 
(127.6
)
Proceeds from sale of business
58.5

 
—

Settlement of acquisition-related foreign currency derivatives
—

 
(304.8
)
Other investing
(1.0
)
 
(2.7
)
Net cash from (for) investing activities
(524.3
)
 
(2,939.0
)
Cash Flows From (For) Financing Activities
 
 
 
Issuances of long-term debt
1,190.3

 
—

Payments on long-term debt
(545.8
)
 
(903.3
)
Borrowings (repayments) of revolving credit agreements and other financing, net
(803.6
)
 
28.6

Deferred financing fees
(2.8
)
 
(3.3
)
Premium on early debt retirement
(0.6
)
 
—

Issuance of ordinary shares
8.2

 
6.2

Cash dividends
(62.4
)
 
(54.2
)
Other financing
(17.4
)
 
(15.5
)
Net cash from (for) financing activities
(234.1
)
 
(941.5
)
Effect of exchange rate changes on cash
(0.2
)
 
(75.8
)
Net increase (decrease) in cash and cash equivalents
(55.1
)
 
(3,089.6
)
Cash and cash equivalents, beginning of period
417.8

 
3,596.1

Cash and cash equivalents, end of period
$
362.7

 
$
506.5

 
 
 
 
Supplemental Disclosures of Cash Flow Information
 
 
 
Cash paid/received during the year for:
 
 
 
Interest paid
$
124.1

 
$
92.5

Interest received
$
1.1

 
$
1.0

Income taxes paid
$
116.6

 
$
130.0

Income taxes refunded
$
6.0

 
$
3.1


See accompanying Notes to the Condensed Consolidated Financial Statements

5
Perrigo Company plc - Item 1
Note 1



NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

a.     General Information

The Company

Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013 and became the successor registrant of Perrigo Company, a Michigan corporation, on December 18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo," the "Company," "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries. We are a leading global over-the-counter ("OTC") consumer goods and specialty pharmaceutical company, offering patients and customers high quality products at affordable prices. From our beginning in 1887 as a packager of home remedies, we have grown to become the world's largest manufacturer of OTC healthcare products and supplier of infant formulas for the store brand market. We are also a leading provider of generic extended topical prescription products, and we receive royalties from sales of the multiple sclerosis drug Tysabri®. We provide “Quality Affordable Healthcare Products®” across a wide variety of product categories and geographies, primarily in North America, Europe, and Australia, as well as in other markets, including Israel, China, and Latin America.

Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the consolidated financial statements and footnotes included in our Transition Report on Form 10-KT for the transition period from June 28, 2015 to December 31, 2015. In the opinion of management, all adjustments (consisting of normal recurring accruals and other adjustments) considered necessary for a fair presentation have been included. The Condensed Consolidated Financial Statements include our accounts and the accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

Our fiscal year previously consisted of a 52- or 53-week year ending on or around June 30 of each year with each quarter ending on the Saturday closest to each calendar quarter-end. Beginning on January 1, 2016, we changed our fiscal year to begin on January 1 and end on December 31 of each year. We will continue to cut off our quarterly accounting periods on the Saturday closest to the end of the calendar quarter, with the fourth quarter ending on December 31 of each year.

During the three months ended April 2, 2016, we identified certain errors in our consolidated financial statements for the transition period of June 28, 2015 to December 31, 2015, related primarily to the accrual estimates associated with product returns and tax-related items in our Branded Consumer Healthcare ("BCH") segment. These errors were corrected during the three months ended April 2, 2016 by increasing the consolidated operating loss by $14.5 million, which when combined with tax-related items, increased the consolidated net loss by $13.7 million within the Condensed Consolidated Statements of Operations. We concluded that these errors were not material to the consolidated financial statements for the transition period of June 28, 2015 to December 31, 2015 and are not expected to be material to the consolidated financial statements for the year ending December 31, 2016.


6
Perrigo Company plc - Item 1
Note 1


b.     Recent Accounting Standard Pronouncements

Below are recent accounting standard updates that we are still assessing to determine the effect on our consolidated financial statements. We do not believe that any other recently issued accounting standards could have a material effect on our consolidated financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.
Recently Issued Accounting Standards Not Yet Adopted
Standard
 
Description
 
Effective Date
 
Effect on the Financial Statements or Other Significant Matters
Improvements to Employee Share-Based Payment Accounting

 
This guidance is intended to simplify several aspects of the accounting for share-based payment award transactions. It will require all income tax effects of awards to be recorded through the income statement when they vest or settle as opposed to certain amounts being recorded in additional paid-in capital. An entity will also have to elect whether to account for forfeitures as they occur or by estimating the number of awards expected to be forfeited and adjusting the estimate when it is likely to change (as currently required). The guidance will also increase the amount an employer can withhold to cover income taxes on awards. Early adoption is permitted.
 
January 1, 2017
 
We are currently evaluating the implications of adoption on our consolidated financial statements.
Revenue from Contracts with Customers
 
The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps: identify the contract(s) with a customer; identify the performance obligations in the contract; determine the transaction price; allocate the transaction price to the performance obligations in the contract; and recognize revenue when (or as) the entity satisfies a performance obligation. This guidance allows for two adoption methods, full retrospective approach or modified retrospective approach. Early adoption is not permitted.
 
January 1, 2018
 
We are currently evaluating the possible adoption methodologies and the implications of adoption on our consolidated financial statements.
Leases
 
This guidance was issued to increase transparency and comparability among organizations by requiring recognition of lease assets and lease liabilities on the balance sheet and disclosure of key information about leasing arrangements. For leases with a term of 12 months or less, lessees are permitted to make an election to not recognize right-of-use assets and lease liabilities. Upon adoption, lessees will apply the new standard as of the beginning of the earliest comparative period presented in the financial statements, however lessees will be able to exclude leases that expire as of the implementation date. Early adoption is permitted.


 
January 1, 2019
 
We are currently evaluating the implications of adoption on our consolidated financial statements and considering whether to early adopt the standard.


7
Perrigo Company plc - Item 1
Note 1


Recently Issued Accounting Standards Not Yet Adopted (continued)
Standard
 
Description
 
Effective Date
 
Effect on the Financial Statements or Other Significant Matters
Measurement of Credit Losses on Financial Instruments
 
This guidance changes the impairment model for most financial assets and certain other instruments, replacing the current "incurred loss" approach with an "expected loss" credit impairment model, which will apply to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities, and off-balance sheet credit exposures such as letters of credit. Early adoption is permitted.


 
January 1, 2020
 
We are currently evaluating the new standard for potential impacts on our receivables, debt, and other financial instruments and considering whether to early adopt the standard.

NOTE 2 – ACQUISITIONS AND DIVESTITURES

All of the below acquisitions, with the exception of the generic Benzaclin™ product purchase, have been accounted for under the acquisition method of accounting based on our analysis of the acquired inputs and processes, and the related assets acquired and liabilities assumed were recorded at fair value as of the acquisition date.

Fair value estimates are based on a complex series of judgments about future events and rely heavily on estimates and assumptions. The judgments used to determine the estimated fair value assigned to each class of assets acquired and liabilities assumed, as well as asset lives, can materially impact our results of operations.

The effects of all of the acquisitions described below are included in the Condensed Consolidated Financial Statements prospectively from the date of each acquisition. Unless otherwise indicated, acquisition costs incurred were immaterial and were recorded in Administration expense.

Current Year Acquisitions

Generic Benzaclin™ Product

On August 2, 2016, we purchased the remaining 60.9% product rights to a generic Benzaclin™ product ("Generic Benzaclin™"), which we had developed and marketed in collaboration with Barr Laboratories, Inc. ("Barr"), a subsidiary of Teva Pharmaceuticals, for $62.0 million in cash. In September 2007, we entered into an initial development, marketing and commercialization agreement with Barr, in which Barr contributed to the product's development costs and we developed and marketed the product in the U.S. and Israel. Under this agreement, we paid Barr a percentage of net income from the product's sales in these territories, adjusted for Barr's contributions to the product's development costs. By purchasing the remaining product right from Barr, we are now entitled to 100% of income from sales of the product. Operating results attributable to Generic Benzaclin™ are included within our Prescription Pharmaceuticals ("Rx") segment. The intangible asset acquired is a distribution and license agreement with a nine-year useful life.

Tretinoin Product Portfolio

On January 22, 2016, we acquired a portfolio of generic dosage forms and strengths of Retin-A® (tretinoin), a topical prescription acne treatment, from Matawan Pharmaceuticals, LLC, for $416.4 million in cash ("Tretinoin Products"), which further expanded our extended topicals portfolio. We were the authorized generic distributor of these products from 2005 to 2013. Operating results attributable to the acquisition are included within our Rx segment. The intangible assets acquired included generic product rights valued using the multi-period excess earnings method and assigned a 20-year useful life, and non-compete agreements valued using the lost income method and assigned a five-year useful life. The goodwill acquired is deductible for tax purposes.


8
Perrigo Company plc - Item 1
Note 2


Development-Stage Rx Products

In May 2015, we entered into an agreement with a clinical stage biotechnology company for two specialty pharmaceutical products in development ("Development-Stage Rx Products"). We paid $18.0 million for an option to acquire the two products, which was recorded in Research and Development expense. On March 1, 2016, to further invest in our specialty Rx portfolio, we exercised the option for both products, which requires us to make contingent payments if we obtain regulatory approval and achieve certain sales milestones. We will also be obligated to make certain royalty payments over periods ranging from seven to ten years from the launch of each product. 

We accounted for the option exercise as a business acquisition within our Rx segment, recording IPR&D and contingent consideration on the balance sheet. The IPR&D was valued using the multi-period excess earnings method and has an indefinite useful life until such time as the research is completed (at which time it will become a definite-lived intangible asset), or is determined to have no future use (at which time it would be impaired). The contingent consideration is an estimate of the future milestone payments and royalties based on probability-weighted outcomes, sensitivity analysis, and discount rates reflective of the risk involved. The amount of contingent consideration recognized was $24.9 million and was recorded in Other non-current liabilities.


9
Perrigo Company plc - Item 1
Note 2


Purchase Price Allocation of Current Year Acquisitions

The purchase accounting allocation for four small product acquisitions in our Consumer Healthcare ("CHC") and Rx segments (included in "All Other" in the table below) are preliminary and are based on the valuation information, estimates, and assumptions available at October 1, 2016. As we finalize the fair value estimate, additional purchase price adjustments may be recorded during the measurement period to contingent consideration and intangible assets.

The below table indicates the purchase price allocation for acquisitions completed in the current year (in millions):
 
Tretinoin Products
 
Development-Stage Rx Products
 
All Other(1)*
Purchase price paid
$
416.4

 
$
—

 
$
21.9

Contingent consideration
—

 
24.9

 
30.6

Total purchase consideration
$
416.4

 
$
24.9

 
$
52.5

 
 
 
 
 
 
Assets acquired:
 
 
 
 
 
Cash and cash equivalents
$
—

 
$
—

 
$
3.8

Accounts receivable
—

 
—

 
4.9

Inventories
1.4

 
—

 
7.1

Prepaid expenses and other current assets
—

 
—

 
0.1

Property and equipment
—

 
—

 
1.2

Goodwill
1.7

 
—

 
0.2

Definite-lived intangibles:
 
 
 
 
 
Distribution and license agreements, supply agreements
—

 
—

 
3.4

Developed product technology, formulations, and product rights
411.0

 
—

 
23.3

Customer relationships and distribution networks
—

 
—

 
8.2

Non-compete agreements
2.3

 
—

 
—

Indefinite-lived intangibles:
 
 
 
 
 
In-process research and development
—

 
24.9

 
7.0

Total intangible assets
$
413.3

 
$
24.9

 
$
41.9

Total assets
$
416.4

 
$
24.9

 
$
59.2

Liabilities assumed:
 
 
 
 
 
Accounts payable
$
—

 
$
—

 
$
2.8

Accrued liabilities
—

 
—

 
0.1

Long-term debt
—

 
—

 
3.3

Net deferred income tax liabilities
—

 
—

 
0.5

Total liabilities
$
—

 
$
—

 
$
6.7

Net assets acquired
$
416.4

 
$
24.9

 
$
52.5


*    Opening balance sheet is preliminary
(1)
Consists of four product acquisitions in the CHC and Rx segments


10
Perrigo Company plc - Item 1
Note 2


Prior Year Acquisitions

Entocort® 

On December 15, 2015, we completed our acquisition of Entocort® (budesonide) capsules, as well as the authorized generic capsules, for sale within the U.S., from AstraZeneca plc for $380.2 million in cash. Entocort® is a gastroenterology medicine for patients with mild to moderate Crohn's disease. The acquisition complemented our Rx portfolio. Operating results attributable to the acquisition are included within our Rx segment. The intangible assets acquired included branded and authorized generic product rights with useful lives of 10 and 15 years, respectively, which were valued using the multi-period excess earnings method.

Naturwohl Pharma GmbH

On September 15, 2015, we completed our acquisition of 100% of Naturwohl Pharma GmbH ("Naturwohl"), a Munich, Germany-based nutritional business known for its leading German dietary supplement brand, Yokebe®. The acquisition built on our BCH segment's OTC product portfolio and European commercial infrastructure. The assets were purchased through an all-cash transaction valued at €133.5 million ($150.4 million). Operating results attributable to Naturwohl are included in the BCH segment. The intangible assets acquired included a trademark with a 20-year useful life, customer relationships with a 15-year useful life, non-compete agreements with a three-year useful life, and a licensing agreement with a three-year useful life. We utilized the relief from royalty method for valuing the trademark, the multi-period excess earnings method for valuing the customer relationships, and the lost income method for valuing the non-compete agreements and the licensing agreement. The goodwill acquired is not deductible for tax purposes.

ScarAway® 
    
On August 28, 2015, we completed our acquisition of ScarAway®, a leading U.S. OTC scar management brand portfolio comprised of five products, from Enaltus, LLC, for $26.7 million in cash. This acquisition served as our entry into the niche branded OTC business in the U.S. Operating results attributable to ScarAway® are included in the CHC segment. The intangible assets acquired included a trademark with a 25-year useful life, non-compete agreements with a four-year useful life, developed product technology with an eight-year useful life, and customer relationships with a 15-year useful life. We utilized the relief from royalty method for valuing the trademark and developed product technology, the multi-period excess earnings method for valuing the customer relationships, and the lost income method for valuing the non-compete agreements. The goodwill acquired is deductible for tax purposes.

GlaxoSmithKline Consumer Healthcare Product Portfolio
    
On August 28, 2015, we completed our acquisition of a portfolio of well-established OTC brands from GlaxoSmithKline Consumer Healthcare (“GSK Products”). This acquisition further leveraged our European market share and expanded our product offerings. The assets were purchased through an all-cash transaction valued at €200.0 million ($223.6 million). Operating results attributable to the acquired GSK Products are included primarily in the BCH segment. The intangible assets acquired included trademarks with a 20-year useful life and customer relationships with a 15-year useful life. We utilized the relief from royalty method for valuing the trademarks and the multi-period excess earnings method for valuing the customer relationships. The goodwill acquired is deductible for tax purposes and recorded primarily in the BCH segment.

Gelcaps Exportadora de Mexico, S.A. de C.V.

On May 12, 2015, we completed our acquisition of 100% of Gelcaps Exportadora de Mexico, S.A. de C.V. ("Gelcaps"), the Mexican operations of Durham, North Carolina-based Patheon Inc., for $37.9 million in cash. The acquisition added softgel manufacturing technology to our supply chain capabilities and broadened our presence, product portfolio, and customer network in Mexico. Operating results attributable to Gelcaps are included in the CHC segment. The intangible assets acquired included a trademark with a 25-year useful life and customer relationships with a 20-year useful life. We utilized the relief from royalty method for valuing the trademark and the multi-period excess earnings method for valuing the customer relationships.


11
Perrigo Company plc - Item 1
Note 2


Based on valuation estimates utilizing the comparative sales method, a step-up in the value of inventory of $0.6 million was recorded in the opening balance sheet, which was charged to cost of goods sold during the three months ended June 27, 2015. In addition, property, plant and equipment was written up by $0.9 million to its estimated fair market value based on a valuation method that included both the cost and market approaches. This additional step-up in value is being depreciated over the estimated remaining useful lives of the assets. The goodwill recorded is not deductible for tax purposes.

Omega Pharma Invest N.V.

On March 30, 2015, we completed our acquisition of Omega Pharma Invest N.V. ("Omega"), a limited liability company incorporated under the laws of Belgium. Omega was a leading European OTC company and is providing us several key benefits, including advancing our growth strategy outside the U.S. by providing access across a larger global platform with critical mass in key European countries, establishing commercial infrastructure in the high barrier-to-entry European OTC marketplace, strengthening our product portfolio while enhancing scale and distribution, and expanding our international management capabilities.

We purchased 95.77% of the issued and outstanding share capital of Omega (685,348,257 shares) from Alychlo N.V. (“Alychlo”) and Holdco I BE N.V. (together with Alychlo, the “Sellers”), limited liability companies incorporated under the laws of Belgium, under the terms of the Share Purchase Agreement dated November 6, 2014 (the "Share Purchase Agreement"). Omega holds the remaining 30,243,983 shares as treasury shares.

The acquisition was a cash and stock transaction made up of the following consideration (in millions except per share data):
Perrigo ordinary shares issued
 
5.4

Perrigo per share price at transaction close on March 30, 2015
 
$
167.64

Total value of Perrigo ordinary shares issued
 
$
904.9

Cash consideration
 
2,078.3

Total consideration
 
$
2,983.2


The cash consideration shown in the above table was financed by a combination of debt and equity. We issued $1.6 billion of debt as described in Note 10, and issued 6.8 million ordinary shares, which raised $999.3 million, net of issuance costs.

The Sellers agreed to indemnify us for certain potential future losses. The Sellers’ indemnification and other obligations to us under the Share Purchase Agreement are secured by up to €120.9 million ($135.9 million as of October 1, 2016) in cash that has been escrowed or is committed to be escrowed and 1.08 million of our ordinary shares, which are both being held in escrow to secure such obligations. Under the terms of the Share Purchase Agreement, Alychlo and its affiliates are subject to a three-year non-compete in Europe, and the Sellers are subject to a two-year non-solicit, in each case subject to certain exceptions. The Share Purchase Agreement contains other customary representations, warranties, and covenants of the parties thereto. Our Board of Directors has authorized us to issue an arbitral claim against the sellers, which we plan to do.

The operating results attributable to Omega are included in the BCH segment. We incurred general transaction costs (legal, banking and other professional fees), financing fees, and debt extinguishment charges in connection with the Omega acquisition. The amounts recorded were not allocated to a reporting segment. The table below details the acquisition costs, as well as losses on hedging activities associated with the acquisition purchase price, and where they were recorded for the nine months ended September 26, 2015 (in millions):

12
Perrigo Company plc - Item 1
Note 2


 
 
Nine Months Ended
Line item
 
September 26, 2015
Administration
 
$
18.1

Interest expense, net
 
18.7

Other expense, net
 
258.2

Total acquisition-related costs
 
$
295.0


See Note 8 for further details on losses on the Omega-related hedging activities shown above in Other expense, net, and Note 10 for details on the loss on extinguishment of debt.

We acquired the following intangible assets: indefinite-lived brands, a definite-lived trade name with an eight-year useful life, definite-lived brands with a 22-year useful life, a distribution network with a 21-year useful life, and developed product technology with useful lives ranging from four to 13 years. We also recorded goodwill, which is not deductible for tax purposes and represents the value we assigned to the expected synergies described above, in our BCH segment. We utilized the multi-period excess earnings method to value the indefinite-lived brands, the definite-lived brands, and distribution network. We utilized the relief from royalty method to value the developed product technology and definite-lived trade name.

Based on valuation estimates utilizing the comparative sales method, a step-up in the value of inventory of $15.1 million was recorded in the opening balance sheet and was charged to cost of goods sold during the three months ended June 27, 2015. In addition, property, plant and equipment were written up $41.5 million to their estimated fair market value based on a valuation method that included both the cost and market approaches. This additional step-up in value is being depreciated over the estimated remaining useful lives of the assets. Additionally, the fair value of the debt assumed on the date of acquisition exceeded par value by $101.9 million, which was recorded as part of the carrying value of the underlying debt and will be amortized as a reduction of interest expense over the remaining terms of the respective debt instruments. For more information on the debt we assumed from Omega and our subsequent payments on the debt, see Note 10.


13
Perrigo Company plc - Item 1
Note 2


Purchase Price Allocation of Prior Year Acquisitions

The purchase accounting allocation for the Entocort® and GSK Products acquisitions were finalized during the three months ended April 2, 2016. Changes to the allocations were due to adjustments to the intangible asset valuation assumptions. The purchase accounting for all other prior year acquisitions was final as of December 31, 2015. The below table indicates the purchase price allocation for acquisitions completed during the year ended December 31, 2015 (in millions):
 
Entocort®
 
Naturwohl
 
ScarAway®
 
GSK Products
 
Gelcaps
 
Omega
 
All Other(1)
Purchase price paid
$
380.2

 
$
150.4

 
$
26.7

 
$
223.6

 
$
37.9

 
$
2,983.2

 
$
15.3

Contingent consideration
—

 
—

 
—

 
—

 
—

 
—

 
13.9

Total purchase consideration
$
380.2

 
$
150.4

 
$
26.7

 
$
223.6

 
$
37.9

 
$
2,983.2

 
$
29.2

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets acquired:
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
—

 
$
4.6

 
$
—

 
$
—

 
$
4.6

 
$
14.7

 
$
—

Accounts receivable
—

 
3.3

 
—

 
—

 
7.3

 
260.1

 
—

Inventories
0.2

 
1.5

 
1.0

 
—

 
7.2

 
202.5

 
—

Prepaid expenses and other current assets
—

 
—

 
—

 
—

 
2.1

 
39.2

 
—

Property and equipment
—

 
—

 
—

 
—

 
6.0

 
130.8

 
—

Goodwill
—

 
61.0

 
3.5

 
32.6

 
6.0

 
1,900.4

 
—

Definite-lived intangibles:
 
 
 
 
 
 
 
 
 
 
 
 
 
Distribution and license agreements, supply agreements
—

 
21.4

 
—

 
—

 
—

 
—

 
—

Developed product technology, formulations, and product rights
380.0

 
—

 
0.5

 
—

 
—

 
27.2

 
—

Customer relationships and distribution networks
—

 
25.9

 
9.8

 
61.5

 
6.6

 
1,056.3

 
—

Trademarks, trade names, and brands
—

 
64.2

 
11.4

 
129.5

 
—

 
287.5

 
—

Non-compete agreements
—

 
0.3

 
0.5

 
—

 
—

 
—

 
—

Indefinite-lived intangibles:
 
 
 
 
 
 
 
 
 
 
 
 
 
Trademarks, trade names, and brands
—

 
—

 
—

 
—

 
4.4

 
2,003.8

 
—

In-process research and development
—

 
—

 
—

 
—

 
—

 
—

 
29.2

Total intangible assets
$
380.0

 
$
111.8

 
$
22.2

 
$
191.0

 
$
11.0

 
$
3,374.8

 
$
29.2

Other non-current assets
—

 
—

 
—

 
—

 
0.4

 
2.4

 
—

Total assets
$
380.2

 
$
182.2

 
$
26.7

 
$
223.6

 
$
44.6

 
$
5,924.9

 
$
29.2

Liabilities assumed:
 
 
 
 
 
 
 
 
 
 
 
 
 
Accounts payable
$
—

 
$
2.8

 
$
—

 
$
—

 
$
3.3

 
$
243.1

 
$
—

Short-term debt
—

 
—

 
—

 
—

 
—

 
24.6

 
—

Accrued liabilities
—

 
1.6

 
—

 
—

 
1.6

 
43.9

 
—

Payroll and related taxes
—

 
—

 
—

 
—

 
—

 
51.3

 
—

Accrued customer programs
—

 
—

 
—

 
—

 
—

 
39.8

 
—

Long-term debt
—

 
—

 
—

 
—

 
—

 
1,471.0

 
—

Net deferred income tax liabilities
—

 
27.4

 
—

 
—

 
1.4

 
1,014.5

 
—

Other non-current liabilities
—

 
—

 
—

 
—

 
0.4

 
53.5

 
—

Total liabilities
—

 
31.8

 
—

 
—

 
6.7

 
2,941.7

 
—

Net assets acquired
$
380.2

 
$
150.4

 
$
26.7

 
$
223.6

 
$
37.9

 
$
2,983.2

 
$
29.2


(1)
Consists of eight product acquisitions in the CHC, BCH, and Rx segments


14
Perrigo Company plc - Item 1
Note 2


Actual and Unaudited Pro Forma Impact of Acquisitions

Our Condensed Consolidated Financial Statements include operating results from the Tretinoin Products, Entocort®, Naturwohl, GSK Products, ScarAway®, Omega, and Gelcaps acquisitions, as well as from four small product acquisitions, from the date of each acquisition through October 1, 2016. Net sales and operating income attributable to acquisitions completed in the current year and included in our financial statements totaled $25.3 million and $13.0 million, respectively, for the three months ended October 1, 2016 and totaled $47.7 million and $31.3 million, respectively, for the nine months ended October 1, 2016.

The following unaudited pro forma information gives effect to the Tretinoin Products, Entocort®, Naturwohl, GSK Products, ScarAway®, Omega, and Gelcaps acquisitions, as well as four small product acquisitions, as if the acquisitions had occurred on the first day of the nine months ended September 26, 2015 and had been included in our Results of Operations for all periods presented thereafter (in millions):
 
Three Months Ended
 
Nine Months Ended
(Unaudited)
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Net sales
$
1,359.6

 
$
1,429.9

 
$
4,243.3

 
$
4,451.4

Net income (loss)
$
(1,254.9
)
 
$
142.0

 
$
(1,392.8
)
 
$
154.7


The historical consolidated financial information of Perrigo, and the Tretinoin Products, Entocort®, Naturwohl, GSK Products, ScarAway®, Omega and Gelcaps acquisitions and the four small product acquisitions, has been adjusted in the pro forma information to give effect to pro forma events that are (1) directly attributable to the transactions, (2) factually supportable and (3) expected to have a continuing impact on combined results. In order to reflect the occurrence of the acquisitions on the first day of the nine months ended September 26, 2015 as required, the unaudited pro forma results include adjustments to reflect the incremental amortization expense to be incurred based on the current values of each acquisition's identifiable intangible and tangible assets, along with the reclassification of acquisition-related costs from the nine months ended October 1, 2016 to the nine months ended September 26, 2015. The unaudited pro forma results do not reflect future events that have occurred or may occur after the acquisitions.

Current Year Divestitures

On August 5, 2016, we completed the sale of our U.S. Vitamins, Minerals, and Supplements ("VMS") business within our CHC segment to International Vitamins Corporation ("IVC") for $61.8 million inclusive of an estimated working capital adjustment. The assets and liabilities related to this sale were classified as held-for-sale at December 31, 2015. Prior to closing the sale, we determined that the carrying value of the VMS business exceeded its fair value less the cost to sell, resulting in an impairment charge of $6.2 million, which was recorded in Impairment charges on the Condensed Consolidated Statements of Operations during the nine months ended October 1, 2016.

NOTE 3 – GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):
Reporting Segments:
 
December 31, 2015
 
Business acquisitions
 
Business divestitures
 
Impairments
 
Changes in assets held for sale
 
Currency translation adjustment
 
October 1,
2016
CHC
 
$
1,890.0

 
$
0.2

 
$
(8.5
)
 
$
—

 
$
13.0

 
$
(6.8
)
 
$
1,887.9

BCH
 
1,980.5

 
—

 
—

 
(967.5
)
 
—

 
92.4

 
1,105.4

Rx
 
1,222.2

 
1.7

 
—

 
—

 
—

 
(13.7
)
 
1,210.2

Specialty Sciences
 
200.7

 
—

 
—

 
—

 
—

 
—

 
200.7

Other
 
71.5

 
—

 
—

 
—

 
11.7

 
3.2

 
86.4

Total goodwill
 
$
5,364.9

 
$
1.9

 
$
(8.5
)
 
$
(967.5
)
 
$
24.7

 
$
75.1

 
$
4,490.6



15
Perrigo Company plc - Item 1
Note 3


In connection with the preparation of our financial statements for the three-month period ended April 2, 2016, we identified indicators of goodwill impairment in our BCH - rest of world (“BCH - ROW”) reporting unit, which comprises primarily operations attributable to the Omega acquisition in all geographic regions except for Belgium. The primary impairment indicators included the decline in our 2016 performance expectations and a reduction in our long-range revenue growth forecast. Step one of the goodwill impairment test involved determining the fair value of the reporting unit using a discounted cash flow technique and comparing it to the reporting unit’s carrying value. The main assumptions supporting the cash flow projections used to determine the reporting unit’s fair value included revenue growth based on product line extensions, product life cycle strategies, and geographical expansion within the markets in which the reporting unit distributes products, gross margins consistent with historical trends, and advertising and promotion investments largely consistent with the reporting unit's growth plans. The BCH - ROW reporting unit did not pass step one of goodwill impairment testing. The change in fair value from previous estimates was due primarily to the changes in the market and performance of certain brands such that the evaluation of brand prioritization and product extensions or launches in new regions are being more focused to maximize the potential of all brands in the segment's portfolio.

The second step of the goodwill impairment test required that we determine the implied fair value of the BCH - ROW reporting unit’s goodwill, which involved determining the value of the reporting unit’s individual assets and liabilities. Due to the complex and time-consuming nature of step two, based on our evaluation and initial estimates of the fair values of the assets and liabilities and the deficit of the fair value when compared to the related book value, we recorded an estimated impairment charge of $193.6 million for the three months ended April 2, 2016. We finalized the step two fair value calculation during the three months ended July 2, 2016, which resulted in a $30.3 million reduction to the estimated impairment charge recorded during the three months ended April 2, 2016.

In connection with the preparation of our financial statements for the three months ended October 1, 2016, we identified additional indicators of goodwill impairment in both our BCH - ROW and our BCH - Belgium reporting units. With respect to both reporting units, the primary impairment indicators included an additional decline in our 2016 performance expectations for the remainder of the year and a reduction in our long-range revenue growth and margin forecasts due to the factors outlined below. Step one of the goodwill impairment test involved determining the fair value of the reporting units using a discounted cash flow technique and comparing it to the respective reporting units' carrying value. The main assumptions supporting the cash flow projections used to determine each reporting unit’s fair value included revenue growth based on product line extensions, product life cycle strategies, and geographical expansion within the markets in which the reporting unit distributes products, gross margins consistent with historical trends and including supply chain cost improvement plans, and advertising and promotion investments largely consistent with the reporting unit's growth plans. Both the BCH - ROW and the BCH - Belgium reporting units did not pass step one of goodwill impairment testing. As it relates to the BCH - ROW reporting unit, the changes in fair value from previous estimates were due primarily to (1) changes in the market and performance of certain brands due to moderated new product launch assumptions, (2) execution of certain key product strategies falling short of expectations causing a reduction to baseline forecast models in France, Germany and Italy, (3) certain macro-economic factors having continued to impact the business more than expected in France, Russia and Turkey in addition to unfavorable foreign currency impacts experienced primarily in the UK related to Brexit. As it relates to BCH - Belgium reporting unit, the changes in fair value from previous estimates due to change in the forecast as a result of a reduction in volume with a major wholesaler due to factors consistent with those outlined for BCH - ROW.

The second step of the goodwill impairment test required that we determine the implied fair value of both the BCH - ROW and BCH - Belgium reporting units' goodwill, which involved determining the value of each reporting unit’s individual assets and liabilities. Based on our evaluation and initial estimates of the fair values of the assets and liabilities and the deficit of the fair value when compared to the related book value, we recorded an estimated impairment charge of $734.7 million related to the BCH - ROW reporting unit and $69.4 million related to the BCH - Belgium reporting unit for the three months ended October 1, 2016. Both charges were recorded in Impairment charges on the Condensed Consolidated Statements of Operations within our BCH segment. Due to the complex and time-consuming nature of step two, we expect to finalize the fair value calculation during the fourth quarter of 2016, which could result in an adjustment to the estimated impairment charge. As of October 1, 2016, the implied fair value of goodwill that remains in the BCH - ROW and BCH - Belgium reporting units is $1.0 billion and $70.2 million, respectively.


16
Perrigo Company plc - Item 1
Note 3


While no impairment charges were recorded as a result of the goodwill impairment testing for the transition period of June 28, 2015 to December 31, 2015, our Specialty Sciences reporting unit's fair value exceeded the carrying value by less than 10%. Management evaluated the primary source of cash flow in this segment, the Tysabri® royalty stream, based on a combination of factors including independent external research, information provided from our royalty partner, and internal estimates. Based on this information, management’s assessment of future cash flow from this royalty stream has been reduced primarily due to anticipated new competitors entering the market and unfavorable currency exchange effects. Future performance different from the assumptions utilized in our quantitative analysis may further reduce the fair value of the reporting unit, which may result in the fair value no longer exceeding the carrying value. In February 2016, a competitor's pipeline product, Ocrevus®, received breakthrough therapy designation from the FDA and could potentially be approved in 2016. The product would compete with Tysabri® and could have a significant negative impact on the royalty we receive from Biogen Idec, Inc. ("Biogen") and the performance of the Specialty Sciences segment. We continue to monitor the progress of all potential competing products and assess the reporting unit for potential impairment should impairment indicators arise, as applicable, and at least annually during our fourth quarter impairment testing.

During the three months ended June 27, 2015, we performed our annual goodwill impairment testing, which indicated that our CHC Mexico reporting unit's goodwill fair value was below its net book value as of March 28, 2015. As a result, we initiated the second step of the goodwill impairment test to measure the amount of impairment. We concluded that the goodwill was fully impaired and recorded an impairment of $6.8 million in the CHC segment during the nine months ended September 26, 2015 in Other expense, net.

Intangible Assets

Other intangible assets and related accumulated amortization consisted of the following (in millions):
 
October 1, 2016
 
December 31, 2015
 
Gross
 
Accumulated Amortization
 
Gross
 
Accumulated Amortization
Definite-lived intangibles:
 
 
 
 
 
 
 
Distribution and license agreements, supply agreements
$
6,122.3

 
$
914.0

 
$
6,053.4

 
$
667.2

Developed product technology, formulations, and product rights
1,805.9

 
529.0

 
1,383.5

 
426.0

Customer relationships and distribution networks
1,564.0

 
288.8

 
1,520.7

 
193.0

Trademarks, trade names, and brands
631.6

 
54.7

 
539.4

 
22.8

Non-compete agreements
14.6

 
11.0

 
15.2

 
12.7

Total definite-lived intangibles
$
10,138.4

 
$
1,797.5

 
$
9,512.2

 
$
1,321.7

Indefinite-lived intangibles:
 
 
 
 
 
 
 
Trademarks, trade names, and brands
$
724.2

 
$
—

 
$
1,868.1

 
$
—

In-process research and development
67.9

 
—

 
48.2

 
—

Total indefinite-lived intangibles
792.1

 
—

 
1,916.3

 
—

Total other intangible assets
$
10,930.5

 
$
1,797.5

 
$
11,428.5

 
$
1,321.7


Certain intangible assets are denominated in currencies other than the U.S. dollar; therefore, their gross and net carrying values are subject to foreign currency movements.

We recorded amortization expense of $162.1 million and $147.6 million for the three months ended October 1, 2016 and September 26, 2015, respectively, and $481.8 million and $397.9 million for the nine months ended October 1, 2016 and September 26, 2015, respectively. The increase in amortization expense for the 2016 nine-month period was due primarily to the incremental amortization expense incurred on the definite-lived intangible assets acquired from the Omega, Entocort®, and Tretinoin Products acquisitions.

During our impairment testing for the transition period of June 28, 2015 to December 31, 2015, we identified an impairment of certain indefinite-lived intangible assets purchased in conjunction with the Omega acquisition based on management’s expectations of the prospects for future revenues, profits, and cash flows associated with

17
Perrigo Company plc - Item 1
Note 3


these assets. The assessment resulted in an impairment charge of $185.1 million within our BCH segment, which represented the difference between the carrying amount of the intangible assets and their estimated fair value. See our Transition Report on Form 10-KT filed on February 25, 2016 for a further discussion of this impairment charge.

In connection with the preparation of our financial statements for the three-month period ended April 2, 2016, we identified indicators of impairment associated with certain indefinite-lived intangible assets acquired in conjunction with the Omega acquisition. The primary impairment indicators included the decline in our 2016 performance expectations and a reduction in our long-range revenue growth forecast. The assessment utilized the excess earnings method to determine fair value and resulted in an impairment charge of $273.4 million in Impairment charges on the Condensed Consolidated Statements of Operations within our BCH segment, which represented the difference between the carrying amount of the intangible assets and their estimated fair value. The change in fair value from previous estimates was due primarily to the changes in the market and performance of the brands such that the evaluation of brand prioritization and product extensions or launches in new regions are being more focused to maximize the potential of all brands in the segment's portfolio. The main assumptions supporting the fair value of these assets and cash flow projections included revenue growth based on product line extensions, product life cycle strategies, and geographical expansion within the markets in which the BCH segment distributes products, gross margins consistent with historical trends, and advertising and promotion investments largely consistent with the segment's growth plans.

In connection with the preparation of our financial statements for the three months ended October 1, 2016, we identified additional indicators of impairment associated with certain indefinite-lived and definite-lived intangible brand category assets acquired in conjunction with the Omega acquisition. The primary impairment indicators are discussed above in goodwill. The assessment of the indefinite-lived assets utilized the excess earnings method to determine fair value and resulted in an impairment charge of $575.7 million for the three months ended October 1, 2016. With regards to the definite-lived asset, it was determined that the carrying value of the asset group was not recoverable based on an assessment of the undiscounted future cash flows expected to be generated by the asset group. Given this, the excess earnings method was utilized to determine fair value of the definite-lived asset and resulted in an impairment charge of $290.2 million for the three months ended October 1, 2016. Both charges, which represented the difference between the carrying amount of the intangible assets and their estimated fair value, were recorded in Impairment charges on the Condensed Consolidated Statements of Operations within our BCH segment. The main assumptions supporting the fair value of these assets and cash flow projections are included in the goodwill discussions above.

The carrying value for certain intangible assets and goodwill equals estimated and implied fair values, respectively, and as a result, any further deterioration in those assets' fair value would lead to a further impairment charge. Future performance different from the assumptions utilized in our quantitative analyses may result in additional changes in the fair value. We will continue to monitor and assess these assets for potential impairment should further impairment indicators arise. We will complete our required annual impairment testing during the fourth quarter of 2016.

In addition, given the additional change in performance expectations for our remaining impaired cough/cold/allergy, anti-parasite, personal care and natural health brands previously recorded as indefinite-lived assets, we reclassified the remaining asset balance of $672.4 million related to these four assets to definite-lived assets with a 20-year useful life and began amortizing the assets as of October 2, 2016.

NOTE 4 - ACCOUNTS RECEIVABLE FACTORING

We have multiple accounts receivable factoring arrangements with non-related third-party financial institutions (the “Factors”). Pursuant to the terms of the arrangements, we sell to the Factors certain of our accounts receivable balances on a non-recourse basis for credit approved accounts. An administrative fee ranging from 0.14% to 0.15% per invoice is charged on the gross amount of accounts receivables assigned to the Factors, plus interest is calculated at the applicable EUR LIBOR rate plus 70 basis points. The total amount factored and excluded from accounts receivable was $36.4 million and $106.7 million at October 1, 2016 and December 31, 2015, respectively.


18
Perrigo Company plc - Item 1
Note 5


NOTE 5 – INVENTORIES

Major components of inventory were as follows (in millions):
 
 
October 1,
2016
 
December 31,
2015
Finished goods
$
511.6

 
$
483.4

Work in process
171.0

 
151.4

Raw materials
202.0

 
209.6

Total inventories
$
884.6

 
$
844.4


NOTE 6 – FAIR VALUE MEASUREMENTS

Fair value is the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The following fair value hierarchy is used in selecting inputs, with the highest priority given to Level 1, as these are the most transparent or reliable.

Level 1:
Quoted prices for identical instruments in active markets.

Level 2:
Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets.

Level 3:
Valuations derived from valuation techniques in which one or more significant inputs are not observable.

The following table summarizes the valuation of our financial instruments carried at fair value and measured at fair value on a recurring and non-recurring basis by the above pricing categories (in millions):
 
 
 
 
Fair Value
 
 
Fair Value Hierarchy
 
October 1,
2016
 
December 31,
2015
Measured at fair value on a recurring basis:
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
Investment securities
 
Level 1
 
$
53.0

 
$
14.9

 
 
 
 
 
 
 
Foreign currency forward contracts
 
Level 2
 
$
5.2

 
$
4.8

 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
Interest rate swap agreements
 
Level 2
 
$
—

 
$
0.3

Foreign currency forward contracts
 
Level 2
 
0.8

 
3.9

Total level 2 liabilities
 
 
 
$
0.8

 
$
4.2

 
 
 
 
 
 
 
Contingent consideration
 
Level 3
 
$
75.0

 
$
17.9

 
 
 
 
 
 
 
Measured at fair value on a non-recurring basis:
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
Goodwill(1)
 
Level 3
 
$
1,105.4

 
$
—

Indefinite-lived intangible assets(2)
 
Level 3
 
672.4

 
1,031.8

Definite-lived intangible assets(3)
 
Level 3
 
66.9

 
—

Assets held for sale, net
 
Level 3
 
14.1

 
37.5

Total level 3 assets
 
 
 
$
1,858.8

 
$
1,069.3


(1)
Goodwill with a carrying amount of $1.9 billion was written down to its implied fair value of $1.1 billion, resulting in an impairment charge of $804.1 million for the three months ended October 1, 2016; impairment charges totaled $967.5 million for the nine months ended October 1, 2016 and are included in Impairment charges on the Condensed Consolidated Statements of Operations.


19
Perrigo Company plc - Item 1
Note 6


(2)
Indefinite-lived intangible assets with a carrying amount of $1.2 billion were written down to a fair value of $672.4 million resulting in total impairment charges of $575.7 million for the three months ended October 1, 2016; impairment charges totaled $849.1 million for the nine months ended October 1, 2016 and are included in Impairment charges on the Condensed Consolidated Statements of Operations.

(3)
Definite-lived intangible assets with a carrying amount of $357.1 million were written down to a fair value of $66.9 million resulting in an impairment charge of $290.2 million for the three and nine months ended October 1, 2016, which is included in Impairment charges on the Condensed Consolidated Statements of Operations.

There were no transfers among Level 1, 2, and 3 during the three and nine months ended October 1, 2016 and September 26, 2015. Our policy regarding the recording of transfers between levels is to record any such transfers at the end of the reporting period. See Note 7 for information on our investment securities. See Note 8 for a discussion of derivatives.

Contingent consideration represents milestone payment obligations obtained through product acquisitions, which are valued using estimates based on probability-weighted outcomes, sensitivity analysis, and discount rates reflective of the risk involved. The estimates are updated quarterly and the liabilities are adjusted to fair value depending on a number of assumptions, including the competitive landscape and regulatory approvals that may impact the future sales of a product.

The non-recurring fair values included in the table above represent only those assets whose carrying values were adjusted to fair value during the reporting period. See Note 3 for a more detailed discussion of the impaired goodwill and indefinite-lived intangible assets and the valuation methods used, and Note 9 for information on the impaired assets held for sale, net.

The table below presents a reconciliation for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (in millions). Net realized losses in the table were recorded in Administrative expense.
 
Three Months Ended
 
Nine Months Ended
 
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Contingent Consideration
 
 
 
 
 
 
 
Beginning balance
$
44.9

 
$
—

 
$
17.9

 
$
12.4

Net realized (gains) losses
(0.4
)
 
—

 
(4.0
)
 
(12.4
)
Purchases or additions
30.6

 
—

 
61.1

 
—

Foreign currency effect
—

 
—

 
0.1

 
—

Settlements
(0.1
)
 
—

 
(0.1
)
 
—

Ending balance
$
75.0

 
$
—

 
$
75.0

 
$
—


As of October 1, 2016 and December 31, 2015, our fixed rate long-term debt consisted of public bonds, a private placement note, and retail bonds. As of October 1, 2016, the public bonds and private placement note had a carrying value of $4.6 billion and a fair value of $4.7 billion, based on quoted market prices (Level 1). As of December 31, 2015, the public bonds and private placement note had a carrying value of $3.9 billion and fair value of $3.8 billion, based on quoted market prices (Level 1). As of October 1, 2016, our retail bonds had a carrying value of $826.4 million (excluding a premium of $60.7 million) and a fair value of $891.4 million. As of December 31, 2015, our retail bonds had a carrying value of $798.3 million (excluding a premium of $82.5 million) and a fair value of $859.8 million. The fair value of our related bonds for both periods was based on interest rates offered for borrowings of a similar nature and remaining maturities (Level 2).

The carrying amounts of our other financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, short-term debt and variable rate long-term debt, approximate their fair value.


20
Perrigo Company plc - Item 1
Note 7


NOTE 7 – INVESTMENTS

Available for Sale Securities
    
Our available for sale securities are reported in Prepaid expenses and other current assets. Unrealized investment gains (losses) on available for sale securities were as follows (in millions):
 
October 1,
2016
 
December 31, 2015
Equity securities, at cost less impairments
$
20.1

 
$
6.4

Gross unrealized gains
32.9

 
9.3

Gross unrealized losses
—

 
(0.8
)
Estimated fair value of equity securities
$
53.0

 
$
14.9


The factors affecting the assessment of impairments include both general financial market conditions and factors specific to a particular company. We recorded impairment charges of $1.8 million related to other-than-temporary impairments of marketable equity securities during the nine months ended October 1, 2016 due to prolonged losses incurred on each of the investments.

Cost Method Investments

Our cost method investments totaled $7.0 million and $6.9 million at October 1, 2016 and December 31, 2015, respectively, and are included in Other non-current assets.

Equity Method Investments

Our equity method investments totaled $4.9 million and $45.5 million at October 1, 2016 and December 31, 2015, respectively, and are included in Other non-current assets.

Due to significant and prolonged losses incurred on one of our equity method investments, we recorded a $22.3 million impairment in Other expense, net, during the nine months ended October 1, 2016. In addition, during the nine months ended October 1, 2016, one of our equity method investments became publicly traded. As a result, we transferred the $15.5 million investment to available for sale and recorded an $8.7 million unrealized gain, net of tax, in Other Comprehensive Income ("OCI"), as reflected in the available for sale securities table above.

We recorded a net gain of $0.1 million and a net loss of $4.1 million during the three months ended October 1, 2016 and September 26, 2015, respectively, and a net loss of $3.8 million and $7.7 million during the nine months ended October 1, 2016, and September 26, 2015, respectively, for our proportionate share of the equity method investment earnings or losses. The gains and losses were recorded in Other expense, net.
    
NOTE 8 – DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

We enter into certain derivative financial instruments, when available on a cost-effective basis, to mitigate our risk associated with changes in interest rates and foreign currency exchange rates as follows:

Interest rate risk management - We are exposed to the impact of interest rate changes through our cash investments and borrowings. We utilize a variety of strategies to manage the impact of changes in interest rates including using a mix of debt maturities along with both fixed-rate and variable-rate debt. In addition, we may enter into treasury-lock agreements and interest rate swap agreements on certain investing and borrowing transactions to manage our exposure to interest rate changes and our overall cost of borrowing.

Foreign currency exchange risk management - We conduct business in several major currencies other than the U.S. dollar and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce cash flow volatility associated with foreign exchange rate changes on a consolidated basis to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments, and anticipated foreign currency sales and expenses.

21
Perrigo Company plc - Item 1
Note 8


    
All derivative instruments are managed on a consolidated basis to efficiently net exposures and thus take advantage of any natural offsets. Gains and losses related to the derivative instruments are expected to be offset largely by gains and losses on the original underlying asset or liability. We do not use derivative financial instruments for speculative purposes.

All of our designated derivatives were classified as cash flow hedges as of October 1, 2016 and December 31, 2015. Designated derivatives meet hedge accounting criteria, which means the fair value of the hedge is recorded in shareholders’ equity as a component of OCI, net of tax. The deferred gains and losses are recognized in income in the period in which the hedged item affects earnings. Any ineffective portion of the change in fair value of the derivative is immediately recognized in earnings. All of our designated derivatives are assessed for hedge effectiveness quarterly.

We also have economic non-designated derivatives that do not meet hedge accounting criteria. These derivative instruments are adjusted to current market value at the end of each period through earnings. Gains or losses on these instruments are offset substantially by the remeasurement adjustment on the hedged item.    

Interest Rate Swaps and Treasury Locks

Interest rate swap agreements are contracts to exchange floating rate for fixed rate payments (or vice versa) over the life of the agreement without the exchange of the underlying notional amounts. The notional amounts of the interest rate swap agreements are used to measure interest to be paid or received and do not represent the amount of exposure to credit loss. The differential paid or received on the interest rate swap agreements is recognized as an adjustment to interest expense.

During the six months ended December 31, 2015, we entered into a forward interest rate swap to hedge against changes in the benchmark interest rate between the date the interest rate swap was entered into and the date of expected future debt issuance. The interest rate swap was designated as a cash flow hedge and had a notional amount totaling $200.0 million. The interest rate swap was settled upon the issuance of an aggregate $1.2 billion principal amount of senior notes on March 7, 2016 for a cumulative after-tax loss of $7.0 million in OCI during the nine months ended October 1, 2016.

In connection with the Omega acquisition, we assumed a $20.0 million private placement note. We also assumed an interest rate swap agreement with a notional amount totaling $20.0 million that was in place to hedge the cross currency exchange differences between the U.S. dollar and the euro on the above-mentioned debt. On May 29, 2015, we repaid the loan and the interest rate swap. We also assumed €500.0 million ($544.5 million) of debt under Omega's revolving credit facility, as well as an interest rate swap agreement with a notional amount of €135.0 million ($147.0 million) that was in place to hedge the change in the floating rate on that credit facility. On April 8, 2015, we repaid the loan and terminated the interest rate swap. Because both interest rate swaps mentioned above were recorded at fair market value on the date of termination, no gain or loss was recorded. For more information on the acquired debt and termination, see Note 10.

During the nine months ended September 26, 2015, we repaid a $300.0 million term loan with floating interest rates priced off the LIBOR yield curve, see Note 10. As a result of the term loan repayment on June 25, 2015, the forward interest rate swap agreements with notional amounts totaling $240.0 million that were in place to hedge the change in the LIBOR rate were terminated as well. We recorded a loss of $3.6 million in Other expense, net, during the nine months ended September 26, 2015 for the amount remaining in Accumulated Other Comprehensive Income ("AOCI") when the hedges were terminated.

Foreign Currency Derivatives

We enter into foreign currency forward contracts, both designated and non-designated, in order to manage the impact of foreign exchange fluctuations on expected future purchases and related payables denominated in a foreign currency, as well as to hedge the impact of foreign exchange fluctuations on expected future sales and related receivables denominated in a foreign currency. Both types of forward contracts have a maximum maturity date of 15 months. The total notional amount for these contracts was $482.5 million and $755.5 million as of October 1, 2016 and December 31, 2015, respectively.

22
Perrigo Company plc - Item 1
Note 8



In order to economically hedge the foreign currency exposure associated with the planned payment of the euro-denominated purchase price of Omega, we entered into non-designated forward contracts that matured during the three months ended March 28, 2015. We recorded losses of $259.8 million during the nine months ended September 26, 2015 related to the settlement of the forward contracts in Other expense, net. The losses on the derivatives due to changes in the euro-to-U.S. dollar exchange rates were economically offset at closing in the final settlement of the euro-denominated Omega purchase price. In June 2015, in order to economically hedge the foreign currency exposure associated with the planned payment of the euro-denominated GSK Products acquisition discussed in Note 2, we entered into a non-designated option contract to protect against a strengthening of the euro relative to the U.S. dollar. We recorded losses of $1.9 million for the change in fair value of the option contract during the nine months ended September 26, 2015 in Other expense, net. Because these derivatives were economically hedging future acquisitions, the cash outflows associated with their settlement are shown as investing activity on the Consolidated Statements of Cash Flows.

Effects of Derivatives on the Financial Statements
    
The below tables indicate the effects of all derivative instruments on the Condensed Consolidated Financial Statements. All amounts exclude income tax effects and are presented in millions.

The balance sheet location and gross fair value of our outstanding derivative instruments were as follows:
 
Asset Derivatives
 
Balance Sheet Location
 
Fair Value
 
 
 
October 1,
2016
 
December 31, 2015
Designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Other current assets
 
$
3.8

 
$
3.8

Total designated derivatives
 
 
$
3.8

 
$
3.8

Non-designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Other current assets
 
$
1.4

 
$
1.0

Total non-designated derivatives
 
 
$
1.4

 
$
1.0

 
Liability Derivatives
 
Balance Sheet Location
 
Fair Value
 
 
 
October 1,
2016
 
December 31, 2015
Designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Accrued liabilities
 
$
0.3

 
$
2.0

Interest rate swap agreements
Other non-current liabilities
 
—

 
0.3

Total designated derivatives
 
 
$
0.3

 
$
2.3

Non-designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Accrued liabilities
 
$
0.5

 
$
1.9

Total non-designated derivatives
 
 
$
0.5

 
$
1.9


The gains (losses) recorded in OCI for the effective portion of our designated cash flow hedges were as follows:
 
 
Amount of Gain/(Loss) Recorded in OCI
(Effective Portion)
 
 
Three Months Ended
 
Nine Months Ended
Designated Cash Flow Hedges
 
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Interest rate swap agreements
 
$
—

 
$
—

 
$
(9.0
)
 
$
(12.0
)
Foreign currency forward contracts
 
3.4

 
(0.5
)
 
4.7

 
(1.6
)
Total
 
$
3.4

 
$
(0.5
)
 
$
(4.3
)
 
$
(13.6
)

23
Perrigo Company plc - Item 1
Note 8



The gains (losses) reclassified from AOCI into earnings for the effective portion of our designated cash flow hedges were as follows:
 
 
 
 
Amount of Gain/(Loss) Reclassified from AOCI to Income
(Effective Portion)
 
 
 
 
Three Months Ended
 
Nine Months Ended
Designated Cash Flow Hedges
 
Income Statement Location
 
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Treasury locks
 
Interest expense, net
 
$
—

 
$
—

 
$
(0.1
)
 
$
(0.1
)
Interest rate swap agreements
 
Interest expense, net
 
(0.6
)
 
(0.4
)
 
(1.7
)
 
(18.6
)
Foreign currency forward contracts
 
Net sales
 
0.1

 
(0.1
)
 
1.0

 
1.8

 
 
Cost of sales
 
0.9

 
0.2

 
1.8

 
(4.4
)
 
 
Interest expense, net
 
(0.4
)
 
—

 
(1.3
)
 
—

 
 
Other expense, net
 
(1.4
)
 
(0.1
)
 
—

 
(0.6
)
Total
 
 
 
$
(1.4
)
 
$
(0.4
)
 
$
(0.3
)
 
$
(21.9
)

The gains (losses) recognized against earnings for the ineffective portion of our designated cash flow hedges were as follows:
 
 
 
 
Amount of Gain/(Loss) Recognized in Income
(Ineffective Portion)
 
 
 
 
Three Months Ended
 
Nine Months Ended
Designated Cash Flow Hedges
 
Income Statement
Location
 
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Interest rate swap agreements
 
Other expense, net
 
$
—

 
$
—

 
$
(0.1
)
 
$
—

Foreign currency forward contracts
 
Net sales
 
—

 
—

 
0.1

 
(0.3
)
 
 
Cost of sales
 
—

 
—

 
—

 
0.1

 
 
Other expense, net
 
—

 
—

 
0.6

 
—

Total
 
 
 
$
—

 
$
—

 
$
0.6

 
$
(0.2
)

The effects of our non-designated derivatives on the Condensed Consolidated Statements of Operations were as follows:
 
 
 
 
Amount of Gain/(Loss) Recognized in Income
 
 
 
 
Three Months Ended
 
Nine Months Ended
Non-Designated Derivatives
 
Income Statement Location
 
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Foreign currency forward contracts
 
Other expense, net
 
$
(0.2
)
 
$
(8.9
)
 
$
(8.7
)
 
$
(259.4
)
 
 
Interest expense, net
 
(1.0
)
 
0.1

 
(1.5
)
 
(3.4
)
Total
 
 
 
$
(1.2
)
 
$
(8.8
)
 
$
(10.2
)
 
$
(262.8
)

NOTE 9 – ASSETS HELD FOR SALE

During the six months ended December 31, 2015, management committed to a plan to sell our U.S. VMS and India Active Pharmaceutical Ingredients ("API") businesses. As a result, the net assets attributable to both businesses were classified as held-for-sale beginning at December 31, 2015. As described in Note 2, we completed the sale of our U.S. VMS business to IVC on August 5, 2016. In addition, during the three months ended October 1, 2016, management committed to a plan to sell certain fixed assets associated with our Animal Health pet treats plant. Such assets were classified as held-for-sale beginning at October 1, 2016.

When a group of assets is classified as held-for-sale, the book value is evaluated and adjusted to the lower of its carrying amount or fair value less the cost to sell. At December 31, 2015, we determined that the carrying value of the India API business exceeded its fair value less cost to sell, resulting in an impairment charge of

24
Perrigo Company plc - Item 1
Note 9


$29.0 million. We recorded additional impairment charges totaling $10.8 million during the nine months ended October 1, 2016. The API business is reported primarily in our Other segment.

At October 1, 2016, we determined that the carrying value of the fixed assets associated with our Animal Health pet treats plant exceeded the fair value less the cost to sell, resulting in an impairment charge of $3.4 million. The assets associated with our Animal Health pet treats plant are reported in our CHC segment.

The assets held-for-sale were reported within Prepaid expenses and other current assets and liabilities held-for-sale were reported in Accrued liabilities. The amounts consisted of the following (in millions):
 
October 1,
2016
 
December 31,
2015
 
CHC
 
Other
 
CHC
 
Other
Assets held for sale
 
 
 
 
 
 
 
Current assets
$
—

 
$
7.3

 
$
55.1

 
$
13.6

Goodwill
—

 
2.8

 
13.0

 
14.5

Property, plant and equipment
13.3

 
34.0

 
18.8

 
37.4

Other assets
—

 
3.2

 
—

 
3.2

Less: impairment reserves
(3.4
)
 
(39.8
)
 
—

 
(29.0
)
Total assets held for sale
$
9.9

 
$
7.5

 
$
86.9

 
$
39.7

Liabilities held for sale
 
 
 
 
 
 
 
Current liabilities
$
0.3

 
$
0.9

 
$
30.5

 
$
0.5

Other liabilities
—

 
2.1

 
—

 
1.7

Total liabilities held for sale
$
0.3

 
$
3.0

 
$
30.5

 
$
2.2



25
Perrigo Company plc - Item 1
Note 10


NOTE 10 – INDEBTEDNESS

Total borrowings outstanding are summarized as follows (in millions):
 
 
 
 
 
October 1,
2016
 
December 31,
2015
Revolving credit agreements
 
 
 
 
 
 
2015 Revolver
$
—

 
$
380.0

 
2014 Revolver
—

 
300.0

 
Total revolving credit agreements
—

 
680.0

Term loans
 
 
 
 
 
*
2014 Term loan due December 5, 2019
463.8

 
488.8

Notes and Bonds
 
 
 
 
 
 
Coupon
Due
 
 
 
 
 
 
1.300%
November 8, 2016
(2) 
 
—

 
500.0

*
4.500%
May 23, 2017
(3) 
 
202.4

 
195.5

*
5.125%
December 12, 2017
(3) 
 
337.3

 
325.8

 
2.300%
November 8, 2018
(2) 
 
600.0

 
600.0

*
5.000%
May 23, 2019
(3) 
 
134.9

 
130.3

 
3.500%
March 15, 2021
(4) 
 
500.0

 
—

 
3.500%
December 15, 2021
(1) 
 
500.0

 
500.0

*
5.105%
July 19, 2023
(3) 
 
151.8

 
146.7

 
4.000%
November 15, 2023
(2) 
 
800.0

 
800.0

 
3.900%
December 15, 2024
(1) 
 
700.0

 
700.0

 
4.375%
March 15, 2026
(4) 
 
700.0

 
—

 
5.300%
November 15, 2043
(2) 
 
400.0

 
400.0

 
4.900%
December 15, 2044
(1) 
 
400.0

 
400.0

 
Total notes and bonds
 
 
5,426.4

 
4,698.3

Other financing
4.1

 
86.0

Unamortized premium (discount), net
43.3

 
73.4

Deferred financing fees
(34.6
)
 
(36.6
)
Total borrowings outstanding
5,903.0

 
5,989.9

 
Current indebtedness
(265.0
)
 
(1,018.3
)
Total long-term debt less current portion
$
5,638.0

 
$
4,971.6


(1)
Discussed below collectively as the "2014 Notes."
(2)
Discussed below collectively as the "2013 Notes."
(3)
Debt assumed from Omega.
(4)
Discussed below collectively as the "2016 Notes."

*
Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.

We were in compliance with all covenants under our debt agreements as of October 1, 2016.

Revolving Credit Agreements

On December 9, 2015, our 100% owned finance subsidiary, Perrigo Finance Unlimited Company (formerly Perrigo Finance plc) ("Perrigo Finance"), entered into a $750.0 million revolving credit agreement (the "2015 Revolver"). On March 15, 2016, we used the proceeds of the long-term debt issuance described below under "2016 Notes" to repay the $750.0 million then outstanding under the 2015 Revolver and terminated the facility.

On March 30, 2015, we assumed a revolving credit facility with €500.0 million ($544.5 million) outstanding from Omega. On April 8, 2015, the €500.0 million ($539.1 million) outstanding under the assumed revolving credit facility was repaid and the facility was terminated.

26
Perrigo Company plc - Item 1
Note 10



On December 5, 2014, Perrigo Finance entered into a $600.0 million revolving credit agreement, which we increased to $1.0 billion on March 30, 2015 (the "2014 Revolver"). On March 15, 2016, we used the proceeds of the long-term debt issuance described below under "2016 Notes" to repay the $435.0 million then outstanding under the 2014 Revolver. There were no borrowings outstanding under the 2014 Revolver as of October 1, 2016.

Term Loans

On December 5, 2014, Perrigo Finance entered into a term loan agreement consisting of a €500.0 million ($614.3 million) tranche, with the ability to draw an additional €300.0 million ($368.6 million) tranche, maturing December 5, 2019, and we entered into a $300.0 million term loan tranche maturing December 18, 2015, which we repaid in full on June 25, 2015. During the nine months ended October 1, 2016, we made $41.9 million in scheduled principal payments on the euro-denominated term loan.

Notes and Bonds

2016 Notes

On March 7, 2016, Perrigo Finance issued $500.0 million in aggregate principal amount of 3.500% senior notes due 2021 and $700.0 million in aggregate principal amount of 4.375% senior notes due 2026 (together, the "2016 Notes") and received net proceeds of $1.2 billion after fees and market discount. Interest on the 2016 Notes is payable semiannually in arrears in March and September of each year, beginning in September 2016. The 2016 Notes are governed by a base indenture and a second supplemental indenture (collectively, the "2016 Indenture"). The 2016 Notes are fully and unconditionally guaranteed on a senior basis by Perrigo, and no other subsidiary of Perrigo guarantees the 2016 Notes. The proceeds were used to repay amounts borrowed under the 2015 Revolver and the 2014 Revolver, as mentioned above. There are no restrictions under the 2016 Notes on our ability to obtain funds from our subsidiaries. Perrigo Finance may redeem the 2016 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2016 Indenture.

Notes and Bonds Assumed from Omega

In connection with the Omega acquisition, on March 30, 2015, we assumed:

•
$20.0 million in aggregate principal amount of 6.190% senior notes due 2016, which was repaid on May 29, 2015 in full;
•
€135.0 million ($147.0 million) in aggregate principal amount of 5.1045% senior notes due 2023 (the "2023 Notes");
•
€300.0 million ($326.7 million) in aggregate principal amount of 5.125% retail bonds due 2017; €180.0 million ($196.0 million) in aggregate principal amount of 4.500% retail bonds due 2017; and €120.0 million ($130.7 million) in aggregate principal amount of 5.000% retail bonds due 2019 (collectively, the "Retail Bonds").

The fair value of the 2023 Notes and Retail Bonds exceeded par value by €93.6 million ($101.9 million) on the date of the Omega acquisition. As a result, a fair value adjustment was recorded as part of the carrying value of the underlying debt and will be amortized as a reduction of interest expense over the remaining terms of the respective debt instruments. The adjustment does not affect cash interest payments.

2014 Notes

On December 2, 2014, Perrigo Finance issued $500.0 million in aggregate principal amount of 3.500% senior notes due 2021 (the "2021 Notes”), $700.0 million in aggregate principal amount of 3.900% senior notes due 2024 (the “2024 Notes”), and $400.0 million in aggregate principal amount of 4.900% senior notes due 2044 (the “2044 Notes” and, together with the 2021 Notes and the 2024 Notes, the “2014 Notes”) and received net proceeds of $1.6 billion after fees and market discount. Interest on the 2014 Notes is payable semiannually in arrears in June and December of each year, beginning in June 2015. The 2014 Notes are governed by a base indenture and a first supplemental indenture (collectively, the "2014 Indenture"). The 2014 Notes are fully and unconditionally guaranteed on a senior unsecured basis by Perrigo, and no other subsidiary of Perrigo guarantees the 2014 Notes.

27
Perrigo Company plc - Item 1
Note 10


There are no restrictions under the 2014 Notes on our ability to obtain funds from our subsidiaries. Perrigo Finance may redeem the 2014 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2014 Indenture.

2013 Notes

On November 8, 2013, Perrigo Company issued $500.0 million aggregate principal amount of its 1.300% senior notes due 2016 (the "1.300% 2016 Notes"), $600.0 million aggregate principal amount of its 2.300% senior notes due 2018 (the "2018 Notes"), $800.0 million aggregate principal amount of its 4.000% senior notes due 2023 (the "4.000% 2023 Notes") and $400.0 million aggregate principal amount of its 5.300% senior notes due 2043 (the "2043 Notes" and, together with the 1.300% 2016 Notes, the 2018 Notes and the 4.000% 2023 Notes, the "2013 Notes") in a private placement with registration rights. We received net proceeds of $2.3 billion from the issuance of the 2013 Notes after fees and market discount. On September 29, 2016, we repaid all $500.0 million of the 1.300% 2016 Notes outstanding.

Interest on the 2013 Notes is payable semiannually in arrears in May and November of each year, beginning in May 2014. The 2013 Notes are governed by a base indenture and a first supplemental indenture (collectively, the "2013 Indenture"). The 2013 Notes are our unsecured and unsubordinated obligations, ranking equally in right of payment to all of our existing and future unsecured and unsubordinated indebtedness. The 2013 Notes are not entitled to mandatory redemption or sinking fund payments. We may redeem the 2013 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2013 Indenture. The 2013 Notes were guaranteed on an unsubordinated, unsecured basis by the same entities that guaranteed our then-outstanding credit agreement until November 21, 2014, at which time the 2013 Indenture was amended to remove all guarantors.

Other Financing

Overdraft Facilities

On March 30, 2015, we assumed and repaid certain overdraft facilities totaling €51.4 million ($56.0 million) with the Omega acquisition. Our BCH segment uses overdraft facilities to increase the efficiency of its cash utilization and meet its short-term liquidity needs. We repaid the balance outstanding under the overdraft facilities during the nine months ended October 1, 2016, but retain the ability to use the facilities in our day-to-day cash operations. The balance outstanding under the facilities was $82.9 million at December 31, 2015 and is shown in the above table under "Other Financing".


28
Perrigo Company plc - Item 1
Note 11


NOTE 11 – EARNINGS PER SHARE AND SHAREHOLDERS' EQUITY

Earnings per Share

A reconciliation of the numerators and denominators used in the basic and diluted earnings per share ("EPS") calculation is as follows (in millions):
 
Three Months Ended
 
Nine Months Ended
 
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Numerator:
 
 
 
 
 
 
 
Net income (loss)
$
(1,255.2
)
 
$
112.6

 
$
(1,395.4
)
 
$
74.2

 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
Weighted average shares outstanding for basic EPS
143.3

 
146.3

 
143.2

 
144.4

Dilutive effect of share-based awards*
—

 
0.6

 
—

 
0.6

Weighted average shares outstanding for diluted EPS
143.3

 
146.9

 
143.2

 
145.0

 
 
 
 
 
 
 
 
Anti-dilutive share-based awards excluded from computation of diluted EPS*
—

 
0.1

 
—

 
—


* In the period of a net loss, diluted shares equal basic shares.

Shareholders' Equity

Shares

We issued shares related to the exercise and vesting of share-based compensation as follows:
Three Months Ended
 
Nine Months Ended
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
185,000

 
154,000

 
283,000

 
246,000


Share Repurchases

On October 22, 2015, the Board of Directors approved a share repurchase plan of up to $2.0 billion, of which $1.5 billion is still available to be repurchased through December 31, 2018. We did not repurchase any shares under the share repurchase plan during the nine months ended October 1, 2016.

NOTE 12 – ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

Changes in our AOCI balances, net of tax were as follows (in millions):
 
Foreign currency translation adjustments
 
Fair value of derivative financial instruments, net of tax
 
Fair value of investment securities, net of tax
 
Post-retirement and pension liability adjustments, net of tax
 
Total AOCI
Balance at December 31, 2015
$
(4.4
)
 
$
(14.2
)
 
$
6.3

 
$
(3.2
)
 
$
(15.5
)
OCI before reclassifications
71.8

 
(3.7
)
 
17.1

 
0.3

 
85.5

Amounts reclassified from AOCI
—

 
0.2

 
1.3

 
—

 
1.5

Other comprehensive income (loss)
71.8

 
(3.5
)
 
18.4

 
0.3

 
87.0

Balance at October 1, 2016
$
67.4

 
$
(17.7
)
 
$
24.7

 
$
(2.9
)
 
$
71.5

    

29
Perrigo Company plc - Item 1
Note 13


NOTE 13 – INCOME TAXES

The effective tax rate for the three months ended October 1, 2016 was 20.1% on a net loss compared to 14.8% on net income for the three months ended September 26, 2015. The effective tax rate for the nine months ended October 1, 2016 was 21.6% on a net loss reported in the period compared to 60.3% on net income for the nine months ended September 26, 2015. For the three and nine months ended October 1, 2016, we have estimated income taxes using the annual effective tax rate method.

Income taxes recorded through July 2, 2016 were estimated using the discrete method. For the three and nine months ended ended October 1, 2016, we had significant changes to our estimates related to additional asset impairments recognized in the third quarter and therefore determined that estimating income taxes using the annual effective tax rate method was the more appropriate method for the period ending October 1, 2016.

Our tax rate is subject to adjustment over the balance of the fiscal year due to, among other things: income tax rate changes by governments; the jurisdictions in which our profits are determined to be earned and taxed; changes in the valuation of our deferred tax assets and liabilities; adjustments to estimated taxes upon finalization of various tax returns; adjustments based on differing interpretations of the applicable transfer pricing standards; changes in available tax credits, grants and other incentives; changes in stock-based compensation expense; changes in tax laws or the interpretation of such tax laws (for example, proposals for fundamental U.S. international tax reform); changes in U.S. GAAP; expiration of or the inability to renew tax rulings or tax holiday incentives; and the repatriation of earnings with respect to which we have not previously provided for taxes.

Israel passed legislation in January 2016, effective immediately, reducing the tax rate from 26.5% to 25%. The impact on our effective tax rate was minimal.

The United Kingdom passed legislation in September 2016, reducing the tax rate effective April 1, 2020, from 18% to 17%. We expect the impact on our effective tax rate to be minimal.

The total liability for uncertain tax positions was $368.4 million and $334.7 million as of October 1, 2016 and December 31, 2015, respectively, before considering the federal tax benefit of certain state and local items.

We recognize interest and penalties related to uncertain tax positions as a component of income tax expense. The total amount accrued for interest and penalties in the liability for uncertain tax positions was $56.4 million and $52.1 million as of October 1, 2016 and December 31, 2015, respectively.

We file income tax returns in numerous jurisdictions and are therefore subject to audits by tax authorities. Our primary income tax jurisdictions are Ireland, the U.S., Israel, Belgium, France, and the U.K.

Although we believe that the tax estimates are reasonable and that we prepare our tax filings in accordance with all applicable tax laws, the final determination with respect to any tax audit and any related litigation could be materially different from estimates or from historical income tax provisions and accruals. The results of an audit or litigation could have a material effect on our operating results and/or cash flows in the periods for which that determination is made. In addition, future period earnings may be adversely impacted by litigation costs, settlements, penalties, and/or interest assessments.

The IRS audit of our fiscal years ended June 27, 2009 and June 26, 2010 had previously concluded with the issuance of a statutory notice of deficiency on August 27, 2014. While we had previously agreed on certain adjustments and made associated payments of $8.0 million (inclusive of interest) in November 2014, the statutory notice of deficiency asserted various additional adjustments, including transfer pricing adjustments. The statutory notice of deficiency's adjustments for fiscal years 2009 and 2010 asserted an incremental tax obligation of approximately $68.9 million, inclusive of interest and penalties. We disagree with the IRS’s positions asserted in the statutory notice of deficiency. To contest the IRS's adjustments, in January 2015 we paid the incremental tax obligation (a prerequisite to contesting the proposed adjustments in U.S. district court), and in June 2015, we filed an administrative request for a refund with the IRS. The payment was recorded during the three months ended March 28, 2015 as a deferred charge on the balance sheet given our anticipated action to recover this amount. The IRS subsequently denied our request for a refund. We anticipate filing a complaint in U.S. district court claiming a

30
Perrigo Company plc - Item 1
Note 13


refund of the paid amounts prior to August 2017. An unfavorable resolution of this matter could have a material impact on our consolidated financial statements in future periods.

We have ongoing audits in multiple jurisdictions the resolution of which remains uncertain. These jurisdictions include, but are not limited to, the United States and Belgium. The IRS is auditing our fiscal years ended June 25, 2011 and June 30, 2012, and may make adjustments consistent with the adjustments made in the statutory notice of deficiency for fiscal years 2009 and 2010. In February 2016, the Belgium Tax Authority notified us that all Belgium locations will be audited for the years ended December 31, 2013 and December 31, 2014. At this time, we cannot predict the outcome of any audit or related litigation.
 
NOTE 14 – COMMITMENTS AND CONTINGENCIES

In view of the inherent difficulties of predicting the outcome of various types of legal proceedings, we cannot determine the ultimate resolution of the matters described below. We establish reserves for litigation and regulatory matters when losses associated with the claims become probable and the amounts can be reasonably estimated. The actual costs of resolving legal matters may be substantially higher or lower than the amounts reserved for those matters. For matters where the likelihood or extent of a loss is not probable or cannot be reasonably be estimated as of October 1, 2016, we have not recorded a loss reserve. If certain of these matters are determined against the Company, there could be a material adverse effect on our financial condition, results of operations, or cash flows. We currently believe we have valid defenses to the claims in these lawsuits and intend to defend these lawsuits vigorously regardless of whether or not we have a loss reserve. Other than what is disclosed below, we do not expect the outcome of the litigation matters to which we are currently subject to, individually or in the aggregate, have a material adverse effect on our financial condition, results of operations, or cash flows. 

Securities Litigation
 
On May 18, 2016, a shareholder filed a securities case against the Company and our former CEO, Joseph Papa, in the District of New Jersey (Roofers’ Pension Fund v. Papa, et al.). The plaintiff purports to represent a class of shareholders for the period from April 21, 2015 through May 11, 2016, inclusive. The complaint alleges violations of Securities Exchange Act sections 10(b) (and Rule 10b‑5) and 14(e) against both defendants and 20(a) control person liability against Mr. Papa. In general, the allegations concern the actions taken by the Company and the former executive to defend against the hostile takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015. The plaintiff also alleges that we provided inadequate disclosure concerning alleged integration problems related to the Omega acquisition in the period from April 21, 2015 through May 11, 2016. The case is in an early stage. Four different plaintiff groups have sought appointment as lead plaintiff/lead counsel. The court will decide who will represent the purported class. Once the court has chosen a lead plaintiff, the plaintiff will likely file an amended complaint and the defendants will then have an opportunity to make a motion to dismiss the case. 
 
On July 19, 2016, a shareholder filed a securities class action against the Company and our former CEO, Joseph Papa, in the District of New Jersey. (Wilson v. Papa, et al.) The plaintiff purports to represent a class of persons who sold put options on the Company shares between April 21, 2015 and May 11, 2016. In general, the allegations and the claims are the same as those made in the Roofers' Pension Fund case described above. Subsequently, this shareholder filed papers in the Roofers' Pension Fund case as one of four candidates seeking to be named lead plaintiff or co-lead plaintiff in that case. The Wilson plaintiff also filed a motion to have the Wilson case consolidated with the Roofers' Pension Fund case. The court has not yet acted on the motion to consolidate or the motion for appointment as lead plaintiff.
 
On May 22, 2016, shareholders filed a securities class action against the Company and five individual defendants: Mr. Papa, our former Executive Vice President and General Manager of the BCH segment Marc Coucke, our Chief Executive Officer John Hendrickson, and our Board members Gary Kunkle, Jr. and Laurie Brlas alleging violations of Israeli law in the District Court of Tel Aviv-Jaffa (Schwieger et al. v. Perrigo Company plc, et al.). On June 15, 2016, Perrigo filed a motion to stay the case pending the outcome of the securities class action pending in the New Jersey federal court. The plaintiffs did not oppose the motion. The Israeli court granted the motion on the same day, and the action is stayed.


31
Perrigo Company plc - Item 1
Note 14


Eltroxin

During October and November 2011, nine applications to certify a class action lawsuit were filed in various courts in Israel related to Eltroxin, a prescription thyroid medication manufactured by a third party and distributed in Israel by our subsidiary, Perrigo Israel Agencies Ltd. The respondents included our subsidiaries, Perrigo Israel Pharmaceuticals Ltd. and/or Perrigo Israel Agencies Ltd., the manufacturers of the product, and various healthcare providers who provide healthcare services as part of the compulsory healthcare system in Israel.

One of the applications was dismissed and the remaining eight applications were consolidated into one application. The applications arose from the 2011 launch of a reformulated version of Eltroxin in Israel. The consolidated application generally alleges that the respondents: (a) failed to timely inform patients, pharmacists and physicians about the change in the formulation; and (b) failed to inform physicians about the need to monitor patients taking the new formulation in order to confirm patients were receiving the appropriate dose of the drug. As a result, claimants allege they incurred the following damages: (a) purchases of product that otherwise would not have been made by patients had they been aware of the reformulation; (b) adverse events to some patients resulting from an imbalance of thyroid functions that could have been avoided; and (c) harm resulting from the patients' lack of informed consent prior to the use of the reformulation.

Several hearings on whether or not to certify the consolidated application took place in December 2013 and January 2014. On May 17, 2015, the District Court certified the motion against Perrigo Israel Agencies Ltd. and dismissed it against the remaining respondents, including Perrigo Israel Pharmaceuticals Ltd.

On June 16, 2015, Perrigo submitted a motion for permission to appeal the decision to certify to the Israeli Supreme Court together with a motion to stay the proceedings of the class action until the motion for permission to appeal is adjudicated. Perrigo has filed its statement of defense to the underlying proceedings and the underlying proceedings have been stayed pending a decision on the motion to appeal.

During a July 11, 2016 hearing on Perrigo’s motion to appeal the certification decision, the court noted that permission should be granted to Perrigo's appeal given issues with the scope of the District Court's decision.  The court ultimately recommended the parties pursue mediation, noting that no decision on Perrigo's motion to appeal will be made pending the results of the mediation. The parties are now engaged in the mediation process. At this stage, we cannot reasonably predict the outcome or the liability, if any, associated with this claim.

Tysabri® Product Liability Lawsuits

Perrigo and collaborator Biogen are co-defendants in product liability lawsuits arising out of the occurrence of Progressive Multifocal Leukoencephalopathy, a serious brain infection, and serious adverse events, including deaths, which occurred in patients taking Tysabri®. Perrigo and Biogen will each be responsible for 50% of losses and expenses arising out of any Tysabri® product liability claims. During calendar year 2016, one case in the U.S. was settled and two others were dismissed with prejudice. While the remaining lawsuits will be vigorously defended, management cannot predict how these cases will be resolved. Adverse results in one or more of these lawsuits could result in substantial judgments against the Company.

NOTE 15 – COLLABORATION AGREEMENTS AND OTHER CONTRACTUAL ARRANGEMENTS

In May 2015, we entered into a development agreement wherein we transferred the ownership rights to two pharmaceutical products to a clinical stage development company to fund and conduct development activities for the products. We do not expect to incur any expense related to the development of either product. If the products are approved by the FDA, we will execute a buy-back agreement to purchase each product for a multiple of the development costs incurred. Based on the initial development budget for each product, the estimated purchase price for both products is approximately $78.0 million. If development costs exceed the initial budgeted amounts, the purchase price will increase but will not exceed approximately $105.0 million. If the products are approved by the FDA and we purchase the products, we estimate the acquisitions will occur in 2019 and 2020. 


32
Perrigo Company plc - Item 1
Note 15


In June 2016, we added an additional product to the May 2015 development agreement that is subject to similar buy-back terms if the product is approved by the FDA. The estimated purchase price for this additional product, based on the initial development budget, is approximately $42.0 million. If development costs exceed the initial budgeted amounts, the purchase price will increase, but will not exceed approximately $57.0 million. If the product is approved by the FDA and we purchase the product, we estimate the acquisition will occur in 2020. There can be no assurance that any such products will be approved by the FDA on the anticipated schedule or at all.

NOTE 16 – RESTRUCTURING CHARGES

We periodically take action to reduce redundant expenses and improve operating efficiencies, typically in connection with business acquisitions. The following reflects our restructuring activity (in millions):
 
Three Months Ended
 
Nine Months Ended
 
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Beginning balance
$
12.2

 
$
1.7

 
$
20.7

 
$
3.2

Additional charges
6.6

 
2.2

 
17.9

 
3.1

Payments
(8.6
)
 
(1.9
)
 
(33.3
)
 
(4.5
)
Non-cash adjustments
0.1

 
(0.7
)
 
5.0

 
(0.5
)
Ending balance
$
10.3

 
$
1.3

 
$
10.3

 
$
1.3


Restructuring activity includes severance, lease exit costs, and asset impairments. The charges incurred during the three and nine months ended October 1, 2016 were associated primarily with actions we took to streamline our organization as announced on October 22, 2015 and did not materially impact any one reportable segment. There were no other material restructuring programs in any of the periods presented. All charges are recorded in Restructuring expense. The remaining $5.1 million liability for employee severance benefits will be paid within the next year, while cash expenditures related to the remaining $5.2 million liability for lease exit costs will be incurred over the remaining terms of the applicable leases.

NOTE 17 – SEGMENT INFORMATION

Our reporting segments are as follows:

•
CHC is focused primarily on the global sale of OTC store brand products including cough, cold, allergy and sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, and diagnostic products.

•
BCH develops, manufactures, markets and distributes many well-known European OTC brands in the natural health and vitamins, cough, cold and allergy, smoking cessation, personal care and derma-therapeutics, lifestyle, and anti-parasite categories.

•
Rx develops, manufactures and markets a portfolio of generic and specialty pharmaceutical prescription drugs primarily for the U.S. and U.K. markets.

•
Specialty Sciences is comprised primarily of royalties received from assets focused on the management of multiple sclerosis (Tysabri®).

We also have an Other reporting segment that consists of our API business, which does not meet the quantitative threshold required to be a separately reportable segment. Our segments reflect the way in which our chief operating decision maker reviews our operating results and allocates resources.


33
Perrigo Company plc - Item 1
Note 17


The below tables show select financial measures by reporting segment (in millions):
Total Assets
 
October 1,
2016
 
December 31, 2015
CHC
 
$
3,873.8

 
$
4,007.8

BCH
 
4,460.2

 
6,324.0

Rx
 
3,304.0

 
3,015.5

Specialty Sciences
 
5,634.0

 
5,833.5

Other
 
195.6

 
213.1

Total
 
$
17,467.6

 
$
19,393.9

 
Three Months Ended
 
October 1, 2016
 
September 26, 2015
 
Net Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
 
Net Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
CHC
$
669.1

 
$
100.1

 
$
19.2

 
$
675.2

 
$
117.3

 
$
19.4

BCH
304.0

 
(1,684.3
)
 
38.9

 
302.2

 
4.4

 
36.3

Rx
267.4

 
77.9

 
30.7

 
260.3

 
91.0

 
18.6

Specialty Sciences
93.4

 
23.3

 
72.8

 
84.5

 
9.0

 
72.8

Other
21.0

 
(1.6
)
 
0.5

 
22.5

 
6.2

 
0.5

Unallocated
—

 
(30.6
)
 
—

 
—

 
(39.3
)
 
—

Total
$
1,354.9

 
$
(1,515.2
)
 
$
162.1

 
$
1,344.7

 
$
188.6

 
$
147.6

 
Nine Months Ended
 
October 1, 2016
 
September 26, 2015
 
Net Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
 
Net Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
CHC
$
2,055.6

 
$
313.6

 
$
58.1

 
$
2,106.4

 
$
364.8

 
$
52.1

BCH*
1,015.3

 
(2,128.7
)
 
113.9

 
703.4

 
31.0

 
70.5

Rx
817.4

 
262.1

 
90.1

 
790.1

 
290.4

 
55.5

Specialty Sciences
271.3

 
49.7

 
218.3

 
250.1

 
21.0

 
218.4

Other
59.5

 
2.6

 
1.4

 
75.4

 
18.6

 
1.4

Unallocated
—

 
(80.0
)
 
—

 
—

 
(111.1
)
 
—

Total*
$
4,219.1

 
$
(1,580.7
)
 
$
481.8

 
$
3,925.4

 
$
614.7

 
$
397.9


*
The BCH segment was created on March 30, 2015 as a result of the Omega acquisition, thus data for the nine months ended September 26, 2015 includes only six months of results from operations attributable to Omega.

ITEM 2.        MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

EXECUTIVE OVERVIEW

This Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the financial statements included in this Form 10-Q and our Form 10-KT for the transition period from June 28, 2015 to December 31, 2015. These historical financial statements may not be indicative of our future performance. This discussion contains a number of forward-looking statements, all of which are based on our current expectations and could be affected by the uncertainties and risks referred to under “Risk Factors” in Item 1A of our Form 10-KT for the transition period from June 28, 2015 to December 31, 2015 and Part II, Item 1A of this Form 10-Q.

34
Perrigo Company plc - Item 2
Executive Overview




Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013 and became the successor registrant of Perrigo Company, a Michigan corporation, on December 18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo," the "Company," "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries.

We are a leading global over-the-counter ("OTC") consumer goods and specialty pharmaceutical company, offering patients and customers high quality products at affordable prices. From our beginning in 1887 as a packager of home remedies, we have grown to become the world's largest manufacturer of OTC healthcare products and supplier of infant formulas for the store brand market. We are also a leading provider of generic extended topical prescription products, and we receive royalties from sales of the multiple sclerosis drug Tysabri.® We provide “Quality Affordable Healthcare Products®” across a wide variety of product categories and geographies, primarily in North America, Europe, and Australia, as well as in other markets, including Israel, China, and Latin America.
    
             Our reporting segments are as follows:

•
Consumer Healthcare ("CHC") is focused primarily on the global sale of OTC store brand products including cough, cold, allergy and sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, and diagnostic products.

•
Branded Consumer Healthcare ("BCH") develops, manufactures, markets and distributes many well-known European OTC brands in the natural health and vitamins, cough, cold and allergy, smoking cessation, personal care and derma-therapeutics, lifestyle, and anti-parasite categories.

•
Prescription Pharmaceuticals ("Rx") develops, manufactures and markets a portfolio of generic and specialty pharmaceutical prescription drugs primarily for the U.S. and U.K. markets.

•
Specialty Sciences is comprised primarily of royalties received from assets focused on the management of multiple sclerosis (Tysabri®).

We also have an "Other" segment comprised of our active pharmaceutical ingredients ("API") business, which develops, manufactures, and markets active API used worldwide by both generic and branded pharmaceutical companies. For results by segment, see "Segment Results" below and Item 1. Note 17.

Leadership Changes

On August 29, 2016, Jim Michaud joined the Company as Executive Vice President, Chief Human Resources Officer.

On November 8, 2016, we appointed John Wesolowski the General Manager, Rx Pharmaceuticals. Mr. Wesolowski served as Acting General Manager, Rx Pharmaceuticals following the resignation of Doug Boothe on July 20, 2016.

On April 27, 2016, Sharon Kochan's role as Executive Vice President and General Manager, International, was expanded to lead the BCH segment following the resignation of Marc Coucke as Executive Vice President and General Manager of the BCH segment.

On April 24, 2016, we named Laurie Brlas as Chairman of the Board of Directors, promoted John T. Hendrickson from President to Chief Executive Officer, and accepted the resignation of Joseph C. Papa as Chairman and Chief Executive Officer.

Interim Impairment Testing

In connection with the preparation of our financial statements for the three-month period ended April 2, 2016, we identified indicators of goodwill impairment in our BCH - rest of world (“BCH - ROW”) reporting unit, which

35
Perrigo Company plc - Item 2
Executive Overview



comprises primarily operations attributable to the Omega acquisition in all geographic regions except for Belgium. The primary impairment indicators included the decline in our 2016 performance expectations and a reduction in our long-range revenue growth forecast. Step one of the goodwill impairment test involved determining the fair value of the reporting unit using a discounted cash flow technique and comparing it to the reporting unit’s carrying value. The main assumptions supporting the cash flow projections used to determine the reporting unit’s fair value included revenue growth based on product line extensions, product life cycle strategies, and geographical expansion within the markets in which the reporting unit distributes products, gross margins consistent with historical trends, and advertising and promotion investments largely consistent with the reporting unit's growth plans. The BCH-ROW reporting unit did not pass step one of goodwill impairment testing. The change in fair value from previous estimates was due primarily to the changes in the market and performance of certain brands such that the evaluation of brand prioritization and product extensions or launches in new regions are being more focused to maximize the potential of all brands in the segment's portfolio.

The second step of the goodwill impairment test required that we determine the implied fair value of the BCH - ROW reporting unit’s goodwill, which involved determining the value of the reporting unit’s individual assets and liabilities. Due to the complex and time-consuming nature of step two, based on our evaluation and initial estimates of the fair values of the assets and liabilities and the deficit of the fair value when compared to the related book value, we recorded an estimated impairment charge of $193.6 million for the three months ended April 2, 2016. We finalized the step two fair value calculation during the three months ended July 2, 2016, which resulted in a $30.3 million reduction to the estimated impairment charge recorded during the three months ended April 2, 2016,

In connection with the preparation of our financial statements for the three months ended October 1, 2016, we identified additional indicators of goodwill impairment in both our BCH - ROW and our BCH - Belgium reporting units. With respect to both reporting units, the primary impairment indicators included an additional decline in our 2016 performance expectations for the remainder of the year and a reduction in our long-range revenue growth and margin forecasts due to the factors outlined below. Step one of the goodwill impairment test involved determining the fair value of the reporting units using a discounted cash flow technique and comparing it to the respective reporting units' carrying value. The main assumptions supporting the cash flow projections used to determine each reporting unit’s fair value included revenue growth based on product line extensions, product life cycle strategies, and geographical expansion within the markets in which the reporting unit distributes products, gross margins consistent with historical trends and including supply chain cost improvement plans, and advertising and promotion investments largely consistent with the reporting unit's growth plans. Both the BCH - ROW and the BCH - Belgium reporting units did not pass step one of goodwill impairment testing. As it relates to the BCH - ROW reporting unit, the changes in fair value from previous estimates were due primarily to (1) changes in the market and performance of certain brands due to moderated new product launch assumptions, (2) execution of certain key product strategies falling short of expectations causing a reduction to baseline forecast models in France, Germany and Italy, (3) certain macro-economic factors having continued to impact the business more than expected in France, Russia and Turkey in addition to unfavorable foreign currency impacts experienced primarily in the UK related to Brexit. As it relates to BCH - Belgium reporting unit, the changes in fair value from previous estimates due to change in the forecast as a result of a reduction in volume with a major wholesaler due to factors consistent with those outlined for BCH - ROW.

The second step of the goodwill impairment test required that we determine the implied fair value of both the BCH - ROW and BCH - Belgium reporting units' goodwill, which involved determining the value of each reporting unit’s individual assets and liabilities. Based on our evaluation and initial estimates of the fair values of the assets and liabilities and the deficit of the fair value when compared to the related book value, we recorded an estimated impairment charge of $734.7 million related to the BCH - ROW reporting unit and $69.4 million related to the BCH - Belgium reporting unit for the three months ended October 1, 2016. Both charges were recorded in Impairment charges on the Condensed Consolidated Statements of Operations within our BCH segment. Due to the complex and time-consuming nature of step two we expect to finalize the fair value calculation during the fourth quarter of 2016, which could result in an adjustment to the estimated impairment charge. As of October 1, 2016, $1.0 billion and $70.2 million of goodwill remains in the BCH - ROW and BCH - Belgium reporting units, respectively.

In connection with the preparation of our financial statements for the three-month period ended April 2, 2016, we identified indicators of impairment associated with certain indefinite-lived intangible assets acquired in conjunction with the Omega acquisition. The primary impairment indicators included the decline in our 2016

36
Perrigo Company plc - Item 2
Executive Overview



performance expectations and a reduction in our long-range revenue growth forecast. The assessment utilized the excess earnings method to determine fair value and resulted in an impairment charge of $273.4 million in Impairment charges on the Condensed Consolidated Statements of Operations within our BCH segment, which represented the difference between the carrying amount of the intangible assets and their estimated fair value. The change in fair value from previous estimates was due primarily to the changes in the market and performance of the brands such that the evaluation of brand prioritization and product extensions or launches in new regions are being more focused to maximize the potential of all brands in the segment's portfolio. The main assumptions supporting the fair value of these assets and cash flow projections included revenue growth based on product line extensions, product life cycle strategies, and geographical expansion within the markets in which the BCH segment distributes products, gross margins consistent with historical trends, and advertising and promotion investments largely consistent with the segment's growth plans.

In connection with the preparation of our financial statements for the three months ended October 1, 2016, we identified additional indicators of impairment associated with certain indefinite-lived and definite-lived intangible brand category assets acquired in conjunction with the Omega acquisition. The primary impairment indicators are discussed above in goodwill. The assessment of the indefinite-lived assets utilized the excess earnings method to determine fair value and resulted in an impairment charge of $575.7 million for the three months ended October 1, 2016. With regards to the definite-lived asset, it was determined that the carrying value of the asset group was not recoverable based on an assessment of the undiscounted future cash flows expected to be generated by the asset group. Given this, the excess earnings method was utilized to determine fair value of the definite-lived asset and resulted in an impairment charge of $290.2 million for the three months ended October 1, 2016. Both charges, which represented the difference between the carrying amount of the intangible assets and their estimated fair value, were recorded in Impairment charges on the Condensed Consolidated Statements of Operations within our BCH segment. The main assumptions supporting the fair value of these assets and cash flow projections are included in the goodwill discussions above.

The carrying value for certain intangible assets and goodwill equals estimated and implied fair values, respectively, and as a result, any further deterioration in those assets' fair value would lead to a further impairment charge. Future performance different from the assumptions utilized in our quantitative analyses may result in additional changes in the fair value. We will continue to monitor and assess these assets for potential impairment should further impairment indicators arise. We will complete our required annual impairment testing during the fourth quarter of 2016.

In addition, given the additional change in performance expectations for our remaining impaired cough/cold/allergy, anti-parasite, personal care and natural health brands previously recorded as indefinite-lived assets, we reclassified the remaining asset balance of $672.4 million related to these four assets to definite-lived assets with a 20-year useful life and began amortizing the assets as of October 2, 2016.


See Item 1. Note 3 for more information.


37
Perrigo Company plc - Item 2
Executive Overview



2016 Year-to-Date Highlights

•
Consistent with previously announced actions, we added a number of positions and processes to our Dublin headquarters across a range of corporate functions, including supply chain/global operations, procurement, enterprise risk management, and corporate finance, leveraging the strength of our global platform;

•
We continued restructuring associated primarily with actions we took to streamline our organization as announced on October 22, 2015;

•
We issued $1.2 billion of senior notes and repaid borrowings under revolving credit facilities;

•
We prepaid $500.0 million outstanding under our 1.300% Senior Notes due 2016 ("1.300% 2016 Notes") on September 29, 2016;

•
We completed several strategic acquisitions within our CHC and Rx segments that expanded our portfolio of products; and

•
We completed the sale of our U.S. Vitamins, Minerals, and Supplements ("VMS") business to International Vitamins Corporation ("IVC") on August 5, 2016.

RESULTS OF OPERATIONS

CONSOLIDATED

Recent Trends and Developments

•
We have experienced a reduction in pricing expectations during 2016 in comparison to historical patterns in our U.S. businesses, in particular in our Rx segment, due to industry and competitive pressures in the sector. The reduced pricing is attributable to a variety of factors including increased focus from customers to capture supply chain productivity savings, low raw material commodity pricing, competition in specific product categories, the loss of exclusivity on certain products, and consolidation of certain customers in the Rx segment. We have seen year-over-year pricing in the third quarter of 2016 moderate from the levels experienced in the first half of 2016. We expect this pricing environment to continue to impact the Company for the foreseeable future.

•
Our expectations for the BCH segment continue to be impacted by market dynamics in key countries such as Belgium, France, Germany and Italy. Factors impacting these countries include softness in certain leading brand categories primarily due to lower sell-through during the current year due to the re-staging launch timing of certain products, changes in timing of certain advertising and promotional campaigns compared to the prior year, and macro-economic factors, including unfavorable foreign currency impacts experienced primarily in the UK related to Brexit. The BCH segment has established a brand prioritization strategy to address these market dynamics, with an objective to balance the cost of advertising and promotion investments with expected contributions from category sales. The segment has further impacted in Belgium by a change in the forecasts with a major wholesaler, as management implements improved supply chain efficiencies in this market.

•
Our expectations for 2016 new product sales are consistent with those communicated in our Form 10-Q for the three months ended April 2, 2016, but continue to remain lower than we anticipated as of December 31, 2015. Several new product launches have been delayed due to the regulatory approval process for certain new products in the U.S. and modifications to market share penetration and timing assumptions for new products in our Rx and BCH segments.

•
On November 10, 2016, we announced the following strategic actions: (1) we are exploring strategic alternatives for the potential sale our Tysabri® asset, which is reported in our Specialty Sciences segment; (2) as part of the Company’s portfolio review process, we are conducting a comprehensive internal evaluation of the Rx pharmaceuticals segments’ market position, growth opportunities and interdependencies with other Company manufacturing and shared service operations to determine if 

38
Perrigo Company plc - Item 2
Consolidated


strategic alternatives should be explored;  and (3) we are conducting a review of segment and corporate cost structures to align with existing and future expected market dynamics.  We expect to complete these evaluations and reviews by the end of March 2017.

Consolidated Results
 
Three Months Ended
 
% Change
 
Nine Months Ended
 
% Change
($ in millions)
September 26,
2015
 
October 1,
2016
 
 
September 26,
2015
 
October 1,
2016
 
Net sales
$
1,344.7

 
$
1,354.9

 
1
 %
 
$
3,925.4

 
$
4,219.1

 
7
 %
Gross profit
$
548.8

 
$
506.3

 
(8
)%
 
$
1,555.7

 
$
1,596.4

 
3
 %
Gross profit %
40.8
%
 
37.4
 %
 
 
 
39.6
%
 
37.8
 %
 
 
Operating expenses
$
360.2

 
$
2,021.5

 
461
 %
 
$
941.0

 
$
3,177.1

 
238
 %
Operating expenses %
26.8
%
 
149.2
 %
 
 
 
24.0
%
 
75.3
 %
 
 
Operating income (loss)
$
188.6

 
$
(1,515.2
)
 
(904
)%
 
$
614.7

 
$
(1,580.7
)
 
(357
)%
Operating income (loss) %
14.0
%
 
(111.8
)%
 
 
 
15.7
%
 
(37.5
)%
 
 
Interest and other, net
$
56.4

 
$
56.3

 
—
 %
 
$
427.8

 
$
198.4

 
(54
)%
Income tax expense (benefit)
$
19.6

 
$
(316.3
)
 
(1,719
)%
 
$
112.7

 
$
(383.7
)
 
(440
)%
Net income (loss)
$
112.6

 
$
(1,255.2
)
 
(1,215
)%
 
$
74.2

 
$
(1,395.4
)
 
(1,981
)%
cy16q210q_chart-31361a01.jpgcy16q210q_chart-32495a01.jpg

The increase in consolidated sales for the three months ended October 1, 2016 as compared to the prior year period was primarily due to higher sales in the Rx segment attributable to contributions from acquisitions and new products and in the Specialty Sciences segment as a result of increased royalties from sales of Tysabri®. These increases were offset partially by lower sales in the CHC segment due to the sale of the U.S. VMS business in August 2016 and lower sales in the cough/cold and analgesics categories. Consolidated operating income for the three months ended October 1, 2016 decreased from the prior year period due primarily to lower gross profit margin flow through primarily as a result of reduced pricing in the Rx segment and product mix in the BCH segment.

The most significant change in our consolidated nine-month year-over-year results was the addition of Omega Pharma Invest N.V. ("Omega"). Omega was acquired on March 30, 2015; thus, results for the nine-months ended September 26, 2015 included only six months of operations attributable to Omega. The net loss for the nine months ended October 1, 2016 was due primarily to the recording of goodwill and intangible asset impairment charges totaling $2.1 billion, as described above under "Interim Impairment Testing" and in Item 1. Note 3. Net income in the prior year period included a $259.8 million loss on derivatives we used to economically hedge fluctuations in the euro-denominated purchase price of the Omega acquisition as described in Item 1. Note 8.

Further details and analysis of our financial results for the three and nine months ended October 1, 2016 and September 26, 2015 are provided below by reporting segment and line item.


39
Perrigo Company plc - Item 2
CHC


CONSUMER HEALTHCARE

Recent Trends and Developments

•
On August 5, 2016, we completed the sale of our U.S. VMS business to IVC for $61.8 million inclusive of an estimated working capital adjustment. Sales attributable to the U.S. VMS business totaled $21.0 million and $40.9 million for the three months ended October 1, 2016 and September 26, 2015, respectively, and $110.1 million and $118.0 million for the nine months ended October 1, 2016 and September 26, 2015, respectively.

•
We have experienced a reduction in pricing expectations, primarily in the cough/cold, animal health and analgesics categories within our CHC segment in 2016 due to various factors, including increased focus from customers to capture supply chain productivity savings, low raw material commodity pricing, and competition in specific product categories. We expect this pricing environment to continue to impact our CHC segment for the foreseeable future.

Segment Results

Three Month Comparison
cy16q110q_chart-04822a02.jpg
 

 
Three Months Ended
($ in millions)
September 26, 2015
 
October 1,
2016
Net sales
$
675.2

 
$
669.1

Gross profit
$
231.0

 
$
216.8

Gross profit %
34.2
%
 
32.4
%
Operating income
$
117.3

 
$
100.1

Operating income %
17.4
%
 
15.0
%

Three Months Ended October 1, 2016 vs. Three Months Ended September 26, 2015

Net sales decreased $6.1 million, or 1%, over the prior year period due to:

•
Lower year-over-year sales of $19.9 million attributable to the U.S. VMS business, which was sold in August 2016;
•
A net decrease in sales of existing products of $12.3 million due to:
•
Strong sales in our infant nutrition and smoking cessation categories; more than offset by
•
Pricing pressure primarily in the cough/cold, animal health, and analgesics categories;
•
A milder allergy season, which impacted sales in the cough/cold category; and
•
Lower sales in the antacids category; and
•
Discontinued products of $5.6 million; and
•
Unfavorable foreign currency movement of $7.0 million; offset partially by
•
New product sales of $33.1 million related primarily to the launches of fluticasone nasal spray (store brand equivalent to Flonase®), the guaifenesin family of products (store brand equivalent to Mucinex®), and several new infant formula and food products; and
•
Incremental net sales of $5.6 million from acquisitions (primarily the ScarAway® acquisition).

40
Perrigo Company plc - Item 2
CHC


Operating income decreased $17.2 million, or 15%, as a result of:

•
A decrease of $14.2 million in gross profit due to:
•
Pricing pressure as noted above; and
•
Increased intangible asset amortization expense associated primarily with the ScarAway® acquisition; offset partially by
•
Margin contributions from new products and strong performance in the infant health and smoking cessation categories; and
•
Continued manufacturing and supply chain efficiencies.

•
An increase of $3.0 million in operating expenses due to:
•
Increased research and development investments of $1.1 million due to timing of clinical trials;
•
Increased restructuring expenses of $3.2 million related primarily to the sale of our U.S. VMS business; and
•
A $3.4 million impairment charge recorded on the held-for-sale assets associated with our Animal Health pet treats plant; offset partially by
•
Decreased administrative expenses of $4.3 million due to cost containment.

Nine Month Comparison
cy16q210q_chart-31980a01.jpg
 

 
Nine Months Ended
($ in millions)
September 26,
2015
 
October 1,
2016
Net sales
$
2,106.4

 
$
2,055.6

Gross profit
$
701.1

 
$
660.8

Gross profit %
33.3
%
 
32.1
%
Operating income
$
364.8

 
$
313.6

Operating income %
17.3
%
 
15.3
%

Nine Months Ended October 1, 2016 vs. Nine Months Ended September 26, 2015

Net sales decreased $50.8 million, or 2%, over the prior year period due to:

•
A net $94.4 million decrease in existing product sales as a result of:
•
Strong sales in our infant nutrition and smoking cessation categories; more than offset by
•
A milder cold and flu season in the first and second quarters of 2016, which led to weaker sales in the cough/cold and analgesics categories;
•
Pricing pressure, which particularly impacted sales in the cough/cold, analgesics, and animal health categories;
•
Lower sales in the antacids category; and
•
Timing of promotions in the second and third quarters of 2015 and a milder allergy season in the third quarter of 2016, which impacted current year sales in the cough/cold category; and
•
Discontinued products of $55.0 million related primarily to a label refresh within the infant formula category;
•
Lower year-over-year sales of $7.9 million attributable to the U.S. VMS business, which was sold in August 2016; and
•
Unfavorable foreign currency movement of $19.6 million; offset partially by
•
New product sales of $96.3 million related primarily to the launches of fluticasone nasal spray (store brand equivalent to Flonase®), the guaifenesin family of products (store brand equivalent to Mucinex®), several new infant formula and food products, and new animal health products; and
•
Incremental net sales of $29.8 million due primarily to the Gelcaps Exportadora de Mexico, S.A. de C.V. ("Gelcaps") and the ScarAway® acquisitions.


41
Perrigo Company plc - Item 2
CHC


Operating income decreased $51.2 million, or 14%, as a result of:

•
A decrease of $40.3 million in gross profit due to:
•
Pricing pressure as noted above; and
•
Increased intangible asset amortization expense associated primarily with the Gelcaps and ScarAway® acquisitions; offset partially by
•
Margin contributions from new products and strong performance in the infant nutrition and smoking cessation categories; and
•
Continued manufacturing and supply chain efficiencies.

•
An increase of $10.9 million in operating expenses due to:
•
A $6.2 million impairment charge related to the sale of the U.S. VMS business;
•
A $3.4 million impairment charge recorded on the held-for-sale assets associated with our Animal Health Pet treats plant;
•
Increased restructuring expenses of $5.0 million related primarily to the sale of the U.S. VMS business; and
•
Increased research and development investments due to timing of clinical trials; offset partially by
•
Decreased administrative expenses due to cost containment.

BRANDED CONSUMER HEALTHCARE


Recent Trends and Developments

•
Our expectations for the BCH segment continue to be impacted by market dynamics in key countries such as Belgium, France, Germany and Italy. Factors impacting these countries include softness in certain leading brand categories primarily due to lower sell-through during the current year due to the re-staging launch timing of certain products, changes in timing of certain advertising and promotional campaigns compared to the prior year, and macro-economic factors, including unfavorable foreign currency impacts experienced primarily in the UK related to Brexit. The BCH segment has established a brand prioritization strategy to address these market dynamics, with an objective to balance the cost of advertising and promotion investments with expected contributions from category sales. The segment has further impacted in Belgium by a change in the forecasts with a major wholesaler, as management implements improved supply chain efficiencies in this market.

•
Our expectations for 2016 new product sales are consistent with those communicated in our Form 10-Q for the three months ended April 2, 2016, but continue to remain lower than anticipated as of December 31, 2015. Several new product launches have been delayed due to modifications to market share penetration and timing assumptions for new products in Europe.

•
We continue to make progress on our previously announced restructuring plans to right-size the BCH business due to the impact of market dynamics on sales volumes. In addition, we made several strategic leadership changes during the three months ended October 1, 2016, including new leaders for Belgium, France and Germany. Management continues to evaluate the overall cost structure relative to current and expected market dynamics.

•
Management continues to evaluate the most effective business model for each country and has announced strategic evaluations for Russia, South Africa, and Argentina.


42
Perrigo Company plc - Item 2
BCH


Segment Results

Three Month Comparison

cy16q210q_chart-30851a01.jpg
 

 
Three Months Ended
($ in millions)
September 26,
2015
 
October 1,
2016
Net sales
$
302.2

 
$
304.0

Gross profit
$
164.3

 
$
131.6

Gross profit %
54.4
%
 
43.3
 %
Operating income (loss)
$
4.4

 
$
(1,684.3
)
Operating income (loss) %
1.4
%
 
(554.1
)%


Three Months Ended October 1, 2016 vs. Three Months Ended September 26, 2015

Net sales increased $1.8 million, or 1%, over the prior year period due to:

•
New product sales of $25.8 million; and
•
Incremental net sales of $17.5 million from the Naturwohl Pharma GmbH ("Naturwohl") and GlaxoSmithKline Consumer Healthcare Product Portfolio ("GSK Products") acquisitions; offset by
•
Decreased sales volumes of existing products totaling $32.1 million due primarily to weaker current year sales in the lifestyle category attributable in large part to a product launch in the prior year period and the natural health/vitamins category due primarily to timing of promotional activities and the planned divestment of the Etixx® brand;
•
Unfavorable foreign currency movement of $5.5 million; and
•
Discontinued products of $4.1 million.

Operating income decreased $1.7 billion, as a result of:

•
A decrease of $32.7 million in gross profit due to:
•
Decreased sales of existing products in the higher-margin lifestyle and natural health/vitamins categories as noted above;
•
Weaker performance in Belgium;
•
Higher inventory obsolescence realized primarily from prior year product levels; and
•
Unfavorable foreign currency effect; offset partially by

•
An increase of $1.7 billion in operating expenses due primarily to intangible asset and goodwill impairment charges totaling $1.7 billion, as described above under "Interim Impairment Testing"; and
•
A decrease of advertising and promotional spending due to previously announced strategic initiatives to better align promotional investments with sales.

Nine Month Comparison*

* The BCH segment was created on March 30, 2015 as a result of the Omega acquisition, thus comparative prior year data for the nine months ended September 26, 2015 includes only six months of results from operations.

43
Perrigo Company plc - Item 2
BCH


cy16q210q_chart-31816a01.jpg
 


 
Nine Months Ended
($ in millions)
September 26, 2015*
 
October 1,
2016
Net sales
$
703.4

 
$
1,015.3

Gross profit
$
354.5

 
$
461.2

Gross profit %
50.4
%
 
45.4
 %
Operating income (loss)
$
31.0

 
$
(2,128.7
)
Operating income (loss) %
4.4
%
 
(209.7
)%


Nine Months Ended October 1, 2016 vs. Nine Months Ended September 26, 2015

Net sales increased $311.9 million, or 44%, over the prior year period due to:

•
An additional three months of results from operations attributable to Omega;
•
New products totaling $85.3 million; and
•
Sales from the Naturwohl and GSK Products acquisitions totaling $84.2 million; offset partially by
•
Decreased sales volumes of existing products due primarily to weaker current year sales in the lifestyle category due in part to a product launch in the prior year period and the natural health/vitamins category due primarily to timing of promotional activities and the planned divestment of the Etixx® brand;
•
Unfavorable foreign currency movement of $5.0 million; and
•
Discontinued products of $5.6 million.

Operating income decreased $2.2 billion due to:

•
A $106.7 million increase in gross profit due to an additional three months of operations attributable to Omega; more than offset by
•
Decreased sales of existing products in the higher-margin lifestyle and natural health/vitamins categories noted above,
•
Weaker performance in Belgium,
•
Higher inventory obsolescence realized primarily from a prior year product levels, and
•
Unfavorable foreign currency effect; more than offset by

•
An increase of $2.3 billion in operating expenses due primarily to:
•
Intangible asset and goodwill impairment charges totaling $2.1 billion, as described above under "Interim Impairment Testing";
•
An additional three months of operations; and
•
Restructuring charges totaling $8.3 million related to strategic organizational enhancements; offset partially by
•
Cost control measures employed to mitigate lower forecasted sales and operating income.


44
Perrigo Company plc - Item 2
Rx


PRESCRIPTION PHARMACEUTICALS


Recent Trends and Developments

•
We continue to experience a significant reduction in pricing expectations in our Rx segment due to industry and competitive pressures in the sector. This softness in pricing is attributed to various factors, including increased focus from customers to capture supply chain productivity savings, low raw material commodity pricing, competition in specific products, and consolidation of certain customers. We expect this softness to continue to impact the segment for the foreseeable future.

•
On January 22, 2016, we acquired a portfolio of generic dosage forms and strengths of Retin-A® (tretinoin), a topical prescription acne treatment, from Matawan Pharmaceuticals, LLC, for $416.4 million in cash ("Tretinoin Products").

•
On March 1, 2016, we completed the acquisition of two development-stage specialty Rx products to further invest in our specialty Rx portfolio.

•
On August 22, 2016, we purchased the remaining 60.9% ownership right to a generic BenzaclinTM product ("Generic BenzaclinTM"), which we developed and marketed in collaboration with Barr Laboratories. As a result of this transaction, we are now entitled to 100% of income from sales of the product.

Segment Results

Three Month Comparison
cy16q110q_chart-05779a02.jpg

 
 
Three Months Ended
($ in millions)
September 26, 2015
 
October 1,
2016
Net sales
$
260.3

 
$
267.4

Gross profit
$
130.4

 
$
128.1

Gross profit %
50.1
%
 
47.9
%
Operating income
$
91.0

 
$
77.9

Operating income %
34.9
%
 
29.1
%

Three Months Ended October 1, 2016 vs. Three Months Ended September 26, 2015

Net sales increased $7.1 million, or 3%, due to:

•
Sales attributable to the Entocort® and Tretinoin Products acquisitions totaling $32.2 million; and
•
New product sales of $18.3 million due primarily to sales of benzoyl peroxide 5%-clindamycin 1% gel (a generic version of Benzaclin™); offset partially by
•
Decreased sales of existing products of $40.7 million due to lower sales volume of certain products, pricing pressure across the portfolio, and the lack of exclusive market position for two key products versus the prior year; and
•
Unfavorable foreign exchange movement of $2.8 million.

Segment operating income decreased $13.1 million, or 14%, as a result of:

•
A decrease of $2.3 million in gross profit due primarily to the pricing pressure noted above as well as higher amortization expense from the Entocort® and Tretinoin Products acquisitions, offset largely by an increase

45
Perrigo Company plc - Item 2
Rx


in gross profit attributable to product acquisitions, new product sales, and increased manufacturing productivity.

•
An increase of $10.8 million in operating expenses due primarily to increased research and development investments of $5.7 million as a result of the timing of clinical trials and a $4.9 million fair value adjustment on contingent consideration related to the two development-stage specialty Rx products that we acquired on March 1, 2016.

Nine Month Comparison
cy16q210q_chart-31672a01.jpg
 


 
Nine Months Ended
($ in millions)
September 26,
2015
 
October 1,
2016
Net sales
$
790.1

 
$
817.4

Gross profit
$
433.4

 
$
394.7

Gross profit %
54.8
%
 
48.3
%
Operating income
$
290.4

 
$
262.1

Operating income %
36.7
%
 
32.1
%

Nine Months Ended October 1, 2016 vs. Nine Months Ended September 26, 2015

Net sales increased $27.3 million, or 3%, due to:

•
Net sales attributable to the Entocort® and Tretinoin Products acquisitions totaling $121.5 million; and
•
New product sales of $55.1 million due primarily to sales of benzoyl peroxide 5%-clindamycin 1% gel (a generic version of Benzaclin™); offset partially by
•
Decreased sales of existing products of $140.9 million due to declined sales volume of certain products, pricing pressure across the portfolio, and the lack of exclusive market position for two key products versus the prior year;
•
Discontinued products of $3.6 million; and
•
Unfavorable foreign exchange movement of $4.8 million.

Segment operating income decreased $28.3 million, or 10%, as a result of:

•
A decrease of $38.7 million in gross profit due primarily to the pricing pressure noted above, as well as higher amortization expense from the Entocort® and Tretinoin Products acquisitions; offset partially by

•
A decrease of $10.4 million in operating expenses due primarily to:
•
The absence of an $18.0 million research and development payment made in connection with a research and development contractual arrangement in the prior year; offset by
•
Increased selling and administration expenses of $4.1 million; and
•
Increased research and development investments of $3.2 million due to timing of clinical trials.


46
Perrigo Company plc - Item 2
Specialty Sciences


SPECIALTY SCIENCES

Recent Trends and Developments

•
In February 2016, a competitor's pipeline product, Ocrevus®, received breakthrough therapy designation from the FDA and could potentially be approved in 2016. The product would compete with Tysabri® and could have a significant negative impact on the royalty we receive from Biogen Idec, Inc. ("Biogen") and the performance of the Specialty Sciences segment. We continue to monitor the progress of all potential competing products.

•
On November 10, 2016, we announced that we are exploring strategic alternatives for our Tysabri® asset, which is reported in our Specialty Sciences segment.

Segment Results

Three Month Comparison

cy16q110q_chart-04671a02.jpg
 





 
Three Months Ended
($ in millions)
September 26, 2015
 
October 1,
2016
Net sales
$
84.5

 
$
93.4

Gross profit
$
12.0

 
$
20.6

Gross profit %
14.2
%
 
22.1
%
Operating income
$
9.0

 
$
23.3

Operating income %
10.7
%
 
25.0
%


Three Months Ended October 1, 2016 vs. Three Months Ended September 26, 2015

Net sales increased $8.9 million due to an increase in royalties received from Biogen's sales of Tysabri®, inclusive of a one-time favorable adjustment Biogen made to their discounts and allowances. Based on the current royalty percentage that we receive, the effect of this benefit was approximately $3.6 million. Operating income increased $14.3 million due to the increased royalties as well a $5.7 million reduction in operating expenses due to lower legal costs in the current year.

Nine Month Comparison
cy16q210q_chart-31701a01.jpg
 

 
Nine Months Ended
($ in millions)
September 26,
2015
 
October 1,
2016
Net sales
$
250.1

 
$
271.3

Gross profit
$
32.5

 
$
53.0

Gross profit %
13.0
%
 
19.5
%
Operating income
$
21.0

 
$
49.7

Operating income %
8.4
%
 
18.3
%


47
Perrigo Company plc - Item 2
Specialty Sciences


Nine Months Ended October 1, 2016 vs. Nine Months Ended September 26, 2015

Net sales increased $21.2 million due to an increase in royalties received from Biogen's sales of Tysabri®, inclusive of a one-time favorable adjustment Biogen made to their discounts and allowances. Based on the current royalty percentage that we receive, the effect of this benefit was approximately $3.6 million in the three months ended October 1, 2016. This increase was offset partially by $1.4 million of unfavorable foreign currency movement. Operating income increased $28.7 million due to the increased royalties as well a $8.2 million reduction in operating expenses due primarily to lower legal costs in the current year.


OTHER

Recent Trends and Developments

We are pursuing the sale of our API business based in India and expect the sale to take place in the next 12 months. On October 1, 2016, the net assets of the India API business were classified as "held for sale" as discussed in Item 1. Note 9.

Segment Results

Three Month Comparison
cy16q110q_chart-04657a02.jpg
 
 
Three Months Ended
($ in millions)
September 26, 2015
 
October 1,
2016
Net sales
$
22.5

 
$
21.0

Gross profit
$
11.1

 
$
9.3

Gross profit %
49.5
%
 
44.5
 %
Operating income (loss)
$
6.2

 
$
(1.6
)
Operating income (loss) %
27.5
%
 
(7.4
)%

Three Months Ended October 1, 2016 vs. Three Months Ended September 26, 2015

Net sales decreased $1.5 million due primarily to increased competition on certain products, in particular, U.S. sales of Temozolomide. The operating loss in the current year period was due primarily to a $6.5 million impairment charge recorded on the India API held-for-sale business, offset partially by reduced operating expenses.

Nine Month Comparison


48
Perrigo Company plc - Item 2
Other


cy16q210q_chart-31555a01.jpg
 


 
Nine Months Ended
($ in millions)
September 26,
2015
 
October 1,
2016
Net sales
$
75.4

 
$
59.5

Gross profit
$
34.2

 
$
26.8

Gross profit %
45.4
%
 
45.0
%
Operating income
$
18.6

 
$
2.6

Operating income %
24.6
%
 
4.4
%

Nine Months Ended October 1, 2016 vs. Nine Months Ended September 26, 2015

Net sales decreased $15.9 million due primarily to competition on certain products, in particular, U.S. sales of Temozolomide. Operating income decreased $16.0 million due primarily to a $7.4 million decrease in gross profit due to increased competition and a $10.8 million impairment charge recorded on the India API held-for-sale business, offset partially by a reduction in operating expenses.

Unallocated Expenses

Unallocated expenses are comprised of certain corporate expenses not allocated to the segments and are recorded in operating income. Unallocated expenses were $30.5 million for the three months ended October 1, 2016, compared to $39.3 million for the three months ended September 26, 2015, a decrease of $8.8 million. The reduction in unallocated expenses was due primarily to fees of $15.6 million related to our defense against the hostile takeover bid by Mylan N.V. ("Mylan") incurred in the prior-year period, offset partially by a $7.4 million increase in legal and professional fees in the current period.

Unallocated expenses were $79.9 million for the nine months ended October 1, 2016 compared to $111.1 million for the prior year period, a decrease of $31.2 million. The reduction in unallocated expense was due primarily to $18.1 million of Omega acquisition-related fees and $29.0 million of legal and professional fees related to our defense against the hostile takeover bid by Mylan, both of which were incurred only in the prior-year period. We also experienced a $14.9 million reduction in share-based compensation in the current year period due primarily to the resignation of Joseph C. Papa. These decreases were offset partially by a $20.2 million increase in legal and professional fees in the current period.
  
Interest and Other (Consolidated)

Interest Expense, Net

Interest expense, net was $54.6 million for the three months ended October 1, 2016, compared to $43.4 million for the prior year period. The $11.2 million increase was due to interest incurred in the current year on the $1.2 billion senior notes issued on March 7, 2016.

Interest expense, net was $163.2 million for the nine months ended October 1, 2016, compared to $132.7 million for the prior year period. The $30.5 million increase was due to interest incurred on the debt assumed in the Omega acquisition, borrowings on our revolving credit agreements during the nine months ended October 1, 2016, and the issuance of $1.2 billion of senior notes on March 7, 2016. See the "Borrowings and Capital Resources" section below and Item 1. Note 10 for more information.

Other Expense, Net

Other expense, net, was $1.0 million for the three months ended October 1, 2016, compared to $13.0 million in the prior year period. The $12.0 million decrease was due primarily to the absence of a $4.2 million

49
Perrigo Company plc - Item 2
Unallocated, Interest, Other, and Taxes


loss on equity methods investments and a $4.8 million loss associated with an acquisition-related derivative recorded in the prior year. See Item 1. Notes 7 and 8, for more information on the derivative losses and equity method investment losses, respectively.

Other expense, net, was $34.1 million for the nine months ended October 1, 2016, compared to $294.2 million in the prior year period. The $260.1 million decrease was due primarily to the absence of the $259.8 million loss incurred in the prior year period on the derivatives we used to economically hedge fluctuations in the euro-denominated purchase price of the Omega and GSK Products acquisitions. The losses on the derivatives due to the changes in the EUR/USD exchange rate prior to their settlement economically offset the final settlement of the euro-denominated Omega purchase price paid on March 30, 2015.

Income Taxes (Consolidated)

The effective tax rate for the three months ended October 1, 2016 was 20.1% on a net loss compared to 14.8% on net income for the three months ended September 26, 2015. The effective tax rate for the nine months ended October 1, 2016 was 21.6% on a net loss reported in the period compared to 60.3% on net income for the nine months ended September 26, 2015. For the three and nine months ended October 1, 2016, we have estimated income taxes using the annual effective tax rate method.

Income taxes recorded through July 2, 2016 were estimated using the discrete method.  For the three and nine months ended October 1, 2016, we had significant changes to our estimates related to additional asset impairments recognized in the third quarter and therefore determined that estimating income taxes using the annual effective tax rate method was the more appropriate method for the period ending October 1, 2016.

Our tax rate is subject to adjustment over the balance of the fiscal year due to, among other things: income tax rate changes by governments; the jurisdictions in which our profits are determined to be earned and taxed; changes in the valuation of our deferred tax assets and liabilities; adjustments to estimated taxes upon finalization of various tax returns; adjustments based on differing interpretations of the applicable transfer pricing standards; changes in available tax credits, grants and other incentives; changes in stock-based compensation expense; changes in tax laws or the interpretation of such tax laws (for example, proposals for fundamental U.S. international tax reform); changes in U.S. GAAP; expiration of or the inability to renew tax rulings or tax holiday incentives; and the repatriation of earnings with respect to which we have not previously provided for taxes.

Although we believe that the tax estimates are reasonable and that we prepare our tax filings in accordance with all applicable tax laws, the final determination with respect to any tax audit and any related litigation could be materially different from estimates or from historical income tax provisions and accruals. The results of an audit or litigation could have a material effect on our operating results and/or cash flows in the periods for which that determination is made. In addition, future period earnings may be adversely impacted by litigation costs, settlements, penalties, and/or interest assessments.

The IRS audit of our fiscal years ended June 27, 2009 and June 26, 2010 had previously concluded with the issuance of a statutory notice of deficiency on August 27, 2014. While we had previously agreed on certain adjustments and made associated payments of $8.0 million (inclusive of interest) in November 2014, the statutory notice of deficiency asserted various additional adjustments, including transfer pricing adjustments. The statutory notice of deficiency's adjustments for fiscal years 2009 and 2010 asserted an incremental tax obligation of approximately $68.9 million, inclusive of interest and penalties. We disagree with the IRS’s positions asserted in the statutory notice of deficiency. To contest the IRS's adjustments, in January 2015 we paid the incremental tax obligation (a prerequisite to contesting the proposed adjustments in U.S. district court), and in June 2015, we filed an administrative request for a refund with the IRS. The payment was recorded during the three months ended March 28, 2015 as a deferred charge on the balance sheet given our anticipated action to recover this amount. The IRS subsequently denied our request for a refund. We anticipate filing a complaint in U.S. district court claiming a refund of the paid amounts prior to August 2017. An unfavorable resolution of this matter could have a material impact on our consolidated financial statements in future periods.

We have ongoing audits in multiple jurisdictions the resolution of which remains uncertain. These jurisdictions include, but are not limited to, the United States and Belgium. The IRS is auditing our fiscal years ended June 25, 2011 and June 30, 2012, and may make adjustments consistent with the adjustments made in the

50
Perrigo Company plc - Item 2
Unallocated, Interest, Other, and Taxes


statutory notice of deficiency for fiscal years 2009 and 2010. In February 2016, the Belgium Tax Authority notified us that all Belgium locations will be audited for the years ended December 31, 2013 and December 31, 2014. At this time, we cannot predict the outcome of any audit or related litigation.

FINANCIAL CONDITION, LIQUIDITY, AND CAPITAL RESOURCES

Cash and Cash Equivalents

cy16q310q_chart-47518.jpg
*    Working capital represents current assets less current liabilities, excluding cash and cash equivalents, and current indebtedness.

Cash, cash equivalents, and cash flows from operations are expected to be sufficient to finance our known and/or foreseeable liquidity and capital expenditures. In addition, we have the ability to borrow under our credit facilities. Although our lenders have made commitments to make funds available to us in a timely fashion under our revolving credit agreements and overdraft facilities, if economic conditions worsen or new information becomes publicly available impacting the institutions’ credit rating or capital ratios, these lenders may be unable or unwilling to lend money pursuant to our existing credit facilities.

Operating Activities
 
Nine Months Ended
 
September 26,
2015
 
October 1,
2016
 
Increase/(Decrease)
Cash Flows From (For) Operating Activities
 
 
 
 
 
Net income (loss)
$
74.2

 
$
(1,395.4
)
 
$
(1,469.6
)
Non-cash adjustments
827.1

 
2,245.8

 
1,418.7

Subtotal
901.3

 
850.4

 
(50.9
)
 
 
 
 
 
 
Increase (decrease) in cash due to:
 
 
 
 
 
Accounts receivable
(30.9
)
 
113.6

 
144.5

Inventories
(28.6
)
 
(29.9
)
 
(1.3
)
Accounts payable
(6.5
)
 
(51.8
)
 
(45.3
)
Payroll and related taxes
(26.6
)
 
(40.0
)
 
(13.4
)
Accrued customer programs
17.7

 
(74.7
)
 
(92.4
)
Accrued liabilities
46.7

 
(42.8
)
 
(89.5
)
Accrued income taxes
0.3

 
9.7

 
9.4

Other
(6.7
)
 
(31.0
)
 
(24.3
)
Subtotal
$
(34.6
)
 
$
(146.9
)
 
$
(112.3
)
 
 
 
 
 
 
Net cash from (for) operating activities
$
866.7


$
703.5


$
(163.2
)


51
Perrigo Company plc - Item 2
Financial Condition, Liquidity and Capital Resources


We generated $703.5 million of cash from operating activities during the nine months ended October 1, 2016, a $163.2 million decrease over the comparable prior year period, due primarily to increased working capital, as noted above, as a result of the following:

•
Decreased net earnings after adjusting for non-cash items such as impairment charges and depreciation and amortization;

•
Changes in accounts payable due to changes to the Omega accounts payable structure as discussed below;

•
Changes in accrued customer-related programs due to the pricing dynamics in the Rx segment;

•
Changes in accounts receivable due to increased sales volumes and timing of collections, offset partially by a reduction of factoring in the current period; and

•
Changes in accrued liabilities due primarily to lower legal expenses.

Our operating cash flow for the current year period was unfavorably impacted by actions we took to establish a more normalized cash flow pattern within our BCH segment. Generally our BCH segment has seasonally stronger sales and cash flow inflows in the second and fourth quarters and stronger cash outflows in the first and third quarters. In the past, accounts payable terms with suppliers were structured to take account of this seasonality. This payment structure had a favorable impact on operating cash flow during the prior year period as only the second quarter inflow from these payment structures was included. In order to establish a more sustainable cash flow pattern during the year, we changed these payment structures during the nine months ended October 1, 2016, which had a one-time unfavorable impact on operating cash flow.

Investing Activities
cy16q310q_chart-47496.jpg
Cash used for investing activities totaled $524.3 million for the nine months ended October 1, 2016, compared to $2.9 billion in the prior year period. The cash used in the current year was due primarily to the Tretinoin Products and Generic Benzaclin™ acquisitions, which used $478.4 million in cash. In the comparable prior year period, cash used for investing activities consisted primarily of a $2.5 billion outflow for business acquisitions, mainly attributable to Omega, as well as a $304.8 million outflow related to the cash settlement of the non-designated foreign currency derivatives we used to hedge the euro-denominated Omega and GSK Products purchase prices. Cash used for capital expenditures totaled $84.6 million during nine months ended October 1, 2016 compared to $127.6 million in the prior period year. The decrease in cash used for capital expenditures over the prior year period was due primarily to several large infrastructure projects nearing completion.


52
Perrigo Company plc - Item 2
Financial Condition, Liquidity and Capital Resources


Financing Activities
cy16q310q_chart-47479.jpg
Cash used for financing activities totaled $234.1 million for the nine months ended October 1, 2016, compared to $941.5 million for the comparable prior year period. In the current year period, cash used for financing included $803.6 million to repay balances outstanding under our revolving credit agreements and other short-term financing and $500.0 million used to prepay our 1.300% 2016 Notes. These payments were offset by the borrowing of $1.2 billion of long-term debt. In the prior year period, the cash used for financing activities was due primarily to payments of $903.3 million on long-term debt, which included the repayment of debt assumed from Omega and a $300.0 million legacy Perrigo term loan. For more information see "Borrowings and Capital Resources" below and Item 1. Note 10.

The declaration and payment of dividends, if any, is subject to the discretion of our Board of Directors and will depend on our earnings, financial condition, availability of distributable reserves, capital and surplus requirements, and other factors our Board of Directors may consider relevant.

In October 2015, the Board of Directors approved a share repurchase plan of up to $2.0 billion, of which $1.5 billion is still available to be repurchased through December 31, 2018. We did not repurchase any shares under the share repurchase plan during the nine months ended October 1, 2016. The timing and amount of future repurchases, if any, will depend upon several factors, including market and business conditions, the trading price of our ordinary shares, available cash flow, and other investment opportunities.

Borrowings and Capital Resources

cy16q310q_chart-47646.jpg


53
Perrigo Company plc - Item 2
Financial Condition, Liquidity and Capital Resources


Overdraft Facilities

Our BCH segment uses overdraft facilities to increase the efficiency of its cash utilization and meet its short-term liquidity needs. We repaid the balance outstanding under the overdraft facilities during the nine months ended October 1, 2016, but retain the ability to use the facilities in our day-to-day cash operations. The balance outstanding under the overdraft facilities was $82.9 million at December 31, 2015.

Accounts Receivable Factoring

We have multiple accounts receivable factoring arrangements with non-related third-party financial institutions (the “Factors”). Pursuant to the terms of the arrangements, we sell to the Factors certain of our accounts receivable balances on a non-recourse basis for credit approved accounts. An administrative fee ranging from 0.14% to 0.15% per invoice is charged on the gross amount of accounts receivables assigned to the Factors, plus interest is calculated at the applicable EUR LIBOR rate plus 70 basis points. The total amount factored and excluded from accounts receivable on the Condensed Consolidated Balance Sheets was $36.4 million and $106.7 million at October 1, 2016 and December 31, 2015, respectively.

Revolving Credit Agreements

On December 9, 2015, our 100% owned finance subsidiary, Perrigo Finance Unlimited Company (formerly Perrigo Finance plc) ("Perrigo Finance"), entered into a $750.0 million revolving credit agreement (the "2015 Revolver"). At December 31, 2015, $380.0 million was outstanding under the 2015 Revolver. On March 15, 2016, we used the proceeds of the debt issuance described below under "Long-Term Debt" to repay the $750.0 million then outstanding under the 2015 Revolver and terminated the facility.

On December 5, 2014, Perrigo Finance entered into a $600.0 million revolving credit agreement, which we increased to $1.0 billion on March 30, 2015 (the "2014 Revolver"). At December 31, 2015, $300.0 million was outstanding under the 2014 Revolver. On March 15, 2016, we used the proceeds of the debt issuance described below under "Long-Term Debt" to repay the $435.0 million then outstanding under the 2014 Revolver. There were no borrowings outstanding under the 2014 Revolver as of October 1, 2016.

Long-Term Debt

On March 7, 2016, Perrigo Finance issued $500.0 million in aggregate principal amount of 3.500% senior notes due 2021 and $700.0 million in aggregate principal amount of 4.375% senior notes due 2026 (together, the "2016 Notes") and received net proceeds of $1.2 billion after fees and market discount, which were used to repay the amounts outstanding under the 2015 Revolver and 2014 Revolver mentioned above.

We had $5.4 billion and $4.7 billion outstanding under our notes and bonds, and $463.8 million and $488.8 million outstanding under our term loan, as of October 1, 2016 and December 31, 2015, respectively. On September 29, 2016, we repaid the $500.0 million outstanding under the 1.300% 2016 Notes.

We were in compliance with all covenants under our debt agreements as of October 1, 2016. See Item 1. Note 10 for more information on all of the above debt facilities.

Credit Ratings
    
Our credit ratings on October 1, 2016 were Baa3 (negative) and BBB- (stable) by Moody's Investors Service and Standard and Poor's ("S&P") Global Ratings, respectively.
 
Credit rating agencies review their ratings periodically and, therefore, the credit rating assigned to us by each agency may be subject to revision at any time. Accordingly, we are not able to predict whether current credit ratings will remain as disclosed above. Factors that can affect our credit ratings include changes in operating performance, the economic environment, our financial position, and changes in business strategy. If changes in our credit ratings were to occur, they could impact, among other things, future borrowing costs, access to capital markets, and vendor financing terms.


54
Perrigo Company plc - Item 2
Financial Condition, Liquidity and Capital Resources


Contractual Obligations and Commitments

Other than the obligations related to the changes to our debt structure in relation to the 2016 Notes, as discussed in Note 10 of the Notes to the Condensed Consolidated Financial Statements, there were no material changes in contractual obligations as of October 1, 2016 from those provided in our Transition Report on Form
10-KT for the transition period from June 28, 2015 to December 31, 2015. See below for a revised schedule of our enforceable and legally binding obligations as of October 1, 2016 related to our short and long-term debt arrangements.
 
Payment Due by Period (in millions)
 
2016(1)
 
2017 - 2018
 
2019 - 2020
 
After 2020
 
Total
Short and long-term debt(2)
$
77.7

 
$
1,691.1

 
$
817.0

 
$
5,510.1

 
$
8,095.9


(1)     Reflects remaining three months of 2016.
(2) 
Short and long-term debt includes interest payments, which were calculated using the effective interest rate at October 1, 2016.

ITEM 3.        QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes to our quantitative or qualitative disclosures found in Item 7A, "Quantitative and Qualitative Disclosures about Market Risk," of our Transition Report on Form 10-KT for the transition period from June 28, 2015 to December 31, 2015.

ITEM 4.        CONTROLS AND PROCEDURES

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e) of the Exchange Act) as of October 1, 2016. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were not effective as of October 1, 2016 because of the material weakness in our internal control over financial reporting described below.

All systems of internal control, no matter how well designed, have inherent limitations. Therefore, even those systems deemed to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a company’s annual or interim consolidated financial statements will not be prevented or detected on a timely basis.

Evaluation of Disclosure Controls and Procedures
    
We conducted an evaluation of the effectiveness of our internal control over financial reporting based upon the framework established in the 2013 Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).

In connection with the preparation of our financial statements for the quarter ended April 2, 2016, management determined that we did not design and maintain effective management review controls that operated at a sufficient level of precision to ensure interim income taxes were properly recorded and disclosed in our consolidated financial statements in connection with the recording of an indefinite-lived intangible asset impairment and an estimated goodwill impairment. These control deficiencies resulted in a material misstatement in income taxes in the preliminary financial statements for the quarter ended April 2, 2016. The material misstatement in interim income taxes was corrected prior to the filing of the Form 10-Q for the quarter ended April 2, 2016. These control deficiencies did not result in a misstatement of the consolidated financial statements for the transition period from June 28, 2015 to December 31, 2015, and would have no effect on the accounting for income taxes for the fiscal year ending December 31, 2016. However, these control deficiencies created a reasonable possibility that a material misstatement to the interim consolidated financial statements would not be prevented or detected on a timely basis. Accordingly, management concluded that these control deficiencies represented a material weakness.


55
Perrigo Company plc - Item 4
Controls and Procedures


Remediation Plan for the Material Weakness

To remediate the material weakness in internal control over financial reporting described above, with oversight from the Audit Committee, we have:

•
Reviewed the processes and controls in place to measure and record income taxes to enhance the efficiency and effectiveness of the design and operation of those controls;
•
Enhanced monitoring activities related to income taxes by adding additional internal controls and checklists; and
•
Evaluated and enhanced the level of precision in the management review controls related to income taxes by adding additional levels of review.

We are in the process of testing and evaluating the design and operating effectiveness of the control procedures and are assessing the effectiveness of the remediation plan, which we began implementing during the three months ended July 2, 2016 and are continuing to implement. Until the remediation actions are fully implemented and the operational effectiveness of related internal controls is validated through testing, the material weakness described above will continue to exist. We are committed to achieving and maintaining a strong internal control environment and believe the remediation measures will strengthen our internal control over financial reporting and remediate the material weakness identified. We will continue to monitor the effectiveness of these remediation measures and will make any changes and take such other actions that we deem appropriate given the circumstances.

Changes in Internal Control over Financial Reporting

As discussed above under the heading entitled "Remediation Plan for the Material Weakness," there were changes in our internal control over financial reporting during the three months ended October 1, 2016 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II.     OTHER INFORMATION

ITEM 1.    LEGAL PROCEEDINGS

Refer to Part I, Item 1. Note 14 to the Condensed Consolidated Financial Statements.

.00ITEM 1A.    RISK FACTORS

Our Transition Report on Form 10-KT for the transition period from June 28, 2015 to December 31, 2015 includes a detailed discussion of our risk factors. At the time of this filing, there have been no material changes to the risk factors that were included in the Form 10-KT other than those described below.

As part of our ongoing strategic portfolio review, we are considering alternatives that could result in certain asset divestitures, which may impact our future operations and financial position.

On November 10, 2016, as part of our ongoing strategic portfolio review, we announced the following strategic actions: (1) exploring strategic alternatives for the potential sale our Tysabri® royalty asset, which is reported in our Specialty Sciences segment; (2) conducting a comprehensive internal evaluation of our businesses, including the Rx pharmaceuticals segments’ market position, growth opportunities and interdependencies with our other manufacturing and shared service operations to determine if strategic alternatives should be explored; and (3) conducting a review of segment and corporate cost structures to align with existing and future expected market dynamics. If we determine that we will pursue a strategic divestiture as a result of this portfolio review, our future business, prospects, financial condition, liquidity and operating results could be significantly different than those in historical periods or projected by our management, which may in turn have a material adverse effect on the market value of our ordinary shares or credit ratings. We cannot provide any commitment regarding if or when any such divestiture would occur.

We are dependent on the services of certain key executive and scientific employees. This year, we replaced our chief executive officer and the general managers of both our BCH and Rx segments. Our inability to successfully manage the transition with respect to these key executives, or the failure to attract and retain

56
Perrigo Company plc - Item 1A
Risk Factors




other key executive and scientific employees, may have a material adverse impact on our results of operations.
 
As previously disclosed in the "Risk Factors" section of our Form 10-KT, we are dependent on the services of certain key employees, and our future success will depend in large part upon our ability to attract and retain highly skilled employees. 

•
In April 2016, we announced that our former Chairman and Chief Executive Officer, Joseph C. Papa, resigned from the Company and that John T. Hendrickson, formerly our President, was appointed to serve as our new Chief Executive Officer. Mr. Hendrickson was later appointed to serve as a member of our Board of Directors.

•
In April 2016, we announced that the former Executive Vice President and General Manager of our BCH segment, Marc Coucke, resigned from the Company and that our current Executive Vice President and General Manager, International, Sharon Kochan, would undertake expanded responsibilities that include providing leadership and strategic direction to our BCH segment.

•
On November 8, 2016, we appointed John Wesolowski the General Manager, Rx Pharmaceuticals. Mr. Wesolowski served as Acting General Manager, Rx Pharmaceuticals following the resignation of Doug Boothe on July 20, 2016.

If this management transition is not successful, or if we are unable to attract or retain other key qualified employees, our future operating results may be adversely impacted.

Publishing earnings guidance subjects us to risks, including increased stock volatility that could lead to potential lawsuits by investors.

Because we publish earnings guidance, we are subject to a number of risks. For a variety of reasons discussed under “Cautionary Note Regarding Forward-Looking Statements”, this Item 1A, and Item 1A of our Transition Report on Form 10-KT for the transition period from June 28, 2015 to December 31, 2015, actual results may vary from the guidance we provide investors from time to time, such that our stock price may decline following, among other things, any earnings releases or guidance that do not meet market expectations. 

On February 18, 2016, we announced our results for the fourth quarter and calendar year ended December 31, 2015, as well as our updated guidance for calendar year 2016, and on April 25, 2016 we announced our preliminary financial results for the first quarter ended April 2, 2016, as well as our updated guidance for calendar year 2016. Our stock price declined following each such announcement, resulting in a decrease in our market capitalization. Additionally, we announced updated guidance on August 10, 2016. It has become increasingly commonplace for investors to file lawsuits against companies following a rapid decrease in market capitalization. These types of lawsuits can be costly and divert management attention and other resources away from our business, regardless of their merits, and could result in adverse settlements or judgments.

We are or may become involved in shareholder class action lawsuits and may experience unfavorable outcomes of such proceedings.

We are a defendant to a securities lawsuit in which the complaint alleges violations of Securities Exchange Act sections 10(b) (and Rule 10b‑5) and 14(e) against both Perrigo and our former Chief Executive Officer, Joseph C. Papa, and 20(a) control person liability against Mr. Papa. In general, the allegations concern the actions taken by the Company and former executive to defend against the hostile takeover bid by Mylan in the period April 21, 2015 through November 13, 2015. The plaintiff also alleges that we provided inadequate disclosure concerning alleged integration problems as a result of the Omega acquisition in the period April 21, 2015 through May 11, 2016. Another securities class action case was also filed in the same court making essentially the same claims on behalf of a class of persons who sold put options in Perrigo shares during the same class period. There is a motion pending to consolidate the two actions.

We along with certain of our current and former executive officers and board members are also defendants in a securities class action suit where the plaintiff allege violations of Israeli law in the District Court of Tel Aviv-Jaffa.

57
Perrigo Company plc - Item 1A
Risk Factors




On June 15, 2016, Perrigo filed a motion to stay the case pending the outcome of the securities class action pending in the New Jersey federal court. The plaintiffs did not oppose the motion. The Israeli court granted the motion on the same day, and the action is stayed.

We intend to vigorously defend against these lawsuits, however, we cannot predict how the cases will be resolved. Adverse results in the cases could result in substantial monetary judgments. See Part I. Item 1. Note 14 for more information on the above mentioned lawsuits. 

We may not be able to improve operating results in our business segments.
    
•
We have experienced a reduction in pricing expectations during 2016 in comparison to historical patterns in our U.S. businesses, in particular in our Rx segment, due to industry and competitive pressures in the sector. The reduced pricing is attributable to a variety of factors including increased focus from customers to capture supply chain productivity savings, low raw material commodity pricing, competition in specific product categories, the loss of exclusivity on certain products, and consolidation of certain customers in the Rx segment. We have seen year-over-year pricing in the third quarter of 2016 moderate from the levels experienced in the first half of 2016. We expect this pricing environment to continue to impact the Company for the foreseeable future.

•
Our expectations for the BCH segment continue to be impacted by market dynamics in key countries such as Belgium, France, Germany and Italy. Factors impacting these countries include softness in certain leading brand categories primarily due to lower sell-through during the current year due to the re-staging launch timing of certain products, changes in timing of certain advertising and promotional campaigns compared to the prior year, and macro-economic factors, including unfavorable foreign currency impacts experienced primarily in the UK related to Brexit. The BCH segment has established a brand prioritization strategy to address these market dynamics, with an objective to balance the cost of advertising and promotion investments with expected contributions from category sales. The segment has further impacted in Belgium by a change in the forecasts with a major wholesaler, as management implements improved supply chain efficiencies in this market.

•
Our expectations for 2016 new product sales are consistent with those communicated in our Form 10-Q for the three months ended April 2, 2016, but continue to remain lower than we anticipated as of December 31, 2015. Several new product launches have been delayed due to the regulatory approval process for certain new products in the U.S. and modifications to market share penetration and timing assumptions for new products in our Rx and BCH segments.

There can be no assurance that we will not continue to experience challenges related to our segments, and these challenges could have a material impact on our business, cash flows, and results of operations or result in impairment charges, and the market value of our ordinary shares and/or debt securities may decline.

We have acquired significant intangible assets and goodwill that could become impaired or subject us to losses and may result in an adverse impact on our results of operations.

We have recorded significant intangible assets and goodwill on our balance sheet as a result of previous acquisitions, which could become impaired and lead to material charges in the future. We regularly review our intangible assets and goodwill for impairment. Goodwill and indefinite-lived intangible assets are subject to impairment review on an annual basis and whenever impairment indicators are present.

In connection with the preparation of our financial statements for the three-month period ended April 2, 2016, we identified indicators of goodwill impairment in our BCH - rest of world (“BCH - ROW”) reporting unit, which comprises primarily operations attributable to the Omega acquisition in all geographic regions except for Belgium. The primary impairment indicators included the decline in our 2016 performance expectations and a reduction in our long-range revenue growth forecast. Step one of the goodwill impairment test involved determining the fair value of the reporting unit using a discounted cash flow technique and comparing it to the reporting unit’s carrying value. The main assumptions supporting the cash flow projections used to determine the reporting unit’s fair value included revenue growth based on product line extensions, product life cycle strategies, and geographical expansion within the markets in which the reporting unit distributes products, gross margins consistent with historical trends, and

58
Perrigo Company plc - Item 1A
Risk Factors




advertising and promotion investments largely consistent with the reporting unit's growth plans. The BCH-ROW reporting unit did not pass step one of goodwill impairment testing. The change in fair value from previous estimates was due primarily to the changes in the market and performance of certain brands such that the evaluation of brand prioritization and product extensions or launches in new regions are being more focused to maximize the potential of all brands in the segment's portfolio.

The second step of the goodwill impairment test required that we determine the implied fair value of the BCH - ROW reporting unit’s goodwill, which involved determining the value of the reporting unit’s individual assets and liabilities. Due to the complex and time-consuming nature of step two, based on our evaluation and initial estimates of the fair values of the assets and liabilities and the deficit of the fair value when compared to the related book value, we recorded an estimated impairment charge of $193.6 million for the three months ended April 2, 2016. We finalized the step two fair value calculation during the three months ended July 2, 2016, which resulted in a $30.3 million reduction to the estimated impairment charge recorded during the three months ended April 2, 2016,

In connection with the preparation of our financial statements for the three months ended October 1, 2016, we identified additional indicators of goodwill impairment in both our BCH - ROW and our BCH - Belgium reporting units. With respect to both reporting units, the primary impairment indicators included an additional decline in our 2016 performance expectations for the remainder of the year and a reduction in our long-range revenue growth and margin forecasts due to the factors outlined below. Step one of the goodwill impairment test involved determining the fair value of the reporting units using a discounted cash flow technique and comparing it to the respective reporting units' carrying value. The main assumptions supporting the cash flow projections used to determine each reporting unit’s fair value included revenue growth based on product line extensions, product life cycle strategies, and geographical expansion within the markets in which the reporting unit distributes products, gross margins consistent with historical trends and including supply chain cost improvement plans, and advertising and promotion investments largely consistent with the reporting unit's growth plans. Both the BCH - ROW and the BCH - Belgium reporting units did not pass step one of goodwill impairment testing. As it relates to the BCH - ROW reporting unit, the changes in fair value from previous estimates were due primarily to (1) changes in the market and performance of certain brands due to moderated new product launch assumptions, (2) execution of certain key product strategies falling short of expectations causing a reduction to baseline forecast models in France, Germany and Italy, (3) certain macro-economic factors having continued to impact the business more than expected in France, Russia and Turkey in addition to unfavorable foreign currency impacts experienced primarily in the UK related to Brexit. As it relates to BCH - Belgium reporting unit, the changes in fair value from previous estimates due to change in the forecast as a result of a reduction in volume with a major wholesaler due to factors consistent with those outlined for BCH - ROW.

The second step of the goodwill impairment test required that we determine the implied fair value of both the BCH - ROW and BCH - Belgium reporting units' goodwill, which involved determining the value of each reporting unit’s individual assets and liabilities. Based on our evaluation and initial estimates of the fair values of the assets and liabilities and the deficit of the fair value when compared to the related book value, we recorded an estimated impairment charge of $734.7 million related to the BCH - ROW reporting unit and $69.4 million related to the BCH - Belgium reporting unit for the three months ended October 1, 2016. Both charges were recorded in Impairment charges on the Condensed Consolidated Statements of Operations within our BCH segment. Due to the complex and time-consuming nature of step two, we expect to finalize the fair value calculation during the fourth quarter of 2016, which could result in an adjustment to the estimated impairment charge. As of October 1, 2016, $1.0 billion and $70.2 million of goodwill remains in the BCH - ROW and BCH - Belgium reporting units, respectively.

While no impairment charges were recorded as a result of the goodwill impairment testing for the transition period of June 28, 2015 to December 31, 2015, our Specialty Sciences reporting unit's fair value exceeded the carrying value by less than 10%. Management evaluated the primary source of cash flow in this segment, the Tysabri® royalty stream, based on a combination of factors including independent external research, information provided from our royalty partner, and internal estimates. Based on this information, management’s assessment of future cash flow from this royalty stream has been reduced primarily due to anticipated new competitors entering the market and unfavorable currency exchange effects. Future performance different from the assumptions utilized in our quantitative analysis may further reduce the fair value of the reporting unit, which may result in the fair value no longer exceeding the carrying value. In February 2016, a competitor's pipeline product, Ocrevus®, received breakthrough therapy designation from the FDA and could potentially be approved in 2016. The product would

59
Perrigo Company plc - Item 1A
Risk Factors




compete with Tysabri® and could have a significant negative impact on the royalty we receive from Biogen Idec Inc. ("Biogen") and the performance of the Specialty Sciences segment. We continue to monitor the progress of all potential competing products and assess the reporting unit for potential impairment should impairment indicators arise, as applicable, and at least annually during our fourth quarter impairment testing.

In connection with the preparation of our financial statements for the three-month period ended April 2, 2016, we identified indicators of impairment associated with certain indefinite-lived intangible assets acquired in conjunction with the Omega acquisition. The primary impairment indicators included the decline in our 2016 performance expectations and a reduction in our long-range revenue growth forecast. The assessment utilized the excess earnings method to determine fair value and resulted in an impairment charge of $273.4 million in Impairment charges on the Condensed Consolidated Statements of Operations within our BCH segment, which represented the difference between the carrying amount of the intangible assets and their estimated fair value. The change in fair value from previous estimates was due primarily to the changes in the market and performance of the brands such that the evaluation of brand prioritization and product extensions or launches in new regions are being more focused to maximize the potential of all brands in the segment's portfolio. The main assumptions supporting the fair value of these assets and cash flow projections included revenue growth based on product line extensions, product life cycle strategies, and geographical expansion within the markets in which the BCH segment distributes products, gross margins consistent with historical trends, and advertising and promotion investments largely consistent with the segment's growth plans.

In connection with the preparation of our financial statements for the three months ended October 1, 2016, we identified additional indicators of impairment associated with certain indefinite-lived and definite-lived intangible brand category assets acquired in conjunction with the Omega acquisition. The primary impairment indicators are discussed above in goodwill. The assessment of the indefinite-lived assets utilized the excess earnings method to determine fair value and resulted in an impairment charge of $575.7 million for the three months ended October 1, 2016. With regards to the definite-lived asset, it was determined that the carrying value of the asset group was not recoverable based on an assessment of the undiscounted future cash flows expected to be generated by the asset group. Given this, the excess earnings method was utilized to determine fair value of the definite-lived asset and resulted in an impairment charge of $290.2 million for the three months ended October 1, 2016. Both charges, which represented the difference between the carrying amount of the intangible assets and their estimated fair value, were recorded in Impairment charges on the Condensed Consolidated Statements of Operations within our BCH segment. The main assumptions supporting the fair value of these assets and cash flow projections are included in the goodwill discussions above.

The carrying value for certain intangible assets and goodwill equals estimated and implied fair values, respectively, and as a result, any further deterioration in those assets' fair value would lead to a further impairment charge. Future performance different from the assumptions utilized in our quantitative analyses may result in additional changes in the fair value. We will continue to monitor and assess these assets for potential impairment should further impairment indicators arise. We will complete our required annual impairment testing during the fourth quarter of 2016.

In addition, given the additional change in performance expectations for our remaining impaired cough/cold/allergy, anti-parasite, personal care and natural health brands previously recorded as indefinite-lived assets, we reclassified the remaining asset balance of $672.4 million related to these four assets to definite-lived assets with a 20-year useful life and began amortizing the assets as of October 2, 2016.

See Part I. Item 1. Note 3 for more information on the above impairment charges.

We identified a material weakness in our internal controls over financial reporting; failure to remediate the material weakness could negatively impact our business and the price of our ordinary shares.

In connection with the preparation of our financial statements for the three-month period ended April 2, 2016, we concluded that a material weakness existed in our internal controls over financial reporting, as described under Item 4. “Controls and Procedures.” More specifically, we did not design and maintain effective management review controls that operated at a sufficient level of precision to ensure interim income taxes are properly recorded and disclosed in our consolidated financial statements in connection with the recording of an indefinite-lived intangible asset impairment and an estimated goodwill impairment for the three months ended April 2, 2016. In

60
Perrigo Company plc - Item 1A
Risk Factors




response to the identified material weakness, and with oversight from our Audit Committee, we are focused on improving our internal controls over financial reporting and remedying the identified material weakness.

To remediate the material weakness in internal control over financial reporting described above, with oversight from the Audit Committee, we have:

•
Reviewed the processes and controls in place to measure and record income taxes to enhance the efficiency and effectiveness of the design and operation of those controls;
•
Enhanced monitoring activities related to income taxes by adding additional internal controls and checklists; and
•
Evaluated and enhanced the level of precision in the management review controls related to income taxes by adding additional levels of review.

We are in the process of testing and evaluating the design and operating effectiveness of the control procedures and are assessing the effectiveness of the remediation plan, which we began implementing during the three months ended July 2, 2016 and are continuing to implement. Until the remediation actions are fully implemented and the operational effectiveness of related internal controls is validated through testing, the material weakness described above will continue to exist. We will continue to monitor the effectiveness of these remediation measures and will make any changes and take such other actions that we deem appropriate given the circumstances. We cannot assure you that we will be able to remediate this material weakness on a timely basis or at all. Failure to remediate this material weakness or difficulties encountered during implementation of these remediation efforts could result in material misstatements in or a future restatement of our financial statements, a failure to meet our reporting obligations, or the loss of investor confidence in our reported financial information, any of which could negatively impact our business and the price of our ordinary shares.

Our global operations could be negatively impacted by the economic and political instability caused by the United Kingdom ("UK") vote to leave the European Union ("EU").

The UK held a referendum on June 23, 2016 on its membership in the EU. A majority of UK voters voted to exit the EU (“Brexit”), and negotiations will commence to determine the future terms of the UK’s relationship with the EU, subject to a negotiation period that could last up to two years after the UK government formally initiates the withdraw process, including the terms of trade between the UK and the EU. Brexit has created significant instability and volatility in the global financial markets, has led to significant weakening of the British pound compared to the U.S. dollar and other currencies, and could adversely affect European or worldwide economic or market conditions. Although it is unknown what those terms will be, they may impair the ability of our operations in the EU to transact business in the future in the UK, and similarly the ability of our UK operations to transact business in the future in the EU. Specifically, it is possible that there will be greater restrictions on imports and exports between the UK and EU countries and increased regulatory complexities. These changes may adversely affect our operations and financial results. In addition, Brexit could lead to legal uncertainty and potentially divergent national laws and regulations as the UK determines which EU laws to replace or replicate. Further, among other things, Brexit could reduce consumer spending in the UK and the EU, which could result in decreased demand for our products. Any of these effects of Brexit, and others we cannot anticipate, could adversely affect our business, business opportunities, results of operations, financial condition and cash flows.

ITEM 5.    OTHER INFORMATION

Director Appointments

On November 7, 2016, the Board of Directors appointed each of Geoffrey M. Parker and Theodore R. Samuels as members of the Board, effective November 7, 2016 and January 4, 2017, respectively. Each of Messrs. Parker and Samuels will serve as directors until the Company’s 2017 annual meeting of shareholders or until their successors are duly elected and qualified. Mr. Parker will serve on the Board’s Audit Committee. In connection with their appointment and service to the Board, Messrs. Parker and Samuels will receive, on a prorated basis, the same director compensation that our non-employee directors are eligible to receive, as previously disclosed in the Company’s definitive proxy statement on Schedule 14A filed with the SEC on March 17, 2016.


61
Perrigo Company plc - Item 1A
Risk Factors




There are no arrangements or understandings between either of Messrs. Parker and Samuels and any other person in connection with their respective appointments to the Board. There are no transactions in which either Messrs. Parker or Samuels, or any member of their immediate family, has an interest that would require disclosure under Item 404(a) of Regulation S-K.

Directors Not Standing for Re-election

On November 7, 2016, Michael Jandernoa and Gary Kunkle advised the Board that they will not stand for re-election as directors of the Company at the 2017 annual meeting of shareholders. Messrs. Jandernoa and Kunkle will continue to serve as directors until the Company’s 2017 annual meeting of shareholders. Mr. Kunkle has served as a director since 2002 and held the position of Lead Independent Director of the Company between August 2009 and April 2016. In addition, Mr. Kunkle served on the Board’s Audit Committee and Remuneration Committee. Mr. Jandernoa has served as a director since 1981, and was the Company’s Chief Executive Officer from 1988 to 2000 and Chairman of the Board from 1991 to 2003. Each of Messrs. Kunkle and Jandernoa advised the Board that he has determined to retire from the Board after many years of distinguished service and that his decision not to stand for re-election at the 2017 annual meeting of shareholders is not the result of any disagreement with the other Board members or with the Company on any matters involving the Company’s operations, policies or practices.


62
Perrigo Company plc - Part II - Item 6
Exhibits


ITEM 6.    EXHIBITS

Exhibit
Number
 
Description
 
 
 
3.1
 
Certificate of Incorporation of Perrigo Company plc (formerly known as Perrigo Company Limited) (incorporated by reference from Exhibit 4.1 to the Company's Registration Statement on Form S-8 filed on December 19, 2013).
 
 
 
3.2
 
Memorandum and Articles of Association of Perrigo Company plc, as amended (incorporated by reference from Exhibit 3.2 to the Company's Transition Report on Form 10-KT filed on February 25, 2016).
 
 
 
10.1
 
Employment Agreement, dated as of August 3, 2016, by and among the Company, Perrigo Management Company and John T. Hendrickson (incorporated by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on August 5, 2016).
 
 
 
10.2
 
Amendment No. 2, dated September 9, 2016, to the Revolving Credit Agreement by and among Perrigo Finance Unlimited Company, the Company, JPMorgan Chase Bank, N.A. and the other lenders party thereto, dated as of December 5, 2014, as amended by Amendment No. 1, dated as of February 26, 2016 (incorporated by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on September 9, 2016).
 
 
 
10.3
 
Amendment No. 2, dated September 9, 2016, to the Term Loan Credit Agreement by and among Perrigo Finance Unlimited Company, the Company, JPMorgan Chase Bank, N.A. and the other lenders party thereto, dated as of December 5, 2014, as amended by Amendment No. 1, dated as of February 26, 2016 (incorporated by reference from Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on September 9, 2016).
 
 
 
31.1
 
Rule 13a-14(a) Certification by John T. Hendrickson, Chief Executive Officer (filed herewith).
 
 
 
31.2
 
Rule 13a-14(a) Certification by Judy L. Brown, Executive Vice President, Business Operations and Chief Financial Officer (filed herewith).
 
 
 
32
 
Certification Pursuant to 18 United States Code 1350 and Rule 13a-14(b) of the Securities Exchange Act of 1934 (furnished herewith).
 
 
 
101.INS
 
XBRL Instance Document.
 
 
 
101.SCH
 
XBRL Taxonomy Extension Schema Document.
 
 
 
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document.
 
 
 
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document.
 
 
 
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document.
 
 
 
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document.

63

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
 
PERRIGO COMPANY PLC
 
 
 
(Registrant)
 
 
 
 
Date:
November 10, 2016
 
By: /s/ John T. Hendrickson
 
 
 
John T. Hendrickson
 
 
 
Chief Executive Officer
 
 
 
(Principal Executive Officer)
 
 
 
 
Date:
November 10, 2016
 
By: /s/ Judy L. Brown
 
 
 
Judy L. Brown
 
 
 
Executive Vice President, Business Operations and Chief Financial Officer
 
 
 
(Principal Accounting and Financial Officer)


64
 EX-31.1 2 cy16q310qex311.htm EXHIBIT 31.1 Exhibit


Exhibit 31.1
CERTIFICATION
I, John T. Hendrickson, certify that:
1.
I have reviewed this report on Form 10-Q of Perrigo Company plc;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:
a.
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 10, 2016
/s/ John T. Hendrickson
John T. Hendrickson
Chief Executive Officer
 



 EX-31.2 3 cy16q310qex312.htm EXHIBIT 31.2 Exhibit


Exhibit 31.2
CERTIFICATION
I, Judy L. Brown, certify that:
1.
I have reviewed this report on Form 10-Q of Perrigo Company plc;
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:
a.
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 10, 2016
/s/ Judy L. Brown
Judy L. Brown
Executive Vice President, Business Operations and Chief Financial Officer
 



 EX-32 4 cy16q310qex32.htm EXHIBIT 32 Exhibit


Exhibit 32
The following statement is being made to the Securities and Exchange Commission solely for the purposes of Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350), which carries with it certain criminal penalties in the event of a knowing or willful misrepresentation.
Securities and Exchange Commission
450 Fifth Street NW
Washington, D.C. 20549
 
Re:
Perrigo Company plc

Ladies and Gentlemen:
In accordance with the requirements of Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350), each of the undersigned hereby certifies that:
(i)
this Quarterly Report on Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
(ii)
the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of Perrigo Company plc.


 
 
 
 
Date:
November 10, 2016
 
/s/ John T. Hendrickson
 
 
 
John T. Hendrickson
 
 
 
Chief Executive Officer
 
 
 
(Principal Executive Officer)
 
 
 
 
Date:
November 10, 2016
 
/s/ Judy L. Brown
 
 
 
Judy L. Brown
 
 
 
Executive Vice President, Business Operations and Chief Financial Officer
 
 
 
(Principal Accounting and Financial Officer)




 EX-101.INS 5 prgo-20161001.xml XBRL INSTANCE DOCUMENT 0001585364 2016-01-01 2016-10-01 0001585364 2016-11-04 0001585364 2016-07-03 2016-10-01 0001585364 2014-12-28 2015-09-26 0001585364 2015-06-28 2015-09-26 0001585364 2015-12-31 0001585364 2016-10-01 0001585364 2015-09-26 0001585364 2014-12-27 0001585364 prgo:AmountoferrorgrossoftaxMember 2016-01-01 2016-04-02 0001585364 prgo:AmountoferrornetoftaxMember 2016-01-01 2016-04-02 0001585364 prgo:OmegaMember 2015-03-30 2015-03-30 0001585364 prgo:OmegaMember 2015-03-30 0001585364 prgo:DevelopmentstagerxproductsMember 2016-03-01 0001585364 prgo:TretinoinMember 2016-01-22 0001585364 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2016-10-01 0001585364 prgo:DevelopmentstagerxproductsMember us-gaap:LicensingAgreementsMember 2016-03-01 0001585364 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:CustomerRelationshipsMember 2016-10-01 0001585364 prgo:TretinoinMember us-gaap:CustomerRelationshipsMember 2016-01-22 0001585364 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:DevelopedTechnologyRightsMember 2016-10-01 0001585364 prgo:DevelopmentstagerxproductsMember us-gaap:NoncompeteAgreementsMember 2016-03-01 0001585364 prgo:DevelopmentstagerxproductsMember 2016-03-01 2016-03-01 0001585364 prgo:TretinoinMember us-gaap:DevelopedTechnologyRightsMember 2016-01-22 0001585364 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:NoncompeteAgreementsMember 2016-10-01 0001585364 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:LicensingAgreementsMember 2016-10-01 0001585364 prgo:TretinoinMember us-gaap:NoncompeteAgreementsMember 2016-01-22 0001585364 prgo:TretinoinMember us-gaap:InProcessResearchAndDevelopmentMember 2016-01-22 0001585364 prgo:TretinoinMember 2016-01-22 2016-01-22 0001585364 prgo:DevelopmentstagerxproductsMember us-gaap:DevelopedTechnologyRightsMember 2016-03-01 0001585364 prgo:DevelopmentstagerxproductsMember us-gaap:CustomerRelationshipsMember 2016-03-01 0001585364 prgo:DevelopmentstagerxproductsMember us-gaap:InProcessResearchAndDevelopmentMember 2016-03-01 0001585364 prgo:TretinoinMember us-gaap:LicensingAgreementsMember 2016-01-22 0001585364 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:InProcessResearchAndDevelopmentMember 2016-10-01 0001585364 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2016-01-01 2016-10-01 0001585364 prgo:EntocortMember 2015-12-15 2015-12-15 0001585364 prgo:ScarAwayMember 2015-08-28 2015-08-28 0001585364 prgo:BenzaclinMember 2016-08-02 2016-08-02 0001585364 prgo:NaturwohlPharmaMember 2015-09-15 2015-09-15 0001585364 prgo:ConsumerHealthcareMember 2016-08-05 2016-08-05 0001585364 prgo:GSKMember currency:EUR 2015-08-28 2015-08-28 0001585364 us-gaap:PropertyPlantAndEquipmentMember prgo:GelcapsMember 2015-05-12 2015-05-12 0001585364 2014-06-29 2015-06-27 0001585364 prgo:OmegaMember currency:EUR us-gaap:MaximumMember 2015-03-30 2015-03-30 0001585364 prgo:TretinoinMember 2016-07-03 2016-10-01 0001585364 us-gaap:PropertyPlantAndEquipmentMember prgo:OmegaMember 2015-03-30 2015-03-30 0001585364 prgo:TretinoinMember us-gaap:DevelopedTechnologyRightsMember 2016-01-22 2016-01-22 0001585364 us-gaap:InventoriesMember prgo:OmegaMember 2015-03-30 2015-03-30 0001585364 us-gaap:CommonStockMember 2014-06-29 2015-06-27 0001585364 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2015-06-28 2015-12-31 0001585364 prgo:TretinoinMember 2016-01-01 2016-10-01 0001585364 prgo:NaturwohlPharmaMember us-gaap:LicensingAgreementsMember 2015-09-15 2015-09-15 0001585364 prgo:GelcapsMember us-gaap:TrademarksAndTradeNamesMember 2015-05-12 2015-05-12 0001585364 prgo:OmegaMember prgo:BrandsMember 2015-03-30 2015-03-30 0001585364 prgo:GelcapsMember 2015-05-12 0001585364 prgo:GelcapsMember us-gaap:CustomerRelationshipsMember 2015-05-12 2015-05-12 0001585364 prgo:NaturwohlPharmaMember us-gaap:NoncompeteAgreementsMember 2015-09-15 2015-09-15 0001585364 prgo:OmegaMember us-gaap:DevelopedTechnologyRightsMember us-gaap:MinimumMember 2015-03-30 2015-03-30 0001585364 prgo:ConsumerHealthcareMember 2016-01-01 2016-10-01 0001585364 prgo:ScarAwayMember us-gaap:CustomerRelationshipsMember 2015-08-28 2015-08-28 0001585364 prgo:OmegaMember us-gaap:MaximumMember 2015-03-30 2015-03-30 0001585364 prgo:NaturwohlPharmaMember 2015-09-15 0001585364 prgo:GSKMember 2015-08-28 2015-08-28 0001585364 prgo:OmegaMember us-gaap:DevelopedTechnologyRightsMember us-gaap:MaximumMember 2015-03-30 2015-03-30 0001585364 prgo:ContractualarrangementMember 2015-05-01 2015-05-31 0001585364 prgo:NaturwohlPharmaMember us-gaap:TrademarksAndTradeNamesMember 2015-09-15 2015-09-15 0001585364 prgo:ScarAwayMember us-gaap:TrademarksAndTradeNamesMember 2015-08-28 2015-08-28 0001585364 prgo:TretinoinMember us-gaap:NoncompeteAgreementsMember 2016-01-22 2016-01-22 0001585364 prgo:GelcapsMember 2015-05-12 2015-05-12 0001585364 prgo:OmegaMember prgo:NonsolicitagreementMember 2015-03-30 2015-03-30 0001585364 prgo:ScarAwayMember us-gaap:NoncompeteAgreementsMember 2015-08-28 2015-08-28 0001585364 us-gaap:InventoriesMember prgo:GelcapsMember 2015-05-12 2015-05-12 0001585364 prgo:BenzaclinMember us-gaap:LicensingAgreementsMember 2016-08-02 2016-08-02 0001585364 prgo:GSKMember us-gaap:CustomerRelationshipsMember 2015-08-28 2015-08-28 0001585364 prgo:ScarAwayMember us-gaap:DevelopedTechnologyRightsMember 2015-08-28 2015-08-28 0001585364 us-gaap:LongTermDebtMember prgo:OmegaMember 2015-03-30 2015-03-30 0001585364 prgo:EntocortMember us-gaap:DevelopedTechnologyRightsMember us-gaap:MinimumMember 2015-12-15 2015-12-15 0001585364 prgo:GSKMember us-gaap:TrademarksAndTradeNamesMember 2015-08-28 2015-08-28 0001585364 prgo:EntocortMember us-gaap:DevelopedTechnologyRightsMember us-gaap:MaximumMember 2015-12-15 2015-12-15 0001585364 prgo:NaturwohlPharmaMember us-gaap:CustomerRelationshipsMember 2015-09-15 2015-09-15 0001585364 prgo:A2014bondsMember 2014-12-02 0001585364 prgo:OmegaMember us-gaap:CustomerRelationshipsMember 2015-03-30 2015-03-30 0001585364 prgo:BenzaclinMember 2016-08-02 0001585364 prgo:NaturwohlPharmaMember currency:EUR 2015-09-15 2015-09-15 0001585364 prgo:OmegaMember us-gaap:TrademarksAndTradeNamesMember 2015-03-30 2015-03-30 0001585364 prgo:OmegaMember us-gaap:NoncompeteAgreementsMember 2015-03-30 2015-03-30 0001585364 prgo:OmegaMember us-gaap:InterestExpenseMember 2014-12-28 2015-09-26 0001585364 prgo:OmegaMember us-gaap:OtherExpenseMember 2014-12-28 2015-09-26 0001585364 prgo:OmegaMember 2014-12-28 2015-09-26 0001585364 prgo:OmegaMember us-gaap:GeneralAndAdministrativeExpenseMember 2014-12-28 2015-09-26 0001585364 prgo:GelcapsMember us-gaap:LicensingAgreementsMember 2015-05-12 0001585364 2015-03-30 0001585364 prgo:ScarAwayMember 2015-08-28 0001585364 prgo:ScarAwayMember us-gaap:InProcessResearchAndDevelopmentMember 2015-08-28 0001585364 2015-09-15 0001585364 prgo:EntocortMember us-gaap:TrademarksAndTradeNamesMember 2015-12-15 0001585364 prgo:GSKMember 2015-08-28 0001585364 prgo:ScarAwayMember us-gaap:NoncompeteAgreementsMember 2015-08-28 0001585364 prgo:NaturwohlMember us-gaap:InProcessResearchAndDevelopmentMember 2015-09-15 0001585364 prgo:EntocortMember 2015-12-15 0001585364 2015-08-28 0001585364 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:NoncompeteAgreementsMember 2015-12-31 0001585364 prgo:GelcapsMember us-gaap:TrademarksAndTradeNamesMember 2015-05-12 0001585364 prgo:ScarAwayMember us-gaap:DevelopedTechnologyRightsMember 2015-08-28 0001585364 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2015-12-31 0001585364 prgo:NaturwohlPharmaMember us-gaap:LicensingAgreementsMember 2015-09-15 0001585364 prgo:GSKMember us-gaap:CustomerRelationshipsMember 2015-08-28 0001585364 prgo:EntocortMember us-gaap:InProcessResearchAndDevelopmentMember 2015-12-15 0001585364 prgo:GelcapsMember us-gaap:NoncompeteAgreementsMember 2015-05-12 0001585364 prgo:GSKMember us-gaap:DevelopedTechnologyRightsMember 2015-08-28 0001585364 2015-12-15 0001585364 prgo:ScarAwayMember us-gaap:CustomerRelationshipsMember 2015-08-28 0001585364 prgo:GSKMember us-gaap:InProcessResearchAndDevelopmentMember 2015-08-28 0001585364 prgo:EntocortMember us-gaap:NoncompeteAgreementsMember 2015-12-15 0001585364 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:InProcessResearchAndDevelopmentMember 2015-12-31 0001585364 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:TrademarksAndTradeNamesMember 2015-12-31 0001585364 us-gaap:DevelopedTechnologyRightsMember 2015-09-15 0001585364 prgo:OmegaMember us-gaap:LicensingAgreementsMember 2015-03-30 0001585364 prgo:GSKMember us-gaap:NoncompeteAgreementsMember 2015-08-28 0001585364 prgo:NaturwohlPharmaMember us-gaap:TrademarksAndTradeNamesMember 2015-09-15 0001585364 prgo:OmegaMember us-gaap:CustomerRelationshipsMember 2015-03-30 0001585364 prgo:OmegaMember us-gaap:TrademarksAndTradeNamesMember 2015-12-31 0001585364 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:LicensingAgreementsMember 2015-12-31 0001585364 prgo:NaturwohlPharmaMember us-gaap:CustomerRelationshipsMember 2015-09-15 0001585364 prgo:GSKMember us-gaap:LicensingAgreementsMember 2015-08-28 0001585364 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:CustomerRelationshipsMember 2015-12-31 0001585364 prgo:EntocortMember us-gaap:LicensingAgreementsMember 2015-12-15 0001585364 prgo:NaturwohlPharmaMember us-gaap:NoncompeteAgreementsMember 2015-09-15 0001585364 prgo:GSKMember us-gaap:TrademarksAndTradeNamesMember 2015-08-28 0001585364 prgo:EntocortMember us-gaap:DevelopedTechnologyRightsMember 2015-12-15 0001585364 prgo:GelcapsMember us-gaap:TrademarksAndTradeNamesMember 2015-05-12 0001585364 prgo:ScarAwayMember us-gaap:LicensingAgreementsMember 2015-08-28 0001585364 prgo:OmegaMember us-gaap:DevelopedTechnologyRightsMember 2015-12-31 0001585364 prgo:OmegaMember us-gaap:InProcessResearchAndDevelopmentMember 2015-03-30 0001585364 prgo:OmegaMember 2015-12-31 0001585364 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:TrademarksAndTradeNamesMember 2015-12-31 0001585364 prgo:OmegaMember us-gaap:NoncompeteAgreementsMember 2015-03-30 0001585364 prgo:EntocortMember us-gaap:CustomerRelationshipsMember 2015-12-15 0001585364 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:DevelopedTechnologyRightsMember 2015-12-31 0001585364 prgo:GelcapsMember us-gaap:DevelopedTechnologyRightsMember 2015-05-12 0001585364 prgo:OmegaMember us-gaap:TrademarksAndTradeNamesMember 2015-03-30 0001585364 prgo:GelcapsMember us-gaap:InProcessResearchAndDevelopmentMember 2015-05-12 0001585364 prgo:GelcapsMember us-gaap:CustomerRelationshipsMember 2015-05-12 0001585364 prgo:ScarAwayMember us-gaap:TrademarksAndTradeNamesMember 2015-08-28 0001585364 us-gaap:TrademarksMember 2015-12-31 0001585364 us-gaap:DevelopedTechnologyRightsMember 2016-10-01 0001585364 us-gaap:LicensingAgreementsMember 2015-12-31 0001585364 us-gaap:CustomerRelationshipsMember 2016-10-01 0001585364 us-gaap:CustomerRelationshipsMember 2015-12-31 0001585364 us-gaap:TrademarksMember 2016-10-01 0001585364 us-gaap:TrademarksMember 2016-10-01 0001585364 us-gaap:InProcessResearchAndDevelopmentMember 2015-12-31 0001585364 us-gaap:NoncompeteAgreementsMember 2016-10-01 0001585364 us-gaap:NoncompeteAgreementsMember 2015-12-31 0001585364 us-gaap:LicensingAgreementsMember 2016-10-01 0001585364 us-gaap:InProcessResearchAndDevelopmentMember 2016-10-01 0001585364 us-gaap:DevelopedTechnologyRightsMember 2015-12-31 0001585364 us-gaap:TrademarksMember 2015-12-31 0001585364 prgo:RxPharmaceuticalsMember 2016-01-01 2016-10-01 0001585364 prgo:OtherMember 2016-01-01 2016-10-01 0001585364 prgo:BrandedCHCMember 2016-01-01 2016-10-01 0001585364 prgo:SpecialtySciencesMember 2016-01-01 2016-10-01 0001585364 prgo:OtherMember 2016-10-01 0001585364 prgo:OtherMember 2015-12-31 0001585364 prgo:BrandedCHCMember 2016-10-01 0001585364 prgo:BrandedCHCMember 2015-12-31 0001585364 prgo:SpecialtySciencesMember 2015-12-31 0001585364 prgo:RxPharmaceuticalsMember 2016-10-01 0001585364 prgo:SpecialtySciencesMember 2016-10-01 0001585364 prgo:RxPharmaceuticalsMember 2015-12-31 0001585364 prgo:ConsumerHealthcareMember 2015-12-31 0001585364 prgo:ConsumerHealthcareMember 2016-10-01 0001585364 prgo:BrandedCHCBelgiumMember prgo:BrandedCHCMember 2016-07-03 2016-10-01 0001585364 prgo:BrandedCHCrestofworldMember prgo:BrandedCHCMember 2016-01-01 2016-04-02 0001585364 prgo:OmegaMember prgo:BrandsMember 2016-07-03 2016-10-01 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:LicensingAgreementsMember prgo:BrandedCHCMember 2016-10-01 0001585364 prgo:BrandedCHCrestofworldMember prgo:BrandedCHCMember 2016-07-03 2016-10-01 0001585364 prgo:ConsumerHealthcareMember country:MX 2014-12-28 2015-09-26 0001585364 prgo:BrandedCHCrestofworldMember prgo:BrandedCHCMember 2016-04-03 2016-07-02 0001585364 prgo:OmegaMember prgo:BrandsMember 2015-09-27 2015-12-31 0001585364 prgo:BrandedCHCrestofworldMember prgo:BrandedCHCMember 2016-10-01 0001585364 prgo:BrandedCHCBelgiumMember prgo:BrandedCHCMember 2016-10-01 0001585364 prgo:OmegaMember prgo:BrandsMember 2016-01-01 2016-04-02 0001585364 us-gaap:MaximumMember 2016-10-01 0001585364 us-gaap:MinimumMember 2016-10-01 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2015-12-31 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2016-10-01 0001585364 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001585364 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001585364 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2016-10-01 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:ContingentConsiderationClassifiedAsEquityMember us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:ContingentConsiderationClassifiedAsEquityMember us-gaap:FairValueMeasurementsRecurringMember 2016-10-01 0001585364 us-gaap:FairValueInputsLevel3Member 2016-01-01 2016-10-01 0001585364 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2016-10-01 0001585364 prgo:RetailBondsMember 2015-12-31 0001585364 prgo:BrandedCHCMember 2016-07-03 2016-10-01 0001585364 prgo:RetailBondsMember 2016-10-01 0001585364 prgo:PublicBondsandPrivatePlacementMember 2016-10-01 0001585364 prgo:PublicBondsandPrivatePlacementMember us-gaap:FairValueInputsLevel1Member 2015-12-31 0001585364 prgo:OmegaMember prgo:BrandsMember 2016-01-01 2016-10-01 0001585364 prgo:PublicBondsandPrivatePlacementMember us-gaap:FairValueInputsLevel1Member 2016-10-01 0001585364 prgo:RetailBondsMember us-gaap:FairValueInputsLevel2Member 2015-12-31 0001585364 prgo:RetailBondsMember us-gaap:FairValueInputsLevel2Member 2016-10-01 0001585364 prgo:PublicBondsandPrivatePlacementMember 2015-12-31 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:ContingentConsiderationClassifiedAsEquityMember us-gaap:FairValueMeasurementsRecurringMember 2014-12-28 2015-09-26 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:ContingentConsiderationClassifiedAsEquityMember us-gaap:FairValueMeasurementsRecurringMember 2016-07-03 2016-10-01 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:ContingentConsiderationClassifiedAsEquityMember us-gaap:FairValueMeasurementsRecurringMember 2015-06-28 2015-09-26 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:ContingentConsiderationClassifiedAsEquityMember us-gaap:FairValueMeasurementsRecurringMember 2015-09-26 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:ContingentConsiderationClassifiedAsEquityMember us-gaap:FairValueMeasurementsRecurringMember 2014-12-27 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:ContingentConsiderationClassifiedAsEquityMember us-gaap:FairValueMeasurementsRecurringMember 2016-07-02 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:ContingentConsiderationClassifiedAsEquityMember us-gaap:FairValueMeasurementsRecurringMember 2016-01-01 2016-10-01 0001585364 us-gaap:FairValueInputsLevel3Member us-gaap:ContingentConsiderationClassifiedAsEquityMember us-gaap:FairValueMeasurementsRecurringMember 2015-06-27 0001585364 us-gaap:OtherNoncurrentAssetsMember 2015-12-31 0001585364 us-gaap:OtherNoncurrentAssetsMember 2016-10-01 0001585364 us-gaap:AvailableforsaleSecuritiesMember 2016-10-01 0001585364 us-gaap:AvailableforsaleSecuritiesMember 2015-12-31 0001585364 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2016-10-01 0001585364 us-gaap:OtherCurrentAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-10-01 0001585364 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-12-31 0001585364 us-gaap:OtherCurrentAssetsMember us-gaap:NondesignatedMember 2016-10-01 0001585364 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-10-01 0001585364 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2015-12-31 0001585364 us-gaap:OtherCurrentAssetsMember us-gaap:NondesignatedMember 2015-12-31 0001585364 us-gaap:OtherCurrentAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-12-31 0001585364 prgo:OmegaMember prgo:CreditfacilityindebtednessMember 2015-03-30 0001585364 us-gaap:OtherExpenseMember 2014-12-28 2015-09-26 0001585364 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-06-27 0001585364 us-gaap:ForeignExchangeContractMember 2015-12-31 0001585364 prgo:PerrigoCoPLCMember us-gaap:ForeignExchangeOptionMember us-gaap:NondesignatedMember 2014-12-28 2015-09-26 0001585364 prgo:OmegaMember prgo:OmegaMember prgo:A6.19SeniorNoteMember 2015-03-30 0001585364 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-12-31 0001585364 prgo:OmegaMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-03-30 0001585364 us-gaap:ForeignExchangeOptionMember us-gaap:DesignatedAsHedgingInstrumentMember 2014-12-28 2015-09-26 0001585364 prgo:OmegaMember currency:EUR prgo:CreditfacilityindebtednessMember 2015-03-30 0001585364 us-gaap:ForeignExchangeContractMember 2016-10-01 0001585364 currency:EUR us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-03-30 0001585364 us-gaap:ForeignExchangeForwardMember 2016-01-01 2016-10-01 0001585364 prgo:OmegaMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-03-30 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2014-12-28 2015-09-26 0001585364 us-gaap:NondesignatedMember 2016-07-03 2016-10-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-07-03 2016-10-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2014-12-28 2015-09-26 0001585364 us-gaap:NondesignatedMember 2015-06-28 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2015-06-28 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2015-06-28 2015-09-26 0001585364 us-gaap:NondesignatedMember 2014-12-28 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-01-01 2016-10-01 0001585364 us-gaap:NondesignatedMember 2016-01-01 2016-10-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2016-01-01 2016-10-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:InterestExpenseMember 2016-07-03 2016-10-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2014-12-28 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2016-07-03 2016-10-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2015-06-28 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-07-03 2016-10-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesRevenueGoodsNetMember 2016-01-01 2016-10-01 0001585364 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2015-06-28 2015-09-26 0001585364 us-gaap:TreasuryLockMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2016-07-03 2016-10-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesRevenueGoodsNetMember 2014-12-28 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2014-12-28 2015-09-26 0001585364 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2016-07-03 2016-10-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2016-01-01 2016-10-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesRevenueGoodsNetMember 2015-06-28 2015-09-26 0001585364 us-gaap:DesignatedAsHedgingInstrumentMember 2016-01-01 2016-10-01 0001585364 us-gaap:DesignatedAsHedgingInstrumentMember 2016-07-03 2016-10-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2016-07-03 2016-10-01 0001585364 us-gaap:DesignatedAsHedgingInstrumentMember 2015-06-28 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2016-01-01 2016-10-01 0001585364 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2016-01-01 2016-10-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2015-06-28 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-01-01 2016-10-01 0001585364 us-gaap:TreasuryLockMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2016-01-01 2016-10-01 0001585364 us-gaap:TreasuryLockMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2014-12-28 2015-09-26 0001585364 us-gaap:DesignatedAsHedgingInstrumentMember 2014-12-28 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesRevenueGoodsNetMember 2016-07-03 2016-10-01 0001585364 us-gaap:TreasuryLockMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2015-06-28 2015-09-26 0001585364 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2014-12-28 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2014-12-28 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2015-06-28 2015-09-26 0001585364 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2016-10-01 0001585364 us-gaap:NondesignatedMember 2015-12-31 0001585364 us-gaap:DesignatedAsHedgingInstrumentMember 2016-10-01 0001585364 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-10-01 0001585364 us-gaap:NondesignatedMember 2016-10-01 0001585364 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-12-31 0001585364 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2015-12-31 0001585364 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-12-31 0001585364 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-10-01 0001585364 us-gaap:DesignatedAsHedgingInstrumentMember 2015-12-31 0001585364 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-01-01 2016-10-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-06-28 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-01-01 2016-10-01 0001585364 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-07-03 2016-10-01 0001585364 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2014-12-28 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2014-12-28 2015-09-26 0001585364 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-06-28 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-07-03 2016-10-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:CostOfSalesMember 2015-06-28 2015-09-26 0001585364 us-gaap:InterestRateSwapMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-01-01 2016-10-01 0001585364 us-gaap:InterestRateSwapMember us-gaap:OtherNonoperatingIncomeExpenseMember 2015-06-28 2015-09-26 0001585364 us-gaap:InterestRateSwapMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-07-03 2016-10-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:OtherNonoperatingIncomeExpenseMember 2014-12-28 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:OtherNonoperatingIncomeExpenseMember 2015-06-28 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:SalesRevenueGoodsNetMember 2014-12-28 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:SalesRevenueGoodsNetMember 2016-07-03 2016-10-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:SalesRevenueGoodsNetMember 2016-01-01 2016-10-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-07-03 2016-10-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:SalesRevenueGoodsNetMember 2015-06-28 2015-09-26 0001585364 us-gaap:InterestRateSwapMember us-gaap:OtherNonoperatingIncomeExpenseMember 2014-12-28 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:CostOfSalesMember 2014-12-28 2015-09-26 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-01-01 2016-10-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:CostOfSalesMember 2016-01-01 2016-10-01 0001585364 us-gaap:ForeignExchangeForwardMember us-gaap:CostOfSalesMember 2016-07-03 2016-10-01 0001585364 prgo:OmegaMember 2015-03-29 2015-06-27 0001585364 us-gaap:DiscontinuedOperationsHeldforsaleMember prgo:OtherMember 2016-10-01 0001585364 us-gaap:DiscontinuedOperationsHeldforsaleMember prgo:ConsumerHealthcareMember 2015-12-31 0001585364 us-gaap:DiscontinuedOperationsHeldforsaleMember prgo:OtherMember 2015-12-31 0001585364 us-gaap:DiscontinuedOperationsHeldforsaleMember prgo:ConsumerHealthcareMember 2016-10-01 0001585364 us-gaap:DiscontinuedOperationsHeldforsaleMember prgo:ConsumerHealthcareMember 2015-06-28 2015-12-31 0001585364 us-gaap:DiscontinuedOperationsHeldforsaleMember prgo:OtherMember 2016-01-01 2016-10-01 0001585364 us-gaap:DiscontinuedOperationsHeldforsaleMember prgo:ConsumerHealthcareMember 2016-01-01 2016-10-01 0001585364 2015-06-28 2015-12-31 0001585364 prgo:A2.30UnsecuredSeniornotesNovember82018Member 2015-12-31 0001585364 prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member 2015-12-31 0001585364 prgo:A5.000UnsecuredSeniornotesdueMay232019Domain 2015-12-31 0001585364 prgo:A4.9SeniorLoandue2044Member 2015-12-31 0001585364 prgo:A5.105SeniornotedueJuly192023Domain 2016-10-01 0001585364 prgo:A4.500UnsecuredSeniorNotesdueMay232017Domain 2015-12-31 0001585364 prgo:PerrigoCoPLCMember 2015-12-31 0001585364 prgo:A4.375seniornotedueMarch152026Member 2016-10-01 0001585364 prgo:A5.125UnsecuredSeniorNotesdueDecember122017Domain 2016-10-01 0001585364 prgo:A5.105SeniornotedueJuly192023Domain 2015-12-31 0001585364 prgo:A4.375seniornotedueMarch152026Member 2015-12-31 0001585364 prgo:A2015RevolverMember 2016-10-01 0001585364 prgo:A5.125UnsecuredSeniorNotesdueDecember122017Domain 2016-01-01 2016-10-01 0001585364 prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member 2016-01-01 2016-10-01 0001585364 prgo:A2015RevolverMember 2015-12-31 0001585364 prgo:A3.5SeniornotedueDecember152021Member 2016-10-01 0001585364 prgo:A3.500UnsecuredSeniornotesdueMarch152021Domain 2016-01-01 2016-10-01 0001585364 prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member 2015-12-31 0001585364 prgo:A2014RevolverMember 2016-10-01 0001585364 prgo:A3.9seniornotedue2024Member 2016-01-01 2016-10-01 0001585364 prgo:A2014EuroDenominatedTermLoandueDecember52019Member 2016-10-01 0001585364 prgo:A1.30UnsecuredSeniorNotesdueNovember82016Member 2015-12-31 0001585364 prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member 2016-10-01 0001585364 prgo:A5.125UnsecuredSeniorNotesdueDecember122017Domain 2015-12-31 0001585364 prgo:A4.500UnsecuredSeniorNotesdueMay232017Domain 2016-01-01 2016-10-01 0001585364 prgo:A3.5SeniornotedueDecember152021Member 2016-01-01 2016-10-01 0001585364 prgo:A3.9seniornotedue2024Member 2016-10-01 0001585364 prgo:A4.9SeniorLoandue2044Member 2016-01-01 2016-10-01 0001585364 prgo:PerrigoCoPLCMember 2016-10-01 0001585364 prgo:A1.30UnsecuredSeniorNotesdueNovember82016Member 2016-10-01 0001585364 prgo:A3.5SeniornotedueDecember152021Member 2015-12-31 0001585364 prgo:A4.375seniornotedueMarch152026Member 2016-01-01 2016-10-01 0001585364 prgo:A3.9seniornotedue2024Member 2015-12-31 0001585364 prgo:A3.500UnsecuredSeniornotesdueMarch152021Domain 2015-12-31 0001585364 prgo:A5.105SeniornotedueJuly192023Domain 2016-01-01 2016-10-01 0001585364 prgo:A2.30UnsecuredSeniornotesNovember82018Member 2016-01-01 2016-10-01 0001585364 prgo:A2014RevolverMember 2015-12-31 0001585364 prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member 2016-10-01 0001585364 prgo:A4.500UnsecuredSeniorNotesdueMay232017Domain 2016-10-01 0001585364 prgo:A1.30UnsecuredSeniorNotesdueNovember82016Member 2016-01-01 2016-10-01 0001585364 prgo:A2014EuroDenominatedTermLoandueDecember52019Member 2015-12-31 0001585364 prgo:A3.500UnsecuredSeniornotesdueMarch152021Domain 2016-10-01 0001585364 prgo:A2.30UnsecuredSeniornotesNovember82018Member 2016-10-01 0001585364 prgo:A4.9SeniorLoandue2044Member 2016-10-01 0001585364 prgo:A5.000UnsecuredSeniornotesdueMay232019Domain 2016-10-01 0001585364 prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member 2016-01-01 2016-10-01 0001585364 prgo:A5.000UnsecuredSeniornotesdueMay232019Domain 2016-01-01 2016-10-01 0001585364 2015-03-30 2015-03-30 0001585364 prgo:OmegaMember prgo:A5.0RetailBondMember 2015-03-30 0001585364 prgo:OmegaMember prgo:A5.1045SeniorNoteMember 2015-03-30 2015-03-30 0001585364 currency:EUR prgo:A2014EuroDenominatedTermLoandueDecember52019Member 2014-12-05 0001585364 prgo:OmegaMember prgo:A6.19SeniorNoteMember 2015-03-30 0001585364 prgo:A3.5SeniornotedueDecember152021Member 2014-12-02 0001585364 prgo:DebtsecuritiesMemberMember 2016-03-07 0001585364 prgo:OmegaMember 2015-03-30 2015-03-30 0001585364 prgo:OmegaMember prgo:A4.5RetailBondMember 2015-03-30 0001585364 prgo:A1.30UnsecuredSeniorNotesdueNovember82016Member 2016-09-29 2016-09-29 0001585364 2013-11-08 0001585364 prgo:A2015RevolverMember 2015-12-09 0001585364 prgo:A2014RevolverMember 2016-03-15 2016-03-15 0001585364 prgo:OmegaMember currency:EUR 2015-03-30 2015-03-30 0001585364 prgo:OmegaMember prgo:OverDraftMember 2015-03-30 0001585364 prgo:OmegaMember prgo:A5.1045SeniorNoteMember 2015-03-30 0001585364 prgo:A4.375seniornotedueMarch152026Member 2016-03-07 0001585364 prgo:OmegaMember prgo:A5.0RetailBondMember 2015-03-30 2015-03-30 0001585364 prgo:OmegaMember currency:EUR prgo:A5.0RetailBondMember 2015-03-30 0001585364 prgo:A3.9seniornotedue2024Member 2014-12-02 0001585364 prgo:A3.5SeniornotedueDecember152021Member 2014-12-02 2014-12-02 0001585364 prgo:OmegaMember prgo:A6.19SeniorNoteMember 2015-03-30 2015-03-30 0001585364 prgo:OmegaMember currency:EUR prgo:A4.5RetailBondMember 2015-03-30 0001585364 prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member 2013-11-08 0001585364 prgo:OmegaMember prgo:A5.125RetailBondMember 2015-03-30 0001585364 prgo:A4.9SeniorLoandue2044Member 2014-12-02 0001585364 prgo:A2014EuroDenominatedTermLoandueDecember52019Member 2016-01-01 2016-10-01 0001585364 prgo:A3.500UnsecuredSeniornotesdueMarch152021Domain 2016-03-07 0001585364 2014-12-05 2014-12-05 0001585364 prgo:OmegaMember 2015-04-08 2015-04-08 0001585364 prgo:A2.30UnsecuredSeniornotesNovember82018Member 2013-11-08 0001585364 prgo:OmegaMember currency:EUR prgo:A5.125RetailBondMember 2015-03-30 0001585364 2016-03-07 2016-03-07 0001585364 prgo:A2014RevolverMember 2014-12-05 0001585364 prgo:OmegaMember currency:EUR 2015-04-08 2015-04-08 0001585364 prgo:A2014EuroDenominatedTermLoandueDecember52019additionaldrawDomain 2014-12-05 0001585364 2015-12-09 2015-12-09 0001585364 prgo:OmegaMember currency:EUR prgo:OverDraftMember 2015-03-30 0001585364 currency:EUR prgo:A2014EuroDenominatedTermLoandueDecember52019additionaldrawDomain 2014-12-05 0001585364 prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member 2013-11-08 0001585364 prgo:OmegaMember currency:EUR prgo:A5.1045SeniorNoteMember 2015-03-30 0001585364 prgo:A2015RevolverMember 2016-03-15 2016-03-15 0001585364 prgo:OmegaMember prgo:A4.5RetailBondMember 2015-03-30 2015-03-30 0001585364 prgo:A2014EuroDenominatedTermLoandueDecember52019Member 2014-12-05 0001585364 prgo:OmegaMember prgo:A5.125RetailBondMember 2015-03-30 2015-03-30 0001585364 prgo:A4.9SeniorLoandue2044Member 2014-12-28 2015-12-31 0001585364 prgo:A2014EuroDenominatedTermLoandueDecember52019additionaldrawDomain 2014-12-28 2015-12-31 0001585364 prgo:A5.30UnsecuredSeniorNotesdueNovember152043Member 2014-12-28 2015-12-31 0001585364 prgo:A5.000UnsecuredSeniornotesdueMay232019Domain 2014-12-28 2015-12-31 0001585364 prgo:A3.5SeniornotedueDecember152021Member 2014-12-28 2015-12-31 0001585364 prgo:A2014RevolverMember 2014-12-28 2015-12-31 0001585364 prgo:A2.30UnsecuredSeniornotesNovember82018Member 2014-12-28 2015-12-31 0001585364 prgo:A4.00UnsecuredSeniorNotesdueNovember152023Member 2014-12-28 2015-12-31 0001585364 prgo:A4.500UnsecuredSeniorNotesdueMay232017Domain 2014-12-28 2015-12-31 0001585364 prgo:A3.9seniornotedue2024Member 2014-12-28 2015-12-31 0001585364 prgo:A5.125UnsecuredSeniorNotesdueDecember122017Domain 2014-12-28 2015-12-31 0001585364 prgo:A2014EuroDenominatedTermLoandueDecember52019additionaldrawDomain 2016-01-01 2016-10-01 0001585364 prgo:A1.30UnsecuredSeniorNotesdueNovember82016Member 2014-12-28 2015-12-31 0001585364 prgo:A2014RevolverMember 2016-01-01 2016-10-01 0001585364 prgo:A5.105SeniornotedueJuly192023Domain 2014-12-28 2015-12-31 0001585364 prgo:PerrigoCoPLCMember 2015-10-22 0001585364 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-01-01 2016-10-01 0001585364 us-gaap:AccumulatedTranslationAdjustmentMember 2016-10-01 0001585364 us-gaap:AccumulatedTranslationAdjustmentMember 2016-01-01 2016-10-01 0001585364 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2016-01-01 2016-10-01 0001585364 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2016-01-01 2016-10-01 0001585364 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2015-12-31 0001585364 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2016-10-01 0001585364 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2015-12-31 0001585364 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-10-01 0001585364 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2016-10-01 0001585364 us-gaap:AccumulatedTranslationAdjustmentMember 2015-12-31 0001585364 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2015-12-31 0001585364 2014-11-01 2014-11-30 0001585364 us-gaap:ForeignCountryMember us-gaap:MinimumMember 2016-01-01 2016-10-01 0001585364 2015-01-01 2015-01-31 0001585364 prgo:AllOtherEntitiesMember 2016-07-03 2016-10-01 0001585364 us-gaap:ForeignCountryMember us-gaap:MaximumMember 2016-01-01 2016-10-01 0001585364 prgo:May2015agreementMember us-gaap:MinimumMember 2015-05-01 2015-05-31 0001585364 prgo:May2015agreementMember us-gaap:MaximumMember 2015-05-01 2015-05-31 0001585364 prgo:June2016agreementMember us-gaap:MinimumMember 2016-06-01 2016-06-30 0001585364 prgo:June2016agreementMember us-gaap:MaximumMember 2016-01-01 2016-10-01 0001585364 us-gaap:ContractTerminationMember 2016-10-01 0001585364 us-gaap:EmployeeSeveranceMember 2016-10-01 0001585364 2016-07-02 0001585364 2015-06-27 0001585364 us-gaap:MaterialReconcilingItemsMember 2014-12-28 2015-09-26 0001585364 us-gaap:MaterialReconcilingItemsMember 2016-01-01 2016-10-01 0001585364 prgo:BrandedCHCMember 2014-12-28 2015-09-26 0001585364 prgo:RxPharmaceuticalsMember 2014-12-28 2015-09-26 0001585364 us-gaap:AllOtherSegmentsMember 2014-12-28 2015-09-26 0001585364 us-gaap:AllOtherSegmentsMember 2016-01-01 2016-10-01 0001585364 prgo:ConsumerHealthcareMember 2014-12-28 2015-09-26 0001585364 prgo:SpecialtySciencesMember 2014-12-28 2015-09-26 0001585364 prgo:ConsumerHealthcareMember 2015-06-28 2015-09-26 0001585364 prgo:BrandedCHCMember 2015-06-28 2015-09-26 0001585364 prgo:RxPharmaceuticalsMember 2015-06-28 2015-09-26 0001585364 us-gaap:AllOtherSegmentsMember 2015-06-28 2015-09-26 0001585364 prgo:ConsumerHealthcareMember 2016-07-03 2016-10-01 0001585364 prgo:RxPharmaceuticalsMember 2016-07-03 2016-10-01 0001585364 prgo:SpecialtySciencesMember 2015-06-28 2015-09-26 0001585364 us-gaap:MaterialReconcilingItemsMember 2015-06-28 2015-09-26 0001585364 prgo:SpecialtySciencesMember 2016-07-03 2016-10-01 0001585364 us-gaap:AllOtherSegmentsMember 2016-07-03 2016-10-01 0001585364 us-gaap:MaterialReconcilingItemsMember 2016-07-03 2016-10-01 0001585364 us-gaap:AllOtherSegmentsMember 2015-12-31 0001585364 us-gaap:AllOtherSegmentsMember 2016-10-01 xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:EUR xbrli:shares iso4217:USD iso4217:EUR false --12-31 Q3 2016 2016-10-01 10-Q 0001585364 143374427 Yes Large Accelerated Filer PERRIGO CO PLC No Yes 240000000 755500000 200000000 20000000 147000000 135000000 482500000 106700000 36400000 398000000 325500000 101900000 93600000 2078300000 0 0 0 39800000 0 0 0 0 0 51300000 0 0 0 0 0 24600000 0 0 8 101900000 1018300000 265000000 0 0 0 0 0.0015 0.0014 0.18 0.17 0.25 0.265 7281200000 5282700000 17700000 -74700000 68900000 1100000 120900000 135900000 105000000 78000000 42000000 57000000 334700000 368400000 554900000 507900000 1193100000 1129200000 85200000 76200000 308400000 258700000 -15500000 -3200000 -14200000 6300000 -4400000 71500000 -2900000 -17700000 24700000 67400000 P2Y P3Y 901300000 850400000 3000000 4400000 397900000 70500000 52100000 55500000 218400000 1400000 0 162100000 481800000 113900000 58100000 90100000 218300000 1400000 0 38900000 19200000 30700000 72800000 500000 0 147600000 36300000 19400000 18600000 72800000 500000 0 0 0 0 100000 0 1679900000 2127100000 0 19393900000 6324000000 4007800000 3015500000 5833500000 213100000 17467600000 4460200000 3873800000 3304000000 5634000000 195600000 2744400000 2627100000 1069300000 1858800000 37500000 14100000 16649500000 14840500000 86900000 39700000 9900000 7500000 55100000 13600000 0 7300000 9300000 32900000 800000 0 6400000 20100000 14900000 53000000 2015-03-30 2015-05-12 2015-09-15 2015-08-28 2015-08-28 2016-01-22 2016-03-01 2015-12-15 2016-08-02 904900000 1 0.9577 1.00 0.6090 167.64 154700000 -1254900000 -1392800000 142000000 4451400000 1359600000 4243300000 1429900000 295000000 18100000 18700000 258200000 2983200000 37900000 150400000 223600000 26700000 416400000 24900000 380200000 52500000 29200000 12400000 0 0 13900000 17900000 0 0 0 0 0 0 24900000 44900000 0 30600000 75000000 15100000 600000 41500000 900000 29200000 223600000 26700000 44600000 5924900000 182200000 416400000 24900000 380200000 59200000 0 0 0 4600000 14700000 4600000 0 0 0 3800000 0 0 0 2100000 39200000 0 0 0 0 100000 0 0 0 7300000 260100000 3300000 0 0 0 4900000 0 0 0 1600000 43900000 1600000 0 0 0 100000 0 0 0 3300000 243100000 2800000 0 0 0 2800000 20000000 180000000 120000000 300000000 500000000 51400000 196000000 130700000 326700000 544500000 56000000 0 0 0 1400000 1014500000 27400000 0 0 0 500000 0 24900000 7000000 29200000 2003800000 0 0 0 0 0 0 191000000 61500000 0 0 129500000 22200000 9800000 0 500000 11400000 11000000 6600000 0 0 0 4400000 3374800000 1056300000 0 0 287500000 0 111800000 25900000 21400000 300000 64200000 413300000 0 411000000 0 2300000 24900000 0 0 0 0 0 380000000 0 0 0 0 41900000 8200000 23300000 3400000 0 0 0 1000000 7200000 202500000 1500000 1400000 0 200000 7100000 0 0 0 6700000 2941700000 31800000 0 0 0 6700000 29200000 223600000 26700000 37900000 2983200000 150400000 416400000 24900000 380200000 52500000 0 0 400000 2400000 0 0 53500000 0 0 400000 0 0 0 0 0 1471000000 135000000 147000000 0 0 0 0 3300000 0 0 0 6000000 130800000 0 0 0 0 1200000 3596100000 506500000 417800000 362700000 -3089600000 -55100000 0 0 0.375 0.145 0.435 0.125 0.001 0.001 10000000000 10000000000 143100000 143400000 143100000 143300000 8144600000 8151400000 132000000 -1215000000 -1308400000 75400000 6900000 7000000 2369700000 848600000 2622700000 795900000 yes 600000000 800000000 400000000 500000000 300000000 614300000 368600000 600000000 500000000 700000000 400000000 750000000 500000000 700000000 3800000000 859800000 4700000000 891400000 36600000 34600000 0.013 0.01300 0.023 0.02300 0.03500 0.03500 0.03900 0.0400 0.04000 0.04375 0.04500 0.04900 0.05000 0.05105 0.05125 0.053 0.05300 0.0350 0.0390 0.0490 0.04500 0.05000 0.051045 0.05125 0.0619 0.0350 0.0438 2014-12-05 2014-12-02 2015-03-30 2015-12-09 2016-03-07 2017-01-01 2019-01-01 2023-01-01 2017-01-01 2016-01-01 2016-11-08 2018-11-08 2019-12-05 2019-12-05 2021-12-15 2024-12-15 2023-11-15 2017-05-23 2044-12-15 2019-05-23 2023-07-19 2017-12-12 2043-11-15 2016-11-08 2018-11-08 2019-12-05 2019-12-05 2021-03-15 2021-12-15 2024-12-15 2023-11-15 2026-03-15 2017-05-23 2044-12-15 2019-05-23 2023-07-19 2017-12-12 2043-11-15 41900000 -73400000 -43300000 82500000 60700000 5989900000 5903000000 7700000 -507200000 54600000 129300000 1563700000 1169300000 470400000 556300000 3800000 1000000 3800000 1000000 3800000 1400000 3800000 1400000 2000000 1900000 300000 2300000 1900000 300000 500000 0 300000 500000 259800000 -3400000 -259400000 -1900000 -262800000 7000000 -1500000 -8700000 -10200000 -1000000 -200000 -1200000 0 100000 -8900000 -8800000 -4400000 0 -600000 1800000 -18600000 -100000 -21900000 1800000 -1300000 0 1000000 -1700000 -100000 -300000 900000 -400000 -1400000 100000 -600000 0 -1400000 200000 0 -100000 -100000 -400000 0 -400000 -200000 100000 0 -300000 0 0 600000 0 600000 100000 -100000 0 0 0 0 0 0 0 0 0 -1600000 -12000000 -13600000 4700000 -9000000 -4300000 3400000 0 3400000 -500000 0 -500000 300000000 3600000 0 13000000 14500000 0 2800000 0 1700000 0 2100000 0 3200000 0 3200000 18800000 37400000 13300000 34000000 0.51 -8.76 -9.74 0.77 0.51 -8.76 -9.74 0.77 -75800000 -200000 0.603 0.201 0.216 0.148 125300000 106800000 22300000 45500000 4900000 539100000 500000000 -12400000 -4000000 -400000 0 0 100000 0 0 0 61100000 30600000 0 0 100000 100000 0 P22Y P21Y P13Y P4Y P8Y P20Y P25Y P15Y P3Y P3Y P20Y P15Y P20Y P15Y P8Y P4Y P25Y P20Y P5Y P15Y P10Y P9Y 1321700000 193000000 426000000 667200000 12700000 22800000 1797500000 288800000 529000000 914000000 11000000 54700000 0 66900000 9512200000 27200000 0 1520700000 1383500000 6053400000 15200000 539400000 0 500000 0 0 380000000 10138400000 1564000000 1805900000 6122300000 14600000 631600000 357100000 8190500000 8340900000 3900000 800000 4800000 5200000 -900000 -700000 -1100000 0 343300000 108600000 316800000 123600000 5364900000 0 1980500000 1890000000 71500000 1222200000 200700000 32600000 3500000 6000000 1900400000 61000000 1700000 0 0 4490600000 200000 1105400000 1887900000 86400000 1210200000 200700000 1900000 0 200000 0 1700000 0 0 70200000 1035200000 1105400000 -75100000 -92400000 6800000 -3200000 13700000 0 1909500000 6800000 193600000 -30300000 967500000 967500000 0 0 0 0 69400000 734700000 804100000 24700000 0 13000000 11700000 0 0 8500000 0 8500000 0 0 0 1555700000 506300000 1596400000 548800000 14.5 13.7 290200000 290200000 185100000 273400000 849100000 575700000 3400000 3400000 39800000 6200000 10800000 29000000 0 186900000 -1571500000 -1779100000 132200000 -7700000 100000 -3800000 -4100000 8000000 112700000 -316300000 -383700000 19600000 130000000 116600000 -6500000 -51800000 30900000 -113600000 300000 9700000 46700000 -42800000 -26600000 -40000000 28600000 29900000 34600000 146900000 6700000 31000000 600000 0 0 600000 1916300000 29200000 48200000 1868100000 0 0 0 0 0 0 792100000 67900000 724200000 1031800000 672400000 1200000000 11428500000 10930500000 -132700000 -54600000 -163200000 -43400000 92500000 124100000 300000 0 483400000 511600000 844400000 884600000 209600000 202000000 151400000 171000000 14900000 53000000 9357800000 8796300000 19393900000 17467600000 2490100000 1540100000 4200000 800000 6867700000 7256200000 30500000 2200000 300000 3000000 30500000 500000 300000 900000 680000000 300000000 380000000 0 0 0 0 1000000000 82900000 300000000 488800000 463800000 798300000 826400000 1018300000 265000000 4971600000 4971600000 5638000000 5638000000 P15M -600000 -600000 -941500000 -234100000 -2939000000 -524300000 866700000 703500000 74200000 -1255200000 -1395400000 112600000 941000000 2021500000 3177100000 360200000 614700000 31000000 364800000 290400000 21000000 18600000 -111100000 -1515200000 -1580700000 31300000 -2128700000 313600000 262100000 49700000 2600000 -80000000 13000000 -1684300000 100100000 77900000 23300000 -1600000 -30600000 188600000 4400000 117300000 91000000 9000000 6200000 -39300000 237000000 206300000 -2400000 9800000 18400000 2500000 3700000 -200000 300000 0 5600000 3600000 -3500000 100000 50900000 27000000 71800000 -39800000 85500000 300000 -3700000 17100000 71800000 57800000 40200000 87000000 300000 -3500000 18400000 71800000 -37200000 332400000 448900000 86000000 4100000 -294200000 -1000000 -34100000 -13000000 15300000 34500000 1800000 304800000 0 2700000 1000000 4500000 8600000 33300000 1900000 0 600000 54200000 62400000 3300000 2800000 2983200000 37900000 150400000 133500000 223600000 200000000 26700000 416400000 0 380200000 62000000 21900000 15300000 2499900000 432100000 4000000 65100000 127600000 84600000 0.0001 0.0001 10000000 10000000 0 0 0 0 0 0 289100000 250600000 0 61800000 58500000 3100000 6000000 1000000 1100000 6200000 8200000 1200000000 0 1190300000 999300000 -15500000 -17400000 28600000 -803600000 63300000 21600000 65900000 24900000 886200000 881300000 -1500000 0 -200000 -1300000 0 435000000 750000000 903300000 545800000 500000000 18000000 139700000 50200000 142500000 41600000 3100000 6600000 17900000 2200000 3100000 17900000 3200000 1700000 1300000 20700000 12200000 10300000 5200000 5100000 -500000 100000 5000000 -700000 1907600000 449000000 47700000 25300000 3925400000 703400000 2106400000 790100000 250100000 75400000 0 1354900000 4219100000 1015300000 2055600000 817400000 271300000 59500000 0 304000000 669100000 267400000 93400000 21000000 0 1344700000 302200000 675200000 260300000 84500000 22500000 0 391600000 154600000 506900000 167900000 4698300000 500000000 600000000 0 500000000 700000000 800000000 0 195500000 400000000 130300000 146700000 325800000 400000000 3900000000 2300000000 1600000000 1200000000 5426400000 0 600000000 500000000 500000000 700000000 800000000 700000000 202400000 400000000 134900000 151800000 337300000 400000000 4600000000 29700000 16100000 5400000 685348257 6800000 246000 185000 283000 154000 2000000000 0 1500000000 10036700000 8671900000 10036100000 8671300000 15500000 30243983 8700000 52100000 56400000 145000000 143300000 143200000 146900000 144400000 143300000 143200000 146300000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">COLLABORATION AGREEMENTS AND OTHER CONTRACTUAL ARRANGEMENTS</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In May 2015, we entered into a development agreement wherein we transferred the ownership rights to two pharmaceutical products to a clinical stage development company to fund and conduct development activities for the products.&#160;We do not expect to incur any expense related to the development of either product. If the products are approved by the FDA, we will execute a buy-back agreement to purchase each product for a multiple of the development costs incurred.&#160;Based on the initial development budget for each product, the estimated purchase price for both products is approximately </font><font style="font-family:Arial;font-size:10pt;">$78.0&#160;million</font><font style="font-family:Arial;font-size:10pt;">.&#160;If development costs exceed the initial budgeted amounts, the purchase price will increase but will not exceed approximately </font><font style="font-family:Arial;font-size:10pt;">$105.0&#160;million</font><font style="font-family:Arial;font-size:10pt;">. If the products are approved by the FDA and we purchase the products, we estimate the acquisitions will occur in 2019 and 2020.&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In June 2016, we added an additional product to the May 2015 development agreement that is subject to similar buy-back terms if the product is approved by the FDA. The estimated purchase price for this additional product, based on the initial development budget, is approximately </font><font style="font-family:Arial;font-size:10pt;">$42.0 million</font><font style="font-family:Arial;font-size:10pt;">.&#160;If development costs exceed the initial budgeted amounts, the purchase price will increase, but will not exceed approximately </font><font style="font-family:Arial;font-size:10pt;">$57.0 million</font><font style="font-family:Arial;font-size:10pt;">. If the product is approved by the FDA and we purchase the product, we estimate the acquisition will occur in 2020. There can be no assurance that any such products will be approved by the FDA on the anticipated schedule or at all.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The acquisition was a cash and stock transaction made up of the following consideration (in millions except per share data):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:74.21383647798741%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Perrigo ordinary shares issued</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Perrigo per share price at transaction close on March 30, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">167.64</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total value of Perrigo ordinary shares issued</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">904.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cash consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,078.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,983.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Other intangible assets and related accumulated amortization consisted of the following (in millions):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Gross</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Gross</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Accumulated Amortization</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Definite-lived intangibles</font><font style="font-family:Arial;font-size:9pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Distribution and license agreements, supply agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6,122.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">914.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6,053.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">667.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Developed product technology, formulations, and product rights</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,805.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">529.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,383.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">426.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Customer relationships and distribution networks</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,564.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">288.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,520.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">193.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">631.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">54.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">539.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">22.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-compete agreements</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">14.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">15.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total definite-lived intangibles</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">10,138.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,797.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9,512.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,321.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Indefinite-lived intangibles</font><font style="font-family:Arial;font-size:9pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">724.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,868.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">In-process research and development</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">67.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">48.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total indefinite-lived intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">792.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,916.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total other intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">10,930.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,797.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11,428.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,321.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The table below details the acquisition costs, as well as losses on hedging activities associated with the acquisition purchase price, and where they were recorded for the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">September&#160;26, 2015</font><font style="font-family:Arial;font-size:10pt;"> (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:52.41090146750524%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Line item</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Administration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">18.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">18.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">258.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total acquisition-related costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">295.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The gains (losses) recognized against earnings for the ineffective portion of our designated cash flow hedges were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:712px;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td style="width:200px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:122px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:79px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:79px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:79px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:79px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in Income<br clear="none"/>(Ineffective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Designated Cash Flow Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">During the three months ended April 2, 2016, we identified certain errors in our consolidated financial statements for the transition period of June 28, 2015 to December 31, 2015, related primarily to the accrual estimates associated with product returns and tax-related items in our Branded Consumer Healthcare ("BCH") segment. These errors were corrected during the three months ended April 2, 2016 by increasing the consolidated operating loss by </font><font style="font-family:Arial;font-size:10pt;">$14.5&#160;million</font><font style="font-family:Arial;font-size:10pt;">, which when combined with tax-related items, increased the consolidated net loss by </font><font style="font-family:Arial;font-size:10pt;">$13.7&#160;million</font><font style="font-family:Arial;font-size:10pt;"> within the Condensed Consolidated Statements of Operations.&#160;We concluded that these errors were not material to the consolidated financial statements for the transition period of June 28, 2015 to December 31, 2015 and are not expected to be material to the consolidated financial statements for the year ending December 31, 2016.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Basis of Presentation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the consolidated financial statements and footnotes included in our Transition Report on Form 10-KT for the transition period from </font><font style="font-family:Arial;font-size:10pt;">June 28, 2015</font><font style="font-family:Arial;font-size:10pt;"> to </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Arial;font-size:10pt;">. In the opinion of management, all adjustments (consisting of normal recurring accruals and other adjustments) considered necessary for a fair presentation have been included.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following unaudited pro forma information gives effect to the Tretinoin Products, Entocort</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">, Naturwohl, GSK Products, ScarAway</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">, Omega, and Gelcaps acquisitions, as well as four small product acquisitions, as if the acquisitions had occurred on the first day of the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">September&#160;26, 2015</font><font style="font-family:Arial;font-size:10pt;"> and had been included in our Results of Operations for all periods presented thereafter (in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:92.45283018867924%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(Unaudited)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,359.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,429.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,243.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,451.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net income (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1,254.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">142.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1,392.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">154.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">ACQUISITIONS AND DIVESTITURES</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">All of the below acquisitions, with the exception of the generic Benzaclin&#8482; product purchase, have been accounted for under the acquisition method of accounting based on our analysis of the acquired inputs and processes, and the related assets acquired and liabilities assumed were recorded at fair value as of the acquisition date. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Fair value estimates are based on a complex series of judgments about future events and rely heavily on estimates and assumptions. The judgments used to determine the estimated fair value assigned to each class of assets acquired and liabilities assumed, as well as asset lives, can materially impact our results of operations. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The effects of all of the acquisitions described below are included in the Condensed Consolidated Financial Statements prospectively from the date of each acquisition. Unless otherwise indicated, acquisition costs incurred were immaterial and were recorded in Administration expense.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Current Year Acquisitions</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Generic Benzaclin</font><font style="font-family:Arial;font-size:10pt;">&#8482;</font><font style="font-family:Arial;font-size:10pt;font-style:italic;"> Product </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">August&#160;2, 2016</font><font style="font-family:Arial;font-size:10pt;">, we purchased the remaining </font><font style="font-family:Arial;font-size:10pt;">60.9%</font><font style="font-family:Arial;font-size:10pt;"> product rights to a generic Benzaclin&#8482; product ("Generic Benzaclin&#8482;"), which we had developed and marketed in collaboration with Barr Laboratories, Inc. ("Barr"), a subsidiary of Teva Pharmaceuticals, for </font><font style="font-family:Arial;font-size:10pt;">$62.0 million</font><font style="font-family:Arial;font-size:10pt;"> in cash. In September 2007, we entered into an initial development, marketing and commercialization agreement with Barr, in which Barr contributed to the product's development costs and we developed and marketed the product in the U.S. and Israel. Under this agreement, we paid Barr a percentage of net income from the product's sales in these territories, adjusted for Barr's contributions to the product's development costs. By purchasing the remaining product right from Barr, we are now entitled to 100% of income from sales of the product. Operating results attributable to Generic Benzaclin&#8482; are included within our Prescription Pharmaceuticals ("Rx") segment. The intangible asset acquired is a distribution and license agreement with a </font><font style="font-family:Arial;font-size:10pt;">nine</font><font style="font-family:Arial;font-size:10pt;">-year useful life.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Tretinoin Product Portfolio</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;font-style:italic;"></font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">On</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:Arial;font-size:10pt;">January&#160;22, 2016</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">, we acquired a portfolio of generic dosage forms and strengths of</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">Retin-A</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174; </sup></font><font style="font-family:Arial;font-size:10pt;">(tretinoin), a topical prescription acne treatment, from Matawan Pharmaceuticals, LLC, for </font><font style="font-family:Arial;font-size:10pt;">$416.4&#160;million</font><font style="font-family:Arial;font-size:10pt;"> in cash ("Tretinoin Products"), which further expanded our extended topicals portfolio. We were the authorized generic distributor of these products from 2005 to 2013. Operating results attributable to the acquisition are included within our Rx segment. The intangible assets acquired included generic product rights valued using the multi-period excess earnings method and assigned a </font><font style="font-family:Arial;font-size:10pt;">20</font><font style="font-family:Arial;font-size:10pt;">-year useful life, and non-compete agreements valued using the lost income method and assigned a </font><font style="font-family:Arial;font-size:10pt;">five</font><font style="font-family:Arial;font-size:10pt;">-year useful life. The goodwill acquired is deductible for tax purposes.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Development-Stage Rx Products</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In May 2015, we entered into an agreement with a clinical stage biotechnology company for two specialty pharmaceutical products in development ("Development-Stage Rx Products").&#160;We paid </font><font style="font-family:Arial;font-size:10pt;">$18.0&#160;million</font><font style="font-family:Arial;font-size:10pt;"> for an option to acquire the two products, which was recorded in Research and Development expense. On </font><font style="font-family:Arial;font-size:10pt;">March&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;">, to further invest in our specialty Rx portfolio, we exercised the option for both products, which requires us to make contingent payments if we obtain regulatory approval and achieve certain sales milestones.&#160;We will also be obligated to make certain royalty payments over periods ranging from </font><font style="font-family:Arial;font-size:10pt;">seven</font><font style="font-family:Arial;font-size:10pt;"> to </font><font style="font-family:Arial;font-size:10pt;">ten</font><font style="font-family:Arial;font-size:10pt;"> years from the launch of each product.&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We accounted for the option exercise as a business acquisition within our Rx segment, recording IPR&amp;D and contingent consideration on the balance sheet. The IPR&amp;D was valued using the multi-period excess earnings method and has an indefinite useful life until such time as the research is completed (at which time it will become a definite-lived intangible asset), or is determined to have no future use (at which time it would be impaired). The contingent consideration is an estimate of the future milestone payments and royalties based on probability-weighted outcomes, sensitivity analysis, and discount rates reflective of the risk involved. The amount of contingent consideration recognized was </font><font style="font-family:Arial;font-size:10pt;">$24.9 million</font><font style="font-family:Arial;font-size:10pt;"> and was recorded in </font><font style="font-family:Arial;font-size:10pt;">Other non-current liabilities</font><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Purchase Price Allocation of Current Year Acquisitions</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;"></font><font style="font-family:Arial;font-size:10pt;">The purchase accounting allocation for four small product acquisitions in our Consumer Healthcare ("CHC") and Rx segments (included in "All Other" in the table below) are preliminary a</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">nd are</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">based on the valuation information, estimates, and assumptions available at </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;">. As we finalize the fair value estimate, additional purchase price adjustments may be recorded during the measurement period to contingent consideration and intangible assets. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The below table indicates the purchase price allocation for acquisitions completed in the current year (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:613px;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:345px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:74px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:74px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:74px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Tretinoin Products</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Development-Stage Rx Products</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">All Other</font><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font><font style="font-family:Arial;font-size:9pt;font-weight:bold;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Purchase price paid</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">416.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">21.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">24.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">30.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total purchase consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">416.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">24.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">52.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Assets acquired:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">7.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Property and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Definite-lived intangibles</font><font style="font-family:Arial;font-size:9pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Distribution and license agreements, supply agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Developed product technology, formulations, and product rights</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">411.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">23.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Customer relationships and distribution networks</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">8.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-compete agreements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Indefinite-lived intangibles</font><font style="font-family:Arial;font-size:9pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">In-process research and development</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">24.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">7.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">413.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">24.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">41.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">416.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">24.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">59.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Liabilities assumed:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accounts payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net deferred income tax liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">416.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">24.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">52.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">*&#160;&#160;&#160;&#160;Opening balance sheet is preliminary</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Consists of </font><font style="font-family:Arial;font-size:8pt;">four</font><font style="font-family:Arial;font-size:8pt;"> product acquisitions in the CHC and Rx segments</font></div></td></tr></table><div style="line-height:120%;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Prior Year Acquisitions</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Entocort</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup>&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">December&#160;15, 2015</font><font style="font-family:Arial;font-size:10pt;">, we completed our acquisition of Entocort</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174; </sup></font><font style="font-family:Arial;font-size:10pt;">(budesonide) capsules, as well as the authorized generic capsules, for sale within the U.S., from AstraZeneca plc for </font><font style="font-family:Arial;font-size:10pt;">$380.2 million</font><font style="font-family:Arial;font-size:10pt;"> in cash. Entocort</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174; </sup></font><font style="font-family:Arial;font-size:10pt;">is a gastroenterology medicine for patients with mild to moderate Crohn's disease. The acquisition complemented our Rx portfolio. Operating results attributable to the acquisition are included within our Rx segment. The intangible assets acquired included branded and authorized generic product rights with useful lives of </font><font style="font-family:Arial;font-size:10pt;">10</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">15</font><font style="font-family:Arial;font-size:10pt;"> years, respectively, which were valued using the multi-period excess earnings method.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Naturwohl Pharma GmbH</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">September&#160;15, 2015</font><font style="font-family:Arial;font-size:10pt;">, we completed our acquisition of </font><font style="font-family:Arial;font-size:10pt;">100%</font><font style="font-family:Arial;font-size:10pt;"> of Naturwohl Pharma GmbH ("Naturwohl"), a Munich, Germany-based nutritional business known for its leading German dietary supplement brand, Yokebe</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">. The acquisition built on our BCH segment's OTC product portfolio and European commercial infrastructure. The assets were purchased through an all-cash transaction valued at </font><font style="font-family:Arial;font-size:10pt;">&#8364;133.5&#160;million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$150.4 million</font><font style="font-family:Arial;font-size:10pt;">). Operating results attributable to Naturwohl are included in the BCH segment. The intangible assets acquired included a trademark with a </font><font style="font-family:Arial;font-size:10pt;">20</font><font style="font-family:Arial;font-size:10pt;">-year useful life, customer relationships with a </font><font style="font-family:Arial;font-size:10pt;">15</font><font style="font-family:Arial;font-size:10pt;">-year useful life, non-compete agreements with a </font><font style="font-family:Arial;font-size:10pt;">three</font><font style="font-family:Arial;font-size:10pt;">-year useful life, and a licensing agreement with a </font><font style="font-family:Arial;font-size:10pt;">three</font><font style="font-family:Arial;font-size:10pt;">-year useful life. We utilized the relief from royalty method for valuing the trademark, the multi-period excess earnings method for valuing the customer relationships, and the lost income method for valuing the non-compete agreements and the licensing agreement. The goodwill acquired is not deductible for tax purposes.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">ScarAway</font><font style="font-family:Arial;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup>&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">August&#160;28, 2015</font><font style="font-family:Arial;font-size:10pt;">, we completed our acquisition of ScarAway</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">, a leading U.S. OTC scar management brand portfolio comprised of five products, from Enaltus, LLC, for </font><font style="font-family:Arial;font-size:10pt;">$26.7&#160;million</font><font style="font-family:Arial;font-size:10pt;"> in cash. This acquisition served as our entry into the niche branded OTC business in the U.S. Operating results attributable to ScarAway</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174; </sup></font><font style="font-family:Arial;font-size:10pt;">are included in the CHC segment. The intangible assets acquired included a trademark with a </font><font style="font-family:Arial;font-size:10pt;">25</font><font style="font-family:Arial;font-size:10pt;">-year useful life, non-compete agreements with a </font><font style="font-family:Arial;font-size:10pt;">four</font><font style="font-family:Arial;font-size:10pt;">-year useful life, developed product technology with an </font><font style="font-family:Arial;font-size:10pt;">eight</font><font style="font-family:Arial;font-size:10pt;">-year useful life, and customer relationships with a </font><font style="font-family:Arial;font-size:10pt;">15</font><font style="font-family:Arial;font-size:10pt;">-year useful life. We utilized the relief from royalty method for valuing the trademark and developed product technology, the multi-period excess earnings method for valuing the customer relationships, and the lost income method for valuing the non-compete agreements. The goodwill acquired is deductible for tax purposes.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">GlaxoSmithKline</font><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Consumer Healthcare Product Portfolio</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">August&#160;28, 2015</font><font style="font-family:Arial;font-size:10pt;">, we completed our acquisition of a portfolio of well-established OTC brands from GlaxoSmithKline Consumer Healthcare (&#8220;GSK Products&#8221;). This acquisition further leveraged our European market share and expanded our product offerings. The assets were purchased through an all-cash transaction valued at </font><font style="font-family:Arial;font-size:10pt;">&#8364;200.0 million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$223.6 million</font><font style="font-family:Arial;font-size:10pt;">). Operating results attributable to the acquired GSK Products are included primarily in the BCH segment. The intangible assets acquired included trademarks with a </font><font style="font-family:Arial;font-size:10pt;">20</font><font style="font-family:Arial;font-size:10pt;">-year useful life and customer relationships with a </font><font style="font-family:Arial;font-size:10pt;">15</font><font style="font-family:Arial;font-size:10pt;">-year useful life. We utilized the relief from royalty method for valuing the trademarks and the multi-period excess earnings method for valuing the customer relationships. The goodwill acquired is deductible for tax purposes and recorded primarily in the BCH segment.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Gelcaps Exportadora de Mexico, S.A. de C.V. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">May&#160;12, 2015</font><font style="font-family:Arial;font-size:10pt;">, we completed our acquisition of </font><font style="font-family:Arial;font-size:10pt;">100%</font><font style="font-family:Arial;font-size:10pt;"> of Gelcaps Exportadora de Mexico, S.A. de C.V. ("Gelcaps"), the Mexican operations of Durham, North Carolina-based Patheon Inc., for </font><font style="font-family:Arial;font-size:10pt;">$37.9 million</font><font style="font-family:Arial;font-size:10pt;"> in cash. The acquisition added softgel manufacturing technology to our supply chain capabilities and broadened our presence, product portfolio, and customer network in Mexico. Operating results attributable to Gelcaps are included in the CHC segment. The intangible assets acquired included a trademark with a </font><font style="font-family:Arial;font-size:10pt;">25</font><font style="font-family:Arial;font-size:10pt;">-year useful life and customer relationships with a </font><font style="font-family:Arial;font-size:10pt;">20</font><font style="font-family:Arial;font-size:10pt;">-year useful life. We utilized the relief from royalty method for valuing the trademark and the multi-period excess earnings method for valuing the customer relationships.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Based on valuation estimates utilizing the comparative sales method, a step-up in the value of inventory of </font><font style="font-family:Arial;font-size:10pt;">$0.6&#160;million</font><font style="font-family:Arial;font-size:10pt;"> was recorded in the opening balance sheet, which was charged to cost of goods sold during the three months ended June 27, 2015. In addition, property, plant and equipment was written up by </font><font style="font-family:Arial;font-size:10pt;">$0.9&#160;million</font><font style="font-family:Arial;font-size:10pt;"> to its estimated fair market value based on a valuation method that included both the cost and market approaches. This additional step-up in value is being depreciated over the estimated remaining useful lives of the assets. The goodwill recorded is not deductible for tax purposes.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Omega Pharma Invest N.V.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">March&#160;30, 2015</font><font style="font-family:Arial;font-size:10pt;">, we completed our acquisition of Omega Pharma Invest N.V. ("Omega"), a limited liability company incorporated under the laws of Belgium. Omega was a leading European OTC company and is providing us several key benefits, including advancing our growth strategy outside the U.S. by providing access across a larger global platform with critical mass in key European countries, establishing commercial infrastructure in the high barrier-to-entry European OTC marketplace, strengthening our product portfolio while enhancing scale and distribution, and expanding our international management capabilities. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We purchased</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">95.77%</font><font style="font-family:Arial;font-size:10pt;"> of the issued and outstanding share capital of Omega (</font><font style="font-family:Arial;font-size:10pt;">685,348,257</font><font style="font-family:Arial;font-size:10pt;"> shares) from Alychlo N.V. (&#8220;Alychlo&#8221;) and Holdco I BE N.V. (together with Alychlo, the &#8220;Sellers&#8221;), limited liability companies incorporated under the laws of Belgium, under the terms of the Share Purchase Agreement dated November 6, 2014 (the "Share Purchase Agreement"). Omega holds the remaining </font><font style="font-family:Arial;font-size:10pt;">30,243,983</font><font style="font-family:Arial;font-size:10pt;"> shares as treasury shares. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The acquisition was a cash and stock transaction made up of the following consideration (in millions except per share data):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:74.21383647798741%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Perrigo ordinary shares issued</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Perrigo per share price at transaction close on March 30, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">167.64</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total value of Perrigo ordinary shares issued</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">904.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cash consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,078.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total consideration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,983.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The cash consideration shown in the above table was financed by a combination of debt and equity. We issued </font><font style="font-family:Arial;font-size:10pt;">$1.6&#160;billion</font><font style="font-family:Arial;font-size:10pt;"> of debt as described in </font><a style="font-family:Arial;font-size:10pt;" href="#s131F6B21358C5724A2B7FB979DA59832"><font style="font-family:Arial;font-size:10pt;">Note 10</font></a><font style="font-family:Arial;font-size:10pt;">, and issued </font><font style="font-family:Arial;font-size:10pt;">6.8&#160;million</font><font style="font-family:Arial;font-size:10pt;"> ordinary shares, which raised </font><font style="font-family:Arial;font-size:10pt;">$999.3&#160;million</font><font style="font-family:Arial;font-size:10pt;">, net of issuance costs. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Sellers agreed to indemnify us for certain potential future losses. The Sellers&#8217; indemnification and other obligations to us under the Share Purchase Agreement are secured by up to </font><font style="font-family:Arial;font-size:10pt;">&#8364;120.9&#160;million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$135.9&#160;million</font><font style="font-family:Arial;font-size:10pt;"> as of October 1, 2016) in cash that has been escrowed or is committed to be escrowed and </font><font style="font-family:Arial;font-size:10pt;">1.08 million</font><font style="font-family:Arial;font-size:10pt;"> of our ordinary shares, which are both being held in escrow to secure such obligations. Under the terms of the Share Purchase Agreement, Alychlo and its affiliates are subject to a </font><font style="font-family:Arial;font-size:10pt;">three</font><font style="font-family:Arial;font-size:10pt;">-year non-compete in Europe, and the Sellers are subject to a </font><font style="font-family:Arial;font-size:10pt;">two</font><font style="font-family:Arial;font-size:10pt;">-year non-solicit, in each case subject to certain exceptions. The Share Purchase Agreement contains other customary representations, warranties, and covenants of the parties thereto. Our Board of Directors has authorized us to issue an arbitral claim against the sellers, which we plan to do.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The operating results attributable to Omega are included in the BCH segment. We incurred general transaction costs (legal, banking and other professional fees), financing fees, and debt extinguishment charges in connection with the Omega acquisition. The amounts recorded were not allocated to a reporting segment. The table below details the acquisition costs, as well as losses on hedging activities associated with the acquisition purchase price, and where they were recorded for the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">September&#160;26, 2015</font><font style="font-family:Arial;font-size:10pt;"> (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:52.41090146750524%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Line item</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Administration</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">18.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">18.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">258.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total acquisition-related costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">295.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">See </font><a style="font-family:Arial;font-size:10pt;" href="#sD1A1E57DB0945765A915BE808691EE8C"><font style="font-family:Arial;font-size:10pt;">Note 8</font></a><font style="font-family:Arial;font-size:10pt;"> for further details on losses on the Omega-related hedging activities shown above in Other expense, net, and </font><a style="font-family:Arial;font-size:10pt;" href="#s131F6B21358C5724A2B7FB979DA59832"><font style="font-family:Arial;font-size:10pt;">Note 10</font></a><font style="font-family:Arial;font-size:10pt;"> for details on the loss on extinguishment of debt. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We acquired the following intangible assets: indefinite-lived brands, a definite-lived trade name with an </font><font style="font-family:Arial;font-size:10pt;">eight</font><font style="font-family:Arial;font-size:10pt;">-year useful life, definite-lived brands with a </font><font style="font-family:Arial;font-size:10pt;">22</font><font style="font-family:Arial;font-size:10pt;">-year useful life, a distribution network with a </font><font style="font-family:Arial;font-size:10pt;">21</font><font style="font-family:Arial;font-size:10pt;">-year useful life, and developed product technology with useful lives ranging from </font><font style="font-family:Arial;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">to </font><font style="font-family:Arial;font-size:10pt;">13</font><font style="font-family:Arial;font-size:10pt;"> years. We also recorded goodwill, which is not deductible for tax purposes and represents the value we assigned to the expected synergies described above, in our BCH segment. We utilized the multi-period excess earnings method to value the indefinite-lived brands, the definite-lived brands, and distribution network. We utilized the relief from royalty method to value the developed product technology and definite-lived trade name.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Based on valuation estimates utilizing the comparative sales method, a step-up in the value of inventory of </font><font style="font-family:Arial;font-size:10pt;">$15.1&#160;million</font><font style="font-family:Arial;font-size:10pt;"> was recorded in the opening balance sheet and was charged to cost of goods sold during the three months ended June 27, 2015. In addition, property, plant and equipment were written up </font><font style="font-family:Arial;font-size:10pt;">$41.5&#160;million</font><font style="font-family:Arial;font-size:10pt;"> to their estimated fair market value based on a valuation method that included both the cost and market approaches. This additional step-up in value is being depreciated over the estimated remaining useful lives of the assets. Additionally, the fair value of the debt assumed</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font><font style="font-family:Arial;font-size:10pt;">on the date of acquisition exceeded par value by </font><font style="font-family:Arial;font-size:10pt;">$101.9&#160;million</font><font style="font-family:Arial;font-size:10pt;">, which was recorded as part of the carrying value of the underlying debt and will be amortized as a reduction of interest expense over the remaining terms of the respective debt instruments. For more information on the debt we assumed from Omega and our subsequent payments on the debt, see </font><a style="font-family:Arial;font-size:10pt;" href="#s131F6B21358C5724A2B7FB979DA59832"><font style="font-family:Arial;font-size:10pt;">Note 10</font></a><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Purchase Price Allocation of Prior Year Acquisitions </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The purchase accounting allocation for the Entocort</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174; </sup></font><font style="font-family:Arial;font-size:10pt;">and GSK Products acquisitions were finalized during the three months ended April 2, 2016. Changes to the allocations were due to adjustments to the intangible asset valuation assumptions. The purchase accounting for all other prior year acquisitions was final as of </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Arial;font-size:10pt;">. </font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">The below table indicates the purchase price allocation for acquisitions co</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">mpleted during the</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">year ended</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">December&#160;31, 2015</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">(in millions):</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;"> </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:686px;border-collapse:collapse;text-align:left;"><tr><td colspan="28" rowspan="1"></td></tr><tr><td style="width:176px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:59px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:58px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:62px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:50px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:54px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:54px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:59px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Entocort</font><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Naturwohl</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">ScarAway</font><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">GSK Products</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Gelcaps</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Omega</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">All Other</font><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Purchase price paid</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">380.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">150.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">26.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">223.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">37.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,983.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">15.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">13.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total purchase consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">380.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">150.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">26.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">223.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">37.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,983.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">29.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;font-weight:bold;">Assets acquired:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">14.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">7.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">260.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">7.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">202.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">39.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Property and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">130.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">61.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">32.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,900.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Definite-lived intangibles</font><font style="font-family:Arial;font-size:9pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Distribution and license agreements, supply agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">21.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Developed product technology, formulations, and product rights</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">380.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">27.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Customer relationships and distribution networks</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">25.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">61.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,056.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">64.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">129.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">287.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-compete agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Indefinite-lived intangibles</font><font style="font-family:Arial;font-size:9pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,003.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">In-process research and development</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">29.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">380.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">111.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">22.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">191.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,374.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">29.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other non-current assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">380.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">182.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">26.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">223.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">44.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,924.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">29.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;font-weight:bold;">Liabilities assumed:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accounts payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">243.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Short-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">24.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">43.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Payroll and related taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">51.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued customer programs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">39.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,471.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net deferred income tax liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">27.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,014.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other non-current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">53.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">31.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,941.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">380.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">150.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">26.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">223.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">37.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,983.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">29.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Consists of </font><font style="font-family:Arial;font-size:8pt;">eight</font><font style="font-family:Arial;font-size:8pt;"> product acquisitions in the CHC, BCH, and Rx segments</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Actual and Unaudited Pro Forma Impact of Acquisitions</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our Condensed Consolidated Financial Statements include operating results from the Tretinoin Products, Entocort</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">, Naturwohl, GSK Products, ScarAway</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">, Omega, and Gelcaps acquisitions, as well as from four small product acquisitions, from the date of each acquisition through </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;">. Net sales and operating </font><font style="font-family:Arial;font-size:10pt;">income</font><font style="font-family:Arial;font-size:10pt;"> attributable to acquisitions completed in the current year and included in our financial statements totaled </font><font style="font-family:Arial;font-size:10pt;">$25.3&#160;million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$13.0 million</font><font style="font-family:Arial;font-size:10pt;">, respectively, for the </font><font style="font-family:Arial;font-size:10pt;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;"> and totaled </font><font style="font-family:Arial;font-size:10pt;">$47.7&#160;million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$31.3&#160;million</font><font style="font-family:Arial;font-size:10pt;">, respectively, for the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following unaudited pro forma information gives effect to the Tretinoin Products, Entocort</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">, Naturwohl, GSK Products, ScarAway</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">, Omega, and Gelcaps acquisitions, as well as four small product acquisitions, as if the acquisitions had occurred on the first day of the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">September&#160;26, 2015</font><font style="font-family:Arial;font-size:10pt;"> and had been included in our Results of Operations for all periods presented thereafter (in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:92.45283018867924%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(Unaudited)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,359.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,429.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,243.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,451.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net income (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1,254.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">142.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1,392.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">154.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The historical consolidated financial information of Perrigo, and the Tretinoin Products, Entocort</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">, Naturwohl, GSK Products, ScarAway</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">, Omega and Gelcaps acquisitions and the four small product acquisitions, has been adjusted in the pro forma information to give effect to pro forma events that are (1) directly attributable to the transactions, (2) factually supportable and (3) expected to have a continuing impact on combined results. In order to reflect the occurrence of the acquisitions on the first day of the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">September&#160;26, 2015</font><font style="font-family:Arial;font-size:10pt;"> as required, the unaudited pro forma results include adjustments to reflect the incremental amortization expense to be incurred based on the current values of each acquisition's identifiable intangible and tangible assets, along with the reclassification of acquisition-related costs from the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;"> to the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">September&#160;26, 2015</font><font style="font-family:Arial;font-size:10pt;">. The unaudited pro forma results do not reflect future events that have occurred or may occur after the acquisitions. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Current Year Divestitures</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">August&#160;5, 2016</font><font style="font-family:Arial;font-size:10pt;">, we completed the sale of our U.S. Vitamins, Minerals, and Supplements ("VMS") business within our CHC segment to International Vitamins Corporation ("IVC") for </font><font style="font-family:Arial;font-size:10pt;">$61.8 million</font><font style="font-family:Arial;font-size:10pt;"> inclusive of an estimated working capital adjustment. The assets and liabilities related to this sale were classified as held-for-sale at December 31, 2015. Prior to closing the sale, we determined that the carrying value of the VMS business exceeded its fair value less the cost to sell, resulting in an impairment charge of </font><font style="font-family:Arial;font-size:10pt;">$6.2&#160;million</font><font style="font-family:Arial;font-size:10pt;">, which was recorded in Impairment charges on the Condensed Consolidated Statements of Operations during the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The below table indicates the purchase price allocation for acquisitions completed in the current year (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:613px;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:345px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:74px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:74px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:74px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Tretinoin Products</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Development-Stage Rx Products</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">All Other</font><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font><font style="font-family:Arial;font-size:9pt;font-weight:bold;">*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Purchase price paid</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">416.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">21.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">24.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">30.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total purchase consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">416.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">24.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">52.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Assets acquired:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">7.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Property and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Definite-lived intangibles</font><font style="font-family:Arial;font-size:9pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Distribution and license agreements, supply agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Developed product technology, formulations, and product rights</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">411.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">23.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Customer relationships and distribution networks</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">8.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-compete agreements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Indefinite-lived intangibles</font><font style="font-family:Arial;font-size:9pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">In-process research and development</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">24.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">7.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">413.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">24.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">41.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">416.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">24.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">59.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Liabilities assumed:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accounts payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net deferred income tax liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">416.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">24.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">52.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">*&#160;&#160;&#160;&#160;Opening balance sheet is preliminary</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Consists of </font><font style="font-family:Arial;font-size:8pt;">four</font><font style="font-family:Arial;font-size:8pt;"> product acquisitions in the CHC and Rx segments</font></div></td></tr></table></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"></font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">The below table indicates the purchase price allocation for acquisitions co</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">mpleted during the</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">year ended</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">December&#160;31, 2015</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;"> </font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;">(in millions):</font><font style="font-family:Arial;font-size:10pt;background-color:#ffffff;"> </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:686px;border-collapse:collapse;text-align:left;"><tr><td colspan="28" rowspan="1"></td></tr><tr><td style="width:176px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:59px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:58px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:62px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:50px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:54px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:54px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:59px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Entocort</font><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Naturwohl</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">ScarAway</font><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">GSK Products</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Gelcaps</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Omega</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">All Other</font><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Purchase price paid</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">380.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">150.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">26.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">223.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">37.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,983.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">15.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">13.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total purchase consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">380.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">150.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">26.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">223.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">37.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,983.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">29.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;font-weight:bold;">Assets acquired:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">14.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">7.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">260.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">7.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">202.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Prepaid expenses and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">39.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Property and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">130.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">61.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">32.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,900.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Definite-lived intangibles</font><font style="font-family:Arial;font-size:9pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Distribution and license agreements, supply agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">21.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Developed product technology, formulations, and product rights</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">380.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">27.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Customer relationships and distribution networks</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">25.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">61.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,056.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">64.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">129.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">287.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-compete agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Indefinite-lived intangibles</font><font style="font-family:Arial;font-size:9pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,003.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">In-process research and development</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">29.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">380.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">111.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">22.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">191.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,374.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">29.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other non-current assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">380.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">182.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">26.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">223.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">44.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,924.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">29.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;font-weight:bold;">Liabilities assumed:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accounts payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">243.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Short-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">24.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">43.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Payroll and related taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">51.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued customer programs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">39.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,471.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net deferred income tax liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">27.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,014.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other non-current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">53.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">31.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,941.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Net assets acquired</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">380.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">150.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">26.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">223.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">37.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,983.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">29.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Consists of </font><font style="font-family:Arial;font-size:8pt;">eight</font><font style="font-family:Arial;font-size:8pt;"> product acquisitions in the CHC, BCH, and Rx segments</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">COMMITMENTS AND CONTINGENCIES</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In view of the inherent difficulties of predicting the outcome of various types of legal proceedings, we cannot determine the ultimate resolution of the matters described below.&#160;We establish reserves for litigation and regulatory matters when losses associated with the claims become probable and the amounts can be reasonably estimated.&#160;The actual costs of resolving legal matters may be substantially higher or lower than the amounts reserved for those matters.&#160;For matters where the likelihood or extent of a loss is not probable or cannot be reasonably be estimated as of </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;">, we have not recorded a loss reserve. If certain of these matters are determined against the Company, there could be a material adverse effect on our financial condition, results of operations, or cash flows.&#160;We currently believe we have valid defenses to the claims in these lawsuits and intend to defend these lawsuits vigorously regardless of whether or not we have a loss reserve.&#160;Other than what is disclosed below, we do not expect the outcome of the litigation matters to which we are currently subject to, individually or in the aggregate, have a material adverse effect on our financial condition, results of operations, or cash flows.&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Securities Litigation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On May 18, 2016, a shareholder filed a securities case against the Company and our former CEO, Joseph Papa, in the District of New Jersey (</font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers&#8217; Pension Fund v. Papa, et al.)</font><font style="font-family:Arial;font-size:10pt;">.&#160;The plaintiff purports to represent a class of shareholders for the period from April 21, 2015 through May 11, 2016, inclusive.&#160;The complaint alleges violations of Securities Exchange Act sections 10(b) (and Rule 10b&#8209;5) and 14(e) against both defendants and 20(a) control person liability against Mr. Papa.&#160;In general, the allegations concern the actions taken by the Company and the former executive to defend against the hostile takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015.&#160;The plaintiff also alleges that we provided inadequate disclosure concerning alleged integration problems related to the Omega acquisition in the period from April 21, 2015 through May 11, 2016.&#160;The case is in an early stage.&#160;Four different plaintiff groups have sought appointment as lead plaintiff/lead counsel.&#160;The court will decide who will represent the purported class.&#160;Once the court has chosen a lead plaintiff, the plaintiff will likely file an amended complaint and the defendants will then have an opportunity to make a motion to dismiss the case.&#160; </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On July 19, 2016, a shareholder filed a securities class action against the Company and our former CEO, Joseph Papa, in the District of New Jersey. (</font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Wilson v. Papa, et al</font><font style="font-family:Arial;font-size:10pt;">.) The plaintiff purports to represent a class of persons who sold put options on the Company shares between April 21, 2015 and May 11, 2016. In general, the allegations and the claims are the same as those made in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case described above. Subsequently, this shareholder filed papers in the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund</font><font style="font-family:Arial;font-size:10pt;"> case as one of four candidates seeking to be named lead plaintiff or co-lead plaintiff in that case. The </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Wilson</font><font style="font-family:Arial;font-size:10pt;"> plaintiff also filed a motion to have the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Wilson</font><font style="font-family:Arial;font-size:10pt;"> case consolidated with the </font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Roofers' Pension Fund </font><font style="font-family:Arial;font-size:10pt;">case. The court has not yet acted on the motion to consolidate or the motion for appointment as lead plaintiff.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On May 22, 2016, shareholders filed a securities class action against the Company and five individual defendants: Mr. Papa, our former Executive Vice President and General Manager of the BCH segment Marc Coucke, our Chief Executive Officer John Hendrickson, and our Board members Gary Kunkle, Jr. and Laurie Brlas alleging violations of Israeli law in the District Court of Tel Aviv-Jaffa (</font><font style="font-family:Arial;font-size:10pt;font-style:italic;">Schwieger et al. v. Perrigo Company plc, et al.).</font><font style="font-family:Arial;font-size:10pt;">&#160;On June 15, 2016, Perrigo filed a motion to stay the case pending the outcome of the securities class action pending in the New Jersey federal court.&#160;The plaintiffs did not oppose the motion. The Israeli court granted the motion on the same day, and the action is stayed.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Eltroxin </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">During October and November 2011, nine applications to certify a class action lawsuit were filed in various courts in Israel related to Eltroxin, a prescription thyroid medication manufactured by a third party and distributed in Israel by our subsidiary, Perrigo Israel Agencies Ltd. The respondents included our subsidiaries, Perrigo Israel Pharmaceuticals Ltd. and/or Perrigo Israel Agencies Ltd., the manufacturers of the product, and various healthcare providers who provide healthcare services as part of the compulsory healthcare system in Israel. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">One of the applications was dismissed and the remaining eight applications were consolidated into one application. The applications arose from the 2011 launch of a reformulated version of Eltroxin in Israel. The consolidated application generally alleges that the respondents: (a) failed to timely inform patients, pharmacists and physicians about the change in the formulation; and (b) failed to inform physicians about the need to monitor patients taking the new formulation in order to confirm patients were receiving the appropriate dose of the drug. As a result, claimants allege they incurred the following damages: (a) purchases of product that otherwise would not have been made by patients had they been aware of the reformulation; (b) adverse events to some patients resulting from an imbalance of thyroid functions that could have been avoided; and (c) harm resulting from the patients' lack of informed consent prior to the use of the reformulation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Several hearings on whether or not to certify the consolidated application took place in December 2013 and January 2014. On May 17, 2015, the District Court certified the motion against Perrigo Israel Agencies Ltd. and dismissed it against the remaining respondents, including Perrigo Israel Pharmaceuticals Ltd. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On June 16, 2015, Perrigo submitted a motion for permission to appeal the decision to certify to the Israeli Supreme Court together with a motion to stay the proceedings of the class action until the motion for permission to appeal is adjudicated. Perrigo has filed its statement of defense to the underlying proceedings and the underlying proceedings have been stayed pending a decision on the motion to appeal. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">During a July 11, 2016 hearing on Perrigo&#8217;s motion to appeal the certification decision, the court noted that permission should be granted to Perrigo's appeal given issues with the scope of the District Court's decision.&#160; The court ultimately recommended the parties pursue mediation, noting that no decision on Perrigo's motion to appeal will be made pending the results of the mediation. The parties are now engaged in the mediation process. At this stage, we cannot reasonably predict the outcome or the liability, if any, associated with this claim. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Tysabri</font><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"> Product Liability Lawsuits</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Perrigo and collaborator Biogen are co-defendants in product liability lawsuits arising out of the occurrence of Progressive Multifocal Leukoencephalopathy, a serious brain infection, and serious adverse events, including deaths, which occurred in patients taking Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">. Perrigo and Biogen will each be responsible for 50% of losses and expenses arising out of any Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> product liability claims. During calendar year 2016, one case in the U.S. was settled and two others were dismissed with prejudice. While the remaining lawsuits will be vigorously defended, management cannot predict how these cases will be resolved. Adverse results in one or more of these lawsuits could result in substantial judgments against the Company.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Changes in our AOCI balances, net of tax were as follows (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:31%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Foreign currency translation adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair value of derivative financial instruments, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair&#160;value&#160;of investment securities, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Post-retirement and pension liability adjustments, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total AOCI</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Balance at December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(4.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(14.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(3.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(15.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">OCI before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">71.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(3.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">85.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Amounts reclassified from AOCI </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">71.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(3.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">18.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">87.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Balance at October 1, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">67.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(17.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">24.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(2.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">71.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Condensed Consolidated Financial Statements include our accounts and the accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our fiscal year previously consisted of a 52- or 53-week year ending on or around June 30 of each year with each quarter ending on the Saturday closest to each calendar quarter-end. Beginning on January 1, 2016, we changed our fiscal year to begin on January 1 and end on December 31 of each year. We will continue to cut off our quarterly accounting periods on the Saturday closest to the end of the calendar quarter, with the fourth quarter ending on December 31 of each year. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">INVESTMENTS</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Available for Sale Securities </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our available for sale securities are reported in </font><font style="font-family:Arial;font-size:10pt;">Prepaid expenses and other current assets</font><font style="font-family:Arial;font-size:10pt;">. Unrealized investment gains (losses) on available for sale securities were as follows (in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:455px;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:276px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:75px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:75px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Equity securities, at cost less impairments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">20.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Gross unrealized gains</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">32.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Gross unrealized losses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Estimated fair value of equity securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">53.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">14.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The factors affecting the assessment of impairments include both general financial market conditions and factors specific to a particular company. We recorded impairment charges of </font><font style="font-family:Arial;font-size:10pt;">$1.8&#160;million</font><font style="font-family:Arial;font-size:10pt;"> related to other-than-temporary impairments of marketable equity securities during the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;"> due to prolonged losses incurred on each of the investments. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Cost Method Investments</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;"></font><font style="font-family:Arial;font-size:10pt;">Our cost method investments totaled </font><font style="font-family:Arial;font-size:10pt;">$7.0 million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$6.9&#160;million</font><font style="font-family:Arial;font-size:10pt;"> at </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Arial;font-size:10pt;">, respectively, and are included in </font><font style="font-family:Arial;font-size:10pt;">Other non-current assets</font><font style="font-family:Arial;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Equity Method Investments</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our equity method investments totaled</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">$4.9&#160;million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$45.5&#160;million</font><font style="font-family:Arial;font-size:10pt;"> at </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Arial;font-size:10pt;">, respectively, and are included in </font><font style="font-family:Arial;font-size:10pt;">Other non-current assets</font><font style="font-family:Arial;font-size:10pt;">. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Due to significant and prolonged losses incurred on one of our equity method investments, we recorded a </font><font style="font-family:Arial;font-size:10pt;">$22.3 million</font><font style="font-family:Arial;font-size:10pt;"> impairment in Other expense, net, during the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;">. In addition, during the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;">, one of our equity method investments became publicly traded. As a result, we transferred the </font><font style="font-family:Arial;font-size:10pt;">$15.5&#160;million</font><font style="font-family:Arial;font-size:10pt;"> investment to available for sale and recorded an </font><font style="font-family:Arial;font-size:10pt;">$8.7&#160;million</font><font style="font-family:Arial;font-size:10pt;"> unrealized gain, net of tax, in Other Comprehensive Income ("OCI"), as reflected in the available for sale securities table above. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We recorded a net gain of </font><font style="font-family:Arial;font-size:10pt;">$0.1&#160;million</font><font style="font-family:Arial;font-size:10pt;"> and a net </font><font style="font-family:Arial;font-size:10pt;">loss</font><font style="font-family:Arial;font-size:10pt;"> of </font><font style="font-family:Arial;font-size:10pt;">$4.1&#160;million</font><font style="font-family:Arial;font-size:10pt;"> during the </font><font style="font-family:Arial;font-size:10pt;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">September&#160;26, 2015</font><font style="font-family:Arial;font-size:10pt;">, respectively, and a net loss of </font><font style="font-family:Arial;font-size:10pt;">$3.8&#160;million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$7.7&#160;million</font><font style="font-family:Arial;font-size:10pt;"> during the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;">, and </font><font style="font-family:Arial;font-size:10pt;">September&#160;26, 2015</font><font style="font-family:Arial;font-size:10pt;">, respectively, for our proportionate share of the equity method investment earnings or losses. The gains and losses were recorded in Other expense, net.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">INDEBTEDNESS</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total borrowings outstanding are summarized as follows (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:86.58280922431865%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br clear="none"/>2015</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Revolving credit agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2015 Revolver</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">380.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2014 Revolver</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">300.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total revolving credit agreements</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">680.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Term loans</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td colspan="4" style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2014 Term loan due December 5, 2019</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">463.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">488.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Notes and Bonds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;text-decoration:underline;">Coupon</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;text-decoration:underline;">Due</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.300%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">November&#160;8, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">500.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.500%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">May&#160;23, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">202.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">195.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.125%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">December&#160;12, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">337.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">325.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.300%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">November&#160;8, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">600.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">600.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.000%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">May&#160;23, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">134.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">130.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.500%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">March&#160;15, 2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">500.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.500%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">December&#160;15, 2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">500.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">500.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.105%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">July&#160;19, 2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">151.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">146.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.000%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">November&#160;15, 2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">800.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">800.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.900%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">December&#160;15, 2024</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">700.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">700.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.375%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">March&#160;15, 2026</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">700.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.300%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">November&#160;15, 2043</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">400.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">400.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.900%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">December&#160;15, 2044</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">400.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">400.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total notes and bonds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,426.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,698.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="5" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Other financing</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">86.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Unamortized premium (discount), net</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">43.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">73.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Deferred financing fees</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(34.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(36.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total borrowings outstanding</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,903.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,989.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Current indebtedness</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(265.0</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1,018.3</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total long-term debt less current portion</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,638.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,971.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Discussed below collectively as the "2014 Notes." </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Discussed below collectively as the "2013 Notes."</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Debt assumed from Omega.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(4)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Discussed below collectively as the "2016 Notes."</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">*</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We were in compliance with all covenants under our debt agreements as of </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Revolving Credit Agreements</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#ee2724;"></font><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">December&#160;9, 2015</font><font style="font-family:Arial;font-size:10pt;">, our 100% owned finance subsidiary, Perrigo Finance Unlimited Company (formerly Perrigo Finance plc) ("Perrigo Finance"), entered into a </font><font style="font-family:Arial;font-size:10pt;">$750.0 million</font><font style="font-family:Arial;font-size:10pt;"> revolving credit agreement (the "2015 Revolver"). On March 15, 2016, we used the proceeds of the long-term debt issuance described below under "2016 Notes" to repay the </font><font style="font-family:Arial;font-size:10pt;">$750.0&#160;million</font><font style="font-family:Arial;font-size:10pt;"> then outstanding under the 2015 Revolver and terminated the facility.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">March&#160;30, 2015</font><font style="font-family:Arial;font-size:10pt;">, we assumed a revolving credit facility with </font><font style="font-family:Arial;font-size:10pt;">&#8364;500.0 million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$544.5&#160;million</font><font style="font-family:Arial;font-size:10pt;">) outstanding from Omega. On </font><font style="font-family:Arial;font-size:10pt;">April&#160;8, 2015</font><font style="font-family:Arial;font-size:10pt;">, the </font><font style="font-family:Arial;font-size:10pt;">&#8364;500.0 million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$539.1&#160;million</font><font style="font-family:Arial;font-size:10pt;">) outstanding under the assumed revolving credit facility was repaid and the facility was terminated.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">December&#160;5, 2014</font><font style="font-family:Arial;font-size:10pt;">, Perrigo Finance entered into a </font><font style="font-family:Arial;font-size:10pt;">$600.0 million</font><font style="font-family:Arial;font-size:10pt;"> revolving credit agreement, which we increased to </font><font style="font-family:Arial;font-size:10pt;">$1.0&#160;billion</font><font style="font-family:Arial;font-size:10pt;"> on March 30, 2015 (the "2014 Revolver"). On March 15, 2016, we used the proceeds of the long-term debt issuance described below under "2016 Notes" to repay the </font><font style="font-family:Arial;font-size:10pt;">$435.0&#160;million</font><font style="font-family:Arial;font-size:10pt;"> then outstanding under the 2014 Revolver. There were no borrowings outstanding under the 2014 Revolver as of </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Term Loans</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">December&#160;5, 2014</font><font style="font-family:Arial;font-size:10pt;">, Perrigo Finance entered into a term loan agreement consisting of a </font><font style="font-family:Arial;font-size:10pt;">&#8364;500.0&#160;million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$614.3 million</font><font style="font-family:Arial;font-size:10pt;">) tranche, with the ability to draw an additional </font><font style="font-family:Arial;font-size:10pt;">&#8364;300.0 million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$368.6&#160;million</font><font style="font-family:Arial;font-size:10pt;">) tranche, maturing December 5, 2019, and we entered into a </font><font style="font-family:Arial;font-size:10pt;">$300.0 million</font><font style="font-family:Arial;font-size:10pt;"> term loan tranche maturing December 18, 2015, which we repaid in full on June 25, 2015. During the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;">, we made </font><font style="font-family:Arial;font-size:10pt;">$41.9 million</font><font style="font-family:Arial;font-size:10pt;"> in scheduled principal payments on the euro-denominated term loan.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Notes and Bonds</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">2016 Notes</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">March&#160;7, 2016</font><font style="font-family:Arial;font-size:10pt;">, Perrigo Finance issued </font><font style="font-family:Arial;font-size:10pt;">$500.0&#160;million</font><font style="font-family:Arial;font-size:10pt;"> in aggregate principal amount of </font><font style="font-family:Arial;font-size:10pt;">3.500%</font><font style="font-family:Arial;font-size:10pt;"> senior notes due 2021 and </font><font style="font-family:Arial;font-size:10pt;">$700.0&#160;million</font><font style="font-family:Arial;font-size:10pt;"> in aggregate principal amount of </font><font style="font-family:Arial;font-size:10pt;">4.375%</font><font style="font-family:Arial;font-size:10pt;"> senior notes due 2026 (together, the "2016 Notes") and received net proceeds of </font><font style="font-family:Arial;font-size:10pt;">$1.2&#160;billion</font><font style="font-family:Arial;font-size:10pt;"> after fees and market discount. Interest on the 2016 Notes is payable semiannually in arrears in March and September of each year, beginning in September 2016. The 2016 Notes are governed by a base indenture and a second supplemental indenture (collectively, the "2016 Indenture"). The 2016 Notes are fully and unconditionally guaranteed on a senior basis by Perrigo, and no other subsidiary of Perrigo guarantees the 2016 Notes. The proceeds were used to repay amounts borrowed under the 2015 Revolver and the 2014 Revolver, as mentioned above. There are no restrictions under the 2016 Notes on our ability to obtain funds from our subsidiaries. Perrigo Finance may redeem the 2016 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2016 Indenture. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Notes and Bonds Assumed from Omega</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In connection with the Omega acquisition, on </font><font style="font-family:Arial;font-size:10pt;">March&#160;30, 2015</font><font style="font-family:Arial;font-size:10pt;">, we assumed:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$20.0&#160;million</font><font style="font-family:Arial;font-size:10pt;"> in aggregate principal amount of </font><font style="font-family:Arial;font-size:10pt;">6.190%</font><font style="font-family:Arial;font-size:10pt;"> senior notes due </font><font style="font-family:Arial;font-size:10pt;">2016</font><font style="font-family:Arial;font-size:10pt;">, which was repaid on May 29, 2015 in full;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8364;135.0 million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$147.0&#160;million</font><font style="font-family:Arial;font-size:10pt;">) in aggregate principal amount of </font><font style="font-family:Arial;font-size:10pt;">5.1045%</font><font style="font-family:Arial;font-size:10pt;"> senior notes due </font><font style="font-family:Arial;font-size:10pt;">2023</font><font style="font-family:Arial;font-size:10pt;"> (the "2023 Notes");</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8364;300.0 million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$326.7&#160;million</font><font style="font-family:Arial;font-size:10pt;">) in aggregate principal amount of </font><font style="font-family:Arial;font-size:10pt;">5.125%</font><font style="font-family:Arial;font-size:10pt;"> retail bonds due </font><font style="font-family:Arial;font-size:10pt;">2017</font><font style="font-family:Arial;font-size:10pt;">; </font><font style="font-family:Arial;font-size:10pt;">&#8364;180.0&#160;million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$196.0&#160;million</font><font style="font-family:Arial;font-size:10pt;">) in aggregate principal amount of </font><font style="font-family:Arial;font-size:10pt;">4.500%</font><font style="font-family:Arial;font-size:10pt;"> retail bonds due </font><font style="font-family:Arial;font-size:10pt;">2017</font><font style="font-family:Arial;font-size:10pt;">; and </font><font style="font-family:Arial;font-size:10pt;">&#8364;120.0&#160;million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$130.7&#160;million</font><font style="font-family:Arial;font-size:10pt;">) in aggregate principal amount of </font><font style="font-family:Arial;font-size:10pt;">5.000%</font><font style="font-family:Arial;font-size:10pt;"> retail bonds due </font><font style="font-family:Arial;font-size:10pt;">2019</font><font style="font-family:Arial;font-size:10pt;"> (collectively, the "Retail Bonds").</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The fair value of the 2023 Notes and Retail Bonds</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font><font style="font-family:Arial;font-size:10pt;">exceeded par value by </font><font style="font-family:Arial;font-size:10pt;">&#8364;93.6 million</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font><font style="font-family:Arial;font-size:10pt;">(</font><font style="font-family:Arial;font-size:10pt;">$101.9&#160;million</font><font style="font-family:Arial;font-size:10pt;">) on the date of the Omega acquisition. As a result, a fair value adjustment was recorded as part of the carrying value of the underlying debt and will be amortized as a reduction of interest expense over the remaining terms of the respective debt instruments. The adjustment does not affect cash interest payments. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">2014 Notes</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">December&#160;2, 2014</font><font style="font-family:Arial;font-size:10pt;">, Perrigo Finance issued </font><font style="font-family:Arial;font-size:10pt;">$500.0&#160;million</font><font style="font-family:Arial;font-size:10pt;"> in aggregate principal amount of </font><font style="font-family:Arial;font-size:10pt;">3.500%</font><font style="font-family:Arial;font-size:10pt;"> senior notes due </font><font style="font-family:Arial;font-size:10pt;">2021</font><font style="font-family:Arial;font-size:10pt;"> (the "2021 Notes&#8221;), </font><font style="font-family:Arial;font-size:10pt;">$700.0&#160;million</font><font style="font-family:Arial;font-size:10pt;"> in aggregate principal amount of </font><font style="font-family:Arial;font-size:10pt;">3.900%</font><font style="font-family:Arial;font-size:10pt;"> senior notes due </font><font style="font-family:Arial;font-size:10pt;">2024</font><font style="font-family:Arial;font-size:10pt;"> (the &#8220;2024 Notes&#8221;), and </font><font style="font-family:Arial;font-size:10pt;">$400.0&#160;million</font><font style="font-family:Arial;font-size:10pt;"> in aggregate principal amount of </font><font style="font-family:Arial;font-size:10pt;">4.900%</font><font style="font-family:Arial;font-size:10pt;"> senior notes due </font><font style="font-family:Arial;font-size:10pt;">2044</font><font style="font-family:Arial;font-size:10pt;"> (the &#8220;2044 Notes&#8221; and, together with the 2021 Notes and the 2024 Notes, the &#8220;2014 Notes&#8221;) and received net proceeds of </font><font style="font-family:Arial;font-size:10pt;">$1.6&#160;billion</font><font style="font-family:Arial;font-size:10pt;"> after fees and market discount. Interest on the 2014 Notes is payable semiannually in arrears in June and December of each year, beginning in June 2015. The 2014 Notes are governed by a base indenture and a first supplemental indenture (collectively, the "2014 Indenture"). The 2014 Notes are fully and unconditionally guaranteed on a senior unsecured basis by Perrigo, and no other subsidiary of Perrigo guarantees the 2014 Notes. There are no restrictions under the 2014 Notes on our ability to obtain funds from our subsidiaries. Perrigo Finance may redeem the 2014 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2014 Indenture. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">2013 Notes</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On November&#160;8, 2013, Perrigo Company issued </font><font style="font-family:Arial;font-size:10pt;">$500.0 million</font><font style="font-family:Arial;font-size:10pt;"> aggregate principal amount of its 1.300% senior notes due 2016 (the "1.300% 2016 Notes"), </font><font style="font-family:Arial;font-size:10pt;">$600.0 million</font><font style="font-family:Arial;font-size:10pt;"> aggregate principal amount of its 2.300% senior notes due 2018 (the "2018 Notes"), </font><font style="font-family:Arial;font-size:10pt;">$800.0 million</font><font style="font-family:Arial;font-size:10pt;"> aggregate principal amount of its 4.000% senior notes due 2023 (the "4.000% 2023 Notes") and </font><font style="font-family:Arial;font-size:10pt;">$400.0 million</font><font style="font-family:Arial;font-size:10pt;"> aggregate principal amount of its 5.300% senior notes due 2043 (the "2043 Notes" and, together with the 1.300% 2016 Notes, the 2018 Notes and the 4.000% 2023 Notes, the "2013 Notes") in a private placement with registration rights. We received net proceeds of </font><font style="font-family:Arial;font-size:10pt;">$2.3&#160;billion</font><font style="font-family:Arial;font-size:10pt;"> from the issuance of the 2013 Notes after fees and market discount. On September 29, 2016, we repaid all </font><font style="font-family:Arial;font-size:10pt;">$500.0 million</font><font style="font-family:Arial;font-size:10pt;"> of the 1.300% 2016 Notes outstanding.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Interest on the 2013 Notes is payable semiannually in arrears in May and November of each year, beginning in May 2014. The 2013 Notes are governed by a base indenture and a first supplemental indenture (collectively, the "2013 Indenture"). The 2013 Notes are our unsecured and unsubordinated obligations, ranking equally in right of payment to all of our existing and future unsecured and unsubordinated indebtedness. The 2013 Notes are not entitled to mandatory redemption or sinking fund payments. We may redeem the 2013 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2013 Indenture. The 2013 Notes were guaranteed on an unsubordinated, unsecured basis by the same entities that guaranteed our then-outstanding credit agreement until November 21, 2014, at which time the 2013 Indenture was amended to remove all guarantors. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Other Financing</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Overdraft Facilities</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On </font><font style="font-family:Arial;font-size:10pt;">March&#160;30, 2015</font><font style="font-family:Arial;font-size:10pt;">, we assumed and repaid certain overdraft facilities totaling </font><font style="font-family:Arial;font-size:10pt;">&#8364;51.4 million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$56.0&#160;million</font><font style="font-family:Arial;font-size:10pt;">) with the Omega acquisition. Our BCH segment uses overdraft facilities to increase the efficiency of its cash utilization and meet its short-term liquidity needs.&#160;We repaid the balance outstanding under the overdraft facilities during the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;">, but retain the ability to use the facilities in our day-to-day cash operations. The balance outstanding under the facilities was </font><font style="font-family:Arial;font-size:10pt;">$82.9&#160;million</font><font style="font-family:Arial;font-size:10pt;"> at </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Arial;font-size:10pt;"> and is shown in the above table under "Other Financing".</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We enter into certain derivative financial instruments, when available on a cost-effective basis, to mitigate our risk associated with changes in interest rates and foreign currency exchange rates as follows: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Interest rate risk management - </font><font style="font-family:Arial;font-size:10pt;">We are exposed to the impact of interest rate changes through our cash investments and borrowings. We utilize a variety of strategies to manage the impact of changes in interest rates including using a mix of debt maturities along with both fixed-rate and variable-rate debt. In addition, we may enter into treasury-lock agreements and interest rate swap agreements on certain investing and borrowing transactions to manage our exposure to interest rate changes and our overall cost of borrowing. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Foreign currency exchange risk management - </font><font style="font-family:Arial;font-size:10pt;">We conduct business in several major currencies other than the U.S. dollar and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce cash flow volatility associated with foreign exchange rate changes on a consolidated basis to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments, and anticipated foreign currency sales and expenses.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">All derivative instruments are managed on a consolidated basis to efficiently net exposures and thus take advantage of any natural offsets. Gains and losses related to the derivative instruments are expected to be offset largely by gains and losses on the original underlying asset or liability. We do not use derivative financial instruments for speculative purposes. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"> All of our designated derivatives were classified as cash flow hedges as of </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Arial;font-size:10pt;">. Designated derivatives meet hedge accounting criteria, which means the fair value of the hedge is recorded in shareholders&#8217; equity as a component of OCI, net of tax. The deferred gains and losses are recognized in income in the period in which the hedged item affects earnings. Any ineffective portion of the change in fair value of the derivative is immediately recognized in earnings. All of our designated derivatives are assessed for hedge effectiveness quarterly.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We also have economic non-designated derivatives that do not meet hedge accounting criteria. These derivative instruments are adjusted to current market value at the end of each period through earnings. Gains or losses on these instruments are offset substantially by the remeasurement adjustment on the hedged item.&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Interest Rate Swaps and Treasury Locks </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Interest rate swap agreements are contracts to exchange floating rate for fixed rate payments (or vice versa) over the life of the agreement without the exchange of the underlying notional amounts. The notional amounts of the interest rate swap agreements are used to measure interest to be paid or received and do not represent the amount of exposure to credit loss. The differential paid or received on the interest rate swap agreements is recognized as an adjustment to interest expense.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">During the </font><font style="font-family:Arial;font-size:10pt;">six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Arial;font-size:10pt;">, we entered into a forward interest rate swap to hedge against changes in the benchmark interest rate between the date the interest rate swap was entered into and the date of expected future debt issuance. The interest rate swap was designated as a cash flow hedge and had a notional amount totaling </font><font style="font-family:Arial;font-size:10pt;">$200.0&#160;million</font><font style="font-family:Arial;font-size:10pt;">. The interest rate swap was settled upon the issuance of an aggregate </font><font style="font-family:Arial;font-size:10pt;">$1.2&#160;billion</font><font style="font-family:Arial;font-size:10pt;"> principal amount of senior notes on March 7, 2016 for a cumulative after-tax </font><font style="font-family:Arial;font-size:10pt;">loss</font><font style="font-family:Arial;font-size:10pt;"> of </font><font style="font-family:Arial;font-size:10pt;">$7.0&#160;million</font><font style="font-family:Arial;font-size:10pt;"> in OCI during the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In connection with the Omega acquisition, we assumed a </font><font style="font-family:Arial;font-size:10pt;">$20.0&#160;million</font><font style="font-family:Arial;font-size:10pt;"> private placement note. We also assumed an interest rate swap agreement with a notional amount totaling </font><font style="font-family:Arial;font-size:10pt;">$20.0 million</font><font style="font-family:Arial;font-size:10pt;"> that was in place to hedge the cross currency exchange differences between the U.S. dollar and the euro on the above-mentioned debt. On May 29, 2015, we repaid the loan and the interest rate swap. We also assumed </font><font style="font-family:Arial;font-size:10pt;">&#8364;500.0&#160;million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$544.5&#160;million</font><font style="font-family:Arial;font-size:10pt;">) of debt under Omega's revolving credit facility, as well as an interest rate swap agreement with a notional amount of </font><font style="font-family:Arial;font-size:10pt;">&#8364;135.0&#160;million</font><font style="font-family:Arial;font-size:10pt;"> (</font><font style="font-family:Arial;font-size:10pt;">$147.0&#160;million</font><font style="font-family:Arial;font-size:10pt;">) that was in place to hedge the change in the floating rate on that credit facility. On April 8, 2015, we repaid the loan and terminated the interest rate swap. Because both interest rate swaps mentioned above were recorded at fair market value on the date of termination, no gain or loss was recorded. For more information on the acquired debt and termination, see </font><a style="font-family:Arial;font-size:10pt;" href="#s131F6B21358C5724A2B7FB979DA59832"><font style="font-family:Arial;font-size:10pt;">Note 10</font></a><font style="font-family:Arial;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">During the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">September&#160;26, 2015</font><font style="font-family:Arial;font-size:10pt;">, we repaid a </font><font style="font-family:Arial;font-size:10pt;">$300.0 million</font><font style="font-family:Arial;font-size:10pt;"> term loan with floating interest rates priced off the LIBOR yield curve, see </font><a style="font-family:Arial;font-size:10pt;" href="#s131F6B21358C5724A2B7FB979DA59832"><font style="font-family:Arial;font-size:10pt;">Note 10</font></a><font style="font-family:Arial;font-size:10pt;">. As a result of the term loan repayment on June 25, 2015, the forward interest rate swap agreements with notional amounts totaling </font><font style="font-family:Arial;font-size:10pt;">$240.0&#160;million</font><font style="font-family:Arial;font-size:10pt;"> that were in place to hedge the change in the LIBOR rate were terminated as well. We recorded a loss of </font><font style="font-family:Arial;font-size:10pt;">$3.6&#160;million</font><font style="font-family:Arial;font-size:10pt;"> in Other expense, net, during the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">September&#160;26, 2015</font><font style="font-family:Arial;font-size:10pt;"> for the amount remaining in Accumulated Other Comprehensive Income ("AOCI") when the hedges were terminated.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Foreign Currency Derivatives</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;"></font><font style="font-family:Arial;font-size:10pt;">We enter into foreign currency forward contracts, both designated and non-designated, in order to manage the impact of foreign exchange fluctuations on expected future purchases and related payables denominated in a foreign currency, as well as to hedge the impact of foreign exchange fluctuations on expected future sales and related receivables denominated in a foreign currency. Both types of forward contracts have a maximum maturity date of </font><font style="font-family:Arial;font-size:10pt;">15</font><font style="font-family:Arial;font-size:10pt;"> months. The total notional amount for these contracts was </font><font style="font-family:Arial;font-size:10pt;">$482.5 million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$755.5 million</font><font style="font-family:Arial;font-size:10pt;"> as of </font><font style="font-family:Arial;font-size:10pt;">October 1, 2016</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Arial;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In order to economically hedge the foreign currency exposure associated with the planned payment of the euro-denominated purchase price of Omega, we entered into non-designated forward contracts that matured during the </font><font style="font-family:Arial;font-size:10pt;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> March 28, 2015. We recorded losses of </font><font style="font-family:Arial;font-size:10pt;">$259.8 million</font><font style="font-family:Arial;font-size:10pt;"> during the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">September&#160;26, 2015</font><font style="font-family:Arial;font-size:10pt;"> related to the settlement of the forward contracts in Other expense, net. The losses on the derivatives due to changes in the euro-to-U.S. dollar exchange rates were economically offset at closing in the final settlement of the euro-denominated Omega purchase price. In June 2015, in order to economically hedge the foreign currency exposure associated with the planned payment of the euro-denominated GSK Products acquisition discussed in </font><a style="font-family:Arial;font-size:10pt;" href="#sBA56EADBE97A5703A07A5DC8B0A20CDA"><font style="font-family:Arial;font-size:10pt;">Note 2</font></a><font style="font-family:Arial;font-size:10pt;">, we entered into a non-designated option contract to protect against a strengthening of the euro relative to the U.S. dollar. We recorded losses of </font><font style="font-family:Arial;font-size:10pt;">$1.9 million</font><font style="font-family:Arial;font-size:10pt;"> for the change in fair value of the option contract during the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">September&#160;26, 2015</font><font style="font-family:Arial;font-size:10pt;"> in Other expense, net. Because these derivatives were economically hedging future acquisitions, the cash outflows associated with their settlement are shown as investing activity on the Consolidated Statements of Cash Flows. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Effects of Derivatives on the Financial Statements</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The below tables indicate the effects of all derivative instruments on the Condensed Consolidated Financial Statements. All amounts exclude income tax effects and are presented in millions.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The balance sheet location and gross fair value of our outstanding derivative instruments were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:87.0020964360587%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:26%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Asset Derivatives</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance&#160;Sheet&#160;Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Designated derivatives:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other&#160;current&#160;assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total designated derivatives</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-designated derivatives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total non-designated derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:88.25995807127882%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Liability Derivatives</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance&#160;Sheet&#160;Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Designated derivatives:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other non-current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total designated derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-designated derivatives:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total non-designated derivatives</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The gains (losses) recorded in OCI for the effective portion of our designated cash flow hedges were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:624px;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:79px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:79px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:79px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:79px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recorded in OCI<br clear="none"/>(Effective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Designated Cash Flow Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(9.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(12.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(4.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(13.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The gains (losses) reclassified from AOCI into earnings for the effective portion of our designated cash flow hedges were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:704px;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td style="width:194px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:126px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:77px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:79px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:75px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:79px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Reclassified from AOCI to Income <br clear="none"/>(Effective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Designated Cash Flow Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Treasury locks</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(18.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(4.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(21.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The gains (losses) recognized against earnings for the ineffective portion of our designated cash flow hedges were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:712px;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td style="width:200px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:122px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:79px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:79px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:79px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:79px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in Income<br clear="none"/>(Ineffective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Designated Cash Flow Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The effects of our non-designated derivatives on the Condensed Consolidated Statements of Operations were as follows: </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in Income</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Non-Designated Derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(8.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(8.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(259.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(3.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(8.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(10.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(262.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We enter into certain derivative financial instruments, when available on a cost-effective basis, to mitigate our risk associated with changes in interest rates and foreign currency exchange rates as follows: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Interest rate risk management - </font><font style="font-family:Arial;font-size:10pt;">We are exposed to the impact of interest rate changes through our cash investments and borrowings. We utilize a variety of strategies to manage the impact of changes in interest rates including using a mix of debt maturities along with both fixed-rate and variable-rate debt. In addition, we may enter into treasury-lock agreements and interest rate swap agreements on certain investing and borrowing transactions to manage our exposure to interest rate changes and our overall cost of borrowing. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Foreign currency exchange risk management - </font><font style="font-family:Arial;font-size:10pt;">We conduct business in several major currencies other than the U.S. dollar and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce cash flow volatility associated with foreign exchange rate changes on a consolidated basis to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments, and anticipated foreign currency sales and expenses.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">All derivative instruments are managed on a consolidated basis to efficiently net exposures and thus take advantage of any natural offsets. Gains and losses related to the derivative instruments are expected to be offset largely by gains and losses on the original underlying asset or liability. We do not use derivative financial instruments for speculative purposes. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"> All of our designated derivatives were classified as cash flow hedges as of </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Arial;font-size:10pt;">. Designated derivatives meet hedge accounting criteria, which means the fair value of the hedge is recorded in shareholders&#8217; equity as a component of OCI, net of tax. The deferred gains and losses are recognized in income in the period in which the hedged item affects earnings. Any ineffective portion of the change in fair value of the derivative is immediately recognized in earnings. All of our designated derivatives are assessed for hedge effectiveness quarterly.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We also have economic non-designated derivatives that do not meet hedge accounting criteria. These derivative instruments are adjusted to current market value at the end of each period through earnings. Gains or losses on these instruments are offset substantially by the remeasurement adjustment on the hedged item.&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Standard Pronouncements</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"></font><font style="font-family:Arial;font-size:10pt;">Below are recent accounting standard updates that we are still assessing to determine the effect on our consolidated financial statements. We do not believe that any other recently issued accounting standards could have a material effect on our consolidated financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:37%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:26%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Recently Issued Accounting Standards Not Yet Adopted</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Standard</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Description</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Effective Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Effect on the Financial Statements or Other Significant Matters</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Improvements to Employee Share-Based Payment Accounting</font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">This guidance is intended to simplify several aspects of the accounting for share-based payment award transactions. It will require all income tax effects of awards to be recorded through the income statement when they vest or settle as opposed to certain amounts being recorded in additional paid-in capital. An entity will also have to elect whether to account for forfeitures as they occur or by estimating the number of awards expected to be forfeited and adjusting the estimate when it is likely to change (as currently required). The guidance will also increase the amount an employer can withhold to cover income taxes on awards. Early adoption is permitted.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">January 1, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">We are currently evaluating the implications of adoption on our consolidated financial statements.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Revenue from Contracts with Customers </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps: identify the contract(s) with a customer; identify the performance obligations in the contract; determine the transaction price; allocate the transaction price to the performance obligations in the contract; and recognize revenue when (or as) the entity satisfies a performance obligation. This guidance allows for two adoption methods, full retrospective approach or modified retrospective approach. Early adoption is not permitted.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">January 1, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">We are currently evaluating the possible adoption methodologies and the implications of adoption on our consolidated financial statements.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:13px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">This guidance was issued to increase transparency and comparability among organizations by requiring recognition of lease assets and lease liabilities on the balance sheet and disclosure of key information about leasing arrangements. For leases with a term of 12 months or less, lessees are permitted to make an election to not recognize right-of-use assets and lease liabilities. Upon adoption, lessees will apply the new standard as of the beginning of the earliest comparative period presented in the financial statements, however lessees will be able to exclude leases that expire as of the implementation date. Early adoption is permitted.</font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">January 1, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">We are currently evaluating the implications of adoption on our consolidated financial statements and considering whether to early adopt the standard.</font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:37%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:26%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Recently Issued Accounting Standards Not Yet Adopted (continued)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Standard</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Description</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Effective Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Effect on the Financial Statements or Other Significant Matters</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Measurement of Credit Losses on Financial Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:13px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">This guidance changes the impairment model for most financial assets and certain other instruments, replacing the current "incurred loss" approach with an "expected loss" credit impairment model, which will apply to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities, and off-balance sheet credit exposures such as letters of credit. Early adoption is permitted.</font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">January 1, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">We are currently evaluating the new standard for potential impacts on our receivables, debt, and other financial instruments and considering whether to early adopt the standard.</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">ASSETS HELD FOR SALE</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">During the </font><font style="font-family:Arial;font-size:10pt;">six months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Arial;font-size:10pt;">, management committed to a plan to sell our U.S. VMS and India Active Pharmaceutical Ingredients ("API") businesses. As a result, the net assets attributable to both businesses were classified as held-for-sale beginning at December 31, 2015. As described in </font><a style="font-family:Arial;font-size:10pt;" href="#s725E8282B5AB57078DFC9AA40A7D91D9"><font style="font-family:Arial;font-size:10pt;">Note 2</font></a><font style="font-family:Arial;font-size:10pt;">, we completed the sale of our U.S. VMS business to IVC on August 5, 2016. In addition, during the </font><font style="font-family:Arial;font-size:10pt;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;">, management committed to a plan to sell certain fixed assets associated with our Animal Health pet treats plant. Such assets were classified as held-for-sale beginning at October 1, 2016. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">When a group of assets is classified as held-for-sale, the book value is evaluated and adjusted to the lower of its carrying amount or fair value less the cost to sell. At December 31, 2015, we determined that the carrying value of the India API business exceeded its fair value less cost to sell, resulting in an impairment charge of </font><font style="font-family:Arial;font-size:10pt;">$29.0&#160;million</font><font style="font-family:Arial;font-size:10pt;">. We recorded additional impairment charges totaling </font><font style="font-family:Arial;font-size:10pt;">$10.8&#160;million</font><font style="font-family:Arial;font-size:10pt;"> during the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;">. The API business is reported primarily in our Other segment. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">At October 1, 2016, we determined that the carrying value of the fixed assets associated with our Animal Health pet treats plant exceeded the fair value less the cost to sell, resulting in an impairment charge of </font><font style="font-family:Arial;font-size:10pt;">$3.4&#160;million</font><font style="font-family:Arial;font-size:10pt;">. The assets associated with our Animal Health pet treats plant are reported in our CHC segment.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The assets held-for-sale were reported within </font><font style="font-family:Arial;font-size:10pt;">Prepaid expenses and other current assets</font><font style="font-family:Arial;font-size:10pt;"> and liabilities held-for-sale were reported in </font><font style="font-family:Arial;font-size:10pt;">Accrued liabilities</font><font style="font-family:Arial;font-size:10pt;">. The amounts consisted of the following (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:83.22851153039832%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;font-weight:bold;">CHC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;font-weight:bold;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;font-weight:bold;">CHC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;font-weight:bold;">Other</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;font-weight:bold;">Assets held for sale</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">Current assets</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">7.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">55.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">13.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">Goodwill</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">13.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">14.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">Property, plant and equipment</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">13.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">34.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">18.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">37.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">Other assets</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">3.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">3.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">Less: impairment reserves</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">(3.4</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">(39.8</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">(29.0</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;font-weight:bold;">Total assets held for sale </font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">9.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">7.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">86.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">39.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;font-weight:bold;">Liabilities held for sale</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">Current liabilities</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">30.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">Other liabilities</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;font-weight:bold;">Total liabilities held for sale</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">3.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">30.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">2.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">EARNINGS PER SHARE AND SHAREHOLDERS' EQUITY</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Earnings per Share</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">A reconciliation of the numerators and denominators used in the basic and diluted earnings per share ("EPS") calculation is as follows (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net income (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1,255.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">112.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1,395.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">74.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Weighted average shares outstanding for basic EPS</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">143.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">146.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">143.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">144.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Dilutive effect of share-based awards*</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Weighted average shares outstanding for diluted EPS</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">143.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">146.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">143.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">145.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Anti-dilutive share-based awards excluded from computation of diluted EPS*</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">* In the period of a net loss, diluted shares equal basic shares.</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Shareholders' Equity</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Shares</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We issued shares related to the exercise and vesting of share-based compensation as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:59.538784067085956%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">185,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">154,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">283,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">246,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Share Repurchases</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On October 22, 2015, the Board of Directors approved a share repurchase plan of up to </font><font style="font-family:Arial;font-size:10pt;">$2.0 billion</font><font style="font-family:Arial;font-size:10pt;">, of which </font><font style="font-family:Arial;font-size:10pt;">$1.5 billion</font><font style="font-family:Arial;font-size:10pt;"> is still available to be repurchased through December 31, 2018. We did not repurchase any shares under the share repurchase plan during the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;color:#252525;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;color:#252525;">.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table summarizes the valuation of our financial instruments carried at fair value and measured at fair value on a recurring and non-recurring basis by the above pricing categories (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:93.50104821802935%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:54%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value Hierarchy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Measured at fair value on a recurring basis:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:normal;">Assets:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Investment securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Level 1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">53.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">14.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Level 2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:normal;">Liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Level 2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total level 2 liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">75.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Measured at fair value on a non-recurring basis:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:normal;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Goodwill</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,105.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Indefinite-lived intangible assets</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Level 3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">672.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,031.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Definite-lived intangible assets</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">66.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Assets held for sale, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Level 3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">14.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">37.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total level 3 assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,858.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,069.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">FAIR VALUE MEASUREMENTS</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Fair value is the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The following fair value hierarchy is used in selecting inputs, with the highest priority given to Level 1, as these are the most transparent or reliable. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:150px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:Arial;font-size:10pt;">Level 1:</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Quoted prices for identical instruments in active markets.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:150px;text-indent:-90px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:150px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:Arial;font-size:10pt;">Level 2:</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets. </font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:150px;text-indent:-90px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:150px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><font style="font-family:Arial;font-size:10pt;">Level 3:</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Valuations derived from valuation techniques in which one or more significant inputs are not observable.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:150px;text-indent:-90px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table summarizes the valuation of our financial instruments carried at fair value and measured at fair value on a recurring and non-recurring basis by the above pricing categories (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:93.50104821802935%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:54%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value Hierarchy</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Measured at fair value on a recurring basis:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:normal;">Assets:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Investment securities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Level 1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">53.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">14.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Level 2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:normal;">Liabilities:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Level 2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total level 2 liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">75.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Measured at fair value on a non-recurring basis:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:normal;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Goodwill</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,105.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Indefinite-lived intangible assets</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Level 3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">672.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,031.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Definite-lived intangible assets</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">66.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Assets held for sale, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Level 3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">14.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">37.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total level 3 assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,858.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,069.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Goodwill with a carrying amount of </font><font style="font-family:Arial;font-size:8pt;">$1.9 billion</font><font style="font-family:Arial;font-size:8pt;"> was written down to its implied fair value of </font><font style="font-family:Arial;font-size:8pt;">$1.1 billion</font><font style="font-family:Arial;font-size:8pt;">, resulting in an impairment charge of </font><font style="font-family:Arial;font-size:8pt;">$804.1 million</font><font style="font-family:Arial;font-size:8pt;"> for the </font><font style="font-family:Arial;font-size:8pt;">three months ended</font><font style="font-family:Arial;font-size:8pt;"> </font><font style="font-family:Arial;font-size:8pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:8pt;">; impairment charges totaled </font><font style="font-family:Arial;font-size:8pt;">$967.5 million</font><font style="font-family:Arial;font-size:8pt;"> for the </font><font style="font-family:Arial;font-size:8pt;">nine months ended</font><font style="font-family:Arial;font-size:8pt;"> </font><font style="font-family:Arial;font-size:8pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:8pt;"> and are included in </font><font style="font-family:Arial;font-size:8pt;">Impairment charges</font><font style="font-family:Arial;font-size:8pt;"> on the Condensed Consolidated Statements of Operations.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Indefinite-lived intangible assets with a carrying amount of </font><font style="font-family:Arial;font-size:8pt;">$1.2 billion</font><font style="font-family:Arial;font-size:8pt;"> were written down to a fair value of </font><font style="font-family:Arial;font-size:8pt;">$672.4 million</font><font style="font-family:Arial;font-size:8pt;"> resulting in total impairment charges of </font><font style="font-family:Arial;font-size:8pt;">$575.7 million</font><font style="font-family:Arial;font-size:8pt;"> for the </font><font style="font-family:Arial;font-size:8pt;">three months ended</font><font style="font-family:Arial;font-size:8pt;"> </font><font style="font-family:Arial;font-size:8pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:8pt;">; impairment charges totaled </font><font style="font-family:Arial;font-size:8pt;">$849.1 million</font><font style="font-family:Arial;font-size:8pt;"> for the </font><font style="font-family:Arial;font-size:8pt;">nine months ended</font><font style="font-family:Arial;font-size:8pt;"> </font><font style="font-family:Arial;font-size:8pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:8pt;"> and are included in </font><font style="font-family:Arial;font-size:8pt;">Impairment charges</font><font style="font-family:Arial;font-size:8pt;"> on the Condensed Consolidated Statements of Operations.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:24px;text-indent:-24px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Definite-lived intangible assets with a carrying amount of </font><font style="font-family:Arial;font-size:8pt;">$357.1 million</font><font style="font-family:Arial;font-size:8pt;"> were written down to a fair value of </font><font style="font-family:Arial;font-size:8pt;">$66.9 million</font><font style="font-family:Arial;font-size:8pt;"> resulting in an impairment charge of </font><font style="font-family:Arial;font-size:8pt;">$290.2 million</font><font style="font-family:Arial;font-size:8pt;"> for the </font><font style="font-family:Arial;font-size:8pt;">three and nine months ended</font><font style="font-family:Arial;font-size:8pt;"> </font><font style="font-family:Arial;font-size:8pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:8pt;">, which is included in </font><font style="font-family:Arial;font-size:8pt;">Impairment charges</font><font style="font-family:Arial;font-size:8pt;"> on the Condensed Consolidated Statements of Operations.</font></div></td></tr></table><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">There were no transfers among Level 1, 2, and 3 during the </font><font style="font-family:Arial;font-size:10pt;">three and nine months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">September&#160;26, 2015</font><font style="font-family:Arial;font-size:10pt;">. Our policy regarding the recording of transfers between levels is to record any such transfers at the end of the reporting period. See </font><a style="font-family:Arial;font-size:10pt;" href="#sC841E01E08D259AF84A7E575FA0B7C7D"><font style="font-family:Arial;font-size:10pt;">Note 7</font></a><font style="font-family:Arial;font-size:10pt;"> for information on our investment securities. See </font><a style="font-family:Arial;font-size:10pt;" href="#sD1A1E57DB0945765A915BE808691EE8C"><font style="font-family:Arial;font-size:10pt;">Note 8</font></a><font style="font-family:Arial;font-size:10pt;"> for a discussion of derivatives.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Contingent consideration represents milestone payment obligations obtained through product acquisitions, which are valued using estimates based on probability-weighted outcomes, sensitivity analysis, and discount rates reflective of the risk involved. The estimates are updated quarterly and the liabilities are adjusted to fair value depending on a number of assumptions, including the competitive landscape and regulatory approvals that may impact the future sales of a product. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"> The non-recurring fair values included in the table above represent only those assets whose carrying values were adjusted to fair value during the reporting period. See </font><a style="font-family:Arial;font-size:10pt;" href="#sA3313743876052B082B6018772A1E600"><font style="font-family:Arial;font-size:10pt;">Note 3</font></a><font style="font-family:Arial;font-size:10pt;"> for a more detailed discussion of the impaired goodwill and indefinite-lived intangible assets and the valuation methods used, and </font><a style="font-family:Arial;font-size:10pt;" href="#s52173E4D66665132B0427776810A6E38"><font style="font-family:Arial;font-size:10pt;">Note 9</font></a><font style="font-family:Arial;font-size:10pt;"> for information on the impaired assets held for sale, net. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The table below presents a reconciliation for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (in millions). Net realized losses in the table were recorded in Administrative expense.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:610px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:214px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:83px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:83px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:83px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:83px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Contingent Consideration</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Beginning balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">44.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net realized (gains) losses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(12.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Purchases or additions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">30.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">61.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency effect</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Settlements</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Ending balance</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">75.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">75.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">As of </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Arial;font-size:10pt;">, our fixed rate long-term debt consisted of public bonds, a private placement note, and retail bonds. As of </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;">, the public bonds and private placement note had a carrying value of </font><font style="font-family:Arial;font-size:10pt;">$4.6&#160;billion</font><font style="font-family:Arial;font-size:10pt;"> and a fair value of </font><font style="font-family:Arial;font-size:10pt;">$4.7 billion</font><font style="font-family:Arial;font-size:10pt;">, based on quoted market prices (Level 1). As of </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Arial;font-size:10pt;">, the public bonds and private placement note had a carrying value of </font><font style="font-family:Arial;font-size:10pt;">$3.9&#160;billion</font><font style="font-family:Arial;font-size:10pt;"> and fair value of </font><font style="font-family:Arial;font-size:10pt;">$3.8 billion</font><font style="font-family:Arial;font-size:10pt;">, based on quoted market prices (Level 1). As of </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;">, our retail bonds had a carrying value of </font><font style="font-family:Arial;font-size:10pt;">$826.4&#160;million</font><font style="font-family:Arial;font-size:10pt;"> (excluding a premium of </font><font style="font-family:Arial;font-size:10pt;">$60.7&#160;million</font><font style="font-family:Arial;font-size:10pt;">) and a fair value of </font><font style="font-family:Arial;font-size:10pt;">$891.4&#160;million</font><font style="font-family:Arial;font-size:10pt;">. As of </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Arial;font-size:10pt;">, our retail bonds had a carrying value of </font><font style="font-family:Arial;font-size:10pt;">$798.3&#160;million</font><font style="font-family:Arial;font-size:10pt;"> (excluding a premium of </font><font style="font-family:Arial;font-size:10pt;">$82.5 million</font><font style="font-family:Arial;font-size:10pt;">) and a fair value of </font><font style="font-family:Arial;font-size:10pt;">$859.8&#160;million</font><font style="font-family:Arial;font-size:10pt;">. The fair value of our related bonds for both periods was based on interest rates offered for borrowings of a similar nature and remaining maturities (Level 2). </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The carrying amounts of our other financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, short-term debt and variable rate long-term debt, approximate their fair value.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The table below presents a reconciliation for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (in millions). Net realized losses in the table were recorded in Administrative expense.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:610px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:214px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:83px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:83px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:83px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:83px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Contingent Consideration</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Beginning balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">44.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net realized (gains) losses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(4.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(12.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Purchases or additions</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">30.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">61.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency effect</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Settlements</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Ending balance</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">75.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">75.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">GOODWILL AND OTHER INTANGIBLE ASSETS</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Goodwill</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="29" rowspan="1"></td></tr><tr><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Reporting Segments:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Business acquisitions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Business divestitures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Impairments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Changes in assets held for sale</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Currency translation adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHC</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,890.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(8.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">13.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(6.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,887.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">BCH</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,980.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(967.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">92.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,105.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Rx</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,222.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(13.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,210.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Specialty Sciences</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">200.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">200.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">71.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">86.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,364.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(8.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(967.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">24.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">75.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,490.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In connection with the preparation of our financial statements for the three-month period ended April 2, 2016, we identified indicators of goodwill impairment in our BCH - rest of world (&#8220;BCH - ROW&#8221;) reporting unit, which comprises primarily operations attributable to the Omega acquisition in all geographic regions except for Belgium. The primary impairment indicators included the decline in our 2016 performance expectations and a reduction in our long-range revenue growth forecast. Step one of the goodwill impairment test involved determining the fair value of the reporting unit using a discounted cash flow technique and comparing it to the reporting unit&#8217;s carrying value. The main assumptions supporting the cash flow projections used to determine the reporting unit&#8217;s fair value included revenue growth based on product line extensions, product life cycle strategies, and geographical expansion within the markets in which the reporting unit distributes products, gross margins consistent with historical trends, and advertising and promotion investments largely consistent with the reporting unit's growth plans. The BCH - ROW reporting unit did not pass step one of goodwill impairment testing. The change in fair value from previous estimates was due primarily to the changes in the market and performance of certain brands such that the evaluation of brand prioritization and product extensions or launches in new regions are being more focused to maximize the potential of all brands in the segment's portfolio. </font></div><div style="line-height:120%;text-align:left;text-indent:22px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The second step of the goodwill impairment test required that we determine the implied fair value of the BCH - ROW reporting unit&#8217;s goodwill, which involved determining the value of the reporting unit&#8217;s individual assets and liabilities. Due to the complex and time-consuming nature of step two, based on our evaluation and initial estimates of the fair values of the assets and liabilities and the deficit of the fair value when compared to the related book value, we recorded an estimated impairment charge of </font><font style="font-family:Arial;font-size:10pt;">$193.6&#160;million</font><font style="font-family:Arial;font-size:10pt;"> for the three months ended April 2, 2016. We finalized the step two fair value calculation during the three months ended July 2, 2016, which resulted in a </font><font style="font-family:Arial;font-size:10pt;">$30.3 million</font><font style="font-family:Arial;font-size:10pt;"> reduction to the estimated impairment charge recorded during the three months ended April 2, 2016.</font></div><div style="line-height:120%;text-align:left;text-indent:22px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In connection with the preparation of our financial statements for the three months ended October 1, 2016, we identified additional indicators of goodwill impairment in both our BCH - ROW and our BCH - Belgium reporting units. With respect to both reporting units, the primary impairment indicators included an additional decline in our 2016 performance expectations for the remainder of the year and a reduction in our long-range revenue growth and margin forecasts due to the factors outlined below. Step one of the goodwill impairment test involved determining the fair value of the reporting units using a discounted cash flow technique and comparing it to the respective reporting units' carrying value. The main assumptions supporting the cash flow projections used to determine each reporting unit&#8217;s fair value included revenue growth based on product line extensions, product life cycle strategies, and geographical expansion within the markets in which the reporting unit distributes products, gross margins consistent with historical trends and including supply chain cost improvement plans, and advertising and promotion investments largely consistent with the reporting unit's growth plans. Both the BCH - ROW and the BCH - Belgium reporting units did not pass step one of goodwill impairment testing. As it relates to the BCH - ROW reporting unit, the changes in fair value from previous estimates were due primarily to (1) changes in the market and performance of certain brands due to moderated new product launch assumptions, (2) execution of certain key product strategies falling short of expectations causing a reduction to baseline forecast models in France, Germany and Italy, (3) certain macro-economic factors having continued to impact the business more than expected in France, Russia and Turkey in addition to unfavorable foreign currency impacts experienced primarily in the UK related to Brexit. As it relates to BCH - Belgium reporting unit, the changes in fair value from previous estimates due to change in the forecast as a result of a reduction in volume with a major wholesaler due to factors consistent with those outlined for BCH - ROW.</font></div><div style="line-height:120%;text-align:left;text-indent:22px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The second step of the goodwill impairment test required that we determine the implied fair value of both the BCH - ROW and BCH - Belgium reporting units' goodwill, which involved determining the value of each reporting unit&#8217;s individual assets and liabilities. Based on our evaluation and initial estimates of the fair values of the assets and liabilities and the deficit of the fair value when compared to the related book value, we recorded an estimated impairment charge of </font><font style="font-family:Arial;font-size:10pt;">$734.7 million</font><font style="font-family:Arial;font-size:10pt;"> related to the BCH - ROW reporting unit and </font><font style="font-family:Arial;font-size:10pt;">$69.4 million</font><font style="font-family:Arial;font-size:10pt;"> related to the BCH - Belgium reporting unit for the three months ended October 1, 2016. Both charges were recorded in Impairment charges on the Condensed Consolidated Statements of Operations within our BCH segment. Due to the complex and time-consuming nature of step two, we expect to finalize the fair value calculation during the fourth quarter of 2016, which could result in an adjustment to the estimated impairment charge. As of October 1, 2016, the implied fair value of goodwill that remains in the BCH - ROW and BCH - Belgium reporting units is </font><font style="font-family:Arial;font-size:10pt;">$1.0 billion</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$70.2 million</font><font style="font-family:Arial;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">While no impairment charges were recorded as a result of the goodwill impairment testing for the transition period of </font><font style="font-family:Arial;font-size:10pt;">June 28, 2015</font><font style="font-family:Arial;font-size:10pt;"> to </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Arial;font-size:10pt;">, our Specialty Sciences reporting unit's fair value exceeded the carrying value by less than 10%. Management evaluated the primary source of cash flow in this segment, the Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> royalty stream, based on a combination of factors including independent external research, information provided from our royalty partner, and internal estimates.&#160;Based on this information, management&#8217;s assessment of future cash flow from this royalty stream has been reduced primarily due to anticipated new competitors entering the market and unfavorable currency exchange effects.&#160;Future performance different from the assumptions utilized in our quantitative analysis may further reduce the fair value of the reporting unit, which may result in the fair value no longer exceeding the carrying value. In February 2016, a competitor's pipeline product, Ocrevus</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">, received breakthrough therapy designation from the FDA and could potentially be approved in 2016. The product would compete with Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;"> and could have a significant negative impact on the royalty we receive from Biogen Idec, Inc. ("Biogen") and the performance of the Specialty Sciences segment.&#160;We continue to monitor the progress of all potential competing products and assess the reporting unit for potential impairment should impairment indicators arise, as applicable, and at least annually during our fourth quarter impairment testing.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">During the </font><font style="font-family:Arial;font-size:10pt;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> June 27, 2015, we performed our annual goodwill impairment testing, which indicated that our CHC Mexico reporting unit's goodwill fair value was below its net book value as of March 28, 2015. As a result, we initiated the second step of the goodwill impairment test to measure the amount of impairment. We concluded that the goodwill was fully impaired and recorded an impairment of </font><font style="font-family:Arial;font-size:10pt;">$6.8 million</font><font style="font-family:Arial;font-size:10pt;"> in the CHC segment during the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">September&#160;26, 2015</font><font style="font-family:Arial;font-size:10pt;"> in Other expense, net. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Intangible Assets</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Other intangible assets and related accumulated amortization consisted of the following (in millions):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Gross</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Accumulated Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Gross</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Accumulated Amortization</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Definite-lived intangibles</font><font style="font-family:Arial;font-size:9pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Distribution and license agreements, supply agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6,122.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">914.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6,053.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">667.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Developed product technology, formulations, and product rights</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,805.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">529.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,383.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">426.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Customer relationships and distribution networks</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,564.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">288.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,520.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">193.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">631.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">54.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">539.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">22.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-compete agreements</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">14.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">15.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total definite-lived intangibles</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">10,138.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,797.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9,512.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,321.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Indefinite-lived intangibles</font><font style="font-family:Arial;font-size:9pt;">:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Trademarks, trade names, and brands</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">724.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,868.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">In-process research and development</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">67.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">48.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total indefinite-lived intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">792.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,916.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total other intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">10,930.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,797.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11,428.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,321.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Certain intangible assets are denominated in currencies other than the U.S. dollar; therefore, their gross and net carrying values are subject to foreign currency movements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We recorded amortization expense of </font><font style="font-family:Arial;font-size:10pt;">$162.1&#160;million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$147.6&#160;million</font><font style="font-family:Arial;font-size:10pt;"> for the </font><font style="font-family:Arial;font-size:10pt;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">September&#160;26, 2015</font><font style="font-family:Arial;font-size:10pt;">, respectively, and </font><font style="font-family:Arial;font-size:10pt;">$481.8 million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$397.9 million</font><font style="font-family:Arial;font-size:10pt;"> for the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">September&#160;26, 2015</font><font style="font-family:Arial;font-size:10pt;">, respectively. The increase in amortization expense for the 2016 nine-month period was due primarily to the incremental amortization expense incurred on the definite-lived intangible assets acquired from the Omega, Entocort</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">,</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> </sup></font><font style="font-family:Arial;font-size:10pt;">and Tretinoin Products acquisitions.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">During our impairment testing for the transition period of </font><font style="font-family:Arial;font-size:10pt;">June 28, 2015</font><font style="font-family:Arial;font-size:10pt;"> to </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Arial;font-size:10pt;">, we identified an impairment of certain indefinite-lived intangible assets purchased in conjunction with the Omega acquisition based on management&#8217;s expectations of the prospects for future revenues, profits, and cash flows associated with these assets. The assessment resulted in an impairment charge of </font><font style="font-family:Arial;font-size:10pt;">$185.1 million</font><font style="font-family:Arial;font-size:10pt;"> within our BCH segment, which represented the difference between the carrying amount of the intangible assets and their estimated fair value. See our Transition Report on Form 10-KT filed on February 25, 2016 for a further discussion of this impairment charge. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In connection with the preparation of our financial statements for the three-month period ended April 2, 2016, we identified indicators of impairment associated with certain indefinite-lived intangible assets acquired in conjunction with the Omega acquisition. The primary impairment indicators included the decline in our 2016 performance expectations and a reduction in our long-range revenue growth forecast. The assessment utilized the excess earnings method to determine fair value and resulted in an impairment charge of </font><font style="font-family:Arial;font-size:10pt;">$273.4&#160;million</font><font style="font-family:Arial;font-size:10pt;"> in </font><font style="font-family:Arial;font-size:10pt;">Impairment charges</font><font style="font-family:Arial;font-size:10pt;"> on the Condensed Consolidated Statements of Operations within our BCH segment, which represented the difference between the carrying amount of the intangible assets and their estimated fair value. The change in fair value from previous estimates was due primarily to the changes in the market and performance of the brands such that the evaluation of brand prioritization and product extensions or launches in new regions are being more focused to maximize the potential of all brands in the segment's portfolio. The main assumptions supporting the fair value of these assets and cash flow projections included revenue growth based on product line extensions, product life cycle strategies, and geographical expansion within the markets in which the BCH segment distributes products, gross margins consistent with historical trends, and advertising and promotion investments largely consistent with the segment's growth plans.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:Arial;font-size:10pt;">In connection with the preparation of our financial statements for the three months ended October 1, 2016, we identified additional indicators of impairment associated with certain indefinite-lived and definite-lived intangible brand category assets acquired in conjunction with the Omega acquisition. The primary impairment indicators are discussed above in goodwill. The assessment of the indefinite-lived assets utilized the excess earnings method to determine fair value and resulted in an impairment charge of </font><font style="font-family:Arial;font-size:10pt;">$575.7 million</font><font style="font-family:Arial;font-size:10pt;"> for the three months ended October&#160;1, 2016. With regards to the definite-lived asset, it was determined that the carrying value of the asset group was not recoverable based on an assessment of the undiscounted future cash flows expected to be generated by the asset group. Given this, the excess earnings method was utilized to determine fair value of the definite-lived asset and resulted in an impairment charge of </font><font style="font-family:Arial;font-size:10pt;">$290.2 million</font><font style="font-family:Arial;font-size:10pt;"> for the </font><font style="font-family:Arial;font-size:10pt;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;">. Both charges, which represented the difference between the carrying amount of the intangible assets and their estimated fair value, were recorded in Impairment charges on the Condensed Consolidated Statements of Operations within our BCH segment. The main assumptions supporting the fair value of these assets and cash flow projections are included in the goodwill discussions above. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The carrying value for certain intangible assets and goodwill equals estimated and implied fair values, respectively, and as a result, any further deterioration in those assets' fair value would lead to a further impairment charge. Future performance different from the assumptions utilized in our quantitative analyses may result in additional changes in the fair value. We will continue to monitor and assess these assets for potential impairment should further impairment indicators arise. We will complete our required annual impairment testing during the fourth quarter of 2016.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In addition, given the additional change in performance expectations for our remaining impaired cough/cold/allergy, anti-parasite, personal care and natural health brands previously recorded as indefinite-lived assets, we reclassified the remaining asset balance of </font><font style="font-family:Arial;font-size:10pt;">$672.4 million</font><font style="font-family:Arial;font-size:10pt;"> related to these four assets to definite-lived assets with a </font><font style="font-family:Arial;font-size:10pt;">20</font><font style="font-family:Arial;font-size:10pt;">-year useful life and began amortizing the assets as of October 2, 2016.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">INCOME TAXES</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The effective tax rate for the </font><font style="font-family:Arial;font-size:10pt;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;"> was </font><font style="font-family:Arial;font-size:10pt;">20.1%</font><font style="font-family:Arial;font-size:10pt;"> on a net loss compared to </font><font style="font-family:Arial;font-size:10pt;">14.8%</font><font style="font-family:Arial;font-size:10pt;"> on net income for the </font><font style="font-family:Arial;font-size:10pt;">three months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">September&#160;26, 2015</font><font style="font-family:Arial;font-size:10pt;">. The effective tax rate for the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;"> was </font><font style="font-family:Arial;font-size:10pt;">21.6%</font><font style="font-family:Arial;font-size:10pt;"> on a net loss reported in the period compared to </font><font style="font-family:Arial;font-size:10pt;">60.3%</font><font style="font-family:Arial;font-size:10pt;"> on net income for the </font><font style="font-family:Arial;font-size:10pt;">nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">September&#160;26, 2015</font><font style="font-family:Arial;font-size:10pt;">. For the three and nine months ended </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;">, we have estimated income taxes using the annual effective tax rate method.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Income taxes recorded through July 2, 2016 were estimated using the discrete method.&#160;For the </font><font style="font-family:Arial;font-size:10pt;">three and nine months ended</font><font style="font-family:Arial;font-size:10pt;"> ended </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;">, we had significant changes to&#160;our estimates related to additional asset impairments recognized in the third quarter and therefore determined that estimating income taxes using the annual effective tax rate method&#160;was the more appropriate method for the period ending </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;">. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our tax rate is subject to adjustment over the balance of the fiscal year due to, among other things: income tax rate changes by governments; the jurisdictions in which our profits are determined to be earned and taxed; changes in the valuation of our deferred tax assets and liabilities; adjustments to estimated taxes upon finalization of various tax returns; adjustments based on differing interpretations of the applicable transfer pricing standards; changes in available tax credits, grants and other incentives; changes in stock-based compensation expense; changes in tax laws or the interpretation of such tax laws (for example, proposals for fundamental U.S. international tax reform); changes in U.S. GAAP; expiration of or the inability to renew tax rulings or tax holiday incentives; and the repatriation of earnings with respect to which we have not previously provided for taxes.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Israel passed legislation in January 2016, effective immediately, reducing the tax rate from </font><font style="font-family:Arial;font-size:10pt;">26.5%</font><font style="font-family:Arial;font-size:10pt;"> to </font><font style="font-family:Arial;font-size:10pt;">25%</font><font style="font-family:Arial;font-size:10pt;">. The impact on our effective tax rate was minimal.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The United Kingdom passed legislation in September 2016, reducing the tax rate effective April 1, 2020, from </font><font style="font-family:Arial;font-size:10pt;">18%</font><font style="font-family:Arial;font-size:10pt;"> to </font><font style="font-family:Arial;font-size:10pt;">17%</font><font style="font-family:Arial;font-size:10pt;">. We expect the impact on our effective tax rate to be minimal.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The total liability for uncertain tax positions was </font><font style="font-family:Arial;font-size:10pt;">$368.4 million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$334.7 million</font><font style="font-family:Arial;font-size:10pt;"> as of </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Arial;font-size:10pt;">, respectively, before considering the federal tax benefit of certain state and local items.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We recognize interest and penalties related to uncertain tax positions as a component of income tax expense. The total amount accrued for interest and penalties in the liability for uncertain tax positions was </font><font style="font-family:Arial;font-size:10pt;">$56.4&#160;million</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">$52.1&#160;million</font><font style="font-family:Arial;font-size:10pt;"> as of </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;"> and </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Arial;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We file income tax returns in numerous jurisdictions and are therefore subject to audits by tax authorities. Our primary income tax jurisdictions are Ireland, the U.S., Israel, Belgium, France, and the U.K.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Although we believe that the tax estimates are reasonable and that we prepare our tax filings in accordance with all applicable tax laws, the final determination with respect to any tax audit and any related litigation could be materially different from estimates or from historical income tax provisions and accruals. The results of an audit or litigation could have a material effect on our operating results and/or cash flows in the periods for which that determination is made. In addition, future period earnings may be adversely impacted by litigation costs, settlements, penalties, and/or interest assessments.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The IRS audit of our fiscal years ended June 27, 2009 and June 26, 2010 had previously concluded with the issuance of a statutory notice of deficiency on August 27, 2014. While we had previously agreed on certain adjustments and made associated payments of </font><font style="font-family:Arial;font-size:10pt;">$8.0 million</font><font style="font-family:Arial;font-size:10pt;"> (inclusive of interest) in November 2014, the statutory notice of deficiency asserted various additional adjustments, including transfer pricing adjustments. The statutory notice of deficiency's adjustments for fiscal years 2009 and 2010 asserted an incremental tax obligation of approximately </font><font style="font-family:Arial;font-size:10pt;">$68.9&#160;million</font><font style="font-family:Arial;font-size:10pt;">, inclusive of interest and penalties. We disagree with the IRS&#8217;s positions asserted in the statutory notice of deficiency. To contest the IRS's adjustments, in January 2015 we paid the incremental tax obligation (a prerequisite to contesting the proposed adjustments in U.S. district court), and in June 2015, we filed an administrative request for a refund with the IRS. The payment was recorded during the three months ended March 28, 2015 as a deferred charge on the balance sheet given our anticipated action to recover this amount. The IRS subsequently denied our request for a refund. We anticipate filing a complaint in U.S. district court claiming a refund of the paid amounts prior to August 2017. An unfavorable resolution of this matter could have a material impact on our consolidated financial statements in future periods. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We have ongoing audits in multiple jurisdictions the resolution of which remains uncertain. These jurisdictions include, but are not limited to, the United States and Belgium. The IRS is auditing our fiscal years ended June 25, 2011 and June 30, 2012, and may make adjustments consistent with the adjustments made in the statutory notice of deficiency for fiscal years 2009 and 2010. In February 2016, the Belgium Tax Authority notified us that all Belgium locations will be audited for the years ended December 31, 2013 and December 31, 2014. At this time, we cannot predict the outcome of any audit or related litigation.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">INVENTORIES</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Major components of inventory were as follows (in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:9pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:63.312368972746334%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:42%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:26%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:26%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Finished goods</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">511.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">483.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">171.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">151.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Raw materials</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">202.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">209.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total inventories</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">884.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">844.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">a. &#160;&#160;&#160;&#160;General Information</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">The Company</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013 and became the successor registrant of Perrigo Company, a Michigan corporation, on December&#160;18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo," the "Company," "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries. We are a leading global over-the-counter ("OTC") consumer goods and specialty pharmaceutical company, offering patients and customers high quality products at affordable prices. From our beginning in 1887 as a packager of home remedies, we have grown to become the world's largest manufacturer of OTC healthcare products&#160;and supplier of infant formulas for the store brand market. We are also a leading provider of generic extended topical prescription products, and we receive royalties from sales of the multiple sclerosis drug Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">. We provide &#8220;Quality Affordable Healthcare Products</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">&#8221; across a wide variety of product categories and geographies, primarily in North America, Europe, and Australia, as well as in other markets, including Israel, China, and Latin America. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Basis of Presentation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the consolidated financial statements and footnotes included in our Transition Report on Form 10-KT for the transition period from </font><font style="font-family:Arial;font-size:10pt;">June 28, 2015</font><font style="font-family:Arial;font-size:10pt;"> to </font><font style="font-family:Arial;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Arial;font-size:10pt;">. In the opinion of management, all adjustments (consisting of normal recurring accruals and other adjustments) considered necessary for a fair presentation have been included. The Condensed Consolidated Financial Statements include our accounts and the accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our fiscal year previously consisted of a 52- or 53-week year ending on or around June 30 of each year with each quarter ending on the Saturday closest to each calendar quarter-end. Beginning on January 1, 2016, we changed our fiscal year to begin on January 1 and end on December 31 of each year. We will continue to cut off our quarterly accounting periods on the Saturday closest to the end of the calendar quarter, with the fourth quarter ending on December 31 of each year. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:Arial;font-size:10pt;">During the three months ended April 2, 2016, we identified certain errors in our consolidated financial statements for the transition period of June 28, 2015 to December 31, 2015, related primarily to the accrual estimates associated with product returns and tax-related items in our Branded Consumer Healthcare ("BCH") segment. These errors were corrected during the three months ended April 2, 2016 by increasing the consolidated operating loss by </font><font style="font-family:Arial;font-size:10pt;">$14.5&#160;million</font><font style="font-family:Arial;font-size:10pt;">, which when combined with tax-related items, increased the consolidated net loss by </font><font style="font-family:Arial;font-size:10pt;">$13.7&#160;million</font><font style="font-family:Arial;font-size:10pt;"> within the Condensed Consolidated Statements of Operations.&#160;We concluded that these errors were not material to the consolidated financial statements for the transition period of June 28, 2015 to December 31, 2015 and are not expected to be material to the consolidated financial statements for the year ending December 31, 2016.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">b. &#160;&#160;&#160;&#160;Recent Accounting Standard Pronouncements</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;"></font><font style="font-family:Arial;font-size:10pt;">Below are recent accounting standard updates that we are still assessing to determine the effect on our consolidated financial statements. We do not believe that any other recently issued accounting standards could have a material effect on our consolidated financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:37%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:26%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Recently Issued Accounting Standards Not Yet Adopted</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Standard</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Description</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Effective Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Effect on the Financial Statements or Other Significant Matters</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Improvements to Employee Share-Based Payment Accounting</font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">This guidance is intended to simplify several aspects of the accounting for share-based payment award transactions. It will require all income tax effects of awards to be recorded through the income statement when they vest or settle as opposed to certain amounts being recorded in additional paid-in capital. An entity will also have to elect whether to account for forfeitures as they occur or by estimating the number of awards expected to be forfeited and adjusting the estimate when it is likely to change (as currently required). The guidance will also increase the amount an employer can withhold to cover income taxes on awards. Early adoption is permitted.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">January 1, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">We are currently evaluating the implications of adoption on our consolidated financial statements.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Revenue from Contracts with Customers </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps: identify the contract(s) with a customer; identify the performance obligations in the contract; determine the transaction price; allocate the transaction price to the performance obligations in the contract; and recognize revenue when (or as) the entity satisfies a performance obligation. This guidance allows for two adoption methods, full retrospective approach or modified retrospective approach. Early adoption is not permitted.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">January 1, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">We are currently evaluating the possible adoption methodologies and the implications of adoption on our consolidated financial statements.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Leases</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:13px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">This guidance was issued to increase transparency and comparability among organizations by requiring recognition of lease assets and lease liabilities on the balance sheet and disclosure of key information about leasing arrangements. For leases with a term of 12 months or less, lessees are permitted to make an election to not recognize right-of-use assets and lease liabilities. Upon adoption, lessees will apply the new standard as of the beginning of the earliest comparative period presented in the financial statements, however lessees will be able to exclude leases that expire as of the implementation date. Early adoption is permitted.</font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">January 1, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">We are currently evaluating the implications of adoption on our consolidated financial statements and considering whether to early adopt the standard.</font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:37%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:26%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Recently Issued Accounting Standards Not Yet Adopted (continued)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Standard</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Description</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Effective Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Effect on the Financial Statements or Other Significant Matters</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Measurement of Credit Losses on Financial Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:13px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">This guidance changes the impairment model for most financial assets and certain other instruments, replacing the current "incurred loss" approach with an "expected loss" credit impairment model, which will apply to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities, and off-balance sheet credit exposures such as letters of credit. Early adoption is permitted.</font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">January 1, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">We are currently evaluating the new standard for potential impacts on our receivables, debt, and other financial instruments and considering whether to early adopt the standard.</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The gains (losses) reclassified from AOCI into earnings for the effective portion of our designated cash flow hedges were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:704px;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td style="width:194px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:126px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:77px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:79px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:75px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:79px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Reclassified from AOCI to Income <br clear="none"/>(Effective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Designated Cash Flow Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Treasury locks</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(18.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(4.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(21.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">RESTRUCTURING CHARGES</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We periodically take action to reduce redundant expenses and improve operating efficiencies, typically in connection with business acquisitions. The following reflects our restructuring activity (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:597px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:184px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:86px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:86px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:8px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:86px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:8px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:86px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Beginning balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">20.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Additional charges</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(8.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(33.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(4.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-cash adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Ending balance</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">10.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">10.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Restructuring activity includes severance, lease exit costs, and asset impairments. The charges incurred during the </font><font style="font-family:Arial;font-size:10pt;">three and nine months ended</font><font style="font-family:Arial;font-size:10pt;"> </font><font style="font-family:Arial;font-size:10pt;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;"> were associated primarily with actions we took to streamline our organization as announced on October 22, 2015 and did not materially impact any one reportable segment. There were no other material restructuring programs in any of the periods presented. All charges are recorded in Restructuring expense. The remaining </font><font style="font-family:Arial;font-size:10pt;">$5.1&#160;million</font><font style="font-family:Arial;font-size:10pt;"> liability for employee severance benefits will be paid within the next year, while cash expenditures related to the remaining </font><font style="font-family:Arial;font-size:10pt;">$5.2&#160;million</font><font style="font-family:Arial;font-size:10pt;"> liability for lease exit costs will be incurred over the remaining terms of the applicable leases.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Changes in our AOCI balances, net of tax were as follows (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:31%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Foreign currency translation adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair value of derivative financial instruments, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair&#160;value&#160;of investment securities, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Post-retirement and pension liability adjustments, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total AOCI</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Balance at December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(4.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(14.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(3.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(15.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">OCI before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">71.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(3.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">85.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Amounts reclassified from AOCI </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">71.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(3.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">18.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">87.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Balance at October 1, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">67.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(17.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">24.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(2.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">71.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total borrowings outstanding are summarized as follows (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:86.58280922431865%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br clear="none"/>2015</font></div></td></tr><tr><td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Revolving credit agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2015 Revolver</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">380.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2014 Revolver</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">300.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total revolving credit agreements</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">680.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Term loans</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td colspan="4" style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2014 Term loan due December 5, 2019</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">463.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">488.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="3" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Notes and Bonds</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;text-decoration:underline;">Coupon</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;text-decoration:underline;">Due</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.300%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">November&#160;8, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">500.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.500%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">May&#160;23, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">202.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">195.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.125%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">December&#160;12, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">337.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">325.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.300%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">November&#160;8, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">600.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">600.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.000%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">May&#160;23, 2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">134.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">130.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.500%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">March&#160;15, 2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">500.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.500%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">December&#160;15, 2021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">500.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">500.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.105%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">July&#160;19, 2023</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">151.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">146.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.000%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">November&#160;15, 2023</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">800.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">800.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.900%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">December&#160;15, 2024</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">700.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">700.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.375%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">March&#160;15, 2026</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">700.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.300%</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">November&#160;15, 2043</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">400.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">400.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.900%</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">December&#160;15, 2044</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup>&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">400.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">400.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total notes and bonds</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,426.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,698.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="5" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Other financing</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">86.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Unamortized premium (discount), net</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">43.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">73.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Deferred financing fees</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(34.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(36.6</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total borrowings outstanding</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,903.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,989.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="4" style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Current indebtedness</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(265.0</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1,018.3</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total long-term debt less current portion</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,638.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,971.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Discussed below collectively as the "2014 Notes." </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Discussed below collectively as the "2013 Notes."</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Debt assumed from Omega.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(4)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Discussed below collectively as the "2016 Notes."</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">*</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The gains (losses) recorded in OCI for the effective portion of our designated cash flow hedges were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:624px;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:240px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:79px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:79px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:79px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:79px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recorded in OCI<br clear="none"/>(Effective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Designated Cash Flow Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(9.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(12.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(4.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(13.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The balance sheet location and gross fair value of our outstanding derivative instruments were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:87.0020964360587%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:26%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Asset Derivatives</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance&#160;Sheet&#160;Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Designated derivatives:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other&#160;current&#160;assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total designated derivatives</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-designated derivatives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total non-designated derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:88.25995807127882%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:39%;" rowspan="1" colspan="1"></td><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Liability Derivatives</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Balance&#160;Sheet&#160;Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Designated derivatives:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other non-current liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total designated derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-designated derivatives:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Accrued liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total non-designated derivatives</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The amounts consisted of the following (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:83.22851153039832%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;font-weight:bold;">CHC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;font-weight:bold;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;font-weight:bold;">CHC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;font-weight:bold;">Other</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;font-weight:bold;">Assets held for sale</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">Current assets</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">7.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">55.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">13.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">Goodwill</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">13.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">14.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">Property, plant and equipment</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">13.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">34.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">18.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">37.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">Other assets</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">3.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">3.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">Less: impairment reserves</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">(3.4</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">(39.8</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">(29.0</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;font-weight:bold;">Total assets held for sale </font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">9.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">7.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">86.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">39.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;font-weight:bold;">Liabilities held for sale</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">Current liabilities</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">30.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">Other liabilities</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">2.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">1.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;font-weight:bold;">Total liabilities held for sale</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">3.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">30.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;color:#252525;">2.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">A reconciliation of the numerators and denominators used in the basic and diluted earnings per share ("EPS") calculation is as follows (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Net income (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1,255.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">112.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1,395.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">74.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Weighted average shares outstanding for basic EPS</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">143.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">146.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">143.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">144.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Dilutive effect of share-based awards*</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Weighted average shares outstanding for diluted EPS</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">143.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">146.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">143.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">145.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Anti-dilutive share-based awards excluded from computation of diluted EPS*</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">* In the period of a net loss, diluted shares equal basic shares.</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="29" rowspan="1"></td></tr><tr><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;text-decoration:underline;">Reporting Segments:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Business acquisitions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Business divestitures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Impairments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Changes in assets held for sale</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Currency translation adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHC</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,890.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(8.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">13.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(6.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,887.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">BCH</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,980.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(967.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">92.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,105.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Rx</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,222.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(13.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,210.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Specialty Sciences</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">200.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">200.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">71.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">11.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">86.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,364.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(8.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(967.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">24.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">75.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,490.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Major components of inventory were as follows (in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:9pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:63.312368972746334%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:42%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:26%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:26%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Finished goods</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">511.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">483.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">171.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">151.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Raw materials</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">202.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">209.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total inventories</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">884.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">844.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The effects of our non-designated derivatives on the Condensed Consolidated Statements of Operations were as follows: </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="padding-bottom:1px;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in Income</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Non-Designated Derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Income Statement Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(8.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(8.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(259.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(3.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(8.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(10.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(262.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following reflects our restructuring activity (in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:597px;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:184px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:86px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:86px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:8px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:86px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:8px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:86px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Beginning balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">12.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">20.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Additional charges</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(8.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(33.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(4.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Non-cash adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Ending balance</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">10.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">10.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The below tables show select financial measures by reporting segment (in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:49.10807974816369%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;padding-left:18px;text-indent:-18px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHC</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,873.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,007.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">BCH</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,460.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6,324.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Rx</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,304.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,015.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Specialty Sciences</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,634.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,833.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">195.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">213.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17,467.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">19,393.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October 1, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Net Sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Net Sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">669.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">100.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">19.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">675.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">117.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">19.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">BCH</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">304.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1,684.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">38.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">302.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">36.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Rx</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">267.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">77.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">30.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">260.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">91.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">18.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Specialty Sciences</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">93.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">23.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">84.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">21.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">22.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Unallocated</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(30.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(39.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,354.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1,515.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">162.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,344.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">188.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">147.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October 1, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Net Sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Net Sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,055.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">313.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">58.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,106.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">364.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">52.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">BCH*</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,015.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(2,128.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">113.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">703.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">31.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">70.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Rx</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">817.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">262.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">90.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">790.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">290.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">55.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Specialty Sciences</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">271.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">49.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">218.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">250.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">21.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">218.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">59.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">75.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">18.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Unallocated</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(80.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(111.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total*</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,219.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1,580.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">481.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,925.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">614.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">397.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">* </font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">The BCH segment was created on March 30, 2015 as a result of the Omega acquisition, thus data for the </font><font style="font-family:Arial;font-size:8pt;">nine months ended</font><font style="font-family:Arial;font-size:8pt;"> </font><font style="font-family:Arial;font-size:8pt;">September 26, 2015</font><font style="font-family:Arial;font-size:8pt;"> includes only six months of results from operations attributable to Omega.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We issued shares related to the exercise and vesting of share-based compensation as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:59.538784067085956%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September&#160;26, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">185,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">154,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">283,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">246,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">SEGMENT INFORMATION</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our reporting segments are as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-weight:bold;">CHC</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font><font style="font-family:Arial;font-size:10pt;">is focused primarily on the global sale of OTC store brand products including cough, cold, allergy and sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, and diagnostic products.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-weight:bold;">BCH</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font><font style="font-family:Arial;font-size:10pt;">develops, manufactures, markets and distributes many well-known European OTC brands in the natural health and vitamins, cough, cold and allergy, smoking cessation, personal care and derma-therapeutics, lifestyle, and anti-parasite categories.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-weight:bold;">Rx</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"> </font><font style="font-family:Arial;font-size:10pt;">develops, manufactures and markets a portfolio of generic and specialty pharmaceutical prescription drugs primarily for the U.S. and U.K. markets.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-weight:bold;">Specialty Sciences</font><font style="font-family:Arial;font-size:10pt;"> is comprised primarily of royalties received from assets focused on the management of multiple sclerosis (Tysabri</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">&#174;</sup></font><font style="font-family:Arial;font-size:10pt;">).</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We also have an </font><font style="font-family:Arial;font-size:10pt;">Other</font><font style="font-family:Arial;font-size:10pt;"> reporting segment that consists of our API business, which does not meet the quantitative threshold required to be a separately reportable segment. Our segments reflect the way in which our chief operating decision maker reviews our operating results and allocates resources.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The below tables show select financial measures by reporting segment (in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:49.10807974816369%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:27%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;padding-left:18px;text-indent:-18px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Total Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHC</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,873.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,007.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">BCH</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,460.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6,324.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Rx</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,304.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,015.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Specialty Sciences</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,634.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">5,833.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">195.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">213.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">17,467.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">19,393.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October 1, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Net Sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Net Sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">669.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">100.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">19.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">675.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">117.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">19.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">BCH</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">304.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1,684.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">38.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">302.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">36.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Rx</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">267.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">77.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">30.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">260.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">91.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">18.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Specialty Sciences</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">93.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">23.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">84.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">72.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">21.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">22.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">0.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Unallocated</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(30.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(39.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,354.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1,515.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">162.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,344.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">188.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">147.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="23" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Nine Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October 1, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">September 26, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Net Sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Net Sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Operating Income (Loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Intangible Asset Amortization</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">CHC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,055.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">313.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">58.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,106.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">364.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">52.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">BCH*</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,015.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(2,128.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">113.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">703.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">31.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">70.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Rx</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">817.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">262.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">90.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">790.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">290.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">55.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Specialty Sciences</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">271.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">49.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">218.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">250.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">21.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">218.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">59.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">75.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">18.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Unallocated</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(80.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(111.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total*</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,219.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1,580.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">481.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">3,925.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">614.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">397.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">* </font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">The BCH segment was created on March 30, 2015 as a result of the Omega acquisition, thus data for the </font><font style="font-family:Arial;font-size:8pt;">nine months ended</font><font style="font-family:Arial;font-size:8pt;"> </font><font style="font-family:Arial;font-size:8pt;">September 26, 2015</font><font style="font-family:Arial;font-size:8pt;"> includes only six months of results from operations attributable to Omega.</font></div></td></tr></table></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;"></font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">ACCOUNTS RECEIVABLE FACTORING</font><font style="font-family:Arial;font-size:10pt;font-style:italic;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;color:#252525;">We have multiple accounts receivable factoring arrangements with non-related third-party financial institutions (the &#8220;Factors&#8221;). Pursuant to the terms of the arrangements, we sell to the Factors certain of our accounts receivable balances on a non-recourse basis for credit approved accounts. An administrative fee ranging from </font><font style="font-family:Arial;font-size:10pt;color:#252525;">0.14%</font><font style="font-family:Arial;font-size:10pt;color:#252525;"> to </font><font style="font-family:Arial;font-size:10pt;color:#252525;">0.15%</font><font style="font-family:Arial;font-size:10pt;color:#252525;"> per invoice is charged on the gross amount of accounts receivables assigned to the Factors, plus interest is calculated at the applicable EUR LIBOR rate plus 70 basis points. The total amount factored and excluded from accounts receivable was </font><font style="font-family:Arial;font-size:10pt;color:#252525;">$36.4 million</font><font style="font-family:Arial;font-size:10pt;color:#252525;"> and </font><font style="font-family:Arial;font-size:10pt;color:#252525;">$106.7 million</font><font style="font-family:Arial;font-size:10pt;color:#252525;"> at </font><font style="font-family:Arial;font-size:10pt;color:#252525;">October&#160;1, 2016</font><font style="font-family:Arial;font-size:10pt;color:#252525;"> and </font><font style="font-family:Arial;font-size:10pt;color:#252525;">December&#160;31, 2015</font><font style="font-family:Arial;font-size:10pt;color:#252525;">, respectively.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Unrealized investment gains (losses) on available for sale securities were as follows (in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:455px;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:276px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:75px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td><td style="width:5px;" rowspan="1" colspan="1"></td><td style="width:6px;" rowspan="1" colspan="1"></td><td style="width:75px;" rowspan="1" colspan="1"></td><td style="width:4px;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">October&#160;1, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">December&#160;31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Equity securities, at cost less impairments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">20.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">6.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Gross unrealized gains</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">32.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">9.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Gross unrealized losses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Estimated fair value of equity securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">53.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">14.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> (3)Debt assumed from Omega. (2)Indefinite-lived intangible assets with a carrying amount of $1.2 billion were written down to a fair value of $672.4 million resulting in total impairment charges of $575.7 million for the three months ended October 1, 2016; impairment charges totaled $849.1 million for the nine months ended October 1, 2016 and are included in Impairment charges on the Condensed Consolidated Statements of Operations. (4)Discussed below collectively as the "2016 Notes." (1)Goodwill with a carrying amount of $1.9 billion was written down to its implied fair value of $1.1 billion, resulting in an impairment charge of $804.1 million for the three months ended October 1, 2016; impairment charges totaled $967.5 million for the nine months ended October 1, 2016 and are included in Impairment charges on the Condensed Consolidated Statements of Operations. Consists of four product acquisitions in the CHC and Rx segment In the period of a net loss, diluted shares equal basic shares. (2)Discussed below collectively as the "2013 Notes." * Opening balance sheet is preliminary The BCH segment was created on March 30, 2015 as a result of the Omega acquisition, thus data for the nine months ended September 26, 2015 includes only six months of results from operations attributable to Omega. Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate. Consists of eight product acquisitions in the CHC, BCH, and Rx segments (1)Discussed below collectively as the "2014 Notes." EX-101.SCH 6 prgo-20161001.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2404402 - Disclosure - Accounts Receivable Factoring (Details) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Accounts Receivable Factoring (Notes) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Accounts Receivable Factoring (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Schedule - Accumulated Other Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 2412402 - Schedule - Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 2312301 - Schedule - Accumulated Other Comprehensive Income (Loss) (Tables) link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - Assets Held for Sale (Details) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Assets Held for Sale (Notes) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - Assets Held for Sale (Tables) link:presentationLink link:calculationLink link:definitionLink 2402402 - Disclosure - Business Acquisitions (Details) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Business Acquisitions (Notes) link:presentationLink link:calculationLink link:definitionLink 2302301 - Disclosure - Business Acquisitions (Tables) link:presentationLink link:calculationLink link:definitionLink 2418402 - Disclosure - Collaboration agreements and other contractual arrangements (Details) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Collaboration agreements and other contractual arrangements (Notes) link:presentationLink link:calculationLink link:definitionLink 2318301 - Disclosure - Collaboration agreements and other contractual arrangements (Tables) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1004501 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Consolidated Statements of Income link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - Derivative Instruments and Hedging Activities - balance sheet location (Details) link:presentationLink link:calculationLink link:definitionLink 2408405 - Disclosure - Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities -Fair value hedges (Details) link:presentationLink link:calculationLink link:definitionLink 2408406 - Disclosure - Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities- Non-designated derivatives (Details) link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities - other comprehensive income movement (Details) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities - text links (Details) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Derivative Instruments and Hedging Activities (Note) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Derivative Instruments and Hedging Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - (Details) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information Document link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2406404 - Disclosure - Fair Value Measurements Fair value measurements - items not carried at fair value (Details) link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - Fair value measurements - level 3 roll (Details) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Fair value measurements (Note) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Fair value measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Fair value on recurring and non-recurring basis (Details) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - Goodwill and Other Intangible Assets link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Goodwill and Other Intangible Assets - Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 2403403 - Disclosure - Goodwill and Other Intangible Assets - Intangible categories (Details) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Goodwill and Other Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2413401 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Indebtedness (note) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Indebtedness (Tables) link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Inventories (Notes) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Investments (Details) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Investments (Notes) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 2420402 - Disclosure - Restructuring Charges (Details) link:presentationLink link:calculationLink link:definitionLink 2120100 - Disclosure - Restructuring Charges (Notes) link:presentationLink link:calculationLink link:definitionLink 2320301 - Disclosure - Restructuring Charges (Tables) link:presentationLink link:calculationLink link:definitionLink 2121100 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 2421402 - Disclosure - Segment Information (Details) link:presentationLink link:calculationLink link:definitionLink 2321301 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2422401 - Disclosure - Subsequent event (Details) link:presentationLink link:calculationLink link:definitionLink 2322300 - Disclosure - Subsequent event (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2401402 - Disclosure - Summary of Significant Accounting Policies and Basis of Presentation Policy (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Summary of Significant Accounting Policies and Change in Accounting Principles (Policies) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 prgo-20161001_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 prgo-20161001_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 prgo-20161001_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Aggregate Indebtedness [Abstract] Indebtedness [Text Block] Debt Disclosure [Text Block] Statement of Financial Position [Abstract] Statement [Table] Statement [Table] Statement, Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Statement [Line Items] Statement [Line Items] Assets Assets [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Accounts receivable, net of allowance for doubtful accounts of $4.4 million and $3.0 million, respectively Accounts Receivable, Net, Current Inventories Inventory, Net Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Total current assets Assets, Current Property and equipment, net Property, Plant and Equipment, Net Goodwill and other indefinite-lived intangible assets Goodwill And Indefinite Lived Intangibles Aggregate carrying amount, as of the balance sheet date, of goodwill and other indefinite-lived intangible assets. Goodwill represents the carrying amount as of the balance sheet date, which is the cumulative amount paid, adjusted for any amortization recognized prior to adoption of ASC Topic 350 and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions. Indefinite-lived intangible assets represent the carrying amount of intangible assets which have a projected indefinite period of benefit (hence are not amortized), allocated to the reportable segment. These assets, acquired either individually or as part of a group of assets, in either an asset acquisition or business combination, are assessed at least annually for impairment. Examples may include trade secrets, contractual rights, trade names, and licensing agreements. Other intangible assets, net Finite-Lived Intangible Assets, Net Non-current deferred income taxes Deferred Tax Assets, Net, Noncurrent Other non-current assets Other Assets, Noncurrent Total non-current assets Assets, Noncurrent Total assets Assets Liabilities and Shareholders’ Equity Liabilities and Equity [Abstract] Liabilities Liabilities [Abstract] Accounts payable Accounts Payable, Current Payroll and related taxes Employee-related Liabilities, Current Accrued customer programs Accrued Customer Programs Carrying value as of the balance sheet date of customer programs, which include customer chargebacks and rebates payable. Accrued liabilities Accrued Liabilities, Current Accrued income taxes Accrued Income Taxes, Current Current indebtedness Long-term Debt, Current Maturities Total current liabilities Liabilities, Current Long-term debt, less current portion Long-term Debt, Excluding Current Maturities Non-current deferred income taxes Deferred Tax Liabilities, Net, Noncurrent Other non-current liabilities Other Liabilities, Noncurrent Total non-current liabilities Liabilities, Noncurrent Total liabilities Liabilities Commitments and contingencies - Note 14 Commitments and Contingencies Disclosure [Abstract] Shareholders’ equity Stockholders' Equity Attributable to Parent [Abstract] Preferred shares, $0.0001 par value, 10 million shares authorized Preferred Stock, Value, Issued Ordinary shares, €0.001 par value, 10 billion shares authorized Common Stock, Value, Issued Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Retained earnings Retained Earnings (Accumulated Deficit) Total controlling interest Stockholders' Equity Attributable to Parent Noncontrolling interest Stockholders' Equity Attributable to Noncontrolling Interest Total shareholders’ equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total liabilities and shareholders' equity Liabilities and Equity Supplemental Disclosures of Balance Sheet Information Balance Sheet Related Disclosures [Abstract] Preferred shares, issued and outstanding Preferred Stock, Shares Issued Ordinary shares, issued and outstanding Common Stock, Shares, Issued Subsequent Events [Abstract] Business Combinations [Abstract] Schedule of acquisition-related costs [Table Text Block] Schedule of acquisition-related costs [Table Text Block] Schedule of acquisition-related costs by income statement line item [Table Text Block] Business acquisition, pro forma information Business Acquisition, Pro Forma Information [Table Text Block] Business combination, separately recognized transactions Business Combination, Separately Recognized Transactions [Table Text Block] Fair value of consideration transferred in business acquisition [Table Text Block] Fair value of consideration transferred in business acquisition [Table Text Block] Fair value of consideration transferred in business acquisition; cash and stock. [Table Text Block] Inventory Disclosure [Abstract] Finished goods Inventory, Finished Goods, Gross Work in process Inventory, Work in Process, Gross Raw materials Inventory, Raw Materials, Gross Total inventories Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative [Table] Derivative [Table] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Other nonoperating income (expense) [Member] Other Nonoperating Income (Expense) [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Interest rate swap agreements Interest Rate Swap [Member] Derivative [Line Items] Derivative [Line Items] Derivative, Gain (Loss) on Derivative, Net Derivative, Gain (Loss) on Derivative, Net Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Reclassification out of Accumulated Other Comprehensive Income (Loss) [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Foreign currency translation adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Fair value of derivative financial instruments, net of tax Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Fair value of investment securities, net of tax Accumulated Net Investment Gain (Loss) Attributable to Parent [Member] Post-retirement and pension liability adjustments, net of tax Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] Balance at December 31, 2015 OCI before reclassifications Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Amounts reclassified from AOCI Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax Balance at October 1, 2016 Collaboration agreements and other contractual arrangements [Abstract] Collaboration agreements and other contractual arrangements [Abstract] Comprehensive income (loss) note [Text Block] Comprehensive Income (Loss) Note [Text Block] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Segments [Axis] Segments [Axis] Segment [Domain] Segments [Domain] CHC Consumer Healthcare [Member] Consumer Healthcare [Member] Research and development contractual arrangement [Axis] Research and development contractual arrangement [Axis] Research and development contractual arrangement [Axis] Research and development contractual arrangement [Domain] Research and development contractual arrangement [Domain] [Domain] for Research and development contractual arrangement [Axis] contractual arrangement [Member] contractual arrangement [Member] contractual arrangement used for R&D projects Administration General and Administrative Expense [Member] Interest expense, net Interest Expense [Member] Other expense, net Other Expense [Member] Common stock [Member] Common Stock [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] 2014 bonds 2014 bonds [Member] 2014 bonds [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Inventories [Member] Inventories [Member] Property, plant and equipment [Member] Property, Plant and Equipment [Member] Long-term debt [Member] Long-term Debt [Member] Currency [Axis] Currency [Axis] All Currencies [Domain] All Currencies [Domain] Euro member countries, euro Euro Member Countries, Euro Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum [Member] Minimum [Member] Maximum [Member] Maximum [Member] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Trademarks and trade names [Member] Trademarks and Trade Names [Member] In-process research and development In Process Research and Development [Member] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Developed technology rights [Member] Developed Technology Rights [Member] Non-compete agreements Noncompete Agreements [Member] Non-solicit agreement [Member] Non-solicit agreement [Member] Non-solicit agreement [Member] Licensing Agreements [Member] Licensing Agreements [Member] Brands [Member] Brands [Member] Brands [Member] Customer Relationships [Member] Customer Relationships [Member] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Benzaclin [Member] Benzaclin [Member] Benzaclin [Member] Tretinoin [Member] Tretinoin [Member] Tretinoin [Member] Development stage rx products [Member] Development stage rx products [Member] Development stage rx products [Member] ScarAway [Member] ScarAway [Member] ScarAway [Member] Entocort [Member] Entocort [Member] Entocort [Member] Naturwohl [Member] Naturwohl [Member] Naturwohl [Member] Naturwohl Pharma [Member] Naturwohl Pharma [Member] Naturwohl Pharma [Member] GSK [Member] GSK [Member] GSK [Member] Gelcaps [Member] Gelcaps [Member] Gelcaps [Member] Omega [Member] Omega [Member] Omega [Member] Series of Individually Immaterial Business Acquisitions [Member] Series of Individually Immaterial Business Acquisitions [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Payments to Acquire Businesses, Net of Cash Acquired Payments to Acquire Businesses, Net of Cash Acquired Proceeds from sale of business Proceeds from Divestiture of Businesses Business acquisitions, number of products purchased Business acquisitions, number of products purchased Business acquisitions, number of products purchased Business Acquisition, Pro Forma Revenue Business Acquisition, Pro Forma Revenue Sales Revenue, Goods, Net Sales Revenue, Goods, Net Business Combination, Acquisition Related Costs Business Combination, Acquisition Related Costs Shares, Issued Shares, Issued Business Combination, Consideration Transferred Business Combination, Consideration Transferred Purchase price paid Payments to Acquire Businesses, Gross Contingent consideration Business Combination, Contingent Consideration, Liability Finite-Lived Intangible Asset, Useful Life Finite-Lived Intangible Asset, Useful Life Research and Development Expense Research and Development Expense Inventories Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Prepaid expenses and other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Property and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Goodwill Goodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles In-process research and development Indefinite-Lived Intangible Assets (Excluding Goodwill) Finite-Lived Intangible Assets, Gross Finite-Lived Intangible Assets, Gross Other non-current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Business Acquisition, Effective Date of Acquisition Business Acquisition, Effective Date of Acquisition Business Acquisition, Percentage of Voting Interests Acquired Business Acquisition, Percentage of Voting Interests Acquired Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment Shares, Outstanding Shares, Outstanding Treasury Stock, Shares, Acquired Treasury Stock, Shares, Acquired Senior Notes Senior Notes Stock Issued During Period, Shares, New Issues Stock Issued During Period, Shares, New Issues Proceeds from Issuance or Sale of Equity Proceeds from Issuance or Sale of Equity Indemnification available from acquired company's sellers Indemnification available from acquired company's sellers Indemnification available from acquired company's sellers Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Business Acquisition, Share Price Business Acquisition, Share Price Business Acquisition, Equity Interest Issued or Issuable, Value Assigned Business Acquisition, Equity Interest Issued or Issuable, Value Assigned Business Acquisition, Cash Exchange Business Acquisition, Cash Exchange Business Acquisition, Cash Exchange Business combination fair value adjustment Business combination fair value adjustment Business combination fair value adjustment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, short term debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, short term debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, short term debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, accrued payroll Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, accrued payroll Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, accrued payroll Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, accrued customer programs Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, accrued customer programs Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, accrued customer programs Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Operating Income Operating Income (Loss) Business Acquisition, Pro Forma Net Income (Loss) Business Acquisition, Pro Forma Net Income (Loss) Impairment of Long-Lived Assets to be Disposed of Impairment of Long-Lived Assets to be Disposed of Document and Entity Information [Abstract] Document and Entity Information [Abstract] Entity registrant name Entity Registrant Name Entity central index key Entity Central Index Key Current calendar year end date Current Fiscal Year End Date Entity filer category Entity Filer Category Document type Document Type Document period end date Document Period End Date Document calendar year focus Document Fiscal Year Focus Document calendar period focus Document Fiscal Period Focus Amendment flag Amendment Flag Entity common stock, shares outstanding Entity Common Stock, Shares Outstanding Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Voluntary Filers Entity Current Reporting Status Entity Current Reporting Status Accounting Policies [Abstract] Basis of presentation Basis of Accounting, Policy [Policy Text Block] Principles of consolidation Consolidation, Policy [Policy Text Block] Accounting error corrections [Text Block] Accounting Changes and Error Corrections [Text Block] Recently issued accounting standards not yet adopted Description of New Accounting Pronouncements Not yet Adopted [Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Schedule of goodwill [Table Text Block] Schedule of Goodwill [Table Text Block] Schedule of finite and indefinite-lived intangible assets [Table Text Block] Schedule Of Finite And Indefinite Lived Intangible Assets [Table Text Block] Schedule of Finite and Indefinite-Lived Intangible Assets [Table Text Block] Business combination disclosure Business Combination Disclosure [Text Block] Segment Reporting [Abstract] Segment reporting disclosure [Text Block] Segment Reporting Disclosure [Text Block] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] BCH Branded CHC [Member] Branded CHC [Member] Rx Rx Pharmaceuticals [Member] Rx Pharmaceuticals [Member] Specialty Sciences Specialty Sciences [Member] Specialty Sciences [Member] Other Other Segments [Member] Unallocated Segment Reconciling Items [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Net sales Revenue, Net Operating Income (Loss) Intangible Asset Amortization Amortization of Intangible Assets Total Assets Accounts Receivable Factoring [Abstract] Accounts Receivable Factoring [Abstract] Financial asset servicing fees paid Financial asset servicing fees paid Financial asset servicing fees paid Accounts receivable factored and excluded from balance sheet Accounts receivable factored and excluded from balance sheet Accounts receivable factored and excluded from balance sheet - non-recourse Restructuring Charges [Abstract] Restructuring charges Restructuring and Related Activities Disclosure [Text Block] Correction of error [Abstract] Correction of error [Abstract] Adjustments for Error Corrections [Axis] Adjustments for Error Corrections [Axis] Adjustments for Error Correction [Domain] Adjustments for Error Correction [Domain] Amount of error gross of tax [Member] Amount of error gross of tax [Member] Amount of error gross of tax [Member] Amount of error net of tax [Member] Amount of error net of tax [Member] Amount of error net of tax Immaterial Error Correction Immaterial Error Correction Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Foreign currency forward contracts Foreign Exchange Forward [Member] Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Non-designated derivatives: Not Designated as Hedging Instrument [Member] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Income Tax Disclosure [Abstract] Income Tax Authority [Axis] Income Tax Authority [Axis] Income Tax Authority [Domain] Income Tax Authority [Domain] Foreign Tax Authority [Member] Foreign Tax Authority [Member] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] All Other Entities [Member] All Other Entities [Member] All Other Entities [Member] Foreign statutory corporate tax rate, year one Foreign Statutory Corporate Tax Rate, Year One Foreign Statutory Corporate Tax Rate, Year One Foreign statutory corporate tax rate, current year Foreign Statutory Corporate Tax Rate, Current Year Foreign Statutory Corporate Tax Rate, Current Year Foreign Statutory Corporate Tax Rate Foreign Statutory Corporate Tax Rate Foreign Statutory Corporate Tax Rate Effective tax rate on income from continuing operations Effective Income Tax Rate Reconciliation, Percent Unrecognized tax benefits, including income tax penalties and interest accrued Unrecognized Tax Benefits, Including Income Tax Penalties And Interest Accrued Unrecognized Tax Benefits, including Income Tax Penalties and Interest Accrued Unrecognized tax benefits liability, interest and penalties accrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Income tax examination, penalties and interest expense Income Tax Examination, Penalties and Interest Expense Incremental tax obligation Incremental tax obligation Incremental tax obligation Schedule Of Finite And Indefinite Lived Assets By Major Class [Table] Schedule Of Finite And Indefinite Lived Assets By Major Class [Table] Schedule Of Finite And Indefinite Lived Assets By Major Class [Table] Measurement Frequency [Axis] Measurement Frequency [Axis] Fair Value, Measurement Frequency [Domain] Fair Value, Measurement Frequency [Domain] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Distribution and license agreements, supply agreements Developed product technology, formulations, and product rights Customer relationships and distribution networks Trademarks, trade names, and brands Trademarks [Member] Finite And Indefinite Lived Assets By Major Class [Line Items] Finite And Indefinite Lived Assets By Major Class [Line Items] Finite and Indefinite-Lived Assets By Major Class [Line Items] Goodwill, impairment loss Goodwill, Impairment Loss Intangible assets subject to amortization, accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Total other intangible assets Intangible Assets, Net (Excluding Goodwill) Intangible assets amortization expense Impairment of intangible assets, indefinite-lived (excluding goodwill) Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Impairment of Intangible Assets, Finite-lived Impairment of Intangible Assets, Finite-lived Restructuring and related costs [Table Text Block] Restructuring and Related Costs [Table Text Block] Income Statement [Abstract] Cost of sales Cost of Goods and Services Sold Gross profit Gross Profit Operating expenses Operating Expenses [Abstract] Distribution Production and Distribution Costs Research and development Selling Selling and Marketing Expense Administration General and Administrative Expense Impairment charges Asset Impairment Charges Restructuring Restructuring Charges Total operating expenses Operating Expenses Operating income (loss) Interest expense, net Interest Income (Expense), Net Other expense, net Other Nonoperating Income (Expense) Loss on extinguishment of debt Gain (Loss) on Extinguishment of Debt Income (loss) before income taxes Income (Loss) from Continuing Operations before Income Taxes, Domestic Income tax expense (benefit) Income Tax Expense (Benefit) Net income (loss) Net Income (Loss) Attributable to Parent Income (loss) per share Earnings Per Share [Abstract] Basic Earnings Per Share, Basic Diluted Earnings Per Share, Diluted Weighted-average shares outstanding Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic Weighted Average Number of Shares Outstanding, Basic Diluted Weighted Average Number of Shares Outstanding, Diluted Dividends declared per share Common Stock, Dividends, Per Share, Declared Fair Value Disclosures [Abstract] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Liability Class [Axis] Liability Class [Axis] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Contingent Consideration Classified as Equity [Member] Contingent Consideration Classified as Equity [Member] Measured at fair value on a recurring basis: Fair Value, Measurements, Recurring [Member] Measured at fair value on a non-recurring basis: Fair Value, Measurements, Nonrecurring [Member] Fair value, inputs, level 1 [Member] Fair Value, Inputs, Level 1 [Member] Fair value, inputs, level 2 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Finite-Lived Intangible Assets, Gross Settlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Fair Value, Assets, Level 1, Level 2, Level 3 Transfers, Amount Fair Value, Assets, Level 1, Level 2, Level 3 Transfers, Amount Fair Value, Assets, Level 1, Level 2, Level 3 Transfers, Amount Goodwill, Gross Goodwill, Gross Intangible Assets, Gross (Excluding Goodwill) Intangible Assets, Gross (Excluding Goodwill) Assets: Assets, Fair Value Disclosure [Abstract] Investment securities Investments, Fair Value Disclosure Foreign currency forward contracts Foreign Currency Contract, Asset, Fair Value Disclosure Goodwill(1) Goodwill, Fair Value Disclosure Indefinite-lived intangible assets(2) Indefinite-lived Intangible Assets (Excluding Goodwill), Fair Value Disclosure Definite-lived intangible assets(3) Finite-lived Intangible Assets, Fair Value Disclosure Assets held for sale, net Assets Held-for-sale, Long Lived, Fair Value Disclosure Total level 3 assets Assets, Fair Value Disclosure Liabilities: Liabilities, Fair Value Disclosure [Abstract] Interest rate swap agreements Interest Rate Derivative Liabilities, at Fair Value Foreign currency forward contracts Foreign Currency Cash Flow Hedge Liability at Fair Value Contingent Consideration Total level 2 liabilities Financial and Nonfinancial Liabilities, Fair Value Disclosure Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Beginning balance Net realized (gains) losses Fair Value, Liabilities Measured on Recurring Basis, Change in Unrealized Gain (Loss) Purchases or additions Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases Foreign currency effect Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) Ending balance Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Restructuring Type [Axis] Restructuring Type [Axis] Type of Restructuring [Domain] Type of Restructuring [Domain] Employee severance [Member] Employee Severance [Member] Lease exit Contract Termination [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Beginning balance Restructuring Reserve Additional charges Payments Payments for Restructuring Non-cash adjustments Restructuring Reserve, Settled without Cash Ending balance Public Bonds and Private Placement [Member] Public Bonds and Private Placement [Member] Public Bonds and Private Placement Retail Bonds [Member] Retail Bonds [Member] Retail Bonds [Member] Fair value, inputs, level 3 [Member] Debt Instrument, Unamortized Premium Debt Instrument, Unamortized Premium Debt instrument, fair value disclosure Debt Instrument, Fair Value Disclosure Long-term Debt Long-term Debt Commitments and contingencies [Text Block] Commitments and Contingencies Disclosure [Text Block] Inventory disclosure [Text Block] Inventory Disclosure [Text Block] Schedule of derivative instruments in statement of financial position, fair value [Table Text Block] Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Schedule of derivative instruments, effect on other comprehensive income (loss) [Table Text Block] Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block] Reclassification out of AOCI [Table Text Block] Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Schedule of hedge ineffectiveness [Table Text Block] Schedule of hedge ineffectiveness [Table Text Block] Schedule of hedge ineffectiveness [Table Text Block] Schedule of non-designated derivatives Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] Subsequent Event [Table] Subsequent Event [Table] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event [Line Items] Subsequent Event [Line Items] Perrigo Co PLC [Member] Perrigo Co PLC [Member] Perrigo Co PLC [Member] Numerator: Numerator [Abstract] Numerator: [Abstract] Net income (loss) Denominator: Denominator [Abstract] Denominator [Abstract] Weighted average shares outstanding for basic EPS Dilutive effect of share-based awards Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Weighted average shares outstanding for diluted EPS Share-based compensation arrangement by share-based payment award, options, exercises in period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Stock repurchase program, authorized amount Stock Repurchase Program, Authorized Amount Stock repurchase program, remaining authorized repurchase amount Stock Repurchase Program, Remaining Authorized Repurchase Amount Anti-dilutive share-based awards excluded from computation of diluted EPS Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Research & development stage [Axis] Research & development stage [Axis] Research & development stage [Axis] Research & development stage [Domain] Research & development stage [Domain] [Domain] for Research & development stage [Axis] Collaborative Partner [Axis] Collaborative Partner [Axis] Collaborative Partner [Axis] Collaborative Partner [Domain] Collaborative Partner [Domain] [Domain] for Collaborative Partner [Axis] May 2015 agreement [Member] May 2015 agreement [Member] May 2015 agreement [Member] June 2016 agreement [Member] June 2016 agreement [Member] June 2016 agreement [Member] Potential Contingent Milestone Payments Potential Contingent Milestone Payments Potential Contingent Milestone Payments Designated derivatives: Designated as Hedging Instrument [Member] Sales revenue, goods, net [Member] Sales Revenue, Goods, Net [Member] Cost of sales [Member] Cost of Sales [Member] Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Statement of Comprehensive Income [Abstract] Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Change in fair value of derivative financial instruments, net of tax Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent Change in fair value of investment securities, net of tax Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Change in post-retirement and pension liability adjustments, net of tax Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net Unamortized Gain (Loss) Arising During Period, Net of Tax Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Fair value disclosures [Text Block] Fair Value Disclosures [Text Block] Indebtness [Abstract] Indebtness [Abstract] Schedule of debt Schedule of Debt [Table Text Block] Derivative instruments and hedging activities disclosure [Text Block] Derivative Instruments and Hedging Activities Disclosure [Text Block] Derivatives, policy [Policy Text Block] Derivatives, Policy [Policy Text Block] Assets held for sale [Abstract] Assets held for sale [Abstract] Disposal Group Classification [Axis] Disposal Group Classification [Axis] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Discontinued operations, held-for-sale Discontinued Operations, Held-for-sale [Member] Other Other [Member] Other [Member] Current assets Disposal Group, Including Discontinued Operation, Assets, Current Goodwill Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent Property, plant and equipment Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent Other assets Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent Less: impairment reserves Total assets held for sale Disposal Group, Including Discontinued Operation, Assets Current liabilities Disposal Group, Including Discontinued Operation, Liabilities, Current Other liabilities Disposal Group, Including Discontinued Operation, Other Liabilities Total liabilities held for sale Disposal Group, Including Discontinued Operation, Liabilities Disposal groups, including discontinued operations, disclosure [Text Block] Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Schedule of fair value, assets and liabilities measured on recurring and non-recurring basis [Table Text Block] Fair Value, Liabilities Measured on Recurring and Nonrecurring Basis [Table Text Block] Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block] Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block] Income tax disclosure [Text Block] Income Tax Disclosure [Text Block] Statement of Cash Flows [Abstract] Business Combination, Separately Recognized Transactions [Axis] Business Combination, Separately Recognized Transactions [Axis] Business Combination, Separately Recognized Transactions [Domain] Business Combination, Separately Recognized Transactions [Domain] Cash Flows From (For) Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to derive cash flows Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Loss on acquisition-related foreign currency derivatives Derivative, Loss on Derivative Share-based compensation Share-based Compensation Impairment charges Non-cash restructuring charges Restructuring Costs and Asset Impairment Charges Deferred income taxes Deferred Income Tax Expense (Benefit) Other non-cash adjustments Other Operating Activities, Cash Flow Statement Subtotal Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities Increase (decrease) in cash due to: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventories Increase (Decrease) in Inventories Accounts payable Increase (Decrease) in Accounts Payable Payroll and related taxes Increase (Decrease) in Employee Related Liabilities Accrued customer programs Increase Decrease In Accrued Customer Programs The net change during the reporting period in the aggregate amount of accrued customer programs including chargebacks and rebate payables. Accrued liabilities Increase (Decrease) in Accrued Liabilities Accrued income taxes Increase (Decrease) in Income Taxes Payable Other Increase (Decrease) in Other Operating Assets and Liabilities, Net Subtotal Increase (Decrease) in Operating Capital Net cash from (for) operating activities Net Cash Provided by (Used in) Operating Activities Cash Flows From (For) Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Acquisitions of businesses, net of cash acquired Asset acquisitions Payments to Acquire Intangible Assets Additions to property and equipment Payments to Acquire Property, Plant, and Equipment Settlement of acquisition-related foreign currency derivatives Payments for Derivative Instrument, Investing Activities Other investing Payments for (Proceeds from) Other Investing Activities Net cash from (for) investing activities Net Cash Provided by (Used in) Investing Activities Cash Flows From (For) Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Issuances of long-term debt Proceeds from Issuance of Long-term Debt Payments on long-term debt Repayments of Long-term Debt Borrowings (repayments) of revolving credit agreements and other financing, net Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less Deferred financing fees Payments of Financing Costs Premium on early debt retirement Payments of Debt Restructuring Costs Issuance of ordinary shares Proceeds from Issuance of Common Stock Cash dividends Payments of Dividends Other financing Proceeds from (Payments for) Other Financing Activities Net cash from (for) financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rate changes on cash Effect of Exchange Rate on Cash and Cash Equivalents Net increase (decrease) in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Cash paid/received during the year for: Supplemental Cash Flow Information [Abstract] Interest paid Interest Paid Interest received Proceeds from Interest Received Income taxes paid Income Taxes Paid Income taxes refunded Proceeds from Income Tax Refunds Schedule of inventory, current [Table Text Block] Schedule of Inventory, Current [Table Text Block] Disposal groups, including discontinued operations [Table Text Block] Disposal Groups, Including Discontinued Operations [Table Text Block] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Goodwill reporting unit [Axis] Goodwill reporting unit [Axis] Goodwill reporting unit [Axis] Goodwill reporting unit [Domain] Goodwill reporting unit [Domain] [Domain] for Goodwill reporting unit [Axis] Branded CHC Rest of World [Member] Branded CHC rest of world [Member] Branded CHC rest of world [Member] Branded CHC Belgium [Member] Branded CHC Belgium [Member] Branded CHC Belgium [Member] Fair Value, Measurements, Nonrecurring [Member] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] MEXICO MEXICO Goodwill [Line Items] Goodwill [Line Items] Indefinite-lived Intangible Assets (Excluding Goodwill), Fair Value Disclosure Goodwill [Roll Forward] Goodwill [Roll Forward] December 31, 2015 Business acquisitions Goodwill, Acquired During Period Business divestitures Goodwill, Written off Related to Sale of Business Unit Impairments Goodwill, Fair Value Disclosure Changes in assets held for sale Goodwill, Transfers Currency translation adjustment Goodwill, Foreign Currency Translation Gain (Loss) October 1, 2016 Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Other Current Assets [Member] Other Current Assets [Member] Accrued liabilities [Member] Other Liabilities [Member] Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Derivative Asset, Fair Value, Net Derivative Asset, Fair Value, Amount Not Offset Against Collateral Derivative Liability, Fair Value, Amount Not Offset Against Collateral Derivative Liability, Fair Value, Amount Not Offset Against Collateral Summary of significant accounting policies and change in accounting principles [Text Block] Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Stockholders' Equity: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Preferred shares, par value Preferred Stock, Par or Stated Value Per Share Preferred shares, authorized Preferred Stock, Shares Authorized Ordinary shares, par value Common Stock, Par or Stated Value Per Share Ordinary shares, authorized Common Stock, Shares Authorized Preferred shares outstanding Preferred Stock, Shares Outstanding Ordinary shares outstanding Common Stock, Shares, Outstanding Allowance for doubtful accounts Allowance for Doubtful Accounts Receivable Commitments and contingencies Commitments and Contingencies 6.19% senior notes 6.19% Senior Note [Member] 6.19% Senior Note [Member] Other liabilities [Member] Other noncurrent liabilities [Member] Other Noncurrent Liabilities [Member] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Credit facility indebtedness Credit facility indebtedness [Member] Credit facility indebtedness [Member] Treasury locks Treasury Lock [Member] Foreign exchange contract [Member] Foreign Exchange Contract [Member] Foreign exchange option [Member] Foreign Exchange Option [Member] Derivative, Notional Amount Derivative, Notional Amount Derivative, Loss on Derivative Term loans Loans Payable Proceeds from Issuance of Debt Proceeds from Issuance of Debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt Maximum Remaining Maturity of Foreign Currency Derivatives Maximum Remaining Maturity of Foreign Currency Derivatives Investments [Abstract] Cost and equity method investments disclosure [Text Block] Cost and Equity Method Investments Disclosure [Text Block] Goodwill and intangible assets disclosure Goodwill and Intangible Assets Disclosure [Text Block] Schedule of Debt Instruments [Table] Schedule of Debt Instruments [Table] Schedule of Debt Instruments [Table] Over draft Over Draft [Member] Over Draft [Member] 2015 Revolver 2015 Revolver [Member] 2015 Revolver [Member] 2014 Revolver 2014 Revolver [Member] 2014 Revolver [Member] 2014 Term loan due December 5, 2019 2014 Euro-Denominated Term Loan due December 5, 2019 [Member] 2014 Euro-Denominated Term Loan due December 5, 2019 [Member] 1.30% unsecured senior notes due November 8, 2016 1.30% Unsecured Senior Notes due November 8, 2016 [Member] 1.30% Unsecured Senior Notes due November 8, 2016 [Member] 4.500% unsecured senior notes due May 23, 2017 4.500% Unsecured Senior Notes due May 23, 2017 [Domain] 4.500% Unsecured Senior Notes due May 23, 2017 [Domain] 5.125% unsecured senior notes due December 12, 2017 5.125% Unsecured Senior Notes due December 12, 2017 [Domain] 5.125% Unsecured Senior Notes due December 12, 2017 [Domain] 2.30% unsecured senior notes November 8, 2018 2.30% Unsecured Senior notes November 8, 2018 [Member] 2.30% Unsecured Senior notes November 8, 2018 [Member] 5.000% unsecured senior notes due May 23, 2019 5.000% Unsecured Senior notes due May 23, 2019 [Domain] 5.000% Unsecured Senior notes due May 23, 2019 [Domain] 3.500% unsecured senior notes due March 15, 2021 3.500% Unsecured Senior notes due March 15, 2021 [Domain] 3.500% Unsecured Senior notes due March 15, 2021 [Domain] 3.5% Senior note due December 15, 2021 [Member] 3.5% Senior note due December 15, 2021 [Member] 3.5% Senior note due 2021 [Member] 5.105% senior note due July 19, 2023 5.105% Senior note due July 19, 2023 [Domain] 5.105% Senior note due July 19, 2023 [Domain] 4.00% unsecured senior notes due November 15, 2023 4.00% Unsecured Senior Notes due November 15, 2023 [Member] 4.00% Unsecured Senior Notes due November 15, 2023 [Member] 3.9% senior note due December 15, 2024 3.9% senior note due 2024 [Member] 3.9% senior note due 2024 [Member] 4.375% senior note due March 15, 2026 4.375% senior note due March 15, 2026 [Member] 4.375% senior note due March 15, 2026 [Member] 5.30% unsecured senior notes due November 15, 2043 5.30% Unsecured Senior Notes due November 15, 2043 [Member] 5.30% Unsecured Senior Notes due November 15, 2043 [Member] 4.9% senior notes due December 15, 2044 4.9% Senior Loan due 2044 [Member] 4.9% Senior Loan due 2044 [Member] 2014 Euro-Denominated Term Loan due December 5, 2019 additional draw [Domain] 2014 Euro-Denominated Term Loan due December 5, 2019 additional draw [Domain] 2014 Euro-Denominated Term Loan due December 5, 2019 additional draw [Domain] Debt securities Debt securities [Member] [Member] Debt securities [Member] [Member] 5.1045% senior notes 5.1045% Senior Note [Member] 5.1045% Senior Note [Member] 5.125% retail bonds 5.125% Retail Bond [Member] 5.125% Retail Bond [Member] 4.5% retail bonds 4.5% Retail Bond [Member] 4.5% Retail Bond [Member] 5.0% retail bond 5.0% Retail Bond [Member] 5.0% Retail Bond [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Long-term line of credit Long-term Line of Credit Debt Instrument, Issuance Date Debt Instrument, Issuance Date Debt Instrument, Interest Rate, Stated Percentage Debt Instrument, Interest Rate, Stated Percentage Debt Instrument, Periodic Payment Debt Instrument, Periodic Payment Repayments of Long-term Debt Other financing Other Long-term Debt Unamortized premium (discount), net Debt Instrument, Unamortized Discount (Premium), Net Deferred financing fees Debt Instrument, Fee Amount Total borrowings outstanding Debt, Long-term and Short-term, Combined Amount Current indebtedness Debt, Short Term and Current Portion of Long Term Debt, Short Term and Current Portion of Long Term Line of Credit Facility, Maximum Borrowing Capacity Line of Credit Facility, Maximum Borrowing Capacity Debt Instrument, Face Amount Debt Instrument, Face Amount Proceeds from Lines of Credit Repayments of Debt Debt Instrument, Maturity Date Debt Instrument, Maturity Date Amount debt exceeded par value Amount debt exceeded par value Amount debt exceeded par value Extinguishment of Debt, Amount Extinguishment of Debt, Amount Line of Credit, Current Line of Credit, Current Debt Instrument, Covenant Compliance Debt Instrument, Covenant Compliance Line of Credit Facility, Fair Value of Amount Outstanding Line of Credit Facility, Fair Value of Amount Outstanding Transfers and servicing of financial assets [Text Block] Transfers and Servicing of Financial Assets [Text Block] Schedule of earnings per share, basic and diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of share-based compensation, stock options, activity Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Collaboration agreements [Text Block] Collaboration Agreements [Text Block] Collaboration Agreements [Text Block] Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Estimated fair value of equity securities Available-for-sale Securities [Member] Other non-current assets [Member] Other Noncurrent Assets [Member] Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Other than temporary impairment losses, investments, portion recognized in earnings, net, available-for-sale securities Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net, Available-for-sale Securities Cost method investments Cost Method Investments Equity method investments Equity Method Investments Loss from equity method investments Income (Loss) from Equity Method Investments Equity method investment, other than temporary impairment Equity Method Investment, Other than Temporary Impairment Unrealized Gain (Loss) on Investments [Abstract] Unrealized Gain (Loss) on Investments [Abstract] Equity securities, at cost less impairments Available-for-sale Equity Securities, Amortized Cost Basis Gross unrealized gains Available-for-sale Equity Securities, Accumulated Gross Unrealized Gain, before Tax Gross unrealized losses Available-for-sale Equity Securities, Accumulated Gross Unrealized Loss, before Tax Estimated fair value of equity securities Available-for-sale Securities, Equity Securities Transfer from investments Transfer from Investments Unrealized gain (loss) on investments Unrealized Gain (Loss) on Investments Schedule of accumulated other comprehensive income (loss) [Table Text Block] Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Schedule of segment reporting information, by segment [Table Text Block] Schedule of Segment Reporting Information, by Segment [Table Text Block] Unrealized gain (loss) on investments [Table Text Block] Unrealized Gain (Loss) on Investments [Table Text Block] Earnings per share [Text Block] Earnings Per Share [Text Block] EX-101.PRE 10 prgo-20161001_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 11 cy16q110q_chart-04657a02.jpg begin 644 cy16q110q_chart-04657a02.jpg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end GRAPHIC 12 cy16q110q_chart-04671a02.jpg begin 644 cy16q110q_chart-04671a02.jpg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end GRAPHIC 13 cy16q110q_chart-04822a02.jpg begin 644 cy16q110q_chart-04822a02.jpg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end GRAPHIC 14 cy16q110q_chart-05779a02.jpg begin 644 cy16q110q_chart-05779a02.jpg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end GRAPHIC 15 cy16q210q_chart-30851a01.jpg begin 644 cy16q210q_chart-30851a01.jpg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end GRAPHIC 16 cy16q210q_chart-31361a01.jpg begin 644 cy16q210q_chart-31361a01.jpg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end GRAPHIC 17 cy16q210q_chart-31555a01.jpg begin 644 cy16q210q_chart-31555a01.jpg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end GRAPHIC 18 cy16q210q_chart-31672a01.jpg begin 644 cy16q210q_chart-31672a01.jpg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end GRAPHIC 19 cy16q210q_chart-31701a01.jpg begin 644 cy16q210q_chart-31701a01.jpg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end GRAPHIC 20 cy16q210q_chart-31816a01.jpg begin 644 cy16q210q_chart-31816a01.jpg M_]C_X 02D9)1@ ! 0 0 ! #_VP!# $! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_ MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P 1" #I 4P# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#^_BBBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ K\Y?^"F'[=>O?L#?"3X.^/?"WPR\&?%+Q'\9_ MVG_A!^S/HFE_$7XPQ_ GP#X=U/XMKXF%IXR\9?$J;P1\08= \.:#+X>4ZK-) MXX\Y&MEAG_1JORW_X*Q?L3?$W]N3X+_ OP9\*$^!6I>)/@O\ M=_ M[]I6[\'?M):=XCU?X-_$;0OA,/%CZG\/?&>E^&- \2ZA?Z5XH.OVUI>6LNDS MV,UDEVER#F.*4 ^:O!'_ 6PM6^$_P"U[XG^*O[/=A'\3_V6/B+^SQ\(-"\) M?LW?'OPE^T?\+?VB?BI^U6NDV'P4^'_PA^.3>%?AEHL?BN?Q/KFE:-\2]&\5 M>&]+G^&&G:CI_B75&U+3+^T27MOC!_P4M_:W_9=_9R_;"^-'[4O_ 3ZA\ : MU^S+\%M'^-G@^?X>?M(6?Q4^!OQBL-3UN'0;_P Q?%V?X1^!O%/@GXE^%+Z M4R>(M"O/A)KFE/I/V;6=(UR_M;R!'^8O"W_!%OXQ^)_"7[5FK>,_$O[)G[+G MQ$^+GB/]D/XD_ CX<_L5?"3Q/IO[.7P9^-_[&?Q!U#XH>"?C=XE\*>*YO"4O MCKQQ\1]9N-/\#?$JXT'P]X%N+KX8:3:Z1#J=_K<-CJ]C[-^T#^P[_P %-/VT MOV7_ -N'X3?M,?M#_LT>&M3_ &A?@#H7P2^#'P6^"GA?QV?@5X \06/B9O$W MB7XS^./B'XZ\.W7QDU[Q?XR$D'AQ/#&BV%OX-\*>'-'L4CLO$6MW-QK<(!]A MZ#_P4;^&'CG]MCX)_LA_"^[^'?Q0L_BK^S5\8?C_ *[\1_ ?Q<\.>*QX"O\ MX7>*OA7X;L_ ^I>&O#EGJ\5Q+XEC^(MY?QZQ>>(M(DLO^$=D@M](U-;R>?3O M%O$7_!7;P'X+_P""G7Q#_P"";'C+X:WVA:UH_P - ^+7PN^+!\227'A[XD> M/]5\(^+?']Q\%;_3/^$:B@\(^*KOP5X+\3^(O!]R^OZS)XMM/"WBJ*#2K.ZT MNVAU#J/!W_!,GX>_"+]OWX#?M7_ CX<_L]_!;P!\//V4OC?\#/B+X3^%_P . M-$^'?B+QOXV^(_C#X/>(/#'B>6#P;X4TK1-8TS1+#P%XCM;JZUW44U:TFU>U MCTZTN(+J_DM_"OVI?^"0FL?M1?%__@H1\1M:^(VA>#[G]I'X6?L9?\,P^-?# MB:ROQ'_9]_:,_9 C^,M]X7^*\MT=/M[:&Q?5_B-I^FRVOA_5KB]UWP9>>,_# MNJ1V46J1_: #W+X-_P#!8/\ 9%U_]FW]C/XV_M'_ !4^%?[+GC/]LOX4>$?B M?X/^%/C+XB1:M=:/:^)YK+3G-UXB;0M$2W\*V&O:A9>'QX]\4Z1X1\,W.LW5 MOIANH-0E%H/9/V??^"CO[/'[2G[77[7?[&/P[U'57^*W['%_X4TWQ^-3M/LN MF^()M;TRSN/$-YX4=1)++I7@C7M3T[P5KEWJO]G7-WXG_M :187NA6<&N7_X M:>)/^" O[1LOP\_9H\*:1\5_@9XCGT;_ ()T?"C_ ()Y_M)^'_&7C?\ ; \) M> 9?#OPV\>^*_&3^/? ^D_L__$CX/W/QFT?5K7X@>*-)U+X,?&K_ (1WP;J> MHV>@>*H]4T;4UU*&?]E?V8?V-OBQ^SI^W1^W!\;H/$WPYUK]GG]J_0?V:=:\ M/:)YGC,_&'P5\1?@#\$O!_P"?1]3EU&&\\+ZQX$U?PEX3CUVWU=M!K74M?\ V<=%U#6%OH?&5M\6 M(M?USP7IFL^,=)\-S16#Z4WW5->_!G3?$3OXBN?$'PY\)W?C+Q=X.MK^.PGT.Y\7>&]"M)=3\3^%=/U*^\3 M^&M,BN[_ %C1+6*QNQ%^6/[4/_!(_P#:E_:C^/\ 'JWQ#\9?L7^*/!&F?M2> M /CQ\./VQ-1^"&J>%/\ @HY\#OAAX'^)7ASXF6'[.G@'QC\/=(\/>!_$&C:2 MGAY_AMX<^)'BWQ))JD/@?6KJ^\1>%/$'B>PL[YKVI_\ !*[]MKQG^V[X$_:( M^)_[0/PK\^)?PT\(_#*P^$T M;M^S_P##O5_@^GB_2=.U#Q/X7\/:GXM^-ME;W'B;QMX[TC6+)](\0@'V/\&_ M^"P?[(GB#]F[]C+XV_M'_%3X5_LM^,_VR_A1X1^)_@_X5>,_B)%JMSH]KXHF MLM.77B&'QK?Z-7[27A_QGXW_; \)> )?#OPU\>>*_&+>/O!&D M?L__ !(^#US\9]'U>U\?^*-*U3X,?&K_ (1WP;J>I6>@>*H]5T?4QJ<4_P!N M>)_^"8O[3UC^W3HWQX^!OQ6^&_P&^%4WQ[^"WQ6^('B'X$OB;H?AR6*9 M]!UC7]&L]0N0#]Z000".01D'U!HH'^?\]\>O>B@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BHY98X(I)II$BBB1Y99)&5(XXXU+N[NQ" MJB(I9F8A54$D@ FO+/A1\=O@K\=M,US6O@K\6OAM\6](\,Z]=^%O$.I_#7QO MX;\;V&B>([''VK0]5N_#>I:E!8:I"K+*;.Y>.:2!X[B%9()(Y6 /5Z*H:9JN MF:U9QZCH^HV.JV$SW$45[IUW;WUI)+:7,UE=1I#?%=UXAL?#'BOPUXBO?".KR:!XJM-"U[2=8NO#6NPQK-- MHOB"WTZ\N9M%U:*%EEETS4TM;Z.-E=X%4@T =117%>(?B3\//"7AK6_&7BKQ MWX-\->$?#5\VF>(O%'B#Q1H6B^'=!U)+^#2GT_6M;U/4+72]*O4U.YM].>TU M"[M[A;Z>&S,8N98XFN>#?''@SXB^';'Q?X \6^&?''A74VNDT[Q+X/U_2?$^ M@7[V-W-87JV6M:%>7^F7;6E];W%G#? M'EA=:KX(\5^&O&&F6.J7VB7NH^%M>TGQ%86>LZ9((M2TFZO-&O+VVM]3T^5E MCOM/FE2[M)&"7$,;$ ]10 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'S[^UGI/ M@C7OV6_VC]"^)EQXVM/ASK?P(^+FC^/KOX:Z;?ZQ\0[3P7JG@#Q!8^*;OP-I M&E:?J^IZKXNM=#GOKCP]INGZ3JMY?:I%;6MOIFH/*+.;\;/^"9FI>%?BOK_[ M4?P&C\3_ :^*^E7?AO2+J?]L']C*2Y^#7B3Q#\-Y_C?\6]$\%_"KXEWOPW\ M3:O;_#[Q2^C66N^.OA>WPT\=6/V3X9^/-8;0-!^''D:3=:Q_0H1D$'OZ$@_@ M1@@^A!!!Y'-#_ %::M8>#/#>B^&++7?$NO\ C#6+71-/MM.@U/Q1 MXIU"35?$.O7L=LD:W&J:QJ,TEW?7D@,L\K9)"JJJ ?D+_P $Z-;MO __ 2C M^ WPW\ >(/#WA7XF^)OAM^T;X(_9V\,ZAK<-IJGB#QCX,\0?&_5?#NB^%K6] MO3JVOWGAS2M CUF_2UEO=2MM&TF\U>^F9;>YNQXG^PE8?!/QE\2OV3_#'[-N MJZ#H]I#_ ,$FO%7@K]K/4?A%>6^B>-?"?Q*U7QA^SY9_"FV^*FL:%$U]X=^. MVC>+5_:KU/3O^$Q9/B-I'BG_ (69JM_$+R?5Y)OWIO/!7A6_OO">HW>AZ?+> M>!M4U'6_"4JPB%=!U;5M#UGPUJ&H:?!;F*WAN[K0O$.MZ7),8F;[+JM\B[6N M9'.KI^BZ/I,VHW&EZ7IVG3ZQ>OJ6K36-C:VO%%%$ M]W=--$OB!XJ^(/B1]+T:^\3>+],TO4K#XJ?& M?7M:T6^^(UIX?TC6T\0>)_%^CV-]][?LR?M$?#SQ]^R3\3O"WQXU7X?>(O#& MDVW[8?A_2-3^#>A7'AU?VH?V9/@=XBD\&^,OCY\(/A7\--2U;Q5?Z9K.F^*= M/T37+WX276L66K>-;^WU?X?W-O9>,O"6GQ_J3=Z#HE_IU_I%]I&EWFE:J;HZ MGIMUI]G<:?J)OG:2]^WV4T#VMY]KD9I+G[3%+]HD)>;>Q)JQ!I>G6OV+[-86 M=O\ V;9-IVG^1:P0FQT]Q;!K*S,<:FTLR+.T!M;%?AS\&?'FAZ#XB\6Z'KGQQ/A"[3Q7??$2/6])U;Q!\.AX1\-W?PQ^'/AW MP=X0G\8?L_65I&A:+H$$]KH>DZ9H]MR>;>7TT-E#! M%+>7+#_@HOI'[)_AF\_9T\#^'+/5/#J6 M/P\^-,OC3PO\6/VAO FH>&?AAXD\9_$_X&>.CJMEX/G'A%_&GC+PQX=\#:1X M.^(=YXC\7?"#QII/C;7/AY::YX?U72^I\2?M4?M/?"3]H3Q?X3^)-[^SSXQ^ M"OP9^ WQ4_:?_:&UGX?>"OBIX;\9?##X3:/8^+5^#FD0ZIXG^)/B'PCK?Q%^ M)^J>$/%]S%H]Q8Z/IMIX5^&OC7Q!+=V1O_"]E>@'ZL45^4W@/]L3]K;5[Q_A MQXA^ _P?O/CM\4OV:O#'[47P"\(>'OBEXATOPCI_AK6?'O@WP%X[\$_&'Q7X MA\-S74&J?!8_$;P5XJUKQ7X+T>:'XDZ5^(_@[\8XO"&C^%=3O_&OP[N- M4DNM5LK/2=;\1ZI\.?%&CSZKXDM=+\?>!O%5GH_BKQ#I:6M[0!]K45^>OPK_ M &X9/B_^W-\1OV9/"?@RWE^$O@7X'7?CG2?C+-?S;OB!\2/"WQGO_A%\3_#7 MA/2DS!-X-^'&N6O_ BM_P"+9V U[X@Z=XPT+2(SI_@^?4=4_0J@ HHHH ** M** "BBB@ K\$O^"W/[#?"GBW^ MT!X6'P__ +$\K_A)M+U+[!]E.O:GO^Q&'[3YZ?:/,\B+;^]M?RM?\'+O7]CC MZ_'G^7PFK]F^C[E.5YYXN<)Y7G678+-LMQ7]N?6VP MV(A4HU/95Z5*M3YX/DJTX3C:44U^*_2'SC-,P_MN(\HP];V.)P\Z=6G[6A5JT:G)-<]*I.$KQDT_S,_P"'Y'_!2C_H MMWAO_P ,W\*?_F8H_P"'Y'_!2C_HMWAO_P ,W\*?_F8K\CZ*_P!,O^(3^%__ M $;O@G_Q&,F_^8_+\^[/\O\ _B,'BK_T<;C;_P 2;./_ )K_ *N_*WZX?\/R M/^"E'_1;O#?_ (9OX4__ #,4?\/R/^"E'_1;O#?_ (9OX4__ #,5^1]%'_$) M_"__ *-WP3_XC&3?_,?E^?=A_P 1@\5?^CC<;?\ B39Q_P#-?]7?E;]*O_1QN-O\ Q)LX_P#FO^KORM^N'_#\ MC_@I1_T6[PW_ .&;^%/_ ,S%=U\+_P#@M;_P47\3?$SX<^&]8^-'AVYTCQ#\ M0? V@ZK;I\(?A=;/<:7K/BS1],U*W6XA\,K- T]C=W$(FA=)H3)YL,B2HCC\ M5:]0^"'_ "6CX/?]E8^&7_J=^'ZXLQ\*O#*GE^.J4_#W@N$X83$2A./#.3J4 M91HR<91:P=U)-)IK5/5:GH95XN>*57-,MI5?$3C2I3JX_!TZD)\2YO*,X3Q% M*,XR3Q=G&46TT]&FTU8_T]E)(Y_O,/P#$#\@!3J:O0_[S_\ H;4ZO\=#_9E; M+T04444#"BBB@ HHHH **** "J6I7HTW3[[4#:WEZ+&TN;LV>G6[7=_="V@D MG-M8VJ$-X>.($%P1=HH _$;0?\ @IU\7/C5X2^"UM\$? WP M9T#Q]X^^"'C7]JOXI:Q\0?%?BWQ;\+O@)\$;'7AHWPR\,>/M6\$6NAZO9?$K MQ[J-U<^'O%&HZI_8?ACX::E\.OC!JB:=XWL/!]C9ZO\ J-^S+\:D_:._9[^# M'QYC\)ZQX%3XN_#7P?\ $%?"6NL9K_0AXIT.RU?[$M\;:R&K:>OVO?I&N)96 M,>NZ2]EJ\=E9I>"VB^1?CC\9/V-/@EJOQ@^#]S^S?:?$SQ9\3-;^$,?Q#^$_ MPU^"/PVU*?X^_$KX\ZOXTA\!^%M;/BRZ\'>!O'OCVYT+X;^./B'XCN/'VNQZ M?X4\!>&)_$OB;7]/^WZ):ZI]V?";XB^$/B]\+_AY\5/ $\MSX(^(W@GPOXW\ M)3W%A-I5R_AWQ/HMGK&CB[TJX2.XTN[CL;N&*[TVYCCN-/N(Y;2:-)(64 'H M-%%% !111TH **^%/C'_ ,%+_P!AW]G_ .(WB'X2_&#X^:-X+^(?A7^R_P#A M(/#5WX3^(>I3Z=_;6D6.O:9OO=#\(:II7.LD2> M8_\ #Y7_ ()H_P#1TOA[_P (7XL__,#7V&&\/>/L;AL/C,'P/QAB\)BZ-+$X M7%8;AG.J^&Q.'KPC4HU\/7I8*=*M1K4YPJ4JM.4H5(2C.$G&2;^/Q7B'P!@L M3B,'C..>#\)C,)6JX;%87%<39+A\3AL10G*E6P^(H5<;"K1K4:D94ZM*I&-2 MG.,H3BI)I(;/Q3X;TOP5]5:5^R;H-_=?MK'XBZO'XLLOVR_$$EGXACT_3CH]_X M?^%,?P"\&_ S3OAY%>W%SJ<=]]@BTCQIXIAU);:VM?[5\=ZD?[+\Q+F>]\!_ MX?*_\$T?^CI?#W_A"_%G_P"8&C_A\K_P31_Z.E\/?^$+\6?_ )@:W_XAGXC_ M /1O^-__ !%,^_\ F#S7WF'_ !$SPW_Z.#P1_P")7D/_ ,WF5X-_8?\ VE-( MDG\:Z[^U3X5B^-WP]_9]\$_LT_L^_$7PA\#ELM+T3P/X3^(?A#XB>*M?^+WA M'Q3\0/%/_">Z_P#&V?X?>"O"?Q*TWPGK?P^TO2/"NGZT_P /+OPWXEURVU[0 MO8_@=^S+\7_AOXO^)7Q,\5?$SX<:EXV_:(^+FD>.?CWIO@CX=>+?!_@\>"_" M7P)7X/\ A#PO\)XF^)M_KWAKQU'J&A>#/$WBWXL^*M2\5:EXDL].U+PS8>'/ M#EG!X/N?"OF/_#Y7_@FC_P!'2^'O_"%^+/\ \P-'_#Y7_@FC_P!'2^'O_"%^ M+/\ \P-'_$,_$?\ Z-_QO_XBF??_ #!YK[P_XB9X;_\ 1P>"/_$KR'_YO+7P M,_X)E?"C]G']J/PE\>?A/XK^)6D>"? W[,DW[.WA;X2>(/C%\=_'ND:7'+\0 M6\71:LD_CWXK>)=*N=!LM)8Z5IW@^\T&XTVPUO\ XK2UDC\2EM0;]+Z_,;_A M\K_P31_Z.E\/?^$+\6?_ )@:/^'RO_!-'_HZ7P]_X0OQ9_\ F!H_XAGXC_\ M1O\ C?\ \13/O_F#S7WA_P 1,\-_^C@\$?\ B5Y#_P#-Y^G-%?$WP-_X*,_L M7?M)^/[7X7?!'XY:3X\\>7NE:MKEMX?L_"WC[2II=+T*."75;L7OB'PGI&F* MMI';9+G.0XI8+/,IS/)L9*E"O'"9M@,5EV*E0 MG*<85EA\92HU72G*G.,*BAR2E":3;BTOI,ISK)L^PKQV1YMEF?"MU:_$/]I/]I#XP_"GQCXUTGXKV?QJ^&UYKWPX\!_"WQMX+TRSU#X:^%=3 M\9^!]*^/,LMY\5/"$WQ-\1^%_!.L>"]+O9KGQ#^O_P "="TKPO\ !3X1>&M" MM_ -GHGA[X9>!=$T>T^%=Q=7?PSMM,TKPSIMA80?#VZOKB[O;GP5%:P1)X8N M+NZN;J?1UM);BXGF=Y7_ "9_;?MO#^J?M)^+[;XY>*OBK\&/ ]K\&/ !^ WB MCX.?L=^!OVA[SXL>.K[4_B*/'FD^(O$?B7]E_P#:.OM9\3^"IK7P39>#_@7' M+X(_M[2O$>IZ_;VGC,ZE+<>#/U+_ &99_'5U^SG\![CXG^$=,\ ?$>;X._#6 M3QYX'T72+7P]I'A'Q@_@_1V\1^'--\/V,US9>'[+1]6-U8P:#9W=[:Z(D/\ M95O?7L5HMS* >XT444 %(W0_0_RI:1NA^A_E0!_ 7_P6L9A_P4L_:.PQ'_)* M>A(_YHWX!K\KM[_WF_[Z/^-?JA_P6L_Y26?M'?\ =*?_ %37@&ORMK_9WPM_ MY-GX>?\ 9$<*_P#JCP)_B=XKM_\ $4/$;7_FN>*__5[CO\E]P[>_]YO^^C_C M1O?^\W_?1_QIM%?=GP%WW?\ 7_#+[AV]_P"\W_?1_P :-[_WF_[Z/^--HH"[ M[O\ K_AE]P[>_P#>;_OH_P"-&]_[S?\ ?1_QIM% 7?=_U_PR^X_:'_@@DS'_ M (*&^%LDG_BTOQ_[*Q\,O_4[\/UY?7J'P0_Y+1\'O^RL?#+_U._#]<&:_\BS,/^P+%?\ MIF9Z63?\CC*O^QE@?_4JD?Z>R]#_ +S_ /H;4ZFKT/\ O/\ ^AM3J_PV/]W8 M[+T7Y!1110,**** "BBB@ HHHH *0_U'KZCT_P#U>O&:6D/3CU!_(@_GZ=L] M>,T ?RW>-]$M*G\ Z4-'^'G_!?70G7P[HNN:_>V-EK,O@ MBUTRP\0ZG'/K5\UUKU^VJZAJ$4T$2:I=:3:Z1%;_ -''P#C$/P/^#T*HL2Q? M##P)&L:P?$2V6,)X9TU0BVWQ_$CPUJ4&GZTTWB?Q1X[^#DVG65XTFFR?$"^T+1] M)F@_H*_9[NM'OO@-\%K[P_XG\->-M!O?A1\/KS1/&/@S5?$>N^$/%>D77A32 MI]-\2>%M:\8^(O%_BS5_#VMV :_*VOU2_P"" MUG_*2S]H[_NE/_JFO -?E;7^SOA;_P FS\//^R(X5_\ 5'@3_$[Q7_Y.AXC? M]ESQ7_ZO<<%%%%?=GP 4444 %%%% '[0?\$$?^4AWA;_ +)+\7/_ $V:+7]U M%?PK_P#!!'_E(=X6_P"R2_%S_P!-FBU_=17^9?TN_P#DZ>%_[)/*?_4W-C_4 MGZ'_ /R:6K_V5> ],\6L? /P^M]%6:&PTV7P#X&\*WS6 MEI"U]=WEV]Q&](\2>(&\6>(=+T+2=/USQ0VDZ?H#>(M7L M[&"WU'7&T/2?^)7HYU6[CEO3I>G?Z#8>=]EM?W$25T-% !1110 4C=#]#_*E MI&Z'Z'^5 '\!7_!:S_E)9^T=_P!TI_\ 5-> :_*VOU2_X+6?\I+/VCO^Z4_^ MJ:\ U^5M?[.^%O\ R;/P\_[(CA7_ -4>!/\ $[Q7_P"3H>(W_9<\5_\ J]QP M4445]V? !1110 4444 ?M!_P01_Y2'>%O^R2_%S_ --FBU_=17\*_P#P01_Y M2'>%O^R2_%S_ --FBU_=17^9?TN_^3IX7_LD\I_]37UZA\$/^2T?![_LK'PR_P#4 M[\/UP9K_ ,BS,/\ L"Q7_IF9Z63?\CC*O^QE@?\ U*I'^GLO0_[S_P#H;4ZF MKT/^\_\ Z&U.K_#8_P!W8[+T7Y!1110,**** "BBB@ HHHH **** "BBB@ H MK@?BGJOQ%T3X<>-M7^$?A/P[X[^)NF^&=6O/ ?@WQ;XLN/ GAGQ/XI@M7?1M M$U[QE:Z%XGN?#.E:A=A(+S6H/#VLRV$+-.FG717RC^7!^/\ _P %K&Q5'VM#*:M&K[*M3J0]I1J5*4^3FISG"49/\ R^\0/HX^ M,.>\=\:9UEG"E/$9;F_%?$&9Y?B'GW#=%U\%CLVQ6)PM9T:^;TJU)U*%6$_9 MUJ=.K"_+4A&2DH_EU17ZB_\ #BC_ (+!_P#1(OV0/_$J?$W_ ,Y"C_AQ1_P6 M#_Z)%^R!_P")4^)O_G(5]7_Q,WX*_P#17U/_ !'>*/+_ *DOF_N\SY'_ (E= M\;_^B.I_^)'PMY?]3KS_ ];?EU17ZB_\.*/^"P?_1(OV0/_ !*GQ-_\Y"C_ M (<4?\%@_P#HD7[('_B5/B;_ .7_4Z\_P /6WK?_!!'_E(=X6_[)+\7/_39HM?W45_& M%^PI_P $X?\ @L?^Q)^T!IGQXL?V:/V.?B+<:;X2\7>%E\-7'[9GBKPM%*/% M5I:6WVXZM'^SMX@9/L)M%D^S#36-R'*?:+/L/G?"N82S++(4(J46_V%HK\>O^%__P#!:[_I M'5^Q-_XL5\:__0@4?\+_ /\ @M=_TCJ_8F_\6*^-?_H0*_!C]\/V%HK\>O\ MA?\ _P %KO\ I'5^Q-_XL5\:_P#T(%'_ O_ /X+7?\ 2.K]B;_Q8KXU_P#H M0* /V%K^5K_@Y=Z_L=^S1X:_L_^SO\ A&(]N/MOVK[6P/V<0+YGZQX'\3Y)P=XG\,\1 M\18QX#)\N_MCZYBUAL5BW2^MY#F>"H6P^"HXC$U.?$XFC3_=T9\O/SSY81E) M?DGCIPOGG&?A9Q1PUPY@UC\YS)9,L'A'B<+A%5^JY_E>-Q'^T8VOA\-3]GAL M-6J_O:T.;DY(7_ M %)?-_=YA_Q*[XW_ /1'4_\ Q(^%O+_J=>?X>MORZHK]1?\ AQ1_P6#_ .B1 M?L@?^)4^)O\ YR%'_#BC_@L'_P!$B_9 _P#$J?$W_P Y"C_B9OP5_P"BOJ?^ M([Q1Y?\ 4E\W]WF'_$KOC?\ ]$=3_P#$CX6\O^IUY_AZV_+JO4/@A_R6CX/? M]E8^&7_J=^'Z^]?^'%'_ 6#_P"B1?L@?^)4^)O_ )R%=-X+_P"")?\ P6&\ M'>,?"/BZ/X+_ +'U^_A3Q5X;\3I8M^UAXGMEO6\.ZY8:TMFUP/@9,;=;MK$6 MYG$,Q@$OFB&4H(VY,?\ 26\&*^!QE&GQ;4E4JX6O3IQ_U>XF7-.=*48QO+)E M%7D[7;25KMI';EGT8_&O#YCE^(K<(4XTJ&-PE:K+_6'AB7+3I5ZB_O;7H?\ >?\ ]#:G5^/9^/\ _P %K-S;?^"=/[$X4N[*&_X* M+>,V959BP4LO['R!B 0"P1 2,A5!P$_X7_\ \%KO^D=7[$W_ (L5\:__ $(% M?Y6G^L*T279(_86BOQZ_X7__ ,%KO^D=7[$W_BQ7QK_]"!7WG^R]XP_:A\:^ M M6U3]K+X+_"[X&?$.#Q7?6.C^%/A+\:-4^.?AW4/"$>EZ//8:]>>*]5^''P MQN-/UBZU:XUJPGT%-"NX;:TTZROUU69]1>ULP9])4444 %%%% !1110 4444 M %%%% !2$@=3R>@[G'7 ZG'?%+7Y>_\ !0&/XVZSX]^ VD?"+1M9^-WAW1-) M^*7BSXO?LG?"G]K'_ADO]H#XA: S>!M \(?%KP9XMMO$O@2Y\6>$?A/KE_JV MA^*/ >K?$KX:>%=8USXC^$=7U/Q/>ZEX X_&GC_X?Z#X;@\*P^'=,^('P7L# M$GNI/%%B ?N1D'H<]OQ]**_GR^'W_!0K]J7P;;>+/ OCB#PY\2OB9\2_V^/V M^/A?\(];T/X2_'[XCZ/\/?@C^R[\0M5TN[3Q-X ^ 7@WQK\1/$U[9?:_"/A+ MP?::1I^D:>FEW][XC\9>-)M4TMK'7][QI_P55_:ATGP1\3OB'IG[+7@[PQ9_ MLY_LJ_"O]ISXV^!OBSXG^)_@3QSJ\OBGXY?M&?!_Q%\/?A_I^K?#K3-7T6WU M;2/@%/\ $?X>^._B'X1TV\?1?$FAZ/XL^'-AJ-]?W'AX _>^BOP5^+G[6'[8 MVK?M#_!;X Z9I_PN\.?&GX:_M^^"/AWKC^%_'7Q'T_X(_$7X5?&G_@GE^UA\ M:-!/CVQGTV'Q;KC_ [UKP3<:E?>#$3^RO&7B;P=X)U[3M6\%W&H31>%NRU? M_@I]\7]03P+\,_"/P^&D:#5]-\:^)&ATF8 _;BDW+G M&1G(&,C.2,@8]2.0/3FOS-_9;_;&^._[3GQZ\4>$G^#?A?X0_"[X>_!S]FWX MA^.=/\>ZOXM?XX:=XR_:/^#E[\1XOAS+X670]*\/Z+>_##5[#^Q?%6IZQ-YN MM)>!-,T?3;BQEENO)_B^?&D?[:/@KP)\&OCQ\=/B9^T3J?QY^%7Q6^(_A31_ M&>L:3^SM^R]^Q+9)9Z9XT\$?%KX=V5Q>?"NXU#XPZ)HWB^Q^$EUXDTBZ_:"\ M>?%CQ''XX\+:EI'PM^%>NW/AT _8K(SC(SSQD9XQGCVR,^F102 ,D@#U)P/3 M^=?SY?L#_'KXS_$7QU^RG\>OC)/^T%H%G^V%XG_:=\-:-->_&_3/%7PS\1>* M_#L7Q"\8:'\*/$?[,5YIUQX>^!/ACX<>"?A)XFD^#WQ)^%WB"\\>^+)_">LV M7QY2TU/Q[%!-^N?[7B:$GP*\3ZSXS_: UC]FCX:^%KS0/&/Q5^*.@ZW#X1U> MW^&?A?6+36?%_A>U\ E\;:?:CPM>>+?"\L7C;3+#4[J'P5^>WK7X$?"F^^.7Q'\:_ MLY_!'Q]XL_:<^&'[.7[0_P :/VO_ (O_ JT7QI\4/B#X+_:=D_9Y^%WPU^% M4'P<^%_Q*^),>LZ)\>_"G_"5>/?&WQ'^.>B^%/$'BH_%O0_AMH?@+X=_%+5[ M>XT;Q;X2$&J_&+]JGQ;^P3^QY\6K+]H#7O#,_A?]MCX(_!OXL7UCX$?V7-#?Q%X^2ZLK3POX>\/?V@OC)X8 M\<>+?@9JG[8WP"^ OPLU_P"'W[;7Q-L;'X7V'CCPE\)/@[X2FUO]DGP9J-A\ M*/%&AZG^TCXOUQ/B;;^,];?X@V5IXITGQ"_@/7_#OAZ%H/OO]FCX,?&3X1ZK M\;[SXK_'C6_C78?$7XIZIXU^']AK.CZ-I1^&7A.\C-M:^"H9M)TK3CK@[GOP.IXYX[%/V9O%/C;XB>"/@YX4_9EU/X_7/A_P"& M/Q \7_";7/C-XUU7XI_\*S^Q:UX^^'FN>&_B&O@_X-Z3;6&L:EX7\+^(_#^F MZSXB^*7A2\\82:W8:7I6ECYN\)?M&_'7X2?&CXB_L4?"W4XOC!K4G[45M\-_ M@C\2/VB?%WBGQ#:_#?P#)^R9H'[4WQ+\(>/_ !;HMI>?$#XN^(OA=-JNGZ!X M$T_7-:M?'&M>'/B7X1'C/QY?CP5K.M:H ?M=_G_/Y&BOPCU']M[]LKX<_'S] MH74OB!X;^#>K^&?!W[*_[#5KX4^!OA3QSJVIZ#I_[3_[2O[5OQS_ &9=-N_^ M%QIX:B1/A_K/C7P]IMWX^UW4?"E[KOA/P7HGA[3=-\)Q>,+'Q;#JF5\5/VI_ MVS=0_;"_9G_9DL8?A;X?^.?@OX_:]IWBZ7P]XT^)=A^SQ\3/A9\5OV(/VE?B M'X&\1^+O#WV1O&EYJO@/Q=\*O$+3_"Z[O;ZWOM?T/P9XMTSQWH<6L3Q>& #] M\:*_#35?^"J?QAUVR\%>$/A[\![2;XS6/@3XX>+OBOHEMX,_:;^-O@H>(O@/ M^T5\1OV7;WP+X&U?]GOX+>-/$>FZ;\1?B/\ "7QQJ>@?$[XC:!H6E>%_"<>@ M3WOA/Q7K&I:EI^B?5G[+'[6_QQ_::^.WQ7\/R_"/PS\*O@Y\)?#?P,FUFU\: MZMXD;XZOXT^.G[-_PP^/<'A75?"L&GV_ACPO+\.)?'%UX4\6&\U"^N]4OTB6 MPM-+?3+QM2 /T?\ \_Y_,4$@ DG '))Z >IK\S?B7KOQQ\/?\%0?V6-#N_C% M?2_ WXD_ 7]K.?3O@EH.@KX?T*TU[X;0?LW2P^-/'.N'5=2U'X@>*I=1\:^( M+;PVI@\/>&O"'AZ06MGX>OO$5[JWB>^^W?CAHNK^(_A!\1M$T+XJWWP.U'4_ M"&MVL?Q?TVUT&YU/X;VSV4 ]4W+_>'&,\CC.,?GD8])8]4UB\O?'_Q1^"J^ M'?"'CGP%XEO=WXS>/_VFM,_X)W_\%2M&^%?[1'C7P#JO[&GQ+_:H\.>!/B[K M$$_Q&^,VJ_"/P!\!?#/QIT+P;HGQ&\5:N]S8^*=$\3^/W^&T7Q>\1VOCWQO8 M>"_"V12U^!?[9WQ<^._B#X^? M'[PEX;MOV@8?AY^RI^PW\'/V@KF_^#/Q_L/@%J.AZE\2/$GQUN_%WQ5T2.XL M-9MOV@_B9X5T3X%6EAX%^"WQ>33_ ("7=O;>-8_'.JRZIXOTB.W_ '*\#>)= M+\9^#/"?B[1-0FU;1O%/AG0/$>DZI/9MI\^I:9KND66JZ??S6#Q0O8RWMI>0 MW,EF\,36KRM;F-/+V@ ZJBBB@ HHHH **** "BBB@ HHHH **** "O"?C)^S M5\&_CWJ'@K6_B3X9U.Y\4?#B?79O ?CCP?XX\?\ PM^(GA"/Q19VMAXIT[P] M\1OA9XI\%^.=+T3Q3:V&F1^)_#]MX@30O$1TG2)-9TV]FTG39+7W:B@#X\UK M]@C]E77/"'@GP3+\-;[1=)^'MI\0[#PQJ?@OXD_%CX?^.([#XN7J:I\6;'6O MB7X%\=>'?B/XMLOBIK$<.N_$VT\7>*M=@^('B&VM/$/BU-7UNSM;^'PWPI_P M2_\ @)IO[0/Q9^+?B?PWHVK^"O%&E?LI:!\-OA)H=SXS\(^!/!WA[]E/PE<: M+X$\->+?!'A_Q5I_P]^)WACP[X@_L_Q3X"\->-/"FM:'X*U33X+W2[!-1CCN MT_36B@#Y&UC]A7]F'6KCQ!>R^ M) M]%N_#WB_QQ\./$'@WQ_H.M_"C5/'&DZCJ5OX]@^&5_X2TOQW)JNKWGB_3]:O MM5U"YN'6G["/[)EAX%\6_#2Q^"_A^R\#>//@WX2^ 'B_P]9:IXJL[37OA/X( M\0_$#Q;X=\,7LUOK\=[Y\7BGXJ?$/Q)JGB6&ZB\6^)-=\6ZOJWB77M7OIDGC M^MZ* /E'XF?L0_LQ?%_Q5?\ CKQY\-9+_P ;:A\0? GQ6;QAHOCCXC^#/%.G M_$?X8_#WQC\*O /C7P_X@\$^,/#NK>&/$7A7P#X_\7Z!I&I>&[O2IH!K,FIL M9-8M;#4+7+UG]@G]E36O!/P]^'Y^&5WH&@?"W1O'/A[P5=^!?B)\5/ASXPT_ M0?BC=C4OBAHVH_$3P!XX\-?$'Q/I?Q0UA4\0?$VQ\5>*-;M_B%XFCB\3^,(] M9\0Q1ZFGV%10!XU\,/V>_@Q\%]2\0ZK\*_A]H?@6Y\4>'OAMX2UB'P\+VSTM M_#/P?\)_\(+\--!T[0_M;Z+H>E>#_"(70=)LM#L--@6Q2-;A+B2*.1?*]&_8 M;_9S\.?%+Q?\9/#>C?$[PWX\^('Q0@^,_CF?PW^T9^T?X?\ "WC'XE6VG:%H MT'B3Q/\ #K1_BQ9?#K7?+T+PSX?\/?V/J?A6YT!_#NDV>@/I3:/&;)OKFFNZ M1HTDC*B(K.[NP555069F9B%554$LQ( )) % 'R##^PE^S)IOB7Q?XU\/_#Q MM"\5^+-/^+=M%=VOB_X@3Z!X,U/XZ0NGQ:\3_#+P)<^+W\#?"KQ;\1;EWU#Q MSXK^&7A_P?XE\5W\]]=ZSJ]Q)KGQ!H>MZ38> M)8+M]6,;>([2TUF2%[ZRM)H/H==5TQ[:QO%U"R:UU1K9-.N1=VQ@OVO$,MHM ME,)?*NS=1CS+86SRFXC^>'>G-6;6ZMKZVM[VRN(+NTNX8KFUNK::.XM[BWF0 M21303PL\,T,J,KQRQ.\;H0R,RD$@'RQJ7[%'[/NM>"]+\"ZWI?Q/UW3= \=7 M7Q)\->(]>_:)_:,USXH>$O&E]X>NO">H:QX+^,^J_%>[^+W@Q=2\,ZAJF@ZG MI?A?QQI.C:EI6M:]97VG7$.NZNMYZ%+^SC\$9?A3X&^!Z_#K0K3X3_#34_A7 MK'@;P/I9O](T;PWJ7P3\7>&_'GPPN;!=+O;2Z/\ PBOB_P (^'M<@AN;FX@U M*[T_;K<>IV]W?0W7ME4I-2T^&^MM,EOK.+4;V&YN;.PDNK=+VZM[,Q"[GM[1 MI!<3PVQFA%Q+%$\.-*^*%V M5\4>-XO VH_%30O#2>#M$^+&J_"2'Q-'\)=6^+.C>&8;71=*^*&I>![KQYIU MC8:8EIX@B?2].DM?J$ #@ 8 ] *IQ:A8SWEWI\-Y:RWUC';2WMG'B4VDES;)(T]O'=""8V[S1HL_DR^47\M]MR@ HJO\N([6U@625D1IKBYEB@@B#&2::2.*-6DD16L4 >)_&+]G?X1?'E_ M"-U\2O#-Y?:YX U#4]3\#>,O"_BWQK\-OB)X,N=;L%TO7T\)_$GX:>(O"'C[ MPY9>(].C@L/$NF:1XCM-+\1V5M:6VN66H16=HL'GLG[$/[,1^'/AOX6VGPT. MB>&_"/C^^^*_AS5_"_C3XA^$OB5I/Q4U9-6AUWXGVOQE\,>+M)^,'_"Q_$MK MKVN:?XK\=S>.IO%/BO2]9U;2O$>JZIINHW5I)]/ZGJFFZ+876J:QJ%CI6FV4 M?G7FH:E=VUA8VL6Y4\VYN[N6&V@CW,J[Y947+ M_"WB2YLX8[B[M] \1:-K4]K!*YBBFN(=,OKJ2"*216C22541W4HK%@10!\S? M\, ?L@C2I=!3X*:#%X>NO@C%^SOJ7AJ#6O&-OX7UWX46WBO6?'>GZ-XF\-0^ M)(]#\4>(-%\<^(_$OC3P]\0_$-CJ7Q(\.^+O$_B?Q-H?B[3]<\1ZU?WV1=?\ M$ZOV1KZVTM;SX=^*+K7=%^)5Q\8=.^(EQ\;/CS-\8XOB?/\ #RZ^$T7CF;XW M2?$YOB]>>)-*^&E]=^"/#FH7OC:X?PMX;G?3/#:Z5!@#[PBXL[F" MZ@,DT0FMIHKB(R6TTEM<1B6%WC+P7$4L$R!MT4T#_ 'X$G^$R:!X<^&W@?Q/\,_"T7P_\)?A MOXS\*>)_&_@[QUJ=I#K?CGPUXWUCQ%I'C+Q )/$7B6UU/7;BXU&7W'X;_ WX M2_!_4_&6K?#'P+HO@F[\?2^"Y?%,6@KF7H^'?@#PY\+/!-O9:*+EM&T*P M\-_#_P )>'/"^FZ;H%AI>GQ:?I5L7M9+DRW$OI]U=VME";B\N(+6!7AB,US- M%!$)+B:.W@C,LSI&'GN)8H(4+;I9I(XHPTCJIL4 >?ZW\+/ 7B+XB^ _BSK/ MAZ"]^(?PRT7QUX=\"^)7N]2CN/#^B_$L^%#XXL(+."]BTRZ37_\ A"/"_GRZ MC8WEQ:_V3$=.EL_/O/M'D%[^R+\'?$_[,^O?LE_$?3M>^(WP:\6Z)XD\->+] M$\0^,/&,&I>(O#GBGQ/J7B?5- O?%.D^(;'Q>NDF;4GTF."/Q#]H;P_!#HUW M=7=FUPD_T_10!\HQ_L4?L^'P3XK^'FJ:/\2O%GA3QC?>#-6U"S^('[0G[0_Q M'U#1M:^'FKQZ]X'U_P ^(?'GQ4\1>(_A?XC\*ZW!9ZMH?B+X:ZMX3UO3]2T MS1[R&_6?1M+:TZRP_98^ NG? GQA^S3!X @E^#/Q#T;X@:%X]\+ZAK_BO5=1 M\;6OQ6EU>X^)%_XN\;:IKUYX]\1^)?&]UKVKWOB7QAK'BB\\6:K?W\]_#P3XG\.6WQ3^%]WJ]A#J-U\-OB1#XJ\#W%W)>S3:"[:EJ M7VSZ8AAAMXHX((HX888TBBAB18XHHHU"1QQQH%2..-%5$1%"(BJJ@* !)10 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>8?&R2 M2'X._%66)MDL7PV\>R1. I*2)X2UED;# J=K '# J<8((R*]/J&XMX+N":UN MH8KFVN(I(+BWGC2:">"9&CEAFBD5HY8I8W:.2-U9'1F1E*D@@'\C?P./C/\ M9\^"/_!&#]F/Q1+KFN_!OXN?%_\ X)Y?'?\ 9,\87\FI^(9O#%U-\%=4\4_M M!?LT>)O$UPUS<6J^!=>U6;XK_!*X\07&=6^%GBWQ'\.]+NI1\&;==4]9\"?M MB_M8:3^Q[XF^+7P]^)?@CX9^%_V4?^"67_!,K]J#P[\'O!OP/^%FG> O&/C/ MXP^ /B+KWQ)\$ZQ;0:+'+X0^$VI:)X TW1/#?A;X7GP5JG@ZYG2]\/>([?2; M >&[W^FM_!?@^2P\,:6_A7PX^F>"KG2[WP?IS:%I36'A6\T2QFTS1KKPW9M: M&VT*YTG3;B>PTRXTF*SFT^RFFM+-X;>62)L^+X:?#N'2K[0H? ?@R+1=3\/: M+X2U+2(_"N@1Z7J'A;PW;W-KX>\-WVGIIZV=WH&A6MY=V^C:-<0R:9I<%U<0 MV%K;QSRJX!^(\/[<_P"T]JO[8&N^&HM4T#PIX1\,_MZ:;^R@_P */&7B_P#9 MHT'PIK?PSN+;28$UZUT74M>3]K'4/CIXO\.:G=_&?X<-I$,/PWUGPA;:5HLO M@NYT6YU+X@PYW_!1:\/@7_@HQ^S!^TK%-^.?B&]@3S8+;X*7 M/[3/[-'PP_::FU"W,R(^FZ3\ O'WCCQTSR+*8-1\"Z5,OEE&E7]QYOAE\.;C MQW:_%&?P%X+F^)5CI4FAV7Q!F\*Z!+XXM-%E65)='M?%SZ%M76O#=Q-=VLTL^@ZO+:6LFJ:-*[Z;J#VT#WEK,T,94 _F&\(?%?QW\/OVH?V MEOC_ .&_&NE_"_6/V^(O^"9.I>)/C5XCT_1M>TSX(_ OXP_'+_@H'X#^#'B( MZ;XC9O"<.KS_ 7^%GP:\#^#[CQ-9W7A'3?BA\8;36?$>B:\GGZ)JGT[X$_: M3_:U^,O[2ES^ROX0_:GL;7P3X%3]NRR7]I7PC\*/@]XA\3_&!?@1I_["^J^! M+BV@O]#UCX467B/X9>,OVEOB'\(OB]=>%?"5OX=\5WO@.]M+'PY\/_%@N+K0 MOW)O_AQ\/M5T_5]*U/P-X/U#3-?\-Z=X-UW3[[PQH=W8ZUX1T@7XTKPMJUG< MV$MMJ7AS31JNIBPT.]BGTJR&HWWV:TB^V7/FN\/?#KP!X2M- L?"W@CPAX;L MO"FBZCX<\,6>@^&=#T:U\.>'M7N;&\U70M!M]-L+6'1M&U.[TO3;K4-+TU+6 MPO;G3[*XNK>6:TMWC /Y0OB/\3_CK^T;#X;^+NN?'>?PQXK^.O[*'_!N9\7] M'^&+^'/!^I?#'P_\2?BG_P %"]1;Q9XW\)^%;V"W\8WNF^#_ !3IXUM].M_& M7D7TWBFS\/\ C34]8TK1_!UII/WI\0OVGOVO?!]_\2/@SIOQSA\4ZK\+OV[O M$?P/C\66Z?LK_"[]I;XI_#*\_8K^$W[2N@Z)\.8?C7H_AK]D[7O'G@;QA\5; MR3QII^M:5\.KWQ7\'_"9F\-ZEI/BRVUC5KS]MI/A!\*);SPWJ$OPR^'LM_X- MT:Q\.^$;V3P5X8>[\+>'],U32=;T[0_#ERVE&?0]'L=9T'1-6L],TN2TL;74 M]'TJ_M[>.[TZSFA=XK^$?PK\=Z5K>A>-OAKX \8:)XFUBR\0^(]'\4^#/#7B M'2M?U_3;&QTO3M;UO3M8TN]L]5U>PTW3-.L++4[^"XOK6RL+*TM[B.WM8(HP M#\>OVY/BE:_M"_\ !?BE;:YX=\:#XF0_L0ZS=>(/B/X!_X0'P;XEU'4_V MK/V?+75]1\*_@TW_!/?X;?%WQ9\>_V+/A!H?BW]E7X2Z1//IGA' MXT?MVMVMX##$AAC*\%X2_9S_ &?O ,E_+X&^!WP>\&RZJ^B2ZG)X M4^&'@7PX^HR>&M:MO$?AU[Y]&T"Q:\?0?$%G::YHSW!D;2M8M;?5+ V]_!%< M( ?DI)^TU^T7H_Q/O?V7_%O[1\7A?2=+_P""A?B?]G>\_:Q\0>!/@]I?C&#X M?V/[#?PL_:]\#?#^[TRZ\-V?P4M/B;X[\9>/=<\!Z+XJF^'<=EJ/@;P/J=K8 M^%O^$^U&RU^/\_?@+^UY\?/AI^SY\&?A/\-/B5H^E^&_^%8?MZ_M%+\??#.H M_LR>#O"GQ4\6:'^WG\>M$NM4E7]J+Q+:^&V^#/A32'LOB#\1="^&EY_PG!T3 MQ]X6^P?$'PEID-MJ.N?U,^(_AA\-O%^D^(] \5_#_P $^)M#\8:E9:QXMT;Q M!X3\/ZUI7BC5M-M]+M-.U/Q%INIZ==66N:C86NB:-;V5]JD%W=6D&DZ9#;RQ MQV%HL.=X@^#'PA\5Z-HGAWQ1\+?ASXC\/^&M8?Q%X=T/7O WA76-'T'7Y+JY MO9-WOFN;JXG:X,L\KN ?SG_ +5?[2GQ9_:! M^$_Q"A^)_P =_AC\(G\"?%'_ ()*6VG_ +-GAO3_ =K>C_&-_C-\0OV4?C1 MXC^(&@>,]>:\^)>NZ5KGQ$\0>*_AY\%]5\&:AI'AFULO@[XHN/&N@^)]1O-5 ME\,?T\1_=/\ OR?^C&KA]?\ A=\-?%?B+2_%_BCX?>!_$?BO0[";2M&\3:]X M2\/:SX@TG3+F\@U&XT[3-:U+3;K4]/L9[^UMKZ:SM+N&VEO+>"ZDB:>))%[O M_/Y]: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 3 **** "BBB@ HHHH **** /_V0$! end GRAPHIC 21 cy16q210q_chart-31980a01.jpg begin 644 cy16q210q_chart-31980a01.jpg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end GRAPHIC 22 cy16q210q_chart-32495a01.jpg begin 644 cy16q210q_chart-32495a01.jpg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cy16q310q_chart-47479.jpg begin 644 cy16q310q_chart-47479.jpg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end GRAPHIC 24 cy16q310q_chart-47496.jpg begin 644 cy16q310q_chart-47496.jpg M_]C_X 02D9)1@ ! 0 0 ! #_VP!# $! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_ MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P 1" #I 3T# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#^_BBBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _)K] MJ/\ X*M^ ?V3?^"A_P"R/^PY\2O %[#X8_:L\$ZSJ]M\>(O$$BZ/\.?&LWCN MQ^'/P[\,>+?#2^'IH8-!^(7C/4M)\(6?C&Y\4:=!IOBWQ'X8T>72[J'5);ZS M3X9?\%??V9&_9]G^/W[4OC#P#^RCI-S^TS^TS^SAX8T?QCXXG\077BF__9P^ M+7C+X<:GXBTR*T\,Z;K4L%WHWA(^-/%$4&@W&D_#[3;QUUWQ!)I]LFKW-;]K M7_@F'I/[8W[7.I?%+XJZGX=OO@%XK_X)Z?&7]C?Q3X2A.IP_$:R\9_$+XZ_" MOXP^#OB7X0U :=)I&D7?P_OOAU!KF@:RNJ0:YI'C2PT#4+&SE@@FFB_*S0?^ M"#_[87@GX ?LEZ99_M$?"OXG?M%?LZ^*_P!ORW\9:QXN^(7[5OPA\$?%SPC^ MW#\0+#QOJ7C#4?'/[.?BGX?_ !;T?QYHU]X=T:^\8>#B^I>!?B-9ZOX@\&Z] MJ;Z=:Z1KP /VR^&__!3K]ESXL?MS>-OV!_ WBL:[\5O!?P)^'GQZCU_3IK34 MO!'C#PS\1K$^(M.M?!.NZ7)?6VNMI7@>^\)^--4U@S6NAW.C^./#:>'KW7+D MZPFD^2?&?_@H;^T*GQQ_:)^#W[&G[%@_:OB_8\T_P3_PT;K6K_'O2?@IJD^)M5@\2:Y\,?"5MJ.MZ)X2@ M\376MWEXNG\_^R)_P3I^*G[('[5G@[X@^#/$WP>U+]GUO^">?[-G[(?C;PO! M:?$W2?&V@>//V8M1\<77A;7/AA9^(-=\?6G_ K/Q-%\0-86[T?QSX^UOQ=X M6M]/TC2K'5]<@6>\.7\6OV*_V\?AO\>OVMOB5^P#\;?V=/A_X;_;K;P5XB^* M&]9G^'?Q1 MMM(T:T^(/A:TUB3Q)J&@:QJ7AZ$ ^MO&?_!23]C7X4^-OA+\)_C?\;_!WP-^ M-/QA\.> ?$.A_!KXGZI;Z3\0/#C?$F:#3O"NC>/[;27UKP_X'U?4O$,EQX5L M1XA\06.G:QXBT_4-/T#4=6%LTQWM/_X*!_L>:Y\=-9_9D\.?'WX>ZY\>]'O_ M !MH/_"N+34KU;W4O%_PXT-O$/COP-HVN/IH\+ZYXY\%:2K7_C+P7H>MZGXK M\*6<-W"'\B?V_O^"3?[>/[7>K>.?",/[5_@/QG\(_$GP_\ V/K; MPY/\2M5^+7PV\1^&OB7^S3XUT;QG\0O$&N_#?X#6VC_!;XI7WQ^UO1;7Q#+X MV^)VA>*)?@K=";0?A=\/[&SFMM8L/9/!W_!-3]J7P9^WQJ?Q_P#!/Q/^%7P> M^!6N?M$_&;XX_$?PY\(O'G[35G%\?O#OQ3\(ZOI4?@+XH?LK>./%?C']E_PS M\2I/$>J6NO>//VH/AA/X>\;>.;K1CJ:^!M"U77]2>$ ^AO\ @FY_P5O_ &9? M^"A_P[^$3Z!XW^''@W]H_P"(7P9M?C-XI_9HTSXAQ>-?%7@71FU>;1]3M%UP MZ#X:MO$DV@S'3FU^&RTZUU?0!J^G_P!O:+I:75M)/Z7I'[=S:I^TE_P4'_9^ M_P"%8K /V%?@=\!/C*OBK_A+S(?B8?C;X%^+?C0^'FT7_A&T'A >&S\+AIPU M0:GXC_M;^VC=FPT_^S_L]Y\2_L5?\$G?BM^R_?\ _!):XUOQ[\+]1M?^"?\ M^R[^UI\$/B?;^%HO%$"^.?%O[1.K_#G6=+\0>"H[WP_I\;Z79WWA+6;SQ)/X MB_LC4KF]U&WN+6SO99KEX.V_:@_85_;23]I?]J/X\?L3_$/]F72+#]N#]FOX M:_L_?';1OVB]#^*DVJ^ ]9^$EC\3_#7@[XK_ OOOAL]W8^)KL>$/BOJ]GJ7 M@/Q99Z#93ZKX?T6\B\5+:W=Y:0 'KOPV_P""O?[(=Q^SM^R5\:/VC/BE\//V M;/%G[4_[/'PM_:&MOAKXD\5:AXC_ .$#\+_$RUTB"VU'Q1XJL?#%A::%X'M/ M%&J_\(G9_$CQOIW@GPQJ^KVMS;0S07=O=VEK]/>*?V[_ -CSP3^T3X5_9-\5 M?M%_"O0_VB?&D>B'PY\*K_Q/;1>);^Y\46MW?>$])D*H^EZ=XA\86-C=WW@[ MPSJVI6'B'Q=9V\MUX;TO5( )&_'K]H'_ ((W_'X>!_V9? 7[)?Q2^&/@'7O@ M)^P]\,?V--&_:4F\=_M0_ C]H?PH_P ,KNQEL/'E\OP*\;W_ ,+OVCOAS=2C M4?$<'[,WQO\ !MKX2TKQ=>:I>V?CQM/\2ZK90:?C7_@C?\9_$'[>>O?'JY^* M/PV^('P/^+'[0'[)O[3OQ9B\>>,?VK_"GQ#T?XG?LP>#/ ?AR4>"_A)\'OB_ MX+_9Q\67GC#6_AGX=\6>#/'?Q%TF?5?@A>:KK6CZ%X<\7^'K;3=)(!]@^,/^ M"P'[+Q_:W_9T_9!^"'CKX:_'CXA_%K]HOQY^S[\4K;PE\1HHM3^"NH> _A!\ M0?B3JFM2:9#H&J6GCEK+Q!X'C\ >(+#2-9LK3PQKFJ-;ZQK,.LV:Z#=/_: _ MX*G^"/@Y_P %&OV9_P#@G3HVA^!=6\=_&CP'XC^*OQ#\5^.OB9K?P_M/AOX% MT>YCCTJV\-:9IWPP\;V?CWQOXDTVR\6>(]/T/6/$7P]\/6>@^#-9N-6\76%Q M+9P2_&'[/O\ P22_:T^#OQ-_8<\,:Q\6OV;=>_9C_P""?O[5W[1WQN^%-YIW MA'XBV'[0_P 2/!/[1NA_':;4;'XDZM!M.\8>$/$?Q9L["6'Q#T^ MS;Q5K.LZ!K6DV^B:W]I_M;_\$Y_$/[5?[3FL?$G4?B#IGA'X5^,_^":G[7O[ M!OBJ/21JC?$C2M8_:;\3_#V^L_'/AB,6L6@R67AO1?#&KM-'?:S9WDNJ2:;; MI:7-A/>3VH!ZKX/_ ."KO_!.?Q_X(^+_ ,1_!W[87P1\1>"O@+I>GZ_\6?$& ME^*FN+/PAX7U76X?#>E^,IT-E'>:MX&U+7KB+2=.\<^'[75O"-]>L8+?6I&5 ML_X)X?&C_@H=\#H]&_:5^'7PLT?4M1T:TT'Q)?^$=#\ MA_$G3/AIKEIIGBV]\+ZNT5E8ZS=WS0:W9Z!JVF:HFGB32YKNQNX+^OR=^*W_ M 1<_;9_:/\ @E\1? _QJ^,7[)FA>-/#'_!.RR_X)Q?L[O\ ![P;\4_#WA/6 M_ ;?%GX*_$/6OBC\:I=;COM3T'6)],^"&@:3X<^&/@'2M>\+>%[[6/$&H1>( MK^.YLK>Q_8O_ (*6?L?^*?VT_P#@G]^T%^R!\-]?\*^"?$WQ9\ Z'X.\-Z[X MJCU8>%-$DT?Q5X3UQ7U&+0K'4=56S%CX=FM84LK&XD662W!01B1U .@\8_\ M!2G]A3X=_&B/]G7Q[^U!\)O"/QP/Q%\*?"6?X:ZYX@ELO$=C\1/'/AWP[XH\ M(>&M0BDLA:Z=-XFTKQ7X>.@ZAJ%U:Z/JNH:K:Z+9ZC+K;2:='Z-I_P"V=^R_ MJMEX/O\ 3_C-X0N8O'O[07B;]E;PE DNI+J6L?M"^#+_ ,5:=XL^$\6COIR: MM;>+?#EQX)\5/K5I?V-I;:=9:+=ZE=7<>FF"[F_*_P#:!_X)+_%CXMZC_P % M&M4T+QY\+-)OOVS?VRO^"?G[17@V\U*/Q0MWX=\$_L@+^S^?$_AOQA<67AZ> M5M;UB;X7>+Y?!\&D/J>E1/X@LGU/4-+:ZU(V?I7AW_@D]-I?_!2CXH?M:7GQ M&MT_9T\1:;\3?BO\-_@?H?V_2=>\ ?MD_M#?##P;\ ?C_P#'"TU2.P^PQQ^) M/@UX"@BT0PZC-J%KXS^(/Q!U8V>GI="?5 #ZQ\+?\%0?^"?'C6Q^-^J>%_VO MO@3K&F?LY:3=:_\ &34K?QSIZ:=X/\/6>N3>%I_$9OKE8+7Q#X<'BN!_",7B M#PE+X@T:X\7&+PK;7TWB">WTZ7P+XZ_\%M?V O@A\(?AW\;'^+,'COP3X_\ MVHO!G[)US<^%-/U6#4?AY\1/$8MM7\17'Q/\/>(M.T?Q9X,L/ /@>9O'6OZ; M?^'7\3ZAH4NF-XB^"O@5I%Q9? M#OPL%\'_ +,5K9OX;^*<-C\9_"'B?2=0\.6OA+6/6I_^"3W[>&I? FYTG4OV MCO .K_$;P#^W_P#LK?MK_LX?"/XI?%?]I#]H;X3_ KT[]G!M-?5OACJ_P"T M=\6K*\_:8\9Z1\2-234/$6=9TV[C\"-!IOACP[))I[WFJ* ?HGIG_!5/]E[P MCI7C_5OVC_C!\"/@I;:%^T?^TC\!_ ;V/Q7OO':>-D_9T@T[5/$#ZCL\">&I M?#7Q1CT#4K?4/$GP?M(?$NI:#>SV>BZ-X@\77]VB+ZQXH_X*3_L'>"OA=\#O MC5XH_:K^#.C?"S]I.^DT[X'>-;KQ=;G1OB1/:.8]8E\/M!%-'K*'Q;-JEQX8_;9^%R^"_AYX=T@:AH46GKXN\"ZX7U#Q%/=7 M,&EQV0230M0O[P>6/@?Q]^R/\:/^"8G@7_@G3J5KXAN?$_Q"^$7@[_@HU\%O M&WC#PU^Q]^T9^V!\!8OAU^UE\=C\;K6%?#?P.@_X6GX(^,-E!?:)I?@I?$'@ MJ/X9_$HZ;XO\(>*/'/@W3++3]3U _J9^%GQX^$'QL^$/A[X]_"SX@>&_&GP M<\5Z#>>*/#_Q$TF\9?#&I^'-.GO[>_UN"_OHK/;IMH^EZ@9KJ:.*-4M)I03$ M%=OS9_X)S_\ !7KX:_MT^ OVEO'OC?P%+^R[IG[/5]I?Q $OQ.\86:Z=XF_9 M&^(?A74?'/P/_:HO]8U71_"MIX3\(_$GPEH'BG5;W3+T7MIX3;P_=PW7B+4% M83+\W_LN?L1_M5ZY_P &]7P5_88TG4K/]GOX_?$/]F'0/A7XTU#XAV^O6.K? M#/P5\4O&%U=_%6RNM'TNPO\ 6+#XDVOP<\3^(]#T?1;E;%-$\=7MM;:O?6$& MFW4B>0_%K_@WHU62X\3^$?@=^US\7+CX6_&G]AGX@_L+_&"W_:,\3Q?$;7O" M'P_\*#PUXN_9!N?A#IG@CP1X!T6;1/@]\0] U'2?%?@SQ1?V<6N_#+QEXFT7 M2-?M;J +WX_?"W]G:_F^' M%S)>W_A7Q?\ %&X-]9:UXRTG5+6PUW0/"&D>!;'Q#\1I=9?1;EO$GA7P]?2> M"+;Q+?206Q^E_@9^WM\*/BG\1_%'PH\2^+/A-X9\>7?[2/QP^ _P7\->%/B9 M?>/=5^)T'P-^'O@3XF>*;G6(IO _A.V\!_$O3?"7C:'Q#XE^$TMWXAN]!\.P MVVL6OB76XY]1@TC\^_C/^P)_P44_:3^ 7C1/BS\0OV&_#_[0^C?'_P#8L^-W MP1T#X6_#GXFZ'\'XY_V/_&]CXT:P^+OQ*O;,_%[Q3!\2;M;F&QTNR\.-8_"; M3+2UT3PS=:T-4U754P/B#_P2(_:&UOX%_M90?#?XY?#[X8?M7>.?^"G?CO\ MX*,?LH?[;Q1>Z+\(-8\?^ O!'POU_PQXN2;0DUB^_M?X?CXI>&M2M=(LM M0TJ>/7O#=_(UQ<6$\=L ?2WQJ_X+(_LU?!W2?B3\5H/$?@#XE?L[_#?]D?XH M_M+2^+_AY\17U'XL>,-;^&'[0T/[-MYX'\$_"34_"6EZ7J_A;5/B2TW@V#XL M7/Q'L- MO'(M]"ETM]#EF\5VWIWP8_X*=_ GXJVOQ1^(NI^-?@WX(_9W^'?[ M,W[/_P"TU)\5M7^+HBUFP\(?&NV\>274_P 0_!.M>#?#D/@'0M'O/!4FF>%O M$!\4:]<>/K]]2@M-#T633[*/5_B+XF_\$2KB^M/$'PZ^#OC_ ,(>!_@]'_P1 M#^(?_!*?P5#J]AK=[XILO'/B7QUH7BO1_BIXAM+&T72]0T*Y72;F^\6F#5O^ M$CU#7M4O;B"UE69[D\!X_P#^"-'[2?QX^%G[76B_%?XN_!CP;\1/VD_V4/\ M@FW\,M-O/AH_Q5U/P=X?^-/[ OQ!\5?$62XU(WD/@GQE-\*?'VI-X3TT3Z5K M=MXXTVUN-=U.UCT_6-'T&YO #]46_P""I'_!/\_!OP[\?+?]J3X9:A\,/%GC M;7?AOX>U?2+G6]:UO4_'_A;29?$/BGP9#X$TC1+WXA1^)O"OAN(^)O%&C7/A M2"]\.^&9(/$>M16.B7-M?S?8OPV^)7@#XQ> ?"/Q2^%GC'PY\0/AUX]T#3O% M'@WQIX2U6TUOPYXDT#58%N+#5=)U2RDEM[NTN(VX9&#QR+)!,D4\4L:?SP_\ M.=_VAV^%46MWUI^S#J7[16M?M5^(OVA_$][9?M#_ /!2;P]XFT&&]^">E?!' MP_?_ S_ &YIOC=XG_:C\._%*VT/24;QOXEO/"%UX,^)/A&31_ASKG@:V@\( MZ=XJU#]KOV)/@[\9/V?_ -E3X)?!S]H'XSW/[0GQB\!>#UT;QS\7;NQGL)O% MFI-JNIW]J@%X[ZEJ$'AW2;W3O"MIK^M-_P )#XFM=#A\1>(@NMZI?JH!]3T4 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4A4-US]02I^F5(./;./RI:* 8' %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !156]@GN;2YM[:]FTZ> M:%XXKZWCM9I[61AA9XHKV"ZM))(S\RI<6\T+'AXV'%I)K$GC3Q-H!CL[C2V\/PPV(L=(M&$$EM/+]H,\OV@I(D4?Y2?\ #_/_ M (*$_P#0P?"#_P --:?_ #05^_<+?1N\1N+^'\KXEREY LMS?#O$X3ZUF=6C MB/9*K.C^]I1P=10ES4Y:*+IN<>2JM7".J:MI<_NAHK^%[_A_G_P %"?\ H8/A!_X: M:T_^:"C_ (?Y_P#!0G_H8/A!_P"&FM/_ )H*]_\ XE*\5^_#/_AWK>7_ %+_ M #_#UM\[_P 3>^$7\W$W3_F30\O^HWS?W,_NAHK^%[_A_G_P4)_Z�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�?^&FM/_F@H_X?Y_\ !0G_ *�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end GRAPHIC 25 cy16q310q_chart-47518.jpg begin 644 cy16q310q_chart-47518.jpg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cy16q310q_chart-47646.jpg begin 644 cy16q310q_chart-47646.jpg M_]C_X 02D9)1@ ! 0 0 ! #_VP!# $! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_ MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P 1" $* 6@# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#^_BBBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBD+*"%) )Z GDT +11D9QD9QG M'?'KCTX-)N49!(! R1D<#U/H/?I0 M%-5T;.UU;'7:P./K@G%.R,9SQUSVQZ MT %%("",@@@]"#D'\12T %%%% !1110 4444 %%%% !1110!\B_$3]MOX&?# M/X\>"_V=]=N/'.I>.?%VH>'=)O\ 4O"?PZ\7^+/ _P /=5\;.8? &G?$[QGH M>F7FC^#+OQQC17LDW]GVDEIKOBMO#?AO4=-UF\[;X2?M-?#;XW^)_%_A MOX?6'Q-O;?P9J7BO1[[QIKGP>^*'A+X9:SJG@GQCJ'@+Q-9>#?B7XI\*Z1X) M\;RZ;XITG5=/SX5UK5HKR'3;S4K"2YTN$WA_-[]KSX!?M(^)OVWO@[\3O@5\ M*;[PCKUOJ7@>&#]IKX=_$V/1?#0\&:-=VJ^/?"'[4_PHUJ[M]/\ '=EIGARX M\7Z?\-)M#\-^*M=UVT\8CPYI_BGX;WFCR:H^Y\#_ (-?&']G3QKK'C_P9^SE MXS^&/@3P'\'_ (VZ=\0/A3H?[2FJ_&[0OVC/B;XA^+FB^)OA;K'PAT[QWXSU M.Z\.6_AKP]!\0]7N/$7CC1OAAXJ>Z^)UO\.SX7X7P> M/= ^&R2^.]:\$OXN'B;3/"UO=:M>:;#!:70AX73?V_OV7M7\+WOBJP\9^*)( M[?4?AYIFF>&)_A+\7;'XB^+Y/B[!K=W\*+WP!\,;_P #6OQ \?:-\2+'PSXG MU'P;KWA'PYJ^BZQIOA;Q7?I?Q6OA;Q#+IGQ;X!_9-_:7^%_[2_B/Q!X)L?$( ML]3_ &L?VD/V@-2^*WB#XZZF_P (_&_P1^,WPV\5ZCH7[.VI?!6SUB\O='U[ M3OCKKGA2ZOM;3X975CX?\.^!9/'^@^/=9\1>(;GP%)YIXO\ V3/VE?B9\1?$ M_P 9=;^#'CGPKX6\7_%']DGQ_P#%OX,V?[2>E:K\<_$/BCX2Z-\=8O'^K_LT M?'RW^(%A;+6E8)%K#>&Y-&;PXVEKXL7Q@ MGBI&\'MX&.A#QFOC13X/.@_\)*/[+KI?A+\8O 'QM\,W7BKX?:K?7MEI>OZQ MX2\0:7KGA[Q%X.\5^%/%GA^:*'6O"_B_P;XOTK0_%7A7Q!IWGVMQ+I6NZ18W M,NGWVFZM:+<:5J>GWMU^9N@?LX?M%:5^POX*_9SB^&]E'XR^&_B/P#\>?"L5 MS\1_"QT[5)?A3^VAIO[07@O]G[QOXLM8Y;_Q-\3M6^&?AK1O#_Q#^,VHZ/>> M%_&/Q'O]6\6ZYXDUB\O]4UN^^R?V4OA_\0?#E_\ M)_$OXC>&9_ 6J_M#?M# MZA\5]'^'5[X@T/Q'J_@KPIHOPD^$7P5\.6GB2]\*7VL^$8_%'B*R^$9\::Y8 M^%_$/B32=+E\26^DKX@U6[T^[NF /KFBBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH *_#3]L/XH_%OX9_MW_"GQCXB^,WQ/T; M]FWPYJ'@32[D? ;QIX*O=#^%&M:FUE;^*]+_ &K/@EK41U?Q7X3^)A\5>#VT MSQQ9+XKUGP9X.N[G5_!OA?P5J^C77CO5OW+KYB^(?[''[-WQ4^,O@;X_>.OA M5X:U[XI_#YK"31?$EQ;R1F_DT.:6\\)R^*=.@EBTSQC+X%U2>XUKP#+XHL]5 MD\%:W'M+UK_ (3KX@Z5:^%->U'PK>W$ M%GX*\,R^$_#UO8S^);?QCJ-Q3N/C!^TM9?M3V_@GQAK_ ,<[:U^*_P"US\2O MV?H](\/:)X'L/@%X9_9LO_@9\5/%7PM\>_"SXAIH<^IWOQVT37? UAK7C>P_ MX2;7O&_AW7Y/'=EXN\":7\.M.\":E;?J)\0/V?\ X5?$J3QK>>)O"]N^N?$# MXYL/$U[X L-;U?Q'I_AU-9MYAD M:%KOB"VLS.VD:=XG\0Z#H&A:#XC\5:;IMGXE\1:'HVEZ/K>K:AIMC;VJ 'Y8 M^$)/VEM)_92_;L_:$^$_[4'Q%U#3)-&^+.C?LRZG\>1I7QG_ .$2\&?L[Z3X M\T'Q'\:=,TNTL/A^=1\9?%[Q[H'B34O!MAX@U"_\%Z+X*T7X:ZW>^']9EO/% M&B:[](?'C]H+XL> _P#@G%X'^,GA"[US4/BUXW\*_LC>%X]=TC3O"6H>(K+7 M/VAO'WP8^&.O^,-+M?%TFE^!1KVBQ_$75?$.ES>)X?\ A$;+6;>RN]>TRZT* M"[T^;[HTKX1?#71/AC_PIG2O!NAV/PN/AC4O!A\$06S#06\+ZQ:7MCJFB-:M M*SM87]IJ-]!(88B@!X=^P MYXT\9Z_X/^+O@CXC^(?B%KGC[X*_'3Q+\,O$]K\2K[P-XDUWPXTO@WP!\1O# MFB67Q"^'^C^&M)^)?A^3PA\0- U[0_%^J^%/"WB]++7%\+^,M&7Q!X:O-0U' M[:KSCX6_"/X<_!;PPWA#X9>%-.\*:'/J^K>(M0ALVN[N^UKQ%KUS]KUKQ'XA MUO5;K4-=\2>(=6G"/J.O:_J>IZO>"&WBGO7AMK>.+T>@ HHHH **** "BBB@ M HHHH **** *MW>V=A$)[ZZMK.'>(Q-=SPVT6]@2J"29T3>P4X4-N(!P#@UF M_P#"3>'/^@]HO_@UT_\ ^2:^,O\ @H4JM\![(,JN/^%A>%CAU##(M-=P<,", MCL:_$SR8?^>,/_?J/_XF@#^H#_A)O#G_ $'M%_\ !MI__P DT?\ "3>'/^@] MHO\ X-M/_P#DFOY?_)A_YXP_]^H__B:/)A_YXP_]^H__ (F@#^H#_A)O#G_0 M?T7_ ,&VG_\ R36V"& 92"I ((((((R""."".01P17\L,D,/E2_N8?\ 52_\ MLH_^>;?[-?U$Z#QHFCX_Z!>G?^D4% &M1110 4444 %%%% !1110 4444 %% M%(Q(''J!ST&2!GWZ]._3('( %HK^?72O^"KGQ^^,WAKX>?#_ .#GPW\.>'_V MB?CA\:_CY:Z9HESX-MOBG)^SA^SA\ -6\2Z#XT\1?%_X:Z=\?/ OB?Q-\9=+ M\0Z)X5\(ZIH^JZO\&? VE^,_BKI6CVMWXAB\#W4WC7])/^"?O[3WC/\ :I^" M.K^,?'OA_3;/Q)X*^*OQ5^$.H>-O".FC2_AA\6)OA=XYUSP<_P 1OAA:/XR\ M?W%GX+;7Q!X:TSQCXPT_28/$-Z ?N7LOB?1]#-EJT]Y;VH@U*'4)99 MQ)9?OO.C-F@C4_NR';=R!7T/7PO_ ,%"?^2$67_90O"__I)KM 'S'_P\?^)' M_1.O _\ X-/$/^-'_#Q_XD?]$Z\#_P#@T\0_XU^==% 'Z*?\/'_B1_T3KP/_ M .#3Q#_C37_X*0?$A4=A\.? _P J.V/[4\0\[5+8Z]\8K\[:9)_JI?\ KE+_ M .BVH _J.TVZ>]T^QO)%5'NK.UN71"2J-/;QS,JEN2JLY"D\D 9YJ[63H/\ MR!-(_P"P7IW_ *105K4 %%%% !1110 4444 %%%% !1110!\+_\ !0G_ )(1 M9?\ 90O"_P#Z2:[7XGU^V'_!0G_DA%E_V4+PO_Z2:[7XGT %%%% #)/]5+_U MRE_]%M7]0N@_\@32/^P7IW_I%!7\O4G^JE_ZY2_^BVK^H70?^0)I'_8+T[_T MB@H UJ*** "BBB@ HHHH **** "BBB@ HZ]:** /BSXP?$[]B/\ 9G\2?%#Q M+\4+/X5^"/&GC;X-^,OBM\7M2L_AG!JGB_QS\(?AQ=:!X3UK4/'UWX5\)ZGK M/BNQ;5O&>@^"O"7AWQ+<7^J>-O$.MQ>$? VDZ_J_VK3H?7?V;/'_ ,%_B/\ M!OPAK7P!TVW\._#'28M1\$:-X*C\ :K\)KWX=7O@'5;WPAKGPXUKX4Z]H'A7 M7?AIKG@76M(OO#FJ^"-7\-:'>Z!=6+6IT^*#R'D_-K_@H!X4^%OC/]IWX+Z. M/AE^V7\ ?'WPE^$/QW\,?$?X46?Q]US]H7 MQ3\/]/L-%T_X^Z'!K7A?0OA1X\T3QQXSMM+\9:)XNL]5^'BZE#']P?L1^#9/ M!OP,B&I>"_CKX*\5>+OB%\5?B'XZM_VDI_A%+\7]=\;^//'^N>)?$7BCQ'!\ M!_$GBCX3:5I^MW5\K^$M"\%WUMINA>$+?0])DTO3KRSN82 ?7=%%% !1110 M4444 %%%% !7PO\ \%"?^2$67_90O"__ *2:[7W17PO_ ,%"?^2$67_90O"_ M_I)KM 'XGT444 %,D_U4O_7*7_T6U/IDG^JE_P"N4O\ Z+:@#^H70?\ D":1 M_P!@O3O_ $B@K6K)T'_D":1_V"]._P#2*"M:@ HHHH **** "BBB@ HHHH * M*** /A?_ (*$_P#)"++_ +*%X7_])-=K\3Z_;#_@H3_R0BR_[*%X7_\ 237: M_$^@ HHHH 9)_JI?^N4O_HMJ_J%T'_D":1_V"]._](H*_EZD_P!5+_URE_\ M1;5_4+H/_($TC_L%Z=_Z104 :U%%% !1110 4444 %%%% !1110 444A./S MY]R!V^O'OUXH _'3]N_X=>(_C7^U+\)_ ?P.TWXJ-\=O"OP-\:^+?$'BKPW^ MVI\2_P!B[X=^%OA%K_CO1-&M=.\3ZS\(?A=\7?&OQ.\3>,/&F@2_\(WX=;P= M+X=\*V?A;4_$&IZ]HFHW>C:?XE^L/^"?7B%M:_9TL=,U(_%FW\9^!/B'\6/A MO\2M'^-/QBO_ -H#QIX>^)'@7X@:YH'B_18/C'J-EIL_C_P?;W]LMUX"UQM+ MT:=_!U[HUMJ/A_PWJ]OJ/A_3/QD_;<_:C^#OQ9\<>#([O]K']C[P3\7O@MJW MQP\">(O%^G+_ ,%&?@[\2?#T%[\3KBTLO _A_P"(O[,/Q4^%_BB7PW)X4\+^ M%;?XH^&/$&O>(O"?B+XDZ ?%'ANQTRPM=%CL_P!@?^":%UX1N/V/?AO#X&UO MX+>(O#%AJGC^RL-9^ FC?%K1OA_J5PGCSQ!<:OJ#?\+RU_Q3\4]:\8:CK5UJ M.H_$#Q9XR\0ZSK/B_P :7FM^([K4;N74GG< ^]J*** "BBB@ HHHH **** " MOA?_ (*$_P#)"++_ +*%X7_])-=K[HKX7_X*$_\ )"++_LH7A?\ ])-=H _$ M^BBB@ IDG^JE_P"N4O\ Z+:GTR3_ %4O_7*7_P!%M0!_4+H/_($TC_L%Z=_Z M105K5DZ#_P @32/^P7IW_I%!6M0 4444 %%%% !1110 4444 %%%% 'PO_P4 M)_Y(19?]E"\+_P#I)KM?B?7[8?\ !0G_ )(19?\ 90O"_P#Z2:[7XGT %%%% M #)/]5+_ -EI#COC&1U]TOX9RZ?\4?$6F>#] \/:-K?[,'BJ_N-,U;P?#I^N-HT[V= MU\/)YCX!O[GQ%>Z--K]Y^QW_ 3^O/%5]^S%X.N?&?BC5?&/B!]<\(4M+416T.F6OA.QF\,Q1KH%Y<:A= M6,M[-^$/Q[\??\$@'^+/Q@M?V7=)^%]A\<4^)'C>R^-.MV&K_L9_#/\ 9_?X MN0>)+JR\;#XF6W[=MM>>!=>UN+Q/#>R>+]8_9\^'/B3QQ=WOVXOJPO'DND_= MO_@GM M(X;<0Q?$*>RCM+*?QRFNRV6GV%F\%I" ?:]%%% !1110!\[>/OVL_P!G'X7? M%WP!\!_B!\7_ ;X5^+/Q/>TB\&>#-5U"6*_U&;5+F>PT"WO;J.WETKP]<>+ M=3M;K1O!%OXEU#1Y_'&NVMUH?A&/6M7MIK)/8-,\<>#=:\4^*? ^D>*?#^I^ M,? ]KX=O?&7A:PU>QN_$'A6U\70:C=>%Y_$.DP3O>Z/'XAM=(U.YT9M0AMSJ M-M8W5Q:B2&(R'\2OVQO"/Q;T/]OCX6^,?@/\(/BY;>/?%FJ_#F#4=1&C>%_B M-^RY\?/#?A\V%AKMQ\5X]8MI;KX'^+_@]X4N_%"1>+[/5O"^O:QIZ>";[PO% M\0]1LO\ A%M.^IOAY\/+']F#]I__ (*(_'2'X4ZWHOPQ\<> /V:?';:GX-\, M#4M4^)_CO1(?CU+\4=6L[6TE35/%OC*V;Q!X736)KQWU![2;1].MIGMK.RM+ M< ^Y+?XY?!N[^*5_\$;7XH^ KCXOZ7IG]L:C\-(?%6C2>-K+3OL=GJ3W-QX< M6[.I1>3I>I:7JMQ"T N;;2=5TK5;B"+3M3L;JXH^(/VA/@;X6\,^-?&7B'XN M?#O2/"WPY\7GX>^.M>O?%VB1Z9X5\?8T@KX'UNY%XR67C&1_$&APP^%GSKLU MSJ^G6L5@]S=PPM^8?@_X0?%ZU^/W@_X?3?#?QYI]_P""_P#@I)^T-^V#X@^- MG]A6$7P\UGX$_$;X/_%_0O"^G:;XX-ZJZGXJU!_BKX3^#-QX)M(3XLTJR\!Z MSK>K:=8^%-/\/:_K/DM[^RKX\^%W@_XB^'?A]\*/''PP^&VA_P#!6VR^.ND: MW\$O!/AW7OB=X ^#L/P \%:7#\7_ (*_#[5M*\3Z!XSNM5^*\;>%_'L>K>!O MB%J5_P""O$7Q5\0P^"?$'B>.UU.U /VV;XM?"Y/AM_PN1_B)X(7X2_\ "-#Q ME_PLQO%.B#P%_P (DUL+Q?$W_"6F^_L'^PFM2+A=4^W?8S$0PE)(%?$7[8OQ M*\ ?%O\ 9=T3QQ\,O&/ASQWX1U+XD:';6?B'PMJ]GK.E2W>FCQ%8:G8-=64L MJP:CI=_!/8:IIUR(;_3;^">SOK>WN89(EX3]F^T\7?"#]B/PQ\+O'O[+'Q)^ M)NO>$M&\3?$>3P)?>%/!MUK?C3PY=?M+^)->\,^(?$L&OZY/X$3]I>^\*76E M?'[QI\,M,N;*UM/B$^HZ/X+MO#]R-"T#2_GB7P-XV\$_LJ?&^X\7V?Q ETWQ MW^W'XA^(?@3QG\8M TCPA\:?B7X1\1^$]"CD\:?%'P=H.D^&=(\+ZF/%FG>* M?"O@O2X/!7@&]_X5-X8^'MUKO@W3/$%QJEWJ(!\D4444 %,D_P!5+_URE_\ M1;4^F2?ZJ7_KE+_Z+:@#^H70?^0)I'_8+T[_ -(H*UJR=!_Y FD?]@O3O_2* M"M:@ HHHH **** "BBB@ HHHH **** /A?\ X*$_\D(LO^RA>%__ $DUVOQ/ MK]L/^"A/_)"++_LH7A?_ -)-=K\3Z "BBB@!DG^JE_ZY2_\ HMJ_J%T'_D": M1_V"]._](H*_EZD_U4O_ %RE_P#1;5_4+H/_ "!-(_[!>G?^D4% &M1110 4 M444 %%%% !1110 4444 %%%% 'E6H_ OX*ZO?7.IZK\(OAAJ>I7LTMQ>:AJ' MP^\'WM]=3SR----Y\.^&?#GA'2H=#\* MZ!HOAK1;:2>6WTCP_I.GZ+ID$MU,]QSO'EOS.]C^9O%CZ267^%?%7^J^*X5QF<5/[.PF8?7*&:4<)#EQ3J)4O8U,' M7E>'LVW+GM+FTBK6?^GAE-V[:=V,;O+;=CTSMSCVH)0@@J2"_P#S14?\+V^-_P#T6;XN_P#AT?'O M_P T5?I'_$EV9_\ 1?8'_P 1^OY?]3;U_K?\S_XG;R;_ *(#,O\ P_8;R_ZE MOK_6_P#IX93&-IQC;CRVQM_N_=Z>W2OAG_@H. /@/9!0 !\0O"^ !@#_ $37 M>W&*_P _.3XZ_&_RY?\ B\_Q='[F;_FJ'CWM&_\ U,-?WQ_MGR22_LJ>!999 M'EEDUOX;/))([222._AN_9W=W)9W=B69F)9F)9B22:_%?&/P2Q7A#2X>JXGB M"AGBS^>:0@J.7U,#]6_LR.7.3DYXO%>U]M_:"22Y.3V3UGS*W[AX,>.&#\8I M\0PPG#V)R/\ L"&62F\1CZ6-6)_M)XY)05/#8=TO8_4GS-\_/[1)6Y6Y?CS1 M117X8?NH4R3_ %4O_7*7_P!%M3Z9)_JI?^N4O_HMJ /ZA=!_Y FD?]@O3O\ MTB@K6K)T'_D":1_V"]._](H*UJ "BBB@ HHHH *\X^,7C^X^%'PD^*'Q1M?" MFO\ CRY^&_P[\:^/8/!'A6!KKQ1XQF\'^&M3\0Q^%O#=JL4[W6O:^^G#2M)M MXX)Y)KZZ@CC@G=EA?T>N0^('AG4/&G@7QEX0TCQ=XB\ :KXH\+:_X>TSQUX1 M?3X_%7@S4=8TJZT^Q\5^&FU:RU+2?[>\/74\6K:2NJZ;J.F/?6D,>H6%Y9M- M;R 'YN?LV?MN?M%_M _")O'OA7X,?L_?$.YU/XM^+?!F@>./AC^TVU]\!=,\ M&>%X_&]YJ_B7XA^,;KX<:G\0O">I>'IO"^D^%/[)LOAGKMYXNU/QAX4\5VEE MX5\,7GB6+P;SVD?\%6/#WC"[^ ]CX*^'7A5=3^*WPO\ @3\5->\-_$?X_?#W MX8^*8=-_:!\<>)_!'@CP[\(K36K*ZT3XM^(;X>!_%?BS2KO5=>^&?A+Q5X7D M\!Q>&?$FH>*/B5X<\/1\#'_P2M^,&J^'_B6GB3]IOX>Q^(_CG\8M-\:?M!:/ MHO[.VI6'PE^//PV\&ZW\9O$/A?X,_$_P 79/$?QGN8 MOB0UEXW\->%?!_P+NK&Z^$NC:U9>,/>?B/\ \$\]8^)]SX@NM<^+GA+13\9_ M@U\%_@9^U!:>#/@98:#8_$7P7\"OB!XH\:^"I/A-]J^(FKZI\$-6&G>.?%_@ MRZDOM6^*FEV6AZCINI^'=)T/Q5H-AKC '9_LZ_MM2_M ?'SXN?"RRB^ 6D:! M\-/&'QF\'V6F6'QXU;Q!\?=9_P"%,_$:;X6:SXIU'X0?\*ITGP]H_A:X\5Z5 MK4=WSL#]N!O^%SGPD?AW8CX,_\--']CH?% M@^/%_P"$C_X7R/AR/'?E#X;#PG]D_P"%='62?A>/$W_"?_\ "4_\+!!#> AX M3QXEK2N_V3?BAK/Q/TCXD>)OVA;;Q%-\+KK]HK7/V?+>\^#VB6.J^!_%'Q]L M;_2;:?XEZQHOBW3;+XL>&/A=H>K:AX<\&>'-)T#X7WVM:*UE=?$/Q)XO\7:9 M9>*DRK7]AN6/XOVWC"\^)UM<_"J/]HZ']KRZ^%$'P^M[34;C]H)?ADGP_GU2 M+Q^_BRZ:V^'4VM"3XI)X,;PC<>)(?B"X<_$27PDG_"+, :__ 4'(;X#6+#H MWQ!\+$?0V>N$5^*%?M?_ ,%!P%^ UBHZ+\0?"P'T%GK@%?BA0 4444 ,D_U4 MO_7*7_T6U?U"Z#_R!-(_[!>G?^D4%?R]2?ZJ7_KE+_Z+:OZA=!_Y FD?]@O3 MO_2*"@#6HHHH **** "BBB@ HHHH **** "BBB@ HHHH *3(]_R/^%>=_%SX M<6GQ>^&/CSX7WWBOQ_X&L_'OA;6?"MSXQ^%?C#4_A_\ $?PS#K-H]F^M>"?& MVC$:KX6\3:>LGGZ1KNG_ .EZ==*EQ#\ZBOR9/_!$CX=DD_\ #PC_ (+#\^G_ M 4Q^/V/_2J@#]JLCW_(_P"%&1[_ )'_ K\5?\ AR1\._\ I(1_P6'_ /%F M/Q__ /DJC_AR1\._^DA'_!8?_P 68_'_ /\ DJ@#E_\ @X5R?V#=%P"'/'_ /P4'^,?C#04U6Q2XBLM372/$$>H:>NH6<5W=1VMZ+<7%O'= M7"12(LT@;QG_ (A3>&'!JX8QW#69Y MK76:X[,/K6$QN$H4N3%K#1C3]G6A*?-#V,G)WL[JVVO\C^-7T;LY\5.,O]9\ M#Q-E>4T/[+P67_5<7@L77K<^%E6]/^9GE_E?\ Y=>OW??^1_\ $DW$O_1< MY%_X;,P\O^GOF_N\S^/V16$4ORM_J9OX3_SR?VK_ $,_VR@6_91\!A59C_;/ MPT. K$X_X1J^YP ?Q]#P:_,X_P#!K?\ \$[""#\3/VZ""""#^UMXL(((P01_ M8'((X([BO?=8_P""#OP3\1:7!H?B#]N3_@K1KNB6S6CVVCZS_P %&?C?J>E6 M[V$)M[%X-/O6GM(FLK=F@M&CB4V\+&.$HA(K\ \=O&O+/%VCPQ2R_(\?DSR& MIG$ZKQN*P^(^L?VG'*U!4_81CR>R> GS8RJ.I[>4N=5/KL5#DM;V;?[-?47_$.]^RM_P!'6?\ !3G_ ,3U^*W_ ,BT?\0[O[*QR#^U9_P4 MY((((_X;U^*W(/!!_P!%Z$<&@#]X-!(_L32.O_(+T[L?^?*#VK6R/?\ (_X5 M^*:?\$1?AQ&B1Q_\%!O^"PL<<:)''&G_ 4O^/JHD<:A(T15N0JHB*J(J@*J M@*H %._X$QJLD MBM+&&_-K_AR1\._^DA'_ 6'_P#%F/Q__P#DJN*\>_\ !O\ ?LZ_%70E\+?% M']LG_@JC\2O#":A:ZLGASQ__ ,%!_C'XPT%-5L4N(K+4UTCQ!'J&GKJ%G%=W M4=K>BW%Q;QW5PD4B+-(&]'*9Y73S+!3SNCCL1E,<13>84,MKT,-CZN&3_>0P ME?$T<10I5FO@G5H58)_%!GGYM#-*F6XV&25L#ALVE0FLOKYE0KXG 4L2U^[G MB\/AJV'KU:*?QPI5J!6G_&-^*'3_FI^&/[M_\ FG/)_CW/R[^S M_'?_ **7PNZ?\TQQ/Y?]5%Z^MGW/L;_A^G_P3B_Z*SXP_P##-_%'_P"9JD;_ M (+J?\$XE5F/Q9\8852QQ\&_BB3A02>/^$:YX!XKXZ_XATB:RMV:"T:.)3;PL8X2B$BN1_XAWOV5O^CK/^ M"G/_ (GK\5O_ )%K\BER\TN1-1N^52:;?[-?U!:"1_8FD=?^07IW8_\^4'M7X/_ /$.[^RL<@_M M6?\ !3D@@@C_ (;U^*W(/!!_T7H1P:]*3_@B+\.(T2./_@H-_P %A8XXT2.. M-/\ @I?\?51(XU"1HBK_Y'_"OQ5_ MX+;OP'XO\.>,+;PK\0_ M^"A?QN\:^ O$D_AS5K75XM"\:^#]6N&TOQ3X4U62T6R\0>'M0!LM9TN:YT^Z MS!<2 _KM0 4444 %%%% !1110 4444 %%%% !1110!P_Q,^)'@KX._#KQW\6 M?B3KL/A?X>_#/PAXC\>^./$ES:ZA>V^@>$O"6DW>N^(=8FL])M+_ %2[BTW2 MK&ZNWMM.L;R^G6(Q6EK<3LD3>/\ PL_:^^ 7QB\91_#OP?XKU_3_ !]<^&;O MQGIG@GXD?##XL?!CQ=K_ (2TZ\L+#5?$OA?PY\8_ W@/5_%6A:->:MI%MK>J M>&[35;31)=8TA=6DLO[5T\W/!_\ !2+PKXH\=?\ !/G]M[P9X)\.ZYXN\8^* M_P!D[]H'P[X6\*^&-*OM<\1^(_$&L?"[Q-8:1H>@Z+ID-SJ.K:QJE]/!9:;I MMA;SWE]>30VUM#+-(B'Y$^-_BGXE?M1>,_V;[_\ 9/\ AO\ %73?&/[.^C_M M"_%4_%3XP_!?XC_ SPGI?C#7_P!D;XR? OX7_#.S_P"%Y^"O!.L^+=4\4_%G MXG>#_%VLV>@:1J_A31_#WPTO+_QGJ%G-/X9L=6 /V-WJ<\GCU!!/;@$ L"2 M",@D@"C>N,\_3:V[MU7&X=1U ZCU%?RO_#;X>_M5V?P_\43Z%K'[7>I:)=_" M_P#9K_X:T\%:!\"OVN_A!XYUMS^T%\*-1_:+_P"$/\<_'3]IOXC^+_'/[3UM M\'K+XU:+XBU;]E708_#OCGP/JSMH7C>?QDOP6TL^J?&+P7XKU&X^&UG\*O#G M[5_@O]AJW\1?M%L^G?%CX1_MT_)_B;/IWP$G^'FL>'OA!\&/C+\*?VM/ M?P\._%*'7M;M?">@:7XF^"_B>, _I,+J.I[9S@D8]2 M0, >I)P.YK@/%'Q4\ ^"_%WPU\!^)_$5OI/BWXP:YXB\-_#?19K34YKCQ1K? MA/P9KGQ"\06%I-:V5Q:6DFF^#O#>MZW))J=Q8P306$EO:RSWLEO:R_S<>.OV M?_VO?$WPI^-WC#Q%JG[:GB;XT_#;]D7_ ()@2? WQ/#J7Q;^&?B^7XPQ^._B MFGQY\16O@#X?_$CQGX5N_C-:^!;[PQHGQN2#Q1\1IK>RC4:_JLZ:K>O<]3\8 M_P!GK4O!O[3WAKPQXP^%O[67B']C;X5_\%!M>\6Z4O@2']I7XFW.@?"SXD_\ M$J-0TSQK?6&O>$M0\2?%C5O@WJW[1^KZAI?BK0?">IZGI+^/=9U;0O[(DBU' MQ#IL@!_2[O7@Y)SZ G\\ X [DX /6CL? /C+XYZIX@TG1?%^C^.=(\3Z_X4\>R MZQ>:W^FG_!/[X*?%73/BQ^TW\6_VB[[XT^(?BE:>)?@GX!\&:_\ $?4O$_AO MPSJ/A ?L/?L@3?$S5_!_PMTSQEXC^$.DW/B;XZZ;X_N?'>H>";SQ5I=K\1]- M\5:-HWB^_M+">2< ^S;']KS]G/4_C/+^S_8?%'1KKXIP^(-3\&G1(=/\0MH\ MWCS1/"L7CK6_AQ9^.3HP\ 7_ ,3M$\%2KXOUGX9V7BFX\>Z3X8$FO:AX=M], MAFN8_0_"OQH^%7CCXC?$[X2>$/'?ASQ)\2/@O%X+E^*WA'1[]+_5O #?$2PU M?5O!=IXH2W#P:5J>OZ3H>H:O::1<3KJL>DBRU.[LK:QU;2;B^_+;XT_\)7\2 MOVOOV:H? _PD_: \.^,O@)^UQJM_KWPP\4?">$?LD>*_ACXF\)>,K'QA^V7/ M\7=%\+6OA&Z^)EKX*\7:AI_PJMA\6KWQWIOQ"U2\\(^*/@Y->WNL^*]%[[X6 M>#O#O[*'[5?_ 4D^-!^$^I_#_X(6_[/W[+7Q'EU'P)\-+]=-\:^(/!L'[6? MC'XS:CX9T[PUI0D\?_$".;7-.U3Q='IBZKXHU'5-=TM]3>>\U2S,H!^AGQ<^ M,OPS^!/@]_'?Q6\66/A'PW_;&@^&[.XN+?4M3U+6_$_BG5+?1/#'A7PQX=T* MQU7Q)XL\6>)-7NK?3?#_ (7\,Z1JVOZU>RK;Z=IUS(&"^*:C^W;^RIIGPY\/ M?%.?XLV=SX7\5>*_%?@31++2?"WCW7?'=UXU\!6^MWGQ \)3_"K1/"FH_%/3 MO$GP]L/#FNZE\0M%U3P99:AX#TO2-0U3Q;!H^GVSW-<_^W'\:[_X-?!#0?B+ MX*^ FM?M$?$*Z^('@S2/A+HFG?#SQMX]T?P)XU\4V^IV%A\8?'K?#GP3\0O' M_@KX=?#SP_=:YJWC#Q=X-\(ZOXK_ +-G/A'PS:S^(/%FGV\GYV?"GP]I_P ! M/B#^S?\ M27MA^T1\>]%N'_;@LOVF_BA:?LF?';POXZG_:4_:%E_9P\8Z3X\ MT7]FV^\ 2?%_PW\*/^$>^!]W\#?AV_ASP[XET/PKH/\ PA.B^*O&&OZK=^(_ M&5P ?K[KG[2?P&\.:5\%-;UCXL>"+;2OVC_$7A7PI\!KZ+7+:_@^+FO>-M%G M\2>%['P =/-TWB9=6\.6USXBCO=-6:PMM MY]:OKJUTV)[E<.W_:K^"M[\9] M8^ .FZMXVUGXE>'-=TWPQXDM]!^#?QGU[P7X9\1ZOX-TSX@V.A^)OBQHWP^O MOA/X=U63P=K>BZY-8ZUXWL;BRM]9T>&]CM[S5+&VG_('0/V/?'/A3]F+_@E! M=>(_@M=:C\>/A;^U%^S[JGC+4X/",&O^/O@]\)];\;_%/XBZ_P"$-;U_3(=4 MG\+>%?!,/B;PYHGC:+3M4C\*0ZKHMC%/,OV:]8\'^&M%^)WQ!L?$=AH8^ $?A MN]^&WA/0K7X6Z>/$3_M,>&OC/I>C^$M2A7PHOB.QD /W$_SZ?SHI%SM7=][ MSTZXYZ<=?3CTI: "BBB@ KY$U[]N[]E7PSXTUGP-K7Q4CM+WPUXYL?AEXI\5 MIX-^(EY\(_"/Q&U&[L=.MO 'C'XZ6'A"Z^"OA'QM_:VIZ9H=QX5\2?$#2];L MM>U33-!O[.UUG4+2PE^N7!(P.S(>_175CTYS@''J>N1Q7X-Z8_C+X>?\$]_B MI_P3UU_]GWXV^.?VE;SP-\>O@)H>F:=\(O&VK?"+XUZQ\6]8\-?&_A_QMX,U!?%NBZCX0N?&%IHFDZ\ ?O$ MTL:*SNX1$5G=V^5$5 6^%?#WCCP3XAT?Q M9X-\6Z+IWB3POXH\/7]OJ^@^(?#VL6D=_I.N:-JEB\UIJ.DZG8S0WFGZA:RR M6MY:RQ7%O+)%(CG\0/#'PFUJ'X\>+? GQ]\,?MG_ !*^-[?&KP9X'^%/Q \$ M:I\:-(^!>H?LG+\ O _@Z_U7Q/XJL]:LOV?M&^'L^HQ?$[5/C;X&UB[M?C1X MF^*VHKJ_A?1[W5)OACJ=I\9?!;X/ZG\/?V3_ -G#X??$OX2_MW:;X2\ ?\$U M_"W@7X,>"OA#X>_:ITGQ+X*_X*%^%=8\<:?\=X?$6E^"I++Q3X>\?:CK ^%* M_ 3XD_$Y[#X"VWAW3O'4_@+Q=IWA*_U6XU$ _IP\$?%/P#\1]0^(6E>"O$5O MKU_\*O'][\+OB!;V]KJ-N?#?CS3_ WX7\77GAVZ>_LK2*YN8?#OC3PQJ9N= M.DO-/>+5HH8[Q[J&[@M^^W+DCG\CS_NG&&^BYK^87X$_"S]H/P_\8?%=]XQ\ M _M2:5^V[XG_ ."A?[*_CC5_'V@:/\8M&_9AUGX*0? +]C/2/VUM?CUBPFTW M]FZY\ ^(M+\)_'7PU?6&IQ'Q%XM^*47@T^!M/U.XT#PI?Z%PEC\/_P!N9= ^ M,^I:AXA_:3_X:0VX!_5MN& M,\X^AS^ QDY[8!SVS7F7PG^,_P +/CIX%=*\8>,? 5YXC M\+7G]IZ)_P );\/_ !!>^%/&6CVFJ1(++4I/#_B/3K_1KZZTV>\T\W]G^)?AKH/C;_ (*0?M3^"/A7X:TGX'/AAJ^BC3O^$?\ $ZV]IX1BTV\TC[)="VO+/> ?8_QQ_:K^ M G[.5QH=C\7_ !]#X:U3Q%H_BGQ+I>BV'A[Q?XRU]_"7@:&PN/&_C>]\/^!/ M#WB?6](\ ^"XM5TIO&'CS5["Q\'^%SJFFIKFMV,E_:)-C>)_VSOV8?"'C#P/ MX&UOXQ>%TUWXB:3X#U_PQ-I::QXA\--H7Q5U>3P_\*M;U_QMX=TO5?!7@S1_ MBGX@AFT#X8:IXS\0^'['XB:[#+H_@V?6M1C>W7Y$_P""@?QD\9^%?&O@;X0? M"GP!\0O!?BOXQ_#SQ=IGQ#_;5\)?LR?%WXZ-\!?@Y#JVG6>J>$_ J?"?X;>. M;OQ%\=?'.J:A+>_#/PAXMN=/^'/@TZ-JOQ<\=6OB9?#OA_X?>//A?XH_ [5/ M!WPN_;$_9>^#7PD^-M]H_P"US\%?V)O ?[%WB&'X4?$S4-+\/^#? WPF\$_ MZ+0?B=XTU+PI8CX,:C\!Y/!T_P 6_%:?''4? OB#^S?%,USX9M]6\6I?:#: M'[ZW7QE^%MG\7M%^ 5QXZ\.K\9_$'P^\0?%;2OAJE^D_BZ;X;^%]?\/^%M:\ M:W&D0++/I_AVW\1^*-%T2VU+4OL<&IZG<7%GI)OIM-U1;+SGX7_M??LX?&?X M@:M\+_AG\4]%\5^,]*T_Q+J\6GVEAX@M-/\ $NC>"_%$7@GQIK?P_P#$FJZ- M8>%_B9H?@SQC<6OA7QCK7PZUKQ3I?A3Q%>6.CZ_=Z??WMI!-\Q_$#X O#_P4 M?^%?Q6^'_P /$\+S>-OV.OVTO#OQ/^,OA_PB+=;KX@:QXW_8GTGX61>._&5E M8J]]X@A\+^#M>'@G3M;U&2Z30_"NN1Z%;I::=J(3XK_X)F^!/CU\,_$7['OP MSU*R_:4EO_A-^R=XF^&/[9FD_'KX?WV@?![X>?%/P+9?#/PA\/HOV9O$%UX1 MT;P=(/%>KZ'XMFMD^ /B'Q%X!\9?":TL/&'Q5FD\?KX4U*_ /Z Z*** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ I-H!SCG&,]3CKC)YQGG'3-+10 MW:O]T=,=,\#H/8#L.@]*7:OH/KWYX//7D<'U'6EHH 3 Q@<# XP!TQCI^% M! /7US^/^?UYZTM% ";5XX' (''8]1]#@9'0X&:7&.G^?IZ444 )M&N.,XJ"ZM+6^MKBRO;>"[L[N&2WNK6ZACN+:X@E4I+#/!,KPS12(S M))'(C(ZDJZE3BK%% !C/_P"LC^5)M!ZC/IG)(R,<'J....V?6EHH ,#CMCIC MC^7;VZ4FU!S2T4 )M&OX@8!^N.,]<<=*"JGJ >"/P/4?0]QT]N*6B@!-HSG S_A MP/R[>F3CJ:-H]!W_ SU(]">Y&,GDTM% !5:XL[2[-NUU:V]R;2Y2\M3<013 M&VNXUD2.YMS*CF&XC265$FBVRHLCJK .P-FB@!,#W_ D?R-&!UQSQ^G(SZX/ M(ST/(YI:* "D"@'( !Z?@3D@>F3R<=3R:6B@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **_.?]I/\ X*G_ +'_ .R?\4;SX/?&7Q;XOT?QO8Z'H?B& MXLM'^'?BKQ)9+IGB&*YFTR1=3TBSGLWEDCM93+ '\R A1( 6%>!M_P %Y/\ M@G4JLQ^(/Q#PJLQ_XL[X]Z*"3_S#?0&ON\!X7^(V:8/"YCEO _%&.P&-HT\3 MA,9A&Q>#Q6=8"AB<-7I2Y:E&M1J5XU*=2$DU*$HJ2::MM?]E**HZ9J% MMJVG6.J63,]IJ-G:W]J[HT3O;7EO'-]?^&?ASXG?#W7_ (C>%8I9_%'@'1?&WAC5?&OAR"&6"":;7_"EAJMQX@T: M**:ZMH99-2TZU2.6X@CD*O+&K(9Z/129'J.1D<]1QS].1^8HR#T(/XB@!:*3 M(ZY&.F:MI4-P]_IMKK7]D:K_9-Q M>V\$.I?V9J'V)Y_L5SY6NSHBEW=515+,[,%554%F8L2 %50223@ $G@4 .HK M+T;7-&\1Z/I?B'P_J^F:YH.MZ?::MHVMZ/J%IJFD:MI=_;I=6.I:9J5C-/97 M]A>6LD=Q:7EI/-;7,$B30RO&ZL8])\0Z#KYU,:'K>D:R=%U:^T#6!I6I66HG M2M3>VGG1?:((_,3< ;%%,61'7__E(;XH_[))\(_P#TW:W7XN/_ *N7_KC-_P"BGK^]K]L+_@CI^SY^VC\: MM0^.7Q%^(OQD\-^)=1\-^&_#$NE>"M3\$6NA)9^&(+N"RGCBUWP5KFH"ZG2[ M8Y/D.69?C84LGQ5:G#$X7"TJ-:,*L?=J14 MXM1G'W9+5:'^;WB/]&GQ3XE\0>+.(LKR_*:F69OQ!CLQP4ZN<86C5EAL1B'4 MIRG2E[U.;BU>$M4[I[,_>?P%_P B1X/_ .Q6\._^F6QKK:S='TR'1=)TS2+9 MY9;?2]/LM.@DG*&:2&PM8;2)Y3&D:&1XX5:0HB*7+%55<*-*O\[L1.-2O6J1 MORSJ3E&ZL[.3:TZ:'^C>'A*G0H4Y:2A1IPDD[I2C",7KUU3U/(OV@+/XCZC\ M"OC/8?!ZZ:Q^+=]\)_B/9_"Z]66* VGQ&N?!FMP>![H33RP0Q&W\42:5*LDL MT4<;HKO+&BEU_*3]GWX@?\$[+SP'_P $_? OP_\ #WA;Q'^T-XC:!JFD>//!.G:(]QXNT?]H?4?BS!)IFO M^.=@N/VXK+M]$T>TU&^U>UTK3K?5=36%-1U*"QM8=0U! M+9=ENE]>QQ+=7BVZ?+ MS+*L0 $87 QB;'\POBO_ (*7?'35OV1?A?KGPU_: M1T?4/CKH'_!&G]I'XW?':XTG1?A[XBU7P-^V#\._%'[%WA#2-6^(?AM-"?3_ M MXU\)^(/&GQHL-0^&%];Z%97$LNN0:GX:V:1IUSIGTU\7_ (E?M@_!?QQ_ MP4&'@3]H;XN?&%_V+?V0/@;\2/AA\/\ Q-X7^#\T7COXB_&BW_:A/C;QK\2[ MCPG\(K#7M?TSP+I7A+PWXC\)>#?!\.A6EH_@:WCU"S\6IJ%_IE]^[L?A_0X3 M?-%H^EQMJ9Y*R2JHD=8?-D\H.S",R/Y87>V0#^:#P[^U M;^U-K-]I'P_\)_MB>&_%/A7Q5^V#^PM\,;?XC?#WXG? _P#:@^('A_P[\;;S MXW/\7/#5Q\1_!_[+_P */@>EEXT\&^#O _BCP-I*>&_%'C_X:ZIJVI:MK=K; M>#-<^'^CS:7PE\>_$CQ=_P %#?V2]*^+G[1?CO4+;X&?'?\ X*L_LR>$-=\0 M3_"_P[<_&*'P8W[,/B'X=>$?B$MCX$TC1O%7CW4/"NL>);%4\&:?X5U_7/#_ M ,.X=:M+6/4K'QEK&L?T>V6@:'IMNMIIVCZ786J7LFI);6>G6=K;KJ,LCRRW MZP001Q+>RRN\DEVJ"XDD9G>0L2:EET?29W@>;3-/E>VU#^UK=Y;*UD:#5/+> M+^TH6>(F*_\ *EDC^VQE;KRY'3S=KL" ?@U^U%\>_CMX?_;>\=_"?X:?$YOA M=IOBOXV?\$GOAG?>)_"_P_\ A9?>,8O!/QKO?VQQ\4=.'B#Q)X*UJZU>YUG3 MO VC6WAJY\4'Q#9^ []9M3\,:9:#4==LM9X+2?VH_BS+XPE^!?QN_;8\2_!# MX6_#WXR?\%"OAQ:_M(ZYHWP4TWQI\3?$_P M?\ @3_PHSX3>./$'B'X?6$\ _%'XE>+K_1O#?@[PSXN^+]C\-K&WL;@S:!XW;7OZ)WT^QDF-Q)9VKS ME[:0S/;0-+YEGYOV5_-:,R;[;SYOL[;MT'FR>44\Q]T%SHND7D?DW>EZ=;?M,4J))'*KJK _D>\&_M9?M, M_"K]F/\ 9:\"> OC3X$^!^C?"W_@F)^P7X[^"O\ PL'XG^ OAGH?QI\<^-/A M?K%MXLO-:^%_B?\ 9S^-'Q3^.OA^P\6^'O"?POU3X4_!CQ#X/^(?A=_$/DVM MI<>-/&'@C6M/^C?@9\9_%?P\_:.^-^B_#+]HVXU+XG>,O^"T/Q ^%WB#]C6S MLOAGJ5I??!CX@:#\.IOBY\4&TN7P>_Q?EN?ACH":M\9=-^*:>)[3P%I:^$D\ M!ZKH,JZAK>G:C_2E/H>C74FF2W.DZ;<2Z++Y^CR3V-K-)I4YB,)FTQY(6;3Y MC"QB,MF89#&?++;.*='HND1:@=6BTS3X]4:&>W.HQV5LE\8+J:.XN8#=K$+@ MPW$\,4\\1D\N::*.657D1& !_'G\!OVEOV@/@W^S3\!/A'H/[4"_#KP?X?\ MA-^U'X]U?XL?%'XW? ?X2ZHWQ^\&?M,^-/#7BCX/ZWK_ (^_9M^+.C^)I_@O MX<70_B#XE^!\.B^&_B9K/_"RY[K4M5UC0K'2=&T;Z3_:<^/?Q'^+_A#Q+X8_ M:(_:7TWX8?$#1/B=_P $E/\ A!/V6?"GAO0M#\%?'CP[\1?B;^R)\2_B5\4] M"TKXE>!;3X\>)=)U?XP7_P 2O NB:OH^H^$/^%0:3\)5@\;Z!8:E)XSBU'^G M";PQX[MH+AX);B&WN9HGFABN);6VDGBC=8YI+ M>"216>*-E /YYO!_[3W[9/AJQ^ GQBL?B[XR^.OB+X\?&'_@JW\,8/V?]7\& M_#6R\"7=O^S%_P -B>+/V>-%\'6_@WP5X?\ 'EOXQ@O/@5X-\$:GK%QXTOXO M%NE:YK"7^D1ZBVB7FC^.?#;]M7]J_7_A+\7-?LQ?"CXHZSXM\2 M_%WP+\1KGX/?$GQ?\:OA;X6O6N]:^%7[&FC^%OV7O"7C;PQXB^)/@*;3_CEX M=^*^I_!7Q;X>T/XBZAX5U3P9X&^+.H2?U!I862>1LM+5/LTMQ/;[+>%?(FN_ M.^TRPE8P8I;CSY_/DCVO-YTOFL_F/NJV^A:+:+J:VNDZ;;KK4\]UK"P6%I"N MJW-S&(KFXU-8X5&H7%Q$!%/->":6:,>7*[ID4 ?S(>+/VX?CE<_ KX=ZEHO[ M56O^$Y?"_P 4_P!J#PEX\D\7?&7]CKPCXZ^(=Q\//"WPI\5>&!\"/VIKOX/> M*_V/?V@- ^$]IXWU03^%/$Z_ 3QM\5;K[?I'BO4]*U;X+_$S2M5_HQ^!OC;_ M (67\%OA'\1=WB)O^$]^&/@'QIGQ?X9A\%^+/^*I\)Z1KA_X2?P?;75];^%/ M$)-\6UGPW!>WD&AZBUQID%W<^)?B]\+?!NJOH?BOXA>#O#FL1P074FEZUXATW3K]+:Z#FWG:UN9XY5B MG".8G*A7"L5)P:P#^T3\"0"3\7_AP 23_PE^B\ #))_TKH!R: /9:*9%+'- M''-"ZR12HDD.IP/S/'UHH **** "BB@G'/\@3^@YH **"0.I Y Y]3T'U/:B@ HHH MH **** "BBB@ HHHR,D9&1U'<9Z9^M !10#G_P"N"/YT$X_^L"?Y4 %%%(2 M,DX'J>/YT +111GMZ^Q_GT'X]>U !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 ?AC^WG_R<1JO_ &)_A#_T1J-?&4G^JE_ZY2_^BVK]GOVA/V,] M<^-?Q*O/'ECX]TGP_;W.BZ+I2Z;=^'KW49D?2H[E'F-S!JUI&RSF<%(Q"&CV MD,S[@1X>W_!-GQ0R.O\ PMC0!N1ES_PB&J<;E*Y_Y#_;.: /U7T'_D":1_V" M]._](H*UJIZ=:M96%E9LXD:UM+:V:15*J[6\$<)<*2Q4,4W $D@'!)QFKE ' MFOQEN[NP^$GQ0OK"ZN+*^L_AWXYN[.\LYI;:[M+JV\*ZO-;7-M<0LDT%Q!,B M2P31.DD4J))&RNH(_/7X=?M'?$#X5_\ !+;]BGXF:=:Q?$7XQ?$_X,?L$_#+ M0-1^).O>(%T2_P#BE^T98_!SX::=XV^*'BJWM]7\1W&BZ;XA\;/XK\6W4/G: M_P"(I+:32+6^M]9UNWOX?U%U33+#6M-U#1]5M8K[3-4LKO3=0LIP6AN[&_MY M;2\MIE!4M%<6TTL,@!!*.P!!YKXT\(_\$ZOV/?!/A+7? &C?"(77@#Q%X @^ M%^H^ ?%'C_XK>.O R>!K&XT2[TG0],\'>.?'GB/PWH2^'[GPWH-QX9U'0=,T MS6/#$VD:?+X>U'2WMHV !\@WG[;O[6-O\>_#/['D&A?L^S_&NY_:1N?@YXB^ M*\FA_$Z#X6+X"US]CKQM^U?X/\?Z7\-_^$VD\6VWC+3G\&7O@CQ3\+[_ .)5 MS8722Z5XCL/B)I4&N_V?HW(>#O\ @H[^TY\8/!%A_P *W\ _ +PO\1OAU^S? M^T'\>OC2WQ&UCQ]+X"\5:E\"OCY\5_V<[7P9\+;O2KS2=8\+:3XR\4_!GQ9X MPUWQUXK/C*3X6>'-6\&:/?>#_&>H:]-J]C^FOP^_9#_9T^%TOA"\\%?"_1M, MU;P/X^\6_%/0/$-YJ'B/7_%1^)'CKP1<_#7Q9XZUWQ9XDUO6/$WBWQ7K7P^N MCX+N=<\7:MKNH)X8M].T6VFM['2M,AM/CG]JW_@F;H?QK\-^&?!'PFN?@?\ M#;P9IGA3XZ^$;G0_'_P+O_BA+H4O[0_B6Z\6?$3QAX(UG1OB?\-]9%_K6NZM MK6L>(_AU\0K[Q[\&?&>NOX;UO7O RWWA'3S= 'S5^T-_P4+^,'Q,_8+\,>,? M@AIGQ#^"W[0'B'P;_P $_P#XH:Q\0_$/[/OQHB_9X>T_:!^+/[+MMXS\'_#C MXQZC'X<\&>.));/XQS>'[BP\->-=8UZ3P]8^,K.W:#5=+N];T7U+2/\ @HC\ M>-<^/NL^%/#WP>O_ !1\*_!?[4\_[*/C";3O@;\;+.]>?09;#PKXU^.ME\;+ MC5[KX*:1H.@>/+Z6YM/@I=PZMXGU7X?:=-J5K\3'\7WNG^%)OT43]ESX.7?[ M-'AS]DOQ3X97QM\%_#OPQ\#_ GCT#Q)<7!NK[PS\/=(T'2?#%QXT^\M;66'G9/V)?V7)OBOIWQNNOA!X? MOOB7I>KZ+XG@\1:A?^)-0CN/&_AOPNG@K0/B3JN@WVNW'AC7/BKHOA.*'P]I M?Q6UO1-1^(]CI,%O9V_BF..V@\L _,+X>_M]?MX?$;X=?LK:_:^$OV4/#WB? M]J3]BOXV_MMVT=WI_P 8M:T+X;>%/A7X?_9QU#P]\/;Q+;QGI6H>.=?\::I\ M:+Z#5/$EK<^#[#P=IYL[BUT+QC<^'KBW\8?3_P"QE^VM\8_CG\1_!'A3XM># MOAMH>F?'+]B3X._MP_#&'X>7/BN>^\!>'?B3KAT35OA5X]U?Q1=/:^.="K;Q!\/]+$EZ[#0M4@^'7@F*Y6Y:XO M-OAVP\N[C(G,^EX)_9^^#?PYU?PCKW@GX?Z%X=UCP'\'O#_P \(7]@MX)]!^ M#OA6[M+[P]X!LO/NYT&AZ5=V%I/;+,DUYO@3S+N09! /R$^/G[3/[1GQ,^)/ MPC\0^%[_ ,'> ?V?OA__ ,%8_ 7[,VJZ)HNM>.-,^-?BZT^%L/C#3O'6L:_< M6.KV_AG7/"?C?QC!-INF?"!/##W-YX)L='^(5UXLUIM1C\+:?\U?&S_@HU^U M!\:/V%OC]XXM_AMXL^''AOXH?L%?%3]HCX6>._#OP\^._P %-4^#FMZ39>!/ M$/@+P?J?Q@\)- O+5O!^L>&_$6A>)A M^Z&L_L6?LO>(/C!#\>=8^#?A:^^*EOXP\.?$:#Q/(^M1K%\2/">DQ^'= ^)" M:!!JT/A_V&?%U[X2@M_"NH:S=^'H(M-3C++_@G3^Q186GQ M&TZ#]GCP&VD?%3P/XM^&/B[0KE-;O?#W_"M?'VMQ>)/'7P[\+^'[W6;C1/A] MX$\:Z_;6>M>+O!_P\T_PIX=\2ZI8Z?>ZSIMY/I]D]N ?GM^T[^U/^V]X*/@EX'^,7@W]J_\ X)D:A>?$+P/X=^(&J> O%'P4_:]^.GCCX>WWPUUK MPIK7BVR\1V^N>'_%7PFU_2O%VKV/BZULOB!\--3L;[3=$^'>L:Y*=#U MJZN;RVU ?&[Q;XK\7^.])W&99X='O;[QCK5I;6<4Z&TL)U@BD78K _%CX;_ M /!1O]H'2-"\"^$/!7PF\4?%'1_@?\.?V(_#/Q3DE^%7QM^(/BOXM:Y\9/@= M\%?B5X\\0:3\==$NK;X4_"_4_!W@[XI:5K%C9?$NV\77?Q)\4Z=KFEZIK'@& MWU#2-;N_7++_ (*$?M1P:I\?]"UCX0> 8_B9H'P__:*\4? /X":SX=^*WP\U MOXAZG\(/B%IOA_PE)X"_:'\276I_LU?M,^&/$WP_U?3O'WC-_AMXO^&OCGX= M:O?Z+X#U+P//)J^H>)O#?WIK?[!_[(WB+Q/X+\7:O\#/!MWK/@+2?AMHFA#_ M (G5OI%WIGP:GBNOA%;^+?#=IJ]OX:^(+?"V\AAO_AW<_$#1_%%WX+U&*+4/ M#L^G7D:3+#:_L#?L?VNH?$6__P"%"^"+V/XJ:+\0?#OC'1=7CU?6_"<^B?%G M5XO$'Q1TW0?!>LZM?^#_ 5;?$?Q!!;Z_P".U\#Z%X;?Q9KEO;:QKCWNHV\- MR@!C?L6?M(>(OCYX4^),?CS5?"USX[^&GCV+PUK6B:5\)?CI\ ?'&C:1JW@[ MPWXMT _$CX _'^QG\?\ PZ\1:A#J^H-I"Z5XJ^(W@KQEX=M-*\5>%?&=R=4O M]"T+XJ_X>!?M/:=^SGX%_:SUKPO^S2/AK\>]$^$?C#X2?#BUU_QW%\6?!OA_ MXI?M,? OX6Z?IGBT76I-I?Q.O;?X4?&"X\5^-?$/A32_AY8?"KXA:1IGA&_T M/QOHFNQ>(8/U(^#/[/WPD_9_T?6]%^%7A&/P[#XFUF/Q!XGU*\UGQ)XK\3^) M]9M]+L-#LM0\2^,?&FM>(_%WB"XTW0]+TW1-).L:Y>II&BZ?9:3I:6>GVL-L MGCT'_!/W]C>!?B;"/V?O 4]C\7/#?BGP=XTTB^MM4U'07\*^./$MOXU\9^'? M"_A_4-5N=#^'FC>+/&UEI_C;Q)IWPZT_PG;:WXTTK1_%NHQW'B'1],U*T /E M+XD?MP_M"S?M9WW[*GPA\+?!NSU&?]K31_V?M/\ &WQ#@\<:K9:-X1;_ ()_ M0_MFZ]XLU+0?#/B'0Y]=\11:W'/X,TC1+35O#VG7&F7]E?7NI6US9W$MYXYI MW_!2']IR[^'WPO\ $^H^ _AY!JW[2?[1O[1?P=^#ME\//A#\>/CAJ'@'P7^R MUXQ^/.A>-O'/Q \%^"/$]AXD^(GB3Q[8?"OPXWA3P1X3O/ &E>$WUS6]6\0^ M.-)/$6N:OKGB;Q9J/PQO9_!>H>(/$M_J^J7VB^3#=7,LMK M:S06_$'[(?[.7B;X8:/\'=5^%NA_\(!X:\=:U\3_ KI6FWOB#0M1\(?$7Q% MXE\4>+M;\<^#?%6@ZSIGC#PAXKU'7?&WC"YN==\,^(-*U%K;Q/KNEK.ND:G= MV$H!^6]U_P %$_VS/$%A>:?X<^#WP=^&_BSP'^Q=\?\ ]J3X@V?Q'/"5OJ?A+Q/X3T#XT:'X3;QEH][XU:?Q;\)XM5M=*\2> M%/'&J6M[91^X_L+?M#_'#]H']JW]KS6?%'BK2O\ A1*?"[]AWQQ\(_A?)H^H MMX@^'MQ\;/@+;_$C6[.7Q0NO#1M2C>\O=176Y(?#%MZW:6VI?#_X9I+#X T75-&&JMH6J3^$ M;.:;3="U[4-+N?$MAI$TNCQ:S_9(=0TSX5326^D^%_!&N^#[31/">C:_[2G[8W[1W[0OP=\> M>(O@TG@CX0?"SX=_%C_@F1X=\7O=>*O&=M\;=8U;]HSQU^R'\$] \"?&OPS\.YO#^H:#K=U\7;J;X@::-:\)6EE9Z1KWZ\:%^R)^S M=X9CUN+0?A'X6TR/Q'X!^(?PNUM;==2QJ/@#XK^/?$GQ/^(?A>X\S49"=-\5 M^/?%_B3Q/J839<'4=7NC;3V]N8H(^.\2_L#?L@>+M<\+^(?$'P(\&7^I>#]" M^&7AW13NUVTL3IWP6U"TU3X/2:QI%AK-IH_B;5_A5?V4-S\./$/B?3]9\0^" M6:Y7PWJNG17MY'. ?F#XH_X*)?'WXM>%/BZ_ASX7>)]#^#OC;P[^W1X \-^+ M=/\ A-\;_ 7B?X0_\*,\!?'F#P=\5+[XZ^(+N+X5?$"]\7:_\(+JUN? OP_T MSPYXB^'.K>+/#4FG^*?'$7AKQ9>VG@GQ4_;7_;?^'/["6D^";OQ7\,_#WQG\ M4_L ?LP_M._"KXN^#1X]\3W_ (=TV3XK?L^_"7XI>#?B5=^)O$$=[XN\7:Q9 M_$W2-9\/?%+19O#$?B-[_P :VEWX%TR[T"QU_6?W$/["G[)A^(7BGXHO\$/" M,GC/QB/B-+K%]*^N2Z;%J?Q@TBZT'XL^)- \,2:PWA3PCXQ^)VCW^I:=\0/& MOA'0M"\7>,;75-6C\0ZWJ U743=97A;_ ()\_L;>#/ /Q#^%_AWX!^"K'P'\ M4O NB?##QCX=E;7M2M;KX;>&+:XM_"WP^T:YU76K_4?"'@CPH]Y>:AX5\*^# M;WP]H7AG6[V]\0Z%8V&O7=QJ4@!\5^&?^"AWQ_U[X]W?@_2O@_=>+_AIX._: MJC_9*\=W&B_ OXX:3/<7FC7>F>#_ !Y\>-)^,]UJVL_!K0O#NA>/M1GO--^! MU[!XD\6ZG\/=.>^M?B==^,KW3_"MS\??%S]OC]K+2;+X!?MQ3V'PO3X>^(_V M!OV_?VGOA)\"?#GBOXA:;'=OHB?LRZG\+O"'QYGFU6?2O'&MZ;X_$;P M]J?AWQ%8>(-6U+Q1K2S^-?"/A:'P5X9^)6LZ+J^OWWAWQ)\6-#\)VUMH&F?% MOQ'I&K?$RUTRVM[>/Q8!;PLG,C_@G7^Q6+_QEJ'_ SWX&,WCSP_\1_"6OP$ MZ^=-C\)?%[5=.U_XH>$_#NCG7#I'@OPOX]\1:38>)O%7AWP78^'M&UCQ/ ?$ MMW9/KDT^H2@'Q1\4/^"B/[0GP)\7?%_X'?$+P)\//&'Q>T7XF?LC>#?AKXI^ M$O@CXO\ BCPG#IG[6&E_/-\4?"S3=5\0_$CQAJGPH@^!'CS*>$/$&@1_% M.34?"4$=I\,'O-7;3,?Q%_P4&_;&LOAUX>U6/X")X9O-,^('QZ\(^/?B9K/[ M/'[2'C/3IM(^&_A7X?>*?A7XO/[*O@+5KG]J3X=>"?BDWCV\\/\ CCQI/8?% M:T^!>N>![[^T]&\=:/XW\%:K<_J+\0?V6OV?OBI+\2+CX@?"WPQXGN_BUI_P MWT[Q]?ZA%?+J.M)\'M5UO7?A7>PZC:7UM?:'K?P\USQ%J^M^#_$7AVXTCQ!H M&LW8U33M3@O[:TN+?R^^_P"">O['5_X,\-^!9/@AH%KI'A37O'/B?2M3TK6_ M&NB>-I=>^*,<$/Q/U36_B5HOBC3_ (C^*+GXF06>G6_Q%/BCQ9K*>.K?2M&M M_%2:M#HVE)9@'RK8_M^_%>\_:(^&^@W^E?"?P[^SG\1]2_9XTGP#\3X_#?QO M\>_#OXR0_'7X::)XB&J^!_VHO ND:C\+/AMXMA^(GBG1? OPT^#7Q]^'/P]U MKXQZ9)HWB?1/&^AW'CSPQH"?KP"2 3C.!G&< ]QR >#Z@'U Z5\JI^Q#^RG! M\1?#?Q3LO@EX-TOQ=X37P$VBG1HM4T3PQ%>?"K1(?#7PMUB]\ :1J=C\/M9\ M1?#/P]:V&B?#SQ-K?A;4O$/@C2M*T>P\,:II=MHVE1V?U7TH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ *HHHH **** /_V0$! end XML 27 R1.htm IDEA: XBRL DOCUMENT v3.5.0.2
Document and Entity Information Document - shares
 9 Months Ended
Oct. 01, 2016
Nov. 04, 2016
Document and Entity Information [Abstract]    
Entity registrant name PERRIGO CO PLC  
Entity central index key 0001585364  
Current calendar year end date --12-31  
Entity filer category Large Accelerated Filer  
Document type 10-Q  
Document period end date Oct. 01, 2016  
Document calendar year focus 2016  
Document calendar period focus Q3  
Amendment flag false  
Entity common stock, shares outstanding   143,374,427
Entity Well-known Seasoned Issuer Yes  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
XML 28 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2016
Sep. 26, 2015
Oct. 01, 2016
Sep. 26, 2015
Net sales $ 1,354.9 $ 1,344.7 $ 4,219.1 [1] $ 3,925.4 [1]
Cost of sales 848.6 795.9 2,622.7 2,369.7
Gross profit 506.3 548.8 1,596.4 1,555.7
Operating expenses        
Distribution 21.6 24.9 65.9 63.3
Research and development 50.2 41.6 142.5 139.7
Selling 154.6 167.9 506.9 391.6
Administration 108.6 123.6 316.8 343.3
Impairment charges 1,679.9 0.0 2,127.1 0.0
Restructuring 6.6 2.2 17.9 3.1
Total operating expenses 2,021.5 360.2 3,177.1 941.0
Operating income (loss) (1,515.2) 188.6 (1,580.7) [1] 614.7 [1]
Interest expense, net 54.6 43.4 163.2 132.7
Other expense, net 1.0 13.0 34.1 294.2
Loss on extinguishment of debt (0.7) 0.0 (1.1) (0.9)
Income (loss) before income taxes (1,571.5) 132.2 (1,779.1) 186.9
Income tax expense (benefit) (316.3) 19.6 (383.7) 112.7
Net income (loss) $ (1,255.2) $ 112.6 $ (1,395.4) $ 74.2
Income (loss) per share        
Basic $ (8.76) $ 0.77 $ (9.74) $ 0.51
Diluted $ (8.76) $ 0.77 $ (9.74) $ 0.51
Weighted-average shares outstanding        
Basic 143.3 146.3 143.2 144.4
Diluted 143.3 146.9 143.2 145.0
Dividends declared per share $ 0.145 $ 0.125 $ 0.435 $ 0.375
[1] The BCH segment was created on March 30, 2015 as a result of the Omega acquisition, thus data for the nine months ended September 26, 2015 includes only six months of results from operations attributable to Omega.
XML 29 R3.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2016
Sep. 26, 2015
Oct. 01, 2016
Sep. 26, 2015
Net income (loss) $ (1,255.2) $ 112.6 $ (1,395.4) $ 74.2
Other comprehensive income (loss):        
Foreign currency translation adjustments 27.0 (39.8) 71.8 50.9
Change in fair value of derivative financial instruments, net of tax 3.6 0.1 (3.5) 5.6
Change in fair value of investment securities, net of tax 9.8 2.5 18.4 (2.4)
Change in post-retirement and pension liability adjustments, net of tax (0.2) 0.0 0.3 3.7
Other comprehensive income (loss), net of tax 40.2 (37.2) 87.0 57.8
Comprehensive income (loss) $ (1,215.0) $ 75.4 $ (1,308.4) $ 132.0
XML 30 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Balance Sheets - USD ($)
shares in Millions, $ in Millions
Oct. 01, 2016
Dec. 31, 2015
Assets    
Cash and cash equivalents $ 362.7 $ 417.8
Accounts receivable, net of allowance for doubtful accounts of $4.4 million and $3.0 million, respectively 1,129.2 1,193.1
Inventories 884.6 844.4
Prepaid expenses and other current assets 250.6 289.1
Total current assets 2,627.1 2,744.4
Property and equipment, net 881.3 886.2
Goodwill and other indefinite-lived intangible assets 5,282.7 7,281.2
Other intangible assets, net 8,340.9 8,190.5
Non-current deferred income taxes 129.3 54.6
Other non-current assets 206.3 237.0
Total non-current assets 14,840.5 16,649.5
Total assets 17,467.6 19,393.9
Liabilities    
Accounts payable 507.9 554.9
Payroll and related taxes 106.8 125.3
Accrued customer programs 325.5 398.0
Accrued liabilities 258.7 308.4
Accrued income taxes 76.2 85.2
Current indebtedness 265.0 1,018.3
Total current liabilities 1,540.1 2,490.1
Long-term debt, less current portion 5,638.0 4,971.6
Non-current deferred income taxes 1,169.3 1,563.7
Other non-current liabilities 448.9 332.4
Total non-current liabilities 7,256.2 6,867.7
Total liabilities 8,796.3 9,357.8
Shareholders’ equity    
Preferred shares, $0.0001 par value, 10 million shares authorized 0.0 0.0
Ordinary shares, €0.001 par value, 10 billion shares authorized 8,151.4 8,144.6
Accumulated other comprehensive income 71.5 (15.5)
Retained earnings 449.0 1,907.6
Total controlling interest 8,671.9 10,036.7
Noncontrolling interest (0.6) (0.6)
Total shareholders’ equity (8,671.3) (10,036.1)
Total liabilities and shareholders' equity $ 17,467.6 $ 19,393.9
Supplemental Disclosures of Balance Sheet Information    
Preferred shares, issued and outstanding 0.0 0.0
Ordinary shares, issued and outstanding 143.4 143.1
XML 31 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Balance Sheets (Parenthetical)
shares in Millions, $ in Millions
Oct. 01, 2016
€ / shares
Oct. 01, 2016
USD ($)
$ / shares
shares
Dec. 31, 2015
€ / shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Stockholders' Equity:        
Preferred shares, par value | $ / shares   $ 0.0001   $ 0.0001
Preferred shares, authorized   10.0   10.0
Ordinary shares, par value | € / shares € 0.001   € 0.001  
Ordinary shares, authorized   10,000.0   10,000.0
Preferred shares outstanding   0.0   0.0
Ordinary shares outstanding   143.3   143.1
Allowance for doubtful accounts | $   $ 4.4   $ 3.0
Commitments and contingencies | $   $ 0.0   $ 0.0
XML 32 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Oct. 01, 2016
Sep. 26, 2015
Cash Flows From (For) Operating Activities    
Net income (loss) $ (1,395.4) $ 74.2
Adjustments to derive cash flows    
Depreciation and amortization 556.3 470.4
Loss on acquisition-related foreign currency derivatives 0.0 300.0
Share-based compensation 16.1 29.7
Impairment charges 2,127.1 0.0
Loss on extinguishment of debt (1.1) (0.9)
Non-cash restructuring charges 17.9 3.1
Deferred income taxes (507.2) 7.7
Other non-cash adjustments 34.5 15.3
Subtotal 850.4 901.3
Increase (decrease) in cash due to:    
Accounts receivable 113.6 (30.9)
Inventories (29.9) (28.6)
Accounts payable (51.8) (6.5)
Payroll and related taxes (40.0) (26.6)
Accrued customer programs (74.7) 17.7
Accrued liabilities (42.8) 46.7
Accrued income taxes 9.7 0.3
Other (31.0) (6.7)
Subtotal (146.9) (34.6)
Net cash from (for) operating activities 703.5 866.7
Cash Flows From (For) Investing Activities    
Acquisitions of businesses, net of cash acquired (432.1) (2,499.9)
Asset acquisitions (65.1) (4.0)
Additions to property and equipment (84.6) (127.6)
Proceeds from sale of business 58.5 0.0
Settlement of acquisition-related foreign currency derivatives 0.0 (304.8)
Other investing 1.0 2.7
Net cash from (for) investing activities (524.3) (2,939.0)
Cash Flows From (For) Financing Activities    
Issuances of long-term debt 1,190.3 0.0
Payments on long-term debt (545.8) (903.3)
Borrowings (repayments) of revolving credit agreements and other financing, net (803.6) 28.6
Deferred financing fees 2.8 3.3
Premium on early debt retirement (0.6) 0.0
Issuance of ordinary shares 8.2 6.2
Cash dividends (62.4) (54.2)
Other financing (17.4) (15.5)
Net cash from (for) financing activities (234.1) (941.5)
Effect of exchange rate changes on cash (0.2) (75.8)
Net increase (decrease) in cash and cash equivalents (55.1) (3,089.6)
Cash and cash equivalents, beginning of period 417.8 3,596.1
Cash and cash equivalents, end of period 362.7 506.5
Cash paid/received during the year for:    
Interest paid 124.1 92.5
Interest received 1.1 1.0
Income taxes paid 116.6 130.0
Income taxes refunded $ 6.0 $ 3.1
XML 33 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies
 9 Months Ended
Oct. 01, 2016
Accounting Policies [Abstract]  
Summary of significant accounting policies and change in accounting principles [Text Block]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

a.     General Information

The Company

Perrigo Company plc was incorporated under the laws of Ireland on June 28, 2013 and became the successor registrant of Perrigo Company, a Michigan corporation, on December 18, 2013 in connection with the acquisition of Elan Corporation, plc ("Elan"). Unless the context requires otherwise, the terms "Perrigo," the "Company," "we," "our," "us," and similar pronouns used herein refer to Perrigo Company plc, its subsidiaries, and all predecessors of Perrigo Company plc and its subsidiaries. We are a leading global over-the-counter ("OTC") consumer goods and specialty pharmaceutical company, offering patients and customers high quality products at affordable prices. From our beginning in 1887 as a packager of home remedies, we have grown to become the world's largest manufacturer of OTC healthcare products and supplier of infant formulas for the store brand market. We are also a leading provider of generic extended topical prescription products, and we receive royalties from sales of the multiple sclerosis drug Tysabri®. We provide “Quality Affordable Healthcare Products®” across a wide variety of product categories and geographies, primarily in North America, Europe, and Australia, as well as in other markets, including Israel, China, and Latin America.

Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the consolidated financial statements and footnotes included in our Transition Report on Form 10-KT for the transition period from June 28, 2015 to December 31, 2015. In the opinion of management, all adjustments (consisting of normal recurring accruals and other adjustments) considered necessary for a fair presentation have been included. The Condensed Consolidated Financial Statements include our accounts and the accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

Our fiscal year previously consisted of a 52- or 53-week year ending on or around June 30 of each year with each quarter ending on the Saturday closest to each calendar quarter-end. Beginning on January 1, 2016, we changed our fiscal year to begin on January 1 and end on December 31 of each year. We will continue to cut off our quarterly accounting periods on the Saturday closest to the end of the calendar quarter, with the fourth quarter ending on December 31 of each year.

During the three months ended April 2, 2016, we identified certain errors in our consolidated financial statements for the transition period of June 28, 2015 to December 31, 2015, related primarily to the accrual estimates associated with product returns and tax-related items in our Branded Consumer Healthcare ("BCH") segment. These errors were corrected during the three months ended April 2, 2016 by increasing the consolidated operating loss by $14.5 million, which when combined with tax-related items, increased the consolidated net loss by $13.7 million within the Condensed Consolidated Statements of Operations. We concluded that these errors were not material to the consolidated financial statements for the transition period of June 28, 2015 to December 31, 2015 and are not expected to be material to the consolidated financial statements for the year ending December 31, 2016.

b.     Recent Accounting Standard Pronouncements

Below are recent accounting standard updates that we are still assessing to determine the effect on our consolidated financial statements. We do not believe that any other recently issued accounting standards could have a material effect on our consolidated financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.
Recently Issued Accounting Standards Not Yet Adopted
Standard
 
Description
 
Effective Date
 
Effect on the Financial Statements or Other Significant Matters
Improvements to Employee Share-Based Payment Accounting

 
This guidance is intended to simplify several aspects of the accounting for share-based payment award transactions. It will require all income tax effects of awards to be recorded through the income statement when they vest or settle as opposed to certain amounts being recorded in additional paid-in capital. An entity will also have to elect whether to account for forfeitures as they occur or by estimating the number of awards expected to be forfeited and adjusting the estimate when it is likely to change (as currently required). The guidance will also increase the amount an employer can withhold to cover income taxes on awards. Early adoption is permitted.
 
January 1, 2017
 
We are currently evaluating the implications of adoption on our consolidated financial statements.
Revenue from Contracts with Customers
 
The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps: identify the contract(s) with a customer; identify the performance obligations in the contract; determine the transaction price; allocate the transaction price to the performance obligations in the contract; and recognize revenue when (or as) the entity satisfies a performance obligation. This guidance allows for two adoption methods, full retrospective approach or modified retrospective approach. Early adoption is not permitted.
 
January 1, 2018
 
We are currently evaluating the possible adoption methodologies and the implications of adoption on our consolidated financial statements.
Leases
 
This guidance was issued to increase transparency and comparability among organizations by requiring recognition of lease assets and lease liabilities on the balance sheet and disclosure of key information about leasing arrangements. For leases with a term of 12 months or less, lessees are permitted to make an election to not recognize right-of-use assets and lease liabilities. Upon adoption, lessees will apply the new standard as of the beginning of the earliest comparative period presented in the financial statements, however lessees will be able to exclude leases that expire as of the implementation date. Early adoption is permitted.


 
January 1, 2019
 
We are currently evaluating the implications of adoption on our consolidated financial statements and considering whether to early adopt the standard.


Recently Issued Accounting Standards Not Yet Adopted (continued)
Standard
 
Description
 
Effective Date
 
Effect on the Financial Statements or Other Significant Matters
Measurement of Credit Losses on Financial Instruments
 
This guidance changes the impairment model for most financial assets and certain other instruments, replacing the current "incurred loss" approach with an "expected loss" credit impairment model, which will apply to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities, and off-balance sheet credit exposures such as letters of credit. Early adoption is permitted.


 
January 1, 2020
 
We are currently evaluating the new standard for potential impacts on our receivables, debt, and other financial instruments and considering whether to early adopt the standard.
XML 34 R8.htm IDEA: XBRL DOCUMENT v3.5.0.2
Business Acquisitions (Notes)
 9 Months Ended
Oct. 01, 2016
Business Combinations [Abstract]  
Business combination disclosure
ACQUISITIONS AND DIVESTITURES

All of the below acquisitions, with the exception of the generic Benzaclin™ product purchase, have been accounted for under the acquisition method of accounting based on our analysis of the acquired inputs and processes, and the related assets acquired and liabilities assumed were recorded at fair value as of the acquisition date.

Fair value estimates are based on a complex series of judgments about future events and rely heavily on estimates and assumptions. The judgments used to determine the estimated fair value assigned to each class of assets acquired and liabilities assumed, as well as asset lives, can materially impact our results of operations.

The effects of all of the acquisitions described below are included in the Condensed Consolidated Financial Statements prospectively from the date of each acquisition. Unless otherwise indicated, acquisition costs incurred were immaterial and were recorded in Administration expense.

Current Year Acquisitions

Generic Benzaclin™ Product

On August 2, 2016, we purchased the remaining 60.9% product rights to a generic Benzaclin™ product ("Generic Benzaclin™"), which we had developed and marketed in collaboration with Barr Laboratories, Inc. ("Barr"), a subsidiary of Teva Pharmaceuticals, for $62.0 million in cash. In September 2007, we entered into an initial development, marketing and commercialization agreement with Barr, in which Barr contributed to the product's development costs and we developed and marketed the product in the U.S. and Israel. Under this agreement, we paid Barr a percentage of net income from the product's sales in these territories, adjusted for Barr's contributions to the product's development costs. By purchasing the remaining product right from Barr, we are now entitled to 100% of income from sales of the product. Operating results attributable to Generic Benzaclin™ are included within our Prescription Pharmaceuticals ("Rx") segment. The intangible asset acquired is a distribution and license agreement with a nine-year useful life.

Tretinoin Product Portfolio

On January 22, 2016, we acquired a portfolio of generic dosage forms and strengths of Retin-A® (tretinoin), a topical prescription acne treatment, from Matawan Pharmaceuticals, LLC, for $416.4 million in cash ("Tretinoin Products"), which further expanded our extended topicals portfolio. We were the authorized generic distributor of these products from 2005 to 2013. Operating results attributable to the acquisition are included within our Rx segment. The intangible assets acquired included generic product rights valued using the multi-period excess earnings method and assigned a 20-year useful life, and non-compete agreements valued using the lost income method and assigned a five-year useful life. The goodwill acquired is deductible for tax purposes.

Development-Stage Rx Products

In May 2015, we entered into an agreement with a clinical stage biotechnology company for two specialty pharmaceutical products in development ("Development-Stage Rx Products"). We paid $18.0 million for an option to acquire the two products, which was recorded in Research and Development expense. On March 1, 2016, to further invest in our specialty Rx portfolio, we exercised the option for both products, which requires us to make contingent payments if we obtain regulatory approval and achieve certain sales milestones. We will also be obligated to make certain royalty payments over periods ranging from seven to ten years from the launch of each product. 

We accounted for the option exercise as a business acquisition within our Rx segment, recording IPR&D and contingent consideration on the balance sheet. The IPR&D was valued using the multi-period excess earnings method and has an indefinite useful life until such time as the research is completed (at which time it will become a definite-lived intangible asset), or is determined to have no future use (at which time it would be impaired). The contingent consideration is an estimate of the future milestone payments and royalties based on probability-weighted outcomes, sensitivity analysis, and discount rates reflective of the risk involved. The amount of contingent consideration recognized was $24.9 million and was recorded in Other non-current liabilities.

Purchase Price Allocation of Current Year Acquisitions

The purchase accounting allocation for four small product acquisitions in our Consumer Healthcare ("CHC") and Rx segments (included in "All Other" in the table below) are preliminary and are based on the valuation information, estimates, and assumptions available at October 1, 2016. As we finalize the fair value estimate, additional purchase price adjustments may be recorded during the measurement period to contingent consideration and intangible assets.

The below table indicates the purchase price allocation for acquisitions completed in the current year (in millions):
 
Tretinoin Products
 
Development-Stage Rx Products
 
All Other(1)*
Purchase price paid
$
416.4

 
$
—

 
$
21.9

Contingent consideration
—

 
24.9

 
30.6

Total purchase consideration
$
416.4

 
$
24.9

 
$
52.5

 
 
 
 
 
 
Assets acquired:
 
 
 
 
 
Cash and cash equivalents
$
—

 
$
—

 
$
3.8

Accounts receivable
—

 
—

 
4.9

Inventories
1.4

 
—

 
7.1

Prepaid expenses and other current assets
—

 
—

 
0.1

Property and equipment
—

 
—

 
1.2

Goodwill
1.7

 
—

 
0.2

Definite-lived intangibles:
 
 
 
 
 
Distribution and license agreements, supply agreements
—

 
—

 
3.4

Developed product technology, formulations, and product rights
411.0

 
—

 
23.3

Customer relationships and distribution networks
—

 
—

 
8.2

Non-compete agreements
2.3

 
—

 
—

Indefinite-lived intangibles:
 
 
 
 
 
In-process research and development
—

 
24.9

 
7.0

Total intangible assets
$
413.3

 
$
24.9

 
$
41.9

Total assets
$
416.4

 
$
24.9

 
$
59.2

Liabilities assumed:
 
 
 
 
 
Accounts payable
$
—

 
$
—

 
$
2.8

Accrued liabilities
—

 
—

 
0.1

Long-term debt
—

 
—

 
3.3

Net deferred income tax liabilities
—

 
—

 
0.5

Total liabilities
$
—

 
$
—

 
$
6.7

Net assets acquired
$
416.4

 
$
24.9

 
$
52.5


*    Opening balance sheet is preliminary
(1)
Consists of four product acquisitions in the CHC and Rx segments

Prior Year Acquisitions

Entocort® 

On December 15, 2015, we completed our acquisition of Entocort® (budesonide) capsules, as well as the authorized generic capsules, for sale within the U.S., from AstraZeneca plc for $380.2 million in cash. Entocort® is a gastroenterology medicine for patients with mild to moderate Crohn's disease. The acquisition complemented our Rx portfolio. Operating results attributable to the acquisition are included within our Rx segment. The intangible assets acquired included branded and authorized generic product rights with useful lives of 10 and 15 years, respectively, which were valued using the multi-period excess earnings method.

Naturwohl Pharma GmbH

On September 15, 2015, we completed our acquisition of 100% of Naturwohl Pharma GmbH ("Naturwohl"), a Munich, Germany-based nutritional business known for its leading German dietary supplement brand, Yokebe®. The acquisition built on our BCH segment's OTC product portfolio and European commercial infrastructure. The assets were purchased through an all-cash transaction valued at €133.5 million ($150.4 million). Operating results attributable to Naturwohl are included in the BCH segment. The intangible assets acquired included a trademark with a 20-year useful life, customer relationships with a 15-year useful life, non-compete agreements with a three-year useful life, and a licensing agreement with a three-year useful life. We utilized the relief from royalty method for valuing the trademark, the multi-period excess earnings method for valuing the customer relationships, and the lost income method for valuing the non-compete agreements and the licensing agreement. The goodwill acquired is not deductible for tax purposes.

ScarAway® 
    
On August 28, 2015, we completed our acquisition of ScarAway®, a leading U.S. OTC scar management brand portfolio comprised of five products, from Enaltus, LLC, for $26.7 million in cash. This acquisition served as our entry into the niche branded OTC business in the U.S. Operating results attributable to ScarAway® are included in the CHC segment. The intangible assets acquired included a trademark with a 25-year useful life, non-compete agreements with a four-year useful life, developed product technology with an eight-year useful life, and customer relationships with a 15-year useful life. We utilized the relief from royalty method for valuing the trademark and developed product technology, the multi-period excess earnings method for valuing the customer relationships, and the lost income method for valuing the non-compete agreements. The goodwill acquired is deductible for tax purposes.

GlaxoSmithKline Consumer Healthcare Product Portfolio
    
On August 28, 2015, we completed our acquisition of a portfolio of well-established OTC brands from GlaxoSmithKline Consumer Healthcare (“GSK Products”). This acquisition further leveraged our European market share and expanded our product offerings. The assets were purchased through an all-cash transaction valued at €200.0 million ($223.6 million). Operating results attributable to the acquired GSK Products are included primarily in the BCH segment. The intangible assets acquired included trademarks with a 20-year useful life and customer relationships with a 15-year useful life. We utilized the relief from royalty method for valuing the trademarks and the multi-period excess earnings method for valuing the customer relationships. The goodwill acquired is deductible for tax purposes and recorded primarily in the BCH segment.

Gelcaps Exportadora de Mexico, S.A. de C.V.

On May 12, 2015, we completed our acquisition of 100% of Gelcaps Exportadora de Mexico, S.A. de C.V. ("Gelcaps"), the Mexican operations of Durham, North Carolina-based Patheon Inc., for $37.9 million in cash. The acquisition added softgel manufacturing technology to our supply chain capabilities and broadened our presence, product portfolio, and customer network in Mexico. Operating results attributable to Gelcaps are included in the CHC segment. The intangible assets acquired included a trademark with a 25-year useful life and customer relationships with a 20-year useful life. We utilized the relief from royalty method for valuing the trademark and the multi-period excess earnings method for valuing the customer relationships.

Based on valuation estimates utilizing the comparative sales method, a step-up in the value of inventory of $0.6 million was recorded in the opening balance sheet, which was charged to cost of goods sold during the three months ended June 27, 2015. In addition, property, plant and equipment was written up by $0.9 million to its estimated fair market value based on a valuation method that included both the cost and market approaches. This additional step-up in value is being depreciated over the estimated remaining useful lives of the assets. The goodwill recorded is not deductible for tax purposes.

Omega Pharma Invest N.V.

On March 30, 2015, we completed our acquisition of Omega Pharma Invest N.V. ("Omega"), a limited liability company incorporated under the laws of Belgium. Omega was a leading European OTC company and is providing us several key benefits, including advancing our growth strategy outside the U.S. by providing access across a larger global platform with critical mass in key European countries, establishing commercial infrastructure in the high barrier-to-entry European OTC marketplace, strengthening our product portfolio while enhancing scale and distribution, and expanding our international management capabilities.

We purchased 95.77% of the issued and outstanding share capital of Omega (685,348,257 shares) from Alychlo N.V. (“Alychlo”) and Holdco I BE N.V. (together with Alychlo, the “Sellers”), limited liability companies incorporated under the laws of Belgium, under the terms of the Share Purchase Agreement dated November 6, 2014 (the "Share Purchase Agreement"). Omega holds the remaining 30,243,983 shares as treasury shares.

The acquisition was a cash and stock transaction made up of the following consideration (in millions except per share data):
Perrigo ordinary shares issued
 
5.4

Perrigo per share price at transaction close on March 30, 2015
 
$
167.64

Total value of Perrigo ordinary shares issued
 
$
904.9

Cash consideration
 
2,078.3

Total consideration
 
$
2,983.2



The cash consideration shown in the above table was financed by a combination of debt and equity. We issued $1.6 billion of debt as described in Note 10, and issued 6.8 million ordinary shares, which raised $999.3 million, net of issuance costs.

The Sellers agreed to indemnify us for certain potential future losses. The Sellers’ indemnification and other obligations to us under the Share Purchase Agreement are secured by up to €120.9 million ($135.9 million as of October 1, 2016) in cash that has been escrowed or is committed to be escrowed and 1.08 million of our ordinary shares, which are both being held in escrow to secure such obligations. Under the terms of the Share Purchase Agreement, Alychlo and its affiliates are subject to a three-year non-compete in Europe, and the Sellers are subject to a two-year non-solicit, in each case subject to certain exceptions. The Share Purchase Agreement contains other customary representations, warranties, and covenants of the parties thereto. Our Board of Directors has authorized us to issue an arbitral claim against the sellers, which we plan to do.

The operating results attributable to Omega are included in the BCH segment. We incurred general transaction costs (legal, banking and other professional fees), financing fees, and debt extinguishment charges in connection with the Omega acquisition. The amounts recorded were not allocated to a reporting segment. The table below details the acquisition costs, as well as losses on hedging activities associated with the acquisition purchase price, and where they were recorded for the nine months ended September 26, 2015 (in millions):
 
 
Nine Months Ended
Line item
 
September 26, 2015
Administration
 
$
18.1

Interest expense, net
 
18.7

Other expense, net
 
258.2

Total acquisition-related costs
 
$
295.0



See Note 8 for further details on losses on the Omega-related hedging activities shown above in Other expense, net, and Note 10 for details on the loss on extinguishment of debt.

We acquired the following intangible assets: indefinite-lived brands, a definite-lived trade name with an eight-year useful life, definite-lived brands with a 22-year useful life, a distribution network with a 21-year useful life, and developed product technology with useful lives ranging from four to 13 years. We also recorded goodwill, which is not deductible for tax purposes and represents the value we assigned to the expected synergies described above, in our BCH segment. We utilized the multi-period excess earnings method to value the indefinite-lived brands, the definite-lived brands, and distribution network. We utilized the relief from royalty method to value the developed product technology and definite-lived trade name.

Based on valuation estimates utilizing the comparative sales method, a step-up in the value of inventory of $15.1 million was recorded in the opening balance sheet and was charged to cost of goods sold during the three months ended June 27, 2015. In addition, property, plant and equipment were written up $41.5 million to their estimated fair market value based on a valuation method that included both the cost and market approaches. This additional step-up in value is being depreciated over the estimated remaining useful lives of the assets. Additionally, the fair value of the debt assumed on the date of acquisition exceeded par value by $101.9 million, which was recorded as part of the carrying value of the underlying debt and will be amortized as a reduction of interest expense over the remaining terms of the respective debt instruments. For more information on the debt we assumed from Omega and our subsequent payments on the debt, see Note 10.

Purchase Price Allocation of Prior Year Acquisitions

The purchase accounting allocation for the Entocort® and GSK Products acquisitions were finalized during the three months ended April 2, 2016. Changes to the allocations were due to adjustments to the intangible asset valuation assumptions. The purchase accounting for all other prior year acquisitions was final as of December 31, 2015. The below table indicates the purchase price allocation for acquisitions completed during the year ended December 31, 2015 (in millions):
 
Entocort®
 
Naturwohl
 
ScarAway®
 
GSK Products
 
Gelcaps
 
Omega
 
All Other(1)
Purchase price paid
$
380.2

 
$
150.4

 
$
26.7

 
$
223.6

 
$
37.9

 
$
2,983.2

 
$
15.3

Contingent consideration
—

 
—

 
—

 
—

 
—

 
—

 
13.9

Total purchase consideration
$
380.2

 
$
150.4

 
$
26.7

 
$
223.6

 
$
37.9

 
$
2,983.2

 
$
29.2

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets acquired:
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
—

 
$
4.6

 
$
—

 
$
—

 
$
4.6

 
$
14.7

 
$
—

Accounts receivable
—

 
3.3

 
—

 
—

 
7.3

 
260.1

 
—

Inventories
0.2

 
1.5

 
1.0

 
—

 
7.2

 
202.5

 
—

Prepaid expenses and other current assets
—

 
—

 
—

 
—

 
2.1

 
39.2

 
—

Property and equipment
—

 
—

 
—

 
—

 
6.0

 
130.8

 
—

Goodwill
—

 
61.0

 
3.5

 
32.6

 
6.0

 
1,900.4

 
—

Definite-lived intangibles:
 
 
 
 
 
 
 
 
 
 
 
 
 
Distribution and license agreements, supply agreements
—

 
21.4

 
—

 
—

 
—

 
—

 
—

Developed product technology, formulations, and product rights
380.0

 
—

 
0.5

 
—

 
—

 
27.2

 
—

Customer relationships and distribution networks
—

 
25.9

 
9.8

 
61.5

 
6.6

 
1,056.3

 
—

Trademarks, trade names, and brands
—

 
64.2

 
11.4

 
129.5

 
—

 
287.5

 
—

Non-compete agreements
—

 
0.3

 
0.5

 
—

 
—

 
—

 
—

Indefinite-lived intangibles:
 
 
 
 
 
 
 
 
 
 
 
 
 
Trademarks, trade names, and brands
—

 
—

 
—

 
—

 
4.4

 
2,003.8

 
—

In-process research and development
—

 
—

 
—

 
—

 
—

 
—

 
29.2

Total intangible assets
$
380.0

 
$
111.8

 
$
22.2

 
$
191.0

 
$
11.0

 
$
3,374.8

 
$
29.2

Other non-current assets
—

 
—

 
—

 
—

 
0.4

 
2.4

 
—

Total assets
$
380.2

 
$
182.2

 
$
26.7

 
$
223.6

 
$
44.6

 
$
5,924.9

 
$
29.2

Liabilities assumed:
 
 
 
 
 
 
 
 
 
 
 
 
 
Accounts payable
$
—

 
$
2.8

 
$
—

 
$
—

 
$
3.3

 
$
243.1

 
$
—

Short-term debt
—

 
—

 
—

 
—

 
—

 
24.6

 
—

Accrued liabilities
—

 
1.6

 
—

 
—

 
1.6

 
43.9

 
—

Payroll and related taxes
—

 
—

 
—

 
—

 
—

 
51.3

 
—

Accrued customer programs
—

 
—

 
—

 
—

 
—

 
39.8

 
—

Long-term debt
—

 
—

 
—

 
—

 
—

 
1,471.0

 
—

Net deferred income tax liabilities
—

 
27.4

 
—

 
—

 
1.4

 
1,014.5

 
—

Other non-current liabilities
—

 
—

 
—

 
—

 
0.4

 
53.5

 
—

Total liabilities
—

 
31.8

 
—

 
—

 
6.7

 
2,941.7

 
—

Net assets acquired
$
380.2

 
$
150.4

 
$
26.7

 
$
223.6

 
$
37.9

 
$
2,983.2

 
$
29.2


(1)
Consists of eight product acquisitions in the CHC, BCH, and Rx segments

Actual and Unaudited Pro Forma Impact of Acquisitions

Our Condensed Consolidated Financial Statements include operating results from the Tretinoin Products, Entocort®, Naturwohl, GSK Products, ScarAway®, Omega, and Gelcaps acquisitions, as well as from four small product acquisitions, from the date of each acquisition through October 1, 2016. Net sales and operating income attributable to acquisitions completed in the current year and included in our financial statements totaled $25.3 million and $13.0 million, respectively, for the three months ended October 1, 2016 and totaled $47.7 million and $31.3 million, respectively, for the nine months ended October 1, 2016.

The following unaudited pro forma information gives effect to the Tretinoin Products, Entocort®, Naturwohl, GSK Products, ScarAway®, Omega, and Gelcaps acquisitions, as well as four small product acquisitions, as if the acquisitions had occurred on the first day of the nine months ended September 26, 2015 and had been included in our Results of Operations for all periods presented thereafter (in millions):
 
Three Months Ended
 
Nine Months Ended
(Unaudited)
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Net sales
$
1,359.6

 
$
1,429.9

 
$
4,243.3

 
$
4,451.4

Net income (loss)
$
(1,254.9
)
 
$
142.0

 
$
(1,392.8
)
 
$
154.7



The historical consolidated financial information of Perrigo, and the Tretinoin Products, Entocort®, Naturwohl, GSK Products, ScarAway®, Omega and Gelcaps acquisitions and the four small product acquisitions, has been adjusted in the pro forma information to give effect to pro forma events that are (1) directly attributable to the transactions, (2) factually supportable and (3) expected to have a continuing impact on combined results. In order to reflect the occurrence of the acquisitions on the first day of the nine months ended September 26, 2015 as required, the unaudited pro forma results include adjustments to reflect the incremental amortization expense to be incurred based on the current values of each acquisition's identifiable intangible and tangible assets, along with the reclassification of acquisition-related costs from the nine months ended October 1, 2016 to the nine months ended September 26, 2015. The unaudited pro forma results do not reflect future events that have occurred or may occur after the acquisitions.

Current Year Divestitures

On August 5, 2016, we completed the sale of our U.S. Vitamins, Minerals, and Supplements ("VMS") business within our CHC segment to International Vitamins Corporation ("IVC") for $61.8 million inclusive of an estimated working capital adjustment. The assets and liabilities related to this sale were classified as held-for-sale at December 31, 2015. Prior to closing the sale, we determined that the carrying value of the VMS business exceeded its fair value less the cost to sell, resulting in an impairment charge of $6.2 million, which was recorded in Impairment charges on the Condensed Consolidated Statements of Operations during the nine months ended October 1, 2016.
XML 35 R9.htm IDEA: XBRL DOCUMENT v3.5.0.2
Goodwill and Other Intangible Assets
 9 Months Ended
Oct. 01, 2016
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and intangible assets disclosure
GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):
Reporting Segments:
 
December 31, 2015
 
Business acquisitions
 
Business divestitures
 
Impairments
 
Changes in assets held for sale
 
Currency translation adjustment
 
October 1,
2016
CHC
 
$
1,890.0

 
$
0.2

 
$
(8.5
)
 
$
—

 
$
13.0

 
$
(6.8
)
 
$
1,887.9

BCH
 
1,980.5

 
—

 
—

 
(967.5
)
 
—

 
92.4

 
1,105.4

Rx
 
1,222.2

 
1.7

 
—

 
—

 
—

 
(13.7
)
 
1,210.2

Specialty Sciences
 
200.7

 
—

 
—

 
—

 
—

 
—

 
200.7

Other
 
71.5

 
—

 
—

 
—

 
11.7

 
3.2

 
86.4

Total goodwill
 
$
5,364.9

 
$
1.9

 
$
(8.5
)
 
$
(967.5
)
 
$
24.7

 
$
75.1

 
$
4,490.6



In connection with the preparation of our financial statements for the three-month period ended April 2, 2016, we identified indicators of goodwill impairment in our BCH - rest of world (“BCH - ROW”) reporting unit, which comprises primarily operations attributable to the Omega acquisition in all geographic regions except for Belgium. The primary impairment indicators included the decline in our 2016 performance expectations and a reduction in our long-range revenue growth forecast. Step one of the goodwill impairment test involved determining the fair value of the reporting unit using a discounted cash flow technique and comparing it to the reporting unit’s carrying value. The main assumptions supporting the cash flow projections used to determine the reporting unit’s fair value included revenue growth based on product line extensions, product life cycle strategies, and geographical expansion within the markets in which the reporting unit distributes products, gross margins consistent with historical trends, and advertising and promotion investments largely consistent with the reporting unit's growth plans. The BCH - ROW reporting unit did not pass step one of goodwill impairment testing. The change in fair value from previous estimates was due primarily to the changes in the market and performance of certain brands such that the evaluation of brand prioritization and product extensions or launches in new regions are being more focused to maximize the potential of all brands in the segment's portfolio.

The second step of the goodwill impairment test required that we determine the implied fair value of the BCH - ROW reporting unit’s goodwill, which involved determining the value of the reporting unit’s individual assets and liabilities. Due to the complex and time-consuming nature of step two, based on our evaluation and initial estimates of the fair values of the assets and liabilities and the deficit of the fair value when compared to the related book value, we recorded an estimated impairment charge of $193.6 million for the three months ended April 2, 2016. We finalized the step two fair value calculation during the three months ended July 2, 2016, which resulted in a $30.3 million reduction to the estimated impairment charge recorded during the three months ended April 2, 2016.

In connection with the preparation of our financial statements for the three months ended October 1, 2016, we identified additional indicators of goodwill impairment in both our BCH - ROW and our BCH - Belgium reporting units. With respect to both reporting units, the primary impairment indicators included an additional decline in our 2016 performance expectations for the remainder of the year and a reduction in our long-range revenue growth and margin forecasts due to the factors outlined below. Step one of the goodwill impairment test involved determining the fair value of the reporting units using a discounted cash flow technique and comparing it to the respective reporting units' carrying value. The main assumptions supporting the cash flow projections used to determine each reporting unit’s fair value included revenue growth based on product line extensions, product life cycle strategies, and geographical expansion within the markets in which the reporting unit distributes products, gross margins consistent with historical trends and including supply chain cost improvement plans, and advertising and promotion investments largely consistent with the reporting unit's growth plans. Both the BCH - ROW and the BCH - Belgium reporting units did not pass step one of goodwill impairment testing. As it relates to the BCH - ROW reporting unit, the changes in fair value from previous estimates were due primarily to (1) changes in the market and performance of certain brands due to moderated new product launch assumptions, (2) execution of certain key product strategies falling short of expectations causing a reduction to baseline forecast models in France, Germany and Italy, (3) certain macro-economic factors having continued to impact the business more than expected in France, Russia and Turkey in addition to unfavorable foreign currency impacts experienced primarily in the UK related to Brexit. As it relates to BCH - Belgium reporting unit, the changes in fair value from previous estimates due to change in the forecast as a result of a reduction in volume with a major wholesaler due to factors consistent with those outlined for BCH - ROW.

The second step of the goodwill impairment test required that we determine the implied fair value of both the BCH - ROW and BCH - Belgium reporting units' goodwill, which involved determining the value of each reporting unit’s individual assets and liabilities. Based on our evaluation and initial estimates of the fair values of the assets and liabilities and the deficit of the fair value when compared to the related book value, we recorded an estimated impairment charge of $734.7 million related to the BCH - ROW reporting unit and $69.4 million related to the BCH - Belgium reporting unit for the three months ended October 1, 2016. Both charges were recorded in Impairment charges on the Condensed Consolidated Statements of Operations within our BCH segment. Due to the complex and time-consuming nature of step two, we expect to finalize the fair value calculation during the fourth quarter of 2016, which could result in an adjustment to the estimated impairment charge. As of October 1, 2016, the implied fair value of goodwill that remains in the BCH - ROW and BCH - Belgium reporting units is $1.0 billion and $70.2 million, respectively.

While no impairment charges were recorded as a result of the goodwill impairment testing for the transition period of June 28, 2015 to December 31, 2015, our Specialty Sciences reporting unit's fair value exceeded the carrying value by less than 10%. Management evaluated the primary source of cash flow in this segment, the Tysabri® royalty stream, based on a combination of factors including independent external research, information provided from our royalty partner, and internal estimates. Based on this information, management’s assessment of future cash flow from this royalty stream has been reduced primarily due to anticipated new competitors entering the market and unfavorable currency exchange effects. Future performance different from the assumptions utilized in our quantitative analysis may further reduce the fair value of the reporting unit, which may result in the fair value no longer exceeding the carrying value. In February 2016, a competitor's pipeline product, Ocrevus®, received breakthrough therapy designation from the FDA and could potentially be approved in 2016. The product would compete with Tysabri® and could have a significant negative impact on the royalty we receive from Biogen Idec, Inc. ("Biogen") and the performance of the Specialty Sciences segment. We continue to monitor the progress of all potential competing products and assess the reporting unit for potential impairment should impairment indicators arise, as applicable, and at least annually during our fourth quarter impairment testing.

During the three months ended June 27, 2015, we performed our annual goodwill impairment testing, which indicated that our CHC Mexico reporting unit's goodwill fair value was below its net book value as of March 28, 2015. As a result, we initiated the second step of the goodwill impairment test to measure the amount of impairment. We concluded that the goodwill was fully impaired and recorded an impairment of $6.8 million in the CHC segment during the nine months ended September 26, 2015 in Other expense, net.

Intangible Assets

Other intangible assets and related accumulated amortization consisted of the following (in millions):
 
October 1, 2016
 
December 31, 2015
 
Gross
 
Accumulated Amortization
 
Gross
 
Accumulated Amortization
Definite-lived intangibles:
 
 
 
 
 
 
 
Distribution and license agreements, supply agreements
$
6,122.3

 
$
914.0

 
$
6,053.4

 
$
667.2

Developed product technology, formulations, and product rights
1,805.9

 
529.0

 
1,383.5

 
426.0

Customer relationships and distribution networks
1,564.0

 
288.8

 
1,520.7

 
193.0

Trademarks, trade names, and brands
631.6

 
54.7

 
539.4

 
22.8

Non-compete agreements
14.6

 
11.0

 
15.2

 
12.7

Total definite-lived intangibles
$
10,138.4

 
$
1,797.5

 
$
9,512.2

 
$
1,321.7

Indefinite-lived intangibles:
 
 
 
 
 
 
 
Trademarks, trade names, and brands
$
724.2

 
$
—

 
$
1,868.1

 
$
—

In-process research and development
67.9

 
—

 
48.2

 
—

Total indefinite-lived intangibles
792.1

 
—

 
1,916.3

 
—

Total other intangible assets
$
10,930.5

 
$
1,797.5

 
$
11,428.5

 
$
1,321.7



Certain intangible assets are denominated in currencies other than the U.S. dollar; therefore, their gross and net carrying values are subject to foreign currency movements.

We recorded amortization expense of $162.1 million and $147.6 million for the three months ended October 1, 2016 and September 26, 2015, respectively, and $481.8 million and $397.9 million for the nine months ended October 1, 2016 and September 26, 2015, respectively. The increase in amortization expense for the 2016 nine-month period was due primarily to the incremental amortization expense incurred on the definite-lived intangible assets acquired from the Omega, Entocort®, and Tretinoin Products acquisitions.

During our impairment testing for the transition period of June 28, 2015 to December 31, 2015, we identified an impairment of certain indefinite-lived intangible assets purchased in conjunction with the Omega acquisition based on management’s expectations of the prospects for future revenues, profits, and cash flows associated with these assets. The assessment resulted in an impairment charge of $185.1 million within our BCH segment, which represented the difference between the carrying amount of the intangible assets and their estimated fair value. See our Transition Report on Form 10-KT filed on February 25, 2016 for a further discussion of this impairment charge.

In connection with the preparation of our financial statements for the three-month period ended April 2, 2016, we identified indicators of impairment associated with certain indefinite-lived intangible assets acquired in conjunction with the Omega acquisition. The primary impairment indicators included the decline in our 2016 performance expectations and a reduction in our long-range revenue growth forecast. The assessment utilized the excess earnings method to determine fair value and resulted in an impairment charge of $273.4 million in Impairment charges on the Condensed Consolidated Statements of Operations within our BCH segment, which represented the difference between the carrying amount of the intangible assets and their estimated fair value. The change in fair value from previous estimates was due primarily to the changes in the market and performance of the brands such that the evaluation of brand prioritization and product extensions or launches in new regions are being more focused to maximize the potential of all brands in the segment's portfolio. The main assumptions supporting the fair value of these assets and cash flow projections included revenue growth based on product line extensions, product life cycle strategies, and geographical expansion within the markets in which the BCH segment distributes products, gross margins consistent with historical trends, and advertising and promotion investments largely consistent with the segment's growth plans.

In connection with the preparation of our financial statements for the three months ended October 1, 2016, we identified additional indicators of impairment associated with certain indefinite-lived and definite-lived intangible brand category assets acquired in conjunction with the Omega acquisition. The primary impairment indicators are discussed above in goodwill. The assessment of the indefinite-lived assets utilized the excess earnings method to determine fair value and resulted in an impairment charge of $575.7 million for the three months ended October 1, 2016. With regards to the definite-lived asset, it was determined that the carrying value of the asset group was not recoverable based on an assessment of the undiscounted future cash flows expected to be generated by the asset group. Given this, the excess earnings method was utilized to determine fair value of the definite-lived asset and resulted in an impairment charge of $290.2 million for the three months ended October 1, 2016. Both charges, which represented the difference between the carrying amount of the intangible assets and their estimated fair value, were recorded in Impairment charges on the Condensed Consolidated Statements of Operations within our BCH segment. The main assumptions supporting the fair value of these assets and cash flow projections are included in the goodwill discussions above.

The carrying value for certain intangible assets and goodwill equals estimated and implied fair values, respectively, and as a result, any further deterioration in those assets' fair value would lead to a further impairment charge. Future performance different from the assumptions utilized in our quantitative analyses may result in additional changes in the fair value. We will continue to monitor and assess these assets for potential impairment should further impairment indicators arise. We will complete our required annual impairment testing during the fourth quarter of 2016.

In addition, given the additional change in performance expectations for our remaining impaired cough/cold/allergy, anti-parasite, personal care and natural health brands previously recorded as indefinite-lived assets, we reclassified the remaining asset balance of $672.4 million related to these four assets to definite-lived assets with a 20-year useful life and began amortizing the assets as of October 2, 2016.
XML 36 R10.htm IDEA: XBRL DOCUMENT v3.5.0.2
Accounts Receivable Factoring (Notes)
 9 Months Ended
Oct. 01, 2016
Accounts Receivable Factoring [Abstract]  
Transfers and servicing of financial assets [Text Block]
ACCOUNTS RECEIVABLE FACTORING

We have multiple accounts receivable factoring arrangements with non-related third-party financial institutions (the “Factors”). Pursuant to the terms of the arrangements, we sell to the Factors certain of our accounts receivable balances on a non-recourse basis for credit approved accounts. An administrative fee ranging from 0.14% to 0.15% per invoice is charged on the gross amount of accounts receivables assigned to the Factors, plus interest is calculated at the applicable EUR LIBOR rate plus 70 basis points. The total amount factored and excluded from accounts receivable was $36.4 million and $106.7 million at October 1, 2016 and December 31, 2015, respectively.
XML 37 R11.htm IDEA: XBRL DOCUMENT v3.5.0.2
Inventories (Notes)
 9 Months Ended
Oct. 01, 2016
Inventory Disclosure [Abstract]  
Inventory disclosure [Text Block]
INVENTORIES

Major components of inventory were as follows (in millions):
 
 
October 1,
2016
 
December 31,
2015
Finished goods
$
511.6

 
$
483.4

Work in process
171.0

 
151.4

Raw materials
202.0

 
209.6

Total inventories
$
884.6

 
$
844.4
XML 38 R12.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair value measurements (Note)
 9 Months Ended
Oct. 01, 2016
Fair Value Disclosures [Abstract]  
Fair value disclosures [Text Block]
FAIR VALUE MEASUREMENTS

Fair value is the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The following fair value hierarchy is used in selecting inputs, with the highest priority given to Level 1, as these are the most transparent or reliable.

Level 1:
Quoted prices for identical instruments in active markets.

Level 2:
Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs are observable in active markets.

Level 3:
Valuations derived from valuation techniques in which one or more significant inputs are not observable.

The following table summarizes the valuation of our financial instruments carried at fair value and measured at fair value on a recurring and non-recurring basis by the above pricing categories (in millions):
 
 
 
 
Fair Value
 
 
Fair Value Hierarchy
 
October 1,
2016
 
December 31,
2015
Measured at fair value on a recurring basis:
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
Investment securities
 
Level 1
 
$
53.0

 
$
14.9

 
 
 
 
 
 
 
Foreign currency forward contracts
 
Level 2
 
$
5.2

 
$
4.8

 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
Interest rate swap agreements
 
Level 2
 
$
—

 
$
0.3

Foreign currency forward contracts
 
Level 2
 
0.8

 
3.9

Total level 2 liabilities
 
 
 
$
0.8

 
$
4.2

 
 
 
 
 
 
 
Contingent consideration
 
Level 3
 
$
75.0

 
$
17.9

 
 
 
 
 
 
 
Measured at fair value on a non-recurring basis:
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
Goodwill(1)
 
Level 3
 
$
1,105.4

 
$
—

Indefinite-lived intangible assets(2)
 
Level 3
 
672.4

 
1,031.8

Definite-lived intangible assets(3)
 
Level 3
 
66.9

 
—

Assets held for sale, net
 
Level 3
 
14.1

 
37.5

Total level 3 assets
 
 
 
$
1,858.8

 
$
1,069.3



(1)
Goodwill with a carrying amount of $1.9 billion was written down to its implied fair value of $1.1 billion, resulting in an impairment charge of $804.1 million for the three months ended October 1, 2016; impairment charges totaled $967.5 million for the nine months ended October 1, 2016 and are included in Impairment charges on the Condensed Consolidated Statements of Operations.

(2)
Indefinite-lived intangible assets with a carrying amount of $1.2 billion were written down to a fair value of $672.4 million resulting in total impairment charges of $575.7 million for the three months ended October 1, 2016; impairment charges totaled $849.1 million for the nine months ended October 1, 2016 and are included in Impairment charges on the Condensed Consolidated Statements of Operations.

(3)
Definite-lived intangible assets with a carrying amount of $357.1 million were written down to a fair value of $66.9 million resulting in an impairment charge of $290.2 million for the three and nine months ended October 1, 2016, which is included in Impairment charges on the Condensed Consolidated Statements of Operations.

There were no transfers among Level 1, 2, and 3 during the three and nine months ended October 1, 2016 and September 26, 2015. Our policy regarding the recording of transfers between levels is to record any such transfers at the end of the reporting period. See Note 7 for information on our investment securities. See Note 8 for a discussion of derivatives.

Contingent consideration represents milestone payment obligations obtained through product acquisitions, which are valued using estimates based on probability-weighted outcomes, sensitivity analysis, and discount rates reflective of the risk involved. The estimates are updated quarterly and the liabilities are adjusted to fair value depending on a number of assumptions, including the competitive landscape and regulatory approvals that may impact the future sales of a product.

The non-recurring fair values included in the table above represent only those assets whose carrying values were adjusted to fair value during the reporting period. See Note 3 for a more detailed discussion of the impaired goodwill and indefinite-lived intangible assets and the valuation methods used, and Note 9 for information on the impaired assets held for sale, net.

The table below presents a reconciliation for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (in millions). Net realized losses in the table were recorded in Administrative expense.
 
Three Months Ended
 
Nine Months Ended
 
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Contingent Consideration
 
 
 
 
 
 
 
Beginning balance
$
44.9

 
$
—

 
$
17.9

 
$
12.4

Net realized (gains) losses
(0.4
)
 
—

 
(4.0
)
 
(12.4
)
Purchases or additions
30.6

 
—

 
61.1

 
—

Foreign currency effect
—

 
—

 
0.1

 
—

Settlements
(0.1
)
 
—

 
(0.1
)
 
—

Ending balance
$
75.0

 
$
—

 
$
75.0

 
$
—



As of October 1, 2016 and December 31, 2015, our fixed rate long-term debt consisted of public bonds, a private placement note, and retail bonds. As of October 1, 2016, the public bonds and private placement note had a carrying value of $4.6 billion and a fair value of $4.7 billion, based on quoted market prices (Level 1). As of December 31, 2015, the public bonds and private placement note had a carrying value of $3.9 billion and fair value of $3.8 billion, based on quoted market prices (Level 1). As of October 1, 2016, our retail bonds had a carrying value of $826.4 million (excluding a premium of $60.7 million) and a fair value of $891.4 million. As of December 31, 2015, our retail bonds had a carrying value of $798.3 million (excluding a premium of $82.5 million) and a fair value of $859.8 million. The fair value of our related bonds for both periods was based on interest rates offered for borrowings of a similar nature and remaining maturities (Level 2).

The carrying amounts of our other financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, short-term debt and variable rate long-term debt, approximate their fair value.
XML 39 R13.htm IDEA: XBRL DOCUMENT v3.5.0.2
Investments (Notes)
 9 Months Ended
Oct. 01, 2016
Investments [Abstract]  
Cost and equity method investments disclosure [Text Block]
INVESTMENTS

Available for Sale Securities
    
Our available for sale securities are reported in Prepaid expenses and other current assets. Unrealized investment gains (losses) on available for sale securities were as follows (in millions):
 
October 1,
2016
 
December 31, 2015
Equity securities, at cost less impairments
$
20.1

 
$
6.4

Gross unrealized gains
32.9

 
9.3

Gross unrealized losses
—

 
(0.8
)
Estimated fair value of equity securities
$
53.0

 
$
14.9



The factors affecting the assessment of impairments include both general financial market conditions and factors specific to a particular company. We recorded impairment charges of $1.8 million related to other-than-temporary impairments of marketable equity securities during the nine months ended October 1, 2016 due to prolonged losses incurred on each of the investments.

Cost Method Investments

Our cost method investments totaled $7.0 million and $6.9 million at October 1, 2016 and December 31, 2015, respectively, and are included in Other non-current assets.

Equity Method Investments

Our equity method investments totaled $4.9 million and $45.5 million at October 1, 2016 and December 31, 2015, respectively, and are included in Other non-current assets.

Due to significant and prolonged losses incurred on one of our equity method investments, we recorded a $22.3 million impairment in Other expense, net, during the nine months ended October 1, 2016. In addition, during the nine months ended October 1, 2016, one of our equity method investments became publicly traded. As a result, we transferred the $15.5 million investment to available for sale and recorded an $8.7 million unrealized gain, net of tax, in Other Comprehensive Income ("OCI"), as reflected in the available for sale securities table above.

We recorded a net gain of $0.1 million and a net loss of $4.1 million during the three months ended October 1, 2016 and September 26, 2015, respectively, and a net loss of $3.8 million and $7.7 million during the nine months ended October 1, 2016, and September 26, 2015, respectively, for our proportionate share of the equity method investment earnings or losses. The gains and losses were recorded in Other expense, net.
XML 40 R14.htm IDEA: XBRL DOCUMENT v3.5.0.2
Derivative Instruments and Hedging Activities (Note)
 9 Months Ended
Oct. 01, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative instruments and hedging activities disclosure [Text Block]
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

We enter into certain derivative financial instruments, when available on a cost-effective basis, to mitigate our risk associated with changes in interest rates and foreign currency exchange rates as follows:

Interest rate risk management - We are exposed to the impact of interest rate changes through our cash investments and borrowings. We utilize a variety of strategies to manage the impact of changes in interest rates including using a mix of debt maturities along with both fixed-rate and variable-rate debt. In addition, we may enter into treasury-lock agreements and interest rate swap agreements on certain investing and borrowing transactions to manage our exposure to interest rate changes and our overall cost of borrowing.

Foreign currency exchange risk management - We conduct business in several major currencies other than the U.S. dollar and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce cash flow volatility associated with foreign exchange rate changes on a consolidated basis to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments, and anticipated foreign currency sales and expenses.
    
All derivative instruments are managed on a consolidated basis to efficiently net exposures and thus take advantage of any natural offsets. Gains and losses related to the derivative instruments are expected to be offset largely by gains and losses on the original underlying asset or liability. We do not use derivative financial instruments for speculative purposes.

All of our designated derivatives were classified as cash flow hedges as of October 1, 2016 and December 31, 2015. Designated derivatives meet hedge accounting criteria, which means the fair value of the hedge is recorded in shareholders’ equity as a component of OCI, net of tax. The deferred gains and losses are recognized in income in the period in which the hedged item affects earnings. Any ineffective portion of the change in fair value of the derivative is immediately recognized in earnings. All of our designated derivatives are assessed for hedge effectiveness quarterly.

We also have economic non-designated derivatives that do not meet hedge accounting criteria. These derivative instruments are adjusted to current market value at the end of each period through earnings. Gains or losses on these instruments are offset substantially by the remeasurement adjustment on the hedged item.    

Interest Rate Swaps and Treasury Locks

Interest rate swap agreements are contracts to exchange floating rate for fixed rate payments (or vice versa) over the life of the agreement without the exchange of the underlying notional amounts. The notional amounts of the interest rate swap agreements are used to measure interest to be paid or received and do not represent the amount of exposure to credit loss. The differential paid or received on the interest rate swap agreements is recognized as an adjustment to interest expense.

During the six months ended December 31, 2015, we entered into a forward interest rate swap to hedge against changes in the benchmark interest rate between the date the interest rate swap was entered into and the date of expected future debt issuance. The interest rate swap was designated as a cash flow hedge and had a notional amount totaling $200.0 million. The interest rate swap was settled upon the issuance of an aggregate $1.2 billion principal amount of senior notes on March 7, 2016 for a cumulative after-tax loss of $7.0 million in OCI during the nine months ended October 1, 2016.

In connection with the Omega acquisition, we assumed a $20.0 million private placement note. We also assumed an interest rate swap agreement with a notional amount totaling $20.0 million that was in place to hedge the cross currency exchange differences between the U.S. dollar and the euro on the above-mentioned debt. On May 29, 2015, we repaid the loan and the interest rate swap. We also assumed €500.0 million ($544.5 million) of debt under Omega's revolving credit facility, as well as an interest rate swap agreement with a notional amount of €135.0 million ($147.0 million) that was in place to hedge the change in the floating rate on that credit facility. On April 8, 2015, we repaid the loan and terminated the interest rate swap. Because both interest rate swaps mentioned above were recorded at fair market value on the date of termination, no gain or loss was recorded. For more information on the acquired debt and termination, see Note 10.

During the nine months ended September 26, 2015, we repaid a $300.0 million term loan with floating interest rates priced off the LIBOR yield curve, see Note 10. As a result of the term loan repayment on June 25, 2015, the forward interest rate swap agreements with notional amounts totaling $240.0 million that were in place to hedge the change in the LIBOR rate were terminated as well. We recorded a loss of $3.6 million in Other expense, net, during the nine months ended September 26, 2015 for the amount remaining in Accumulated Other Comprehensive Income ("AOCI") when the hedges were terminated.

Foreign Currency Derivatives

We enter into foreign currency forward contracts, both designated and non-designated, in order to manage the impact of foreign exchange fluctuations on expected future purchases and related payables denominated in a foreign currency, as well as to hedge the impact of foreign exchange fluctuations on expected future sales and related receivables denominated in a foreign currency. Both types of forward contracts have a maximum maturity date of 15 months. The total notional amount for these contracts was $482.5 million and $755.5 million as of October 1, 2016 and December 31, 2015, respectively.

In order to economically hedge the foreign currency exposure associated with the planned payment of the euro-denominated purchase price of Omega, we entered into non-designated forward contracts that matured during the three months ended March 28, 2015. We recorded losses of $259.8 million during the nine months ended September 26, 2015 related to the settlement of the forward contracts in Other expense, net. The losses on the derivatives due to changes in the euro-to-U.S. dollar exchange rates were economically offset at closing in the final settlement of the euro-denominated Omega purchase price. In June 2015, in order to economically hedge the foreign currency exposure associated with the planned payment of the euro-denominated GSK Products acquisition discussed in Note 2, we entered into a non-designated option contract to protect against a strengthening of the euro relative to the U.S. dollar. We recorded losses of $1.9 million for the change in fair value of the option contract during the nine months ended September 26, 2015 in Other expense, net. Because these derivatives were economically hedging future acquisitions, the cash outflows associated with their settlement are shown as investing activity on the Consolidated Statements of Cash Flows.

Effects of Derivatives on the Financial Statements
    
The below tables indicate the effects of all derivative instruments on the Condensed Consolidated Financial Statements. All amounts exclude income tax effects and are presented in millions.

The balance sheet location and gross fair value of our outstanding derivative instruments were as follows:
 
Asset Derivatives
 
Balance Sheet Location
 
Fair Value
 
 
 
October 1,
2016
 
December 31, 2015
Designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Other current assets
 
$
3.8

 
$
3.8

Total designated derivatives
 
 
$
3.8

 
$
3.8

Non-designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Other current assets
 
$
1.4

 
$
1.0

Total non-designated derivatives
 
 
$
1.4

 
$
1.0

 
Liability Derivatives
 
Balance Sheet Location
 
Fair Value
 
 
 
October 1,
2016
 
December 31, 2015
Designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Accrued liabilities
 
$
0.3

 
$
2.0

Interest rate swap agreements
Other non-current liabilities
 
—

 
0.3

Total designated derivatives
 
 
$
0.3

 
$
2.3

Non-designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Accrued liabilities
 
$
0.5

 
$
1.9

Total non-designated derivatives
 
 
$
0.5

 
$
1.9



The gains (losses) recorded in OCI for the effective portion of our designated cash flow hedges were as follows:
 
 
Amount of Gain/(Loss) Recorded in OCI
(Effective Portion)
 
 
Three Months Ended
 
Nine Months Ended
Designated Cash Flow Hedges
 
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Interest rate swap agreements
 
$
—

 
$
—

 
$
(9.0
)
 
$
(12.0
)
Foreign currency forward contracts
 
3.4

 
(0.5
)
 
4.7

 
(1.6
)
Total
 
$
3.4

 
$
(0.5
)
 
$
(4.3
)
 
$
(13.6
)


The gains (losses) reclassified from AOCI into earnings for the effective portion of our designated cash flow hedges were as follows:
 
 
 
 
Amount of Gain/(Loss) Reclassified from AOCI to Income
(Effective Portion)
 
 
 
 
Three Months Ended
 
Nine Months Ended
Designated Cash Flow Hedges
 
Income Statement Location
 
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Treasury locks
 
Interest expense, net
 
$
—

 
$
—

 
$
(0.1
)
 
$
(0.1
)
Interest rate swap agreements
 
Interest expense, net
 
(0.6
)
 
(0.4
)
 
(1.7
)
 
(18.6
)
Foreign currency forward contracts
 
Net sales
 
0.1

 
(0.1
)
 
1.0

 
1.8

 
 
Cost of sales
 
0.9

 
0.2

 
1.8

 
(4.4
)
 
 
Interest expense, net
 
(0.4
)
 
—

 
(1.3
)
 
—

 
 
Other expense, net
 
(1.4
)
 
(0.1
)
 
—

 
(0.6
)
Total
 
 
 
$
(1.4
)
 
$
(0.4
)
 
$
(0.3
)
 
$
(21.9
)


The gains (losses) recognized against earnings for the ineffective portion of our designated cash flow hedges were as follows:
 
 
 
 
Amount of Gain/(Loss) Recognized in Income
(Ineffective Portion)
 
 
 
 
Three Months Ended
 
Nine Months Ended
Designated Cash Flow Hedges
 
Income Statement
Location
 
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Interest rate swap agreements
 
Other expense, net
 
$
—

 
$
—

 
$
(0.1
)
 
$
—

Foreign currency forward contracts
 
Net sales
 
—

 
—

 
0.1

 
(0.3
)
 
 
Cost of sales
 
—

 
—

 
—

 
0.1

 
 
Other expense, net
 
—

 
—

 
0.6

 
—

Total
 
 
 
$
—

 
$
—

 
$
0.6

 
$
(0.2
)


The effects of our non-designated derivatives on the Condensed Consolidated Statements of Operations were as follows:
 
 
 
 
Amount of Gain/(Loss) Recognized in Income
 
 
 
 
Three Months Ended
 
Nine Months Ended
Non-Designated Derivatives
 
Income Statement Location
 
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Foreign currency forward contracts
 
Other expense, net
 
$
(0.2
)
 
$
(8.9
)
 
$
(8.7
)
 
$
(259.4
)
 
 
Interest expense, net
 
(1.0
)
 
0.1

 
(1.5
)
 
(3.4
)
Total
 
 
 
$
(1.2
)
 
$
(8.8
)
 
$
(10.2
)
 
$
(262.8
)
Derivatives, policy [Policy Text Block]

We enter into certain derivative financial instruments, when available on a cost-effective basis, to mitigate our risk associated with changes in interest rates and foreign currency exchange rates as follows:

Interest rate risk management - We are exposed to the impact of interest rate changes through our cash investments and borrowings. We utilize a variety of strategies to manage the impact of changes in interest rates including using a mix of debt maturities along with both fixed-rate and variable-rate debt. In addition, we may enter into treasury-lock agreements and interest rate swap agreements on certain investing and borrowing transactions to manage our exposure to interest rate changes and our overall cost of borrowing.

Foreign currency exchange risk management - We conduct business in several major currencies other than the U.S. dollar and are subject to risks associated with changing foreign exchange rates. Our objective is to reduce cash flow volatility associated with foreign exchange rate changes on a consolidated basis to allow management to focus its attention on business operations. Accordingly, we enter into various contracts that change in value as foreign exchange rates change to protect the value of existing foreign currency assets and liabilities, commitments, and anticipated foreign currency sales and expenses.
    
All derivative instruments are managed on a consolidated basis to efficiently net exposures and thus take advantage of any natural offsets. Gains and losses related to the derivative instruments are expected to be offset largely by gains and losses on the original underlying asset or liability. We do not use derivative financial instruments for speculative purposes.

All of our designated derivatives were classified as cash flow hedges as of October 1, 2016 and December 31, 2015. Designated derivatives meet hedge accounting criteria, which means the fair value of the hedge is recorded in shareholders’ equity as a component of OCI, net of tax. The deferred gains and losses are recognized in income in the period in which the hedged item affects earnings. Any ineffective portion of the change in fair value of the derivative is immediately recognized in earnings. All of our designated derivatives are assessed for hedge effectiveness quarterly.

We also have economic non-designated derivatives that do not meet hedge accounting criteria. These derivative instruments are adjusted to current market value at the end of each period through earnings. Gains or losses on these instruments are offset substantially by the remeasurement adjustment on the hedged item.    
XML 41 R15.htm IDEA: XBRL DOCUMENT v3.5.0.2
Assets Held for Sale (Notes)
 9 Months Ended
Oct. 01, 2016
Assets held for sale [Abstract]  
Disposal groups, including discontinued operations, disclosure [Text Block]
ASSETS HELD FOR SALE

During the six months ended December 31, 2015, management committed to a plan to sell our U.S. VMS and India Active Pharmaceutical Ingredients ("API") businesses. As a result, the net assets attributable to both businesses were classified as held-for-sale beginning at December 31, 2015. As described in Note 2, we completed the sale of our U.S. VMS business to IVC on August 5, 2016. In addition, during the three months ended October 1, 2016, management committed to a plan to sell certain fixed assets associated with our Animal Health pet treats plant. Such assets were classified as held-for-sale beginning at October 1, 2016.

When a group of assets is classified as held-for-sale, the book value is evaluated and adjusted to the lower of its carrying amount or fair value less the cost to sell. At December 31, 2015, we determined that the carrying value of the India API business exceeded its fair value less cost to sell, resulting in an impairment charge of $29.0 million. We recorded additional impairment charges totaling $10.8 million during the nine months ended October 1, 2016. The API business is reported primarily in our Other segment.

At October 1, 2016, we determined that the carrying value of the fixed assets associated with our Animal Health pet treats plant exceeded the fair value less the cost to sell, resulting in an impairment charge of $3.4 million. The assets associated with our Animal Health pet treats plant are reported in our CHC segment.

The assets held-for-sale were reported within Prepaid expenses and other current assets and liabilities held-for-sale were reported in Accrued liabilities. The amounts consisted of the following (in millions):
 
October 1,
2016
 
December 31,
2015
 
CHC
 
Other
 
CHC
 
Other
Assets held for sale
 
 
 
 
 
 
 
Current assets
$
—

 
$
7.3

 
$
55.1

 
$
13.6

Goodwill
—

 
2.8

 
13.0

 
14.5

Property, plant and equipment
13.3

 
34.0

 
18.8

 
37.4

Other assets
—

 
3.2

 
—

 
3.2

Less: impairment reserves
(3.4
)
 
(39.8
)
 
—

 
(29.0
)
Total assets held for sale
$
9.9

 
$
7.5

 
$
86.9

 
$
39.7

Liabilities held for sale
 
 
 
 
 
 
 
Current liabilities
$
0.3

 
$
0.9

 
$
30.5

 
$
0.5

Other liabilities
—

 
2.1

 
—

 
1.7

Total liabilities held for sale
$
0.3

 
$
3.0

 
$
30.5

 
$
2.2
XML 42 R16.htm IDEA: XBRL DOCUMENT v3.5.0.2
Indebtedness (note)
 9 Months Ended
Oct. 01, 2016
Aggregate Indebtedness [Abstract]  
Indebtedness [Text Block]
INDEBTEDNESS

Total borrowings outstanding are summarized as follows (in millions):
 
 
 
 
 
October 1,
2016
 
December 31,
2015
Revolving credit agreements
 
 
 
 
 
 
2015 Revolver
$
—

 
$
380.0

 
2014 Revolver
—

 
300.0

 
Total revolving credit agreements
—

 
680.0

Term loans
 
 
 
 
 
*
2014 Term loan due December 5, 2019
463.8

 
488.8

Notes and Bonds
 
 
 
 
 
 
Coupon
Due
 
 
 
 
 
 
1.300%
November 8, 2016
(2) 
 
—

 
500.0

*
4.500%
May 23, 2017
(3) 
 
202.4

 
195.5

*
5.125%
December 12, 2017
(3) 
 
337.3

 
325.8

 
2.300%
November 8, 2018
(2) 
 
600.0

 
600.0

*
5.000%
May 23, 2019
(3) 
 
134.9

 
130.3

 
3.500%
March 15, 2021
(4) 
 
500.0

 
—

 
3.500%
December 15, 2021
(1) 
 
500.0

 
500.0

*
5.105%
July 19, 2023
(3) 
 
151.8

 
146.7

 
4.000%
November 15, 2023
(2) 
 
800.0

 
800.0

 
3.900%
December 15, 2024
(1) 
 
700.0

 
700.0

 
4.375%
March 15, 2026
(4) 
 
700.0

 
—

 
5.300%
November 15, 2043
(2) 
 
400.0

 
400.0

 
4.900%
December 15, 2044
(1) 
 
400.0

 
400.0

 
Total notes and bonds
 
 
5,426.4

 
4,698.3

Other financing
4.1

 
86.0

Unamortized premium (discount), net
43.3

 
73.4

Deferred financing fees
(34.6
)
 
(36.6
)
Total borrowings outstanding
5,903.0

 
5,989.9

 
Current indebtedness
(265.0
)
 
(1,018.3
)
Total long-term debt less current portion
$
5,638.0

 
$
4,971.6


(1)
Discussed below collectively as the "2014 Notes."
(2)
Discussed below collectively as the "2013 Notes."
(3)
Debt assumed from Omega.
(4)
Discussed below collectively as the "2016 Notes."

*
Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.

We were in compliance with all covenants under our debt agreements as of October 1, 2016.

Revolving Credit Agreements

On December 9, 2015, our 100% owned finance subsidiary, Perrigo Finance Unlimited Company (formerly Perrigo Finance plc) ("Perrigo Finance"), entered into a $750.0 million revolving credit agreement (the "2015 Revolver"). On March 15, 2016, we used the proceeds of the long-term debt issuance described below under "2016 Notes" to repay the $750.0 million then outstanding under the 2015 Revolver and terminated the facility.

On March 30, 2015, we assumed a revolving credit facility with €500.0 million ($544.5 million) outstanding from Omega. On April 8, 2015, the €500.0 million ($539.1 million) outstanding under the assumed revolving credit facility was repaid and the facility was terminated.

On December 5, 2014, Perrigo Finance entered into a $600.0 million revolving credit agreement, which we increased to $1.0 billion on March 30, 2015 (the "2014 Revolver"). On March 15, 2016, we used the proceeds of the long-term debt issuance described below under "2016 Notes" to repay the $435.0 million then outstanding under the 2014 Revolver. There were no borrowings outstanding under the 2014 Revolver as of October 1, 2016.

Term Loans

On December 5, 2014, Perrigo Finance entered into a term loan agreement consisting of a €500.0 million ($614.3 million) tranche, with the ability to draw an additional €300.0 million ($368.6 million) tranche, maturing December 5, 2019, and we entered into a $300.0 million term loan tranche maturing December 18, 2015, which we repaid in full on June 25, 2015. During the nine months ended October 1, 2016, we made $41.9 million in scheduled principal payments on the euro-denominated term loan.

Notes and Bonds

2016 Notes

On March 7, 2016, Perrigo Finance issued $500.0 million in aggregate principal amount of 3.500% senior notes due 2021 and $700.0 million in aggregate principal amount of 4.375% senior notes due 2026 (together, the "2016 Notes") and received net proceeds of $1.2 billion after fees and market discount. Interest on the 2016 Notes is payable semiannually in arrears in March and September of each year, beginning in September 2016. The 2016 Notes are governed by a base indenture and a second supplemental indenture (collectively, the "2016 Indenture"). The 2016 Notes are fully and unconditionally guaranteed on a senior basis by Perrigo, and no other subsidiary of Perrigo guarantees the 2016 Notes. The proceeds were used to repay amounts borrowed under the 2015 Revolver and the 2014 Revolver, as mentioned above. There are no restrictions under the 2016 Notes on our ability to obtain funds from our subsidiaries. Perrigo Finance may redeem the 2016 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2016 Indenture.

Notes and Bonds Assumed from Omega

In connection with the Omega acquisition, on March 30, 2015, we assumed:

•
$20.0 million in aggregate principal amount of 6.190% senior notes due 2016, which was repaid on May 29, 2015 in full;
•
€135.0 million ($147.0 million) in aggregate principal amount of 5.1045% senior notes due 2023 (the "2023 Notes");
•
€300.0 million ($326.7 million) in aggregate principal amount of 5.125% retail bonds due 2017; €180.0 million ($196.0 million) in aggregate principal amount of 4.500% retail bonds due 2017; and €120.0 million ($130.7 million) in aggregate principal amount of 5.000% retail bonds due 2019 (collectively, the "Retail Bonds").

The fair value of the 2023 Notes and Retail Bonds exceeded par value by €93.6 million ($101.9 million) on the date of the Omega acquisition. As a result, a fair value adjustment was recorded as part of the carrying value of the underlying debt and will be amortized as a reduction of interest expense over the remaining terms of the respective debt instruments. The adjustment does not affect cash interest payments.

2014 Notes

On December 2, 2014, Perrigo Finance issued $500.0 million in aggregate principal amount of 3.500% senior notes due 2021 (the "2021 Notes”), $700.0 million in aggregate principal amount of 3.900% senior notes due 2024 (the “2024 Notes”), and $400.0 million in aggregate principal amount of 4.900% senior notes due 2044 (the “2044 Notes” and, together with the 2021 Notes and the 2024 Notes, the “2014 Notes”) and received net proceeds of $1.6 billion after fees and market discount. Interest on the 2014 Notes is payable semiannually in arrears in June and December of each year, beginning in June 2015. The 2014 Notes are governed by a base indenture and a first supplemental indenture (collectively, the "2014 Indenture"). The 2014 Notes are fully and unconditionally guaranteed on a senior unsecured basis by Perrigo, and no other subsidiary of Perrigo guarantees the 2014 Notes. There are no restrictions under the 2014 Notes on our ability to obtain funds from our subsidiaries. Perrigo Finance may redeem the 2014 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2014 Indenture.

2013 Notes

On November 8, 2013, Perrigo Company issued $500.0 million aggregate principal amount of its 1.300% senior notes due 2016 (the "1.300% 2016 Notes"), $600.0 million aggregate principal amount of its 2.300% senior notes due 2018 (the "2018 Notes"), $800.0 million aggregate principal amount of its 4.000% senior notes due 2023 (the "4.000% 2023 Notes") and $400.0 million aggregate principal amount of its 5.300% senior notes due 2043 (the "2043 Notes" and, together with the 1.300% 2016 Notes, the 2018 Notes and the 4.000% 2023 Notes, the "2013 Notes") in a private placement with registration rights. We received net proceeds of $2.3 billion from the issuance of the 2013 Notes after fees and market discount. On September 29, 2016, we repaid all $500.0 million of the 1.300% 2016 Notes outstanding.

Interest on the 2013 Notes is payable semiannually in arrears in May and November of each year, beginning in May 2014. The 2013 Notes are governed by a base indenture and a first supplemental indenture (collectively, the "2013 Indenture"). The 2013 Notes are our unsecured and unsubordinated obligations, ranking equally in right of payment to all of our existing and future unsecured and unsubordinated indebtedness. The 2013 Notes are not entitled to mandatory redemption or sinking fund payments. We may redeem the 2013 Notes in whole or in part at any time for cash at the make-whole redemption prices described in the 2013 Indenture. The 2013 Notes were guaranteed on an unsubordinated, unsecured basis by the same entities that guaranteed our then-outstanding credit agreement until November 21, 2014, at which time the 2013 Indenture was amended to remove all guarantors.

Other Financing

Overdraft Facilities

On March 30, 2015, we assumed and repaid certain overdraft facilities totaling €51.4 million ($56.0 million) with the Omega acquisition. Our BCH segment uses overdraft facilities to increase the efficiency of its cash utilization and meet its short-term liquidity needs. We repaid the balance outstanding under the overdraft facilities during the nine months ended October 1, 2016, but retain the ability to use the facilities in our day-to-day cash operations. The balance outstanding under the facilities was $82.9 million at December 31, 2015 and is shown in the above table under "Other Financing".
XML 43 R17.htm IDEA: XBRL DOCUMENT v3.5.0.2
Earnings Per Share
 9 Months Ended
Oct. 01, 2016
Earnings Per Share [Abstract]  
Earnings per share [Text Block]
EARNINGS PER SHARE AND SHAREHOLDERS' EQUITY

Earnings per Share

A reconciliation of the numerators and denominators used in the basic and diluted earnings per share ("EPS") calculation is as follows (in millions):
 
Three Months Ended
 
Nine Months Ended
 
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Numerator:
 
 
 
 
 
 
 
Net income (loss)
$
(1,255.2
)
 
$
112.6

 
$
(1,395.4
)
 
$
74.2

 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
Weighted average shares outstanding for basic EPS
143.3

 
146.3

 
143.2

 
144.4

Dilutive effect of share-based awards*
—

 
0.6

 
—

 
0.6

Weighted average shares outstanding for diluted EPS
143.3

 
146.9

 
143.2

 
145.0

 
 
 
 
 
 
 
 
Anti-dilutive share-based awards excluded from computation of diluted EPS*
—

 
0.1

 
—

 
—


* In the period of a net loss, diluted shares equal basic shares.

Shareholders' Equity

Shares

We issued shares related to the exercise and vesting of share-based compensation as follows:
Three Months Ended
 
Nine Months Ended
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
185,000

 
154,000

 
283,000

 
246,000



Share Repurchases

On October 22, 2015, the Board of Directors approved a share repurchase plan of up to $2.0 billion, of which $1.5 billion is still available to be repurchased through December 31, 2018. We did not repurchase any shares under the share repurchase plan during the nine months ended October 1, 2016.
XML 44 R18.htm IDEA: XBRL DOCUMENT v3.5.0.2
Accumulated Other Comprehensive Income
 9 Months Ended
Oct. 01, 2016
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Comprehensive income (loss) note [Text Block]
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

Changes in our AOCI balances, net of tax were as follows (in millions):
 
Foreign currency translation adjustments
 
Fair value of derivative financial instruments, net of tax
 
Fair value of investment securities, net of tax
 
Post-retirement and pension liability adjustments, net of tax
 
Total AOCI
Balance at December 31, 2015
$
(4.4
)
 
$
(14.2
)
 
$
6.3

 
$
(3.2
)
 
$
(15.5
)
OCI before reclassifications
71.8

 
(3.7
)
 
17.1

 
0.3

 
85.5

Amounts reclassified from AOCI
—

 
0.2

 
1.3

 
—

 
1.5

Other comprehensive income (loss)
71.8

 
(3.5
)
 
18.4

 
0.3

 
87.0

Balance at October 1, 2016
$
67.4

 
$
(17.7
)
 
$
24.7

 
$
(2.9
)
 
$
71.5
XML 45 R19.htm IDEA: XBRL DOCUMENT v3.5.0.2
Income Taxes
 9 Months Ended
Oct. 01, 2016
Income Tax Disclosure [Abstract]  
Income tax disclosure [Text Block]
INCOME TAXES

The effective tax rate for the three months ended October 1, 2016 was 20.1% on a net loss compared to 14.8% on net income for the three months ended September 26, 2015. The effective tax rate for the nine months ended October 1, 2016 was 21.6% on a net loss reported in the period compared to 60.3% on net income for the nine months ended September 26, 2015. For the three and nine months ended October 1, 2016, we have estimated income taxes using the annual effective tax rate method.

Income taxes recorded through July 2, 2016 were estimated using the discrete method. For the three and nine months ended ended October 1, 2016, we had significant changes to our estimates related to additional asset impairments recognized in the third quarter and therefore determined that estimating income taxes using the annual effective tax rate method was the more appropriate method for the period ending October 1, 2016.

Our tax rate is subject to adjustment over the balance of the fiscal year due to, among other things: income tax rate changes by governments; the jurisdictions in which our profits are determined to be earned and taxed; changes in the valuation of our deferred tax assets and liabilities; adjustments to estimated taxes upon finalization of various tax returns; adjustments based on differing interpretations of the applicable transfer pricing standards; changes in available tax credits, grants and other incentives; changes in stock-based compensation expense; changes in tax laws or the interpretation of such tax laws (for example, proposals for fundamental U.S. international tax reform); changes in U.S. GAAP; expiration of or the inability to renew tax rulings or tax holiday incentives; and the repatriation of earnings with respect to which we have not previously provided for taxes.

Israel passed legislation in January 2016, effective immediately, reducing the tax rate from 26.5% to 25%. The impact on our effective tax rate was minimal.

The United Kingdom passed legislation in September 2016, reducing the tax rate effective April 1, 2020, from 18% to 17%. We expect the impact on our effective tax rate to be minimal.

The total liability for uncertain tax positions was $368.4 million and $334.7 million as of October 1, 2016 and December 31, 2015, respectively, before considering the federal tax benefit of certain state and local items.

We recognize interest and penalties related to uncertain tax positions as a component of income tax expense. The total amount accrued for interest and penalties in the liability for uncertain tax positions was $56.4 million and $52.1 million as of October 1, 2016 and December 31, 2015, respectively.

We file income tax returns in numerous jurisdictions and are therefore subject to audits by tax authorities. Our primary income tax jurisdictions are Ireland, the U.S., Israel, Belgium, France, and the U.K.

Although we believe that the tax estimates are reasonable and that we prepare our tax filings in accordance with all applicable tax laws, the final determination with respect to any tax audit and any related litigation could be materially different from estimates or from historical income tax provisions and accruals. The results of an audit or litigation could have a material effect on our operating results and/or cash flows in the periods for which that determination is made. In addition, future period earnings may be adversely impacted by litigation costs, settlements, penalties, and/or interest assessments.

The IRS audit of our fiscal years ended June 27, 2009 and June 26, 2010 had previously concluded with the issuance of a statutory notice of deficiency on August 27, 2014. While we had previously agreed on certain adjustments and made associated payments of $8.0 million (inclusive of interest) in November 2014, the statutory notice of deficiency asserted various additional adjustments, including transfer pricing adjustments. The statutory notice of deficiency's adjustments for fiscal years 2009 and 2010 asserted an incremental tax obligation of approximately $68.9 million, inclusive of interest and penalties. We disagree with the IRS’s positions asserted in the statutory notice of deficiency. To contest the IRS's adjustments, in January 2015 we paid the incremental tax obligation (a prerequisite to contesting the proposed adjustments in U.S. district court), and in June 2015, we filed an administrative request for a refund with the IRS. The payment was recorded during the three months ended March 28, 2015 as a deferred charge on the balance sheet given our anticipated action to recover this amount. The IRS subsequently denied our request for a refund. We anticipate filing a complaint in U.S. district court claiming a refund of the paid amounts prior to August 2017. An unfavorable resolution of this matter could have a material impact on our consolidated financial statements in future periods.

We have ongoing audits in multiple jurisdictions the resolution of which remains uncertain. These jurisdictions include, but are not limited to, the United States and Belgium. The IRS is auditing our fiscal years ended June 25, 2011 and June 30, 2012, and may make adjustments consistent with the adjustments made in the statutory notice of deficiency for fiscal years 2009 and 2010. In February 2016, the Belgium Tax Authority notified us that all Belgium locations will be audited for the years ended December 31, 2013 and December 31, 2014. At this time, we cannot predict the outcome of any audit or related litigation.
XML 46 R20.htm IDEA: XBRL DOCUMENT v3.5.0.2
Commitments and Contingencies
 9 Months Ended
Oct. 01, 2016
Commitments and Contingencies Disclosure [Abstract]  
Commitments and contingencies [Text Block]
COMMITMENTS AND CONTINGENCIES

In view of the inherent difficulties of predicting the outcome of various types of legal proceedings, we cannot determine the ultimate resolution of the matters described below. We establish reserves for litigation and regulatory matters when losses associated with the claims become probable and the amounts can be reasonably estimated. The actual costs of resolving legal matters may be substantially higher or lower than the amounts reserved for those matters. For matters where the likelihood or extent of a loss is not probable or cannot be reasonably be estimated as of October 1, 2016, we have not recorded a loss reserve. If certain of these matters are determined against the Company, there could be a material adverse effect on our financial condition, results of operations, or cash flows. We currently believe we have valid defenses to the claims in these lawsuits and intend to defend these lawsuits vigorously regardless of whether or not we have a loss reserve. Other than what is disclosed below, we do not expect the outcome of the litigation matters to which we are currently subject to, individually or in the aggregate, have a material adverse effect on our financial condition, results of operations, or cash flows. 

Securities Litigation
 
On May 18, 2016, a shareholder filed a securities case against the Company and our former CEO, Joseph Papa, in the District of New Jersey (Roofers’ Pension Fund v. Papa, et al.). The plaintiff purports to represent a class of shareholders for the period from April 21, 2015 through May 11, 2016, inclusive. The complaint alleges violations of Securities Exchange Act sections 10(b) (and Rule 10b‑5) and 14(e) against both defendants and 20(a) control person liability against Mr. Papa. In general, the allegations concern the actions taken by the Company and the former executive to defend against the hostile takeover bid by Mylan in the period from April 21, 2015 through November 13, 2015. The plaintiff also alleges that we provided inadequate disclosure concerning alleged integration problems related to the Omega acquisition in the period from April 21, 2015 through May 11, 2016. The case is in an early stage. Four different plaintiff groups have sought appointment as lead plaintiff/lead counsel. The court will decide who will represent the purported class. Once the court has chosen a lead plaintiff, the plaintiff will likely file an amended complaint and the defendants will then have an opportunity to make a motion to dismiss the case. 
 
On July 19, 2016, a shareholder filed a securities class action against the Company and our former CEO, Joseph Papa, in the District of New Jersey. (Wilson v. Papa, et al.) The plaintiff purports to represent a class of persons who sold put options on the Company shares between April 21, 2015 and May 11, 2016. In general, the allegations and the claims are the same as those made in the Roofers' Pension Fund case described above. Subsequently, this shareholder filed papers in the Roofers' Pension Fund case as one of four candidates seeking to be named lead plaintiff or co-lead plaintiff in that case. The Wilson plaintiff also filed a motion to have the Wilson case consolidated with the Roofers' Pension Fund case. The court has not yet acted on the motion to consolidate or the motion for appointment as lead plaintiff.
 
On May 22, 2016, shareholders filed a securities class action against the Company and five individual defendants: Mr. Papa, our former Executive Vice President and General Manager of the BCH segment Marc Coucke, our Chief Executive Officer John Hendrickson, and our Board members Gary Kunkle, Jr. and Laurie Brlas alleging violations of Israeli law in the District Court of Tel Aviv-Jaffa (Schwieger et al. v. Perrigo Company plc, et al.). On June 15, 2016, Perrigo filed a motion to stay the case pending the outcome of the securities class action pending in the New Jersey federal court. The plaintiffs did not oppose the motion. The Israeli court granted the motion on the same day, and the action is stayed.

Eltroxin

During October and November 2011, nine applications to certify a class action lawsuit were filed in various courts in Israel related to Eltroxin, a prescription thyroid medication manufactured by a third party and distributed in Israel by our subsidiary, Perrigo Israel Agencies Ltd. The respondents included our subsidiaries, Perrigo Israel Pharmaceuticals Ltd. and/or Perrigo Israel Agencies Ltd., the manufacturers of the product, and various healthcare providers who provide healthcare services as part of the compulsory healthcare system in Israel.

One of the applications was dismissed and the remaining eight applications were consolidated into one application. The applications arose from the 2011 launch of a reformulated version of Eltroxin in Israel. The consolidated application generally alleges that the respondents: (a) failed to timely inform patients, pharmacists and physicians about the change in the formulation; and (b) failed to inform physicians about the need to monitor patients taking the new formulation in order to confirm patients were receiving the appropriate dose of the drug. As a result, claimants allege they incurred the following damages: (a) purchases of product that otherwise would not have been made by patients had they been aware of the reformulation; (b) adverse events to some patients resulting from an imbalance of thyroid functions that could have been avoided; and (c) harm resulting from the patients' lack of informed consent prior to the use of the reformulation.

Several hearings on whether or not to certify the consolidated application took place in December 2013 and January 2014. On May 17, 2015, the District Court certified the motion against Perrigo Israel Agencies Ltd. and dismissed it against the remaining respondents, including Perrigo Israel Pharmaceuticals Ltd.

On June 16, 2015, Perrigo submitted a motion for permission to appeal the decision to certify to the Israeli Supreme Court together with a motion to stay the proceedings of the class action until the motion for permission to appeal is adjudicated. Perrigo has filed its statement of defense to the underlying proceedings and the underlying proceedings have been stayed pending a decision on the motion to appeal.

During a July 11, 2016 hearing on Perrigo’s motion to appeal the certification decision, the court noted that permission should be granted to Perrigo's appeal given issues with the scope of the District Court's decision.  The court ultimately recommended the parties pursue mediation, noting that no decision on Perrigo's motion to appeal will be made pending the results of the mediation. The parties are now engaged in the mediation process. At this stage, we cannot reasonably predict the outcome or the liability, if any, associated with this claim.

Tysabri® Product Liability Lawsuits

Perrigo and collaborator Biogen are co-defendants in product liability lawsuits arising out of the occurrence of Progressive Multifocal Leukoencephalopathy, a serious brain infection, and serious adverse events, including deaths, which occurred in patients taking Tysabri®. Perrigo and Biogen will each be responsible for 50% of losses and expenses arising out of any Tysabri® product liability claims. During calendar year 2016, one case in the U.S. was settled and two others were dismissed with prejudice. While the remaining lawsuits will be vigorously defended, management cannot predict how these cases will be resolved. Adverse results in one or more of these lawsuits could result in substantial judgments against the Company.
XML 47 R21.htm IDEA: XBRL DOCUMENT v3.5.0.2
Collaboration agreements and other contractual arrangements (Notes)
 9 Months Ended
Oct. 01, 2016
Collaboration agreements and other contractual arrangements [Abstract]  
Collaboration agreements [Text Block]
COLLABORATION AGREEMENTS AND OTHER CONTRACTUAL ARRANGEMENTS

In May 2015, we entered into a development agreement wherein we transferred the ownership rights to two pharmaceutical products to a clinical stage development company to fund and conduct development activities for the products. We do not expect to incur any expense related to the development of either product. If the products are approved by the FDA, we will execute a buy-back agreement to purchase each product for a multiple of the development costs incurred. Based on the initial development budget for each product, the estimated purchase price for both products is approximately $78.0 million. If development costs exceed the initial budgeted amounts, the purchase price will increase but will not exceed approximately $105.0 million. If the products are approved by the FDA and we purchase the products, we estimate the acquisitions will occur in 2019 and 2020. 

In June 2016, we added an additional product to the May 2015 development agreement that is subject to similar buy-back terms if the product is approved by the FDA. The estimated purchase price for this additional product, based on the initial development budget, is approximately $42.0 million. If development costs exceed the initial budgeted amounts, the purchase price will increase, but will not exceed approximately $57.0 million. If the product is approved by the FDA and we purchase the product, we estimate the acquisition will occur in 2020. There can be no assurance that any such products will be approved by the FDA on the anticipated schedule or at all.
XML 48 R22.htm IDEA: XBRL DOCUMENT v3.5.0.2
Restructuring Charges (Notes)
 9 Months Ended
Oct. 01, 2016
Restructuring Charges [Abstract]  
Restructuring charges
RESTRUCTURING CHARGES

We periodically take action to reduce redundant expenses and improve operating efficiencies, typically in connection with business acquisitions. The following reflects our restructuring activity (in millions):
 
Three Months Ended
 
Nine Months Ended
 
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Beginning balance
$
12.2

 
$
1.7

 
$
20.7

 
$
3.2

Additional charges
6.6

 
2.2

 
17.9

 
3.1

Payments
(8.6
)
 
(1.9
)
 
(33.3
)
 
(4.5
)
Non-cash adjustments
0.1

 
(0.7
)
 
5.0

 
(0.5
)
Ending balance
$
10.3

 
$
1.3

 
$
10.3

 
$
1.3



Restructuring activity includes severance, lease exit costs, and asset impairments. The charges incurred during the three and nine months ended October 1, 2016 were associated primarily with actions we took to streamline our organization as announced on October 22, 2015 and did not materially impact any one reportable segment. There were no other material restructuring programs in any of the periods presented. All charges are recorded in Restructuring expense. The remaining $5.1 million liability for employee severance benefits will be paid within the next year, while cash expenditures related to the remaining $5.2 million liability for lease exit costs will be incurred over the remaining terms of the applicable leases.
XML 49 R23.htm IDEA: XBRL DOCUMENT v3.5.0.2
Segment Information
 9 Months Ended
Oct. 01, 2016
Segment Reporting [Abstract]  
Segment reporting disclosure [Text Block]
SEGMENT INFORMATION

Our reporting segments are as follows:

•
CHC is focused primarily on the global sale of OTC store brand products including cough, cold, allergy and sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, and diagnostic products.

•
BCH develops, manufactures, markets and distributes many well-known European OTC brands in the natural health and vitamins, cough, cold and allergy, smoking cessation, personal care and derma-therapeutics, lifestyle, and anti-parasite categories.

•
Rx develops, manufactures and markets a portfolio of generic and specialty pharmaceutical prescription drugs primarily for the U.S. and U.K. markets.

•
Specialty Sciences is comprised primarily of royalties received from assets focused on the management of multiple sclerosis (Tysabri®).

We also have an Other reporting segment that consists of our API business, which does not meet the quantitative threshold required to be a separately reportable segment. Our segments reflect the way in which our chief operating decision maker reviews our operating results and allocates resources.

The below tables show select financial measures by reporting segment (in millions):
Total Assets
 
October 1,
2016
 
December 31, 2015
CHC
 
$
3,873.8

 
$
4,007.8

BCH
 
4,460.2

 
6,324.0

Rx
 
3,304.0

 
3,015.5

Specialty Sciences
 
5,634.0

 
5,833.5

Other
 
195.6

 
213.1

Total
 
$
17,467.6

 
$
19,393.9

 
Three Months Ended
 
October 1, 2016
 
September 26, 2015
 
Net Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
 
Net Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
CHC
$
669.1

 
$
100.1

 
$
19.2

 
$
675.2

 
$
117.3

 
$
19.4

BCH
304.0

 
(1,684.3
)
 
38.9

 
302.2

 
4.4

 
36.3

Rx
267.4

 
77.9

 
30.7

 
260.3

 
91.0

 
18.6

Specialty Sciences
93.4

 
23.3

 
72.8

 
84.5

 
9.0

 
72.8

Other
21.0

 
(1.6
)
 
0.5

 
22.5

 
6.2

 
0.5

Unallocated
—

 
(30.6
)
 
—

 
—

 
(39.3
)
 
—

Total
$
1,354.9

 
$
(1,515.2
)
 
$
162.1

 
$
1,344.7

 
$
188.6

 
$
147.6


 
Nine Months Ended
 
October 1, 2016
 
September 26, 2015
 
Net Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
 
Net Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
CHC
$
2,055.6

 
$
313.6

 
$
58.1

 
$
2,106.4

 
$
364.8

 
$
52.1

BCH*
1,015.3

 
(2,128.7
)
 
113.9

 
703.4

 
31.0

 
70.5

Rx
817.4

 
262.1

 
90.1

 
790.1

 
290.4

 
55.5

Specialty Sciences
271.3

 
49.7

 
218.3

 
250.1

 
21.0

 
218.4

Other
59.5

 
2.6

 
1.4

 
75.4

 
18.6

 
1.4

Unallocated
—

 
(80.0
)
 
—

 
—

 
(111.1
)
 
—

Total*
$
4,219.1

 
$
(1,580.7
)
 
$
481.8

 
$
3,925.4

 
$
614.7

 
$
397.9


*
The BCH segment was created on March 30, 2015 as a result of the Omega acquisition, thus data for the nine months ended September 26, 2015 includes only six months of results from operations attributable to Omega.
XML 50 R24.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies and Change in Accounting Principles (Policies)
 9 Months Ended
Oct. 01, 2016
Accounting Policies [Abstract]  
Basis of presentation
Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP") for interim financial information and with the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited Condensed Consolidated Financial Statements should be read in conjunction with the consolidated financial statements and footnotes included in our Transition Report on Form 10-KT for the transition period from June 28, 2015 to December 31, 2015. In the opinion of management, all adjustments (consisting of normal recurring accruals and other adjustments) considered necessary for a fair presentation have been included.
Principles of consolidation
The Condensed Consolidated Financial Statements include our accounts and the accounts of all majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

Our fiscal year previously consisted of a 52- or 53-week year ending on or around June 30 of each year with each quarter ending on the Saturday closest to each calendar quarter-end. Beginning on January 1, 2016, we changed our fiscal year to begin on January 1 and end on December 31 of each year. We will continue to cut off our quarterly accounting periods on the Saturday closest to the end of the calendar quarter, with the fourth quarter ending on December 31 of each year.
Accounting error corrections [Text Block]
During the three months ended April 2, 2016, we identified certain errors in our consolidated financial statements for the transition period of June 28, 2015 to December 31, 2015, related primarily to the accrual estimates associated with product returns and tax-related items in our Branded Consumer Healthcare ("BCH") segment. These errors were corrected during the three months ended April 2, 2016 by increasing the consolidated operating loss by $14.5 million, which when combined with tax-related items, increased the consolidated net loss by $13.7 million within the Condensed Consolidated Statements of Operations. We concluded that these errors were not material to the consolidated financial statements for the transition period of June 28, 2015 to December 31, 2015 and are not expected to be material to the consolidated financial statements for the year ending December 31, 2016.
Recently issued accounting standards not yet adopted
Recent Accounting Standard Pronouncements

Below are recent accounting standard updates that we are still assessing to determine the effect on our consolidated financial statements. We do not believe that any other recently issued accounting standards could have a material effect on our consolidated financial statements. As new accounting pronouncements are issued, we will adopt those that are applicable under the circumstances.
Recently Issued Accounting Standards Not Yet Adopted
Standard
 
Description
 
Effective Date
 
Effect on the Financial Statements or Other Significant Matters
Improvements to Employee Share-Based Payment Accounting

 
This guidance is intended to simplify several aspects of the accounting for share-based payment award transactions. It will require all income tax effects of awards to be recorded through the income statement when they vest or settle as opposed to certain amounts being recorded in additional paid-in capital. An entity will also have to elect whether to account for forfeitures as they occur or by estimating the number of awards expected to be forfeited and adjusting the estimate when it is likely to change (as currently required). The guidance will also increase the amount an employer can withhold to cover income taxes on awards. Early adoption is permitted.
 
January 1, 2017
 
We are currently evaluating the implications of adoption on our consolidated financial statements.
Revenue from Contracts with Customers
 
The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps: identify the contract(s) with a customer; identify the performance obligations in the contract; determine the transaction price; allocate the transaction price to the performance obligations in the contract; and recognize revenue when (or as) the entity satisfies a performance obligation. This guidance allows for two adoption methods, full retrospective approach or modified retrospective approach. Early adoption is not permitted.
 
January 1, 2018
 
We are currently evaluating the possible adoption methodologies and the implications of adoption on our consolidated financial statements.
Leases
 
This guidance was issued to increase transparency and comparability among organizations by requiring recognition of lease assets and lease liabilities on the balance sheet and disclosure of key information about leasing arrangements. For leases with a term of 12 months or less, lessees are permitted to make an election to not recognize right-of-use assets and lease liabilities. Upon adoption, lessees will apply the new standard as of the beginning of the earliest comparative period presented in the financial statements, however lessees will be able to exclude leases that expire as of the implementation date. Early adoption is permitted.


 
January 1, 2019
 
We are currently evaluating the implications of adoption on our consolidated financial statements and considering whether to early adopt the standard.


Recently Issued Accounting Standards Not Yet Adopted (continued)
Standard
 
Description
 
Effective Date
 
Effect on the Financial Statements or Other Significant Matters
Measurement of Credit Losses on Financial Instruments
 
This guidance changes the impairment model for most financial assets and certain other instruments, replacing the current "incurred loss" approach with an "expected loss" credit impairment model, which will apply to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables, loans, held-to-maturity debt securities, and off-balance sheet credit exposures such as letters of credit. Early adoption is permitted.


 
January 1, 2020
 
We are currently evaluating the new standard for potential impacts on our receivables, debt, and other financial instruments and considering whether to early adopt the standard.
XML 51 R25.htm IDEA: XBRL DOCUMENT v3.5.0.2
Business Acquisitions (Tables)
 9 Months Ended
Oct. 01, 2016
Business Combinations [Abstract]  
Schedule of acquisition-related costs [Table Text Block]
The table below details the acquisition costs, as well as losses on hedging activities associated with the acquisition purchase price, and where they were recorded for the nine months ended September 26, 2015 (in millions):
 
 
Nine Months Ended
Line item
 
September 26, 2015
Administration
 
$
18.1

Interest expense, net
 
18.7

Other expense, net
 
258.2

Total acquisition-related costs
 
$
295.0
Business acquisition, pro forma information
The following unaudited pro forma information gives effect to the Tretinoin Products, Entocort®, Naturwohl, GSK Products, ScarAway®, Omega, and Gelcaps acquisitions, as well as four small product acquisitions, as if the acquisitions had occurred on the first day of the nine months ended September 26, 2015 and had been included in our Results of Operations for all periods presented thereafter (in millions):
 
Three Months Ended
 
Nine Months Ended
(Unaudited)
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Net sales
$
1,359.6

 
$
1,429.9

 
$
4,243.3

 
$
4,451.4

Net income (loss)
$
(1,254.9
)
 
$
142.0

 
$
(1,392.8
)
 
$
154.7
Business combination, separately recognized transactions
The below table indicates the purchase price allocation for acquisitions completed in the current year (in millions):
 
Tretinoin Products
 
Development-Stage Rx Products
 
All Other(1)*
Purchase price paid
$
416.4

 
$
—

 
$
21.9

Contingent consideration
—

 
24.9

 
30.6

Total purchase consideration
$
416.4

 
$
24.9

 
$
52.5

 
 
 
 
 
 
Assets acquired:
 
 
 
 
 
Cash and cash equivalents
$
—

 
$
—

 
$
3.8

Accounts receivable
—

 
—

 
4.9

Inventories
1.4

 
—

 
7.1

Prepaid expenses and other current assets
—

 
—

 
0.1

Property and equipment
—

 
—

 
1.2

Goodwill
1.7

 
—

 
0.2

Definite-lived intangibles:
 
 
 
 
 
Distribution and license agreements, supply agreements
—

 
—

 
3.4

Developed product technology, formulations, and product rights
411.0

 
—

 
23.3

Customer relationships and distribution networks
—

 
—

 
8.2

Non-compete agreements
2.3

 
—

 
—

Indefinite-lived intangibles:
 
 
 
 
 
In-process research and development
—

 
24.9

 
7.0

Total intangible assets
$
413.3

 
$
24.9

 
$
41.9

Total assets
$
416.4

 
$
24.9

 
$
59.2

Liabilities assumed:
 
 
 
 
 
Accounts payable
$
—

 
$
—

 
$
2.8

Accrued liabilities
—

 
—

 
0.1

Long-term debt
—

 
—

 
3.3

Net deferred income tax liabilities
—

 
—

 
0.5

Total liabilities
$
—

 
$
—

 
$
6.7

Net assets acquired
$
416.4

 
$
24.9

 
$
52.5


*    Opening balance sheet is preliminary
(1)
Consists of four product acquisitions in the CHC and Rx segments
The below table indicates the purchase price allocation for acquisitions completed during the year ended December 31, 2015 (in millions):
 
Entocort®
 
Naturwohl
 
ScarAway®
 
GSK Products
 
Gelcaps
 
Omega
 
All Other(1)
Purchase price paid
$
380.2

 
$
150.4

 
$
26.7

 
$
223.6

 
$
37.9

 
$
2,983.2

 
$
15.3

Contingent consideration
—

 
—

 
—

 
—

 
—

 
—

 
13.9

Total purchase consideration
$
380.2

 
$
150.4

 
$
26.7

 
$
223.6

 
$
37.9

 
$
2,983.2

 
$
29.2

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets acquired:
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
—

 
$
4.6

 
$
—

 
$
—

 
$
4.6

 
$
14.7

 
$
—

Accounts receivable
—

 
3.3

 
—

 
—

 
7.3

 
260.1

 
—

Inventories
0.2

 
1.5

 
1.0

 
—

 
7.2

 
202.5

 
—

Prepaid expenses and other current assets
—

 
—

 
—

 
—

 
2.1

 
39.2

 
—

Property and equipment
—

 
—

 
—

 
—

 
6.0

 
130.8

 
—

Goodwill
—

 
61.0

 
3.5

 
32.6

 
6.0

 
1,900.4

 
—

Definite-lived intangibles:
 
 
 
 
 
 
 
 
 
 
 
 
 
Distribution and license agreements, supply agreements
—

 
21.4

 
—

 
—

 
—

 
—

 
—

Developed product technology, formulations, and product rights
380.0

 
—

 
0.5

 
—

 
—

 
27.2

 
—

Customer relationships and distribution networks
—

 
25.9

 
9.8

 
61.5

 
6.6

 
1,056.3

 
—

Trademarks, trade names, and brands
—

 
64.2

 
11.4

 
129.5

 
—

 
287.5

 
—

Non-compete agreements
—

 
0.3

 
0.5

 
—

 
—

 
—

 
—

Indefinite-lived intangibles:
 
 
 
 
 
 
 
 
 
 
 
 
 
Trademarks, trade names, and brands
—

 
—

 
—

 
—

 
4.4

 
2,003.8

 
—

In-process research and development
—

 
—

 
—

 
—

 
—

 
—

 
29.2

Total intangible assets
$
380.0

 
$
111.8

 
$
22.2

 
$
191.0

 
$
11.0

 
$
3,374.8

 
$
29.2

Other non-current assets
—

 
—

 
—

 
—

 
0.4

 
2.4

 
—

Total assets
$
380.2

 
$
182.2

 
$
26.7

 
$
223.6

 
$
44.6

 
$
5,924.9

 
$
29.2

Liabilities assumed:
 
 
 
 
 
 
 
 
 
 
 
 
 
Accounts payable
$
—

 
$
2.8

 
$
—

 
$
—

 
$
3.3

 
$
243.1

 
$
—

Short-term debt
—

 
—

 
—

 
—

 
—

 
24.6

 
—

Accrued liabilities
—

 
1.6

 
—

 
—

 
1.6

 
43.9

 
—

Payroll and related taxes
—

 
—

 
—

 
—

 
—

 
51.3

 
—

Accrued customer programs
—

 
—

 
—

 
—

 
—

 
39.8

 
—

Long-term debt
—

 
—

 
—

 
—

 
—

 
1,471.0

 
—

Net deferred income tax liabilities
—

 
27.4

 
—

 
—

 
1.4

 
1,014.5

 
—

Other non-current liabilities
—

 
—

 
—

 
—

 
0.4

 
53.5

 
—

Total liabilities
—

 
31.8

 
—

 
—

 
6.7

 
2,941.7

 
—

Net assets acquired
$
380.2

 
$
150.4

 
$
26.7

 
$
223.6

 
$
37.9

 
$
2,983.2

 
$
29.2


(1)
Consists of eight product acquisitions in the CHC, BCH, and Rx segments
Fair value of consideration transferred in business acquisition [Table Text Block]
The acquisition was a cash and stock transaction made up of the following consideration (in millions except per share data):
Perrigo ordinary shares issued
 
5.4

Perrigo per share price at transaction close on March 30, 2015
 
$
167.64

Total value of Perrigo ordinary shares issued
 
$
904.9

Cash consideration
 
2,078.3

Total consideration
 
$
2,983.2
XML 52 R26.htm IDEA: XBRL DOCUMENT v3.5.0.2
Goodwill and Other Intangible Assets (Tables)
 9 Months Ended
Oct. 01, 2016
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of goodwill [Table Text Block]
Changes in the carrying amount of goodwill, by reportable segment, were as follows (in millions):
Reporting Segments:
 
December 31, 2015
 
Business acquisitions
 
Business divestitures
 
Impairments
 
Changes in assets held for sale
 
Currency translation adjustment
 
October 1,
2016
CHC
 
$
1,890.0

 
$
0.2

 
$
(8.5
)
 
$
—

 
$
13.0

 
$
(6.8
)
 
$
1,887.9

BCH
 
1,980.5

 
—

 
—

 
(967.5
)
 
—

 
92.4

 
1,105.4

Rx
 
1,222.2

 
1.7

 
—

 
—

 
—

 
(13.7
)
 
1,210.2

Specialty Sciences
 
200.7

 
—

 
—

 
—

 
—

 
—

 
200.7

Other
 
71.5

 
—

 
—

 
—

 
11.7

 
3.2

 
86.4

Total goodwill
 
$
5,364.9

 
$
1.9

 
$
(8.5
)
 
$
(967.5
)
 
$
24.7

 
$
75.1

 
$
4,490.6
Schedule of finite and indefinite-lived intangible assets [Table Text Block]
Other intangible assets and related accumulated amortization consisted of the following (in millions):
 
October 1, 2016
 
December 31, 2015
 
Gross
 
Accumulated Amortization
 
Gross
 
Accumulated Amortization
Definite-lived intangibles:
 
 
 
 
 
 
 
Distribution and license agreements, supply agreements
$
6,122.3

 
$
914.0

 
$
6,053.4

 
$
667.2

Developed product technology, formulations, and product rights
1,805.9

 
529.0

 
1,383.5

 
426.0

Customer relationships and distribution networks
1,564.0

 
288.8

 
1,520.7

 
193.0

Trademarks, trade names, and brands
631.6

 
54.7

 
539.4

 
22.8

Non-compete agreements
14.6

 
11.0

 
15.2

 
12.7

Total definite-lived intangibles
$
10,138.4

 
$
1,797.5

 
$
9,512.2

 
$
1,321.7

Indefinite-lived intangibles:
 
 
 
 
 
 
 
Trademarks, trade names, and brands
$
724.2

 
$
—

 
$
1,868.1

 
$
—

In-process research and development
67.9

 
—

 
48.2

 
—

Total indefinite-lived intangibles
792.1

 
—

 
1,916.3

 
—

Total other intangible assets
$
10,930.5

 
$
1,797.5

 
$
11,428.5

 
$
1,321.7
XML 53 R27.htm IDEA: XBRL DOCUMENT v3.5.0.2
Inventories (Tables)
 9 Months Ended
Oct. 01, 2016
Inventory Disclosure [Abstract]  
Schedule of inventory, current [Table Text Block]

Major components of inventory were as follows (in millions):
 
 
October 1,
2016
 
December 31,
2015
Finished goods
$
511.6

 
$
483.4

Work in process
171.0

 
151.4

Raw materials
202.0

 
209.6

Total inventories
$
884.6

 
$
844.4
XML 54 R28.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair value measurements (Tables)
 9 Months Ended
Oct. 01, 2016
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block]
The following table summarizes the valuation of our financial instruments carried at fair value and measured at fair value on a recurring and non-recurring basis by the above pricing categories (in millions):
 
 
 
 
Fair Value
 
 
Fair Value Hierarchy
 
October 1,
2016
 
December 31,
2015
Measured at fair value on a recurring basis:
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
Investment securities
 
Level 1
 
$
53.0

 
$
14.9

 
 
 
 
 
 
 
Foreign currency forward contracts
 
Level 2
 
$
5.2

 
$
4.8

 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
Interest rate swap agreements
 
Level 2
 
$
—

 
$
0.3

Foreign currency forward contracts
 
Level 2
 
0.8

 
3.9

Total level 2 liabilities
 
 
 
$
0.8

 
$
4.2

 
 
 
 
 
 
 
Contingent consideration
 
Level 3
 
$
75.0

 
$
17.9

 
 
 
 
 
 
 
Measured at fair value on a non-recurring basis:
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
Goodwill(1)
 
Level 3
 
$
1,105.4

 
$
—

Indefinite-lived intangible assets(2)
 
Level 3
 
672.4

 
1,031.8

Definite-lived intangible assets(3)
 
Level 3
 
66.9

 
—

Assets held for sale, net
 
Level 3
 
14.1

 
37.5

Total level 3 assets
 
 
 
$
1,858.8

 
$
1,069.3
Fair Value, Inputs, Level 3 [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Schedule of fair value, assets and liabilities measured on recurring and non-recurring basis [Table Text Block]
The table below presents a reconciliation for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (in millions). Net realized losses in the table were recorded in Administrative expense.
 
Three Months Ended
 
Nine Months Ended
 
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Contingent Consideration
 
 
 
 
 
 
 
Beginning balance
$
44.9

 
$
—

 
$
17.9

 
$
12.4

Net realized (gains) losses
(0.4
)
 
—

 
(4.0
)
 
(12.4
)
Purchases or additions
30.6

 
—

 
61.1

 
—

Foreign currency effect
—

 
—

 
0.1

 
—

Settlements
(0.1
)
 
—

 
(0.1
)
 
—

Ending balance
$
75.0

 
$
—

 
$
75.0

 
$
—
XML 55 R29.htm IDEA: XBRL DOCUMENT v3.5.0.2
Investments (Tables)
 9 Months Ended
Oct. 01, 2016
Investments [Abstract]  
Unrealized gain (loss) on investments [Table Text Block]
Unrealized investment gains (losses) on available for sale securities were as follows (in millions):
 
October 1,
2016
 
December 31, 2015
Equity securities, at cost less impairments
$
20.1

 
$
6.4

Gross unrealized gains
32.9

 
9.3

Gross unrealized losses
—

 
(0.8
)
Estimated fair value of equity securities
$
53.0

 
$
14.9
XML 56 R30.htm IDEA: XBRL DOCUMENT v3.5.0.2
Derivative Instruments and Hedging Activities (Tables)
 9 Months Ended
Oct. 01, 2016
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of derivative instruments in statement of financial position, fair value [Table Text Block]
The balance sheet location and gross fair value of our outstanding derivative instruments were as follows:
 
Asset Derivatives
 
Balance Sheet Location
 
Fair Value
 
 
 
October 1,
2016
 
December 31, 2015
Designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Other current assets
 
$
3.8

 
$
3.8

Total designated derivatives
 
 
$
3.8

 
$
3.8

Non-designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Other current assets
 
$
1.4

 
$
1.0

Total non-designated derivatives
 
 
$
1.4

 
$
1.0

 
Liability Derivatives
 
Balance Sheet Location
 
Fair Value
 
 
 
October 1,
2016
 
December 31, 2015
Designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Accrued liabilities
 
$
0.3

 
$
2.0

Interest rate swap agreements
Other non-current liabilities
 
—

 
0.3

Total designated derivatives
 
 
$
0.3

 
$
2.3

Non-designated derivatives:
 
 
 
 
 
Foreign currency forward contracts
Accrued liabilities
 
$
0.5

 
$
1.9

Total non-designated derivatives
 
 
$
0.5

 
$
1.9
Schedule of derivative instruments, effect on other comprehensive income (loss) [Table Text Block]
The gains (losses) recorded in OCI for the effective portion of our designated cash flow hedges were as follows:
 
 
Amount of Gain/(Loss) Recorded in OCI
(Effective Portion)
 
 
Three Months Ended
 
Nine Months Ended
Designated Cash Flow Hedges
 
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Interest rate swap agreements
 
$
—

 
$
—

 
$
(9.0
)
 
$
(12.0
)
Foreign currency forward contracts
 
3.4

 
(0.5
)
 
4.7

 
(1.6
)
Total
 
$
3.4

 
$
(0.5
)
 
$
(4.3
)
 
$
(13.6
)
Reclassification out of AOCI [Table Text Block]
The gains (losses) reclassified from AOCI into earnings for the effective portion of our designated cash flow hedges were as follows:
 
 
 
 
Amount of Gain/(Loss) Reclassified from AOCI to Income
(Effective Portion)
 
 
 
 
Three Months Ended
 
Nine Months Ended
Designated Cash Flow Hedges
 
Income Statement Location
 
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Treasury locks
 
Interest expense, net
 
$
—

 
$
—

 
$
(0.1
)
 
$
(0.1
)
Interest rate swap agreements
 
Interest expense, net
 
(0.6
)
 
(0.4
)
 
(1.7
)
 
(18.6
)
Foreign currency forward contracts
 
Net sales
 
0.1

 
(0.1
)
 
1.0

 
1.8

 
 
Cost of sales
 
0.9

 
0.2

 
1.8

 
(4.4
)
 
 
Interest expense, net
 
(0.4
)
 
—

 
(1.3
)
 
—

 
 
Other expense, net
 
(1.4
)
 
(0.1
)
 
—

 
(0.6
)
Total
 
 
 
$
(1.4
)
 
$
(0.4
)
 
$
(0.3
)
 
$
(21.9
)
Schedule of hedge ineffectiveness [Table Text Block]
The gains (losses) recognized against earnings for the ineffective portion of our designated cash flow hedges were as follows:
 
 
 
 
Amount of Gain/(Loss) Recognized in Income
(Ineffective Portion)
 
 
 
 
Three Months Ended
 
Nine Months Ended
Designated Cash Flow Hedges
 
Income Statement
Location
 
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Interest rate swap agreements
 
Other expense, net
 
$
—

 
$
—

 
$
(0.1
)
 
$
—

Foreign currency forward contracts
 
Net sales
 
—

 
—

 
0.1

 
(0.3
)
 
 
Cost of sales
 
—

 
—

 
—

 
0.1

 
 
Other expense, net
 
—

 
—

 
0.6

 
—

Total
 
 
 
$
—

 
$
—

 
$
0.6

 
$
(0.2
)
Schedule of non-designated derivatives
The effects of our non-designated derivatives on the Condensed Consolidated Statements of Operations were as follows:
 
 
 
 
Amount of Gain/(Loss) Recognized in Income
 
 
 
 
Three Months Ended
 
Nine Months Ended
Non-Designated Derivatives
 
Income Statement Location
 
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Foreign currency forward contracts
 
Other expense, net
 
$
(0.2
)
 
$
(8.9
)
 
$
(8.7
)
 
$
(259.4
)
 
 
Interest expense, net
 
(1.0
)
 
0.1

 
(1.5
)
 
(3.4
)
Total
 
 
 
$
(1.2
)
 
$
(8.8
)
 
$
(10.2
)
 
$
(262.8
)
XML 57 R31.htm IDEA: XBRL DOCUMENT v3.5.0.2
Assets Held for Sale (Tables)
 9 Months Ended
Oct. 01, 2016
Assets held for sale [Abstract]  
Disposal groups, including discontinued operations [Table Text Block]
The amounts consisted of the following (in millions):
 
October 1,
2016
 
December 31,
2015
 
CHC
 
Other
 
CHC
 
Other
Assets held for sale
 
 
 
 
 
 
 
Current assets
$
—

 
$
7.3

 
$
55.1

 
$
13.6

Goodwill
—

 
2.8

 
13.0

 
14.5

Property, plant and equipment
13.3

 
34.0

 
18.8

 
37.4

Other assets
—

 
3.2

 
—

 
3.2

Less: impairment reserves
(3.4
)
 
(39.8
)
 
—

 
(29.0
)
Total assets held for sale
$
9.9

 
$
7.5

 
$
86.9

 
$
39.7

Liabilities held for sale
 
 
 
 
 
 
 
Current liabilities
$
0.3

 
$
0.9

 
$
30.5

 
$
0.5

Other liabilities
—

 
2.1

 
—

 
1.7

Total liabilities held for sale
$
0.3

 
$
3.0

 
$
30.5

 
$
2.2
XML 58 R32.htm IDEA: XBRL DOCUMENT v3.5.0.2
Indebtedness (Tables)
 9 Months Ended
Oct. 01, 2016
Indebtness [Abstract]  
Schedule of debt
Total borrowings outstanding are summarized as follows (in millions):
 
 
 
 
 
October 1,
2016
 
December 31,
2015
Revolving credit agreements
 
 
 
 
 
 
2015 Revolver
$
—

 
$
380.0

 
2014 Revolver
—

 
300.0

 
Total revolving credit agreements
—

 
680.0

Term loans
 
 
 
 
 
*
2014 Term loan due December 5, 2019
463.8

 
488.8

Notes and Bonds
 
 
 
 
 
 
Coupon
Due
 
 
 
 
 
 
1.300%
November 8, 2016
(2) 
 
—

 
500.0

*
4.500%
May 23, 2017
(3) 
 
202.4

 
195.5

*
5.125%
December 12, 2017
(3) 
 
337.3

 
325.8

 
2.300%
November 8, 2018
(2) 
 
600.0

 
600.0

*
5.000%
May 23, 2019
(3) 
 
134.9

 
130.3

 
3.500%
March 15, 2021
(4) 
 
500.0

 
—

 
3.500%
December 15, 2021
(1) 
 
500.0

 
500.0

*
5.105%
July 19, 2023
(3) 
 
151.8

 
146.7

 
4.000%
November 15, 2023
(2) 
 
800.0

 
800.0

 
3.900%
December 15, 2024
(1) 
 
700.0

 
700.0

 
4.375%
March 15, 2026
(4) 
 
700.0

 
—

 
5.300%
November 15, 2043
(2) 
 
400.0

 
400.0

 
4.900%
December 15, 2044
(1) 
 
400.0

 
400.0

 
Total notes and bonds
 
 
5,426.4

 
4,698.3

Other financing
4.1

 
86.0

Unamortized premium (discount), net
43.3

 
73.4

Deferred financing fees
(34.6
)
 
(36.6
)
Total borrowings outstanding
5,903.0

 
5,989.9

 
Current indebtedness
(265.0
)
 
(1,018.3
)
Total long-term debt less current portion
$
5,638.0

 
$
4,971.6


(1)
Discussed below collectively as the "2014 Notes."
(2)
Discussed below collectively as the "2013 Notes."
(3)
Debt assumed from Omega.
(4)
Discussed below collectively as the "2016 Notes."

*
Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.
XML 59 R33.htm IDEA: XBRL DOCUMENT v3.5.0.2
Earnings Per Share (Tables)
 9 Months Ended
Oct. 01, 2016
Earnings Per Share [Abstract]  
Schedule of earnings per share, basic and diluted
A reconciliation of the numerators and denominators used in the basic and diluted earnings per share ("EPS") calculation is as follows (in millions):
 
Three Months Ended
 
Nine Months Ended
 
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Numerator:
 
 
 
 
 
 
 
Net income (loss)
$
(1,255.2
)
 
$
112.6

 
$
(1,395.4
)
 
$
74.2

 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
Weighted average shares outstanding for basic EPS
143.3

 
146.3

 
143.2

 
144.4

Dilutive effect of share-based awards*
—

 
0.6

 
—

 
0.6

Weighted average shares outstanding for diluted EPS
143.3

 
146.9

 
143.2

 
145.0

 
 
 
 
 
 
 
 
Anti-dilutive share-based awards excluded from computation of diluted EPS*
—

 
0.1

 
—

 
—


* In the period of a net loss, diluted shares equal basic shares.
Schedule of share-based compensation, stock options, activity
We issued shares related to the exercise and vesting of share-based compensation as follows:
Three Months Ended
 
Nine Months Ended
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
185,000

 
154,000

 
283,000

 
246,000
XML 60 R34.htm IDEA: XBRL DOCUMENT v3.5.0.2
Accumulated Other Comprehensive Income (Loss) (Tables)
 9 Months Ended
Oct. 01, 2016
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Schedule of accumulated other comprehensive income (loss) [Table Text Block]
Changes in our AOCI balances, net of tax were as follows (in millions):
 
Foreign currency translation adjustments
 
Fair value of derivative financial instruments, net of tax
 
Fair value of investment securities, net of tax
 
Post-retirement and pension liability adjustments, net of tax
 
Total AOCI
Balance at December 31, 2015
$
(4.4
)
 
$
(14.2
)
 
$
6.3

 
$
(3.2
)
 
$
(15.5
)
OCI before reclassifications
71.8

 
(3.7
)
 
17.1

 
0.3

 
85.5

Amounts reclassified from AOCI
—

 
0.2

 
1.3

 
—

 
1.5

Other comprehensive income (loss)
71.8

 
(3.5
)
 
18.4

 
0.3

 
87.0

Balance at October 1, 2016
$
67.4

 
$
(17.7
)
 
$
24.7

 
$
(2.9
)
 
$
71.5
XML 61 R35.htm IDEA: XBRL DOCUMENT v3.5.0.2
Restructuring Charges (Tables)
 9 Months Ended
Oct. 01, 2016
Restructuring Charges [Abstract]  
Restructuring and related costs [Table Text Block]
The following reflects our restructuring activity (in millions):
 
Three Months Ended
 
Nine Months Ended
 
October 1,
2016
 
September 26,
2015
 
October 1,
2016
 
September 26,
2015
Beginning balance
$
12.2

 
$
1.7

 
$
20.7

 
$
3.2

Additional charges
6.6

 
2.2

 
17.9

 
3.1

Payments
(8.6
)
 
(1.9
)
 
(33.3
)
 
(4.5
)
Non-cash adjustments
0.1

 
(0.7
)
 
5.0

 
(0.5
)
Ending balance
$
10.3

 
$
1.3

 
$
10.3

 
$
1.3
XML 62 R36.htm IDEA: XBRL DOCUMENT v3.5.0.2
Segment Information (Tables)
 9 Months Ended
Oct. 01, 2016
Segment Reporting [Abstract]  
Schedule of segment reporting information, by segment [Table Text Block]
The below tables show select financial measures by reporting segment (in millions):
Total Assets
 
October 1,
2016
 
December 31, 2015
CHC
 
$
3,873.8

 
$
4,007.8

BCH
 
4,460.2

 
6,324.0

Rx
 
3,304.0

 
3,015.5

Specialty Sciences
 
5,634.0

 
5,833.5

Other
 
195.6

 
213.1

Total
 
$
17,467.6

 
$
19,393.9

 
Three Months Ended
 
October 1, 2016
 
September 26, 2015
 
Net Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
 
Net Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
CHC
$
669.1

 
$
100.1

 
$
19.2

 
$
675.2

 
$
117.3

 
$
19.4

BCH
304.0

 
(1,684.3
)
 
38.9

 
302.2

 
4.4

 
36.3

Rx
267.4

 
77.9

 
30.7

 
260.3

 
91.0

 
18.6

Specialty Sciences
93.4

 
23.3

 
72.8

 
84.5

 
9.0

 
72.8

Other
21.0

 
(1.6
)
 
0.5

 
22.5

 
6.2

 
0.5

Unallocated
—

 
(30.6
)
 
—

 
—

 
(39.3
)
 
—

Total
$
1,354.9

 
$
(1,515.2
)
 
$
162.1

 
$
1,344.7

 
$
188.6

 
$
147.6


 
Nine Months Ended
 
October 1, 2016
 
September 26, 2015
 
Net Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
 
Net Sales
 
Operating Income (Loss)
 
Intangible Asset Amortization
CHC
$
2,055.6

 
$
313.6

 
$
58.1

 
$
2,106.4

 
$
364.8

 
$
52.1

BCH*
1,015.3

 
(2,128.7
)
 
113.9

 
703.4

 
31.0

 
70.5

Rx
817.4

 
262.1

 
90.1

 
790.1

 
290.4

 
55.5

Specialty Sciences
271.3

 
49.7

 
218.3

 
250.1

 
21.0

 
218.4

Other
59.5

 
2.6

 
1.4

 
75.4

 
18.6

 
1.4

Unallocated
—

 
(80.0
)
 
—

 
—

 
(111.1
)
 
—

Total*
$
4,219.1

 
$
(1,580.7
)
 
$
481.8

 
$
3,925.4

 
$
614.7

 
$
397.9


*
The BCH segment was created on March 30, 2015 as a result of the Omega acquisition, thus data for the nine months ended September 26, 2015 includes only six months of results from operations attributable to Omega.
XML 63 R37.htm IDEA: XBRL DOCUMENT v3.5.0.2
Summary of Significant Accounting Policies and Basis of Presentation Policy (Details)
 3 Months Ended
Apr. 02, 2016
Amount of error gross of tax [Member]  
Immaterial Error Correction 14.5
Amount of error net of tax [Member]  
Immaterial Error Correction 13.7
XML 64 R38.htm IDEA: XBRL DOCUMENT v3.5.0.2
Business Acquisitions (Details)
$ / shares in Units, € in Millions
 1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Aug. 05, 2016
USD ($)
Aug. 02, 2016
USD ($)
Mar. 01, 2016
USD ($)
Jan. 22, 2016
USD ($)
Dec. 15, 2015
USD ($)
Sep. 15, 2015
USD ($)
Sep. 15, 2015
EUR (€)
Aug. 28, 2015
USD ($)
May 12, 2015
USD ($)
Mar. 30, 2015
USD ($)
$ / shares
shares
Mar. 30, 2015
EUR (€)
shares
May 31, 2015
USD ($)
Oct. 01, 2016
USD ($)
Sep. 26, 2015
USD ($)
Dec. 31, 2015
USD ($)
Oct. 01, 2016
USD ($)
Sep. 26, 2015
USD ($)
Jun. 27, 2015
USD ($)
shares
Dec. 02, 2014
USD ($)
Nov. 08, 2013
USD ($)
Business Acquisition [Line Items]                                        
Payments to Acquire Businesses, Net of Cash Acquired                               $ 432,100,000 $ 2,499,900,000      
Proceeds from sale of business                               58,500,000 0      
Business Acquisition, Pro Forma Revenue                         $ 1,359,600,000 $ 1,429,900,000   4,243,300,000 4,451,400,000      
Contingent consideration           $ 0                            
Research and Development Expense                         50,200,000 41,600,000   142,500,000 139,700,000      
Goodwill                         4,490,600,000   $ 5,364,900,000 4,490,600,000        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles         $ 0 0   $ 0   $ 3,374,800,000         29,200,000 [1]          
In-process research and development                         792,100,000   1,916,300,000 792,100,000        
Finite-Lived Intangible Assets, Gross                         10,138,400,000   9,512,200,000 10,138,400,000        
Other non-current assets         0 0   0                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net                   2,983,200,000         29,200,000 [1]          
Senior Notes                         5,426,400,000   4,698,300,000 5,426,400,000       $ 2,300,000,000
Proceeds from Issuance or Sale of Equity                                   $ 999,300,000    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets                   5,924,900,000         29,200,000 [1]          
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable                   243,100,000         0 [1]          
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, short term debt         0 0   0                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, accrued payroll         0 0   0                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, accrued customer programs         0 0   0                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt         0 0   0                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities         0 0   0                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities                   $ 2,941,700,000         0 [1]          
Operating Income                         (1,515,200,000) 188,600,000   (1,580,700,000) [2] 614,700,000 [2]      
Business Acquisition, Pro Forma Net Income (Loss)                         (1,254,900,000) 142,000,000   (1,392,800,000) 154,700,000      
Impairment of Long-Lived Assets to be Disposed of                             29,000,000 3,400,000        
Benzaclin [Member]                                        
Business Acquisition [Line Items]                                        
Purchase price paid   $ 62,000,000                                    
Business Acquisition, Effective Date of Acquisition   Aug. 02, 2016                                    
Business Acquisition, Percentage of Voting Interests Acquired   60.90%                                    
Tretinoin [Member]                                        
Business Acquisition [Line Items]                                        
Sales Revenue, Goods, Net                         25,300,000     47,700,000        
Business Combination, Consideration Transferred       $ 416,400,000                                
Purchase price paid       416,400,000                                
Contingent consideration       0                                
Inventories       1,400,000                                
Prepaid expenses and other current assets       0                                
Property and equipment       0                                
Goodwill       1,700,000                                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles       413,300,000                                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net       $ 416,400,000                                
Business Acquisition, Effective Date of Acquisition       Jan. 22, 2016                                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents       $ 0                                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables       0                                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets       416,400,000                                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable       0                                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities       0                                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt       0                                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent       0                                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities       $ 0                                
Operating Income                         13,000,000     31,300,000        
Development stage rx products [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Consideration Transferred     $ 24,900,000                                  
Purchase price paid     0                                  
Contingent consideration     24,900,000                                  
Inventories     0                                  
Prepaid expenses and other current assets     0                                  
Property and equipment     0                                  
Goodwill     0                                  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles     24,900,000                                  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net     $ 24,900,000                                  
Business Acquisition, Effective Date of Acquisition     Mar. 01, 2016                                  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents     $ 0                                  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables     0                                  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets     24,900,000                                  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable     0                                  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities     0                                  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt     0                                  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent     0                                  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities     0                                  
ScarAway [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Consideration Transferred               26,700,000                        
Purchase price paid               26,700,000                        
Contingent consideration               0                        
Inventories               1,000,000                        
Prepaid expenses and other current assets               0                        
Property and equipment               0                        
Goodwill               3,500,000                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles               22,200,000                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net               $ 26,700,000                        
Business Acquisition, Effective Date of Acquisition               Aug. 28, 2015                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents               $ 0                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables               0                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets               26,700,000                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable               0                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities               0                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent               0                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities               0                        
Entocort [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Consideration Transferred         380,200,000                              
Purchase price paid         380,200,000                              
Contingent consideration         0                              
Inventories         200,000                              
Prepaid expenses and other current assets         0                              
Property and equipment         0                              
Goodwill         0                              
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles         380,000,000                              
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net         $ 380,200,000                              
Business Acquisition, Effective Date of Acquisition         Dec. 15, 2015                              
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents         $ 0                              
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables         0                              
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets         380,200,000                              
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable         0                              
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities         0                              
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent         0                              
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities         0                              
Naturwohl Pharma [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Consideration Transferred           150,400,000                            
Purchase price paid           150,400,000                            
Inventories           1,500,000                            
Prepaid expenses and other current assets           0                            
Property and equipment           0                            
Goodwill           61,000,000                            
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles           111,800,000                            
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net           $ 150,400,000                            
Business Acquisition, Effective Date of Acquisition           Sep. 15, 2015 Sep. 15, 2015                          
Business Acquisition, Percentage of Voting Interests Acquired           100.00%                            
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents           $ 4,600,000                            
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables           3,300,000                            
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets           182,200,000                            
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable           2,800,000                            
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities           1,600,000                            
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent           27,400,000                            
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities           31,800,000                            
GSK [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Consideration Transferred               223,600,000                        
Purchase price paid               223,600,000                        
Contingent consideration               0                        
Inventories               0                        
Prepaid expenses and other current assets               0                        
Property and equipment               0                        
Goodwill               32,600,000                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles               191,000,000                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net               $ 223,600,000                        
Business Acquisition, Effective Date of Acquisition               Aug. 28, 2015                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents               $ 0                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables               0                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets               223,600,000                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable               0                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities               0                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent               0                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities               $ 0                        
Gelcaps [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Consideration Transferred                 $ 37,900,000                      
Purchase price paid                 37,900,000                      
Contingent consideration                 0                      
Inventories                 7,200,000                      
Prepaid expenses and other current assets                 2,100,000                      
Property and equipment                 6,000,000                      
Goodwill                 6,000,000                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles                 11,000,000                      
Other non-current assets                 400,000                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net                 $ 37,900,000                      
Business Acquisition, Effective Date of Acquisition                 May 12, 2015                      
Business Acquisition, Percentage of Voting Interests Acquired                 100.00%                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents                 $ 4,600,000                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables                 7,300,000                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets                 44,600,000                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable                 3,300,000                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, short term debt                 0                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities                 1,600,000                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, accrued payroll                 0                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, accrued customer programs                 0                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt                 0                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent                 1,400,000                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities                 400,000                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities                 6,700,000                      
Omega [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Acquisition Related Costs                                 295,000,000      
Shares, Issued | shares                   5,400,000                    
Business Combination, Consideration Transferred                   $ 2,983,200,000                    
Purchase price paid                   2,983,200,000                    
Contingent consideration                   0                    
Inventories                   202,500,000                    
Prepaid expenses and other current assets                   39,200,000                    
Property and equipment                   130,800,000                    
Goodwill                   1,900,400,000                    
Other non-current assets                   $ 2,400,000                    
Business Acquisition, Effective Date of Acquisition                   Mar. 30, 2015 Mar. 30, 2015                  
Business Acquisition, Percentage of Voting Interests Acquired                   95.77%                    
Shares, Outstanding | shares                   685,348,257                    
Treasury Stock, Shares, Acquired | shares                   30,243,983 30,243,983                  
Indemnification available from acquired company's sellers                   $ 1,100,000                    
Business Acquisition, Share Price | $ / shares                   $ 167.64                    
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned                   $ 904,900,000                    
Business Acquisition, Cash Exchange                   2,078,300,000                    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents                   14,700,000                    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables                   260,100,000                    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, short term debt                   24,600,000                    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities                   43,900,000                    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, accrued payroll                   51,300,000                    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, accrued customer programs                   39,800,000                    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt                   1,471,000,000                    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent                   1,014,500,000                    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities                             53,500,000          
Series of Individually Immaterial Business Acquisitions [Member]                                        
Business Acquisition [Line Items]                                        
Business acquisitions, number of products purchased                             8          
Business Combination, Consideration Transferred                             29,200,000 [1] 52,500,000 [3],[4]        
Purchase price paid                             15,300,000 [1] 21,900,000 [3],[4]        
Contingent consideration                         30,600,000 [3],[4]   13,900,000 [1] 30,600,000 [3],[4]        
Inventories                         7,100,000 [3],[4]   0 [1] 7,100,000 [3],[4]        
Prepaid expenses and other current assets                         100,000 [3],[4]   0 [1] 100,000 [3],[4]        
Property and equipment                         1,200,000 [3],[4]   0 [1] 1,200,000 [3],[4]        
Goodwill                         200,000 [3],[4]   0 [1] 200,000 [3],[4]        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles [3],[4]                         41,900,000     41,900,000        
Other non-current assets [1]                             0          
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [3],[4]                         52,500,000     52,500,000        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents                         3,800,000 [3],[4]   0 [1] 3,800,000 [3],[4]        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables                         4,900,000 [3],[4]   0 [1] 4,900,000 [3],[4]        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [3],[4]                         59,200,000     59,200,000        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable [3],[4]                         2,800,000     2,800,000        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, short term debt [1]                             0          
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities                         100,000 [3],[4]   0 [1] 100,000 [3],[4]        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, accrued payroll [1]                             0          
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, accrued customer programs [1]                             0          
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt                         3,300,000 [3],[4]   0 [1] 3,300,000 [3],[4]        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent                         500,000 [3],[4]   0 [1] 500,000 [3],[4]        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities [1]                             0          
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [3],[4]                         6,700,000     6,700,000        
Developed technology rights [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Assets, Gross           $ 0             1,805,900,000   1,383,500,000 1,805,900,000        
Developed technology rights [Member] | Tretinoin [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Asset, Useful Life       20 years                                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles       $ 411,000,000                                
Developed technology rights [Member] | Development stage rx products [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles     0                                  
Developed technology rights [Member] | ScarAway [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Asset, Useful Life               8 years                        
Finite-Lived Intangible Assets, Gross               $ 500,000                        
Developed technology rights [Member] | Entocort [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Assets, Gross         380,000,000                              
Developed technology rights [Member] | GSK [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Assets, Gross               $ 0                        
Developed technology rights [Member] | Gelcaps [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Assets, Gross                 0                      
Developed technology rights [Member] | Omega [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Assets, Gross                             27,200,000          
Developed technology rights [Member] | Series of Individually Immaterial Business Acquisitions [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles [3],[4]                         23,300,000     23,300,000        
Finite-Lived Intangible Assets, Gross [1]                             0          
Non-compete agreements                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Assets, Gross                         14,600,000   15,200,000 14,600,000        
Non-compete agreements | Tretinoin [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Asset, Useful Life       5 years                                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles       $ 2,300,000                                
Non-compete agreements | Development stage rx products [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles     0                                  
Non-compete agreements | ScarAway [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Asset, Useful Life               4 years                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles               $ 500,000                        
Non-compete agreements | Entocort [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles         0                              
Non-compete agreements | Naturwohl Pharma [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Asset, Useful Life           3 years 3 years                          
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles           $ 300,000                            
Non-compete agreements | GSK [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles               0                        
Non-compete agreements | Gelcaps [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles                 0                      
Non-compete agreements | Omega [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles                   $ 0                    
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life                   3 years 3 years                  
Non-compete agreements | Series of Individually Immaterial Business Acquisitions [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles                         0 [3],[4]   0 [1] 0 [3],[4]        
Non-solicit agreement [Member] | Omega [Member]                                        
Business Acquisition [Line Items]                                        
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life                   2 years 2 years                  
Licensing Agreements [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Assets, Gross                         6,122,300,000   6,053,400,000 6,122,300,000        
Licensing Agreements [Member] | Benzaclin [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Asset, Useful Life   9 years                                    
Licensing Agreements [Member] | Tretinoin [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles       0                                
Licensing Agreements [Member] | Development stage rx products [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles     0                                  
Licensing Agreements [Member] | ScarAway [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles               0                        
Licensing Agreements [Member] | Entocort [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles         0                              
Licensing Agreements [Member] | Naturwohl Pharma [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Asset, Useful Life           3 years 3 years                          
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles           $ 21,400,000                            
Licensing Agreements [Member] | GSK [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles               $ 0                        
Licensing Agreements [Member] | Gelcaps [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles                 $ 0                      
Licensing Agreements [Member] | Omega [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles                   $ 0                    
Licensing Agreements [Member] | Series of Individually Immaterial Business Acquisitions [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles                         3,400,000 [3],[4]   0 [1] 3,400,000 [3],[4]        
Trademarks and trade names [Member] | ScarAway [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Asset, Useful Life               25 years                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles               $ 11,400,000                        
Trademarks and trade names [Member] | Entocort [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles         0                              
Trademarks and trade names [Member] | Naturwohl Pharma [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Asset, Useful Life           20 years 20 years                          
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles           $ 64,200,000                            
Trademarks and trade names [Member] | GSK [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Asset, Useful Life               20 years                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles               $ 129,500,000                        
Trademarks and trade names [Member] | Gelcaps [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Asset, Useful Life                 25 years                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles                 $ 0                      
Trademarks and trade names [Member] | Omega [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Asset, Useful Life                   8 years 8 years                  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles                   $ 287,500,000                    
Trademarks and trade names [Member] | Series of Individually Immaterial Business Acquisitions [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles [1]                             0          
Brands [Member] | Omega [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Asset, Useful Life                   22 years 22 years                  
Customer Relationships [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Assets, Gross                         1,564,000,000   1,520,700,000 1,564,000,000        
Customer Relationships [Member] | Tretinoin [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles       0                                
Customer Relationships [Member] | Development stage rx products [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles     0                                  
Customer Relationships [Member] | ScarAway [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Asset, Useful Life               15 years                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles               $ 9,800,000                        
Customer Relationships [Member] | Entocort [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles         0                              
Customer Relationships [Member] | Naturwohl Pharma [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Asset, Useful Life           15 years 15 years                          
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles           $ 25,900,000                            
Customer Relationships [Member] | GSK [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Asset, Useful Life               15 years                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles               $ 61,500,000                        
Customer Relationships [Member] | Gelcaps [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Asset, Useful Life                 20 years                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles                 $ 6,600,000                      
Customer Relationships [Member] | Omega [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Asset, Useful Life                   21 years 21 years                  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles                   $ 1,056,300,000                    
Customer Relationships [Member] | Series of Individually Immaterial Business Acquisitions [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles                         8,200,000 [3],[4]   0 [1] 8,200,000 [3],[4]        
Trademarks and trade names [Member] | Gelcaps [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles                 4,400,000                      
Trademarks and trade names [Member] | Omega [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles                             2,003,800,000          
Trademarks and trade names [Member] | Series of Individually Immaterial Business Acquisitions [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles [1]                             0          
In-process research and development                                        
Business Acquisition [Line Items]                                        
In-process research and development                         67,900,000   48,200,000 67,900,000        
In-process research and development | Tretinoin [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets       $ 0                                
In-process research and development | Development stage rx products [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets     $ 24,900,000                                  
In-process research and development | ScarAway [Member]                                        
Business Acquisition [Line Items]                                        
In-process research and development               0                        
In-process research and development | Entocort [Member]                                        
Business Acquisition [Line Items]                                        
In-process research and development         $ 0                              
In-process research and development | Naturwohl [Member]                                        
Business Acquisition [Line Items]                                        
In-process research and development           $ 0                            
In-process research and development | GSK [Member]                                        
Business Acquisition [Line Items]                                        
In-process research and development               0                        
In-process research and development | Gelcaps [Member]                                        
Business Acquisition [Line Items]                                        
In-process research and development                 0                      
In-process research and development | Omega [Member]                                        
Business Acquisition [Line Items]                                        
In-process research and development                   $ 0                    
In-process research and development | Series of Individually Immaterial Business Acquisitions [Member]                                        
Business Acquisition [Line Items]                                        
In-process research and development [1]                             29,200,000          
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets [3],[4]                         7,000,000     7,000,000        
Minimum [Member] | Developed technology rights [Member] | Entocort [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Asset, Useful Life         10 years                              
Minimum [Member] | Developed technology rights [Member] | Omega [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Asset, Useful Life                   4 years 4 years                  
Maximum [Member] | Omega [Member]                                        
Business Acquisition [Line Items]                                        
Indemnification available from acquired company's sellers | €                     € 135.9                  
Maximum [Member] | Developed technology rights [Member] | Entocort [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Asset, Useful Life         15 years                              
Maximum [Member] | Developed technology rights [Member] | Omega [Member]                                        
Business Acquisition [Line Items]                                        
Finite-Lived Intangible Asset, Useful Life                   13 years 13 years                  
Euro member countries, euro | Naturwohl Pharma [Member]                                        
Business Acquisition [Line Items]                                        
Purchase price paid | €             € 133.5                          
Euro member countries, euro | GSK [Member]                                        
Business Acquisition [Line Items]                                        
Purchase price paid               $ 200,000,000                        
Euro member countries, euro | Maximum [Member] | Omega [Member]                                        
Business Acquisition [Line Items]                                        
Indemnification available from acquired company's sellers                   $ 120,900,000                    
Inventories [Member] | Gelcaps [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory                 600,000                      
Inventories [Member] | Omega [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory                   15,100,000                    
Property, plant and equipment [Member] | Gelcaps [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment                 $ 900,000                      
Property, plant and equipment [Member] | Omega [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment                   41,500,000                    
Long-term debt [Member] | Omega [Member]                                        
Business Acquisition [Line Items]                                        
Business combination fair value adjustment                   $ 101,900,000                    
2014 bonds                                        
Business Acquisition [Line Items]                                        
Senior Notes                                     $ 1,600,000,000  
Common stock [Member]                                        
Business Acquisition [Line Items]                                        
Stock Issued During Period, Shares, New Issues | shares                                   6,800,000    
Administration | Omega [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Acquisition Related Costs                                 18,100,000      
Interest expense, net | Omega [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Acquisition Related Costs                                 18,700,000      
Other expense, net | Omega [Member]                                        
Business Acquisition [Line Items]                                        
Business Combination, Acquisition Related Costs                                 258,200,000      
contractual arrangement [Member]                                        
Business Acquisition [Line Items]                                        
Research and Development Expense                       $ 18,000,000                
CHC                                        
Business Acquisition [Line Items]                                        
Proceeds from sale of business $ 61,800,000                                      
Goodwill                         1,887,900,000   $ 1,890,000,000 1,887,900,000        
Operating Income                         $ 100,100,000 $ 117,300,000   313,600,000 $ 364,800,000      
Impairment of Long-Lived Assets to be Disposed of                               $ 6,200,000        
[1] Consists of eight product acquisitions in the CHC, BCH, and Rx segments
[2] The BCH segment was created on March 30, 2015 as a result of the Omega acquisition, thus data for the nine months ended September 26, 2015 includes only six months of results from operations attributable to Omega.
[3] * Opening balance sheet is preliminary
[4] Consists of four product acquisitions in the CHC and Rx segment
XML 65 R39.htm IDEA: XBRL DOCUMENT v3.5.0.2
Goodwill and Other Intangible Assets - Goodwill (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2016
Jul. 02, 2016
Apr. 02, 2016
Dec. 31, 2015
Oct. 01, 2016
Sep. 26, 2015
Goodwill [Roll Forward]            
December 31, 2015     $ 5,364.9   $ 5,364.9  
Business acquisitions         1.9  
Business divestitures         (8.5)  
Impairments         (967.5)  
Changes in assets held for sale         24.7  
Currency translation adjustment         75.1  
October 1, 2016 $ 4,490.6     $ 5,364.9 4,490.6  
CHC            
Goodwill [Roll Forward]            
December 31, 2015     1,890.0   1,890.0  
Business acquisitions         0.2  
Business divestitures         (8.5)  
Impairments         0.0  
Changes in assets held for sale         13.0  
Currency translation adjustment         (6.8)  
October 1, 2016 1,887.9     1,890.0 1,887.9  
BCH            
Goodwill [Roll Forward]            
December 31, 2015     1,980.5   1,980.5  
Business acquisitions         0.0  
Business divestitures         0.0  
Impairments (804.1)       (967.5)  
Changes in assets held for sale         0.0  
Currency translation adjustment         92.4  
October 1, 2016 1,105.4     1,980.5 1,105.4  
Rx            
Goodwill [Roll Forward]            
December 31, 2015     1,222.2   1,222.2  
Business acquisitions         1.7  
Business divestitures         0.0  
Impairments         0.0  
Changes in assets held for sale         0.0  
Currency translation adjustment         (13.7)  
October 1, 2016 1,210.2     1,222.2 1,210.2  
Specialty Sciences            
Goodwill [Roll Forward]            
December 31, 2015     200.7   200.7  
Business acquisitions         0.0  
Business divestitures         0.0  
Impairments         0.0  
Changes in assets held for sale         0.0  
Currency translation adjustment         0.0  
October 1, 2016 200.7     200.7 200.7  
Other            
Goodwill [Roll Forward]            
December 31, 2015     71.5   71.5  
Business acquisitions         0.0  
Business divestitures         0.0  
Impairments         0.0  
Changes in assets held for sale         11.7  
Currency translation adjustment         3.2  
October 1, 2016 86.4     71.5 86.4  
Omega [Member] | Brands [Member]            
Goodwill [Line Items]            
Impairment of intangible assets, indefinite-lived (excluding goodwill) 575.7   273.4   849.1  
Impairment of Intangible Assets, Finite-lived 290.2     185.1 290.2  
MEXICO | CHC            
Goodwill [Roll Forward]            
Impairments           $ (6.8)
Fair Value, Inputs, Level 3 [Member] | Fair Value, Measurements, Nonrecurring [Member]            
Goodwill [Line Items]            
Indefinite-lived Intangible Assets (Excluding Goodwill), Fair Value Disclosure       1,031.8    
Goodwill [Roll Forward]            
Goodwill, Fair Value Disclosure 1,105.4 [1]     $ 0.0 1,105.4 [1]  
Licensing Agreements [Member] | Fair Value, Inputs, Level 3 [Member] | Fair Value, Measurements, Nonrecurring [Member] | BCH            
Goodwill [Line Items]            
Indefinite-lived Intangible Assets (Excluding Goodwill), Fair Value Disclosure [2] 672.4       672.4  
Branded CHC Rest of World [Member] | BCH            
Goodwill [Roll Forward]            
Impairments (734.7) $ 30.3 $ (193.6)      
Goodwill, Fair Value Disclosure [1] 1,035.2       1,035.2  
Branded CHC Belgium [Member] | BCH            
Goodwill [Roll Forward]            
Impairments (69.4)          
Goodwill, Fair Value Disclosure [1] $ 70.2       $ 70.2  
[1] (1)Goodwill with a carrying amount of $1.9 billion was written down to its implied fair value of $1.1 billion, resulting in an impairment charge of $804.1 million for the three months ended October 1, 2016; impairment charges totaled $967.5 million for the nine months ended October 1, 2016 and are included in Impairment charges on the Condensed Consolidated Statements of Operations.
[2] (2)Indefinite-lived intangible assets with a carrying amount of $1.2 billion were written down to a fair value of $672.4 million resulting in total impairment charges of $575.7 million for the three months ended October 1, 2016; impairment charges totaled $849.1 million for the nine months ended October 1, 2016 and are included in Impairment charges on the Condensed Consolidated Statements of Operations.
XML 66 R40.htm IDEA: XBRL DOCUMENT v3.5.0.2
Goodwill and Other Intangible Assets - Intangible categories (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Mar. 30, 2015
Oct. 01, 2016
Apr. 02, 2016
Dec. 31, 2015
Sep. 26, 2015
Oct. 01, 2016
Sep. 26, 2015
 [1]
Sep. 15, 2015
Finite And Indefinite Lived Assets By Major Class [Line Items]                
Goodwill, impairment loss           $ 967.5    
Finite-Lived Intangible Assets, Gross   $ 10,138.4   $ 9,512.2   10,138.4    
Intangible assets subject to amortization, accumulated amortization   1,797.5   1,321.7   1,797.5    
In-process research and development   792.1   1,916.3   792.1    
Total other intangible assets   10,930.5   11,428.5   10,930.5    
Intangible assets amortization expense   162.1     $ 147.6 481.8 [1] $ 397.9  
Trademarks, trade names, and brands                
Finite And Indefinite Lived Assets By Major Class [Line Items]                
In-process research and development   724.2   1,868.1   724.2    
In-process research and development                
Finite And Indefinite Lived Assets By Major Class [Line Items]                
In-process research and development   67.9   48.2   67.9    
Distribution and license agreements, supply agreements                
Finite And Indefinite Lived Assets By Major Class [Line Items]                
Finite-Lived Intangible Assets, Gross   6,122.3   6,053.4   6,122.3    
Intangible assets subject to amortization, accumulated amortization   914.0   667.2   914.0    
Developed product technology, formulations, and product rights                
Finite And Indefinite Lived Assets By Major Class [Line Items]                
Finite-Lived Intangible Assets, Gross   1,805.9   1,383.5   1,805.9   $ 0.0
Intangible assets subject to amortization, accumulated amortization   529.0   426.0   529.0    
Customer relationships and distribution networks                
Finite And Indefinite Lived Assets By Major Class [Line Items]                
Finite-Lived Intangible Assets, Gross   1,564.0   1,520.7   1,564.0    
Intangible assets subject to amortization, accumulated amortization   288.8   193.0   288.8    
Trademarks, trade names, and brands                
Finite And Indefinite Lived Assets By Major Class [Line Items]                
Finite-Lived Intangible Assets, Gross   631.6   539.4   631.6    
Intangible assets subject to amortization, accumulated amortization   54.7   22.8   54.7    
Non-compete agreements                
Finite And Indefinite Lived Assets By Major Class [Line Items]                
Finite-Lived Intangible Assets, Gross   14.6   15.2   14.6    
Intangible assets subject to amortization, accumulated amortization   11.0   12.7   11.0    
Omega [Member] | Brands [Member]                
Finite And Indefinite Lived Assets By Major Class [Line Items]                
Impairment of intangible assets, indefinite-lived (excluding goodwill)   575.7 $ 273.4     849.1    
Impairment of Intangible Assets, Finite-lived   290.2   185.1   290.2    
Omega [Member] | In-process research and development                
Finite And Indefinite Lived Assets By Major Class [Line Items]                
In-process research and development $ 0.0              
Omega [Member] | Brands [Member]                
Finite And Indefinite Lived Assets By Major Class [Line Items]                
Finite-Lived Intangible Asset, Useful Life 22 years              
Omega [Member] | Developed product technology, formulations, and product rights                
Finite And Indefinite Lived Assets By Major Class [Line Items]                
Finite-Lived Intangible Assets, Gross       $ 27.2        
Omega [Member] | Customer relationships and distribution networks                
Finite And Indefinite Lived Assets By Major Class [Line Items]                
Finite-Lived Intangible Asset, Useful Life 21 years              
BCH                
Finite And Indefinite Lived Assets By Major Class [Line Items]                
Goodwill, impairment loss   804.1       967.5    
Finite-Lived Intangible Assets, Gross   357.1       357.1    
Intangible assets amortization expense   $ 38.9     $ 36.3 $ 113.9 [1] $ 70.5  
[1] The BCH segment was created on March 30, 2015 as a result of the Omega acquisition, thus data for the nine months ended September 26, 2015 includes only six months of results from operations attributable to Omega.
XML 67 R41.htm IDEA: XBRL DOCUMENT v3.5.0.2
Accounts Receivable Factoring (Details) - USD ($)
$ in Millions
Oct. 01, 2016
Dec. 31, 2015
Accounts receivable factored and excluded from balance sheet $ 36.4 $ 106.7
Minimum [Member]    
Financial asset servicing fees paid 0.14%  
Maximum [Member]    
Financial asset servicing fees paid 0.15%  
XML 68 R42.htm IDEA: XBRL DOCUMENT v3.5.0.2
Inventories (Details) - USD ($)
$ in Millions
Oct. 01, 2016
Dec. 31, 2015
Inventory Disclosure [Abstract]    
Finished goods $ 511.6 $ 483.4
Work in process 171.0 151.4
Raw materials 202.0 209.6
Total inventories $ 884.6 $ 844.4
XML 69 R43.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair value on recurring and non-recurring basis (Details) - USD ($)
 3 Months Ended 9 Months Ended
Oct. 01, 2016
Apr. 02, 2016
Dec. 31, 2015
Sep. 26, 2015
Oct. 01, 2016
Sep. 26, 2015
Jul. 02, 2016
Sep. 15, 2015
Jun. 27, 2015
Mar. 30, 2015
Dec. 27, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Finite-Lived Intangible Assets, Gross $ 10,138,400,000   $ 9,512,200,000   $ 10,138,400,000            
Fair Value, Assets, Level 1, Level 2, Level 3 Transfers, Amount 0     $ 0 0 $ 0          
Goodwill, impairment loss         967,500,000            
Liabilities:                      
Contingent Consideration               $ 0      
Measured at fair value on a recurring basis: | Fair value, inputs, level 1 [Member]                      
Assets:                      
Investment securities 53,000,000   14,900,000   53,000,000            
Measured at fair value on a recurring basis: | Fair value, inputs, level 2 [Member]                      
Assets:                      
Foreign currency forward contracts 5,200,000   4,800,000   5,200,000            
Liabilities:                      
Interest rate swap agreements 0   300,000   0            
Foreign currency forward contracts 800,000   3,900,000   800,000            
Total level 2 liabilities 800,000   4,200,000   800,000            
Measured at fair value on a non-recurring basis: | Fair Value, Inputs, Level 3 [Member]                      
Assets:                      
Goodwill(1) 1,105,400,000 [1]   0   1,105,400,000 [1]            
Indefinite-lived intangible assets(2)     1,031,800,000                
Definite-lived intangible assets(3) 66,900,000   0   66,900,000            
Assets held for sale, net 14,100,000   37,500,000   14,100,000            
Total level 3 assets 1,858,800,000   1,069,300,000   1,858,800,000            
BCH                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Finite-Lived Intangible Assets, Gross 357,100,000       357,100,000            
Goodwill, Gross 1,909,500,000       1,909,500,000            
Goodwill, impairment loss 804,100,000       967,500,000            
Intangible Assets, Gross (Excluding Goodwill) 1,200,000,000       1,200,000,000            
Contingent Consideration Classified as Equity [Member] | Measured at fair value on a recurring basis: | Fair Value, Inputs, Level 3 [Member]                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Settlements 100,000     0 100,000 0          
Liabilities:                      
Contingent Consideration 75,000,000   17,900,000 $ 0 75,000,000 $ 0 $ 44,900,000   $ 0   $ 12,400,000
Omega [Member]                      
Liabilities:                      
Contingent Consideration                   $ 0  
Omega [Member] | Brands [Member]                      
Assets:                      
Impairment of intangible assets, indefinite-lived (excluding goodwill) 575,700,000 $ 273,400,000     849,100,000            
Liabilities:                      
Impairment of Intangible Assets, Finite-lived $ 290,200,000   $ 185,100,000   $ 290,200,000            
[1] (1)Goodwill with a carrying amount of $1.9 billion was written down to its implied fair value of $1.1 billion, resulting in an impairment charge of $804.1 million for the three months ended October 1, 2016; impairment charges totaled $967.5 million for the nine months ended October 1, 2016 and are included in Impairment charges on the Condensed Consolidated Statements of Operations.
XML 70 R44.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair value measurements - level 3 roll (Details) - Measured at fair value on a recurring basis: - Contingent Consideration Classified as Equity [Member] - Fair Value, Inputs, Level 3 [Member] - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2016
Sep. 26, 2015
Oct. 01, 2016
Sep. 26, 2015
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]        
Beginning balance $ 44.9 $ 0.0 $ 17.9 $ 12.4
Net realized (gains) losses (0.4) 0.0 (4.0) (12.4)
Purchases or additions 30.6 0.0 61.1 0.0
Foreign currency effect 0.0 0.0 (0.1) 0.0
Settlements 0.1 0.0 0.1 0.0
Ending balance $ 75.0 $ 0.0 $ 75.0 $ 0.0
XML 71 R45.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value Measurements Fair value measurements - items not carried at fair value (Details) - USD ($)
$ in Millions
Oct. 01, 2016
Dec. 31, 2015
Nov. 08, 2013
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Senior Notes $ 5,426.4 $ 4,698.3 $ 2,300.0
Public Bonds and Private Placement [Member]      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Senior Notes 4,600.0 3,900.0  
Public Bonds and Private Placement [Member] | Fair value, inputs, level 1 [Member]      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Debt instrument, fair value disclosure 4,700.0 3,800.0  
Retail Bonds [Member]      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Debt Instrument, Unamortized Premium 60.7 82.5  
Long-term Debt 826.4 798.3  
Retail Bonds [Member] | Fair value, inputs, level 2 [Member]      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Debt instrument, fair value disclosure $ 891.4 $ 859.8  
XML 72 R46.htm IDEA: XBRL DOCUMENT v3.5.0.2
Investments (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2016
Sep. 26, 2015
Oct. 01, 2016
Sep. 26, 2015
Dec. 31, 2015
Schedule of Equity Method Investments [Line Items]          
Other than temporary impairment losses, investments, portion recognized in earnings, net, available-for-sale securities     $ 1.8    
Loss from equity method investments $ 0.1 $ (4.1) (3.8) $ (7.7)  
Equity method investment, other than temporary impairment     22.3    
Unrealized Gain (Loss) on Investments [Abstract]          
Equity securities, at cost less impairments 20.1   20.1   $ 6.4
Gross unrealized gains 32.9   32.9   9.3
Gross unrealized losses 0.0   0.0   (0.8)
Transfer from investments     15.5    
Unrealized gain (loss) on investments     8.7    
Estimated fair value of equity securities          
Unrealized Gain (Loss) on Investments [Abstract]          
Estimated fair value of equity securities 53.0   53.0   14.9
Other non-current assets [Member]          
Schedule of Equity Method Investments [Line Items]          
Cost method investments 7.0   7.0   6.9
Equity method investments $ 4.9   $ 4.9   $ 45.5
XML 73 R47.htm IDEA: XBRL DOCUMENT v3.5.0.2
Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities - text links (Details)
€ in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2016
USD ($)
Sep. 26, 2015
USD ($)
Jun. 27, 2015
USD ($)
Oct. 01, 2016
USD ($)
Sep. 26, 2015
USD ($)
Dec. 31, 2015
USD ($)
Mar. 30, 2015
USD ($)
Mar. 30, 2015
EUR (€)
Derivative [Line Items]                
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net $ 0.0 $ 0.0   $ 0.6 $ (0.2)      
Derivative, Gain (Loss) on Derivative, Net       7.0        
Derivative, Loss on Derivative       0.0 300.0      
Term loans [1]   300.0     300.0      
Proceeds from Issuance of Debt       1,200.0        
Designated derivatives:                
Derivative [Line Items]                
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net (1.4) (0.4)   (0.3) (21.9)      
Derivative Liability, Fair Value, Amount Not Offset Against Collateral 0.3     0.3   $ 2.3    
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net 3.4 (0.5)   (4.3) (13.6)      
Non-designated derivatives:                
Derivative [Line Items]                
Derivative Liability, Fair Value, Amount Not Offset Against Collateral 0.5     0.5   1.9    
Derivative, Gain (Loss) on Derivative, Net (1.2) (8.8)   (10.2) (262.8)      
Interest rate swap agreements | Designated derivatives:                
Derivative [Line Items]                
Derivative, Notional Amount     $ 240.0     200.0    
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net 0.0 0.0   $ (9.0) (12.0)      
Foreign currency forward contracts                
Derivative [Line Items]                
Maximum Remaining Maturity of Foreign Currency Derivatives       15 months        
Foreign currency forward contracts | Designated derivatives:                
Derivative [Line Items]                
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net 3.4 (0.5)   $ 4.7 (1.6)      
Foreign exchange contract [Member]                
Derivative [Line Items]                
Derivative, Notional Amount 482.5     482.5   755.5    
Foreign exchange option [Member] | Designated derivatives:                
Derivative [Line Items]                
Derivative, Gain (Loss) on Derivative, Net         (1.9)      
Omega [Member]                
Derivative [Line Items]                
Derivative, Gain (Loss) on Derivative, Net     $ 0.0          
Omega [Member] | Interest rate swap agreements | Designated derivatives:                
Derivative [Line Items]                
Derivative, Notional Amount             $ 147.0  
Credit facility indebtedness | Omega [Member]                
Derivative [Line Items]                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt             544.5  
Euro member countries, euro | Interest rate swap agreements | Designated derivatives:                
Derivative [Line Items]                
Derivative, Notional Amount | €               € 135.0
Euro member countries, euro | Credit facility indebtedness | Omega [Member]                
Derivative [Line Items]                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt | €               € 500.0
Perrigo Co PLC [Member] | Foreign exchange option [Member] | Non-designated derivatives:                
Derivative [Line Items]                
Derivative, Gain (Loss) on Derivative, Net         259.8      
Omega [Member] | Interest rate swap agreements | Designated derivatives:                
Derivative [Line Items]                
Derivative, Notional Amount             20.0  
Other liabilities [Member] | Foreign currency forward contracts | Designated derivatives:                
Derivative [Line Items]                
Derivative Liability, Fair Value, Amount Not Offset Against Collateral 0.3     0.3   2.0    
Other liabilities [Member] | Foreign currency forward contracts | Non-designated derivatives:                
Derivative [Line Items]                
Derivative Liability, Fair Value, Amount Not Offset Against Collateral 0.5     0.5   1.9    
Other noncurrent liabilities [Member] | Interest rate swap agreements | Designated derivatives:                
Derivative [Line Items]                
Derivative Liability, Fair Value, Amount Not Offset Against Collateral 0.0     0.0   $ 0.3    
Other expense, net                
Derivative [Line Items]                
Derivative, Loss on Derivative         3.6      
Interest expense, net | Treasury locks | Designated derivatives:                
Derivative [Line Items]                
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net 0.0 0.0   (0.1) (0.1)      
Interest expense, net | Interest rate swap agreements | Designated derivatives:                
Derivative [Line Items]                
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net (0.6) (0.4)   (1.7) (18.6)      
Interest expense, net | Foreign currency forward contracts | Designated derivatives:                
Derivative [Line Items]                
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net (0.4) 0.0   (1.3) 0.0      
Interest expense, net | Foreign currency forward contracts | Non-designated derivatives:                
Derivative [Line Items]                
Derivative, Gain (Loss) on Derivative, Net (1.0) 0.1   (1.5) (3.4)      
Sales revenue, goods, net [Member] | Foreign currency forward contracts                
Derivative [Line Items]                
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 0.0 0.0   0.1 (0.3)      
Sales revenue, goods, net [Member] | Foreign currency forward contracts | Designated derivatives:                
Derivative [Line Items]                
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net 0.1 (0.1)   1.0 1.8      
Cost of sales [Member] | Foreign currency forward contracts                
Derivative [Line Items]                
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 0.0 0.0   0.0 0.1      
Cost of sales [Member] | Foreign currency forward contracts | Designated derivatives:                
Derivative [Line Items]                
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net 0.9 0.2   1.8 (4.4)      
Other nonoperating income (expense) [Member] | Interest rate swap agreements                
Derivative [Line Items]                
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 0.0 0.0   (0.1) 0.0      
Other nonoperating income (expense) [Member] | Foreign currency forward contracts                
Derivative [Line Items]                
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 0.0 0.0   0.6 0.0      
Other nonoperating income (expense) [Member] | Foreign currency forward contracts | Designated derivatives:                
Derivative [Line Items]                
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net (1.4) (0.1)   0.0 (0.6)      
Other nonoperating income (expense) [Member] | Foreign currency forward contracts | Non-designated derivatives:                
Derivative [Line Items]                
Derivative, Gain (Loss) on Derivative, Net $ (0.2) $ (8.9)   $ (8.7) $ (259.4)      
6.19% senior notes | Omega [Member] | Omega [Member]                
Derivative [Line Items]                
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt             $ 20.0  
[1] Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.
XML 74 R48.htm IDEA: XBRL DOCUMENT v3.5.0.2
Derivative Instruments and Hedging Activities - balance sheet location (Details) - USD ($)
$ in Millions
Oct. 01, 2016
Dec. 31, 2015
Designated derivatives:    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Fair Value, Amount Not Offset Against Collateral $ 0.3 $ 2.3
Designated derivatives: | Other Current Assets [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Net 3.8 3.8
Designated derivatives: | Other Current Assets [Member] | Foreign currency forward contracts    
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Net 3.8 3.8
Designated derivatives: | Accrued liabilities [Member] | Foreign currency forward contracts    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Fair Value, Amount Not Offset Against Collateral 0.3 2.0
Non-designated derivatives:    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Fair Value, Amount Not Offset Against Collateral 0.5 1.9
Non-designated derivatives: | Other Current Assets [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Net 1.4 1.0
Non-designated derivatives: | Other Current Assets [Member] | Foreign currency forward contracts    
Derivatives, Fair Value [Line Items]    
Derivative Asset, Fair Value, Net 1.4 1.0
Non-designated derivatives: | Accrued liabilities [Member] | Foreign currency forward contracts    
Derivatives, Fair Value [Line Items]    
Derivative Liability, Fair Value, Amount Not Offset Against Collateral $ 0.5 $ 1.9
XML 75 R49.htm IDEA: XBRL DOCUMENT v3.5.0.2
Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities - other comprehensive income movement (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2016
Sep. 26, 2015
Oct. 01, 2016
Sep. 26, 2015
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net $ 0.0 $ 0.0 $ 0.6 $ (0.2)
Sales revenue, goods, net [Member] | Foreign currency forward contracts        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 0.0 0.0 0.1 (0.3)
Other nonoperating income (expense) [Member] | Interest rate swap agreements        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 0.0 0.0 (0.1) 0.0
Other nonoperating income (expense) [Member] | Foreign currency forward contracts        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 0.0 0.0 0.6 0.0
Cost of sales [Member] | Foreign currency forward contracts        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 0.0 0.0 0.0 0.1
Designated derivatives:        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net 3.4 (0.5) (4.3) (13.6)
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net (1.4) (0.4) (0.3) (21.9)
Designated derivatives: | Interest rate swap agreements        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net 0.0 0.0 (9.0) (12.0)
Designated derivatives: | Foreign currency forward contracts        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net 3.4 (0.5) 4.7 (1.6)
Designated derivatives: | Interest expense, net | Interest rate swap agreements        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net (0.6) (0.4) (1.7) (18.6)
Designated derivatives: | Interest expense, net | Foreign currency forward contracts        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net (0.4) 0.0 (1.3) 0.0
Designated derivatives: | Sales revenue, goods, net [Member] | Foreign currency forward contracts        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net 0.1 (0.1) 1.0 1.8
Designated derivatives: | Other nonoperating income (expense) [Member] | Foreign currency forward contracts        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net (1.4) (0.1) 0.0 (0.6)
Designated derivatives: | Cost of sales [Member] | Foreign currency forward contracts        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net $ 0.9 $ 0.2 $ 1.8 $ (4.4)
XML 76 R50.htm IDEA: XBRL DOCUMENT v3.5.0.2
Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities -Fair value hedges (Details)
$ in Millions
 9 Months Ended
Oct. 01, 2016
USD ($)
Derivative [Line Items]  
Derivative, Gain (Loss) on Derivative, Net $ 7.0
XML 77 R51.htm IDEA: XBRL DOCUMENT v3.5.0.2
Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities- Non-designated derivatives (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2016
Sep. 26, 2015
Oct. 01, 2016
Sep. 26, 2015
Derivative Instruments, Gain (Loss) [Line Items]        
Derivative, Gain (Loss) on Derivative, Net     $ 7.0  
Non-designated derivatives:        
Derivative Instruments, Gain (Loss) [Line Items]        
Derivative, Gain (Loss) on Derivative, Net $ (1.2) $ (8.8) (10.2) $ (262.8)
Foreign currency forward contracts | Other nonoperating income (expense) [Member] | Non-designated derivatives:        
Derivative Instruments, Gain (Loss) [Line Items]        
Derivative, Gain (Loss) on Derivative, Net (0.2) (8.9) (8.7) (259.4)
Foreign currency forward contracts | Interest expense, net | Non-designated derivatives:        
Derivative Instruments, Gain (Loss) [Line Items]        
Derivative, Gain (Loss) on Derivative, Net $ (1.0) $ 0.1 $ (1.5) $ (3.4)
XML 78 R52.htm IDEA: XBRL DOCUMENT v3.5.0.2
Assets Held for Sale (Details) - USD ($)
$ in Millions
 6 Months Ended 9 Months Ended
Dec. 31, 2015
Oct. 01, 2016
Less: impairment reserves $ (29.0) $ (3.4)
CHC    
Less: impairment reserves   (6.2)
Other    
Less: impairment reserves   (10.8)
Discontinued operations, held-for-sale | CHC    
Current assets 55.1 0.0
Goodwill 13.0 0.0
Property, plant and equipment 18.8 13.3
Other assets 0.0 0.0
Less: impairment reserves 0.0 (3.4)
Total assets held for sale 86.9 9.9
Current liabilities 30.5 0.3
Other liabilities 0.0 0.0
Total liabilities held for sale 30.5 0.3
Discontinued operations, held-for-sale | Other    
Current assets 13.6 7.3
Goodwill 14.5 2.8
Property, plant and equipment 37.4 34.0
Other assets 3.2 3.2
Less: impairment reserves   (39.8)
Total assets held for sale 39.7 7.5
Current liabilities 0.5 0.9
Other liabilities 1.7 2.1
Total liabilities held for sale $ 2.2 $ 3.0
XML 79 R53.htm IDEA: XBRL DOCUMENT v3.5.0.2
(Details)
€ in Millions, $ in Millions
 9 Months Ended 12 Months Ended
Sep. 29, 2016
USD ($)
Mar. 15, 2016
USD ($)
Mar. 07, 2016
USD ($)
Dec. 09, 2015
USD ($)
Apr. 08, 2015
USD ($)
Apr. 08, 2015
EUR (€)
Mar. 30, 2015
USD ($)
Mar. 30, 2015
EUR (€)
Dec. 05, 2014
USD ($)
Dec. 02, 2014
USD ($)
Oct. 01, 2016
USD ($)
Sep. 26, 2015
USD ($)
Dec. 31, 2015
USD ($)
Dec. 15, 2015
USD ($)
Sep. 15, 2015
USD ($)
Aug. 28, 2015
USD ($)
Mar. 30, 2015
EUR (€)
Dec. 05, 2014
EUR (€)
Nov. 08, 2013
USD ($)
Debt Instrument [Line Items]                                      
Long-term line of credit                     $ 0.0   $ 680.0            
Debt Instrument, Issuance Date     Mar. 07, 2016 Dec. 09, 2015     Mar. 30, 2015 Mar. 30, 2015 Dec. 05, 2014                    
Term loans [1]                       $ 300.0              
Senior Notes                     5,426.4   4,698.3           $ 2,300.0
Repayments of Long-term Debt                     545.8 $ 903.3              
Other financing                     4.1   86.0            
Unamortized premium (discount), net                     43.3   73.4            
Deferred financing fees                     (34.6)   (36.6)            
Total borrowings outstanding                     5,903.0   5,989.9            
Current indebtedness                     (265.0)   (1,018.3)            
Long-term debt, less current portion                     $ 5,638.0   4,971.6            
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt                           $ 0.0 $ 0.0 $ 0.0      
Debt Instrument, Covenant Compliance                     yes                
Line of Credit Facility, Fair Value of Amount Outstanding                     $ 0.0                
Schedule of debt                    
Total borrowings outstanding are summarized as follows (in millions):
 
 
 
 
 
October 1,
2016
 
December 31,
2015
Revolving credit agreements
 
 
 
 
 
 
2015 Revolver
$
—

 
$
380.0

 
2014 Revolver
—

 
300.0

 
Total revolving credit agreements
—

 
680.0

Term loans
 
 
 
 
 
*
2014 Term loan due December 5, 2019
463.8

 
488.8

Notes and Bonds
 
 
 
 
 
 
Coupon
Due
 
 
 
 
 
 
1.300%
November 8, 2016
(2) 
 
—

 
500.0

*
4.500%
May 23, 2017
(3) 
 
202.4

 
195.5

*
5.125%
December 12, 2017
(3) 
 
337.3

 
325.8

 
2.300%
November 8, 2018
(2) 
 
600.0

 
600.0

*
5.000%
May 23, 2019
(3) 
 
134.9

 
130.3

 
3.500%
March 15, 2021
(4) 
 
500.0

 
—

 
3.500%
December 15, 2021
(1) 
 
500.0

 
500.0

*
5.105%
July 19, 2023
(3) 
 
151.8

 
146.7

 
4.000%
November 15, 2023
(2) 
 
800.0

 
800.0

 
3.900%
December 15, 2024
(1) 
 
700.0

 
700.0

 
4.375%
March 15, 2026
(4) 
 
700.0

 
—

 
5.300%
November 15, 2043
(2) 
 
400.0

 
400.0

 
4.900%
December 15, 2044
(1) 
 
400.0

 
400.0

 
Total notes and bonds
 
 
5,426.4

 
4,698.3

Other financing
4.1

 
86.0

Unamortized premium (discount), net
43.3

 
73.4

Deferred financing fees
(34.6
)
 
(36.6
)
Total borrowings outstanding
5,903.0

 
5,989.9

 
Current indebtedness
(265.0
)
 
(1,018.3
)
Total long-term debt less current portion
$
5,638.0

 
$
4,971.6


(1)
Discussed below collectively as the "2014 Notes."
(2)
Discussed below collectively as the "2013 Notes."
(3)
Debt assumed from Omega.
(4)
Discussed below collectively as the "2016 Notes."

*
Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.
                
Omega [Member]                                      
Debt Instrument [Line Items]                                      
Amount debt exceeded par value             $ 101.9                        
Omega [Member] | Euro member countries, euro                                      
Debt Instrument [Line Items]                                      
Amount debt exceeded par value | €               € 93.6                      
Perrigo Co PLC [Member]                                      
Debt Instrument [Line Items]                                      
Long-term debt, less current portion                     $ 5,638.0   4,971.6            
Omega [Member]                                      
Debt Instrument [Line Items]                                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt             $ 1,471.0                        
Extinguishment of Debt, Amount         $ 539.1                            
Omega [Member] | Euro member countries, euro                                      
Debt Instrument [Line Items]                                      
Extinguishment of Debt, Amount | €           € 500.0                          
BCH                                      
Debt Instrument [Line Items]                                      
Line of Credit, Current                         82.9            
2015 Revolver                                      
Debt Instrument [Line Items]                                      
Long-term line of credit                     0.0   380.0            
Debt Instrument, Face Amount       $ 750.0                              
Proceeds from Lines of Credit   $ 750.0                                  
2014 Revolver                                      
Debt Instrument [Line Items]                                      
Long-term line of credit                     $ 0.0   $ 300.0            
Line of Credit Facility, Maximum Borrowing Capacity | €                                   € 1,000.0  
Debt Instrument, Face Amount                 $ 600.0                    
Proceeds from Lines of Credit   $ 435.0                                  
Debt Instrument, Maturity Date                     Dec. 05, 2019   Dec. 05, 2019            
2014 Term loan due December 5, 2019                                      
Debt Instrument [Line Items]                                      
Term loans [1]                     $ 463.8   $ 488.8            
Debt Instrument, Periodic Payment                     41.9                
Debt Instrument, Face Amount | €                                   614.3  
2014 Term loan due December 5, 2019 | Euro member countries, euro                                      
Debt Instrument [Line Items]                                      
Debt Instrument, Face Amount | €                                   500.0  
1.30% unsecured senior notes due November 8, 2016                                      
Debt Instrument [Line Items]                                      
Debt Instrument, Interest Rate, Stated Percentage                         1.30%            
Senior Notes [2]                     $ 0.0   $ 500.0            
Repayments of Long-term Debt $ 500.0                                    
Debt Instrument, Maturity Date                     Nov. 08, 2016   Nov. 08, 2016            
4.500% unsecured senior notes due May 23, 2017                                      
Debt Instrument [Line Items]                                      
Debt Instrument, Interest Rate, Stated Percentage                         4.50%            
Senior Notes [1],[3]                     $ 202.4   $ 195.5            
Debt Instrument, Maturity Date                     May 23, 2017   May 23, 2017            
5.125% unsecured senior notes due December 12, 2017                                      
Debt Instrument [Line Items]                                      
Debt Instrument, Interest Rate, Stated Percentage                         5.125%            
Senior Notes [1],[3]                     $ 337.3   $ 325.8            
Debt Instrument, Maturity Date                     Dec. 12, 2017   Dec. 12, 2017            
2.30% unsecured senior notes November 8, 2018                                      
Debt Instrument [Line Items]                                      
Debt Instrument, Interest Rate, Stated Percentage                         2.30%            
Senior Notes [2]                     $ 600.0   $ 600.0            
Debt Instrument, Face Amount                                     600.0
Debt Instrument, Maturity Date                     Nov. 08, 2018   Nov. 08, 2018            
5.000% unsecured senior notes due May 23, 2019                                      
Debt Instrument [Line Items]                                      
Debt Instrument, Interest Rate, Stated Percentage                         5.00%            
Senior Notes [1],[3]                     $ 134.9   $ 130.3            
Debt Instrument, Maturity Date                     May 23, 2019   May 23, 2019            
3.500% unsecured senior notes due March 15, 2021                                      
Debt Instrument [Line Items]                                      
Debt Instrument, Interest Rate, Stated Percentage     3.50%                   3.50%            
Senior Notes [4]                     $ 500.0   $ 0.0            
Debt Instrument, Face Amount     $ 500.0                                
Debt Instrument, Maturity Date                     Mar. 15, 2021                
3.5% Senior note due December 15, 2021 [Member]                                      
Debt Instrument [Line Items]                                      
Debt Instrument, Issuance Date                   Dec. 02, 2014                  
Debt Instrument, Interest Rate, Stated Percentage                   3.50%     3.50%            
Senior Notes [5]                     $ 500.0   $ 500.0            
Debt Instrument, Face Amount                   $ 500.0                  
Debt Instrument, Maturity Date                     Dec. 15, 2021   Dec. 15, 2021            
5.105% senior note due July 19, 2023                                      
Debt Instrument [Line Items]                                      
Debt Instrument, Interest Rate, Stated Percentage                         5.105%            
Senior Notes [1],[3]                     $ 151.8   $ 146.7            
Debt Instrument, Maturity Date                     Jul. 19, 2023   Jul. 19, 2023            
4.00% unsecured senior notes due November 15, 2023                                      
Debt Instrument [Line Items]                                      
Debt Instrument, Interest Rate, Stated Percentage                         4.00%            
Senior Notes [2]                     $ 800.0   $ 800.0            
Debt Instrument, Face Amount                                     800.0
Debt Instrument, Maturity Date                     Nov. 15, 2023   Nov. 15, 2023            
3.9% senior note due December 15, 2024                                      
Debt Instrument [Line Items]                                      
Debt Instrument, Interest Rate, Stated Percentage                   3.90%     3.90%            
Senior Notes [5]                     $ 700.0   $ 700.0            
Debt Instrument, Face Amount                   $ 700.0                  
Debt Instrument, Maturity Date                     Dec. 15, 2024   Dec. 15, 2024            
4.375% senior note due March 15, 2026                                      
Debt Instrument [Line Items]                                      
Debt Instrument, Interest Rate, Stated Percentage     4.38%                   4.375%            
Senior Notes [4]                     $ 700.0   $ 0.0            
Debt Instrument, Face Amount     $ 700.0                                
Debt Instrument, Maturity Date                     Mar. 15, 2026                
5.30% unsecured senior notes due November 15, 2043                                      
Debt Instrument [Line Items]                                      
Debt Instrument, Interest Rate, Stated Percentage                         5.30%            
Senior Notes [2]                     $ 400.0   $ 400.0            
Debt Instrument, Face Amount                                     $ 400.0
Debt Instrument, Maturity Date                     Nov. 15, 2043   Nov. 15, 2043            
4.9% senior notes due December 15, 2044                                      
Debt Instrument [Line Items]                                      
Debt Instrument, Interest Rate, Stated Percentage                   4.90%     4.90%            
Senior Notes [5]                     $ 400.0   $ 400.0            
Debt Instrument, Face Amount                   $ 400.0                  
Debt Instrument, Maturity Date                     Dec. 15, 2044   Dec. 15, 2044            
2014 Euro-Denominated Term Loan due December 5, 2019 additional draw [Domain]                                      
Debt Instrument [Line Items]                                      
Debt Instrument, Face Amount | €                                   368.6  
Debt Instrument, Maturity Date                     Dec. 05, 2019   Dec. 05, 2019            
2014 Euro-Denominated Term Loan due December 5, 2019 additional draw [Domain] | Euro member countries, euro                                      
Debt Instrument [Line Items]                                      
Debt Instrument, Face Amount | €                                   € 300.0  
Debt securities                                      
Debt Instrument [Line Items]                                      
Senior Notes     $ 1,200.0                                
6.19% senior notes | Omega [Member]                                      
Debt Instrument [Line Items]                                      
Debt Instrument, Interest Rate, Stated Percentage             6.19%                   6.19%    
Debt Instrument, Maturity Date             Jan. 01, 2016 Jan. 01, 2016                      
6.19% senior notes | Omega [Member] | Omega [Member]                                      
Debt Instrument [Line Items]                                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt             $ 20.0                        
5.1045% senior notes | Omega [Member]                                      
Debt Instrument [Line Items]                                      
Debt Instrument, Interest Rate, Stated Percentage             5.1045%                   5.1045%    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt             $ 147.0                        
Debt Instrument, Maturity Date             Jan. 01, 2023 Jan. 01, 2023                      
5.1045% senior notes | Omega [Member] | Euro member countries, euro                                      
Debt Instrument [Line Items]                                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt | €                                 € 135.0    
5.125% retail bonds | Omega [Member]                                      
Debt Instrument [Line Items]                                      
Debt Instrument, Interest Rate, Stated Percentage             5.125%                   5.125%    
Debt Instrument, Maturity Date             Jan. 01, 2017 Jan. 01, 2017                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt             $ 326.7                        
5.125% retail bonds | Omega [Member] | Euro member countries, euro                                      
Debt Instrument [Line Items]                                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt | €                                 € 300.0    
4.5% retail bonds | Omega [Member]                                      
Debt Instrument [Line Items]                                      
Debt Instrument, Interest Rate, Stated Percentage             4.50%                   4.50%    
Debt Instrument, Maturity Date             Jan. 01, 2017 Jan. 01, 2017                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt             $ 196.0                        
4.5% retail bonds | Omega [Member] | Euro member countries, euro                                      
Debt Instrument [Line Items]                                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt | €                                 € 180.0    
5.0% retail bond | Omega [Member]                                      
Debt Instrument [Line Items]                                      
Debt Instrument, Interest Rate, Stated Percentage             5.00%                   5.00%    
Debt Instrument, Maturity Date             Jan. 01, 2019 Jan. 01, 2019                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt             $ 130.7                        
5.0% retail bond | Omega [Member] | Euro member countries, euro                                      
Debt Instrument [Line Items]                                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt | €                                 € 120.0    
2014 bonds                                      
Debt Instrument [Line Items]                                      
Senior Notes                   $ 1,600.0                  
Over draft | Omega [Member]                                      
Debt Instrument [Line Items]                                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt             56.0                        
Over draft | Omega [Member] | Euro member countries, euro                                      
Debt Instrument [Line Items]                                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt | €                                 51.4    
Credit facility indebtedness | Omega [Member]                                      
Debt Instrument [Line Items]                                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt             $ 544.5                        
Credit facility indebtedness | Omega [Member] | Euro member countries, euro                                      
Debt Instrument [Line Items]                                      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt | €                                 € 500.0    
[1] Debt denominated in euros subject to fluctuations in the euro-to-U.S. dollar exchange rate.
[2] (2)Discussed below collectively as the "2013 Notes."
[3] (3)Debt assumed from Omega.
[4] (4)Discussed below collectively as the "2016 Notes."
[5] (1)Discussed below collectively as the "2014 Notes."
XML 80 R54.htm IDEA: XBRL DOCUMENT v3.5.0.2
Earnings Per Share (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2016
Sep. 26, 2015
Oct. 01, 2016
Sep. 26, 2015
Oct. 22, 2015
Numerator:          
Net income (loss) $ (1,255.2) $ 112.6 $ (1,395.4) $ 74.2  
Denominator:          
Weighted average shares outstanding for basic EPS 143,300,000 146,300,000 143,200,000 144,400,000  
Dilutive effect of share-based awards [1] 0 600,000 0 600,000  
Weighted average shares outstanding for diluted EPS 143,300,000 146,900,000 143,200,000 145,000,000  
Share-based compensation arrangement by share-based payment award, options, exercises in period 185,000 154,000 283,000 246,000  
Stock repurchase program, authorized amount $ 0.0   $ 0.0    
Stock repurchase program, remaining authorized repurchase amount $ 1,500.0   $ 1,500.0    
Anti-dilutive share-based awards excluded from computation of diluted EPS 0 100,000 0 0  
Perrigo Co PLC [Member]          
Denominator:          
Stock repurchase program, authorized amount         $ 2,000.0
[1] In the period of a net loss, diluted shares equal basic shares.
XML 81 R55.htm IDEA: XBRL DOCUMENT v3.5.0.2
Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2016
Sep. 26, 2015
Oct. 01, 2016
Sep. 26, 2015
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Balance at December 31, 2015     $ (15.5)  
OCI before reclassifications     85.5  
Amounts reclassified from AOCI     1.5  
Other comprehensive income (loss), net of tax $ 40.2 $ (37.2) 87.0 $ 57.8
Balance at October 1, 2016 71.5   71.5  
Foreign currency translation adjustments        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Balance at December 31, 2015     (4.4)  
OCI before reclassifications     71.8  
Amounts reclassified from AOCI     0.0  
Other comprehensive income (loss), net of tax     71.8  
Balance at October 1, 2016 67.4   67.4  
Fair value of derivative financial instruments, net of tax        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Balance at December 31, 2015     (14.2)  
OCI before reclassifications     (3.7)  
Amounts reclassified from AOCI     0.2  
Other comprehensive income (loss), net of tax     (3.5)  
Balance at October 1, 2016 (17.7)   (17.7)  
Fair value of investment securities, net of tax        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Balance at December 31, 2015     6.3  
OCI before reclassifications     17.1  
Amounts reclassified from AOCI     1.3  
Other comprehensive income (loss), net of tax     18.4  
Balance at October 1, 2016 24.7   24.7  
Post-retirement and pension liability adjustments, net of tax        
Reclassification Adjustment out of Accumulated Other Comprehensive Income on (Loss) Derivatives [Line Items]        
Balance at December 31, 2015     (3.2)  
OCI before reclassifications     0.3  
Amounts reclassified from AOCI     0.0  
Other comprehensive income (loss), net of tax     0.3  
Balance at October 1, 2016 $ (2.9)   $ (2.9)  
XML 82 R56.htm IDEA: XBRL DOCUMENT v3.5.0.2
Income Taxes (Details) - USD ($)
$ in Millions
 1 Months Ended 3 Months Ended 9 Months Ended
Jan. 31, 2015
Nov. 30, 2014
Oct. 01, 2016
Sep. 26, 2015
Oct. 01, 2016
Sep. 26, 2015
Dec. 31, 2015
Effective tax rate on income from continuing operations     20.10% 14.80% 21.60% 60.30%  
Unrecognized tax benefits, including income tax penalties and interest accrued     $ 368.4   $ 368.4   $ 334.7
Unrecognized tax benefits liability, interest and penalties accrued     $ 56.4   $ 56.4   $ 52.1
Income tax examination, penalties and interest expense   $ 8.0          
Incremental tax obligation $ 68.9            
All Other Entities [Member]              
Foreign statutory corporate tax rate, year one     26.50%        
Foreign statutory corporate tax rate, current year     25.00%        
Foreign Tax Authority [Member] | Maximum [Member]              
Foreign Statutory Corporate Tax Rate         18.00%    
Foreign Tax Authority [Member] | Minimum [Member]              
Foreign Statutory Corporate Tax Rate         17.00%    
XML 83 R57.htm IDEA: XBRL DOCUMENT v3.5.0.2
Collaboration agreements and other contractual arrangements (Details) - USD ($)
$ in Millions
 1 Months Ended 9 Months Ended
Jun. 30, 2016
May 31, 2015
Oct. 01, 2016
Minimum [Member] | May 2015 agreement [Member]      
Potential Contingent Milestone Payments   $ 78.0  
Minimum [Member] | June 2016 agreement [Member]      
Potential Contingent Milestone Payments $ 42.0    
Maximum [Member] | May 2015 agreement [Member]      
Potential Contingent Milestone Payments   $ 105.0  
Maximum [Member] | June 2016 agreement [Member]      
Potential Contingent Milestone Payments     $ 57.0
XML 84 R58.htm IDEA: XBRL DOCUMENT v3.5.0.2
Restructuring Charges (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2016
Sep. 26, 2015
Oct. 01, 2016
Sep. 26, 2015
Restructuring Cost and Reserve [Line Items]        
Beginning balance $ 12.2 $ 1.7 $ 20.7 $ 3.2
Additional charges 6.6 2.2 17.9 3.1
Payments (8.6) (1.9) (33.3) (4.5)
Non-cash adjustments 0.1 (0.7) 5.0 (0.5)
Ending balance 10.3 $ 1.3 10.3 $ 1.3
Employee severance [Member]        
Restructuring Cost and Reserve [Line Items]        
Ending balance 5.1   5.1  
Lease exit        
Restructuring Cost and Reserve [Line Items]        
Ending balance $ 5.2   $ 5.2  
XML 85 R59.htm IDEA: XBRL DOCUMENT v3.5.0.2
Segment Information (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Oct. 01, 2016
Sep. 26, 2015
Oct. 01, 2016
Sep. 26, 2015
Dec. 31, 2015
Segment Reporting Information [Line Items]          
Net sales $ 1,354.9 $ 1,344.7 $ 4,219.1 [1] $ 3,925.4 [1]  
Operating Income (Loss) (1,515.2) 188.6 (1,580.7) [1] 614.7 [1]  
Intangible Asset Amortization 162.1 147.6 481.8 [1] 397.9 [1]  
Total Assets 17,467.6   17,467.6   $ 19,393.9
CHC          
Segment Reporting Information [Line Items]          
Net sales 669.1 675.2 2,055.6 2,106.4  
Operating Income (Loss) 100.1 117.3 313.6 364.8  
Intangible Asset Amortization 19.2 19.4 58.1 52.1  
Total Assets 3,873.8   3,873.8   4,007.8
BCH          
Segment Reporting Information [Line Items]          
Net sales 304.0 302.2 1,015.3 [1] 703.4 [1]  
Operating Income (Loss) (1,684.3) 4.4 (2,128.7) [1] 31.0 [1]  
Intangible Asset Amortization 38.9 36.3 113.9 [1] 70.5 [1]  
Total Assets 4,460.2   4,460.2   6,324.0
Rx          
Segment Reporting Information [Line Items]          
Net sales 267.4 260.3 817.4 790.1  
Operating Income (Loss) 77.9 91.0 262.1 290.4  
Intangible Asset Amortization 30.7 18.6 90.1 55.5  
Total Assets 3,304.0   3,304.0   3,015.5
Specialty Sciences          
Segment Reporting Information [Line Items]          
Net sales 93.4 84.5 271.3 250.1  
Operating Income (Loss) 23.3 9.0 49.7 21.0  
Intangible Asset Amortization 72.8 72.8 218.3 218.4  
Total Assets 5,634.0   5,634.0   5,833.5
Other          
Segment Reporting Information [Line Items]          
Net sales 21.0 22.5 59.5 75.4  
Operating Income (Loss) (1.6) 6.2 2.6 18.6  
Intangible Asset Amortization 0.5 0.5 1.4 1.4  
Total Assets 195.6   195.6   $ 213.1
Unallocated          
Segment Reporting Information [Line Items]          
Net sales 0.0 0.0 0.0 0.0  
Operating Income (Loss) (30.6) (39.3) (80.0) (111.1)  
Intangible Asset Amortization $ 0.0 $ 0.0 $ 0.0 $ 0.0  
[1] The BCH segment was created on March 30, 2015 as a result of the Omega acquisition, thus data for the nine months ended September 26, 2015 includes only six months of results from operations attributable to Omega.
EXCEL 86 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( $N+:DD:LHU,! ( .PC 3 6T-O;G1E;G1?5'EP97-= M+GAM;,W:S4[C,! '\%>IU6 MW17L4NE_:9J./3/))+]3S^^? J79SO5#6E9=SN$;8ZGIR)E4^T!#B:Q\=":7 MT[AFP30;LR8F%HLSUO@ATY#G>C8%]I^\'N/L8PJF$,FT MJ2/*KJ]3?NHI':N_C[Q4OJ*5>>CSNPH_W[LZ4C^M29T-SZ6N=R5+*K\MJQ)- M;ZIPN/%OG5DW#BT,Z]]VC.?_>"T'-W'K^JMH'NU!@>W)QC0>:V?L<&Q4CSYN M?GB_^E\9'>5'!<>,*7HC.1 MVN\YEOD>?S=^77"Z/L:Y3M__-/0IF-AT."$2[^I#@/0A0?I0('UHD#[.0/KX M#-+'%Y ^OH+TP1QW8OG*\M"_V/ MZ'D4X$G1H>)%]2-F Q+M*;V"^GH A3&^.R6:E((C-Z."N[_8_ )02P,$% M @ 2XMJ2?8!U;L. @ WB, !H !X;"]?36'%&F63:R0:07396;$!41>GL/L2#EOO! M40\LG0D((]WZ1Y]1P4.7Z]6/=&S*H>]R>QCRXN?IV.75]/NZ:DL95B'D39M. M3;[IA]1-=W?]>&K*=#GNP]!LWII]"E+7RS!>SJD>'_ZKJOQ>1NKQ6LS M[E-95Q_]^);;E$H.YU.\F1:8;G\.Z7^6[W>[PR8]]9OW4^K*/RK"KP6J,!\D M\T%""=+Y(*4$V7R048)\/L@I0@MI&=M]+#-T5N WL+16X#>PM%;@-["T5N WL+16X#>PM%; M@-["T5N WL+16X'>RM%;@=[*T5N!WDK:*T&;)1R]%>BM'+T5Z*TBM'+T5Z*TAM'+T-Z&TAMI+UNM-G-T=N WL;1 MVX#>QM';@-[&T=N WL;1VX#>QM';@=[.T=N!WL[1VX'>SM';@=[.T=N!WDYZ M5XE>5G+T=J"W<_1VH+=S]':@MW/T=J"W<_1>7NB=VV9,VYN7P>T_53SE-APX7695HIA?/QZG\=YZG?(>&O3WD>OP!02P,$% @ M2XMJ2?8M"&=M P F X ! !D;V-0&ULO5=1<]HX$/XK M&I[2A]:40.^2H9Y)27K)S/7*%)I[5N0%-)4EJI5]27]]5S(AII'E(P_-2X3\ M?;O:_3XM9JIQ>#ZW9@O624!V7RJ-Y[3Y?K!Q;GN>92@V4')\0Q!-3U?&EMS1 M1[O.S&HE!5P:496@738:#M]E<.] %U"\WNZ##O*ISW*QW2HIN)-&YY^DL ;- MRK&K>P%JFOT*" R*O !16>D>\F&#:6\%S$)P!3/*E:^X0FA03YL!,S/EENN' MK/GTM]3?\.MV:2ZY@S;K\$$3?<,M%)3T(/I^,V"N'ZA.Y;FS#==K*-K8YP\? M>W$+%GVE;T=OAO2W;\'C?A,;>"'U>LZEQ7Q:N_,:A#-V)U/M7JI28807'6^7 M=#X;6A%J>FS$Y&S0JOXQ!..Z M8%?:D1W9C6Y2D7CMENQ7,Z/1*%F0N0JV3YP MQ;4 MG@FU?_!LY,Y/[:6&<=-E+.HRI+;!X]9R+66) 6)SRZ$,!5U,,KY4*'4 M@$BH[Y5$Z9M+I_K'.,!74<9?QA3_2:6",I_=!BQUU]'5DW<*V$64LSL"LB\@ M0-;<(S]R[R[R(#N)@"D9V90L:E,DD-V3 .U(YJ'"B.P]] MQ:VF;B&;4\?#A.QJ=556*OBF4<JB=W M.CH+:"$[&4KQ.V/#;65\;0&>Z,9%.5_ ]UBX*KB"QKE=]VB_@'48$GV3(7DS M1N-C;L;2F_"=/F](_49/!4\Z_71XA--360ZMGD(^-WL:GW3] M:5S@#KNETD3\UD-(&>_TCV.,=PF.2_42YYV>'<\9=VB>&N3CM_T.3U;1LC@U MUOK7T*"-/Z#NN-I=U^(U4U#[%]\NSFW@?&IS=K'ZKU*RBN1=&L[ G?/+[;1(7N6/@)/-$)TZ, M\>P-_Y?W^>SP=VC^$U!+ P04 " !+BVI)3 /F4SX! !I P $0 &1O M8U!R;W!S+V-O&ULS9--3\,P#(;_"NJ]2[/!D**N!T"+?S=8))0: #H2-*LNK5;(UM3$D&?55&QS4/.+=2K13(NW8H^YV* MG1&\#DY#ZJO:IIFU$Q271R8DO?YTTLZFUR9@-P(B*J@ M&+8.9MFI\]OD_F'QF%7C@DYS2G-:+.@M&]^PZ\G'8;(S?X-AW0WQ;QV?#*;M MHL(:+MQMTLBTW/290!*"\,JALN8B7,)\$R=8V"T_0>#EH$Z8+ML6VL9Z&:IT MOX;H\'+BRM;6M\?4C^CL555?4$L#!!0 ( $N+:DF97)PC$ 8 )PG 3 M >&PO=&AE;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S M:7;;M)F$[4X?A1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N M+F+HAHB4\GA@V2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?+&A T%116F]?(+3E'S/X M%/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53" MQ,!J9S]6:\?1TDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@ MX_%X.+;+THMP' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMH MG J-6T_3:W?=TXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2 M%;7E0-,@ %AP=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9R MG9 %#@ WQ-%,4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S M>IU].LYKE']IJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88C'(CN]WV6'WV3T=N(]>IP+,B MUY1&)$6?R"VZY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C? MC8CWJV^:/5>A6$G:A/@01AKBG'/F<]%L^P>E1M'V5;SCFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1 MVC?"J_B"P#E_+GW/I>^Y]#VATK\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE M"0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ MZK:4OK4F.$KTL@'37[]EUVY".E,%.70[@:0KX#;;J= MW#HXGIB1N0K34I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B M(>ZAAIC/PT.'>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)5 M8#%;Q@,KD*)\3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6Q MP54=SU5;\K"^:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON>; MG*YZ(G;ZEW?!8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4< M!A87,N10[I*0!A,!S93)1/ "@F2F'("8^@N]\@RY*17.K3XY?T4L@X9.7M(E M$A2*L P%(1=RX^_ODVIWC-?Z+(%MA%0R9-47RD.)P3TSU#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+? M.7#;.MX#7N83+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4 MJUJE9"L1/TL'?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5 MBZPYC0IO0=5 Y3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%0 M2P,$% @ 2XMJ27G>>V.5 @ B@\ T !X;"]S='EL97,N>&ULS9=; M:]LP%,>_BE#':&'$3D*39K4-HQ 8;&70/.RMR+'L"'3Q9#E+^KC/LT^U3S)= M[#@Q<])T-_M%\M$YO_/7S1P'A=I2_+#"6($-H[P(X4JI_*WG%O+FX\ ?^X]5M>^2R&KJ"P''>)R$<3JZA]TMP ^H(G'0$ M=B@Z)JF-GIZ)/LINPV_.@7>"6]#9N8J/2V[AI_X)_(]OWX\L23/:M2C3X;D) MCN);\-%Y\"/H%GALP%YU4:(@%;RY+R/H#%%0/($UHMK?3G(IJ)! Z0NI%;AI M(X:=QQVB));$&%/$"-TZL]5O[W#EQP@7TN9V&=IY!GZ3269Q"/WJ>7ZZN*'; MQDR/4'HX/6V(@APIA26?ZQ=0]1?;7$^."XZ=2.MWPCN3:#L<7>\%V$;GC85, ML-QE'L+:% 44ITH'2)*M3*M$;J0+I033G82@3'!$#;*.J#H:N\24/I@OYN?T M@+U)@?,Q>^Q#8%347;T05;_YI\?V_L-80M/<_8BON2Q5C.[9?Y?&'C:5^5 MF>*FM](F_976XPV]Z:^T66^E37O[[3"%9V^EC?HK;?R;TKRJ0-JKP@YJL)T5 MQ"6ABO!: S)5\[W130_*HZ;^TLQDTY1>=E2A6/\8'V31L 2GJ*3J$UD+90=# MV/0_&/FZ;JN]%CM$")O^1YR0DMF?+Z_Y^XY^ E!+ P04 " !+BVI)ZSC, M8,X$ #M$@ #P 'AL+W=ODG+1?WZ'LK$?U1-L\V9+%P^'P<$CK@S]_ MMN[;W-IOXJ71QI^[2;(*87T^&OEJ!8WT?]DU&/QM85TC UZZY<@N%JJ"*UNU M#9@PRL;CXY$#+8.RQJ_4VB<[FO\=FE\[D+5? 81&;V&-5";Y^,&?+Y2&)W > MP4*NUU]D Y/D12="2Q^N:Q6@GB0%7MIGZ-UP[?JR53I>E.,R&478ZU#OG:AL M#5O8XTKY?W8_)**&A6QU>,1@7_N=)&E69-GQEA$?>U+P["DPWA"R"FH#CW(^ M2<:)D&VP-TH'<%E8YJW77*O[0-<(>_']W,,:@JMZ#09B:& ,^?%=W';MSA5_<79UN M4T5!4Q3#:E5C+FHQ"_@1L5[8!?(J2T 9 64LJ ;CD<(B"2@GH/Q_(KJ46IH* M1)=@3R %@13O@HBC>TE )0&5[\K/5/H5 1T3T/$A:-8VC73?8\.96AJ%"U7B M_%U4E6UQ_@CHA(!.#D&7K5<&O,>F_[;H3;>VQ=$7&\#_03"G!'-ZB/ED;?VL MM.X,^AI6X'#"@S3+***X(* S CH[!.U&X,4#5* V,C:_P36':\4LQ1%5<4Q= M'!^B[LP&DXL-@1M0VE.9I@3GUP[984,WT+]9*BJ,_1DMI(.:&MJ;,HHBXJT3:N[ M-;15;6H;W%Q66# P211%K4T9;6-1:D \RA>@Y2"EDJ:,I=AAH\)^'G!=!QP0 MF$KU0!EU-&,P[#8#?@?(J*X9H^M@:E(N>, MR'QE.8PIIQKGC,;]TL( J+XYH^]A<6$QO7,#H_%@EXT-^0E%4Y_SW#Q!7$*32_:BHSOE[#Q'Y&451LW/&[$%4 M0,VZ1VX,P[J%K7.15':7IENJ!^ M%XS?;Y6A/X6B*ZIV.&;\[U%.'^DQ1NRXHB@I>L <+4M&X#%&S"\;LP9)6 M4+,+:G;!F#V,.J4H:G;!F#V,HF87U.SBO36[I&:7U.R2,7L81O_T6)/W1TL^&*IRR:@\ M>#8LJYEQ/[]0PT+W#?J^';&=YU4 M4E?QE0U^;/]5%64\A\?KS[;&GN.[ED0L6JVG>.^K^=O*[HW$EOSZDN;C3U!+ M P04 " !+BVI)^I#.M7," #!" & 'AL+W=O*%];133RZ, MMT2J(;\&HN>4G(VI;0(3+YSW=).U*SS.+WL_5>T.Z)42XSB=TT?PKGW].)/C'WH MP<_SW@_U&FA#2ZE#$'6YTR-M&AU)D?\.09],;73OQ^C?3;IJ^2'K.(<#1540P((( DVSML6-/YNNSBH.K2&% L@)(''LV!Z068!6=W>%DDT3I0A[I"B9U,!LP M#U>QA0'9"B!SZR $"3/)0JUL5A ;UX]!Q$RR4"W;%<36]<<@8B9)8(3^@UAD MZ(?/""GXS@>-?>DX1 N%A<#>'3FSUOQ26\G F6DV"Q2P@4>*VY]H"V[93(/# M!0K8Q2/%;6.,H#T[#IJA4>(HRN(89PNPM9Y';DMCN-#FFH5*0VN-C]S.QW"M MS35+Q;;6]\AM:YS"E'0ME\ Y,5K*K^8D%5[);ITYN)W9Z;1^Q>;$>9+E5[PMJ!9/WXP3!] MM13_ 5!+ P04 " !+BVI)M!["<6D% #S&0 & 'AL+W=OY05D7KUY?RW'_S5C=5T?4?F_>@O31EL1^-JE/ PS *JN)X7JQ7X]BW9KVJ M/[K3\5Q^:[SVHZJ*YK]->:JOSPNVF >^']\/W3 0K%?!S6Y_K,IS>ZS/7E.^ M/2^^L.4+3P?(B/C[6%Y;\-X;@G^MZQ_#AS_WSXMPB*$\E;MN<%'T+S_+;7DZ M#9[ZF?_53C_G' SA^]E[/M+MPW\MVG);G_XY[KM#'VVX\/;E6_%QZK[7US]* MS4$-#G?UJ1W_>[N/MJNKV63A5<6OZ?5X'E^OTS=QHLUH ZX-^,T@"9T&0AN( MFP&33@.I#>2G@7(:*&V@;@;N"2*-CQZ-*-8&,9X@F'([5B8KNF*]:NJKUTS+ MZ5(,JY8MX[[V.Z\=!YNIX'UMVG[TYYK'J^#GX$=#^ C9($A"03((83=$T,]_ M"X)30>@9.)R!FF"+$"D9PV^=Y!8G*$Q!A2FG7 E@+T(\13PQF2#G*1%"23^E M8%L,D]*/*5@&89*SU&<8-L7U%<7%*$\Y]"12KGQ)>7JQ>$(9DHX,26AO%"&9 M,B1!)(E,_(A";2$J3I69Q@F5012/.#?3.,%R!!-1"F"(F7(P4Y"9()DI,(T* M(Y]$;1&JYY^0S""*J30RZZ6989A2-F81Q4Q,S"+(3-+VL2,S,;179&9B6 !F M*3D"W6TZ;38I6E[34#:&BV%*XU-@<)"I/T3$%FRTHTMQH5Y@7*0%F7K Y2S*8C<;HO6RK&01Q>BMF M",0L:S9'*.%;^B%S208&.ZHD3Z@-@\V9A_T!26[Z+<*)R'+,9!C&8FO)("Z5 M-G:N=L]@OY=TOV>P^SXQQ93E>$1 EECV9&;Z2T*SZVM5A((S9=%<8>@L8G1 MF0DB?TED9>@2-@PJ&TDK&P:%QM/0LFFQCG#]_)^D_HN$FIFG\\\;P2>%]>I2O)=_%&PO=V]R:W-H965T M&ULC59-CYLP$/TKB/L"!LQ'E"!M(%5[J+3JH3VSB9.@!9QB M9[/]][7!(0,[29M#L,U[,_/&@SW+"^_>Q)$Q:7TT=2M6]E'*T\)UQ?;(FE(X M_,1:]6;/NZ:4:MH=7''J6+GK24WM^IX7N4U9M7:V[-=>NFS)S[*N6O;26>+< M-&7W9\UJ?EG9Q+XN_*@.1ZD7W&SICKQ=U;!65+RU.K9?V<]DL2&>AO2(GQ6[ M"#"V=/"OG+_IR;?=RO9T#*QF6ZE-E.KQSG)6U]J2\OS;&+WYU$0XOEK_TLM5 MX;^6@N6\_E7MY%%%Z]G6CNW+$T!#"__5 #8'./+B#]CYS12G+ M;-GQB]4-VWTJ=561!55[L[5$O]@-&Z)R)]3J>T;ITGW7=@S$[R%K"/$3#%) M"!D1KO(_!N%C01@//O2 .<@GB!2-X9]&-G>,3,(,L###(5S1,2#D@'2 M]I GXE/J^!@NASA"?"?"4,746I!2)\1P&XB+0^!R(BW$I 6#M!"6083SZ8/4 M4,B/IT%&0VHH"-*?09(A*Q#R%*1.@J$*B(H)#MI $/6<.[L=/9 404FHDW4$ MG 3S/32:(,9S"*HHFNAV**H(@JAS9X_B!X)B*"A%!<7 ATJ_!W]HZ#ED^'CD M!<209%[#1AX$/?D --&7/-"7 'V1A^I+H!-O_FT.A9I#$&JFF""< -633&HC MQN6D#^2D4 Z:_'4*?(2?Y)@=2B?%%>.B"XA*T*]S R$T!M_=1)*^G.]JTB]O MHF:1$&+N&V]ZB!**'J$36*R.Q@?%:L[3F>7 ^U2,)H;-!$F"^8GJ@DNV8=VA M;V^$M>7G5NHS%:R.+=2SKR_IV?J:+'*"K!>ZY>HO]9OY;'DJ#^Q[V1VJ5EBO M7*K6H+_']YQ+IJ+V''7J'553.$YJMI=Z&*MQ-[1)PT3RT[7K&UO/["]02P,$ M% @ 2XMJ29EKRSF\! '!< !@ !X;"]W;W)K/OO M2WW8&;I#;@ZQ++]#OB(Y#T=<7]KN>W^HJB'YV=2G_FEU&(;S8Y;U+X>J*?NT M/55I)5;7&]^.;X=AO)%MUMDM;G]LJE-_;$])5[T^K7X3CSNT MHV12_'VL+CVY3D;SSVW[??SRY_YIE8\>JKIZ&<8F2O?Q4>VJNAY;H1@;?&GK M?OJ?O+SW0]M<0U9)4_Z'F"6G28(*4LVI=E0E MA4X-[T5&O$CJY:X7,WN1I!#=%Q$U!W1C634&Z,4:FBC7C MJ:1, [.L(EX4]6)9+XKT D4>\.*IC V-BXYXT<2+SEDOFO:B0)-NJ!E/IL,C M8R)N#'7#=K,UWBR)%%DSODJ1A>5YL1$OEGIA%^;6DEX*,/]+IL4,E6EPG@-N M1M@&[8P_?OIAGWJ[:);'1IFG[.K:^3IA\S3 &L$2\^J(TDY+WI&@N>LRG)\N M3U;0U//ML.R\VJ'PU 5O!^@BS=6]';78\62H VYB)!84Q9I-WZV@E!722#H/ MWO!X0J6D#4Y8C,B"(EGS2!8>;+54.L >7VC18=D&/+%<7G8\0<&L ]N,B-%4 M4)QJ'J>"DK+(=2@O/)E;AZ$GBA%54*0:'JF"PE*X=A#0=B6 6*5<-C M%2@NM0I4*9[*%"'(0PRI0)%J)#<)6Z"L!,43PQ.)7)C0TH$84H$BU?!(!6!IP-I\U"U C&L L6J4?P 45H6"OG<\E32:A':=""&5/"0RN^!X->O M*K0)^CIG/ UL/! K=($"U?"0!UK$2FD"./1DB!!,L!B>@>+9\)4W4.YJ*((I M1G7*N+TI-$(Q0(,':'[# $I>HZUS9#__>',TQ&+AS'$AOD\6W->700INFP=: MB,$6*&RMX+.%4C1GL1^0^&^E,<@BA:SEH8]^35J(E,VFW9U.!HM%C($6*6@M MCWVD#'5\X$GKJ1Y$$:K,, 9:I*"U//<1O*3E%Z$G*(@ 13R?R'%4H:3$&6J2@M7P]C12@#Z&7YK#*=Q.#+%+(6AZR2.GY,(W0 M+QGBQ\RC%=@F,09=I-"U=]"]'@11F+*5_O4LR!/&*GUDL;O@#"EV0T#$6"6+ M%(ANA9].Q#? M_ =02P,$% @ 2XMJ26FX\@=5 @ +0@ !@ !X;"]W;W)KX X)<2UXAO:(L; M.7.CK$9"=MD=\)9A=.U--0$^A#&H4=6X>=:/O;$\HP]!J@:_,8<_ZAJQ/P=, M:+=W/?M:MSPBC8.P[>]^\7;%1Y4DE[QL\(=G[0=!7^F M]$-UOE_W+E0,F."+4"&0?#SQ$1.B(LG,OX>@_W(JX[3]BOZU+U?BGQ''1TI^ M55=12EKH.E=\0P\BWFGW#0\U1"K@A1+>?SN7!Q>T?EEK]P)"91GC'8.T]O= M(O56>;M([LW%X?T@TQLBUX[+T6?N03\#3Q5HT/B]YF!J IOF:&I"F^9D:B*; MIC U\:@!LI:Q(-]64* +\HT B3U 8 L0Z@"!$2 U*;VA7"UJ>A'<0 @]JZY8 MT1E X0I0: !MS42QY@DG>3QHDQ0+$@,C6L&(IACS')Y>_4,TJW>^+%IV6I89 M./$*3FS@>-95B8V2Y<>Z,,LJ R99@4D,&-\*DTQKMH+8%09$N@*1&A"SGVFJ M(=)IK6&PL:J*N6IA>[8K,%L#9G8>)!IF.TD3;F8:3Q]0Q504V#G4?; (HB8G M))$URW%067?G1;*@T2A@'_0_P502P,$% @ 2XMJ2>M5!;BZ!0 MRAT !@ !X;"]W;W)K"A.E8/W5!%V?_Y4175\3C4U+?\[USI1YM#0?_S4OOO8W=[ M^_=E6Q7U\9_#8_?2NXW7J\?JJ7P[=M_J]S^JN0]NJ/"A/K;C_ZN'M[:K3TN1 M]>I4_IS^'L[CW_?IERR>B\D%:"Y EP*7=N0"=BY@/PKPV-/)V=BOW\JNW&V; M^GW53"_CM1S>N;FU?>0>5NWXL)G"U?>L[9_^V!F3;#<_AHIF#8V:/6@NBDU? M^Z4)DIJ8BY-7G*0&"E#D<@M6:L%.G;#0B52N@*4*>*J O0HX0X_IU(M)&K.(V] M+H.9-& F]8V8)!)%A2^B/%(& M6QZPDGM6K/QV?-?;03(J9AL*.,'1^&F8NOD;GX\65Y;%1# M(6H:P"8E2A4A;AH )Z5RGWPF&F.C1.Z3+[NQ^HP(L=/X\$PRV8^/QIN>2,J, M0%D6:0$*0=3X%$UE=)D,IH2)1-L%RA)OI**=$$B-3]),7EJ,S\@;CF4S(*)$ M"PZ%8$H^3#-YA2' 9)\>B&.L )E1>4$AFI)/TTR&*1D(#BGO"F2D#'(:PR8)7%T;IG.!OHLWC%$,J#,NQ1E[-1+06/5(&NUX>JBR7&L2V?GJ J==I2R"%4,Z":952S M@]'AM B!S,99KK&(0[QFX+63>';:KA_KMW UW4M[3R_7DE_%V\NKYWMP6TR7C1S6[ M[6OY7/U5-L^'<[NZK[NN/HVW;4]UW56]NSCJZ?%2E8^7+\?JJ1L^IOWG9KIJ MG+YT]>MR[# M2E4?VF<'!K#J"VN;T/W[^D(H5+S@F>&<,V=\R0=M/FP+X-"G%,H><>M<=R#$ MEBU(9F]T!\K_J;61S/G4-,1V!E@525(0FF6W1#*N<)''VHLIX&OAE3>M"P52Y&3B55R"LEPK9* ^XL?-X;0+B AXXS#868R" M][/6'R'Y4QUQ%BR @-(%!>:7"SR!$$'(-_XW:GZW#,1Y?%7_%:?U[L_,PI,6 M[[QRK3>;851!S7KA7O7P&\81]D&PU,+&+RI[Z[2\4C"2[#.M7,5U2'_NLY&V M3J C@?X@D-0HVGQFCA6YT0,R:6L[%DYP6==;7\!5B1=> MPP1(PY1$&MICS[1] ID)9"'\3(/QV"C8?*265J56$])Q M:P?J3S [$+<1-3*AJ./TSJAQU4N5W64EOGBA&4,"YK3!+ CLU)<69*_%3"RX1A:I2PX$^G-;8)Z]WZ6A$-K??C# MQ3I>J9A8-5P?R/)*J[]02P,$% @ 2XMJ2Z]>> *7@RR MO93,_#N#T,,);_"M\,J;UH4"*7(R\2HN05FN%3)0G_#CYGC>!40$O'$8["Q& MP?M%ZX^0_*E.. L60$#I@@+SRQ6>0(@@Y!M_CIK?+0-Q'M_4?\5IO?L+L_"D MQ3NO7.O-9AA54+->N%<]_(9QA'T0++6P\8O*WCHM;Q2,)/M**U=Q'=*?_7:D MK1/H2* 3X2&+QE.C:/.9.5;D1@_(I*WM6#C!S9'ZC2B1C463IO=&K:]>B\UA MGY-K$!HQ-&+."\R$(%Y]:D'76HQT.J/3=?IVC;Y-#K<+AX=U@=V:P"X)[!8" M]\L1$^:\Q#S\:$)F>RK!-/'J6%3J7L6+.JM.M_.1QC/YAA=YQQKXRTS#E447 M[?S)QF.HM7;@361W>XQ:_WZF1$#M0GCO8Y.N5$J<[FX/9'JEQ7]02P,$% M @ 2XMJ223:9!2E 0 L0, !D !X;"]W;W)K&UL;5/;;J,P$/T5RQ]0@Y,TVX@@-5VM=A]6JOJP?79@ *N^L+8)[=_7%T)) MQ0N>&P1=\[U!T)LU8%D]D[WH/R?1AO)G$]-2VQO M@-61) 6A679/).,*ET6L/9NRT(,37,&S07:0DIF/$P@]'G&.KX47WG8N%$A9 MD)E7:('_/#:1L0$?"/PV@7,0K>SUJ_A>1/?<19L "*A<4F%\N M\ 1"!"'?^/^D^=4R$)?Q5?U7G-:[/S,+3UJ\\MIUWFR&40T-&X1[T>-OF$;8 M!<%*"QN_J!JLT_)*P4BR][1R%=2C!MO#H6 M57I0\:(NJO/M?*3Q3+[@9=&S%OXRTW)ET5D[?[+Q&!JM'7@3V=T.H\Z_GSD1 MT+@0[GULTI5*B=/]]8',K[3\!%!+ P04 " !+BVI)-82?=*0! "Q P M&0 'AL+W=O&<\Z<\:6\:]<\.)$%OW()E]T ,H_Z?51C+G4],1.QA@321)06B6/1+)N,)5&6NOIBKU MZ 17\&J0':5DYN\%A)[.^(#OA3?>]2X42%62A==P"N]V0RC!EHV"O>FI^\PCW ,@K46-GY1/5JGY9V"D60?:>4J MKE/ZDQ M0)$$BHW <3MBPERVF,?_FI#5GDHP7;PZ%M5Z5/&BKJK+[7RF\4P^X54YL Y^ M,M-Q9=%5.W^R\1A:K1UX$]G#$:/>OY\E$="Z$#[YV*0KE1*GA_L#65YI]0]0 M2P,$% @ 2XMJ24(\=7&F 0 L0, !D !X;"]W;W)K&UL;5/;;J,P$/T5RQ]0$R=MTH@@-5VM=A]6JOK0/CLP@%5?6-N$ M[M_7%T)AQ0N>&P)M\YU1T)LV8)D]DYWH/R?6AO) MG$]-0VQG@%61) 6A6?9 ).,*%WFLO9@BU[T37,&+0;:7DIE_9Q!Z..$-OA5> M>=.Z4"!%3B9>Q24HR[5"!NH3?MHK,91A74K!?N M50^_8!SA/@B66MCX165OG98W"D:2?::5J[@.Z<_V8:2M$^A(H!/AD$7CJ5&T M^8,Y5N1&#\BDK>U8.,'-D?J-*)&-19.F]T:MKUZ+S7Z?DVL0&C$T8LX+S(0@ M7GUJ0==:C'0ZH]-U^G:-ODT.MPN'AW6!W9K +@GL%@*/RQ$3YKS '++_FI#9 MGDHP3;PZ%I6Z5_&BSJK3[7RB\4R^X47>L0;^,--P9=%%.W^R\1AJK1UX$]G= M/4:M?S]3(J!V(=S[V*0KE1*GN]L#F5YI\0502P,$% @ 2XMJ2;E6_TFD M 0 L0, !D !X;"]W;W)K&UL=5/+;J0P$/P5 MBP^(P_9 U;\(+89DK^/'PR!B+W@[J:JNMJ/8E3Z MU70 %KT++LTQZ:SM#QB;J@-!S8WJ0;H_C=*"6I?J%IM> ZT#27!,TO0'%I3) MI"Q"[4F7A1HL9Q*>-#*#$%1_G("K\9ADR;7PS-K.^@(N"SSS:B9 &J8DTM < MD[OL<,H](@!>&(QF$2/O_:S4JT_^ULZ!R]8*6["%U6#L4I< M*0D2]#VN3(9UC'_VOR;:-H%,!#(3;M-@/#8*-G]32\M"JQ'IN+4]]2>8'8C; MB J94-1Q>F?4N.JES&ZS E^\T(0A 7-:868$=NIS"[+58J*3!9ULTW=;]%UT MN%LY_(] OB601X%\);!;CQ@QIS4F_]8$+_94@&[#U3&H4H,,%W51G6_G'0EG M\@4OBYZV\$AURZ1!9V7=R89C:)2RX$RD-_L$=>[]S F'QOKPIXMUO%(QL:J_ M/I#YE9:?4$L#!!0 ( $N+:DF Y^.SL@$ !8$ 9 >&PO=V]R:W-H M965TFE9/K/!00. MYV23W MOO&FM+] BIQ.OXA*4X:B(AOJE)\[[=_6O8;4N_949>$'QBU>V=6'3 MA%10LU[8-QR^P;B$D+!$8<*7E+VQ*.^4A$CV$5NN0CO$F4,ZTM8)V4C()L(Q M$&@T"C&_,,N*7.- =-S:COD3W)PRMQ$E,:&HX^I=4..JMV)SW.?TYH5&3!8P MEP5F0E"G/EED:Q8C/9O1LW7Z=HV^C0FWBX2/ZP*[-8%=%-@M! [+)4;,98DY MKIOL_V.R7P@\K9HL,$_I/R9T=G 2=!/NIR$E]BJ\AEEU>@+/63CX3WB1=ZR! M'TPW7!ER1>NN3SCK&M&""Y$^N!2M>Z330$!M???@^CK>VSBPV-U?X?0K*/X" M4$L#!!0 ( $N+:DD1*F9#I $ +$# 9 >&PO=V]R:W-H965TVFCKA'-\* MK[SK72B0JB0+K^$2E.5:(0/M"3_EQW,1$!'PD\-D5S$*WB]:OX7D>W/"6; M FH7%)A?KO ,0@0AW_CWK/G1,A#7\4W]:YS6N[\P"\]:_.*-Z[W9#*,&6C8* M]ZJG;S"/87YEA5&CTAD[9V8.$$\R/U&U$C&XLF3>^-6E^]5OGGO"37(#1C:,2<-Y@% M0;SZTH+NM9CI=$6G^_3#'OV0'!XV#O\C4.P)%$F@V @I85.M1Q8NZJBZW\XG&,_F 5^7 .OC!3,>511?M_,G&8VBU=N!-9'?W M&/7^_2R)@-:%\-'')EVIE#@]W![(\DJKOU!+ P04 " !+BVI)U6^1;Z4! M "Q P &0 'AL+W=OV$ *[X0VRSIW]<7ED#%"YX9SCESQI=BU.;= M=@ .?4JA[ EWSO5'0FS5@63V3O>@_)]&&\F<3TU+;&^ U9$D!:%9=D\DXPJ7 M1:R]FK+0@Q-4!$P&\.HUW$*'B_:/T>DI_U"6?! @BH7%!@?KG",P@1A'SCCTGSJV4@ M+N.;^DNN\V0RC&AHV"/>FQQ\PC7 (@I46-GY1-5BGY8V" MD62?:>4JKF/ZL\\GVC:!3@0Z$QZS:#PUBC:_,\?*PN@1F;2U/0LGN#M2OQ$5 MLK%HTO3>J/75:[G[=BC(-0A-&!HQYQ5F1A"O/K>@6RTF.EW0Z39]OT7?)X?[ MEE#QHBZJ\^U\HO%, MON!ET;,6?C'3!/9W0&CSK^?.1'0N! ^^-BD*Y42I_O; M YE?:?D/4$L#!!0 ( $N+:DE@=_4@I $ +$# 9 >&PO=V]R:W-H M965T\,QPSIDSOA03FC?; 3CRH55OC[1S;C@P9JL.M+!W M.$#O_S1HM' ^-2VS@P%11Y)6C&?9%Z:%[&E9Q-J+*0L)5MYT*!E05;>+74T%N)/3'0'.EC?CCM R("?DN8["HFP?L9\2TD M/^LCS8(%4%"YH"#\ S@2^$ M;UDTGAI%F]^%$V5A<"(F;>T@P@GF!^XWHB(V%DV:WANUOGHI\X>'@EV"T(SA M$7.ZP2P(YM67%GRKQ4SG*SK?IN^VZ+OD<+>F9]FVP'Y+8)\$]C<"^>V("7.Z MQ?SODJWV5(-IX]6QI,*QCQ=U55UNYV,\1/8)+XM!M/!+F%;VEIS1^9.-Q] @ M.O FLKM[2CK_?I9$0>-"^-7')EVIE#@:7E/U!+ P04 " !+BVI) MSKN1!Z4! "Q P &0 'AL+W=O@_)]&&\F<3TU+;&^ U9$D!:%9 MMB>2<87+(M9>3%GHP0FNX,4@.TC)S.<)A!Z/>(.OA5?>=BX42%F0F5=S"O=G9N%!BW^\=ITWFV%40\,&X5[U^ 33"+L@6&EAXQ=5 M@W5:7BD82?:15J[B.J8_^U\3;9U )P*="3^S:#PUBC9_,\?*PN@1F;2U/0LG MN#E0OQ$5LK%HTO3>J/752TFS;4$N06C"T(@Y+3&;&4&\^MR"KK68Z'398IV^ M7:-OD\/MC<-\72!?$\B30'XCL+L=,6%.MYC]?TW(8D\EF#9>'8LJ/:AX41?5 M^7;>TW@FW_"RZ%D+?YAIN;+HK)T_V7@,C=8.O(GL;H=1Y]_/G AH7 A_^-BD M*Y42I_OK YE?:?D%4$L#!!0 ( $N+:DFJBA*KI0$ +$# 9 >&PO M=V]R:W-H965TU#^3Z.-9,ZGIB6V-\#J2)*"T"S[023C"I=%K+V8LM"#$US!BT%V MD)*9_R<0>CSB',^%5]YV+A1(69"%5W,)RG*MD('FB!_RPVD?$!'PQF&TJQ@% M[V>MWT/R7!]Q%BR @,H%!>:7"SR"$$'(-_XW:7ZU#,1U/*O_CM-Z]V=FX5&+ MO[QVG3>;851#PP;A7O7X!-,(MT&PTL+&+ZH&Z[2<*1A)]I%6KN(ZIC^[F;9- MH!.!+H3[+!I/C:+-7\RQLC!Z1"9M;<_"">8'ZC>B0C8639K>&[6^>BEI=E>0 M2Q":,#1B3FM,OB"(5U]:T*T6$YVN6VS3=UOT77*XNW)XORVPWQ+8)X']E<#/ MZQ$3YG2%R;-O3"9?\++H60M_F&FYLNBL MG3_9> R-U@Z\B>SF%J/.OY\E$="X$-[YV*0KE1*G^_F!+*^T_ 102P,$% M @ 2XMJ2;D>#&UL=5/;CILP$/T5RQ^P!H>T5420-ENMVH=*JWUHGQT8P%I?6-N$[=_7%T+( MBK[@F>&<,V=\*2=MWFP/X-"'%,H><>_<<"#$UCU(9A_T ,K_:;61S/G4=,0. M!E@325(0FF5?B&1]"P52 ME63A-5R"LEPK9* ]XL?\<"H"(@)^6@;B.K^K/<5KO_LPL/&GQAS>N]V8SC!IHV2CSK1M IT)="%\RZ+QU"C:_,X*YGE)+D%HQM"(.:TQ-P3QZDL+NM5B MIM-UBVWZ;HN^2PYW=P[_(U!L"11)H+@3V-V/F#"G>TSQJ0E9[:D$T\6K8U&M M1Q4OZJJZW,['>(CD!J_*@77PBYF.*XO.VOF3C]ACU_OTLB8#6 MA?"KCTVZ4BEQ>K@^D.655O\ 4$L#!!0 ( $N+:DE7;5IZI0$ +$# 9 M >&PO=V]R:W-H965T:7"SR!$$'(-_X[:7ZW#,1E?%5_CM-Z M]V=FX4F+#UZ[SIO-,*JA88-P;WI\@6F$71"LM+#QBZK!.BVO%(PD^THK5W$= MTY]]/M'6"70BT)GPD$7CJ5&T^8LY5A9&C\BDK>U9.,'\0/U&5,C&HDG3>Z/6 M5R\ES7<%N02A"4,CYK3$Y#.">/6Y!5UK,='ILL4Z?;-&WR2'FQN']^L"VS6! M;1+8W@CL;T=,F-,MYN%'$[+84PFFC5?'HDH/*E[4176^G8\TGLDWO"QZUL(? M9EJN+#IKYT\V'D.CM0-O(KO;8=3Y]S,G AH7PKV/3;I2*7&ZOSZ0^966_P%0 M2P,$% @ 2XMJ2;:_)?"D 0 L0, !D !X;"]W;W)K&UL;5/+;J0P$/P5RQ\0@YED=T<,4B91E!Q6BG+8/7N@ 2M^$-L, MV;]?/QC"1%QP=U-57>U'.6GS;GL ASZE4/: >^>&/2&V[D$R>Z,'4/Y/JXUD MSJ>F(W8PP)I(DH+0++LCDG&%JS+67DU5ZM$)KN#5(#M*R3UJ_A^2E.> L6 ! MM0L*S"]G> A@I!O_#%K?K4,Q'5\47^*TWKW)V;A08N_O'&]-YMAU$#+1N'> M]/0,\PBW0;#6PL8OJD?KM+Q0,)+L,ZUD$E;.[!P@OF>^HVHD8U%DZ;W1JVOGBN:_RK).0C-&!HQQS4F7Q#$ MJR\MZ%:+F4[7+;;IQ1:]2 Z+-9UFVP*[+8%=$MA=">37(R;,\1KSW259[:D$ MT\6K8U&M1Q4OZJJZW,Y[&L_D"UZ5 ^O@-S,=5Q:=M/,G&X^AU=J!-Y'=W&+4 M^_>S) ):%\(?/C;I2J7$Z>'R0)976OT'4$L#!!0 ( $N+:DG4_1O.I $ M +$# 9 >&PO=V]R:W-H965T1)*2E.7Y(U5BX3NE/P6;:-H'-!+80ON;1>&H4;7[CCE>EP8F8M+4##R>X.S*_$36Q ML6C2]-ZH]=5KQ=B^I-<@-&-8Q)S7F-V"H%Y]:<&V6LQTMFZQ3=]OT??)X?[. M8;$M4&P)%$F@N!,XW(^8,.=[S..G)G2UIPI,%Z^.)36..E[4576YG4_Q$.D' MO"H'WL$O;CJA+;F@\R<;CZ%%=.!-Y ^'C/3^_2R)A-:%\(N/3;I2*7$XW![( M\DJK_U!+ P04 " !+BVI)AEUJZ\X! #@! &0 'AL+W=OHET(LC<89)'.\PIVT7%;F+O<@B%X-F;0C& M)!M'Z (5'9A^%>,/F$I(K6 IF')?5 Y*"WZC1(C3#S^VG1M'O[./)UJ80"8" M^4+ WLBE^9UJ6N12C$CZH^VI_8.; S$'42+E@M)7;Q)5)GHM",ER?+5"$X8X MS&F)V)^7:+'G-:8 M;V&3](Y)NA1(XJ#)&O.?D]S=,=FM!$C09(U)PB;9'9-L); -FJPQZ1<3O+B" M'&3M.DVA4@R=Z^M%=&[F1^*N\">\R'M:PR\JZ[93Z"RT:01W:RLA-)@DX@=S MGHUY;N8%@TK;:6;FTG>@7VC1W]Z3^5$K_@%02P,$% @ 2XMJ20K96L;- M 0 X 0 !D !X;"]W;W)K&UL?53;;J,P$/T5 MBP^H"1#H1@2I:57M/JQ4]6'WV8'AHMJ8VB9T_WY](10J-R_8'I_+C/$XG[AX MDRV 0A^,]O(8M$H-!XQEV0(C\HX/T.N=F@M&E%Z*!LM! *DLB5$GZ MH,AM[$44.1\5[7IX$4B.C!'Q[P243\=@%UP#KUW3*A/ 18X77M4QZ&7'>R2@ M/@8/N\,I,P@+^-/!)%=S9'(_<_YF%K^J8Q":%(!"J8P"T<,%'H%2(Z2-WV?- M3TM#7,^OZL^V6IW]F4AXY/1O5ZE6)QL&J(*:C%2]\NDGS"7LC6#)J;1?5(Y2 M<7:E!(B1#S=VO1TGMW,?SC0_(9H)T1<"=D8VS2>B2)$+/B'ACG8@Y@_N#I$^ MB!))&Q2N>IVHU-%+$<5ICB]&:,9$%G-:8W8+ FOUQ2+R6NPR MC-?NZ3<"B4\@<0+)IL1L6Z+#G+:8>[_)_H;)?B/PPVNRP22AWR2]89)N!'9> MDRWFF^/*;IAD&X'8:[+%)%],\.H*,A"-[32)2C[VMJ]7T:69'R)[A3_A13Z0 M!GX3T72]1&>N="/86UMSKD G$=[I\VSU<[,L*-3*3#,]%ZX#W4+QX?J>+(]: M\1]02P,$% @ 2XMJ29F)[">R 0 %@0 !D !X;"]W;W)K&UL?53+;IPP%/T5BP^(&>:5CABD3*JJ752*LFC7'KB %=N7 MVF9(_[Y^, 0BU VV+^=UL4T^H'XS+8 E[U(H=)%C;P57\**)Z:5D^N\%! [G9)/< M"Z^\::TOT"*G$Z_B$I3AJ(B&^IP\;4Z7O4<$P"\.@YG-B<]^17SSBQ_5.4E] M!!!06J_ W'"#9Q#""SGC/Z/FAZ4GSN=W]6^A6Y?^R@P\H_C-*]NZL&E"*JA9 M+^PK#M]A;"$D+%&8\"1E;RS*.R4ADKW'D:LP#O'-\3C2U@G92,@FPF,:@D>C M$/,KLZS(-0Y$QT_;,;^#FU/F/D1)3"CJV+T+:ESU5F2[?4YO7FC$9 %SF6,V M$X(Z])AV6+$7):8X[K) M_C\F^X7 XZK)$O/EDPF=;9P$W83S:4B)O0JW85:=KL!3%C;^ U[D'6O@)],- M5X9&UL;5/;;J,P$/T5RQ]0@T.V5420FE:KW8>5JC[L/CLP@%5?J&U"]^_K M"Z&DX@7;PSEGSGC&Y:3-F^T!'/J00MDC[IT;#H38N@?)[)T>0/D_K3:2.7\T M';&# =9$DA2$9MD/(AE7N"IC[,54I1Z=X I>#+*CE,S\/X'0TQ'G^!IXY5WO M0H!4)5EX#9>@+-<*&6B/^#$_G(J B("_'":[VJ/@_:SU6SC\;HXX"Q9 0.V" M O/+!9Y B"#D$[_/FE\I W&]OZK_C-5Z]V=FX4F+?[QQO3>;8=1 RT;A7O7T M"^82]D&PUL+&+ZI'Z[2\4C"2[".M7,5U2G_VV4S;)M"90!?"0R20E"C:?&:. M5:71$S+I:@<6.I@?J+^(&MD8-*EZ;]3ZZ*6B^ZPDER T8VC$G-:8?$$0K[ZD MH%LI9CI=I]BF[[;HN^1PM\Y^7VP+%%L"11(H;DK,;TM,F-,MYKM+LKI3"::+ MHV-1K4<5!W457:;SD<:>?,&K&PO=V]R:W-H965TA)GF,3Q'G/:BBC/?.U9 MY9GL#6L%/"ND>\ZI^G<")H=CM(FNA9>V;HPKX#S#$Z]L.0C=2H$45,?H<7,X MI0[A :\M#'HV1R[[6 +&G) U_CMJ?EDZXGQ^ M5?_IN[7ISU3#DV1O;6D:&S:.4 D5[9EYD<,O&%M(G& AF?:_J.BUD?Q*B1"G M'V%LA1^'\.4^'FGK!#(2R#<"#D8^Y@]J:)XI.2 5MK:C[A_<'(C=B )I7U2A M>QM4V^HE)\DVPQ-?:9F!8,*N.FJ9VK<'/"PLCN^@Y,CU'^"5!+ P04 " !+BVI) M>!L-IJ4! "Q P &0 'AL+W=O?X$GCA;>="@)0%F7DUEZ L MUPH9: [X(=\?MP$1 :\<1KO8H^#]I/5[./RI#S@+%D! Y8("\\L9'D&((.03 M?TR:/RD#<;F_J/^*U7KW)V;A48LW7KO.F\TPJJ%A@W O>OP-4PF[(%AI8>,7 M58-U6EXH&$GVF5:NXCJF/[N[B;9.H!.!SH3[+!I/B:+-)^9861@](I.NMF>A M@_F>^HNHD(U!DZKW1JV/GDMZFQ7D'(0F#(V8XQ*3SPCBU><4="W%1*?+%.OT MS1I]DQQNEMGO_R.P71/8)H'M58GY=8D)<[S&_)N$+.Y4@FGCZ%A4Z4'%05U$ MY^E\H+$G/_"RZ%D+?YEIN;+HI)WO;&Q#H[4#;R*[V6'4^?&PO M=V]R:W-H965TVA M4I1#>_;"\*/8F-AF2=^^MF$)1.Y>L#U\/S.&F6P4\DTU !I]<-:I4]!HW1\Q M5D4#G*H'T4-GWE1":T[8(\<[$7F6=BT*SMX$4B M-7!.Y=\S,#&>@EUP"[RV=:-M .<97GAERZ%3K>B0A.H4/.Z.Y]0B'.!W"Z-: M[9'-_2+$FSW\+$]!:%, !H6V"M0L5W@"QJR0,7Z?-3\M+7&]OZD_NVI-]A>J MX$FP/VVI&Y-L&* 2*CHP_2K&'S"7<+""A6#*/5$Q*"WXC1(@3C^FM>W<.DYO MTG"F^0ED)I O!#P9N32_4TWS3(H1R>EJ>VJ_X.Y(S$442+F@G*HWB2H3O>8D MCC)\M4(SACC,>8W9+0ALU!<+XK.8Z61MX:='/GHT91BMW=/8+[#W">PG@?VF MQ/VVQ ESWF(.?I/#'9/#1B#VFFPQB=\DOF,2;P12K\D6\\UODMPQ2=8"2>@U MV6+^\T^D=TS2C0#QFFPQT1<3O/K/.&UL=5/;;MLP#/T501]0.8K3K(%CH.DP; \#BCZLSXI-VT)U M\20Y;O^^NCBN,W@O%DF?I5#VB#OG^@,AMNI ,GNG>U#^ M3Z.-9,Z[IB6V-\#J2)*"T"R[)Y)QAC!":[@V2 [2,G,QPF$'H]X M@Z^!%]YV+@1(69"95W,)RG*MD('FB!\WAU,>$!'PA\-H%S8*M9^U?@O.K_J( MLU ""*A<4&#^N, 3"!&$?.*_D^97RD!1)(+]I<7?;8L*<;C'W M_R0ABSN58-JX.A95>E!Q41?1>3L?:9S)%[PL>M;";V9:KBPZ:^VR:M5'*<[J\/9'ZEY2=02P,$% @ 2XMJ2?9< M'_ZF 0 L0, !D !X;"]W;W)K&UL;5/+;MLP M$/P5@A\0RK13NX8L($Y1M(<"00[MF996#X3DJB1EI7]?/F1%#G01=U*(;>BN\=DWK0H$5.9MY5:= VPXU M,5"?Z-/F>-X%1 3\[F"TBY@$[Q?$MY#\K$XT"Q9 0NF"@O#+%9Y!RB#D&_^= M-#]:!N(ROJE_C]-Z]Q=AX1GEGZYRK3>;45)!+0;I7G'\ =,(CT&P1&GCEY2# M=:AN%$J4>$]KI^,ZIC^<3[1U I\(?"8ZK -/'J6%+BH.-%753G MV_D4#Y%]P(N\%PW\$J;IM"47=/YDXS'4B Z\B>SAD9+6OY\YD5"[$.Y];-*5 M2HG#_O9 YE=:_ =02P,$% @ 2XMJ2=((UO6Q 0 %@0 !D !X;"]W M;W)K&UL?53-;J,P$'X5BP>HB9-TJX@@-:U6NX>5 MJA[:LP,#6+49UC:A^_;K'T*@0KU@>_C^!MMD ^H/TP!8\JED:XY)8VUWH-04 M#2AN[K"#UKVI4"MNW5+7U'0:>!E(2E*6IO=4<=$F>19J+SK/L+=2M/"BB>F5 MXOK?"20.QV237 NOHFZL+] \HQ.O% I:([ E&JIC\K@YG/8>$0!O @8SFQ.? M_8SXX1>_RV.2^@@@H;!>@;OA D\@I1=RQG]'S9NE)\[G5_6?H5N7_LP-/*%\ M%Z5M7-@T(254O)?V%8=?,+80$A8H37B2HC<6U962$,4_XRC:, [QS3T;:>L$ M-A+81'A(0_!H%&(^<\OS3.- =/RT'?<[N#DP]R$*8D)1Q^Y=4..JEYP];#)Z M\4(CA@7,:8ZY(:A3GRS8FL5(9W.+=?IVC;Z-";=S>IJN"^S6!'918+=HD2U; MC)C3$K-=-]E_8[)?".Q639:8_1<3.MLX!;H.Y].0 OLVW(99=;H"C^&DT!L\ MSSI>PQ^N:]$:&[CPF)WO873 MKR#_#U!+ P04 " !+BVI)_%=O@Z8! "Q P &0 'AL+W=O@ M_)]&&\FX@E>#[" E,_].(/1X MQ!M\#;SQMG,A0,J"S+R:2U"6:X4,-$?\N#F<\H"(@'<.HUWL4?!^UOHS''[7 M1YP%"R"@4"3R!$$/*)_TZ:WRD#<;F_JC_':KW[,[/PI,4'KUWGS688 MU="P0;@W/;[ 5,)]$*RTL/&+JL$Z+:\4C"3[2BM7<1W3G]UNHJT3Z$2@,V&? M1>,I4;3YBSE6%D:/R*2K[5GHX.9 _454R,:@2=5[H]9'+R7=/Q3D$H0F#(V8 MTQ*SF1'$J\\IZ%J*B4Z7*=;IVS7Z-CG<+NE9OBZ0KPGD22"_*7%W6V+"G&XQ M^Q])R.).)9@VCHY%E1Y4'-1%=)[.1QI[\@TOBYZU\(>9EBN+SMKYSL8V-%H[ M\":RNWN,.O]^YH. QH7MSN]-&JET<+J_/I#YE9;_ 5!+ P04 " !+BVI) MW4^=-*8! "Q P &0 'AL+W=OV$ *S9#;;.D?U]?6$(B7K ]G'/F MC&=<3&A>;0?@R)M6O3W1SKGAR)BM.M#"WN$ O?_3H-'"^:-IF1T,B#J2M&(\ MR[XP+61/RR+&GDU9X.B4[.'9$#MJ+ M2NR)@>9$'_/C>1\0$?!;PF17>Q*\7Q!?P^%G?:)9L **A<4A%^N\ 1*!2&? M^.^L^9XR$-?[F_KW6*UW?Q$6GE#]D;7KO-F,DAH:,2KW@M,/F$LX!,$*E8U? M4HW6H;Y1*-'B+:VRC^N4_ASRF;9-X#.!+X3[+!I/B:+-;\*)LC X$9.N=A"A M@_F1^XNHB(U!DZKW1JV/7DM^_U"P:Q":,3QBSFM,OB"85U]2\*T4,YVO4VS3 M=UOT77*X6]-YMBVPWQ+8)X']6N A^UABPIP_8CX7R59WJL&T<70LJ7#LXZ"N MHLMT/O+8DW=X60RBA5_"M+*WY(+.=S:VH4%TX$UD=P=*.O]^EH."QH7M5[\W M::32P>%P>R#+*RW_ U!+ P04 " !+BVI)EK)(6*0! "Q P &0 'AL M+W=OF\TP:J!EHW"O>GJ&N83;(%AK8>,7U:-U6EXH&$GVD5:NXCJE/_?Y M3-LFT)E %\*/+!I/B:+-7\RQJC1Z0B9=[&[4^>J[H M3UJ2[TT:J71P>K@\D.655E]02P,$% M @ 2XMJ2:0W.+G 0 7 0 !D !X;"]W;W)K&ULC51;;YLP%/XK%C\@)B30-")(3:MI>YA4]6%[=N 5GVAM@G=OY\OA,*$ MHKU@^_A\EV,?DP]2O>L6P*!/SH0^1:TQW1%C7;; B=[(#H3=J:7BQ-BE:K#N M%)#*@SC#21QGF!,JHB+WL5=5Y+(WC IX54CWG!/UYPQ,#J=H&]T";[1IC0O@ M(L<3KJ(C9'SOM%RG>W^%&=HMA9 :E<0S$ M#E=X!L8H@IKTS+S)X3N, M):2.L)1,^R\J>VTDOT$BQ,EG&*GPXQ!V#O$(6PY!RF%&SI)XUD M36/$)PN-;)U@MT:P#R9W"X*'=8+]'8+]@N"PK/(07(844D7 M*H_K!-D=@NP_;&9SF[O-OX>!9]?/036^RS4J92_\FYI%IX?TE/CV^4HO\HXT M\).HA@J-+M+8)O0=4TMIP+J(-[;6UC[U:<&@-F[Z8.[^W\_O-EN'T_^\^[V M__ M?OS1N]O3U#3E]-W-V_?/7K[X^&??W+]\_GSW[N;^OU]L M;^\^?/Y,GHU_/^S\X??GB=/K=KV_?;=\_O+U[?W*__>WS9_\KSW]J MF[27^2CR^NWVP\/1OY_L1__SW=V_]__Q]:^?/VOV@]C>;G]YW+=QL_O'7]LO MM[>W^Z9V7?_?H=5/G>Y_>/SO8^OG'^>[&__/-P_;+^]NOW_[Z^.;W7";9R>_ M;G^[^?/V\?+NPW)[F$2[;_"7N]N'C_]_\LN?#X]W[\:?/#MY=_.?IW^^??_Q MGQ^>_J9O#C^S?Y ./TC1'^3##_+T@R3T!WKX@49_T!Y^T$9_4 X_*-$?=(>:\$^FS?ZTVXEOGHS;+9_V.W?\)^.&R]&. MS_QDW'+1\,#&39?PKLNX[?)IWWO^BW'?);SQ,NZ\A+=>QKV73YNO7 ?'O4_A MO4_CWB<)3CY-FI["G8Q;GW)T)N/.)XT^+&G<^13>^33N?*HU_O3)/'XTKE_= M/-Z\?'%_]^'D_LDE_'&S]SSR?/>K7>,G#Q__]/[):._LZ\/N3_]ZF9OFQ>E? M^Y8.,NFCS)C0PR=5&E*=QZ5%G;=\:PWH2?'TL MZ RF98-I897$G/I%>]2)Y'8H_C)]"[*:ZF4ZGN2QJ";-V9\FB&HK2A:_L/D6 MF&\RY[ L\XO:L4XZZ"1;,[KHCG>X2>[4OST65+&6_K"<':X\>6A ,@\=6 MS;.'>9I/\D4/.S9',LDG.GO;L E\>B:;">GZ<)?@<3%'N%]B&_OT3[OSU:HV+N\T'H:4#= M8)K2P]!!5 8ION)?S32+L[!CK'$6X)129\]"CH?62.Z5S.-8>&@E^5I\-=LP MSL3VC>-,CIUCUUK]+0XR[)&=%UDY(CA6ZH4%W7!O=;,1\*U#G_V%O*QDR8./ M77M//G75HC#ZP7YFP%EK*NR1.9;5LILJ>60B[1XLQT\@G)Y:]1\O&A((Q 39 M[O '.7;)NV@HL_ZH2Q;PR5GL1^38)[=#(K[A$F3Y(U(BCPCU]0+./B=[],<> M=Q?I,./8^5HYCKJ+C)IZ;@'7G9P%EFVSJG9G:P\R(K1P0'2WUB I^83<^^2#(_V%F1E2."@Z5N M+\&9,)L.?)'F_=Z\R,H1P<%2OY? ^>3>-**;A,Y,I?,- \C:AB%%/%ZB'B^! MQ\NVQTO'SN9_I)66G%] 6/J>G&#J=OO&6H^GD5[C2-4^Z4"+1=1O[WNW/5P] MZCH3N$XU7=E%:F&6J26^[-M4G:<;LGK8;AZ2?WQXC>VV]<+@G*G[3N!#U72 MEPE=,IO%L61F07*B?CF!D]3LM&%[R?$2"KRD=PN5J/-*X+Q434/P53KV.Z7> M9;STHNXG@_O1UGK4OZJ$BM,1=1T97(=V=DZ#+H;OR#[JC>ISQ,LTT+^?9#IJQ&QH0YV-5+^8Q]3SW8(O9E*A)R,O?I: M&;NC09S2RXM1M33'GW7E;P9TWGB?HU#K.#:E-D/19MA.Z5S;P,-!;86"K6B= M_0ICMO X?$EEJ(%@^)CLJV@?-=2TU#B^<[^YS4'EL& MR23J!:W^,;+U/RSMH]/BAJ %N($,R8Y:P/Z7ZC^EV/]MZ.1 MLQ)0_T+5OZ#ZVRM7 NI?J/H7#!#LYZ $M+]0[2\8&)A^[:SD\'-0J$X7? MA MV[2SHO'N:'!0\!+#C$+.4*AU;$3A[^+11MA1R%D)A >%&H<"QL&.0LY*P#@4 M:AP*A@5F%')6XL:A4.-0\%+<4:B =>BH=>CP%&%&!V==P#QTU#QT@8OHLRY@ M'CIJ'CHP#W80%*O0-77]@9L.-P3<#5K[HNWAM5ZB[@\5==(-;OJ#9W\ZY^U1TKL[ KPIZJ M=#_O\%=]0*-[JM%]P.&O^H!&]U2C^X##7_7'&IU;MG)4K_N VU_UX/9K)@1[ MH^K=1]S^JM?PD]Y3M]\'W/X*A8KSBJFGYJ*/N/U5'W#[/344?<#MK_J V^\Y M!!=P^ZN^C^\2-11]P.VO^H#;'ZB-& )N?S4$C,1 C<00N!18#0$C,5 C,=!+ M@;&;@-L?J'D8P#R4Y+1A*_W!'P^@])X_'J@F#_2-P.%%^7!\N9?[FD#%[J@^ M#X$7 HNA_(/NJ%H/@1<"BR&@U@-5ZV'^A3$@#8?_FLBK@<4H-K-WG/MK F\'%J/43$^$2Q&J9FY<3BN";PF6(Q2O*<9#!PY<-M;+T0B]F,.U<;K -OZ MBD3LQPQ*#2QU+NJU0O$"D1!?(#.P,=+&MM]>"I"^TC:4(Y\A?1'UM5WW4J3] M)SURG0?BUG:K2P& 5]AY36;@7$!E;=>Z% >YK3KB^HY K>U;EQ)B86=@6*1A M;=^Z% !9"[TM$ ZT"A*MMHM="L"H.]7L:8]<_1%+=5SL4@ IG7LN.5LJ")?: M+G992153ZFM?JAH1CS,0YK0!JV4E51R42SCT*<@^.DY_*4!3*DNY$LY)"H*2 MMNM?"D"*E.,0SB@*0HIV + /68Z?YRVE$0=W2NV05YQ[D>N4U D-&Y M:I<<.7AP@E'R?!"RDAPY=W!V4?)\^+&2"+PHG%Z4' @_5I(CX0=G%R4'PH^5 M +Z8$WTL.,8H&@@_5@(@HPP\X.%$HV@D_%@)0(USSS[G&D4#X<>JDO)NWX5# MC8)4HW?_+AIX/RF<9Y2*5?3V3B,]<>.!1*-S"R] -,YN&3*-S&2\:,2,<;!0D&YW[>(F@C<+91D&XT>'T5A+!&X7SC8* 8W&0.''P MQ=&/([_H^G%.)PKBB0X6MQ;@$W/'*!'AG*(@J&C[\;4@?SC3(==Y)!!M-[X> MI68V=B9/^5CG;3>^'H6>.NIH1,^)1@&DT7;F:T&BD58KX$2C(-)HN_2U --8 MJ-?C:*-4;*/WH/3Q_K@%:#&0,'W#6H!O%.[6.>4/N&%!#M*.7=8"'*3.3)";EA*XFU@+$)'\]H6#D5*1 MD6:U@;642%C!H4@I@9^< MH!1 *'/G%6(Y5OV6[BZG**7'MZ%V*+\1("F-VD95G]P((%1I!_,; :IRODMN M#2K TEG6/F(-.%PI0%?:X?Q&D*YLZBIW58?<' !@:0?T&P&^,M?%A*K^N#U M>-*.Z#>CU)0T1J^P.6DIB%K:,?U& +6470C*U8+'%D!=UE'V)ZW @DBTOYE" M1F!H[*AW4TEUV9)ZY4M5(^*&"!%-.S;>5%*=!QYP3%.0T[0/-1L!4+/T;=8^ MM=[[#$YL"B*;G1D=; 28S=PDS3LS9(F^FA&MQL9M%7*>7><\?$!Z"CVC<^!3 MD/CL*ILUC/U! %.ZSUS,Q&%#I^X@?ND&;W[')FMH:)*1<)14D"7MS>S5C0!, MFIJN+FM7=!@M$G FK8T[3EQY#0U@?/1)@%RNC,T MM$->C:P)'),V"\5,7/0TK%P$Z*E;N4FCHTFQ$9[I[058*->K7..BR;$1>WW M^Y>IP>,2*6Q9-6BV=X7MM6;%Z*?VKJOV/ >=.*N:D%6USR^7"5A5,8LH3=-T MJAOC- %"$:O:VC3-(31-#LJFJF"R^=Q<) !ELUD8^ZG!;ZH&[4CJ$AN4VGS# MNF&#SKJ%!WCM#[!:MYEJE,(."-!E^_AZD:"",UVL%%HL4CMS6JP46:S8N*[]<55KQ3TG MKVT?LB M06UI\(1"T+T]8O,)ZDO*BE[#2X2H/9JNJIIEE2TF@$]<26 M\NM+A&D"97;I+Q.0^^YH>-2%Y:WK-Z?3<+K0>L)G-L@W,:YF1*L9\&BN2@;P MU.>U.*>]"<2%D8'=NT/K%HN'A5B1H-]_KY(D-%@ELR= MELL+XG"Y2#7P:;DBX65T8-?^P'"Y9@J,5Q7&Q=:/% @9+Q)D;;3FB6*<)A>M M9L#CO*KL>')F$ C?+A(D@9"*QU="W@JT\*Q3:1/7+SY2.O;SYV:[I62JA9\F.&O!9F@\_ MKL(#N_8'5BT7#U4PR<>^D+M(D.3C7[)\4S7GKM;\%T*JEKS5BHWKVA]7M5@\ M*L(,I?HJ<7K4YR.4RY0"J%":J3Y4 MPGRHWGFEE)PDI_&B%). YV1D^.9G"2K:?4UMOK_R:>.I6P M^KOSO;SS5-5_YV\]>!)5P@KPO7?#[F1(34L=^Y8#SWY*5?:374HR18JW)Y[V ME##MJ??&ZZ0RC;/6F'KS[*2$>4?V [:JI 9WWERQJIKKMBE9)9*Q>F%-F?*%PD2"F:*6:3>&I1PM2BP2E9E9RTH6GV M,=WB*4$)4X+\G8\H%T\)2I@2-'@!#4\)2K&4H,13@E)+?>>!$DV1BN6)IP(E M3 4:O(C!R>^99AWS63QW)V&-<7O6EPF2=Q+-WDD\>R=A0?+!<]A.4LXT^1 < MFWBJ3:I2;9Q#7QNX];M(6&VNSRQ2I8)YX:D\J MJ,].HDER4G;&S2TQ?>9I.*D$]/DB%>1"_(^B75:BY%-K5S.M5M/@Q@)S=P8O M7'1R=Z8EC1D+GI"32BC 1:G!BQ-Y,DXJL0 7LG$2526>C),P&6=PEXB[X!)S MP3Q])I50>!NI*IYXXDR"Q!EUU\Y)BAEGW<4TEB>\I"X4WH*4-EZ@R%->$J:\ M.(_7*G7A\):GO"1(>='&"_!XD? 4JQ*>>'Y*ZJAJC>$M% IW9SWS[;\.9NW% M=TX.RS3KF$[QO)2$>2GVT[5$*6W,:^FO?2D<$<]<29BYXCR#R]0C_D.>09ZU MDB!K11LO]'(24:9O,88*Z22>9))");P39)FXL^::UZ/F>3&)DS,RS3JF>3P/ M)/4!S5NG2,GMQ-,_4H^:YX4-3E+'-.N8YO%$C-13;S9]@S=2+3OQ/(PTH#LS M+Y,WM92IY*]\J6I$7.D&5#KWVZ5O2='F:LOYGJ(P(^KR#2(:=ZATVWF&0^YH?S@T[:?YTC![_-FA/N&,N)*M]8/BE'8+;,8;8,F)HF)TS+ M#H,V33NF?1S-RL@L>8>_[,!455=#EQ5>\Z!"]NS#UQ52_:!*SRP:W]@U7)QFP#XDR;/KO(:SSE6XSES MI"A72)%]#8U2FKS(E5=WSCEB%%89RCL+]P0<4LH9;8,7>SKXT;32,=O B:*< MJ6T8XY%(7>;,ZS+GC*;!BST=ZFB:=>3I>R7EKC37/J5GS$G? MH3ZRC 6YO"[Y81-@)DWN(O'#IL8.F[RN<49 R5[J-4KYII5C3%DCM\[K',&8 M,L>8,F!,FMU6^.U-#&/*'&/*;>#V9E-)#:9O?^5+52/B_A1Q)S<"A-+'J>_H M,\]K'V=@HS1[<;_#1DT;$KK%S1QXRBU]YW- ="HI&]')4-3871KNDODHI=# M3!D@)LU>L.V02=.L8[Z7%__-)731&RG^FSF]E NJHA7,O)+;G '%7MIZ:O,(:;7C=W@8!VB5)JI[A][4M5(^+*UT7"WF6&^KN) MIF!ECC%EP)A4O6#+@9/&_>AC/I-7R[,91IAQ#F3)'F3*B3-Y1KI+R7 &'F7(?N4->9RAF6QATG7DQVPS< MDZH73#KLBCC3E(7!=M$$IK2NZC4&R*U6-B/O4(7)=M,E04%::ME! M@I>4S0! J7KQHP- C3LRQ"Z,.".4L?RK=[KIM*I :'\@4B5P!E9>*5"!C-+6;86>@55"9V#E-)-6-%,Q]WRA3EF\ MJBNN58@QM9X_X1B3QC FY1B35AB3/>VE1C FY1B3(L;4.N<^Y1B3QC FY1B3 M)L]OP3,>H9B44TR*%%/K1)_**2:-44S**2:M*";[6UP:@9B40TR*$%/K'-&4 M0TP:@YB40TQ:04SV([Y1ASJJNN+:A !0ZYSOE - &@. E - B@!0/>TQ4LR1 M2!&_!$^+-2I'A110H;^YUFE4@;/DA0)/U/EOC*ZX9#5^KLX('K5>=,;!(XV! M1\K!(\T!)'B!4NI]J$J2('K5>>,;1(XVA1\K1(XV@1QN4.LZP/KY+\J6J M$7&]5]1[=UY<[S6F][SDD0).I*72")DF#H4R<_N9VQU7:""*U/N*O/**1QJK M>*0<$E(-W.8N4,J]-U=>ZT@!)=+B13.\UI'&:ATIAX14(P0"2FFQ"01?"D?$ M62)%ELC[0I5REDAC+)%REDB!_]%27_0>7EPIU$22G#_SO#<'A;1%_?,\!*^+ MI+&Z2,KK(BFR/_5]^OAR1[$P4D-K@"D'A100("V>N^&5D316&4EY921%OL?[ M@IM")2-)#3W( IGG%Q )YQ^B5VMN,?#5< >-3YQKS"-\/9ZR;EI(\" MZ:/>!V/506RFJ-"E_DIL\\9W(4F!SU/G2I#F\SS3T6&_)*0(J5@)SO]BI\ M0EOIVVSE:(XB=.-]>5,=Z&:)]+5?P$=D,_]J&\(I!B1:#. M\W:\(I#&*@(I1VJTJ@AD?]#R1X620(?OM9/YC",SBLA,YXV:(S,:0V:4(S.*R(SSA7"%#TM+3PT^ MYV84N!GMW59XF-?'PCS^*6A%%L:=/*1C]*Q:N')L1@&(4>^SBNH ,=/D8T$> MIURT^LRR-WG(0F[KEWE5CUS/@(C1WCOZ.43,./LA%N-QBD4KBB6;-N]?BA1+ M3RT>9U@4&18/IU#.L&B,85'.L"B@'5)_?N,P^R\56)$BU.9Q#$2Q)H[S+3,= M4-5Z\S7S87B7M?10.R2XRIQKNIH-UV/$4;+M,2\4OX[FCX=25OGBWO?]]^^7V]O;AY)>[/]_O?B7-LZ,_/KG?_K;K M6)Y_(<].__;G%_+\&^O/+^7Y=]:?7\GS:^O/7\OS[ZT_WS]NSW_/CW?O=BOU[.2WN[O'[6[-F\]V=NS-]N;7Z3]NM[\][O]U?Q:X?_O[ MF^D_'N_^V/]TW\&'N_M_?]R+E_\/4$L#!!0 ( $N+:DF3B23DK 8 &DH M 9 >&PO=V]R:W-H965T M21F.@:W;V FP0-&+[K6:*(E1V\I*2M-]^]6! MJ_I7\U26[>S/\7!JKN9/;?N\7"R:NZ?R6#19]5R>NC,/57TLVNYG_;AHGNNR MN!\:'0\+P9A9'(O]:;Y>#<>^U>M5]=(>]J?R6SUK7H['HO[O;\G#H/761__5.WV+V#E[X/N'=Y5AV;X/[M[:=KJ.#69SX[% MG_%S?QH^7\5^1=[-F.%J/9=A53-,=_;U6+E\M?O>>O(T8;#:AC7 QDUUHPL\6BRZ# M,R>0>F@_=D@JHO5WL8;C6%5)^S,Q.RVP"Y6R[X7 MF#^8>QR+4^Z0BS+A(\XTKW$N*"+G<4Y,>4A,YF:4N3?RNG*7<#1^9))6,!^4 M.EP19,Y#H+!,) *A..&:H'2N25+G*%*XP<0^#5X(E=3(H4CA%I/Z%":$"D]5 M'4H4[@A:YR%3/IG,)2*A4.$YIF_G]9V#JG/V4K?&ZSM':WC*&_$&)QLHF00D M4\I'G!!>W8)3U"WBA)CR$)BZG9_4B+#/N6-9_'Z$V<&<4.((B2GN#)I$(B<9%8S*@X&;RJE2.I&IT^J)RB:K#/ MPA,3FK05W)%#*:,90=.:?5PW&D6'Y@1-:P(Z-(H.+0B:U@1T:!0=6F*:GC8R MP5Y*AK?FM4$8>N0'\ZD5@*AR$&39"D3'[]H"'XFM%HW.)C2<3427,!L=+DVTU7$27@,S865\0;0#9D[E M66H 45!IN,Z)KXIUB""1IV9P&F[)Z,3:&?$&=_]1HAD&$D]L[1ITX\:0-FX, MRB*#LFC*TJM&Y0A1@,?489L#7C PR1/ M]CFN[RE?0[I"Z)S 0'U''Q9L#%A51+8A1F=?@#-Y4>"<^\[;Z*TG% $QWDTJ M'NP_RB8#V,03MT*#KG1,3JD;BRK6,JQN1J//P$BJZ.!M;#A1,58D"(F8P;31 M.8WE8/@2E\"BSW\LZ?F/1>5OT87,-#+A;.23E>KR'C,"Z2NPDRR3,:MKZ(WG M,O4$S:*S&ZLP 4X77B'"FGJG(%1T8HL LX-YHZ"S '0\Y0,%F"4!S.*/H G/ MH#<6/(0V.6ER95%P6$>Y;@ZY;O[)K@VG*O;=],&_>Y"V@CE'0#5D^S:M>-?& MH6!R#.F"[R:PT:GG<0XEB>,8VZ9 $#>7R%H$+_4(>LF=U5+Z>VKX7@ MZ/D]M<^B?RGHXOB&+[<\QXQNQ_!+SLQ/+F]CQ[GHL;[IK\OY,-Y;+ MF_&%L7=G>'=F? ?NK7/KU7/Q6/Y=U(_[4S/[6;5M=1Q>6GJHJK;LQHQEG5"? MRN+^_.-0/K3]UU[!]?@FW/BCK9ZG%_O.;Q>N_P=02P,$% @ 2XMJ20*< MD%B$!P HBD !D !X;"]W;W)K&ULC5K; L.,GLWZ]\8R33/N,\!)!; M+9TCZ71+\M5'LGSE^'I_GI]=COGFL*^UW+[?; _3FZNZ[*_CS57Q5NZVA_ROX^3TMM]O MCO]]RG?%Q_743+N";]OGE[(JF-]KZ=1U8=\ES^4E8N-^WC/E_EN5WER+?_;.OW5 M9E71_]YY_U+#==W_OCGERV+WS_:Q?'&]C::3Q_QI\[8KOQ4?7_,6@ZTS8"G%;(1Y;(6DK)&,KI&V%]%P!VV>M?3:V@6K(FX&+1C9ASD-M>HW, MFSE2S[#/FW)S; M+$YFMM7PQ+LVZ^!%:2S-0AOO6M)#6S-+1J>O4U!3+8-'?G M.V(W3S-="#,$/@O BKH!8#P (,P8&&>,C!D M/QZX()=%T6\BR"JH(JD^9+>C'=<@0X(];0+X$ M9D;MY2HPBMVD(D9VEJGTAW:<\D" Q_YJ0*',-KNI9CMU']2.]$!(4(J)1DPX(J\9V]_!Q"UB MWTCZ$ME.-^"IQ@J4G^ FA +EOP@I!)2?=.7OIIO@Z0;4EJ#:DD73K6,^2,MM M?Y/:3;;0BJ)^CM^Q#[S58(#"$TSR*4;3J%L[?F9.:=K/ ;N)%.;Y>I(/?=58 M0% A&%0H3/3[XDY W$D7]VXJI7@J :TEJ+64C5&NS&,L9J/GZ:O S'(V$ 2A MMQH-$'C6!;X[3XA&S"6._&Z*OJE=!58N4*VWM!;C0:$"H:A@L.T_$+J@&H+3,L%I^4"-%2@A@H\^V@SX4^B9\)MXT!G M!:;'0G#Q"=!9@2<5@D\J!!V(XQ/QX*0B[=$E+5N^D7 _Q1$@5@+%2L(CA M8 M0*P$BI5@L1(@5@+%2N 10GV\16EW<)K4WEX&5,=QWUEY+]:Q5IXLUHE6GB[6J5:>+=:95FZBQ=I$ MZA/CGJB8C0-M5-3&P38J;N. &Q6Y<="-BMTX\$9%;QQ\H^(WC@"C,F )4#!53FPC@.K<[_W!R?MX?3Y'M1EL6^?G7KJ2C*W$4)%[.FDY=\ M\WC^LV#LG"Y%UD6XJX9[>%%(G7GG,C?%V!B/ =1\$R\TENG;0*7!9YY#>70*RIZ M)*$]!Y^B4Y5;A /\H#"JQ1Q9[U"/%,B/8)R41(/A"P=^;Z^DPT*0LI1B3] M60S$'GET2LS.U4BYI/3;93I3)OLHLR0L\,,*39C882Y+3+R%J):(/)TAV!B8 M7<1;+E+O(EZYB-8UCMZ%Q_0.D^2'= M4+4%1F!^.VUZ2'2_)RDN\+9#N"*0K M@63MTV,N:\P_=BS;*9*M!+)M@7Q'(/\/EVM,_J$(7MRT@=S@.Y$WVBMT%=I< M6G?#6B$T&*7P8/QVYBV9 P:MMM.CF4O_>_E B^'Y6,PO5OD'4$L#!!0 ( M $N+:DD3.2S,ZP$ %8% 9 >&PO=V]R:W-H965T(##X'.HI#V$DY[0$034<&+'9L(J/ZTC(^8*F6_ S$ MQ D^&=- 01Q%&1AP/X95:6*OO"K91=)^)*\\$)=AP/SW,Z%L/H0PO 7>^G,G M=0!4)5A]IWX@H^C9&'#2'L(O<%]G6F$$/WLR"V<>:/8C8^]Z\?UT"".-0"AI MI,Z U7 E-:%4)U*%/Y:74V\I:A=1896"5 *T6\19%8BMCQP_Q.@F0K ;()$J^-PH?,;1M6,UH- MA+ML2U6[*E0DNSLPZ $,\F">_#*9A4%.&9A#7U-8%$^3PGLHZ0.4U$5!T29* MZI2)HW@3Q=<\.7OGH60/4#(/!6X>4>:4*0ITYX@\%4+_[0MPKL"$S^0'YN=^ M%,&1276;S%^_94P2E2O:JYFG-[[^U"LNGVBJU/:?4'4$L# M!!0 ( $N+:DGJ,R6O9 4 *P= 9 >&PO=V]R:W-H965TB_%GMTK3V?N?9H;J:[>KZ./?]ZGF7YDGU MJ3BFA^:7EZ+,D[JY+%_]ZEBFR;8SRC.?!X'V\V1_F"T7W=CW&KP\XQEM MH(R!^C!0I($V!GKJ#*$Q"#\,-&D0&8-H8LRQP<=3/6I7O%^W8++)>:G99)-A ML1F?;#(L-Q.338859Y=+[O?%VY7^35(GRT59G+RROU^/22L+;-Y &W*OZD;+ M_I9JJK]J1M^72O*%_]XR&0SO,"L;PR,,LK$A[(SP&P_.;G#4#3,%MZ? 9K@! MB%ACF+6-T1*#W$(:-)917^['2;[8$!D'&.:KC5$LQ##? $8*#/, >=#4/$(> MB2^10)=(])4B[*"5@T&B#+)GD!:#X!?QLKX@5SWHT%=2P$0D@_8/!:]M<*P8 MYV[L9HP8Q*&H.!3(I8+3Z3X,9*4;H/BXW0PK4E/N&D;Y$G@*])@B MK0%$$+'C5-!C7"P&C\,IBQ9:T[B78@UP@JI]@A Z3^H4 T*E).Y\--%Y&R?= ME;FA"*'SI/XQ((!*X1R<%$ ^20 Y+H#*<$ !U&@2.9 U%BBL7>@#NP:$@J') M!GQXFO]BRCO7E# -I(IRJ*(A[C8'W8U@U/)S7'&'^8#BJ@A/N[#FT]I]1ZT! MTI%0D@RZ3@H]AT*/=C,K#AI!R0C7;:2X['M !"0GC(!L+3G0>HUO^MQN^EBD M(D(\(#;0,2':8[PP#G*_X?9^(V/7_4^VB]S> 9PG#DX*,;>%^(\SQY!/6S>% M"MTEL1F!0L](E>5 936J1BL#,BL2!S%5@R-8>-+#U=OX)H!ZXZ>"E0$-NPUQ M(VT =.0$(-=@0 "W6^83M=&L- W4J@%$&HM'!ST(7O2*5N0*BB M"EX^!QER!(_#KOS< IPCA=.H[AU4,#*R$Q:3.F%!*I, G?#E&7+(CMV^FG+% M]14@68AMA,-Y'T =J1R?=SCX4VP&\P5@)'KF,]!O$^@>8:R<>GXBR-Y>V,HN M0A<'KNQ#+423:H'48!%3M6#"?A#Q>-U*4D\ET-. .SAPY3/Q2OBDUK&C2E*A M)%"H %<&:;>2*E2ANVIN ):' NN$36D#:"1C:N>4I$9*,67E)?TH$FADH-#P M5M)6+!X'Q./%-< VS1,FA.='D30OC -1Q"Z"CV;M3QM2 :6M@)?'(&DBA\\% M+_"KO*>B[=#W3X$M$;/+P$_\_8MQ<7XBLUO&3*^8?-[;'S% MY]<8SX;/[[#Q)DWS1ZDP)JF']Y+^1PC+Q3%Y31^2\G5_J+RGHJZ+O'M7\E(4 M==ID)OC4Y'V7)MOS19:^U.W7L#VV]B\3^XNZ. [O1L\O:)?_ U!+ P04 M" !+BVI)\>/[ZID" !U"0 &0 'AL+W=O\,E7"."M &J]J'2:A_:9V_B)&@!I[:SV?Y]?2'$CB;L MOH ]G#DS9P;P%!="W]@18^Y\]-W UNZ1\]/*\]CVB'O$%N2$!_%D3VB/N-C2 M@\=.%*.=[(9>T&[M7P MTAZ.7!J\LO FOUW;XX&U9' HWJ_=IV#5Y!*A +];?&'&VI&YOQ+R)C<_=VO7 MERG@#F^Y9$#B]HXKW'622 3^.W+>0DI'&2?]U<5U>O2A[^V@[A?])/-'-]@A'!W" MR6&* SLL1X?ES2&:=8A&A^BK$>+1(;Z+X&GMJG(UXJ@L*+DX5'?[A.1+%:QB MT9NMPY21ZH:(VC%A?2_C)"Z\=TDT8D*%V9B8,(,@M0D))H0G$IBR"*$LQ@BA M&0$*4%F(',SA4Y+F 8F5YA)*#&@L4+B)84CPC*;8DW;T=F984&U&^^484!4JT MHOBQ(HVH+9H(BM18D,>"DAE!B24H!P4E1IBEOTA 02D,W)24TX*%G:3?E;Z:@8Q:DGM'L-:8!I+2S:C);-: [X!F\P, :=199^J M^0)+ [-88O(9,;G5F #\S#>Y$2.-X5]!_EC-"*F_0-/ -%J.9QPJ/:8'=9PS M9TO. Y=_1\,Z30Q/H3R4[NR;8%4%@+T6$X8>"&[T97%"!_P+T4,[,.>5<'$4 MJG-K3PC'(F5_(3[WHYB!IDV']UPN4[&F>BS0&TY.UR%GFK3*_U!+ P04 M" !+BVI)DL==NW@" ("0 &0 'AL+W=O,#=&#;U-/;*FII>1-^-Y)4%_#(,F/UY(3V]K4,0W@?> MNE,KU$#9D0_M?W4&T4FT2 M!@=RQ)=>O-';-S+GD"O"/>WY] SV%R[H< \)@P%_Z'V>L/A*PRJ35^X!/@TS[ M*ZW@"#TPL13Z4IBZE4"M-30*$ MW 3019!I F@0P+2R518Z58T9]2)9BJ+,!=N8L Q5901M&-#N;DU<"I/$+3KS MB,XLVS(W0>ZQ+7_&-N11@'RV(6T;LOPP\C1 &Q,$JR4S"H^4PC(C=Q.4'C/* M9\RH/ HJ2P%RFE&99A0+9I@@6"Z9H0ZN12UJTA!3+% XJW_V X!G# '.LKRK ML.JR*.ULR_D$28UT41(5+M3&0I5IM+#!P%?D %IR*K<<:"WT7Y7?]9BPPJIR M6Y"O@(%5P>721OM*&#Q5P\!7Q #Y/MSY\ -FA9856#C\;%A>1>4G0;%Q!9WQ MB?S [-2-/-A1(6^SZ>HY4BJ()$LBF5LK?TL>G9XI8NX>MFIK#[ADU*C5 M7!+'V7^_"0F:.$U&#P+A=;^7IO,(TPOIWND18^9\-G5+9^Z1L=/$]^GVB)N2 M>N2$6WYG3[JF9/RR._CTU.%RUPHW9=6Z\VD_]MK-I^3,ZJK%KYU# MSTU3=O\6N":7F8O<8>"M.AR9&/#G4_\:MZL:W-**M$Z']S/W&4W6J!"0'O&[ MPA>JG3M"_(:0=W'QUR,29_ZJD-TX1J)\/V=?] M=+G\34GQDM1_JAT[N0-(9G$D$S MB60](Z.>(9P@AA+$,D%L)(A,D9F#I,D%I+$((DADD6BD00>@C!+ M'?,4WX-RJ=8 15X.97HQ0)F7P7-*+7-*C3DEH)148PE#+X)9,LOSS0R6%$Z0 M6V3F1H(,DKG(=9E?:J_F8@?)LJYU4.J-]'-AD5L81]*1E08/:'[41+!36'##%VA8U#LC97-9FS(<+9BQ+20S;60:5MCE;?Y M%C*,JXCALNE^D\%5LT"&HIFN-58SFVTAP[>*!#+'!=+M)KZW)/6N?02T-D%? MUZ2O;Y [^EGT]/ MY0'_*KM#U5)G0QC?2O;[OCTA#'/9@<>[\\B_.JX7-=XS<9KQ\T[NP^4%(Z?A ML^+Z;3/_#U!+ P04 " !+BVI)[Z60 MV39MF072@[3=^^^/$(=:J23RK >_=]O]\7;X M7-3\[6_#M-)]5IO-_ORK\/@^+K;K0__?2VWU?OM4 R["S\V3\]U2MGY7;;3'5:^M\XZ\>BS<#T_V[VQ5G?D_P_U\=R5FW_V3S4 MSR=QB^'@H7Q/X]N'\]UM6N&S(<[-:_V[^;_?GO M>WO'%W$8/D#& 3)W@(H#U&6 %.P '0?HW $F#C"Y VP<8','N#C Y0[P<8#/ M'1#B@) [H'GF[9,K>D/&[2,_.\Q\7:^GDT/U/CBT;OZR;J))W(C&)^\'Q_/5 M0^N()Y\YGJZ^34VPD_%;,U/$R#-FEF*DQR"+%"(2Q.G>JKW71&1S;7R2ZB*: M1$6+R\ID3B44MNX<8C2&^2:!B@Z5/V.M9<9:=Q!C,,P*RH/:\SO$A L&6$^A MUE/M@U7)#+8H\!DT.H-N9]!@!@'E%*W_S/3EX;Y-"Q0R9R"NM3Y C"R&6::8 M+\5(X@H93B$#%))P&=N*8I)E'+Z&Y=:P8 V%KF%I@[2(98I0U,-SG!P.R-%S MUA;SU0%GQ029.T*05%@* X3UG+ >"&M0H_ED%2&I90*W3 #+6'R&AE?IJ&KN M7@\K@5-N%$,(,$>/D'SD7)'ZNQAI##6'J )'+?HHA:&6$"7%B& =@9-VIYP$ MRGE<.0D"'I5GP8-:5K@#()F H,@X4W8B0ZH,N,@J]7+J<2AH:(,K!E":>AP M)=2(\E>6PP4@<4'Y*TZ;G<^;+)]G:5'8'+< Q$A9+P-T!T"T)[,,*B"%2EQD M!\,417($\JR#"P !0M!S('3:^(BE&OT;1T!T&D."Q52\%1@XUU:DJD2XCSP#0YSP3JVJ TB.TSEC*'H$164:R["$A>U!SL.PA ML]A#L>RA6/:(%E8I+V@OB3R3![L#,&?,B' OQ?*, CPCB,9#X7'=-7PRRX!L M*:1@7.,I1\'*A,JNBHU^E0:VR 5N!")^JXB*M9/FO!'S0:CAL%(>(G&XR)JK$6.QIK- M=QK$A2PPGU[IM(\P6E-AK-GPT2!\)%%%:3PP.I5UELILQM,@,&3_(9MVCTFG M>QU"41JSX:-!^$BB_])X:'0:NRR-V0RD06A(36B<;B(8!0>)>W<00NW=6982;$H)FF@/+5M%VJPJTO*[_NRV?R1C M"W;UJ4[+LI1@ 25(RM78,M)FE9&6S8(61JG#W21<9 E\L[PW$9ZGEQ"5;JY!Q5CF M$)\B M'I!G.PV?U6EXMJSP.H,;O+YNECD ?WR!T?V$1"L(I4_L"T!=-T6Y@Z2X NE-$:QG8_BAD]4>!K5Z" MRG#=<+4_FG.0SK@J@SJ6Q$10)9;L B [13!+8)NHD-5$!;9T"3;'M%(C XI;-V/0/+,\%P'.*Z-8"VZV%K&XM\ >?V&ZM8P7005$GC@+?C476 M#5?;NF5_(O(X%LMWY]L?JFG"/*)@>[;S[>M&%@5_]*F _-*CS';78]:AD)., M"6S>@_D^2\=WO)]@-H ?;-"R-ZC9%R8X613\R:D"L*&FCHT4;#-WOIUC?;:V M.=^FW_-T;[8Z&+\_+ J$J=I5/D@!&<4?*"JX Y?Q3"8$6=UOX,;)^>Y=>7@Z M?Z'@.+BO7O=U$W[)U5D_E7^N#T^;_7'PLZKK:G?;G$A_K*JZ/)FA&)V> MTG.Y?KA\V):/=?-OTR$?VB\ZM!_JZN4V?G'C\NV1Z?]02P,$% @ 2XMJ M24F$A-B= @ 9 L !D !X;"]W;W)K&ULC5;- MCILP&'P5Q ,$,+]9$:0N5=4>*JWVT)Z=Q EH 5/;"=NWKVU,BK>VRP5L,]\P MW\#(+B=,WFB#$//>^VZ@![]A;'P* GIJ4 _I#H]HX$\NF/20\2FY!G0D")YE M4=\%( RSH(?MX%>E7'LA58EOK&L']$(\>NM[2'X_HPY/!S_REX77]MHPL1!4 M9?"H.[<]&FB+!X^@R\'_%#W5(!40B?C1HHFNQIX0?\3X34R^G0]^*#2@#IV8 MH(#\=DS/;.&JPU][XPN\-:Q M5SQ]1:H'J?"$.RJOWNE&&>Z7$M_KX?M\;P=YG^8G1:C*S 5 %8!'090X"V)5 M$'\H"&9ELJ_/D,&J)'CRR/PQ1BB^>?04<^=.'I6+9+:+=T;YZKW*DK@,[H)( M88#$/*\QP(2H=98'). "'BJ 244RJP#K^C S$\0F@G@FB#4!%@6)0T&B*2CT M+O/9AQDS2$RXBTV8>HT!*XPF)'4(2;5.4C-!YK BVV)%[E"0:P29WF8Q6Y&O MVHQWA0E3VS":D,(AI-"$Y&:"O<.*_18K1-:M$L3#_YJA0&XWK"!=C#&KBQ@] M9C8*8]"4(Q'89(DQ:HN*V!65Q9+8E95,6;(& 8L45V@C+;51:*$PQFTQ)-UD MB#%PBXILBR&99DAJ_D?6H&BWMXAQA3?2TVNC,,9NL:389(DQ>(N*_9;8[+5N M$_,_HH$L.XLKP4!+<&KY1X Q=\H0$&TQ!#@W.+#!$ 5R&Z*#+%)<^05:?E,; MA3%WBR'))D-&PO=V]R:W-H965T+SY]^%#>&C2 M$KK8(+]J=;^@QY)V3U'_;&ZMZS:G&R^SQA%W7G6_7$1= M9FUW6U_=YE[S[#QT*@N7>E[HEEE>V?O=T/:]WN_$HRWRBG^OK>91EEG][X$7 MXOEN$WMJ^)%?;VW?X.YW[JO?.2]YU>2BLFI^>;>_D6WJ#Y)!\5?.G\WLVNJ3 M_Q#B9W_SQ_G=]OH<>,%/;1\BZ[X^><*+HH_4C?R/#/HU9M]Q?CU%_VTHMTO_ M(VMX(HJ_\W-[Z[+U;.O,+]FC:'^(Y^]'_<]Z]\JL@VZ9W.RFJ&Q'A](YUW3M7[NPX#NW,\^D-3007.8 M:VB,28YS"7DIW"Z!5Q84RT*.0.2ADD0CB48S@,(),4TZU[QY#L7K"33U!/-Z MF,*04.-H:.)HI,D@TCD:CH9&:K=&1:)1Q*.?0.$03)-&T$]%-;&FFACX&>$! M-AH_-R9^]OQ4IM#_N.JH%.DLU4FDIT#R]C]7QT"I(A"L"$7<5!%@'(L5(5 ^ M25L)-?(59<>4!3/QE:W[JI%,OC+=Y)]LQ>/ @G0L(P!F+%"$0/$QV1H8V8H" M9,HB-+$U7+=U57+4220!H,11_!,2'= ()%JH"(%29+(U-K(5Y8HW*$ZP%$(N @MC0(T$45M= $P M5'5?A_EBG37]TS<]75K M%I_HW(WDF0@!;^X&$R4+$<5$1R":OY7@9&0NZI:CRX64.SMD*WE]'8XW&^LD M'E7;>S-K?1VA?J/](=VB_4"V"4':CV2;C@>D7^'WNWMVY7]F]36O&NM#M*TH MAW.\BQ M[]+N_L=MZ\:S\^NFX)>VOXRZZWH\)AUO6G&?3GU?1\_[_P!02P,$ M% @ 2XMJ27LQ8&FI 0 L@, !D !X;"]W;W)K&UL;5/;;J,P$/T5RQ]0@TG3*B)(3:O5[L-*51]VGQT8P*HOK&U"]^_K M"R&TX@5[AG/.G!G;Y:3-N^T!'/J00MDC[IT;#H38N@?)[)T>0/D_K3:2.1^: MCMC! &LB20I"LVQ/).,*5V7,O9JJU*,37,&K07:4DIG_)Q!Z.N(<7Q-OO.M= M2)"J) NOX1*4Y5HA ^T1/^6'TRX@(N /A\FN]BAX/VO]'H)?S1%GP0((J%U0 M8'ZYP#,($81\X7^SYJUD(*[W5_4?L5OO_LPL/&OQES>N]V8SC!IHV2C_F>FXLNBLG3_:> ZMU@Z\A>SN M'J/>/Z E$-"ZL'WP>Y/N5 J<'JXO9'FFU2=02P,$% @ 2XMJ23W_R%:2 M @ ,PD !D !X;"]W;W)K&ULC5;+CILP%/T5 MQ+Z S2,D(DB31]4N*HUFT5D[B9.@ 4QM)TS_OGX P1F')HM@7\XY]V'CZZPE M](.=,>;.9U76;.F>.6\6OL_V9UPAYI$&U^+-D= *<3&E)Y\U%*.#(E6E#X,@ M\2M4U&Z>*=LKS3-RX651XU?JL$M5(?IWA4O2+EW@]H:WXG3FTN#GF3_P#D6% M:U:0VJ'XN'1?P&(+0@E1B-\%;MEH[,C@=X1\R,G/P](-9 RXQ'LN)9!X7/$: MEZ54$I[_=*(WGY(X'O?JWU6Z(OP=8GA-RO?BP,\BVL!U#OB(+B5_(^T/W.40 M2\$]*9GZ=_87QDG54URG0I_Z6=3JV>HW:=#1[ 38$>! &/S8"6%'"&^$:)(0 M=83H60]Q1XCO//@Z=U6Y#>(HSRAI':J7NT%R5X%%+-9F[S!EI'I!1.V8L%[S M)(&9?Y5"'08JS&J,@:D-LAE#P(#P10!#%- 61>%;0V@"E7AJ,?\"DI+IXIFY@%]X:*)A +[5G MF4YDF1IEBNP"\XDZSY^ILSSK'H8@7SZN=-I]O<$XV2\5T:BUB4J]N;6Z]ZAD M;OQLG*W)@?'<>U K8#VG^E3-@RI^(&$]9+IZ _A4P:T'0!]%^,0'O.I0_2:T M;FT#$WA6T.9.R(NMF]E$A5_*ZX\Z0H7I2?5BYNS)I>:R."/KT.]?H.PH=_85 M6*R!Q;Z1]P/5@6[R>=:@$_Z%Z*FHF;,C7/0QU72.A' LP@X\<5"=Q0UFF)3X MR.5P)L94]W0]X:3IKRC#/2G_!U!+ P04 " !+BVI)S5'6 6(# "L#P M&0 'AL+W=OB2W;3 "Y(,?IOZ_XC#:S4LDA!O'N[JN5>&QM[J)][2Z< M2^>]KIINZUZDO#[X?G>X\+KH/''EC7IR$FU=2'7;GOWNVO+B. 35E4^#(/'K MHFSVIW&W&35=GPI];I;G5=M'_WO!+WK4O<>>"Y/%]D/^#O-OX2=RQK MWG2E:)R6G[;N(WG(*>LE@^)7R>^==NWTYE^$>.UO?ARW;M![X!4_R#Y%H3[> M>,ZKJL^D*O^9DG[4[ /UZSG[MV&ZROY+T?%<5+_+H[PHMX'K'/FIN%7R6=R_ M\VD.<9_P(*IN^.\<;IT4]1SB.G7Q/GZ6S?!Y'Y_$0*< N@00>T X!82? M OS1V3"OKX4L=IM6W)UV7(QKT:\Y>0A5YPY.-PRV8[O4S#HU^K9+DF3CO_6) M)@T=-'NH89@FUS5D4?C*P6*#8C:F$E0O$:$5= G%*X18A6B<: @FD<(29.S& M?A0U@^@+S:"(C3Z )O0BW$IDL1)I5J(TQ!/$E@2Q;2[I:#/6;2:>H6.)I4JB M+RE-\03,DH"ML,ETFR3P#&522YD4E,GP!)DE0:8G8 'F+T4C_<'$2T@@KLI]$8Q42HD: QN0$Q<+L!+SSC* ]F423D]3#5QBJ M0L^PWPF*A]D.X .C>&,H.FG0%UP"C=@H0JP8F8V$9B-S4]91A-@P0B+0E!!? MHT@KE"9>%FA_Z++F("3S#"\4L0&* $*Q"+>F(RH,O!AWHZL"X^ZQ@8PDP$V, M+UKR_]V#2Z 1&Q )(")+\+:P56UAJ]IBXR8!X&3,D,)&3K(&G22# $"GG0,5 M,TV(VO!)K?BHS17SM<%3S]CP<&COG(&[-<$;51I>#Z2,=#E>HDA.3*@UHUU[FHH_-R4_&3["^9NF['P^1X(\5U/ALO!_3=/U!+ P04 M " !+BVI)EL):31\- :7 &0 'AL+W=OKOY:W\WGFZ._%P^/Z[/CN\WFZ<7)R?K+ MW7PQ6T^63_/'[96OR]5BMMG^N?IVLGY:S6>WNT:+AQ/3=>%D,;M_/#X_W7WV M?G5^NOR^>;A_G+]?':V_+Q:SU3\OYP_+Y[-C."X??+C_=K?I/S@Y/ST9V]W> M+^:/Z_OEX]%J_O7L^-_PXI/I=I@=Y#_W\^=U]?M1;_WGY?*O_H^+V[/CKC=B M_C#_LNGO,=O^^#%_-7]XZ&^U[?I_PUU_=MHWK'\O=W^[&^_6_L^S]?S5\N&_ M][>;NZVYW?'1[?SK[/O#YL/R^??Y, C?W_#+\F&]^__HR_?U9KDH38Z/%K._ M]S_O'W<_G_=74CVR ,#8*V01P: M1&V#-#1(V@9Y:)"U#?HUWZ]M6A+#NHUQW*PH-ZY:$L/:C7'LKB@WKU35E]HUY]4U;?M*M_LN>('<.\GFUF MYZ>KY?/1:L^+3[.>?N'%%KJ]^=%Z]^EJSUQ;DEEO/_UQ'F(Z/?G1WVG F!WF M%<9D"O,:85)'8=Y@#%"8MQAC*,QO&&,IS.\8XRC,18WQF1S[)<:08W^'^_(4 MYJK&6(@4YAICR'']@3'DN*880]KS'F$Z$O,GQ@0*\P%CR#F\43#/_:>\(H>K%.Q,FCH)-:Y@+.4TL:?2G M&F=8JZ-D=40K8$FK([+:3QHOC_L9K%&YLY7-R)HD69,J:\ %TII43\ZD60J7>?:$-NNT;"4-2C:B>NJ?T ;UI=^O&7]U6J.#&G: M -IW^R_K)N143AM8F#!3!73)4"Q"7)T]M2+7 VAPHJU_T 9A5,J3S%A$TWJQ MJ.;U-MD7@TP]=A,\;1!"00>)\VL0TP34>:)-9R5-0)T$?+")-JE&N1R!734Q M70#B9TN;]'Y 2:GK3P7F X/!]HI$#XCI]!\.!1*@ B1JY2,R%RF0Q.;J2QR86I* MVL8;1P!&I"134U+D$J.1:T-5<6C$L#<6V='6'D.E9.J(SG:RK8FK?TR_8G ; MA_IE"BM#!UP9OU>-7XPE$Q2T9X*&]A!*HCTC1IV)FF P=$"5F4FJF1$+#),5 M]'MAZO(!7&0J!BO&G>V0,U@J[GZS==QYFR=<5V+<657<63'NK&Y3)N_*<-PU M%4"?)?HS 8OR+6NM&&FVCC3'1:L5(\VJ(LV*D68#&C%=S=@ZAI*99$4U:L5P MLA%URX2D%Q'!S.-SH4N6U U5/8D7M#.J)<7-'!^6PSLYJUMG)AQQ.6N>24=SABG2* M,.S>V8DUJ:L#-T+;TYYF/KKZ; $ZMBLQOEU0.-4[5P=X8'L20]I%E5/5VWUG M/=.36)BZA*://&JZ;D"& DU9$+9&I!"7T3V8;9ZG0W]P<=]I7-R+0>W1=IH[ MTL)GGU1*O_9UW+M@Z7.;*8:E-&$.4KU($!X11'L0/1Q+^'HW[=C:WHNYW:/< MWAYG[WOZZ-%Y*CANU^Y%MO&HC 8FNWDQN7M5AQ+"8RZ!L0XTQ!S-6A#MA?3FV'8,,@1R>4Z] =3CH( MPZY1$/DAX.,V^FCX50!53V),!Z/@9PPRY#.%*0O"UHAQ'U#<&Z9<#71 #[X9 MG,8W@YCT@U?X)@89)B$%^8&"^$2A^":B!D-N[JX#>E#0F?:QPY )$ RRGS!9 M/8@<$J+&:Q#(D$ENRH*P-6*-$5!E8+@1B8=?077X%46BB9W":S#(,/DFBO00 M0>$U",1Y3:PIQ-K8/N$8O ;#C.?JARAR3=1P#0:92$\B!\+6B%P3,==P(Q*Y M)JJX)HI<$S5<@T&&R8-1Y)JHX1H,XO)@Y/8@*!.R*&RT_.P2[U0:=]B719]B M5'4DDDC4;%0PR-*)D 5A:\3B***ZQS*),(D;E:3:J"21:1(HG!.#+),(D\@- MR2B<,QD%I:5Z P+63\P2#KZ5GA0-@:D4)2U+A6#7*)/GNY3D@FP?$>0C'A MGV2-1))8;^CG34J,-;@GD6A2UC@P9B-.;"$61QG5/9;QJTRST>";&32^F46B MR?C1 ^D-5P@4+5,;9)$:LCT$23545XCHS"*3=Z Y)>1]6H6UE@N M\Q 8R:M+ @>DP!0ZD^67H-F+-2A'3N:41S46R=2'])?L4WE@1)'%K4&U(X,# MBD?0[,D:E"?G<-JBN)1_0!L)FGT91K$;LP([Z-:*K1D=6JS M #3[LP;EN:I!UFX"$F]&SU4-C"RSN*M1;=* $6:.MIC#[CIM4)ZK&F0!)R % M)^N(&,56#4CHZ5A'9&&-Y3+!-!I0VA4_%=C!SN3BRGB-*V*49\H&%M58)'.: MP3S$NAK-0Z/#1IW#RJQ@TF&'O6I0GG-K#M58)%,'EI^R;HW/=KBR :E4!;?F M8,WW*&0BLAIUW14@/:O0F5Q=6=7N#:,\4S:PJ,8BF?N0.C8&=ESR[LWJ=F^R M]!60]I53XA34\'PP)/;K*HQ(=NQ-13$-BI:+\:C&(IEBL.8V<%_G8A2TXUKH M*(;1T(ZV)&DMBA2QP ZH'D$6VP)2V\; 31\CDRT#=ZIG4"!+8,&)&Z"QXD(B MV&TUPXU-ZZ4)45KL"$JF&5BE5OO)18$6LP_4E M1R@6LP:.U5@D1S$2J[)?O@$D5P7VY$F6 MJX)7'#U<-*A 3M(ECVHLDHD#RUH#5XG(NE;0"5M!5K8"EK;&-BA\67,> M0%:Z@D;A>-"A#[IAN>!2V2);"0N@TCHI1D2RP M+GE48Y','%CJVC)F+!9A 1K_J$96NP(6J48NMS,JU>(=09?;&9WJ:(M#(Z>_ MP'938(?*.5G0"EBL&KGDSZA5QX$'W<#E$&W4HTQ8-,I0T@EO>%1CD9RV@T+\ M==&@V+#@4(U%,G5@/2I;2 3TY=',L8*L6P6L28T<\S*BU.(<47?P)VM$ 4D[ M^:B(*&^S7YJ7):" -:"1G3XZD,>!.]W Y0C5Z$ O&I1EHH)%-1;)>3LJ1!$7 M#2J21=TECVHL.O ZA:A)%D@.VDO[V-YD5L!"SLA58HR2<_0.W5-)1LM9;,%B M3C8L$I(TL#L+6?0)2-#IV+!@%)UEX,GH!BZ':!(/Y\>SP%2?IP.K 0990 E8 M01FYLEF64().0PFRB!*0]O$79P^#LR?\9@6N*SFND/HQ\J\@D8OFI"N:94$B MI"QY>BJ.7B<^#Q.NH)%%B8!4B8'[?AG(LD30Z1)!%B8"5B9RY);KQ.>=X[[ M [(Z$;"H,''[)$95.(Y0 M>.^7)_E#7Q@5$Q/71I;D&2RC:Y]JC7TA5&HCZ:1ZK^IBOOJV>_/S^NC+\OOC MI@_(ZM/Q]=(O=^]E_>7S'%Y\[/WOUVN]U_37(GTM]=<2?2WWUS)U;3N++S[V M4TE>@_[:_OVQ/X=U?OHT^S:_GJV^W3^NCSXO-YOEXJQ_8^S7Y7(SWTY7-]F& MW]U\=CO^\3#_NNE_[:O-U?[-U?L_-LNGL^%-W./KP,__#U!+ P04 " !+ MBVI)4^O=SSP# "0#0 &0 'AL+W=OPT2(,!C,]/8)NVA,YDOMVWTK62HL+:=_I$6/F?-950Y?ND;'3W//H]HCK@L[("3=\9$_:NF#\LSUX M]-3B8MJ[KHOWWA"MR6;K '0RO MY>'(A,'+%M[HMRMKW-"2-$Z+]TOW.Y@_@UA .L3O$E^H\NZ(Y-\(>1^:\DO<84CNK[P)YW']\6Y8J_D\@-+#9$@W)**=O^=[9DR4@\NKE,7G_VS;+KGI1])?.EF=H#2 M 8X.*)QT"*1#,#J,B9D=0ND07AVF(T32(7HT I(.Z-$(L72(;QR\OKK=W*P+ M5F2+EERQO'=H9VW[*^>Q0;OW(X@0MO ]!)#&PPZQ4#$Q, MD(T* 2/"XPF,64!3%C("5".8 JPU1&K,X2Y)?I_D&6KUB,U2 I.4H"]HH!$D M9H+01!#V!*%"$-Y4.^[+U4.:#O(-P"B:01-NK>( @#-D0FUTMB"-9J$)EZNX M.%1":M*BB=I$6FU2,P&:J U2"5)?3Q/UQ4&JZ# (?/%G0JYU)+(C-S>P'N$N431)KJ9$)UHJF& M1DG)P].K(U%J5Y<\/+TZ,O(GA*830E--:& 4FJJADLBF4H-%H4VB"H-)8-.G MP4)D%2>:O%6=&%3DW>PF ,BNXMO7E,1L+!@]%6-[&U+1^EL:65(!6A%O:S-F M8X7I"1D[W9"0UF!29)QZ"9KZW6H08%_:]ZER"T379&QY@R:MY_F6Q@",34]V M!J!V/6MK ,;F,F01/;#JGB5*KG#[^O[:A;H8U^W]J\O4?@ZF-FNYGP-]T[\] M>WC*P:[&[:$[M%-G2\X-$VU7L8X7@R%]TR\ MQOR][2\,_0&ULC5C!-.>^A,IH?V3&S99@+(!1RG?U] @D@>258.,8C=?;O2VX?0\L;J]^9,:>M] MED75K&;GMKTL@J#9GVF9-3Z[T*I[ MS=;+8>RU7B_9M2WRBK[67G,MRZS^MZ$%NZUF:#8._,I/Y[8?"-;+8/([Y"6M MFIQ57DV/J]DS6NQPTIL,%K]S>FND:Z]/_HVQ]_[FQV$U"_L<:$'W;1\BZWX^ MZ)8611^I0_XK@GYA]H[R]1C]VU!NE_Y;UM M*_[DA_;<91O.O ,]9M>B_<5N MWZFH(>X#[EG1#/^]_;5I63FZS+PR^^2_>37\WOB3-!1N>@<0#C Y3#AZ!RP< M\)=#9'6(A$/DBA +A_@.(>"U#S/WDK79>EFSFU?SY;YD/:O0(N[69N\UPV#- M%Z2;NZ8;_5B3>;H,/OI P@8&FXUL UJ3%]D$319!E\"4!>BR$ @@(^@ MHK% M7)O#PR [0Q E3:Q+$_/)PI)_$F-]@$@7(.(!(F6V[\H@O QN4PTV3RCV8SU, M;(&))9@T#%68E,/$$DQJ1$DL*(F"@K0HB82"3"#$ D+D*4>Z"=L0"2,*?= 9 M;66C)TSNK1*>KFR5$EV@G6P2$S_5EY1:2DJ5>0/=O&U2"87($R=/KM%(265N M264NI1(3O7^OML:.Z!\^;@FD52"1 T*VIA"E"B.Q?I$?&8"T(C,"@4-;"*-I M4@WKB[0R,0)A6V<(J@DC#A0:4&Q:@B)+:XS51&[5V,0$Q0Y\1;*<),2/0NG/ MD)N;BYJH38^0*D@F+FK59J0S<:*SK;M1ZD+G5!'Y2)(C%Y(GR^ MH,QJ06H]!], F! .C 90EHCX1)^/V4Q- MR"88H J&0=Q JP:"N1"Y,!=LC0ZQ W-!Z5K?A&/K4T@<> O*SH'XIDVE;>\ MQ(6W\@L=&0NRM3RD#KR5.QZEIA<8V!H>YBZ\E1L>(A-MC5;J9M@F"UB5!4,G M8FW'CQMJY,):;&MF# ZLQ:"JAD&=L*U),7:@+5;>ZB8V8=M['4ATG-LJ*#3R6>_T)?/UWD=F*IQ-('[XEK4_#D4/C M[=FU:GO"2:/3L<8S]!_.=^,;M-@BS?@+6NSXH<57^/7RDIWHSZP^Y57CO;&V M^UP?OJV/C+6T2SOTNTD\T^PPW13TV/:7I+NN^=$%OVG993R)F8Z#UO\!4$L# M!!0 ( $N+:DF[@H$6R ( ,+ 9 >&PO=V]R:W-H965T99$WOE><:NLBQJ^LH=<:TJPO^M:,EN M2Q>Y]\"OXG26.N#EF=?S#D5%:U&PVN'TN'2?T&*'0@UI$+\+>A/&O:/-OS'V MKA]^'):NKSW0DNZE3D'4Y8.N:5GJ3$KY;Y?T2U,3S?M[]FU3KK+_1@1=L_)/ M<9!GY=9WG0,]DFLI?[';CG8U1#KAGI6B^7?V5R%9=:>X3D4^VVM1-]=;^R:9 M=S28@#L"[@F]#DP(.D+P10A'"6%'"*T,O! ]T=$B5=-E[X@FR-LYHH93J.A'GOIQYGWH1!T& M-YB5C4D@S,;$X!2";$T(ZA&>,MD[Q9#3S@6V7( 2:QLS!YV:& PAGBT$F&3[ M;9*7[Y/L3$@2S9FP*7>+P=5]$LC!;C4-@^@8$ '[.IW':MEXX&E MB,!V>T]A]5(<@5WA 10/Z(PU,61U#3RP!-%8VT#A%*LVZ'%:>\:V65%^:LY0 MPMFS:RUU#B/:G].>L-YV'^(KM%@C(+Y!BV 9L<^,B:IJL:?J4YP5B?2_J&D1ZEO$W7/VS-:^R#9Y7[D[,^]^7]0 M2P,$% @ 2XMJ21XMII,9 @ C@8 !D !X;"]W;W)K&ULC57+CILP%/T5BP\8\PPD(DB31%6[J#2:1;MVP EH;$QM)TS_ MOGX0 I%#9Q/;E_/B!BYYS_B'J#&6X).25FR]6LIN Z$H:TR1>&$=;M65$^,4 M277D9R@ZCE%E2)3 T/=7D**F]8KPTVA\#7$(/XU>!>3/9 AS\R]J$//ZJM MY^L,F.!2:@FDEBO>8T*TDG+^,XC>/35QNK^I?S.WJ^(?DB-X@&*/NW:M&;M[97,'VAN0C@0PI$P M^K@)T4"([H1HD1 /A/C! =I;,8TX((F*G+,>,R!4CMMV(9A9/!.(%@7@F$,TS!K;G>PMJ#2C-W";)@DDR,XG= JL% M@=474NY6DY3QDU:D"R;IS"1Q"V0+ ME7>IE-4@;^$Y?U@LMZYK)R"^@!\E1! M7_QOT,. LDF3],$'3MY:BOG9C#\!2G9II7ZX)]5QQ+Z&^JU_J.^"S=X.RKM, MD7?HC'\B?FY: 8Y,JIEB!L"),8E5./]%/5*U^CB,!X)/4F]3M>=V7-J#9-UM M^H^?H.(?4$L#!!0 ( $N+:DD'QD >T0( -X* 9 >&PO=V]R:W-H M965T*7OC!T*$\]$V'5^Y!R&."]_GFP-I M,??HD73RSXZR%@LY9'N?'QG!V]ZI;?PP"%*_Q77G%LO>]L2*)3V)IN[($W/X MJ6TQ^_=(&GI>NDXS7M'$9V*_\:=8@'A_C6",G@D%Q%\+7VOG(5 M%KA8,GIVF)[N(U:K"BT2.3<;A_=&IB=$UHY+ZWN11]G2?U=$ R;L,8\F)LPA M2&5"T(CP90)C%B&4Q1 A-"- 4H+<0_F\"W)>H+$2C."THQTL2*K6#E,$$,$ ML2:(#8(DO:IVIFNA,9TN9>B%$*BT0!Y(5)F8,(!!:Q,4&<$L2]9('@^E>W$*VGB"Q)]S.2[JTYFMB,ZO:;/*'4 MS^^/* 3>"$,2"-U0V $TS#"\5*I)D)T,>#%0G7Y7]D?T:)$ M@+U2K5S?+'S2%\LCWI/?F.WKCCNO5,B6H^\/=I0*(K.6V]-U#K+9' <-V0GU MF.DFQY:V^ ]02P,$% @ 2XMJ2;MFFHXS!@ BB$ !D M !X;"]W;W)K&ULC5I+<^(X$/XK%/R M;&=_#OMC3T&&_ MY%&DEX=B=YQOUJ>Q'_5F7;VW^]VQ_%'/FO?#H:C_NRWWU>?-G,W'@9^[E]>V M'UANULNSW-/N4!Z;7767SS?P[6SU(V4-.B%^[\K-QWL]ZXQ^KZG?_X:^G MFWG4VU#NRVW;JRBZEX\R+??[7E,W\[]6Z=>G]SMS'\LFC*M]O_L MGMK7SMIH/GLJGXOW??NS^GPHK0^J5[BM]LWI_VS[WK358129SP[%G^%U=SR] M?@[?*&G%< %N!?A9P$1> 6$%Q%F ^6>05D!^"2BO@+("ZBS@GT!;O ZU*+8" M<> $QN+-9(+EL!BGIT(38$AY&%* 8@WG, -%RC'E M&U-,+3B&2UT<,V:!:LLFVDPTI=)RI#P<#:IR5Y5F%VMB*2(4 8JTAR(-*(I1 MBK3KNN;39;<$ 92,"8)!K9EAY"$: G]M 3 WH,2D_L M.AY+3;E^%3O<17!@9 M+>%<3.T9$]U%H7&= 8A,IFEE-PQP.L(KX>L7(@K(<>&>WF*.;[?3(%0FX$G0 M$$MV :/N^WSG1<$"$ENX1S>E!9[85U VL2'*"$$EMO!U3^%V3\:)0XOP7G4& MW74*7_47OMO.D3N)QQ\("X#A1"8#E$IP5 Y0L:(*"7325_I%R(6E@'>,>/-* M 4H36T$ XL1E@H WGPX*.N9K#B+DFE&X![.+S?3H5P H R!&;+Y($'3+=\(3 M(=># M[G$7=2V368O1P$,-Z=7J@X\W5) <]DK]M)W/VA3 M6KJ%%X6DUR'9=4A.0* WONHN0VX#I5N1OW7[4SQY)[ $;]P9A!ETMY-#$&., MBACI:P+2>QG(F'6/TSQ;3!J R0(P.8&!+ETVI9,S7\>12Q'O$S??HRUI.7 Q M:EI5ELXSUT-9OYP>OS>S;?5^;/L<=T;/C_B_\_Z9[63\EJU2AHQG;'6/CO/5 M':8GYZM[;+PC:?70$87,+.7XJX/EEPN;]5OQ4OY=U"^[8S-[K-JV.IP>'3]7 M55MVQ'2U>CY[+8NG\X=]^=SV;^/N?3W\5&#XT%9OXR\?SC^_V/P/4$L#!!0 M ( $N+:DD+%4$8PIT .B3 @ 4 >&PO0J%@SE!!HP6MG'SJ"J 3J=[,-.W).D1E5.8@]),26JZFJFE MJAKI+/0A4)@7&& N!51=^ESHA^A'B2<9^43DWW0Q&CV63#3RX'323/5?Y)=? M]N4?RK**/L^S1?F/SVZK:OG\FV_*Z6TRC\M^ODP6],UU7LSCBOXL;KXIET42 MS\K;)*GFV3>CP6#_FWF<+IY%JT7ZEU5RDJ\6U3\^.]P;//NG?RC3?_J'ZI]> MYM/5/%E44;R81:>+*JT>HK.%C)GFB\A^OQN5MW&1E/_P3?5/__ -7I8!CJ*W M^:*Z+>GE63*K?_M^6O6CP; 7C0;#_?J7[_([^G+2_N5C"_N7XZNR*N)I]7_7 MW]2'B^0FQ1,TQ"*>)_6G/IR>GY^]?A^=O(\^O#GI&&-*"RCB+$II;Y^C3\E# M_;F355%@D=,X2Q:SN(@>$OI!OT:SN&K,N;L['.V.AQV37:=94M!(57*3%XV9 MWL3%31(=3Z<)/47/S*)7>+X3;-7#LC'_<+#[Q\X7EDF1YK/.M?-)#GO_QW_[ M;VM/*P3$-7W/[/*.[%Q+E]'VUH[9>;J(WJ991K>I[$5;_I_UP<=K+_E%LNQ'HWV^ MQWN-C2555-)!-\;\EV'CYI[D1.QHP:W/OR[RLHR617Z=5@WD7.). #C)9Z** M9?/MEZ %Z=4*M*/^W7E2$K).;YG4S)*[),N7 %YSGP2=)I8SLC<.TT5K.H$CKZ MRHS3BQ9)$YK5+1&B=4^\P5'034H^8\I56M[R!NGH9LE5X^DS?T7154)$/#'+ MK.+/S_,*J+MJV21T,DW=@3\>F3+_NP$)D'_^F,OXC*=-K$F6U5-A/\A M26]NZ?/=^(Z@3F3Y<5+R,KU+9T2W2H+0-*.G9]U+N;Q-HA;@/Z6<74\D/L6T9W<79*I&[4*1W]#9-?)TNXL4T95$"MYW'X:O%9Q9_WG3,='&7R#((/6BA M=+S)A@,MB;KN%DF5%HD5K'"YL+LLC:_2#/S&V^>Z81^%[MHU=;^VEJV]B#." M8A)=0, M?PY#>YE,^]%XV,ZRCLLR:3GEN!0.,<4O"=VM.\@OS0=)1H.<7=(% MF2;T$%T#"XPXR_)[W@.NX2Q?7577JXRNJKY"CVQ-^I-H+NOF^;;&_8'YH(=; MMTRF0*JL(2.>$7(LJKQ(FR3U0Y$0'YI9_L$CYW*(*F'$K=L6!K3^F0\%KC^0 MAP8%9)A]MG*.UWD^NZ>]>/-#N*;[D5;);D;;FM$'1$1O4I"/]OG>ZWNUQUHG M?)NY< L%BWC!Z!0 ^;Q0Y$K M'(LDX_O1NA\:J%C1ER1;5[3I B+431'/.Q_,UBZ*'UD'/R.PXEBO:%6+I'P$ MJ=9,^"9?W.R2R#)GP:(7D5Q8VO=8(&Y*7,T#7#-!\Q0??7C- Q>@0[=Y1I2_ M_.G'?^>[4#6N*=U%Q4.A6T2K!OW!8#"DLU92WXN&]LX;ZA:OJENZV__:HF47 M)') MS#C_?1O_X41ZP->;3H@G?-JOA*DRCLI?5.0K>(4RA%)TR1=W'0=.TD0 M0%T15D4>;;FUFSPF Y8;0;UQ>'QU_'>_ZGCS8K5<9LPS:0!2)*;$J58L[UV' M+,DW4#Q^Z"E4R)D0PF[!L7&VF[VVCF]N?XB!Z;XVB_QYM=2ZH^=X3 MKJP_Q5J0UE_LGJ.^GB>@V;I'CQ^180A$+0+?/!6A4D0HNMLT,@G9N(>M+W3K M!!"_7M$2RDTU >^-5]!5MDG0WXF:IZLYF^GB(GO@ MI49._^\"!9:9A]R@%=XS8]%J/V2[N$T.V>VD^Y!/KZ])[\7JDL]3,6K #Q+) M[WPL&+;#/MA)9#;1Z#M5_UYTE=RD"PB[6)CX,9[P-IPMZ]^#TOZ-$#HZ\9F0 M;)COU+]2-,BC-?'BUD[!C!>X $C%6K1V UGP-]:&\71!O2:Q(T MB8(HY<86/A!WGW:KO?XC:UQ]WCRE-T_L!EF:0?@ K"W,?X) .DU)P*>)+I// M5?0B(QFQ.=7'MV^/S_\4O7\579R]?G?VZNSD^-UE='QR\O[CN\NS=Z^C#^_? MG)V<%L"])KF;(" MM&*KS>)[\>2 Z"[8"OS[U2*)1HIO>Q'0;=&*V,L'S2QC"QN"AF017)E\L8'VB[^_3ZI8G\Y@"YCBE M%=($WF#8W/8S?/YLIQ]]7+ 2CS, M/WQF%O\L>G:?X&>^*O#?JJ2?K-.EI#G';.A8T"F7T0JB$8VKJS*=I7'!EE66XK*,!DN(>#!0RQ90\B;Q;'V$?O0#@:B@?U&6Q)"G MHYLLOX)3YRXI=FE'NXR*M*CM9^\O3Y[M "SE"I::FSR?J9JZA%B9$6]?$D6> MQ]-DQ)[+P*:D<\+,R]TZ A@;SXM%N<%73 M*7Q9X@:I\B6#EDZ\G!;IDA';+$80XCXQ!#0J\@=:,2B,E:=*XX>AY56@+%$Y MS9(B+],RFA6KF^CRH8ROBC3Z7_\SXA7J/G:(Q749Z_0X(5S$UU.6:: )# &\2F/Z6MWQ4=-H$I90D SK<=Z2G MW$;' MDL@(>)4D.#42OT2)X8$)HI!PF'1][%_TY?#I>C_@:[B_9AVL8?O9Z^/C#W0Y M@6QLCDKG@5?'T7E&$$,9:XLZD1T]1!AU;QF0#5+*M\555J0 M]1GT7P;M\C9?9> ^$6*/E$G\>;6H<8FI/U#;&FJ;T!WS@"!%E_#%"9.14 CP M*)+SYP3*W3]<6B)0N>=,6 GNI<\N]W 0EKT9"Q)=Q;,%#T'W?Z',C$@4$3KQ M9@#VGH8;;6-+J>@F].@"IY&!+I B)*+LM*#;[ OVWNM"YD&$:(\+YBR09+"- M6'Q^2_]J.)PV@.FK0+'Y21DD CBMM0:+J_3>&1<4=CJ/_TQTHWK8)3H."U+ MTHZS3"Z!WE6!>JQHSL*(F!S]RYADQ)<7O#Q!$ETNO=./WJ^@,I2@NRS9TN;O MTGQ59@^1@CEA43F.]D:[I)]$>^/=^R3Y9 .N^!06^"8N:",S.?$Q7[,DGM[* M@XR._">QP@),U[T**%S$Q(UF,4V:Y25X%&$*/VYCE?2]7?J+R)B3_DDB(W:& M(U1S)_-"D3AG#')_>\P8;X#:WGNBMXMXYZ%GL /F%^Q $QL:FTB(S4.\N^9I M=(%"TBPEXZM0KMLF/E=]A.]K;<,]=Y6O:9JJ#8+=BW[I%)?JEC3>,/#@F AM M%HT\N$&SK$B!6B$C>@NBEY.!QJ["X)^(!N9UH3A5JAX\!&:Q!M6+S2@!19Q>#5QY/;PTG_3WK MDJ)#NB7%@7XFN,KS*_;["(;4]]FS^O>L.1',8&Z*P59Q> ;S1D_W5L4K4"9T=OG@^.*8&/V,Q/@VL3[G? MCZ[ZQ#(1RNHKX!>P[L?%##(EM*2ICODBR?)[7F(A[WA4I#3OK)8SQGL&[;V( MV'09,O%SEX)3L)=#@T.<$1,7->!L>('Y%%7\N2+>D=PE,A_XC;!362$$6/6) M-9=:TD003Y@-Q0[&3U[,<4FX>A]*AP'@ -9!U,P"7*8Y4O@'A%973MT$6@R M4Q;MG88_38OI:HY5LP9V;G9V)CMK.;B29/8J^A/=GV/,(O=!CN>EI[B(V0R: MRDM8RT[MOC%KJYA 2"4F/-]T\S:N*JB19W,H*XEUB9R25)D_)/ MP@OQ@F^Y MFDK]55_>DKQ_LTI% $]+%A]4W8+"3B"Y?B R=\=FDYAC7*P>Y0$=*%]Z#@^U MKD;Q/3;NBR$DSE5R"BH/LUB3>J&%# H1>.X9H'(/":M("&?"09+$C9'C^3V+ M$4+Y6$2'?1I *]E4#MTH7R[S4K9FN%<\%^GJ*L$N[!3X1DWXT#CC=+;+ALEE M6L49(1VQ/0D#%G2"%LN8#+$DPT'2,OBLZ .%$H.(_ETG:<5>ZKB4=>93DDRQ M4"*URKH,[5^LF&0X2-1(DPZG;F>18LV[A@L*1-(*AYNEGQ+AEVIRVXYMV$;V M8!64'9%A+5JX35J++1\_PXZFCA+!-D3)"X. *Y>G@3$E<%6Q9XTWTX].V?[- MEQ%7@A:X!%TBC"89+A3;#HS%P*TV@5O6P8IQ=1I;IXX==G-:,-:-_M)KK+T1O% !14ST+*X MSQW2SXG\T$'UHNL54]JJR$U\(L!?Y- !Z*5Y/A-QOOV1MCL*QM]Y3P\?O:=$ M@DL)#@S7FF?YC;&'_4+W^0U(55F#&)OSA7M7/D'#4<,H!5>IQ$*0"EW8\%N2 MV4F7*F[BA88-L&@L%-.P#CID8VW/>%")+N3AY ,_S$EYO6KD$6>'2:J##67" M2)^2A]"F=)635IFIAA 7!2ZH;O@5G6@FF];[PLY0&F4XLA'B!4?K2DHB M9,\3,)G'GQ*^M)FZ%"J1]CP\1IS];GZ]NWIDD_WHXY*#M.7LW*3"4BP=@ AG MI=C8"AB!%X_O"6%C"KZNI\/(JH*^VF6$?*.AW#^ J*)L&U;,ZD+[ 'Y MR&,$)-XFV6RWRG?G,%V!4G(X@Y\#P>]?7^^&A$ZW2!O7H,URA4PODE$3.60$ MX? S3[E8H\&C%RL@-3CH95Z!_<);0/">2B0)KEBP78ES;L2"A)DC7W3G&F$J M&O(3!6%*V^]@?F_D8=B'3]C8H_2BVS-OGY^ZYSV&TW#[G_SQX]G%V>79^W<7 MT?&[E]'+L^]/+R[/+C^>GUZPN=E2:C9/>"OV#)-$4I.EX8PL**MO[T6R^-=X MFJ6+G_Z?_V&-<\M509<3OF9GHU8=2L*://7<]W&+&"'A4)9HB3:J!QJ3,O>@ M#B[[MKBAEBL]O27"L"04S$@BQFIF2(!YBSF>'[=Y&^/@OWA4 />5P,\UE<"N/:#&J! M$Y/?B9!U0L< G=+8AV!3XDNJ%U0RW1 9Y5D9+ZU1RWI-FC!'PA\8U!7\<=:V MYGNWUE@X6UG6TLG/M$S6(3$$WK!6=V\!-N+"!E<@-0,LGX'A80>(-GN)A(

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͢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�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�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

:MDYCL$D$QVP5#8 MI;$ (3',83"JSB:P0(S/(7N%8,1"\A;Y*8W/8?AY^2/!C?WL\*Q$R241 M!254%*(HRKC!D0WV??$?",#D!2#J;F4(0/8>T%,2O.O00A22D M]">4I&?L]Y,YE)R P(*GJ)G1$49+D5!$4#IDQ9RQS#PK>3<=.#6U>$=3T[ ( M@A)X?O(?"9,D==$@P#+5@?\1?7S!OU6Z\A\(2,ZZ:$#L$E>0P!AF+RA=9U-8 M,-[GD,?".5=/,G9!&UTO9WFM0I].\?+^J8-8<%3FJ&0DSLL2Q8CQWKY(> '8 MXO)H-?3FUMBBX+,UD!RTM>*3>:,-K@N1#MS:>GW=Z76^[?:T?!(/VLVZ4 L M]['\!L)T \N"N)7'7J$PN97\8OYW>;9_([UV;!,4H&R%&<< MR8SG,1:RMZ\8 IQA\VDU^*PJ-E_P YVZ\$J]V5SJ,JQ#IU'QJ\M,KQ-N.8/R MR#QL\G29"-C.F_Q&PGC*9$S2R&S)/]%S2$A!_*I##U%(0L*O+#@>[6]OOJ(T MB1-T0$ RJ5A*I.!%@DOS:#9R4L,$N5 ,Y0NUIIP1!Q-%S M $P2T^6XAZ4F?&8'Y!SM5LG),_^0]'2Y.-@E*/_Q,$Q1(*+.)JDP=,\A307R MK X_6(&IZFCV= FQ-=R?E2\R4C:SMI(GB'7J>-WQS97R4(7YJ^G\>[W\@UIC%ARREL$K+0L2J*)O1H3CGA1@F5((! M]GL\& M_7"%N/JK=LX]*PXP0:T4, [?%G>DU/)$P);/@,PCQ*TKUA%3;0P?. M[ */&4S)LO7! @]LFY\D>(.1L;,#OLB<0W+PZ<[S\P%^>3(]='WVB%V_#=0F M)]P_,1[C+,L3152",LPD9S'I,?"2 _9A?%L.?OCZC56O89/T4 6#$HCW,)AD MDTM& )9:.O)-KJ?TY%M-0;Q' 78@^W+1L#V4[3\JQ@>S062-',X.0_H<4E4P MW^HIABUL,8SM3C-G8X[T+782WLRF&*4(8T3*O)"BZ,T1F8&6P*R-!%_X8B_G M,L\790AL+<:>4+-5KDFXA*YMO4*C1F:YG&5/(6P1:Q(J;9>NK"DU7KHZY_[( M@I4S8W.0=Q]NU)Y'$FSF@;/TB<'CSDE_S12IN*084\;3E!&22XI.SD!#NCWZ ML!9\AM% ?/FY/-E&!#4A\,*PV41B6G*ADP<#7BWG"QX(ALT1IB7:=E[@A7#C MJ<";G(R4__[XG$-.\.I/'6KDP38NWNQ+H#&0?GK!B"Q4(562B:1(8E72;%@C MRPML]%Q0&,O!MS1,V]ET7R !;G!X#H/9;L?E(@#=^C!MG]*3;Y5OO$) ME$I)FDJ"!1UF5ADG@/4I!R/!)S9/5P&>WWON/C[0 I4+HV8SFDG(A$YDV+#A M.S27U,@L)R_V%,+F+)-0:3M5L:;4>'IRSOV168DS8W/0=Q]NU)Y'4J"NT,O5 M:JW'W?)^M5W^=MBN;Z8_>4YBG"G%N5193'D^7)DD)$R/:"LD@?7?JD?NT1'] M.M1O5@>'@D?0))7,*7BP?//_-VZ!NE('C]^$/:K!#'+>1)3!LMDSMH8"WV;RY,(?(/=,Q*-=5K'GTRQ3 MG'?^7 [P0-<,U-V'%[7?002]:4+2XT);?ZF%QY(F/"8T%00E$O-LF*#Q0@$F M0Y8&@F^_:%1/E[F@=QQL:#/;1PG.&'2[I"/K9$'>NHBP)L!$Q^/?#BZUNJKIM845?&EQ0K;7AS%!J ],%5EK-5(JSTU<]!2)_S/7]EP9,*XV^L+.SCE+&.8%WEK^O'G9- M\'7&U,L>-UQ!7]0R.+6FB&DN%,XKC(3LF? MQ?87E+IGBG' TV*Y7>Z^M( .+O]%*\E?JOO]KO\GK;:\B]$[W*G+&]R\HC&^ MV+RLTGCSHO8[QF"JHW__^E9LJ]5ZOU!(Q*E4)(\SVDA97&0E'CI:YQV?@GE_L*+5B."]Q,)+,X$8HR6N1TN$E! M"PX2"1<[T]8D5U&/+M+P7*H2()TVE4DX)IVJ$U,2)ZA/GC!D7*/8\3H/[?'B MR6BMXL*.I3)MFB^[VNT_-A8_[?71Q5^K9B0V<^Z[:L$)49S%)2N5++!*DE0- MQV!HYC)Q=G6XVYM;U:GWSZ_*'_NM"(*QHDI$8B3)K;)48Q[U-R3&V METJHI:G5L<<7'0"ZJ"&851L!#$FHH^89K5Q^I;]_N[ZUN].J&OI&@<"X(Q0YPE*&,2-T5E(42"&HTLF&29+%.(5%D; M":Q21UQZ*>:X.*.Q3?M1G6-HY'MR)G4>GY*[&[7GP0;[@*[W7ZOM$SM8ZBD9 MXY(QBG%C"9=#B];&%H)\.?!?#_S)M("BV_6FF8"N-W>P-&[!E5GJ#DL3+%UW M#%U23%ZP,:(B]LS-0SX<\->^QI#+#.'OF^5#O=VO_UVMY'IW4S\VB7];/:P? M'WZI]LT?$-!%MU6ICCBF3+"D1]=)VHJWN^67WZVLB?_K.H'[ZL-]7J8#Q66#%"2YH* MF@A.J&##B0')S%Z/]6PR\-SP<[U?ZK/:VVW]6R-%NZA^W._VR\T*/%'T1;&Y M0DW,+ERPKDZFE VE48NR_>M5U .]F(B]S=X;FN:1_OE(G$^G7E$\[YP9]PQJ MS>EI2'YG$-O "U#A+8@NQ:KVD-[#D^ .T7\=O_PT6X M!C8GFIQS^U9%?K@W;UUD0LTK.24,M3.X:N/?I^=-C@(P9G,X7BUOUO?K_8^? ME[^O'QX?BKZ:%,MOS;_9_UC(E!>)E'&:2RQ+SE&*CY.E(\C5&: MZV>+6:E$C.+AE&TBD5$?8>L?#ZPVOV[KFZI:[2(=Q_9&W\[@2I\GWLQD)BAE M,'EY>MCNLD?L $?K0*S-0T3LX8\JQ10VXJ$4':2SE0*/!GL5$#,)4:!;D07IS M34.BW;:#)9F&;;K.>GYN5\$#5S/81_#A1>UW!,&*Q?+W_7IS][C>?=4CJJM+ M#U-:%>>L(%@I*@DM&(V39.CH)%BT0.K\R@6?3A2>Q]Q\-W+7;_J?]@Y7:2X+(I2(15G9:EH MG"HRU*4I34'7)ZT,3+H;>=4?!X#O.,*9,]]9#$J:RP[BVWP%VR5\SLD;NX'6 M%,Y#7]Q<>&5WSY$/NR4Q47^O-DO]OP_?[M>Z]<^"DUS17.$RHYC((E&Y&BY6 M) @5]@MC%L:F7A[K(49'C"Z+9#;TVBR5!6;6<<$,0NH$RV8OR3)>/'/@>1ZJ MY<^=T84T9YYIY7K[OWJ>>'W;56?7Q\L""Y$F>NPMF_%+GO#3HJ$6M__5A=>3:]HJ%_YB8UV47"X=+S>8C$I.=_1IC%'C^ MRTMPYJ&KX=PS. ?FD4=3W?V\76YVMXT$Z2LBU?;[6M\0O;Y5W671Y3W?[:K] M[G/U^[YH:/KG LM2%2@A)49Q@E/&8Z32E+."",$R15E* M&"]4F: RERIG.:;!VSD.<-O#[;L>L/Z^;WO(T;+%'/U#HXY:V,"V^=X#8J:Y MEXP%3'*?AN'3:1@&M!$'A"&(X@+Y'!'<4)&9A]X&\ZZ>9GS#U/;3S==J]7C? MZ'NYW&[T!=A?J^VGK\MM52QWZYL&FUS?/^K;9,LO]]4139EDN2A3DN2L3$N1 MEIG,LB*+"4MPDN>@1M^A, 16WQZV_LZK _#H6[6-=AKZ5?1%@V\E8=7!A\EN ML,B8R>\<@@*3X=-X])AUV\GH4Q>/8HC' 7DCQAI[=#%)MN1X1)I#1VT>$AW< MRWK:;\%6LGL(U4JOAE2;77M6X=.^L7W]3?]QQV_VZ^]-'?\,&,8%QU+03"JI M&,\3Q$4/3*(BQG)OBWU1AD@>%SGE@S".WPV+TS$M=%1 M4%'?-W^NMRT$?K>MJO8T_-%F&BM6%H22-"FH4K2!D*8Y8W&<$$Q3\Q=8G2T% M%O8G^*+E -!B,<03L^/:/#VI,-E]RB>? 9^ 8Z.3\FIW>-2-7[,SI&_1<.XD MJ3?Z9G">U)\O=8@!9KV"\Z]'?76[VG^M5^\WWZO=O@.@,\X",RR8R!@B:__YMO=TM[ZM/U8V^>;6N M=H<7NO.,D[1,XQP+*K!^2"EGO5F"BQBBA,[& FM@N=NO']K7Q6[U]O_W?ON_ MZK[2W0 7IG_N')LIWZ3TPC1O@/:NP?9.@XN.Z*)_=/@F%KNWZ!J1.6],ST/@ M_+E3!QJ1%@^V_-+XWAW@[?8&#Q8)4@J13.0E*LJ89G0XDNLQ0X9&8AS:&< PZ4[7E#E38 M??ZZW'RN'K[5V^7VQ_N';\U431O_4#?*O3L!\V^O&:]YO^0,(O MU?Y\:;I(XSCEDF=IQM(\SE$S'/E0E"H">M9A'H@G*3;WC9?1OGM MHU?1^NCJ5?3MT%5Z.WC;_/OA:%C[YM=5M'PY;[2=A<\C$I!B^.)@0Y?5[8@9 M/(R.+D8?#B/F_>F(Z?N0?WPR8LIAQ/RB1\SH2L,%JO7007RK[I_-()I'EIP9 M)Z_-1>:##I2;1;W;OR@(%K+@!+&B*0204#0K<\K*WE:28E!+8CL+P4]-[/;1 M0UG&(I8QYZF,8U(*WC"BLD3UUFB9@.Y5V-H(O2?53<1=%<::03.-F8(\F,J< M7<"8N/?3Z\2,*(TKE?/0&FXF"XF?PN\J>F/1<0Z%X1BGX)K12X#FH;8A M'32J-#UR::K#?]]LJ^6]7MC[VW*]T;G@>G.B_OS+;K]=WNR;*7?)<8)HD2,I MBR8E)&*P+F@.:NGBRV9@Q3W"C#3.OF:J-T]WJGNXP.,!WH@W4]=+< Z35&]T M!U%20_Y&Y--W!.:AF=Z]JL..6\N#ZZK>?EK>5YUL'W'OFWOF*ZV^O& M [N%5)R4'(D&2F,V)H*@ 0AB"'2//X#Y::K4X_;Y5;3<1S=Z,?Z^:N;UQ[+4 M]GB[QTB8*>>%@P 3T5/#X_W^B+-W[9-6GB:* J](UU]7OZ^2'":4ZP85D25BF1, M%,/I6B5BOWKL"5-@D6ZQ18_'>NNN0>=;CWV%QY-(7R R093[Z$?4A?%9V7P5 M?6F=B1IO9B;I9B%PT7G/0?X/$7_?7D,S0A#6PZ<)/9LH8+Z[99XXCK.Q!=<>D MK,^?6;)GIF_AB8-)V5/.+G:8[%5:1N3)C<9Y*)&C#V?>0G!AQ-,AA$6,)(KC M7 I!98Y82CG/>ZMIHD /,KO:FN[0P5V["W[?[X);ZX\SNV9*-"6Q,$TR.EDP MJ^,$]L<(C&F>AV9Y\P9V; #($KSGRLGTMCW4I5M0;ZNOU6:W_EX=S]T^ZSR= MQ(E,XX(E)8F3+(OCI,"X4 3A(DUSV,/SH;$$UL'3-B'+D^6K[K#KS:D+C3)V M9]H[J02TDK],$,WD=$[Q@\GM:>A.5QZ[D[%/T$=/KR/,YQ4 *\Y'5'NJ:,Y# MU2?S]FSKF"E8MG@=CU;8EV=R]W]S6VX>V.77QX_ OCV@R27*2*XY5 M7@K.TX)1W#[:AZ7 BH)NM=MB4$CEF) F4<9-7BS+O"0B5XE4:98V(X-.F 5V M';9HVR-O='^ ?A5]^3'\/_QE ,\!@RK_Y6)EK_@'6-$ .GK_+$R?X&$*_>8+ MA&R OSS_I$I!53VL5SS(*1R5!LI09YTU>D?IQR*R7!)Y)GRL7 MSRPCE5"2(%&F3*5$J3S/6(X*47"4B42AP,IMM([AK-2>@^%EH2-@' (L>UQ< MA4%LVJ^+6$9E'HH;R#?8FHD3@\;7@I\]YGCR<*-@"B>X1 G*2$P+2EG:/6'- MN* %J _">2LQ23.9%W&3(E#*==>'QB\9QQPA+A0)W?N@?/%FK<,CX0YF+FJ$6GH^%#\Z>__J'_)\U_ MZ>"]=JG^.J]+;= M,_N-BY:8F9Q2BMFZN.SY]0=0IJA,6Q<*(BE*[IXUW_.5__Z__\>__ MS\\__U_]_NU/MAHM'XKIXB+QWW[YY<\_ M__SKET^SR5^KV=TO" #\2]UJYQ/QIY_7C_TII**7\9?77^M%YN>W!\%KXR__][>V'U1!_+J?S13X= M%7_Y7__CIY_^?59-BO?%[4_Q?__Q_LVK]H_%;%;>57\=50^_Q+__HD:C:CE= MS-\7HR+ ^6E2^'RTJ&9!,K98Y.5D'KH2>_1O][/B]F]_>9S=50$ R&#H0AS^ M_VS^AL77Q^)O?YF7#X^3@,4OK7;V]VI1G-+55^V[[.C'^-,I/7W]@C:ZNGQ8 M3N((T^.>RG)=QT6TZP1HT[:1[C:1YL&$G76LFT\,M3^ZRDL,$HF_3_8-,6NC<=AP6TB*^?5Y-R'%?7#XOPWZOO MWMPFV%RGO+.- =7?U/DD;CT^W!=A<6G0Z_T-N^O:NWP6@+DO%N4HGR3W<^M; M6NWT*QGF\WL_J?X\"M>]+^BLJXU9VZ#UR9VTQ2QLFA8KXL\7L^5Z>O^]&-^% MZ:U&X4]AK2SF+V6[=A0T7+G:_$9_ V[\H,_+V7_DDV41_U(T7<[[[L< @?L] M2G=>WDTCQS>MSH=@PPX-$,I=&]#?JL\KQ7$V2(_LV "A_5A\6;P-?3L?+7?U MH#^PHI'=VKA?OJR_(32ST1-?U\(P&G*K90(\AP[""%TPYQ=?WTQOJ]G#T\+[ M_+>#?3KB'2=WV.6S:9##_%TQ^W ?#,Q#G=OU?.L=:2C \U:[U8SUN]O=7*G M:L/DMR*?+V=/ENS67[X)9F[4#R8/KRC&:E$_U1#?#C[5S?#?%I^+"7Y?32:G MC&SG6[KI=)-EX&##;KK6C.@-FK;7O9OI^V*TG,5 5-"-P;:L?]3YO&QJ3B2^ M[N1A_%I5XS_+R63MGGHS7>33NS) ]>0]Y>1./VU5/N9?#O=LRZ-M?KZAI'>W:*$SX^)3 MV!;'$$J3=6#7\ZUVI!EK=K=HH3.?PQ)RS&38"VMK@Y*Z\+^(^>[181DO&A-U''O+9UYO;#^7=M+PM1_ET\9R2 M&";7NVI2-HFM'_>6GCH=K.S5UO+F]MVLF ?H5CQ;_?5K8SZT_*'^AA[TXO2N M>#-]\<>@+D=E^/"\7;$>^;%C(7B982V?0)@6=S'$]3;_5'P3X-_6;C*;O6H6 ML[IES.J&;#7*;6]KKY._%XMV^_GM"]OKZKMB5E9C-VT9V.VO;;O;'Q;YK&6D M=[VXO:Y_+&;SHMU.?__*%KM;+?))R]W][I6M=#>!"8OO>WA8[(\O%'Z,<3X_ M&E_9UFF,I\\67Q;%=%R,5P<_PHB \HZ_R?9\1GV:KQ+VUM^9Q+'^[2_A MQ5G3IAFAF&NE,.;22J:4)II#A*5&7#)@]>LQ3&).3#5[QF[+()X!6TGG-I]_ M6HEH.?_Y+L\??XF#^Z68+.;KWZR&^S. SZ=S_N?SK[,ZW6AE*FT9WO8',RD0 M!TI1@20FW $O.5H/ACKL#PSF)174;/13-1L7L[_]!?[EI_"7VR#_YR5FS_&A M%3,6WTW@?#;ZCE"O&SX_\,]AQ@!IRS2'# %U]WG"..+Y\.I8JO:0:XOP?]6/'PJ9H=$ M__14YJ'TR%O$&:148Z$5L_40N*97(_P$J6V3>Q)L/4C^MW):/BP?#LK^U7,9 MM5)C2+RB'G,1)H.E9CT,@ ^N:Q, T4 M!UAZ0$P]#*2536, NE(&G !=#PRHU[=@H1>KQ)DF1F']<&:LQTH0)YB#4 NL M =>U.01UHF$X0"ZT9 B<#.%>3NS8Z?ARFD]'93[)5Z'T8O:Y' 6;]K8HYH]Y M.=XB\2;-,H8@<UP MBG$>=M!?1I-EV$=' #X]G=>8Q_,:AW;!1[TL(\01*RGCW/CPW\9J4RO2H!03 M[8^,;-.>F:HUC98^11I8Y3$VA.(->4(L;-HBBV=CZJWB6HXU#23D"G! M/>#66! V.LY8NAXP 0!<6B3H1],B5%,G!8'6: J%H42' MO<=*M(I)J,U9M$A8!^,N9I7X$$ERLPR];C#"0W&GD]Z;!:(+AJ22!&"F'%78 MP354$+-$S]05Z9_&7/K6C]VC6/KT>KE_+LO%U]CQ:KHZ#[H_ +:W788(-A9A M9H+ZU=P)KQ!;#],0>45QD7[8L,MUU@+X/7#LFU[:ZB$OIWNXM?7Y##$*&9!2 M&H$L% $K1=;# ERBJ^%42]*MV@>U!ZZ\F#NKS>#D26#C_UH^9>8?#- T>T&F MXV2S8;.(M0120>>(J*<>M.IJV'2BW*L>T.V75L$2^#5 $(T"']#:U$*YF?V? M93XI;[_&\P+/A9*>JLP<0[KDUX>-"X68(Q%$(2#Q!"%2RX12FJC@!N0.[IR2 M?6'?.V'_,9T5H?__78PW9Y36(SV2G(=?E1GNB:<4 N["SMQ8+AFMEQC$$GT7 M^,QD[D]J9S!4XN:R :1F.8NR>SH@V(#I;7XF XPQP*@&A@#E MPF[6RUIP!#+1]2;NT!'&JY\!9Y3FF77]B4J]'C1B"$-@ <8,0JZU@!M7MS,T MT2 Y?EOXW>'3J^=N!^*Y:M-9.&8@!!#P\'\4$(&Y64.!A4]4MC3-=/[V#/W5 ML[5;:9T]0VA;+9(ND0 49!MD[JHM8?W5JZ(XK:>6V';0:Y&S;0DS6\Y<@*8*745XI6>RX=B]O:^<'_M% M_.*13&ILE>8.R*#OP@@ICJ?"GSI$&+XB%7^Z5--QNX!R29Q[+;PB'@@D <7Q M-%[M#/"IP;T!)AFWO=:G0MA' &[E^KFY?64POYG&2BRQ8NTV8_8T[^Z M?O:?R_(Q@MHV4QM\*-.,RV!*TC2<6F(:U.4G"S]>W:/=*W?9%,"PNKPS: MS5A>WY%Y&GNWOCH3!.@PZ[6"3"MMG*>D7I&T=XD5N09XL.@\?&T#]!X8^N;A M,2]GJP2EV[?5].YM^;D8/Y<2JW3Q-. PK-L]5&S\CDQHP\+^+&#,G'<:,0WJ MG1KD.C'*VSP7K._$VQ:IUQ7(P]SZM+OGR11Q6 #EO-::8V\X8:".00B?>!$! MNVI=USW./5#O;9E_*B?EHBS:WGJ?^.9,:ZIHD F3/)C>TFN#Z[ K9SRQH@&_ M:DKVB_D [<,7 +1H&KYX:Z:T%-9#(1C'G,1D/&K7$"&&$B,+XJIIV1_> ]:8 M':C*C$%+XMT'UC!,@97:F%H@"()$'Z6\:C+V!':/Z;YS7*6=W>IC86' -"&>6 TH9UT)J#&S0 MB @J [9Y5V?ICF*#D]'+3:Y,T]W/7R(=SVHZ5B-QV5\+)]L:-.H]O\9>I,A M")7 2@$D.:4$!T,)$<8=-P((ZR[_*L&V:+GS4,Y09=6=QEGGBJG1/Y?EO'S2 MD.>K%;[NCJD>/I73)YP;' O+>$U)8XICMB9KH^M M.;=- OKKBY\.GA(Z\E69)]H0SQ$A1$/**-?:KP&A$%]/;>]V:+%36W0"]\4F M7V.(X^6+4DM "!.:(UD/4UA]/>G\W1'@J/3LX_ >;'JV4- +R15F4(7%.LP\ MZ=;#T(A=_IZG96GN3<\^#LRSIF<38; TQA&EJ0- (0;$NJM0D,14D"'*/4U" MC=*SCP,Q1=[O \RAW7T^'8^+S\6D6N631&LX+J++8//.9O%NU_C;'3/O#OFEH[%Y7$-V62D##[-&,>&.<- MI=RC]?"PN9:]HC )IY* M'&(F;%^[I?;0/A^A#NZ=]K;+;-#1"CO 7 !.0N0 D>MA,NNOQ['3BJR;\2<) MVAX8]&LQ+6;Y9.5I?BBG9?1JQ7IX[LMC,9T?KM+0J'U&D 740"$0T0ACYZFG M]7;%N^NY-*LEZ5?=@]R+=@J %_-%4RYM?3Z#D#-FD V;7(Z1@YZ3>JMK@WJ_ MFAU<-]QI ]0>N++*UFI*E.\?SK -J !L#/)4(BFAA+4;GA"H"'4#4M. M1K3/>$.K=X0*[#@0CBBON(:<& KKF: <2JR9.\2S.;W'&UK NP=:M7,M:%AN MC?7, HDTT2#H5EB[4&/1BZNQ<%J2;J-K08\#M0>NA X^5-,/BVKTQ\%%ZKMG M,R$XXQ@ (*67Q'#J%*Z#,_R*8E0G2K-J%\@^#A<4GQ9OIL$L7^X)8.Q^.+/> M".$55/>]J5N?"U9Y,,<- M1M!R2 0UEM!ZK# 8_E)GWV3 PL*M)9K4URB-BPBJI/2,& M(5XK3002Z^X/\0QN7\M)2U"?B4<'EY7=C3+LK2/"$PN)$AAHZFCM!H#$))8) M&J#".5W$#3B3!&HOKMK/ :)J5C:X9?Z[9S.F<#SZ@@"6ED!.K7'UK)+.7$]M MU#9$^IU_]C0T>R#'SGI !ZERH&4&J!8<"!,V@LKC,+4@KT&C0B5Z;0?HV^^ M..UBV\=QYVIZ][&8/43+[B!SOG\X8PX!0J!7&@(51H$UK2.R7O+K*=79 5E. MAK,/Y]JJ=,3HZP&K]^5C&<-Q*P"L9(3*P'>-1!WSI-(G*I AEO;HR](] =[& M')D7H[_>59]_&3U_ZXDCZY^^YH@DJTG/@$BLQ#9 2R5-C%7K$';-"?>/]_LX$/Z6"#J9S*C!?8:8TN P=CXL-S5.S<#4Y," MAEAAIZ_5(17;OJAQT*Y\\51&#:84!0"DB!E24(D-" JKZSD[E""U;7)/@JT' MR?]63LN'Y<-!V;]Z+F,$&R LM5P)2IWWR.LZ!8H>K#YQ8=(_5G95>]#UP8#\ M2S,&O'PN8YYBS6C<^#!FH"+(V-K1(FVB83! [T,K##@!NEXE6&I>ZKSH;_^EO]7-5O=FG;PN,51;\HH,EX;A%R\4Q0YI!57F^BC M3RRT.\3*:?T=P>A2 NXY8H(3$1$-;.'<:N)VK3 M&5>.XV0+0NB!EQ]G^;AXR&=_S-5TO/HA]O9PQ&=ONXQ:[[F*5-]VY6C<*2L#[X&7IM-P<_&\04&[3/$*,$_7JS]+J#_[P,/-+"._)-F6802.:"#2.9)-@RB<$:"J^N* FP$WXT MYV +X/>21KQ2UO&2E=']M)I4=U_?EW?WB\-VW8&6F71QL(QS 1&G'$.&['JH MR(C+KU71.0>^RSAN$_ >N!5O5:H>'HM%H>YFQ>K#N+*,7$\YIKX8U1K6*5GLX>/S:E*.RD6^_OC^=/:=#3)C@K*6RG," M))6.2$+$NK,\[->O)KFG:V*TBG,?66'EJ)@&(_/N" 6SLTVFK36(2P\,"[L? M[)E&VH'[%I,LYK]87S+VY>W9HOE,!@!E MF!&AC82:$X_J[%(>[R1+C)T/\(A)+_KZ!&A[2&+,>(F @T0P<8-IF7_JC/;#[.*+TO5/IT$FW[2TR M+(#S0%'@##6< \!D#9<(9D[B!G6 .]3^3KJU O696!3_&.V#0O'XL0UH$,XL) M0CU%!!#IC:H]B.J*,L):E%'5&IXI@OXX*Q;EM#HDZ&\>RSQ3%D!K'+$ >801 MQ?6*Z !)7#8&Z(7J2-"GX9DBZ!=%V&D5R-WZDC*K0,< HW/HSRF?HS_[J?":^?RF!@:G2Q.PF9\%9A M;GCM!\,^,;0Q0$=11W(_"_1F@GZHC*9\$9U)$(5\L9W]6]Y,#<837CV5<(D60P#*2$'(@-:[C9@:E MGN08H#>J(SF?AN=)@GYWG\\>\H;B?OEPAJS4&FGN0M>@MIB"E^8E2LR"&* 3 MJ6NAGX!JBNA__?#_[1=W_4 &F1%0$2YX8&3X?A@E7G=&,9M8R&B !_@Z$G$J MDDEB+2:C?(]?^/N'0J>(9$8!2B2R0@$CUE=^<"6T2#R?.<"C$UV)]P0T4T1\ M\U#<'5#5+Q[)="PA[:1GPBF$H:3*UJHDC"_5GS+ A,F.Y)L.9@_^UP]%K%ET M<_MF.BX_E^-E/IE\??/PD >TRWRRS4M],&24^LH,0FFTH10P Y0TGF/+UN P M8U-O+/DA7'<]@W^>R,#;\(LWB^+AR"!3W2SS4"K'$'',!Z&%\0E63S\/8&*9 M>#A G^$Y(TVI>/= JG?YUY63ZV/U/-_6W2_FOQ>+FUN3S^^?_S+>0[)C7I,1 MPQ 0P%D8JP]BI13?)&O!@U>.7W1 (H$*WQ9(ZP[J/O@6#^44X[D/8-GR= G\>NFH=IX*O90_Z^^%Q,E\5QYM6WK3,I/KI/81[F,;F4^*^7/O?JVJ<5R;]VT1MSR>@7AGF='(8!36:B8I]?6@ MI"2)M+F,,,_IM&D!TAZ5CZD>/I73O-[X/J&PRGLLQJ::+YIL\0Z_)$-,4\L\ M8]IRZ TE/DU !2SQ N=+B.DU)XJ:AWH/C32?,LG\Z?A 2/TST[ M7Y,)S1G%SD5'?LR: 0S563.&L\0ZM9<1^.I$^[0%]7D]3;_.JOG>;?^!IAD. M> 9-ZZPP4DI@&(7UL@X1N.J(6Z<>I11XSZ:[%N7T+HSCU9QX6^:?RDFY^'JT M"MO[M@ )!L11@H1'3E*IV.9$BP2I-7@O) C8E2IK$_*S5DKYQ[RX74[>EK?[ M/ =-FF>**,N)!!XX'X9.PNZV/HYJ+$[< UY("/!TGG6 <0_$VEZRZOD>ZSV, MVMLN QP!03@22&K'A!'.U_.'8YMZE^^/XAEO$]SS+)'OBU%U-RW_.\R%<>AZ M>5OF];'-=<0HC&ZM<$8!!/=@WA(P0*K2>UQLCAUKOQH888A"^W"YM+.N]QZFCL[OY]I:;'2U#,# M/ $($T7J@SW,ZE1;Z$>)K0Q12#W,C1A&^K.<3/;0=_U(!JTS @%,$:,8HWC@ MH.Y\V+^F;MQ^E$A+(HX7IB W>]*^S(D77\P M4)S&$^["4.!54C4>Y98_CB1 MHC]*>&<88NF!\0?*=KLOH\ER7$[O&JC'8U^5,6 I)R!L-P@"AB(*Z:;*CT@V M:G^4D%''>)_5R7HP;'2H:4:DCGF,1!+.G (R;&GK\Z!0N-1K,X^.&WTN9I^J M2Z17RPA?V.H=B]2^W.CUM(1_^]E,AA7">.HD<L@*_2C1OO.*XSRG'MSM;3%:A(EI\T5Q M<_OB+TT2 )N]*'-A ?2 R6 9AAV%CR)VB?AW;OBMDH MBO0N=/X_JI@#%-:%(LAY,ZV.HU^#%V84(PXXDL@Q:*2%@OH:&(AA8@ _6C! MLDY1/\_Z_FY6?0Y#JJ;YY,WT-AXRBK]]$XR6,I^HT:A:3I\&%R\HF<0;2L;_ MM9PO8L0B,4^BC2]F DN&G0:<$J1DK(!MZ_QRXY/UZ@\+OH M0<:%ED!JSU6\,@U@H&A=P$,:D7BQ(?I1(G##%%-O!Z5NEK'RZS0ZQP^>EGKQ M;&:DA\AXZ2C1V'*M(=)UN2HF$N.^Z$<)JIT*: _\^#@K\OER]O7#HAK]\=3? M!G;JGE;!2B>4 @.@Q/%TJF:,'0V,;2"?Y302NL( MI]1:BC&9AVEY6XY68!AS8@5"?.UQBI[P[D%'K4VU/;DD_UG$VZ2+L?IFX5I9@4-P#OK/&3&(B/7(&F $D_WXA\E2-$C]N<)6:P6_G>SPHI1AO/_FU>SCY';N:UQ_X0-_:WSI VC 9*"P!CZ2LLJ0;K80@L4BER[7[P M[B"^L&RY51GKISA1&'WE*$8?=X7'#7YS,)D/12 HR@#^8U(EIM+&QC4PW''R4H M,4 97=C$Z/6(P7-Z>L#,,Q3 (YYKSXE%M+;7/8&)ZP#Y4:(H9Y?(A5'\>6*_ M_,-3CLW\7?XUOJ/?16!W/S)"!.<&8164#/7*>('J*(61.#&!@?PH<: A"^N4 M#>:1X\FWC6=^7\T60:X/X^+3P3UIZQ^,M:X 4TPC:H%B 2M/ZS4449-X&ROY M(<)30Y'*Q:O]L^GYS"KJO5+(88[B'>B8T=K%0,+/B?3_40)A@Y+.N35Y/AK- MEL7X,?\:Q+*M2$C'7\PP=QKZ&%SD82\D! D;I(VC@*9:*=<>BMGCK+J;Y5LOX.SKTQD'D(9=/@=A492(& CU9I^O4U-HR+4'\08JGPNS M5C85+U[\[6TUO?L8C#6[W68_2S\R8;C# A-.A(-8&>F@7HL!N-2D'G+M0/^9<7?]R TM.4.=2-#!@/**&*!0'+M M,=P+D-6%39BM^N*<"TMFM49::&.)15PQ(:"L]9/1%"9.C7^%A,\CH N;#_W/ M@I?0.J"\E9X8A2PARE"[OE1<2(Y@JD_T7['?/L72 ^-O'E=W.#T?""_>[J_6 MN>7IS",52R4)$>8L=)(Q0^HA,>Q3;\#]40*NIT-ZGM3H^GKGWXM%(^XT?D>F M(:<" 42M 1(SL&+G#F;>LT[_=$BE6T#W0//WCP\YN4L)D[>W,:MYNI8RI.* M_5CIPI;SQVI>C&]N]_"L\3LRX8VPPAFL(?0"<\Q);7Y8)%)Y=NUQPZZ!WO#L MWW]YB7'H\1^KWW[[R^?6WR$6-.NLO*O^&OC^!/2VF?'JE/]3!XHOBV(Z+L9_ MZ=O6G*M/\\4L'QWI7*B;95 *!8RA!&(F%3=,(1(FMX>6 T<.WGC9VT #-T:3 M:KZ<%1\#V#I\]X_CAKSE!1DW7D$&+0)40^.#@274>O"$F-3[8H8[FT^CP&&+ M]W20^YW*'U]EW5[Z7/9!1^( *[*K,R7<,5L+$BAT*!+:,.SV871?C)>3HKK- M-TC.BDF^B,>2YXLG4/?-TI379$0A# $U4%!,#=,86+8>'*8@,/<^% '0,',F7S?NG8^S?#H/0-5+2J*-A[("^7>; ENY^U9 M&++ET#CFG)',,>8W,%CO4\]/7#D-SR>![DQL4TT"QZJG,:B[65'$O?Y\?3FJ M60ULM%CF$S6;Q6/1JS_;8I&7DR.M\!T3YE4/\KH'^711<2@C#:+S1=#T8#&EBOLV [/!>)?Y=1;H3L.[!'GH?AZJ^E/N\]O4S&200 MQH(7 GFIG(-Q*.ON Y!:1VY 5#E5;%4[R/4E^-^*AT_%[)#HGY[*//.&$JJ M](II@16"9#T$)E'J%8_#$WZ"U+;)/0FV'B3_6SDM'Y8/!V7_ZKD,&2N1(X)[ MPIDQ0"!=*T -4B^O&ZKTCY5=U1YT?3 @_]*, 2^?RP1'!+'0?0.T#?U7P("- M$I2I5[%<*0-.@"YE7_D^@!O:W8^+S\6D6E7LG\<[7G8L[0?;9 [9L// G'F- M>,Q5-%0_=1D1+E,#HP.4]HE+?=M(MBE\6SWDY?18\3^URD)?;=!6UA,B*0K; M7XW9NML8T,12U -2^"U*K@D7DF!-8<.+G<[GXET^6TR+V3XUL.OY+.QTA#38 MQ!IW@#NIB'7KKAH)$@V^ 7HCVU !+:'8EL#W3_W=+<)&5S- &( . >=B0@C! MZ^XRE'J+P="F_>G2.B3[)#A3I/];_C7\DM8NC9U6W9ZGL_!&1)T(*DA@SKWS M"/EU-ZE2U^<#2I93U3:8*3+_?Y?3(OZVH=!W/)XAY9&!(MBVC%'/!8K&[G-' M";")!U('9.-U(O5VT.QAFU7Y-G,+UPQGR@EGJ O>P8P!('/:JZP%) M;5+/*P^''BU[^TZ&,$45O*L6\21"/HFQF#)L7 ,?RTDQ7U330/:O*_-SEUYH MTC8S07^%K:L)DX1)885%&JZ'H!U//$4RH*6A#?%5W:(ZM !?0L+L)87WB).2 M".N 9E8P)V+QWMH(A >WOBE#WT!_,,A_J%U&@9=.$T8HTLQ[A@-IZRTF.QB= M'/Z,[57&.PS]-J ?VK3>FSS[W-$3NO3P4"[6W:AUXZ@\3[KNGNYL M]9[,(@L51\'HY(Q"0S0%*!@;GG%L/6;V+(D#C8;0) 'NN!=EE -@*) FV!N M(2L5,\1+RI67P.+$4X,#TE,=B,: M"W07+T[ L0]Z//?N']/Y8S$J;\MBO#-V<;!-!A0F\30I-MX;I:0GM 9+F=22 M%T/6+FG2_98K+0%Z"4Y-[9V"V*& $1!"Q:N:U@,R4B<:G0/R>7>E1E(A[($3 M3;H2//Q^5N3SPA9/_]O ;#_]Y1G%5G($B$?( HPILP2L 9-8']K^ M7Z#R.9URO<-^1I[Z:E:4=].G$N*CKR].JH7-P^JGR4KXOX:E.8Y?SJ;"DL*X,YQ*PKCP@F&]AESC*TH6[Y.>#6?&^>1XQJEC0[\_ MKT+\\_^SS"?E[=S&^*S:"J&8K&!:+6?EIN5B=N:O>Y0=JN7;URCUGT0&9100X5"LA0U'J)8;_FB>#E>%9%Y+;8+.. M=3$-_UB\FX3E,HSO']/\(8[NOXMQ-\97&Y_-/$9(5"^H^+#??'BYN$SI0KXEY/)RYL M8K'% 7I?VU8CJ1#VP(GGJU@.VUBO'PR8A"T/$L;;8!W'? @DR'H@B)J^TLO. M$IAM+,2J10C[V#SF\_N8UFL@-4^U LHU&U#!U]7XR*T.F@ M1\,6V!R\!G)?LTQ8#0&T7F/BF6&0>6/6@Y227T\J6DO4:1','ACS9OHY]*N: M?0V=W,.0EX]E5!-APNH,HIT%J$)(ZO4@PD1(-%H'&.AJB1$G@-<# ][-BL>\ M'+LOC_%\R_KLW=/0#ZN.!JTSK+F!GGL$-#)>&8"=WMCD\'I.Z+?$E_8Q[KWHDNJQF"V^QKCB M(A WVDZ/S['WO4ID=[-,2$A8T)=06.:A,!+2>I 2'KQ=9@=%!GC/>FO:HS4P M4RI]_%I5XS_+R21\^E>^/+S];=& 1HTS21#$G 0M MIR"2V(7_KK>"1NA$I3' >\1/9$1GD/:@2?RV?C[AL5^7[&^86 5U2XQI \;>=C^-B/'=8!R!R@9 K# VV&-.>8'7@X&> MI'KUCW?.7M8F*!G!WNAPD 09P9+%(LO><(0M)YJI>AI400:1(S" 88^VM?R'M8 ME(9NCS' =_G7&'QJ'OU[W2## H.@CUEN FKJ;5(REI%:W8])9!.DNJ.X-]) M6/9 $O?P.*F^%L7[I]N87T!PF"\'VV; >:RB/\ #K1740+I:2R.>ZJ ;X K5 M)G7:AC7%>1OH.UL68[.<+ZJ'8O9N5MW-\JT9:_L>SVBL ZB4)"[H6885,VJ3 M&AP,]*L)$+*BWJX1'E$S/J!Q@9 M;GF-:07._MCR=!KG8_[E"+9\WR;#4DID$+,&2*,H= ;6/D' ;**CY/A@\26R MY60X^]CJ5-.[C\7LP1:?&B2M;7DZ"_! J*#C5KFP)C(=_4%U0/R*8L5M,N1T M(/O=!C>@QA;;R4*&;3!WJ.(4/.'6VM,N-4''M6&HW\ M[]L;9%)[";64C@1MJ*%C)/!_C1$#B=O= 0:&NU(=R5CV&Q5^&7$\,AB\M6F& M8Q$$C)&(ES CHBF6M=%%%4W<[ PP!MPF<5I&M:_X[['DV=THL\(3"72LS.2( MHQ0JRFM%*FGJB8P!1H+;Y$UK@/9KLC1;F+8."V!*@>).QZM?G(!>\=I*1U*E M'B0>8'2X(\LE&@7F "/&'='A2 3[ M*1]SACM^I";& Q#F K:.&%-&:*O\9AW6U^G\[X18K8')A[Q.K.1[YIDR%_UAEF%.$ *51,!#K M[%$/9&(^W=$+UH4RJUNT>R#>^V*1QY*H+I]-@^$V?S&@6"QU5.ZS@PXWSJP& M1E*-*$4@'KD3'K\X\$T2;],88(R[ W*U#N]9[.FC[.B,>*^H 2CL$PPVSWFN MZ[,-,-6??#Q?>MW@]V0_'PEN#VSYK9Q6L]"S-],P08OY/EWS[:,9PLA X0S M BMI!:.V7L,E!(DQS8'G0W3"E!.A/8M6"6OK9#F.Q;FWU;./7L]X?78U"5VY M:\"N=CZ0 2T(0HX9A#&TS@7-OTD<,*F%IIIG8,@G3DZ+N[A(?+Q&)=:#7 9P M8J:9/WQKT\P2X2RQ%@;[DA.O@,#UZ2)!6.(IRX$G>W1^XJ$%J'O@UD D$-*?>*2"!$8)#P.J3[TRF7O4[0#=GBZ>P.H&V=^?FA_N MV_S-?+XLQGMXM+M1YG"8(;K+KM$'74_6W;8'O=7J> '&_OL^& M!-K1(HOYW0@8#$30N=21L)VN:_A DUI#8("1NX[9TPZ^&^KT=EG$TUU5]\6B M'.63U[VYGILCI+1(*LR4,XP%"6#(,8"&&(HA1?30T?B.!W[DS1$8(08PC,D+ MWCI@#5%B/1@D>*)/9X *OUW1[K\YXCA0>]FCMW%S! GZC$ADL/#00&RUH&8] M+ ET7\;!&6Z.:"S01C=''(=C'_1H]>8(X34682"40> Y#RM@L,B?AQ=6P=1$ ML &KE#3I-KXYXCA ^U0G;]-NCO"$&:I(3'DDR!K+N"3K 0&5>EO .W$MM5( M*H07XP9.2O ZY4-9F$U"RF!,8Q=,:""@UZP&DJ8>W1RRMDH@42>>WT01].Y5 M"9N:F]D*O?$J0^5=,5OMRAI[6':](,,$."D,"?LY :URSK%:'Q!$KJ>0R;D( ML]Z>G;-,P$($ )IP#02C-,!>)N/5!O);JB=7B M_#M1'/UZ!A.48(/6F>1<80V(<9I!%M8<2.H52%&4R,!!QBH&P<#V97(.!W4C MW;>G5>:=MI)+&K910=<;[)%%ZR%:IA*WJ!>1^79NVITHBS.MMC?+Q7R13R-N M1RZW+UIFVBEM/'=(>6H-M2I6D5Z[!AQ,K'N'UG&AJ](%.>H&!8:(T85H X2F!M5%C*$S-"![G5:,W-T@FTYSTV?$") M[6B5<26 YTH3$@MO:&8 K6V$>&?=%6T36F-/>WCVDTA0#WU^D]AZ#NQW&Y ]\URP!$SG'FL9;< "L(-!P[9X7!TK&#"?'#RADPT6 B$CKM M+::4>J;1>C"0XL1S0X-T6[8ATOVY L>!V4>:ZG(>=,]\'O3'IW*ZDM*'(N 5 M>CWY&I:=ZFX:]VT?9_ET'G (?YX?R"9(?&-&A")0"<4]%2!>(H@W"'.B$VV& M(?/L2$I\F\3:"\[#I.#!?(7D=V:2 1261H")5*2J%8#2'SUQ2):475G0QA#YR(EZL'J^'=K/I< M!J-5?_W'/%8[O@E6 M3+#=*P>8D#AOU>_ MW\/R)LTSK#'0+ S/0,:XD-'N60]:.Y9ZT^+PF#H<^GQ7\KEU,?7"S5GY.?3M M\PJMF^GFY[V,W-4H$QA9S)6AFB.MD8%$U0,4G%W/U5@#YF%+PNECPQM#FSH/ M6,2R6D78H!_0A=L;9-8R2H5"GM'P_SS&..JUR'B66%MQ@)&=P;*N%<'T8:W& M"W;?/#SFY2RB:$*W[_8&%+74\RV&!YV+:,>J#D^R*,>3E:+&>ALZ::KV+[1VO&(]Z2<22HYKYO'5I(\-EJ;=2:N77 M .(L\0I*P,7&Q>L2#^X=7TKKQR5FNQ+J@8RK,L!;D%@G=]2!A#VT;/R.#"(I MF0)64:&%=0* C;\7*ICHV!G@O6V#)6A7LKI@W_P9?/)!? @CC5BL3^J8ED:J M6@\P0Q-/VPQPCW\%OO@CA=7#3 B#F!7YO+#%T_^^Z+;)'\M%/FD0;VK^DHP! M"815VAH.O,#<66[7 "CC$B-' _0/],C6SN _"_^..A_1I'F&(.(8^& N68 D M-A@8MEE^0.?!]]>UB3ME71=4.,BVDR$_"\_>3#\'0*O9_F5[;[L,LV VD6 [ M60BX5TXZ[>L9JTRB$=H\JG/MS$K'^JRJZUW^-5EO/;?-HBGND);$.17L9Q0, M!U='"*1/I-8 S;JSJJPTM,]"+O?P.*F^%L5S1=1F5X@>\YH,A/V?$5830JW5 MRG!C-O:'9]=CFYV%KM@Y*HY=S+NYW&;O?*&/X/T>W&DVVS'2S+'*7!A ME@4#U1,=]M/:UB=YD+:)AX*;1SNN?:/9$O"#<-B>Y*C-@@'A13 GA-:>8"X#FJ>VWH+Y)/K M*!V_:^B<;_T>D.H&_O/Q+SH$YVT=[]SSLHQZ0RW3!$L68' ZWAQ:'R<+)O#5 MY.MW?[RS/9C[*$^8?UV%?3]6:O3/93DKUL?HBZ>KK., G_^RMS3P$:_)H([E M@8#DPD$-682^QIL UOG-']\LN><*C;;"DV]K%'8GAW.0\4T0\_2N#%NB58;B MOK7W8-M,(\]LV%(QXQ0EGGD)06W."-GYD:0?B78G@G\.K@6<@J&P^/INDD\7 M:CJ.11\?#Z3O-7])1B%02'H,D'0D6+C>L=KB#;9UXM58S>-;/>YHSTF\M@30 M!P-GU:@HQG,? +3E"IO%?C&L=]QZ572S]61\#?3.-)P'B[[?@U$#I-7]9!B%6B"L.B7+4&N8, MV=1TLBCQE%SSW>X/L/1V)HU^Z?ER>JV>"DA(+$LK?/ M4$@+$E?E 0;5SL/(#F0P*%],*SZ83$##C=5>2.BC5\J8S_YHMEV?(%[7I8A[X.-#(P$PBN#F=&R-E\DDXE1WZ-3\7J]F;4S M;V![0/>\)8FWA,=R\3>W;ZOI7;"9'@X<4C_<..S! JY846T%C$>CN.2Z/@[B MV/74X.V2#'LV)*W WLO!\\=G(Z$QNW8U"9LMA@C77CHMG*52 %U[EJ1(/6%S M<6Z]+JC5$N8]*ZZ7O?YP7\T6ZV[_EC^=>G\S_1B^7?Q631?W\YO9VV)O8^.:VQFM5G:'!9O?;)ADG M5!N"E9/,$FD!UNPYDPIK7P:#\NZVXM7-J":2",$1##K=6H"$J=W;6*C$RF;-$]S/ M'5WH@H2=P=\#_]SM;3%:W-RZ+Z/[?'I7O ^KTLUTE1@X'3;[&O3P M?^23Y?'T^J9]!@2(=^5Z:0&V"DL7-'I]6$FFQD./WHD^KH029#];7#:[3L/W M:FBE%6!A9T0QM4!:#A'W=1"%8Y*8G7ETVL<3K=RTVYS@WDEU'+H]D.K#\O%Q MLH(@GZQ+AKZ9WE:SAR<1-K@3NMD;,LQE3))A(!B;P,=B*Z*>3]#SS@]/7Z*U MU0VVO9R/#C@7\\6[O-QW0.OE8YF2V$)O@Y%(L=*<>,'J^K0&@$37Z@#3,%J7 MZG%3+WO>H#9#]WKFE. M[5W=/'?V?7&[/!"RV=,LTY']@#F!L6+ZY7Z536]]/I@O!(9]F 94.B4DT6%%6@_+.YV8?W8T/7H]0'"D M0'?QX@0<^Z#'<^_^,9T_%J/RMBS&MGK(R[U7=>YJDU'"I- .0$ZXBR6M(<#K MX5FD.Z\#TK^?(DVZWW*E)4#[5">U@Z:)+MEXXV6U8CJ1#VP8E\4LS?%Y^+Z;+87R_RFR,. G#/F(MU7QQ<_MK58WC180?BMGGZ_[O'%4YG7 M'F'#K-1"2J2"7'R]%*.M.Q+4,WRT_+^./! MLS![&V:,K.X?Q4Q 9(6'V,-ZH$:G!D(&:(RT(.OO?9'M(=O+:>5Y$3X3DPYL ML*0FU:J@V#,<>QBTMUWFJ1&(.LV$R/X@44^[8_.QMEG DIL%*4 0<<4AYYLUF2>6)89(!!M?:9 MTQJJ?=BZQ30,?Q(O:!\_E-.H*5?EO0YSYT#+S!AIG;.&8DR0M98Z1M9#=<@E MILH.T.AIGT#M0ML#BU856-\\/.;E+"I)A^.3J]^C(7K%8P[7'N^"!5MCV>,>XU18Y88$'8.XKH;UH/ M"K%4Y3+ D[N=V#6GXGF.#?@Q&^^,:4TETH(@QPE"&,F-=29YJO$RP')W[=/C M5##[Y,;FNO@F[-@\G4$K.3+6:",H4TH(0U$=_#"@MPL5+\E?=SJ./:8J/_7Q MF<*'K@S;WB3CWAHKH2<&4B&9\PC70&F2FN/>?(WI^U!_BUQI"=,^=$D\U/U[ M-:U>L_OP]F=_P\Q[&ZO-&A165@\8D1K2>F8(EYB?DEH1XE)XTRJH?>R>\W(Z MCYJPF-],W9?8XV4YOX]@/-78V;=_/M0V$UHZ@;5Q $N'*9!$\=I9H'EB):3+ M.&23'%5J&=7>$M]CGV/FK*FFH=/+T._G!;>:SG5Q6\4+3^KL;!O^,5^4HX-) MHDEOS4Q8NSWE!&)K*.=0.Z'JB*R5B>;S .LYM+KD]85WGVE8U^561-P90I[1)07PCCJ:G"-X8G'C^$ 4R5:7*XZ1GE E#NTO!WU MGDQ":RP7S'MJ+=/&6EUO%7W0VE>S['5'D$0FIN!_/AH^:^KO1G$\$7>]*9/( M*"HLX,HKR) 3BM>.- I<8A!MD-F%YR9C2S+HY:Q-7>B[KM=<6P_%:)+OO^2] M2?,,:!YWO@I9IQG%S(;];YU[Z7#J_G" J66M'L!I'=GNJC1LNV8TGAOZ>S&^ M>U7[5N>36&#^PWU1+-Y&08M(-3#XO9ZL2>O/-T+:*4G_=/!!=ZG%( M'T-/]=?GL=MB7MY-5\\>JB_1W47T0O3*P& M*K<>5L_O.WJ@.,;V!IG32B+.(0WF!S!2*VC$>F 6N>NY!'$(Y*@Z$,E9N':P MSL:N)IFQV$ '),2<&67"KLB[]>"4=8GG7P?(MU.%>Y K28#VP)9U%\/69/[< MZ\T2\%L1MRE[+9B#K3-JH$+ 4HD %@X K8%>#YDQ<#VG'4\7>M4UNGV$CJM@ MCJ_[?9! 6Y[.H$92&< !]\"X>(^V@+6"IC QQ6Z ;OW6"7,ZFCT09-LJ?L : MVM4D4P( K@5R4&'-*<=AL.O!2.;D/ VW+'3P>U+\:\+?-/Y63E+&G&E^\:9$H[[;FA M5@#ON/=*VGKY%X;(*PK =,674T'M9>?UO<_M?3G_XX MM*]9AA'#?%56EC#. M:,P>Q;4O#EQ1<8RZDK3W!AJ9> MNSS 5:X=4>_DS\G0]L ?7\V*,&_6-PR&'__,9X?W^_N:Q1,\"E)#K(# (J64 MI6 ]2!*6]BODSRFB_C:>TAZT/1[HC5=3?O@S?SS(G.T-,FV1]@@Y@<*(#'"$ MJGI@89R)(;H!>@ ZX4PKH/:Z6LWKE?]M@[K0>]ME@$$ G>%:&X@EU B9VB3$ M6EU/^<9!6TNG2Z97 M:]C<=.U[]<[4O50[6<+GZO%C>WM_''NWAD=6&JR23, MKED^:<33]-=GQG%.F!'&2Q%KN%MA2>TUEO9ZW%(M<6D'#.,N:Z7'0E3J[<,>BWODI(Z@@?K0"82N83J4!OC-DUD\$X69(L0@!K70 M1@.S'@ZRJ:7;![T:=BCSG:HF!>S>"AULTJR;Q9GWM,HX,!3%2+R(-?489P3# M]1 5$(F+TZ#Y=*1LMQ8[: /,\_'EH#]T;[N,60 %#0 I8304A ,UL-D8=9= M#6=:D74S_B1!>_:"8\U"@0>:9]X1R13R''$7;$/(',4UE-A>CX.])=D?584L M">,+C1,B&=0X1!Z&40G.8YUIO1XDUZ*O"//E+&8MHGFAP3TMM3(Z3#9K%'!2 M.(/$>I"2Z\30\@!U3SNB/B:X=QRT%Q2<(1(9$J:8, 9#Q;6UO$;+$W2--O,I MXFT6G#D.U%ZUS7$AF8W'BQD=H C]A]H[#L*_=;WF:JP2EZ,!IJVTOQRE@M@K M+V+QSEC>[&:Z^=W^XLT'VV;24RDQAU8K;11'2()ZN!:8ZSE6SQ!OCX<\<(#_R\G\ N'(/1.!VT$F&0641VT$_9K\0M_,)VB1YC6!*Y# MT^^+R8IF\_OR47_=L8-\&>!^;=XU]R]WW8D,(DZB:T1#A;#56F%?[V\E<]=S MN7DO3&VPDQN$'"_4E2 ITF'KHSST7'@!/2"T7HI\ZHT]ET+6,Q/G&"_%<8*Z M4"^%,!0+ZTR CEC.8P";U 8UM8EG1R^$C<>+^A@OQ7'07F@*,@08\8 9L8XI MJ&V\3[:>>=1<8P[5*:(^)@7Y.&@O,T;L( 4*FS!,:HFB +LZU(6<2,PY&+1; M?;!K87MRNMCPLR).><\4(!XQZP1WAM?9'5:F%K ='AU;D?51X>?CH+V2\+.Q M0?=3I@Q6VD-''32LGHI67H^IWY+L4\+/QV'<8RRH*9.V/I\!XRT43'#E*#$6 M6N V(7O)KB?@W UUV@#U@LK<>< 911Q:3 4!\2 XK>U/1EABGLN@XT&#M:-: M$=&%E;TCPNN@=KV1*%;_=BJ,:#TX#/'U.&!/%6[3LG?' 7H15A>297>:V9C\MSV/>"+(#F 3(RP$@P-=AC M7UL$5)/$BJX#/(-Z 4M=)R*[^$0+[U58"SA3"EE&B:;W$4>_%4PZMZ"%VZ#QN858,XM7^K/J]F]K]R,%Y&MAU6CE#G,+*4 ":< MC%?1$(@=&4V.E!<@)JYP5F,/UD,.N^GK4TNE"3RBS?QRZ%YF\P&*1+^@Q M)E@ C%78X_#U$ &GB:DO PS1G&==:P_ZB\U'$!8AA*UEEEH>_%X=MHMV-,BZ!9\:&47)(.041M/4 I;2)K!G@2M8- M:UI#]DK2GJ3!E M@9+R)U1-C"7"UQD;Z>K(1NJ%3!QCW0"Q3S8-5N)H*!UGT MW;,9Y3SL&*2$V$)D'2,(FO5P$.>)M[D/,*K7#65.!?1"CU()Q#S@!DB%N#7. M&<-([:@-]N+5*)KS[,!:Q/Y"3TTDU7(Q""@O-B?2&$F6\K@?F!+V>37L[XFU8P^4H4"_T+!U@/M; CO74 MA#;.>&GJN*-G-G$Y&^ VK!/FM AM#_SY=D57X_]:SA=1[39=VU\FPS1*L.OJ MDYG@\8H4K;VDC,;"N)K6_A$O7:+&&Z#Q?AXS;"!R.W<.:8"ANIN6_UV,WTR? MAO5F6MS>%C&3HWA7S5;03,=/Q=J#%I@LQ\78!QFZ]4/38C[_&-:6L*5NFN/7 M0S\R1J2P+)#"J&E1(I(KAG5OO:8N$"&J[&9+G?R="?. MI'XR0\)RCX12A!-JD8=2U)+F""CA>JNO)P>M%Y@?NG#D.[%[6UD^+#1P' T'?/IRQL'^6QE*G"!18:\"1K >$ MKR@+.%F2WS'B1 Q[)\7O^4.3$,[V)IGWT$"DD&<**H*5-,JM!\>QOYXCQZ<( M=B]'DL'98G^%\D,Q+:O9[]5B=S+*[H*J6H9S(O,X0Y[2LVU-RIL/(4"W /FUT,,:V[B)1T# M=!^TM82T!^;%9F530K"S0@HM&-+ :&9J>\P[DUB!8( ZIA59'Y65?1RT?:5+ M'I4<^3I-3Q-G*87"00<\XH1+"=8#PMY>SX4N+3.(^HAHRPZG' MVGI '%9(K(>E'+J>A:@;HK0!Z@4F[GO'N & &2^8UQ1)YFHM+)!+S$\;H$>W M&]:TANSP\ZLA949R(8&25GA(O>#UKL"XQ$++ TS1Z(8HIP)Z)0<[,*- :P8P M4IP)10B#>#UH;B*7S23X=%1_NBZ+ICGM7DPP;P:WA MD%)/@/),:%4CAXR]WGOK4K?;+2%Y)IHTG$6DCF;-GJ8959(PC*12Q&(2?@)SW; M[Z[XTQZXC9DT+T9_O:L^_S(NRD@B$O\1N4-><"?\*GM;W.43-UV4BZ\[[)8M M3V7<8N$\P2O[BW")&*\-_,#_Z]DQG6JJG Y>ZQ)_ZLE.Z^/;1S(4R*XA"MS' M2ABKH0XC7ON) +C\8WXGR:AJ!;64@/"[IS0S4[U[:_9'@[]_,@M]L(HB#RPU M))9C9\JLNR?#SOTJA)HFD*I-Y%($>_,0R+A?HB\>R1R+RL@(&E8E+*0WC->! M:&E48A['@%;G=D29#ED?_LN5=3#:M01O>RS3T!C F<2Q<@KF82^TR6$1BB4F M+ _0W]26N^ $](Y>A$?/WWJBP/JG;\6__GVF)I/GWL4LQUU+\[['LZ")C#- M08"\P@9'+7\7;$=>WLC\>NAZ6@+?5]"X ^1!SU^*![P-+P;;',\8(]P("'>\Y M";M2XTF]KC$I$J]H9,/A0]M+0@LHGH$:!SW'VQMD@'MD@59>"B",%#S\>\/Y M*[IDZ#2Q'N!($IBO6'*Y0!X[]E[3:'=LITR LUS MO\*'%^F#; M3#)LG+*446)P@)%R6!NZT6Z]FG7[9'DWX,\IT%[H*MXB#!?C4>NBHJ8#D",. M%?=AA?*..B\VJ4U:)2[X8GB$:>](96MH]DJ9]FID,A[4D]1"6Z6\ @0B6&?* M:D82*[ ,4,>T(^IC:F0>!VT/_/DX*_+YX# M]&!?S(X=,ZS=ND-Q3%5\M0"9E^Q&:'GVPI1.0!V +7UD445$ M>T&Q9AA*9K&CY. $@PIEFJ"CCC'ND#D=0CL\?_8X-"70XW:!>PDQ2S'^5&*6 M,BSI*@1? /RJT*_^&-0*V^$I]/Y[$EM3 CULE?(\$LF8<]%.=,3 N!-7 M&1BLRKV4-^JHA?[HTP+9 04.TDMP)C3N(HJYOORHCIG&VV%6[=HK?- !W$/=-WT5O) M&9# "*D!0XXKG\Z+]P$E $TGX5Y[H6<4O6V&[@"$>E#=P1[ M+"U/,06.6(V*%IP/DAEK-*%0*1>L0:NZJ M2&7I>6[&-3 ^AG1_9)"+XH4.EUYKWNN(8YQSQGH'-*; "6LJ4X1S.QW%J16S MADI9W4P:(Z#Z-*N.<*4%1=&>%@8*&I$QZA =3/AT0KN&G!27%-&@,\7/%JO_ MG-W<%>^_/L1W=_/WYVZ([\K-^Z]?U\5&74>$UAM3WJ058C6[J34)VGU%4"!J M; XSI(C6$BMJ7'76$26<>=0XZF. +OD]*/J#4G<_71^6>*B[,!]I&SATT%"@ MM'$<"8BB1GA(-,?X%"^+=TFV;F!M?%MIL?P1%]O$(7S_W:AHI M'V4TN]E-@!BH#P?RF=(MF,.:TT_H M7,^J?M(H",& \59@SKV2Q /K*@W \=SX^\:WG7X4JR_E*^!+YX@.DQQU(&][ MBG2&YX#W,4QY^V6Q7M"CU8^8W+K MC;BZJ7< >H)H\OXD'Y!@O+JTHA',+34QZL.5 ;UT_8EB '[_-OMS<7MW^[%( MIY2+Y?5OL\W=:K'Y^?[K?0C5/HO(@TJ6\ 2!L]X7(-%>:0RC5HTM1H)I7AV" M0&VKMR<_+6T[K2E]8/%:9B];59"UM(8'X62[X!B42'F#6=H\/9?0*HBPU AI*,_N/ TWU%W MQ@.*?#X26E6C54#"2@.-A90YI R%BJ%]UZV1TRDYT)$$7]H6.X%VD$B\]NGI M';+64:L UP)#']<32/:#DL2\?O]-IY*MDZJ^&:(7H$ENJGII& *","\=(0H M)W"%$HZ_OGJJ="/6>JGJFX&98Z^]_Q$5D]7LZ_$\#"\]%BBW3FAJ*& D=@T1 M)WVUS<#\].'(\&C_8Z TYU@+0C!6%4P.JM=??[9/O:$UGH,3Y-WL MMD[6Y9>;! D!X31. &D$U9(:B:N]4WLVG20^;01[DB/98.;L+2I^1#\6/\J; MN*V=WDY>>#0H:*AA<9$#G%EB>%S?JLT/(?;Z*Z!U)Z*R4RAS94WJR_K)HT%# MRR6/6YJQVD:+FW&+*ZT8ND+GI.T9YB-@Y4_I$ M.HM(\&\8_+Y<%U=W$?=#_;!U[-&[\L>V&R(U.\.B9J\)$AMB&8.26.>D$!K% M7_96E=:9&\LH#P0[I5"O,&?QA_R-@F-=^FWV$^'8AA_5-QN_(S@5=\^4Q-=H MH[4#<6B\&I*PF:ZK41Z&=) M9,X@!DDT^?:#$U)FWFL;91773@G4,]!Y6M#SY7"9NO1P+13G])_Z[P@<& 6= M@$X2()R#<:>NSJ(,4IDG\:-,?M"MYM,;QIF+#WBV%BZ?K(7R[+I3^QT!.T0- MC+!Q%2T#)0 V=C\D+V&F:37*A @=+SE]89Q%&_S"%GKHSNKJ&XRZ.X)GB-/H M+8%PZR4EUBBML=.*0%M9 -#G'NJ.,O5 I]3I$^5<\AQZ\7#+W/;CS!Y5IW'0 MFA,75TZG$#(8:.=]-0BF;IV^,[=S;#/M[*/FVUZ+VO(5GUE*&KXG M,( Y%\@3CR#'TBH)*LR44[DE-J?O%^X7Z,P]2*X?\CA^.SF[\QQK$K5Z%9=$ MR1C$&!(GM#5ZWV%B>>Y^,WT_<&>89BXDF--'WW_0A\YY>6NT#= #QS!F4E$J M"1&6P0=F?_:9X?1]N]V#FZF%G'4QIRZ1,=XM8<* MG7M'"$[?L]LOT)EKC-QUY/YL*W[[N8WF>),@A;/*(FN]MXQ:@@VK%D6N2.Y& M,WV7;6>8]GU$/9O/%[OLRO/5[(\SMD[+]X:X9@I!HK;EHZ)N/0=,B(O I.2.2;=L9I%FK#OL;E(=-\,RF\]+#<4-%TB&/%3>,$XNA/EP/H$QE9KB&T_>Y M=H!FMM^,T-I"?_GQH!6P#"E QAS;VN-H1E?:Y18FF[S[M!,_\((*/VRNK MNEP>+S)YXNE /?," DLC-PF6PA)?'3=JYW*CWW\)MVAK.',CCFK+_(5G \4* M80=8RL%O+'32PJJ+A,/,""+T*W@TVX*9>UK?8(X_>S:D87*)E19 $Z04]: Z M&08(Y5Z#FKZ?LCV8V7;CE_B-9ZZ_/7TN<&Z](UP""BFUB!N**K\&@2)W Y^^ MX[$=D -<8*H2;>QK"GPJKG>Y04Y?=CO9+E@AD".&"B 1L (2+$!U:*=Y9IF2 M$2T+?=Y[ZQ+:(1BTZ]W9>V^/G@M1=;4F.4658=A \/ >!U!V.@FA.Y+F4XZT M #-GY]"K64I38_YA3N\<3Y\+,JJFQAON"TEG<-_K2!-F='>7];7,_. M)%TY/!(X8,AA@RR '!B!M#PX/QS/72]>B:PS95-V@F7M96)??W=>+-(*0=(/ M2?#DP<(0/PIO8T]NW'*3"DZ_O'F\\%2PDC*$!!9&1Z4)4X)0%22J!7G]F1K[ MV##: ]FY]'<].;KZ/WTD4 ^55,9ZJ;0W2B#*JY--%']\]1._E8S*3E![).37 M@5C>: =8$8]L=Q]VZ4!-^>'M&1/J^9,!21+-0P@<2!D:C6'^D&U),Y_K5I^: M1%LC-X!&O*\ =\9L>OA8P( HZ[UC./D<&0%$R"J@2)-,+_N(8K3ZM)5:(-EX M[[NZ_ZX='?:_/:7"_O.@;F[N>Y?R+A_;$4\]'H T3"DF>-PJJ!/.0U,%K6H' M,X]81[36MQ-CV3F$?7/"_?[Q% ?BGX-GB%AH+[MO@+IB9WA2(NX8TINF% *2$(5<-$^] =?H<[,O3"B MR,OA4@WF@CH 7U+7WG_=)=(\09*'CX4X0P"UG@C &=( :.X.7B+%IK-'M);B MTZ3$^2@.OG2\6:_O4F$$.]L4I\I!GV@5I, Z)5Z,!H_Q3#(M6'4XS?0$LI7V M193N0!V>-\L(=['>?(R=W1Y5SJ,5=97$>/U2<87F+PF*$*\D<-)YJ[%'B/HJ M,)GQW(UI1+$ [&J.XR'V*?*V7+]8?;S2(V.EQX+0'DML:+,$.7CCW$8E7(F MJ*:O_DBPMWTJ'\7!UYM(VD4Y7US%[J9?:R\Q3]H% W%4YCD!T#@>A^/1NP35J[5%9*AG$<$':'6%]I M,\\<1W\[L3U!VD(YN#KR^W)V6ZXVB_\IYJGP87D7M\15<;NXNWU7U%=.3KXE M*N=*)D\C\!$*Q(@UKEI+)I MR[6I5;4(2BHI)'7<,8&-(4XBT+G7Q" QUX2YA@U#!E%F)&52]/*[*R&OX!GN!> <[,R;+\] M;;BSY7QW7+;YD%;(W=K2Y7J_*/Q?+:S+['OVQ^UCRZ//>:8*G2R%I MA<76*04I/ER1ACPW%.)7\!GW!_/P6O7LJK%:734)6M X5_VW\."V: MBV(=_Q8!FQ_VY@=_J^F"'+0? 7.)H##.RE1@%UM#277(0PS(M?M^ 0?XF.4T M^+;[VVR3$M']3'$NM3?>AXV"X5!A!A'A!% &&)2\.JNV0N>J;[^ H[TS4%_9 M(FO&L,*>[D1P- 'ML%M_7>D6/.>V=?>#Q0[+1V'GK G?,,4$\JC8$RFAD/,_ZLC=UXT5K".;C: M;LH?Q7*6_KW]?K-(@>JUE??G38,BPC/AL>,,$ZN1%[XZ<$<09J9E&'\&R*Y5 M^-;07LC#[V>+U7^F#?7]U]T2^?YNL][,EO.X@C;T\I]Z53 4":>TB2J;T5AK M+.RA="D%D\U V8^GOT.HAX@!?G3I;WO3[W/QYT;';_O7J:#@$\T")"DQF^#( M6 "EBQJ@KC)L4 @SSR-'N.6IZ^O5]LS\S7*K!\^WR86^1'[-KJ(9Q*!$RAL< ME1GI/$]9$@X9I!X4K'D:*]P=M@<"_:__> AKY.V_MI\^_?"^]3.4ON_2/_SM MJKS=@6O+J^T+/\6JYNMR_:_^UQ7^(0BI2"[_]M&(5QXHOV4!^- MP*C1-E!+I2?I=D_< RSRTA)AC+=*FO@I.'1]7("^-45*LSO2+CF7 ]2/-9=I]6F#9.75"/$B8. M=S6[2.EH_^BS@1#(@3;;K2;N:4!CR43C(8Z35V4:?0S%*"I%+4,&/A(490 0D^J<(2J$E QPY)&G.FYY M>BIY('MC0 LL>Q/][A+JZ6WBQ6>#H*E8AF5&V/%8>?R\9-C:6*//!VJ('"8;6^M4H&$,E8J#*(5Q0RE+O.0?D21)T/R M(Q_8SAFB8J_FVY[=S%YR0#][)L3%+II+6H-T5Q #+I5P+ (-%6$*P\SXWQ%% M:_3+A#9@]N61*&]OR^6G37GUKT_?(C3KTV<2]1I&/1DIQCA-^2:I44P0;J.V M3#SW.,*46VU@1"$8@S@KNH.X)_;\L[BY^3_+\H_EIV*V+I?%/.7S>C%=\]DV MP3()J'-:FHB3,58)HJE&WFO.%<29B9O'=,-R",YT@VY/=/G/\N8NBFBULZJ/ M*2(O/AM@?"L"+NZ*4$=3#$H3M6W"$>?$>R%S(P5_,?]G.U3[VH-V[K>/Q?=T MQW-YG5*V'5533S4)%BJ-(<0, T85(EICR;$WEA%$%,F,SAG3S;HQ M@O!L*M%A!E@GB.!HFP (Y59H0*.^0A50B@K!+0 JCL]X,IV*1.V%_#2^LB-, MAYN.=ENK=_W:9R4SR$-+J(#:"4J-1_ ^=SHT!K0*(^B@ NWG,\E"'S\8&%<" MV12U;3A&"&@OX'XPV$^HLF1[<1XK,)L#9.?Z4EXY,&;B,H.L-\8@)ISFS)NJ MTY3EWLH=G_1SA76B E@S['I2D.M7 )/IC)IB2!WQ6A,D@%/[[E*"0,R6MFB$W M1'CN?H5Z6Z-\R?.' W:88DN884P89I'%7NP'1 1Y_4%@'2WEG4&8,]G?1>-\ ME8 _%\_Z[,%@M-008V.1,HQS0=@^"UH<.**OOUY1%X(I.X1P@#G_KMB\649S MJ7A;KD]-]T?/!8 X89XRK S64%/J/-@/ VB0FVIG/$QH*[ZR._1R)KDMEN5M MNGA]?IJ_\&@DNS71=@?.2X(Q,9P;62UHEKW^,I5=3_3V( XPU?]9+*Z_;8JY M^A%9?5U$=DK9>7)U8"AJ])PC(C7,RSIO(>$ZM :K2?X'10UGW ML:]?RE[=WFTH4 Z'\ !$BTO=:CNK9C?WI\3;CJO-9K7X!V )(-2,64^CV@.GXVZM?WCHGY."@7VXY MM(N;N_AIG7B3S#<%+1DDF@B+F&)1I8B[2F7X@2B6//XU/P35\64G)/H9#5 MQD?M!@@H437[6'9)KA$=/7>HT0T&\U"\^UA\OUM=?8LK\X=5>;V:W:J[S;=R ME7(Q[2Z-GZHS6?,-04,(.$\9#I3%Z1R#452M[\9F9JD9T86>OAC6.;87H]7' M(OE'XT0YC.#P3"[3ZKPT4&L]L"E7GI+.$$"5K3QP-,[!//*-Z"[18.3K >X! M^*B6F\4\*0.+'\6GXBKE4%P4<5V^NKF;%W,?84SI6.YV$G[_]=E![+GL7)V\ M/SCA)2:I(IN6V%OEO=/5[B!T;HJ=\;&T\X/N2^ _7%#*]A3AU<>D$*$!8@XH MEY*$8R P)5QS0"3"6)ESIS\];515>I.G_=[Z3M1R?F]#9"2C:?3&X! 7QE&" MA'34&>JXY7MXD!#3*=[>GB!'4]3TB?B@Z8\.KI*T;A7+]5:N#VT*=177NL7F M9P8O,-8*6\.X]=9+)1!49@^8A>+U^\4&H.A X/>W.549Q7XK9NN[G==O M_>*'6_7S7;DQL_B*:*QLJJOP@,?*]=.;O4[;EN]7J_HA@_?NR_+(N5C\2X]XL MHYZ4DC$O4P:Y+3_.Q6MV_57!8D.QED!:Q"&PD?8658#&&3"9O; ;6I6C$L< M&^7CS(E'@DF//QP$9UBDTD984N@4-@*!_8"(Q*\_/.'R5#B9 S5#"(.S*N5= M.QJZ>JY)T$):YC@S#C,(!4"8N_W@XES.O0\Z/H:U$>Q)CF2#F17A>O?E9G&E MR^5\/5O./ZP6/V:;XL/-[&JKR9R)>:W1-D@"% :. $*B]F8(48+LAZ 1FDX4 M>WLAEOUBFT./CUM]==N-TUQX]F"PA'(1QPVHTLHK(#TW^\Y9**=C,W4K^+9 M#K!=5'NK_OG ZO&KXM]WQ?+JV!67!JT#,):Z5/L3:,1$U/X<]/LA0TPRU901 MEW5.&3(>Z I0 W*38XR875TPH :[6B)] M*7J]*Y>K=@Q[_H9 *!1QODJCD0*::4.0W0_=(3747MIGF/'%:-8:[F&UM>K' M?RR*5?SJ;S_?%C^*F_H*VXD7!$TA$AY;8!A5RA!F/:T&#DEF./L( ^G&J+-U M)YA+K7W/1Y"EP!U]3P > L&!9!9K2TDTRI"HG#/95W?&O-EV1(LZ"V%'J ]) MONUT7&_Q@/4WV^>M@K?.(LF9\UY;+:@TN%*++443]*EW*_EC_&H-]878A++8 MA"I-U7#'C/)",BZTETC#2E/5.#/GTIA='X.S*0_J"[$)9[$)[X=(4Z)[!Q0S MD%%.B,>5"]+HW.SQC96R2RG_P_ I#^PA^=1>4WU;(_%%'U\7>+2CG..,:>^1 MA,Y1 P^"@ID1$2.\/3$^L^)R8AS\S/OWY>PV9/!>,D$!88B+% -,(" M],')Q&1F#KQI:V_M*=5"! .'S^_LIX_ESD=WP]91[MD M>D3L0OX906G-@)Y(4!K&3 #*A?%..>/C_(R[S?V@+3>_5E!:;0;D!*4U0WH M>NTRL1XRJ239)C&>WCM/M J4*A:'Y:$VDE-'C&9@/T0"&6,=@U0*KS"TU98@5&X9R_&1KA-9U^-/%K3#JOW[F??3 MW,S6Z_H*__-V05"'C*6,8FN1 M!QIBKP=&Y!NFE[0CM3]5O+XW6=K#\=<'T3 MH:_O#G&2,TFT2RDV/!!"<<$JK8?Y"4:TM6-=?\Z63@0TP'PPY3*5G(R0QY_6 MBWFJ#A"[O^WSXFO*@;)V_[Z+HSAKHS1\4Q!0Q=W,,B (2*8?U.+@$>,X,[OF MF+EZ>5:50XIL0E MW\9].3$.,#?TW3IV;KTVY>V75! D:O5G^OEP5LYL4FOWW MN V>J:_8S1<$I:!@CG#'XH8+"#9*5+J',^.R MXGR%1756DCTDTOC,?8+E&=QN.?]U>-Z_M :^ M/)4NI$[EOA11TG/.E;91LDQSS9&!TF+LB!;GR[ .-] Z%8=.M@M. 4 TLL(Q M0:&S"G%N&(B#AAY2.\&?KY:K9]3%C!796:Y;*07D5EV!) M]@=- !&OS[D->AZH6J^+S5K%_>WDSA,?>)C#<[L1U;[:V/8[ G*IFI93<4.# MQG AV3Z70*JU)7^1.XVUB71L)1A8#I.XS(@)LYS$;[N$%JWB+)NA_BKC+#6*V G* 4K[!W.4[&^L (3LV:PSKY!8W4J^ M09QE,ZB'9%.+3:!1@&47WQ,,\P@PBI467MEH"1JK]S!J)C/3NXXY^.#R>_0% M!#>>0+2CN#9R[+;]CD"Q]@QQ8ZSRG$=9:B7V\$6%?8+7UH9E75X<6N>"&W[= M[XWR+5X?++9>.V 1C^L3U=I07KGX(,H]\IBH)=8AVX>3V0!'*<^Z__C\>&() M)(T0T$B+H.%6< 25V,M>.,;/G@V,5\<<[G@E F4=I!8QK!63"B/KJOQ*RF66 M4AGS'MN*2+T=KS23PX!10.KJWW>+]:)&CJLC+8*(UI]WT9S$5D,!5(2WNMXD M+,Z,G1XSQ89CPY'PG78BN!"[TH^KHCCK1SS;-F"7BE]1HZV7RGD@*:_@SHQZ^IX\$+:/Z!0%G/KXG M6OT,D^JRES!B.JM+A[(I.\%RD-QW\^+K8KG81)OT1S%_$P6UO%[$%7*WPNJ? MO\W^NUS5R676\$UQ!>9" PB-IHA2HVQ5^5$XRN!?UEAWFU:_HKD\2P_=?S>[ M/;^]9;PMJ)2)R#'%B-/8(* TKA(:( >GDY2D-ZXTXV0'0LC9&O5JMIRO3^^- M#Y\)'",$+6-*,Z37FF*3\0H%1PS%W<0CXB%0!PNT<#<2]\C M7#T[8MW@*3Z;"6B ^7"Y%)\@&G[."(BUA-!;RA&O\K!:]U*J'YWM7PJ;C>!@V=T1Y.M@M1QLP9SHP0 *7X'T.K^ZT^ZE]YS!QS0L^+ M:0]="F((ONUZ=W:G?_1<$%91AB&5(!4AEX !:@YG-;G%KD>XTG4DS6=U6O/! MS+99B[GYAZEAMSYX+D!A(1,$4N,YQ-0Q3:IEF&LQ(3GG2>2959H/WB1N:[%H M?7O*N.&&\+AZ(@:K,P_BFA[#GK\A((,$(]"E]-B"(Q6'6Y6=P"8W'*SQL>>/8O6EG!K- M6L,]H6NGUG$ETZD+T]1#K1D&U^TT6LZ>(01L MNO-&J>?F (.3;()5&#JB1:MKI\U0O]"U4YAU[13N8ZL$$L H9U3<-XP50J)J MB(CC"3KHNY5\C6NG>5!?B$THBTWWK0(10'K-$-$I^YXQSKO*O\-$;B;=,8>G M#CT2, #DF*A*.( M9RH28U9++TOXL4@R)S#@"80["VZG>>\TIL^KV7(=I;Y6M^7=\J5+XEGO"58X M@IWDD)B42-4@J"NG*P*Y5:[&K.U>A*1#"&> )?KO93G_8W%S/1<,#QR M'3 ,D"<1+L,4.=P, +G>GHD&O;5?"-N /R"'WMQ^CW"E!?9,/;^7&P3O@/32 M.<^%AH1:90ZQ08*:S%#*B8:X=,>J5E(8Y/[A"\JN^_/JYFX>P=B/X@3=ZKT@ M6.!0B)T\0#+*MYI7(C+R=Z:->>?KU(90 Z[GK[0KZ5&NE^SK8-6&D# M,+#::G<+!N%?GI].2=BU0 99#G\4Z\UCU^ZAWR>7P5,-4X%58(D5 M'GA+H>?&^,I[H B9CC>G0YD_6](Z1'@(_TRY*A;72Q.G5(H*2C=\TOBW #7C M5L,W!6V9Y Q3["PABA/)<14^R61N[LL1>E+Z(UN_D ]H-C1CVHE6@1BLC"#: M&*(E\YH;64$)+)S.3>[^6-4=O)?/3/),F6RZ7[9^>Y!1144"42)@*GZ9"IY5 MYZ&$Z4QU;H2.DCXWU:'%<-ECN88;;Z,7!A5+NKW7Y\NN@?]X";-A4:.X1:O#11'I0*DA*-,.@(IYW@L"YM)J;*EE @LM)5>@BHJC,->I)_\BZ)'E/B/ARF(U,&E=/J@K?9K A3$4P]2)D&"#3($ MRPIC92:4Z*1K4CP_1^L+] NXH&?K;_ZF_.,?Q?RZ&L//>NQK^JI O, <1&U) M\6BD:>L@.LQR28>Z#?SJ&=@S\ .P<)^"R)2W7Q;+75ZSE].=5>,Y0<2,MP6D M%(OX PZ-3S>RC82'V%U*,@O5-G9=#W$SO6Q<9@<_:/W! <&"";DN=/J"T)1IVADLQ<%@Z50S$I,J/;: M&>4TWX,!J3E7Z^[U6(,]<>3(,7XOZ%]N<=C__8*%'B^S5D11Q#V &6RY--)8 M&Z5/O $.Q77#.5?8\4B+0!5B2?62<7 .&XR= M9OOA2>@S3P=?_>RO+?6G27 [@3GGUMO^^U;%]W*5;*Z[J($6(IEY!WZ$G&@MK;('/#L3_M$$5N>:!(2H9EAX[(RE7@)* MD-UWF-$)U&[M2F!GY9\%: X##HF:DT>Z_/I'N;J9UTV,_:Q)<"YV-MI#T@ $ M1;32431>[CN,C,N,5GH5#&@JLI?39;>%M!T'='%SO;B[K2O_1X\'X!CG$4E. M).(R>5-,Q7XL<\OJCL@YW[?LV\!YV0C(!G4O&[PE>(.\ET@#SX$60A*0LIWN M(+ R-UW)B!C5M4+1/\B7Y5G#RI4-WQ2\-TQK0(&F $E G."5]LZ$?_WZ2Z_\ MJ,_!#L ?Y$3GJEBNDQOX>E7LLI"<36IWM$U@FD$LN<>$,449(#8%-.V&QQ7. M3/+QNKC53N[/#G2Z@7K(K$H])['6,$6( (XT-]AKH3&KM@MB?[ M91_X7BA=5_\IJ35CVBC@A77, @RD0Y5F2K288.;@CFC1*B5U,]2')%]G:5^C MI8L4QYBY:"P9;ZP4?#]$C\%T+K3W)/D&:5^;03WL'ME3/2Z$O-$6(^F)E-@( MK7D%HS:&OLMKH6QUPR8*AQ@&B.E$X.G^JLQ_CIK59= MR#^CNE8SH"^E=O52_DACA)43P$C#'5. 2UH91]CSS!J"8^98%SS(+'[4#.P! M>%857/U[45ZO9M^_+:YFYTS%HVT"0YP+YHC1TG&GH57QE_T4]3PSU\8(;Y)W MO?]U!>D0C-F5;GW8T;K5C)^W"<@JS)'1&*OX/^U24;!*\203JN'>@81?KFK< M&M3:G%D75W^[+G_\QU7*6KOZN:/,_2]/V7+_XPB0NN()% M$Q=S8U4U81PATPGRZ4!:94OT!KPSHZ[^?;=8+[9B.;V9'&D1%%'4.X2 8]1K M#"BCE;;'F9I.;HBNMY)N +T05]*/J^+\L=O9MB$:"B(NI9);Q!PU$FPSF]W[ M_*&=SD%;:WG7X$\;:'/"1=[?%M>STR$B#QX)''C/."90$.&@T4 Y5,6OD F5 M">Y0-F4G6 YR#?UDJJ\&<2$-W[3->**YHPPPPC!/1="J8VD7S;@\6HTPG4S7 M6U"_0%^>%B2ES''B%,6&>@$@9I7S7()<[HUP2>N-*\TXV8$0LN,B MC\=\/'LF.&HE@DRF:WO$6;-+%[SKDK)J.MZZ7N7U+#@R#]XA_7/[K?_>CCRW MUYUL%Z!3E@G)O<<1+08%1-4FSQ3-3+,RPC15O?GI.H!U.%]=7?_<_C"8<*X) M8-%X((P+Z1VM8HPU@].)(^M(FB_[Y;+ S-E#4OJ*N]MB]8]B=K/Y=A5'?GH_ M.?9\4-AH913 \?T.6<* DONN&BZF<]J8*:&R>Q#;W:6H>XEB'^XO=8K#$'$C M@P@8 "2K"$WHA"H5=B#?EN#ER/7CGQ^^S5:WLZOB;I/ M#R)5IE11Z94>.(XM8,)7UP&MF5# 47MA=X-AECLSI2TXX\X\/!(HB0:N$BIN M)<) KS1PE8F+NV]SO*U1*_[9LX%"*I5TR% J&";4 MQ,VG7JC]GJ%(-> M>#I@SZ3G'%E-F%0V*K+ 'W06GNE#&Z%!UAU;VL,X(#-JT"$@%-=)!A'#@'E M@07B$.3-K13G_M)FM-H,P(4M^1[C0$,,!"7 ?;S.W=RFL_\,6 MXQJD>*E95/6(M9@N*=(!H@/2YI^KQ693+-]_ M_?JQN)EMBOGG,E7K>O]U?_3T>]P6:_"HUGM20B=+!4$ "V$-Q03Z*J0< 9/I M.JBOL\@=L9;%];:+KY)??2 ](.$..MC;$<)9"G7:QP0Q;)R M@0N+,YV0]169*5"H%:0#DBO49>$ M:0_I@*SYO)HMUU$H=1:7ZMF@C;(>QRD@I#(8FZC,53%:B,#IW.OH@Q^Y, ZY MECRN^[/M\SA=2-7*E.:W>N MW&W?'AU[/8_*!+1BN,(26?3+3N%=35DC\A$Q2UFM:UZ@=8FX85D ZHI0C MVOO]P+G,K30ZHI.(RR]HW<%_H36M_ZROP%I$(/-8"Q111EZG$L#W4UMEEXD< M#PO[HD6KK*_-4'^U=QX%\]I@I*ASW&%#'71R/TRFV>O/7'VA):Y+U$=[)1)8 M+;2"4!--G+)&J3AG]L-@%J-1=LC)"+2"::44 8I9#S8':#Y<".ITLB*WEW3A963-HLV[W-4M6A@%1 M'L3I0CB0DBI(9.5CP-1,QVG=H6R.)2MKAN40=O/@!>P@9MCPN-4B&X@ MLA$=$$-%W$QN9^I/!I>E8<_U[>(<9IXZQJ%!1$L3_R5[**1WF8[$$:YNO?"C M97V[9N!G&U9-\I4!J@3F($Y!RBW" DAKJRYIE9D1_G7QH9VLCN8J:P;M *M. MM]4,1/D]1=9=?5N6 M-^7USX^+ZV\U&'6F9= *>LP@VV:WA8@1C:NAIF22 _F!I\2K;B$?@%WF;KTI M;XO5]F9'%.3ZV^+[>6:=:!64PX)ZHJRSVA&N"!35(4K<[C-O"3=V$$V)5=W! M/0"C/J]F\^)VMOK7>1H]?30@K1%@<0"8Q6FBO+<,5R:*YM/)]S,4Q$MV?JZTO%& 7'-. $V:H"0N /&[O4F6?J(Z+=A9Q/_I?'-\L.J MO"K6ZX]1?BF"+VY$]Z9WTD_.ZH^UVH=()<4DMD!3%]$3Z?;7 3^::8V,*$[N M$N3J _H<_WU]!>;MB9REN:\*D#$F)8"01DT((0\\K!8M*G6F3W=$%94&UA<' M$L2 UWK;IBV)!AF, R-,$>"$CAJ.JX[:E)M )$W_(J^7S*09T)<]\_[[ZC27 MSC4- DM+9-1Y1),0RQ1*M&Z&RPR()-5HSJ+&IQ7'8-^68:IJZN[V[MMFBAU M6ZXVB__9"CN/%A0$5B-, +40$N8LEM64PUKTGM5K>FM;[T*XO*NE44KF MAJ\*#J.HK"B+H :<1GO4TTI?P1BI:81%#\G(GD4P"!\?=_E=L6G&P?/-@[<> M:TR9959P9BG3&NX'35QN==PSX UQZNS,]339]@V>F&@2&/G%3: M,\23XR?.KD/ GJ.9,2)C.]<8DE^= C[$*C;"H@=8*A:7>>-2H!:QVRP(U?2# M-O,2XMB\)X.N>L.)X\*<[;8F C)&844E]X11A:(F?+CIA[3/M$1&5#]V5$S, M1_ZB1O'OZ^+KWZ*DI?39EMI?KZ1IO(B59!4ACG,XX:HXOX4B'C?XRB3$NF+#A;%'JP M8=;9,TXU"U$;%@@9JA2E-%IGPBB'B=* 2^B%FDX-^TZD_V0D M%E(JR9Q!^\$@8NTO,0UK2_181K4<+ %^$I+Q;;E8_SP8QO_1XP)0@CSFG0&-.(;?, MX -*_O5'_74GUJ>.P/9P#L"1C]%H+,YL,M4SP8*H^ JNE/;Q?82G.K3[[A/' M,G..C-"D[VA?R45N*,&?71,>/!4$%YI;3K145'''.(LDOA^"M+EG!2-<"C*D M]I+"M,P22CGT# EGK1;>5<,@_*%IP( D&+NF8O&MI5,6P;\ MOM->B,R$<"W_7DJ&WX])&@85RAA- (02(E(09BL.\NYBPS MZF1$BWLK&96=H)9SMJ=N;K;G\MNO711GT@.^_'1P&ADJ-7?("HH@2ME@*R5& MBLQSN)$)-T\P9=?H#;!Y5ZO5VQ/W2(\_'*+ZX3B54D,@A##,>PCW W+*9?H& M1W2SH&,;KC6$6;>)=\Z#]-UW$?Z?IEQ]+U>Q(Y]G?WZ,__Q7,5N]7QXM_%BS M>8@@$.PE5];$)<\(Y]C]0!R57$ZH*$,+(9:] ]L'0W:EAS>I0[DL>?"*J =# M SE22DC-L $^ZQ233 M+3!F(Z%G7C1$= "%PWW]6EQM%C^*RD6^Y6\9]:3EW6)Y_?Y[L=JED3RAB-1_ M2?!1#;>8614M;*TC$@BY/0!00C0]!26?4KW#F[/8_+Y<%5?E]7+Q/\4\]D07 MR^+K(EW[N+_G4?7Q0[&QKNQ:L4G;T[JH*:.2T)98;1 ME #&2U^MM\AD;F8CNN38]:)U =0'6-B.CRJ'GAV\-6@$,(TB88@#8R13VLH] M1 #+S/.U$=V.[&'I&P[O(0,\W)^SV\5R*\F7!N#^_%XLUZ?"QAJ^*4CKK;:: MT92HWF#AB4)[*#!3F;ONB*Y ]D"]?C'.V7ICCW9%:6,?9G^67VX6U\?2I9Q\ M/E@L+#7$,<*C"2N-9Z#2$JA"F7$?([J'V/46V1&2?4;WSHLOFV*>"H>]*P\F MWY"QO>KZ>E5$7(J'G:D1W7NR7> R:K(4.R$ I$I%S19:C+F4-,TN=ZY"0#]# MM;&?S:+OC[0(GB(A))#:*TREDLH"91V""D).M7W]_ON.I?RLA$87L XS+W/N M6Q[="=)KS\RO(T\&YU&$U@++.*$*:H6\3CXJ*9%&3IX+]>GIX*.Z Y5$>O82 M6YUF@7F(!,$>" TI]%X"(P#C@NIHI$#S^F.:6DOXZ%W'UFCV.:5^Q';E:G'A MBRR[7OQL>)'E:*N@/9*0<@$01A(CH&"4(#3$$$4]/ZNC]SS,=#-Q'=F1KD.> MOK/P4H-(GFAS20&)! X MX" :^M@*AIQG3#NP'T1*P3?4,5.YF=V\7EXT1W(0M2\Y.":B]!%IXP9.(3'8 M4*^\L, @IC@"-I7*.L?3P899+\' \6:!:08PB-:X=HX29Z43D4&,1B5&.PRG M<\.@$VD?FY#MD1UD@EXNLU3W,U3Y="U0,I $Y(&1"A&J,774.>C=N;HN?7M+ MJJ[?AQQE>$Y.OR)XX;6U2$#$7%0)F, ,6J@)9DAJ@#)+M+ZRF5N;!4<]*IVB MW.\L7F^V=1LO[%VY[T7-Z?ODZ6 \H(H#C+%T*4@< ^,AE(!AA+B@YP[;^YZV M[M]WB\W/WXK-MW+^H/MGTX74>D' $AMIN(Q[#9"$0Q^WF_W@HS(_G11PK21_ M=*IVB.T YI&>W9M$F:1V^L[WL2:!"J.H L"8N/18)9%.5RMV M@V.29II-(R1.U\(N>P'X0NPYFW;D>*. N&%.L6A=,L(\@0X0N!\@H/;U7S;K M3L0U.),%Z@"L43^B9I!FR-=RM9[=%)^*J[O5Z4ML=9L&P16AJ8P?-LQ@YZT6 MK_-YN"@ M=H I@C#9#U'%'R9S>M #?[K#=8B[DN?V\+=U[E#6?DF GAO /6-$8N_C/#): M[P%(P7Z3(5;/RE%OD ^U7'W^-EM^+F[3S9[5S\?U'8OU@W%\2+5;RN7'*H+Y MS=+-5LO%\CK5"3J^5I];^/K^_D!!-*&LXI1+*E(]79 "I^YW"3^E#(,]4/&E M)75D$AM@HIARO7F&Y@EBO_A\L%H1*'5$'1K/N!-,NOVP$,69Q[NO<PQ[CBI'$',H,XQDA+$! Y"G&XP'NV.3 M%E8?<6I.IEKMDX^10.:M@T [:)%WMEIN@,E M[-3+ G*.J@@"Y4QJPK2WJG(S220S=;0Q7G.]U.K6(?P#W7>=W22=\>^SQ3)- MI_?+9L=H-=\050:G,(),"VBMCO,2F6KHAHG,*K)CO,?:/_/ZP7Q(#[ O5Y^B M+;)#Z&"1W!9)[=2S]SI=]&W#T'K?$!"F@F$?%PGBG2=<&ETY4;T! MF;0=H4%[<=KV(I!17VUNE\\^_,*7;R.4"E#X,Z>D0&[#V^$N"$Y)YS!EPE&MD/2.T.N3$A&;> MJ1ZA=3XT(SO#? #2?5[-ENLHK5WDY7G'SXO/!P>LCN,QC!@/HU*?:K=5R%F4 M2:416ME]4ZD+>"]O1>=;SP% "P$0UAAF!924*27V0Z4HM_;["*WFOIG4+="# M1%)?],)2NSAJ[+3AFF/,+*"2&RV$0,#$SP!'RIYS]O1WN*B6\R->F6:WEAJ_ M*WAEF=,8QKW.4&.@,()S3*QS1#LZH0+;K?CPPNECGS /,H\O>Z^IY416E$!F M<907HP(IX3#BGGHD.'9*7>:FX9FUO/9EID;O"= C1A!,F2D])3Z5@Y "ZJA^ M0&[0I,K>M>!!LVVW%<3]3=Z/L7^KNZM--%.6U^;;;'5]T:PQ+W6GQGP^U2QX MQ*7WCA!/H)":6^L\=LY*R[F(/U]D8A^.3A[U/>X 'XNM!R/M!PVN.YU]2S * M D&9!PAY!+$BA*$]#(BJZ50[Z(8,1V,RNT9Z */M,2([12-^5JQ^G"U^>;IE M@-0[23GCFN&T;G&OJZ$"(:9SRM2+_)_63>P4["%<2/&+G@!R]FK4T39!.J.] M-(09(A7Q#@)&]\/#]JP"]GJXU)F:=U\Z[_= \R2W!,4+6="#=IU$]G4 Z2*ST,7?/F*Y O:S.\[;&M: M:& ]]IR9U/Y /.^DO%SG2QZS7S%NCI,7:P51H M22$F+):((F: @Y<)"JOIQ&F4&K?6FT+*C4Z4-M0Q0JWUDALI@"$,4T&B ?YK MS/7:I,@[>LY$N[]I_JFX3I;1F^77"0:TPO5!CL26^;[=TU6@>@$-[F:51:4T:%($P3 M&@>NA"7&92:9&>'T;2_XIU.WR<%LA8; MQIF@\MSNT_=F_+3?#P2@?][_L7X<6.VW!1$Y!ZB V&.C/"%&ZPH6C-ETPBW: M$^/HAMP7VD,DA]Q7_M5WZT4JCGC?W?69B+"3[0+BDG*4TCP P!&/(U75,(V; M9&*\'CCPE&\=0CX$LW:].QL)]NBY0)T%U%$H)-4**>B A?MA )5[G#5&YG0C MS98?YK2RMU@F"/L3]^+JT5<.GY^NEH4RZL3Q0A./1X0B7V$ M0G"DM+4 QO^G^XXB03/O=X[P>+<#87>#X1 Y2&YNMOG\]MK(^3H5+S8(1%B> M+K7BUNDJ&3CJ7/TN1T MPZ 1$!AQ@8E"0C(BA935HI>=P'J$61^ZH4NG: YG"[YD'+^M4WRB1O, @4$^ MPHD5,W'L0"-Z@F>&S8]0PA_0Y=(_\$'2;W13KC\6/8GE7G"Z&_>3)(+R7 ML>,*(6T;V(R^JN M[M,IY?ADPT"II9I:1X W0!H#L:A6909)9D!$8W/YU9.H4YB'X--9WNPZ'LFO M.<0(2\T8X=X)I*M=F[&A JA?/S]RX!SRB/UR86]=GK [Q4G)_S=EW7Q[[O8UJ7B]I<,J'G:A%314%M%,/2 .4RM M] Y1!3S%SH)+!=0\[NW9B)D7'@]6,Z2P9$JCJ(@RK1VC^X%A22=D!+86[=.) MVA[.(=P#3WH9O_= J6B8ZCDQ$0X4;;3B4^\$AQC-SJH_1H=WCXI(+YV#*X$G3[[X'+;[K]G:V M^AGUYL7U[^;C__U(1C;O_[,LJV/!K=&FEVE=Y>)<>7JQ!)UND$ 6*3K M^CYR@5#$N636*: ]]%1RB/!E;.4]9\Y:R8\>#)A$S4TR U*^.,2E$$BD^NF6 M,LRA>?UYP;L2YK$ _AP8A\C&F49Y&/9ZN]HLRM6';?8+-?_ON_LDYND"ZCYZ M_>>#7^X?7,[5;9JR9XSJ/KXN2"^=T(ZF2[64""R,@)@2$'4]+CB7@A#'+@=QN'+U9,QGS7I:[0.T8XPPBGKM'?4 B0=)\HA;K6#&KG,2N3$4^\&2@^77S>S/TU'5)QL%K:167&NBA:*&'UT*E3"98]X=N:%,MBTY02CYL$ZEA4,!3TL:M4HA3.Q^-, M488"I?'9!$*OQQDT#"%:H3ODM=Q:'L1G#P+[3;&>DE^8,DX-4SPN )HR M*Y6W7AJ3Y*X@1Y=)O'?OO7K2[9^[_];QYM9[00!6,T\YQ"#EJR%08\V%T(1P MKJ&FTS%*NB! .0#$ ^P2C_S%]1EUJEF@4AG% <9Q3!1[&O5DS3VE&A*@@1XJ MV/U5\JA#8(=PE%0 [#:(M%4\M?CKT*G1>P*A4#,J(KA>4!GU>>*5AMP +Q4R M,#,YP BOC?? KSZ1'H!PMEA?K1;?=Z=9[XH_'NHCY3+^>%7L2T/_5[%1\_+[ MIIB?(%[6^R+X4BJ./#&840>5U%8+@#@3S&.),ZWK$5YE[X& 0R!^6F'^7_^1 M'OTR6Q?_^__YOU!+ 0(4 Q0 ( $N+:DE#\>\Z_ED" &"P+@ 1 M " 0 !P&UL M4$L! A0#% @ 2XMJ22Q?=1(KY [<8+ !4 ( !0Q4# M '!R9V\M,C Q-C$P,#%?;&%B+GAM;%!+ 0(4 Q0 ( $N+:DG<+L%279X M "KA!P 5 " :'Y P!P

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end XML 87 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 88 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 90 FilingSummary.xml IDEA: XBRL DOCUMENT 3.5.0.2 html 474 317 1 true 108 0 false 6 false false R1.htm 0001000 - Document - Document and Entity Information Document Sheet http://www.perrigo.com/role/DocumentAndEntityInformationDocument Document and Entity Information Document Cover 1 false false R2.htm 1001000 - Statement - Consolidated Statements of Income Sheet http://www.perrigo.com/role/ConsolidatedStatementsOfIncome Consolidated Statements of Income Statements 2 false false R3.htm 1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income Sheet http://www.perrigo.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome Condensed Consolidated Statements of Comprehensive Income Statements 3 false false R4.htm 1004000 - Statement - Consolidated Balance Sheets Sheet http://www.perrigo.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 4 false false R5.htm 1004501 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.perrigo.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 5 false false R6.htm 1005000 - Statement - Consolidated Statements of Cash Flows Sheet http://www.perrigo.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 2101100 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.perrigo.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 7 false false R8.htm 2102100 - Disclosure - Business Acquisitions (Notes) Notes http://www.perrigo.com/role/BusinessAcquisitionsNotes Business Acquisitions (Notes) Notes 8 false false R9.htm 2103100 - Disclosure - Goodwill and Other Intangible Assets Sheet http://www.perrigo.com/role/GoodwillAndOtherIntangibleAssets Goodwill and Other Intangible Assets Notes 9 false false R10.htm 2104100 - Disclosure - Accounts Receivable Factoring (Notes) Notes http://www.perrigo.com/role/AccountsReceivableFactoringNotes Accounts Receivable Factoring (Notes) Notes 10 false false R11.htm 2105100 - Disclosure - Inventories (Notes) Notes http://www.perrigo.com/role/InventoriesNotes Inventories (Notes) Notes 11 false false R12.htm 2106100 - Disclosure - Fair value measurements (Note) Sheet http://www.perrigo.com/role/FairValueMeasurementsNote Fair value measurements (Note) Notes 12 false false R13.htm 2107100 - Disclosure - Investments (Notes) Notes http://www.perrigo.com/role/InvestmentsNotes Investments (Notes) Notes 13 false false R14.htm 2108100 - Disclosure - Derivative Instruments and Hedging Activities (Note) Sheet http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesNote Derivative Instruments and Hedging Activities (Note) Notes 14 false false R15.htm 2109100 - Disclosure - Assets Held for Sale (Notes) Notes http://www.perrigo.com/role/AssetsHeldForSaleNotes Assets Held for Sale (Notes) Notes 15 false false R16.htm 2110100 - Disclosure - Indebtedness (note) Sheet http://www.perrigo.com/role/IndebtednessNote Indebtedness (note) Notes 16 false false R17.htm 2111100 - Disclosure - Earnings Per Share Sheet http://www.perrigo.com/role/EarningsPerShare Earnings Per Share Notes 17 false false R18.htm 2112100 - Schedule - Accumulated Other Comprehensive Income Sheet http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncome Accumulated Other Comprehensive Income Uncategorized 18 false false R19.htm 2113100 - Disclosure - Income Taxes Sheet http://www.perrigo.com/role/IncomeTaxes Income Taxes Uncategorized 19 false false R20.htm 2117100 - Disclosure - Commitments and Contingencies Sheet http://www.perrigo.com/role/CommitmentsAndContingencies Commitments and Contingencies Uncategorized 20 false false R21.htm 2118100 - Disclosure - Collaboration agreements and other contractual arrangements (Notes) Notes http://www.perrigo.com/role/CollaborationAgreementsAndOtherContractualArrangementsNotes Collaboration agreements and other contractual arrangements (Notes) Uncategorized 21 false false R22.htm 2120100 - Disclosure - Restructuring Charges (Notes) Notes http://www.perrigo.com/role/RestructuringChargesNotes Restructuring Charges (Notes) Uncategorized 22 false false R23.htm 2121100 - Disclosure - Segment Information Sheet http://www.perrigo.com/role/SegmentInformation Segment Information Uncategorized 23 false false R24.htm 2201201 - Disclosure - Summary of Significant Accounting Policies and Change in Accounting Principles (Policies) Sheet http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesAndChangeInAccountingPrinciplesPolicies Summary of Significant Accounting Policies and Change in Accounting Principles (Policies) Uncategorized 24 false false R25.htm 2302301 - Disclosure - Business Acquisitions (Tables) Sheet http://www.perrigo.com/role/BusinessAcquisitionsTables Business Acquisitions (Tables) Uncategorized 25 false false R26.htm 2303301 - Disclosure - Goodwill and Other Intangible Assets (Tables) Sheet http://www.perrigo.com/role/GoodwillAndOtherIntangibleAssetsTables Goodwill and Other Intangible Assets (Tables) Uncategorized 26 false false R27.htm 2305301 - Disclosure - Inventories (Tables) Sheet http://www.perrigo.com/role/InventoriesTables Inventories (Tables) Uncategorized 27 false false R28.htm 2306301 - Disclosure - Fair value measurements (Tables) Sheet http://www.perrigo.com/role/FairValueMeasurementsTables Fair value measurements (Tables) Uncategorized 28 false false R29.htm 2307301 - Disclosure - Investments (Tables) Sheet http://www.perrigo.com/role/InvestmentsTables Investments (Tables) Uncategorized 29 false false R30.htm 2308301 - Disclosure - Derivative Instruments and Hedging Activities (Tables) Sheet http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesTables Derivative Instruments and Hedging Activities (Tables) Uncategorized 30 false false R31.htm 2309301 - Disclosure - Assets Held for Sale (Tables) Sheet http://www.perrigo.com/role/AssetsHeldForSaleTables Assets Held for Sale (Tables) Uncategorized 31 false false R32.htm 2310301 - Disclosure - Indebtedness (Tables) Sheet http://www.perrigo.com/role/IndebtednessTables Indebtedness (Tables) Uncategorized 32 false false R33.htm 2311301 - Disclosure - Earnings Per Share (Tables) Sheet http://www.perrigo.com/role/EarningsPerShareTables Earnings Per Share (Tables) Uncategorized 33 false false R34.htm 2312301 - Schedule - Accumulated Other Comprehensive Income (Loss) (Tables) Sheet http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossTables Accumulated Other Comprehensive Income (Loss) (Tables) Uncategorized 34 false false R35.htm 2320301 - Disclosure - Restructuring Charges (Tables) Sheet http://www.perrigo.com/role/RestructuringChargesTables Restructuring Charges (Tables) Uncategorized 35 false false R36.htm 2321301 - Disclosure - Segment Information (Tables) Sheet http://www.perrigo.com/role/SegmentInformationTables Segment Information (Tables) Uncategorized 36 false false R37.htm 2401402 - Disclosure - Summary of Significant Accounting Policies and Basis of Presentation Policy (Details) Sheet http://www.perrigo.com/role/SummaryOfSignificantAccountingPoliciesAndBasisOfPresentationPolicyDetails Summary of Significant Accounting Policies and Basis of Presentation Policy (Details) Uncategorized 37 false false R38.htm 2402402 - Disclosure - Business Acquisitions (Details) Sheet http://www.perrigo.com/role/BusinessAcquisitionsDetails Business Acquisitions (Details) Uncategorized 38 false false R39.htm 2403402 - Disclosure - Goodwill and Other Intangible Assets - Goodwill (Details) Sheet http://www.perrigo.com/role/GoodwillAndOtherIntangibleAssetsGoodwillDetails Goodwill and Other Intangible Assets - Goodwill (Details) Uncategorized 39 false false R40.htm 2403403 - Disclosure - Goodwill and Other Intangible Assets - Intangible categories (Details) Sheet http://www.perrigo.com/role/GoodwillAndOtherIntangibleAssetsIntangibleCategoriesDetails Goodwill and Other Intangible Assets - Intangible categories (Details) Uncategorized 40 false false R41.htm 2404402 - Disclosure - Accounts Receivable Factoring (Details) Sheet http://www.perrigo.com/role/AccountsReceivableFactoringDetails Accounts Receivable Factoring (Details) Uncategorized 41 false false R42.htm 2405402 - Disclosure - Inventories (Details) Sheet http://www.perrigo.com/role/InventoriesDetails Inventories (Details) Uncategorized 42 false false R43.htm 2406402 - Disclosure - Fair value on recurring and non-recurring basis (Details) Sheet http://www.perrigo.com/role/FairValueOnRecurringAndNonRecurringBasisDetails Fair value on recurring and non-recurring basis (Details) Uncategorized 43 false false R44.htm 2406403 - Disclosure - Fair value measurements - level 3 roll (Details) Sheet http://www.perrigo.com/role/FairValueMeasurementsLevel3RollDetails Fair value measurements - level 3 roll (Details) Uncategorized 44 false false R45.htm 2406404 - Disclosure - Fair Value Measurements Fair value measurements - items not carried at fair value (Details) Sheet http://www.perrigo.com/role/FairValueMeasurementsFairValueMeasurementsItemsNotCarriedAtFairValueDetails Fair Value Measurements Fair value measurements - items not carried at fair value (Details) Uncategorized 45 false false R46.htm 2407402 - Disclosure - Investments (Details) Sheet http://www.perrigo.com/role/InvestmentsDetails Investments (Details) Uncategorized 46 false false R47.htm 2408402 - Disclosure - Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities - text links (Details) Sheet http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesDerivativeInstrumentsAndHedgingActivitiesTextLinksDetails Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities - text links (Details) Uncategorized 47 false false R48.htm 2408403 - Disclosure - Derivative Instruments and Hedging Activities - balance sheet location (Details) Sheet http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesBalanceSheetLocationDetails Derivative Instruments and Hedging Activities - balance sheet location (Details) Uncategorized 48 false false R49.htm 2408404 - Disclosure - Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities - other comprehensive income movement (Details) Sheet http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesDerivativeInstrumentsAndHedgingActivitiesOtherComprehensiveIncomeMovementDetails Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities - other comprehensive income movement (Details) Uncategorized 49 false false R50.htm 2408405 - Disclosure - Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities -Fair value hedges (Details) Sheet http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesDerivativeInstrumentsAndHedgingActivitiesFairValueHedgesDetails Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities -Fair value hedges (Details) Uncategorized 50 false false R51.htm 2408406 - Disclosure - Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities- Non-designated derivatives (Details) Sheet http://www.perrigo.com/role/DerivativeInstrumentsAndHedgingActivitiesDerivativeInstrumentsAndHedgingActivitiesNonDesignatedDerivativesDetails Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities- Non-designated derivatives (Details) Uncategorized 51 false false R52.htm 2409402 - Disclosure - Assets Held for Sale (Details) Sheet http://www.perrigo.com/role/AssetsHeldForSaleDetails Assets Held for Sale (Details) Uncategorized 52 false false R53.htm 2410402 - Disclosure - (Details) Sheet http://www.perrigo.com/role/Details (Details) Uncategorized 53 false false R54.htm 2411402 - Disclosure - Earnings Per Share (Details) Sheet http://www.perrigo.com/role/EarningsPerShareDetails Earnings Per Share (Details) Uncategorized 54 false false R55.htm 2412402 - Schedule - Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Details) Sheet http://www.perrigo.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Details) Uncategorized 55 false false R56.htm 2413401 - Disclosure - Income Taxes (Details) Sheet http://www.perrigo.com/role/IncomeTaxesDetails Income Taxes (Details) Uncategorized 56 false false R57.htm 2418402 - Disclosure - Collaboration agreements and other contractual arrangements (Details) Sheet http://www.perrigo.com/role/CollaborationAgreementsAndOtherContractualArrangementsDetails Collaboration agreements and other contractual arrangements (Details) Uncategorized 57 false false R58.htm 2420402 - Disclosure - Restructuring Charges (Details) Sheet http://www.perrigo.com/role/RestructuringChargesDetails Restructuring Charges (Details) Uncategorized 58 false false R59.htm 2421402 - Disclosure - Segment Information (Details) Sheet http://www.perrigo.com/role/SegmentInformationDetails Segment Information (Details) Uncategorized 59 false false All Reports Book All Reports prgo-20161001.xml prgo-20161001.xsd prgo-20161001_cal.xml prgo-20161001_def.xml prgo-20161001_lab.xml prgo-20161001_pre.xml true true ZIP 92 0001585364-16-000426-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001585364-16-000426-xbrl.zip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�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